>AAS90622.1|FEATURES|farme|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MPSMADDDDTPFDRRSMPCRAVGVLADTFWRMPGVLRSDSPHAFAAIGPQAERITLPHPVDVPHGLGSPPGRVYELGGQVLLLGVGHDANTTIHVAENIAGVRYRQAKHATVLEGGRPKRYEYGETDHCCENFRLLDDWLEAEGRQRLGRVGNAEARLARSRDIVSAALERLRRNETVFLHAGGSCGECDTARAGAVPFGA
>AAS90620.1|FEATURES|farme|aminoglycoside|DF40_017605|antibiotic inactivation|1
MSNELHLPTTLQPYLQHMTPEPIFDGYSGAKVWRWTGQNPTLYLKVDTDLRREKDCLMWLKDEIAVPQVVAWHKTPTAHYLLMTEITGIDATSFEHDPATCVRLMAQGLREFHAIPMANCPLDRRLDVVIDAARANVEQGLVNANDFDSQRLGRTAVDLYAELLATRPASEDLVVVHGDYCLPNIFFAGGRVSGFIDVGRAGVGDRYIDLALAVRSILYNLGDDPQWIDLFFAEYGISTSEIDWAKVEYFKLLDEFF
>AAS90609.1|FEATURES|farme|aminoglycoside|AAC(6')-I30|antibiotic inactivation|1
MSENPAIHIQDLTADDETAIQQVAAMLTEGFREHWWDAWPTLEEAVEEVRESFTEERISRIARDSSGAILGWIGGQPTYAEVWELHPLVVRVDQQRRGVGRLLVADLEQQVKERGGLTLMLGSDDQDEMTSLSGVDLYPDPWPHIAKIQNFKDHPYSFYQKLGYAIIGVVPDANGFGKPDILMAKRLA
>AAS90626.1|FEATURES|farme|aminoglycoside|AAC(6')-I30|antibiotic inactivation|1
MQITNVPHGNAEIVNQMAELLIVAFREHWDAWATKPEALDEIQMILGKGFIRVALDDAGQKVLGWIGGLPEYDGNVWELHPLVVQPEHQFQGIGRALVADFEQQAAARGALTITLGSDDEDDMTSLAGVDLYDGLPDKIANIRNLKRHPYEFYLKCGYRIIGVVPDANGRGKPDIILGKRVESRP
>AAS90617.1|FEATURES|farme|aminoglycoside|AAC(6')-I30|antibiotic inactivation|1
MKIASLSRDDSHLIEQVAQLLVDAFREHWPDAWPTLNEALKEVHEMLESERICRIALDEQGHLIGIIGGIPGYDGKVWELHPLAIQPSLQGKGIGAALVDDFEEQVRMKGGLTITLGSDDEDNMTSLSDVDLYENLWEKIRDIRNLKKHPFEFYQKMGYVITGVVPDANGRGKPDILMGKKI
>AAS90627.1|FEATURES|farme|aminoglycoside|AAC(6')-Ii|antibiotic inactivation|1
MIPQFTISNLPSDDTDAVEQCAALLVEGFKQHWPAAWPDLDSARKEVHEMLAENRICRVAVDREANVIGWIGGIPEYDGNVWELHPLVVKPEQQQQGIGRTLVIDFEAQVQARGGLTIRLGSDDEDGMTSLSNVNLFEDTWEQIAGIENLKGHPYEFYQKCGYVIVGVVPDANGPGKPDILMAKSVRRPGETRW
>AAS90614.1|FEATURES|farme|aminoglycoside|AAC(6')-Iih|antibiotic inactivation|1
MEITTLTSDNDRLIHQAAQLLVDAFREHWPDAWPTMEEGLKEVGEMLETGRICRVAVDEKGSLLGIIGGIPGYDGNVWELHPLAVQPLLQGQGIGQRLVEDFEVQVRSKGGLTITLGTDDEDGMTSLANTDLYENLWEKIRDIRNLKGHPFEFYQKIGYIISGIVPDANGPGKPDILMAKRVR
>ACN18084.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MFQIYERNERSFGARRFNVKKEEHLSIPKNEEPNLTRRVILKTAGAAVIAGWTSSAAFDTMASAEETPAISAAQQNNGSLGARLQGVQHFGLTVQNMDRAFAFYTEVLGGTEIMRDGDFQGELIHNTLLTDQEIEARSRQVNPRTMGIPDLKGGAQRLDVRFIQFDNVVIELLQYRDADQPTGGGVSFAEPLDHMSPAFPRMMHICFHIRDDVDFNKFIADLESESARRGMTQVKSNRIITVKSEQERRAAPIEANSNGISEGKSNGWRLIYCKGPEGEQLEFVQALGPVKRIFDNAREARRKAGSR
>ACH59002.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MKTIFGKRRQSAVVLITLIAILLASGQPYQSSQVRGAACLPDIIFDEPSQGPEKNEAISMLTERLSSIINAAGGDIGIAVIHVETGHTTAIQGTTQLPLYSVFKLPLAIAVLKEIEENRLQLDRKVRVTPADVAPGWTANAAMWRRPIDRTVAQLIEVSIIRSDNTSSDKLLQLVGGPAAVTHRMRALGFPNIEIVSTVREFSENRTRPNTGSAEDLARLLVQLQKGELLQPQHSALLLGFMHRATTGTERLRGSLPVGTPVADKTGTGDAGVVTNDVGIITLPKGQGHLAIAVLISGSKLSPAAQEKLIAEIARAAYDAHVSRAE
>ACH58998.1|FEATURES|farme|beta_lactam|LRA-7|antibiotic inactivation|1
MRSKFLLATALVLSTAFTADAADAPKRLPVNITNQDWLKPFPGFKIVGNMYYVGTYDLGCYLIDTGAGLILVNTGIMGSYPLMKASIESLGFKTSDIKIITATHGHSDHVADMASFKKDAPSAVVYMSERDVESLESGGNFDYRRPAPEGRGGLVYDPIHVDVKTKPGDHIKLGNVDMTVLQAYGHTPGATSFQFQQTDAGKTYNVMIVNMNGINAGVKLLGSPKYPTIVEDFKNTIDMQATYKPDIWVSSHAGQFNLHQVYKPGDAYNPARFGDQAAYQQKIATAKANYEKQLAEERAAAK
>ACH58994.1|FEATURES|farme|beta_lactam|LRA-17|antibiotic inactivation|1
MSIFRTILFVSILLLTSLANSPHATAQVTNTDRPEWSKPYKPFRIAGNIYYVGTYDLACYLITTPQGHILINAALAGTVDQVKANVEALGFKFSDIKILLISQAHFDHVGGLAAIQKMTGAKVMIDDQDAPVVEDGGNSDYIYGGKGVGSLFAPVHVDRKLHDHDNITLGGTQLEMLHHPGHTKGSCSYLLTVKDEHRSYRVLIANIPYMLSEVTLPGMPTYPNVGKDFMYTYGAMRKLQFDIWVAAHSSQFGLQDVRKETDGYNPGAFGDKKKYLTTIDKTEDIYKEHFKGGK
>ACH58991.1|FEATURES|farme|beta_lactam|LRA-13|antibiotic inactivation|1
MNFRHIVMAALCGLAWTPAIHATEVCIAIAEAGTGAVLVQRGDCQRQVTPASTFKIAISLMGYDSGFLKDAHAPKLPFRPGYVDWRPSWREPTDPAKWMSDSVVWYSQQVTKSLGMQRFADYTRNFKYGNADVSGDAENDGLSMSWISSSLRISPLEQLAFLDKIVNRRLGVSAHAYDMTAQLTKFDQPPAGWRINGKTGAASGYGWYVGWASKGSRTFVFAHLMQRDATQPQDVSAGVLARDEFLKELPGLMIKDMVDRAVQPLMKKYDIPGMAVAVTDNGKNYFFNYGLASRETGQAVTSHTLFEIGSLSKTMAATLTSYAQVNGQLALTDTVSRHMPKLRGGGFDKISLLNLGTHTAGDFPMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAMENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRFVDANMGLVKLDEKLQRAVTGTHTAYFKTGELTQDLIWEQYPAASKLDRMLAGVSEKMVFESNPATRLAPPMPPQADVLINKTGSTGGFGAYALFNPGKKTGIVMLANKSYPGAERVTAAWHILDQLDQR
>ACH58992.1|FEATURES|farme|beta_lactam|WS86_03395|antibiotic inactivation|1
MMPSDVLALRFLLASCGSVAVGLVVWALLAVCRRCLPEFSLQRSTWLLSQMTVVAAFLVILLPHSERLRLIPPIDLPGAAAAHPAGPDKTGAPASAASQAGAVSAEVDYRAWLASGAQAWLLLYPLGLAYALARLWRARRTLNGLAAAGRRLSALNRHDGFTAPGTRPPALAVIEVDAPISPMLFGLFHPRLLLPRHLRSFEASQQQMIVEHELTHMRRHDLQWMCIGLLLQTLLWFNPCMRLLRARLSWAQELGCDRDVLRGRPQTERKAYAAALVAQLKLQHRQVNAALAFGGVSASTVAARIGLIREPAAASRGPWARCAALAGLAAVFAASLAFQPAFAWRIAPLSRAAPAATETLFSCTEMADADSGRRLVHDGHCDERVTPASTFNIAVSLMGYDSGILRDEHTPRLPFKPGYTDWNPSWRAATDPTSWIRNSTVWYAQQVTSQLGAERFQRYVNSLNYGNRDVSGDPGKDNGLAMSWIGSSLKISPVEQVAFLRSMLNRKLPLSAHAYEMTVRLTELDTLPNGWEIHGKTGTAAPVLANGRDDEMHRYGWFVGWATKGRRTVVFARLVLEDRRQAAAGIRTKNAFLHDLPAQLDAL
>ACH58987.1|FEATURES|farme|beta_lactam|LRA-3|antibiotic inactivation|1
MKSKLLLAAALAALAGTSMAAQAAELQYKPPPITNKEWETPFPGFKIVGNMYYVGTYDLGCYLIDTGAGLILINSGADGSYPLIKANIEKLGFKTSDIKIITSTHGHGDHVGDLAAFQKDAPAAKTYMNFRDAPTIESGGNIDYRRPEGRGFYPYHPVKVDVRTKPGDHIKLGNTDLTLHQAYGHTPGATSFTFTVQDGGRNYNVLIVNMNGINAGVKLLGSPGYPTIVEDFASTLKEQATYTPDLWVSSHAGQFNLHQVYKPGDPYNPARFGDLAAYKLKIANATKAYEKQLAEERAAKAK
>ACN58748.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MPRWVWRVLPMPSVLATRKPLLSRQIDGPSGPVSIHQGGSGTMEKFIDRLIRQFESGALGRREFCQMLGIAAAITAAGGAEANAAPAGRGFKGLGVNHVSYVCPDYTKARDFYSSMFGMQVVNDKGKGRANLAFGPAPDKGGNFLVVHNPGANPPKPSEAIIDHVAYTISNWDEGKVRGALKAKGFDKPTGRDGSLHVYDPFDYDVQIANAVQENAFRRGA
>ACN58749.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MESFYATKIDEFAKGKISRRALLESLTVAVTTTAATASTAANAAASDPALKVALVNHISYNCPDFKKGADWYSKVFSLDQIGTTKIDTALPFGKKGEKPFGVTAGDVPLTSIIVRTRDLNAPAQGGGAPRRKSQALIEHMGYTVADFDREKAKVQLKALGVENVRDGGLYSLHMTDAFGYDVQISGIANNALSDGA
>ACH58980.1|FEATURES|farme|beta_lactam|LRA-1|antibiotic inactivation|1
MNPPIHRRTLLLAASVLPLASACTAWSAKGPQQDASAQLAALEAASGSRLGVVGFNTATGARVQHRAEERFPFCSTFKLMLAAAVLERSAKEGDLLARRVNYSKGDLVSYSPITEKNVATGMTVAELCAATVQYSDNGAANLLMKILGGPSAVTAFARASGDEVFRLDRWETELNTAIPGDLRDTTTPAAMAASVQRLVLGNALGAAQREQLKTWLLGNTTSTQRFLAGVPAGWKVGDKTGSGSYGTTNDVGVLWPPAGAPLVLAVYLTFPQKEAKGRSDVVASATRIAVSALAS
>ACH59005.1|FEATURES|farme|beta_lactam|LRA-19|antibiotic inactivation|1
MNSEMSQTSFKIRILVTCLLSIAQLTMAQQVQVTEPPITNQDWVKPYPPFRIVGNLYYVGTYDLACYLIVTPQGNILINTGLASSAPMIEASIKALGFKFSDTKILLTTQAHYDHVGAMAAIKKSTNAQLMIDEKDSPVMADGGSSDYELFGSTGSTYEPVKADRLLKNGDKITLGGTTLVMLHHPGHTKGSCSFLFDVKDESKSYKVLIANMPSIITSKKFSDIPTYPGIAEDYTYTFDAMKKVHFDIWLSSHASQFGMHSKHKPGEAYNPGVFIDRAGYDKAVGDLEDKFSKKKQADK
>ACH58999.1|FEATURES|farme|beta_lactam|blaLRA-10|antibiotic inactivation|1
MAIAILSSCFAPLASRAADDSARIRAIVDQAIRPVMAEHDVPGMAVAVTVDGQPFVFNYGVASRESNTPVSDATLFELGSISKTFAATLASYAQVTGKLSLDDHPGKYMPQLKGSAIDKATLLNLGTYTAGGLPLQFPDDVSDQQMASYFQHWKPKAAPGVQRTYSNPSLGLFGHLTSLALKSRFTDALETNVLTQMGMKSTYVHVPQSAMANYAWGYDQANKPGRMNPGVLADGIYGIRSTAADMIRYVQANIAPGKLETPLRRAVEGTHVGYFKVGGMVQGLGWEQYPYPVSLQQLQAGNSTTMAWEANPAQKLTPPSVPSGATLFNKTGSTSRFGAYVAFVPEKKIGIVILANKNIPGPDRIKAAHAILEQL
>ACH59000.1|FEATURES|farme|beta_lactam|WS86_03395|antibiotic inactivation|1
MSPADLFVFRFLLASCGCLAAGLGAWGVTALCGRWLPGIAMQRSVWLLGQVTVVAAFLLILLPHSERLRLVPPIDLAEVTATRAAAAATTAAAASAALPASTPDAGAADRSWLVDGARAWLLFYVLGLGYSIATLVQARRMLNGLAAAGGRLPALDRHDGFAGAPAPTPEVIEVDAPISPMLFGLLRPRLLLPLHLRSFEASQQQMIVAHELTHLRRRDLHWMSAGIVLQTLLWFNPFMRLLLARLSWAQELGCDRDVLHGRPAAQRKAYAAALVAQLKLPASPVASALAFGGASASTLAGRIALIRDPAAARQGRWTRVAVIGGLAGILAASLAFQPALTATPPVLAAISCTELADAASGTRLLREGQCDTRITPASTFNIAVSLMGYDSGILADEHAPALPFQQGYADWNPEWRATTDPASWLKYSVVWFAQQITSRLGAARFQGYVNSFNYGNRDVSGDAGEGNGLTQSWISSSLKISPAEQVDFLRNMVNRQLPVTARAYDMTFRIMPSETLANGWEVHGKTGTASPVLPDGRDDAEHQYGWYVGWASKGQRTIVFARMVLDRRQQGFAGGRAKAAFLRDLTTRLDSL
>ACH58990.1|FEATURES|farme|beta_lactam|LRA-12|antibiotic inactivation|1
MNVQNCMVKAVSVSIILFASLSLAAQKVKEPTVSNADWSKPYRPFRIAGNLYYIGTYDLACYLITTKQGNIIVNTGLAASALQIKNNIKALGFKLTDTKILLTTQAHYDHLGAMAEIKKITGAKLMADEGDATVMADGGSSDYAFGGHGSMFEPIIADRLLHDKDTIQLGDTKLVMLHHPGHTKGSCSFLFDTKDEQRSYRILIANMPTIVIEKKFSEVSSYPGIAKDYAYTLQAMKNLSFDIWVASHASQFSMHSKHKPGDGYNPKSFMDRKGYDESLDKLQKEYEKHLNEN
>ACN58756.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MLPKVSSIGQIAITVADVPTALGFYRDVLGLDFLFSPAPTLAFLASGDVRIMLSTPQGAGAVGANSILYFKVMDIESAHAAFVARGARADEAPHLVAKMPDHDLWLGFLRDPDGNLVGLMEEKRR
>ACH58985.1|FEATURES|farme|beta_lactam|LRA-2|antibiotic inactivation|1
MMDGIKKKTAAGAAAGSLLMMLGVFATPAAGGEAAFKDCPQCAQWNQQRKPFRIYGNTYFVGTAGLSSILVTSDYGHVLIDGGLAQSAPLIKANIEALGFKLTDVKAILVSHVHPDHAGGVAELQRQSGAQVYALRTAEAVLRTGRLTQDDPQSASKTATITPVPQVWVVQDDQLLGVGALRMRAIATPGHTPGGTSWTWDACEDGNCLKMIYADSLSAVAAGKYRFKDHPEVLQAFASSFSRAESAPCDVLLTPHPDASQLFQRLDPEGGTRAASIKDDTACRRYVQAARDTLARKLASEG
>ACS83703.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
MPSNPTLMPYPDIILVNGSSSSGKSTLCRALQARILHPYLCIGFDDFVFLSAPRYYRGADTSRQALADDFTAQGVQMISDTQPGTPPCVTAQFGPVFRHIIDSMAPAVRALVDGGNSIIFDHVLHDRGMVESCRRVFEGLDVFTVGVTCPIEILEARERSRGDRVIGRARGLVNVVHSFCDYDVWVDTASDDVDSCVNKVIAAMASTNSRKWSSP
>ACS83714.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MHQWPAKSVNMRIENTSASALPTLREELVQLADDDYQAHNDEDLFYDAAKGDTDAFGELVRRNYGIVYAVGLARLGQRDEAEDLAQEVFLRAFLLLDRLDDPAKFPHWLTRIARNLSVDWQRRGTRAKRLVSMVPMTGLELPASTTDARDAASLSEQNAALQTALDGLAPPQREIILLHYMEGLSHGEIALRLAVARSTVSRQIARAVDAMRGFVDANLKESTAQLRPRKGAAGRTLSILVAVTTLSAKSRNSLAAQANFPIPGNAVPSQEAVQLWNEIKSLFWSGARRLLFKTAMAVGAVGVIVPLGYWYCESPAQAVQNATPQASPGAAPSPGGPKTADLSQRLAEIARRAGGQVGVSVMNIENGDSADFNGDEPRSLYSVFKFPVAVAVLKDVETGKLKLDQKVAVKKSDLSGTAPSSSNRWQNMPVTYTVQQLLEFAMIESDNTAVDKLLTLVGGPSTVTKQIQSLGISGIEMAADSREAAKLADHPNTGSANAIVRLLAGLQKGEVLKPAERTVLWDMMQRATTGVKRLRAGLPARTVLMHKTGTGPNDSGTNDVGIINLPDGKGHLAIAVLINKSTLSSASQEQVIAAIAAAAWDAMTQQ
>ACS83741.1|FEATURES|farme|aminoglycoside|AAC(6')-IIc|antibiotic inactivation|0
MFALRVDDEIELRLLEEHHAEEIFAVVDTNRAHLREWLAWVDEEVSANEAKDYIKMMRERFAAFTGVAMGIWHQDRLVGAMSFVNIDQQSRWAEIGYWLGAPSQGRGIITRSCRAIINYAFDDLKLNRIVIRCADGNHRSRAIPERLGFLQEGRLRQTIWLYDRFWDALIYGMLAGEWKAQKQKGQV
>ACS83742.1|FEATURES|farme|aminoglycoside|AAC(6')-I30|antibiotic inactivation|1
MTGIRKLAQLQRGSQRRKHMRITDLPQDNESIIEQTARVLYDAFKEHSPTWTTMEAAIEEVRESFAEHRISRVAIDDEGSVLGWIGGQPIYDGHVWELHPLAIAPRAQGRGIGRKLVEDLEAQVAARGGVTLWLGSDDEGDRTSLGGVDLYPNPLAHLANIKNLRSHPYEFYQKLGFVIVGVLPDANGAGKPDIFLAKRVRQK
>ACS83728.1|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MQNDRIFFGAIMMRLFKVFIVLFFSLLIPIHSYAVSNDKINDLARNFMKENQVEGMSVAVLDKNRILILNYGIADEFKKTPVTNDTIYTIASFSKTVTATLAAIASVENKLNLDEPFIQHFPGLNNDKDMGSITTRELLGHVSSLPFDFTPRPKTYPELVSALNHFDPKWPPGTEYSYSNASIGVVGYVLQNVYSEKYQDILNGKILKPLHMTSTFLTVPAEKEKYIALGHEKDNKIVPYSKDNGVWFAAASLKSTISDMAKYLNAHINYASLQDKNLARGIAVVHENNYCFADKLSCEQLAWQAHVISELKNSSGDSYFVAYDSNDMPTFARKQIMENGGLDKSKIFIDKTGSGFGMSSYMAYIPADKVGVVILLNKGIADERIKLGRDILRSLGSA
>ACS83690.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MIKSFLTCVIIILMIFPSPAPAQQHDLRKSIQDIIRASGENVAVAIMGLEDKDTLSVNGRIHCPMQSVYKLPLGMAVLKQVDLGKLSLDQKIHITKKDLLPNTWSPLQKKYPEGNVDVPLSEILMYTVSQSDNSGCDILFRLLGGPSNVEKYIHSLGVRGMAIATTEEEMHGDWNVQFSNWSEPVAMVQLLQLVHEDEVLSPSSNDFLLKLMTETTTGPNRIKGLLPKDAKVAHKTGTSGPNEEGVTAAINDAGIVTLPNGKHYAIAVFMLNSRSDPKKLEAVIAAIAKSAWDHYSR
>ACS83738.1|FEATURES|farme|aminoglycoside|AAC(6')-I30|antibiotic inactivation|1
MESQVEVCQKARKLTRLYRHSQSEVSVRIIDFPQEESQLIRQSAELLVEAFKQHWPKAWPTMQDALETVHESFAENRLCRVALDDGGGVLGWIGGIESYDGKVWELHPLAVSPRAQGRGIGRMLVEDLEAQVAARGGLTLWLGSDDEDGMTSLGGIDMYPNPLEHLAKIKNLRGHPYGFYQKLGFVITGVMPDANGFGKPDIYLAKRVAQSKESTKNHAAFKLRVNDEIEIRMYEESDAETVFALVDRNREHLREWLIWVDATNSQEVTLQHIRDFERHYENKVALSAGIWLKGELAGAIGVVGYHWHNRVMEIGYWLSASQQGKGIMTKAVSAMIDNAFNNLGLNRVEIHCASGNTRSRAIPERLNFKQDGVMREAGLVNGQFVDKVIYSMLASEWKTYNQS
>ACS83731.1|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
MRKNIVVAILSVILFASCAETRIKEHADWGKFFESRGIKKACFMLRDNNHESIHYYNKARCTERFMPASTFKVFNSLVALETAIAPDDQLVITWDSVARREDCDKDLTMREAFKASCLGYYQEIARRIGPTKMQHYLDTVKYGNMKMGGRIDNFWINQSLQISADEQTGFLKRMYFAELPFAERSQRIVKTMMLQEQTPRYNLYYKTGTGPIGDKYIYWVVGFAERIEHVKEPKGSMNKSDVRNYPYFFALNFEMPQADTSQDWFKARIEILHDVLKEYGAIPK
>ACS83721.1|FEATURES|farme|beta_lactam|SMB-1|antibiotic inactivation|1
MKVIASLILAAFATVAHVASAQERDWSAPQQPFAIYGNTHYVGTAGISAILLTSPQGHILLDGTTGKGASVVAANIQALGYRLKDVKYILGSHSHEDHAGGIAALQKLTGAQVLVGAANVASMRSGVSPSTDPQFGSLSNFAGAAKVRGVADGEVVKLGPLVVTAHSTPGHTAGGTSWSWQSCEAGQCRNVVYVDSVTAVSADGYRFSDHPELVAQFRNTFSIVEGLSCEVAIAAHPEFNDLWGRQQRAAQEGSAAYVDSKGCRIIAEAGRKRLETRLASEQR
>ACS83694.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MTHILARAIIFTAFFISVFGELQAQEKDVKDKIEQIIDRSNGNIGVGVFDFASGLTVLINNAHQFPMQSVFKFPLGMAVLDMVDRGKLKLDQQVYVSKNDLQPTYSPLRDKFPDGNVNVTLADLLTYSVSLSDNNACDILFRLVGGTQVVNDYIRGLGIKDMAIVATEMQMSKGWDVQFENYSTPEAMLDLLKVFQSGKKLSASSSGFLWKIMTESPTGLKRIKGKLPSTAKVTHKTGTSGKNHKGITAATNDVGIMTLPNGNQIAIVVFVSNSEANETAREMVIADIAKVTWDEFSAK
>BAG82770.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MTQTVIPQFRITNAERSIAFYVEGLGFEIDWEHRFEPGFPVFMQLTRSGQTIFLTEHAGDCEVGGAAYFVVSDVDACYRQFMARGVTAIEPPEDTPWETREMVVTDPDGNRLRFASPATT
>ACT97678.1|FEATURES|farme|aminoglycoside|LS81_08155|antibiotic inactivation|1
MLKIAEKEDVPVAAELAGMLWPHHSREELEGELLSFIESGGMVFLWMEEGNPVAFAQCGIRTDYVEGTHGGAIGYLEGIFVLEKFRRRGIGKVLLTACEEWAKEQGCEEFASDTELDNAEGLSFHSGAGFYEANRIVCFVKNL
>ACT97656.1|FEATURES|farme|beta_lactam|CTX-M-15|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ACT97531.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MDYDKLIAPAAAAMRPSGIRKFFDLAADMPECISLGVGEPDFKTPWAVREAGIESLEHGRTRYTANAGLKELRAEICRYLERRMNLHYDPLSQVLVTVGGSEAIDMCIRTVVQPGDEVVIPEPCFVCYEPITTLSGGVPVHVACRQEDEFRLRPEALKAAITPRTKLLIMPFPNNPTGAVMEKEDLEAIADVLRDTNVLVLSDEIYAELNYGLRPHVSIATLPGMAERTIVVNGFSKSYAMTGWRLGYACGPAPIIKIMTKIHQSAIMSAPTTQPVCRHHGSEGLRRRDRPDAG
>ACT97467.1|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MKIITTIYLSVVLTFLTGCTTMKKLSSGTTVYRYANGFVTDSDNKIVAHYANGFVTKYSDVVNQKHIKINDDLELFRLTPVCYLYTAWANMGRWGRVGSNGLVVIGKGKALLIDSPTLESQIVELAWWFDKNLNVTFESFIPGHWHGDGVGGLAWLNRNGIKSYANRLTNNILASKGLEQSNVSFSDSLLLKVGNIKIEAYYLGGGHTVDNIVVWIPSQKILFGGCMLKDMETLNIGNISDAAPLEEWLQTVDRVERQFPNVEYVIPGHGKYGGKELFKHTKTIIENERQSKMNK
>ACT97458.1|FEATURES|farme|beta_lactam|BL2e_cepa|antibiotic inactivation|1
MKTNRLILLLFILFPAYVLAGNRFQELYTNIHQFISQQKAEVGVAIIADGKDTVTIENNRRYPLMSVFKLHQALAVGDYCKRHQLSFDTLLTVDSTDLQPNTYSPLRDRYPHGGKFSLKQLMEYTLHLSDNNACDILFKFTGGPAVTDRYIRSLGINDFSIQYTEDDMHQDLNLGYENWSTPLATAEVIEALLTRTLFDKPHQEFIKEALVTCQTGTSRIVHPLQDKQVTVGHKTGTGDRNASGQLIAINDAGFVQFPNGHRYTLVVFVKDSQESMEDTEAIIAQISEMVYQAFSNP
>ACT97447.1|FEATURES|farme|beta_lactam|TLA-2|antibiotic inactivation|1
MKKYFSFCLLGIFIFCFSQQNLKRDITKIIQSKNALVAVSVMNSKGKTEVNINGNKKVPMLSVFKFHIALAVLDLVDRGILDLEQNIFVKKSELLENTWSPIRDKYPNGNVNIPLREIIEYTVSQSDNNGCDILLRLIGGVDTVQKFIESKGIKDFAIKYNEEEMNKNGKSIYSNYTTANASSRLLQKFYNGEIISESSRDFLFRIMYETSTGADRLISLLPPDVIVAHKTGTSGIVSGIQAATNDVGIIILPDDEYYTISVFVINSKENTSTNEKIIADISKTVWDYYFRNK
>ACT97384.1|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MKLWTSLCLFLLLGATAFAVRENPLESRLRRIIRLSNTDVGVAVISGSRNWAVGNRKRPLLSVFKFFIAVQTLRQMEQTGTALNAKLTVEENMTDANMYSPMLKKHPRRPFEISLAELLEYMIAESDNNAADILLKYSGGTGQLEKFLHDLGFSGIDIRVNEKQMNQKAENQYLNQAAPSDVAGLIKLVLEKDVLSAEHRKFLSDIMLKTSTGTDKIKQGLPPGVMFGHKTGSSSRTADGIKIADNDAGFVTLTNGRTYYIAVMITESKLDDRANAALAAQISQTVYNYLTTEKTD
>ACT97381.1|FEATURES|farme|beta_lactam|CfxA6|antibiotic inactivation|1
MSNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIVAPLLDKEGVVIAHKTGSGNVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQASQFVAHISAVVYSLLINTALN
>ACT97373.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKSRSLLSKAVVSSLLLFQVLSVSASDLTSDIQEVIKGKKAQVGVAVLYKDDAFTANNDDQYPLMSVFKFHIALAVLKKMEKEGIPLTAVVTLGPSDIDTKTWSPMYKKYKSKKITLSYGDLINYMVSQSDNNACNWLINFVGGIQNVNDFIKNLGIDRIQLIETEKSMGAGHQKKLQQLVNAVVCNSALEKGLHRKGPF
>ACT97683.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MDGITKDSIKTARLMKQLWPQLTDKEAIDEVKRYTNGKNTAIFTEVESDTIVGLALCSLRFDYVEGCKYSPVGFLEGIIVDEEYRLKDIAKNLCTKCEEWAKNKGCKEFASDCTLTNTDSIRFHLNIGFQEANRIIHFKKKL
>ACT97465.1|FEATURES|farme|beta_lactam|BL2e_cepa|antibiotic inactivation|1
MRITKKRSPRLILQSLVKNGCPYIIICIWCVLSGGCVQNKSQDSLKTLKTEIRHIIKDKKATIGVALILDGEDTLAINNAEKYPMMSVYKFHQALAVCDYLQKRHIPLSTSLYLDKKYFKPDTYSPLRDKYPQGNLELPISELLVYTMQSSDNVACDILFDYIGGVNVVDEYIHSLGINDVSITATEDEMHQDMDDCYKNWTTPMEAANLLELFMTQDFMRNEYTDFLKHIMIECGTGKDRLPAPLPESEVKIGHKTGTSDKNDRGEYIGINDIGFVILPDGSRYVVAVFVKDSKENMETNAKIISDISAAVYRYAGNR
>ACT97382.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKRFLMSAVCSFYSIMAFGQIQIGDIKEVIQEKKATVGVAILYQDKIFTLSDNQQYPLMSLFKFHVTVAVLKKMDREHIPLDSTVYITREQMHENTYSPLRNKYPNQGIHISLRDIITYTIIYSDNNTCDWLIDFAGGIKKVDTFIKSLGIKKLNLTETEHSMHENIMNSYNNWSSPLSVVQLIKKIYTDEILSATSFAFLEETMLNCSSGENKLKAGLPPNVKIGHKTGHSDRTSDGLQISETDAGVIYLPDGERCYIAVLIKNSLESDETNARIMADITRVIYHSLQK
>CBI71210.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MTNDLTIRSATADDAALIVQFVAALAAYEKLSHEAKATEADITRDLFGADPRVFCEIAEWQGRPVGFTLWFYTYSTFQGRHGIWLEDLFVDPSLRGKGIGKALLVNLARRCVTEGLGRFEWWVLDWNEPSIEFYKSPGVGVDARTKWTKVRVDGDALRRLGAS
>CBI71185.1|FEATURES|farme|beta_lactam|PMI41_04644|antibiotic inactivation|1
MIPKTAAVLTASLFATCASVTLSHAADDANRVKSFVDAAIQPVMEKNTIPGMAVGVIADGKSYIFEYGVTSKDTGKAVTASTIFEIGSISKTFVVTLATYAQANGQLSLSDPASKYLPALKGTEFGKVPLYHLGTHTPGGFPLQVPDNIKNDDQMMSYLKNWKPAYKAGTTRTYANPSIGMLGVIAAKSMNEDFTALMEGTLFPALGLASTYINVPKSKMKDYAQGYTSKDKPARVNKAVLSSEAYGVKTTAPDMVRFMQANMNMVKLENKLQRAIADTHRGYFKVGAMTQDLLWEQYNYPVSLNALRLGNSREISSKPVPVEQIDPPIAPRSDVWINKTGSTNGFGAYVAFVPEKKIGIVILANKYYPNEERINAAYEV
>CBI71190.1|FEATURES|farme|aminoglycoside|AAC(3)-IIIb|antibiotic inactivation|1
GKWAGTRGADMIIAALRDAVVLGYGAAYADWQGMDDVLADDAVFNDPALRPEIPPFDPKTSRATRDNGSFPELLRTTPGALRSGSPGASCVAIGGRAEWFVADHALDYGYGPDSPFGELVAAEGKVLMLGAPLDTMTLLHHAEHLADIPSKRIRRYEAPILIEGETVWRQFEEFDTSDPVVASLPDDYFALIVEEFLGTGRGVRGNVGAATSVLVPAAEIVPFGVQWLETRFRK
>CBI71182.1|FEATURES|farme|beta_lactam|VEB-3|antibiotic inactivation|1
MVSLVVRSCSVAAVAVGLLFPACAAPVGATATTAPVAELDSVPQVSSGRLGVAILDFQTSKTYHINGKDRFPMQSVFKAMSAVVVMREVDEGKLTLDQEIPVGPDDISVYWSPIAEEFKGTTQTYTVRELLEKSVGMSDNTAADVLMELTGGPQAVTQLLKDAGIEGVRVDRYERQFQAELEGLPPFELGEVINRKAFVEAAKAVPAEVKRPILERYVAGKDERDTATPLGAVDFLVKLQEGKLLSAESTRVLLQIMTDVKTGAGRLKAGLPEGSKLAHKTGTGGDILGVNTATNDIGIATLPDGRKFAVAVFLTGSKESEEKRDAIHADVVRQFVDQLLAEAKE
>CBI71176.1|FEATURES|farme|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MASQYYVHHLGQDDSELMNALLSVFGAAFNEVETYVGKRPGPEYIRRLLGSDYFIALAALEDNEVVGGIAAYHLKKFEQERKEIYISDLAVAEEHRRKGIATGLIRKLRKIAAARGAYVIFVQADTGVEDEPAIALYTKLGVREDVLHFDIAVEDGDDAAAHANE
>CBI71178.1|FEATURES|farme|fosfomycin|FosC2|antibiotic inactivation|1
MFSIECLDHVALLVKDLERSVEWYTRVLGLKRHYAEAWDIPVVLYAGTTGVALFPANSKVSSINPRQAIVMQHFAFRVSRADFEEAQRDFQRRDIKYEFQDHDVAHSIYIYDPDGYEVELTTYDL
>CBI71171.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MKRIFPAYILLTAFLLACSSNATTQNANQSNKPAAAQEAKADDKQNRELQKQIEQIASAARGRVGVHAVVLETGESVSLDEQGRFPMQSVYKFPIGMAVLAQVDAGKLKLDERVRVEKSEYVREGMHSPLRDKNPNEAEVSVRELLRLAVSESDGTASDVLFRLAGGSEAITRYLSDLKVTEIIVADTEKEIGQDWDTQYRNWASPKGAVMLLRAFHEGRGLSAESRALLLKLMTDTPTGPKRLKGLLPKGTVVAHKTGTSGANASGISAATNDIGIVTLPNGRHLAIAVFVSDSPADLTTREGVIAKVAKAAWDQWGK
>AEC04637.1|FEATURES|farme|beta_lactam|bcere0023_30080|antibiotic inactivation|1
MWREVKQHMSNKFIKRVVKMKYWKILSLVFCTFAFAVNCKAHAGVKQIETKYNVKIGVYAIDTNNGNSFSYRQDERFPFQSTVKMVVAAAALKNIEADERIKISSDDIVFWSPIVRLNLDRGYMTIKELAEAAMSYSDNAATNILITRLGGTKSINEFAKSIGNASFYLENLEPNLNSDPNNIHDSSTPKDMAQSVQKLLIENNVLSQENQHILKTWMMNNTTGYKKIRYGLPLGWSAAEKTGGGSGTSHDIGIVWSPACKPIVLAIYTFSNKKDNAQQADKAIAETTKFILDEFSKKNICFSATDFK
>AET35481.1|FEATURES|farme|beta_lactam|TEM-57|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYCAGERFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVGELCAAAITLSDNTAANLLLTTLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPEAMARTLRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRGIIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP
>AET35493.1|FEATURES|farme|beta_lactam|OXA-347|antibiotic inactivation|1
MKNILFVVFISMIFLFVCCNTTTNKNIIETEISDFDKILDSFQVNGSILIYDNDKNTFYSNDFDWAKNGKLPASTFKIPNSIIAVELGIIENDTTILKWNGEQRKMDIWEKDLSFKDAFRISCVPCYQEIARKIGTIKMKEYLEKFEYKNMIFDSLTIDNFWLEGNSKISQKQQIDFLRKFYFSKFPISDRTIKIVKNIMEIERTENYILSGKTGLSSIEEKYNGWFVGYVETKSNVYFFATNVIPTDGLNVDDFISSRINVTKNALKQMNIMK
>AFQ60597.1|FEATURES|farme|chloramphenicol|catB3|antibiotic inactivation|1
MKNYFESPFKGKLLVEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDKLIIGSFCSIGTGASFIMAGNQGHRYDWVTSFPFFYMNEEPAFSESVDAFQAAGNTVIGSDVWIGSEAMIMPGVKVGHGAVIGSRALVTKDIEPYTIVGGNPAKEIKKRFSEQEISMLLDMKWWDWPLEQIKEAMPLLCSSDIAGLYHFWQRSSA
>AFH53889.1|FEATURES|farme|aminoglycoside|AFK71_11355|antibiotic inactivation|1
MMNSYEVTKKLLPVQVSAVTALLQKILQKQLIGVYLYGSAVLGGLKHESDLDILVVIKEYLSEAHRLTLTKRLLELSGEIGDKNNRPLEVTIVSEHILTLTEKIPECEYMYGEWLRADIESGKIPQRYVEPDVILLLFQARSSSIVLYGVPAENLLPEIGFEKINKAILHSLPALMKTINGDERNVLLTLARMWYSLSSQKICPKDIAAYWAAENVPEELAYLLIMAAEGYTGKIKDCWEDKTEELNKLTDFLQQKIKGFA
>AFH53888.1|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MTFTPIDMETWHRKPYFLHYHKDIPCTYSMTVSLDITVLKKTGVSLYPALLYLLTKNVNHYEQFRTAFDEKGNVGIYSNMEPCYTIFHKEQETFSNLWTEYSEDFSTFLARYKADLETYGNVLDMDAKPNTPPNTFPVSMVPWTTFTGFHLHLQKGYDYLLPIFTLGKAWEHHGHWKMPLAIQYIMCLRWVPCEPFXNPSADLHIQHNKIES
>AFH53884.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIXYAXXIKHINDYIXRLSIDSFQTSRKTEDGMQLPAFEAVYRNLEILLXLXSBY
>AFH53881.1|FEATURES|farme|beta_lactam|MHK_007990|antibiotic inactivation|1
MXIQHFRVXLIPFFAAFCLPVFAHPETLVKVKDAEHXLGARXGYIELDLNXGKILESFRPEERFPMMSTFKVLLCGAVLSRIDVGQXQLGRRIHYSQNDLVEYSPFTDKHLTDGMTVRELCIAAITMXDNTAAKLLLTTIGGPKELIAFLXNMGDHXTRXDRWZXZLNEXIPND
>AFH53879.1|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MTSVRLTTALRAIVFALAATGASAAACAQDAERRISEMTAGKPAEVGVAWIADGKAHAVNNADGYPMMSVFKLHGAVAELRQMERRGTPADTLITVRAAEMEKDTYSPMLKRYGGRDFTIRLDSLLRYSVAESDNNACDIIMRLAGGTDGVNAEMRAIGLTGYAITETEASMHADPTRSYNNRSTPLAVAELFRKLYEGGILGEPYATLLKDILLSTSTGPNKIKAALPPGATLAHKTGTGFTLHDGTITADNDAGAITLADGRRIYIAVLVKDSKLGADGNARLIKEIAEAVIYSEVKF
>AGC09671.1|FEATURES|farme|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MSAIRWDSCSFTQLSQASTSLKGRGKLYALDLFIGVPEYWGKGIGTQFIRLLLGYLFDEKGADWVILDPHVDNVRAIRAYEKCGFRKIKLVPRHEWHEGKYVDCWLMGIRWDQQA
>AGC09651.1|FEATURES|farme|aminoglycoside|sat-4|antibiotic inactivation|0
MTDITYAISPPVTNDHINALFLASWPDWREGDFQPVLSHSLLYVCAYEGGRLVGFVNVAWDGGIHGFILDTTVHPDVRRRGIGVQLVRRAAEAARTRGLHWLHVDYEPRLKSFYEACGFFHTEAGLMHLNG
>AGC09639.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MERKNYKGPFLPGYKARKSTYKAEPIGLKYIDHCVGNVELGKMNTWVDFYEKVMGFSLLVTFDDKDISTEYSALMSKVVSNGNGYIKFPINEPAAGKKKSQIEEYLDFYHGPGVQHVAIATDDIIHTITELRKRGVEFLHVPEVYYEDVLDRVGKIDEALEDLKKLNILIDRDEEGYLLQIFTKPIQDRPTMFFEIIERHGAKSFGKGNFKALFESIEREQELRGNL
>AGC09640.1|FEATURES|farme|aminoglycoside|AAC(3)-IIIb|antibiotic inactivation|1
MHSRASLVRDARSLGISPGDTLMVHASVRSVGEIAGGPDQIHLALEEALTERGTLMMYASCPAHYDEVGRGNLTAEQEREVLEKLPAFDAQTARSQRENGALVELLRTYPGSVVNDHVARFVVRGRHARHLISKQPWDYAFGKDSALDRFVQLGGKILLLGCDHDNVTFLHYAEHIVDIPGKRVSRFKVPVLVNGERVWRDMEEFDTSEAAHPSWPDRFFARIVDGYLEKTNNRGGVLGDSQSYVIDARGLLEHALQEMKRQAT
>AHN92779.1|FEATURES|farme|aminoglycoside|BN682_00261|antibiotic inactivation|1
MLCVSFHSAASVEDRLLKFAVIAARYQNQWVFCRHKDRSTWEIPGGHREPGEQILQTAQRELREETGAVSAMLKPLTVYAVTQDEQTTYGMLYLAEILELEPLSDSVEIGEIRLFDDLPERLTYAAIQPKLFARALEELAISIEKATLKDAKSVSTLAAKLWNHHEIEELEAEFSDFLQQEDAAVFLCKRTGAAVGFAQCGLRRDYVEGTETSPVGYLEGIFVEEGCRGRGFAKALLKHCEAWAREKGCTEFASDCELCNDTSLRFHLRMGFQEANRIICFTKKL
>AHN92778.1|FEATURES|farme|aminoglycoside|BN682_00261|antibiotic inactivation|1
MRIEKATPADVNAAVSLMMKLWPGHDAEERTAEMEQMIGSPEAAIFLAWDGEQAVGYAQCQLRHDYVEGCDSSPVGYLEGVYVEEECRGNGVAAALLDACQQWSRSMGCMEFASDCELENEASLRFHLKNGFEEANRIICFVKRL
>AHN92777.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MEIRRAAIDDVRAVAWLACLLWPHHTLAEMEEEMEIFLTDEDSAIFLAWEDNAAVGFAQASLRRDYVEGSTSSPTGYLEGIYVMEAYRSRGFAAELLSACEAWAREKNCLQFASDCEIVNSGSLIFHLKNGFTEANRIICFIKDL
>AHN92776.1|FEATURES|farme|aminoglycoside|BN682_00261|antibiotic inactivation|1
MLHMTEIRKAAAADISTVAKLAAQLWPHHTPQEMEAEFSHIPENSNSALFLAFSGSTAVGFAQCSLRHDYVEGTSSSPVGYLEGIYTSDGCRGAGVARALLAECESWAKERGCSEFASDCELTNTQSLHFHLSVGFEEANRIICFKKKL
>AHN92775.1|FEATURES|farme|aminoglycoside|BN682_00261|antibiotic inactivation|1
MSKGAIAMIRQATVSDAAAVAALSLRLWPDHTMEEMTAEFAALLASPEAAVFLAEDGAPMGFAQCQLRHDYVEGASTSPTGYLEGVYVAPSHQRLGIAGKLLSACEVWAKAHGCTEFASDCEIDNAASLAFHLAKGFTEASRNIHFIKPL
>AHN92773.1|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
VKIEKDEITIRDFTETDLSLMFQWLTDQRVLEYYEGRDVKFTMDTLSAHFLEAIPDGFRMIIEYQKSPIGYAQAYQLSGELFDEYDYPDDGHIVYAMDQFIGEPKYWSKGIGSSFLKMMASHLKENMAAQRVLLDPHQDNKRAIRAYEKAGFKIIKPLPKHELFEGEKVDCWLMELAL
>AHN92772.1|FEATURES|farme|aminoglycoside|LS69_04805|antibiotic inactivation|1
MVRIAINGDSRVLAEMAVQMWDSNTVDELEAEFAETLNDKQSAFFIKYINDLPVGFAQCGLRTDYVEGTESSPVGYLEGIFVKEEYRKNGYAKELLLACEIWAKEIGCSEFASDCEIDNIDSFKFHMAMGFDEANRIICFKKRL
>AHN92771.1|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
MAEAKKVSFRLMNDKDDLRFMLKWLTDERVLEFYDGRGSKFTAETIREKYTEEEDDFYRMIIEYDSVPIGYAQMYRVQGELFEEYDYPETEEKIFAMDQFIGEPEYWNKGIGTEYCKAACRYLAEELGADAVILDPHKSNPRAIRAYEKAGFKVLRDLPAHELHEGKWEDCVLMEWRV
>AHN92769.1|FEATURES|farme|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MEILKDNIRIRLMTDADFPLMLKWLTDVRVLEFYGGRDLAYTMDTLREHYADPTDEQTTRVIIEYCGTAIGYGQFYPVDYMEFGLEESDDIVYGIDQFIGEPDLWNRGIGSAYVIMLCEWLKAEMEADAVVLDPHKDNKRAIRAYEKAGFRIIAELKEHEFFEGRKEDCWLMEWR
>AHN92768.1|FEATURES|farme|aminoglycoside|APH(3')-VIIa|antibiotic inactivation|1
MIPERKETNEFLIMSEIKGKSIDDFAEEPMQYITYLADAIKLLHAVDVSNCPFSSQVDMRLEELDYLLKNNLADTDTDNWEDSTEFTDPQELYSWLCDNKPQEELVFSHGDISNLMIQDDEIFFFDLARCGLADKWLDISMCVREIRNYYHNPDYENLFYDMLGMEPDYEKIDYYLLLDEMF
>AHN92767.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MVKKAKQDDITVIAELAVQMWEVDSIQELIDDISENMAKDDAQYFLKYVNDMPVGFAECQLRHDYVEGTDSSPVGYLEGIFVKEEFRHKGFAKEILIECEKWTKEKGCIEFASDCELDNEESLHFHIAMGFVEAGRIICFKKEL
>AHN92764.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MKDLPVLAELACWLWPHHTTQEMQADLGEIMAKPDAAFFLAYVDKTAIGFAQCQLRHDYVEGTESSPVGYLEGIYVAEEFRKQGIARVLLTACECWAKTKGCTEFASDCELSNVQSLQFHLNVGFEEANRIICFTKKL
>AHN92763.1|FEATURES|farme|aminoglycoside|sat-3|antibiotic inactivation|0
MNLIELTHKNDILQTYEIYKHCMFMPTEEKFNKKVEQFLNNNSVKIFACFRHGKIVGVMAVSFIEQKKVEILGIAIDLSARGKGIGSYMIKQVINNYDLLSVYAETDNDAVGFYQKNNFSITEFSEIYDGETVIRYKCELTQFQ
>AHN92762.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MIRKAETNDAATVAELALLLWPEHSLEELTEEFEELISQDDAACFLAYAGDTAVGFAQCQLRHDYVEGTDSSPVGYLEGIFVRENHRHQGYAKKLLAACEAWAREQGCTEFASDCELTNTDSLKFHLGVGFEEANRIICFTKKL
>AHN92759.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MIRKAERRDISAIAELMVRLWPHQTVEAMEEELHEMMENEEIAFFLAGNVGFAQCQLRHDYVEGTDSSPVGYLEGIYVAEGFRHQGIARELVHACENWAKEKGCGEFASDCELTNTQSLQFHLGVGFGEANRIICFTKKL
>AHN92758.1|FEATURES|farme|aminoglycoside|PROVALCAL_00921|antibiotic inactivation|0
MNKNDYVIRLERKEEFREVEFLVREAFWNVYRPGCLEHYVLNQLRNDPLFVPELDFVMVKDGQLIGQNMFMRAVIRADDGRDVPIMTMGPICIRKDLQRMGYGKILLDHSIEAAARLGCGALCFEGNIRFYGKSCFTYAREYGLRYRGLPAGADDSFFLCRELIPGYLDGVTGEYGPPQGYFVDAAAAEEFDRAFPPKEKLVLPGQLSH
>AHN92757.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MIRKATMNDLPRLTELALELWPENAVDTMYYDLGTIMTGGESVFFLAYREDVAVGFAQCQLRHDYVEGTSTSPVGYLEGIYVRKEDRALGFASQLMKACEEWARTEGCAEFASDCEIHNEESLAFHLKLGFKEANRIICFAKHL
>AHN92754.1|FEATURES|farme|aminoglycoside|Mmwyl1_0154|antibiotic inactivation|0
RFFPGISTLFVSEDYRGNRISGKLIDFANQYAKSIGFDKTYIPTEFIGLYEKYGYCYVKDIVNYGNGIDRLYVREIK
>AHN92753.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MENVVFIRRAQRSQAYIAARLANKLWDEDPDREEEMAEIIESADSDVLLAFCGEQAVGFAQVGLRHDYVEGKESDGPVGYLEGVYVEEAFRRGGVARRLVQAAEYWARERKCAQFASDCELHNEDSIRFHLGSGFEEAGRIVCFIKNL
>AHN92752.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MIRKAEIKDLSILAELACQLWPDHTVEEMCAEFAEILAKPDAAFFLAYAEETAVGFAQCQLRYDYVEGTDSSPVGYLEGIYVTEEYRKQGVARELLTACESWAKAKGCSEFASDCELDNVQSLQFHLNVGFEEANRIICFTKKL
>AHN92736.1|FEATURES|farme|beta_lactam|bla1|antibiotic inactivation|1
MKLKNKASIKFGICVGLLCLSITGFTPFYSSTHAEAKSIEDTNMASCITNKKLVQLEKKFDARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLVTYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAKRFETDLNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRAGAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSNRFTKDANYDNALIAEAAKIVLNDLK
>AHN92733.1|FEATURES|farme|beta_lactam|cepA|antibiotic inactivation|1
MRKLLFIIIYLSFISPAFADGNKAIENALHEYIKGKDARIGVAVIINGKDTVSVNGNRDFPMMSVFKFPLALTVAHWINTNGMSLNDTVTFSEKAMKEDTYSPMLKKYGKSRNTMTIRELLEWSLVESDNNAADILLHRVGGTSGVTSIMRQMGISDEIVIGASEEDMHRDPYLSYLNRTTPLAMAQLFDRFYHELRNASQSYSEISVMLEQCRTGLDRLALPLLPTNALIGHKTGTGFPTPEGRISAVNDCGYVNLPNGTRYSIAVFVADSNYDIATTSAIIAEVSKIVLEGLIKQK
>AHN92730.1|FEATURES|farme|beta_lactam|ABV89_11680|antibiotic inactivation|1
MKKFCFLFLIICGLMFFCLQDCQARQKLNLADLENKYNAVIGVYAVDMENGKKICYKPDTRFSYCSTHKVFTVAELLRQKNTSDLNEIRKFSAEDILSYAPITKDHVADGMTLAEICSASLRWSDNTAANLILQEIGGVENFKVALKNIGDKTTKPARNEPELNLFNPKDNRDTSTPRQMVKNLQVYIFGDILSDDKKKLLIDWMSDNSITDTLIKAGTPQGWKVIDKSGSGDYGARNDIAVIYPPNRKPIVMAIMSRRTEKNAKSDDAMIAEAAKRIFDNLVF
>AHN92728.1|FEATURES|farme|chloramphenicol|cat8|antibiotic inactivation|1
MAFRLIDIENWERKEFYQHFISQVVCTYSVVVNLDITNLKKHRLYPAMIWLLTKTVNDMPEFRTSLTSEGLGIYDEMHPMYTVFNKENKNFSGIWSYFSEDYDTFLKDYEVDAEKYGTSTCYAPKDGTPSNSFNISMVPWLEFSGFNINVFDDGHFLLPIFTMGKYFERKGKRMLPLAIQVHHAVCDGYHVGLFVEKLQKYIDHFG
>AHN92724.1|FEATURES|farme|chloramphenicol|cat22|antibiotic inactivation|1
MAFRLIDLENWERREFYEHFISQVVCTYSVVVNLDITNLKGQKLYPAMIWLLTKTVNDMPEFRTSLTPEGLGIYDDMHPMYTVFNKENKNFSGIWAYFSEDYETFLKDYEDDVARYSTSTRYTPKEGTPANSFNISMVPWVEFTGFNINVFDEGKFLLPIFTMGKFFERDGKRLLPLAIQVHHAVCDGYHVGVFVEKLQDHINEFTQ
>AHN92716.1|FEATURES|farme|chloramphenicol|cat28|antibiotic inactivation|1
MAFHLIDMENWDRREFYEHFINEVVCSYSVTVNLDITNLRDARLYPAMIWLLTKTVNEMQEFRTSLTKAGLGVYDSMHPMYTVFNKENKNFSGIWSYYSENYIDFLKNYDEDVRVYSKSTRYAPKDGTPENSFNISMVPWLEFTSCNLNVYDDGKFLLPIFTMGKYFERDGKRLLPLAIQVHHAVCDGYHVGLFVELLQTNIIRFSAK
>AHN92710.1|FEATURES|farme|chloramphenicol|cat19|antibiotic inactivation|1
MALKLIDMQTWKRREFYEHFIKDVVCTYSAVVNIDITPLKGNKLYPAMIWCLTKTVNDMPEFRTVLTPDGPGIYDDMHPMYTVFNKENKNFSGIWSYFSENYEAFLKSYEVDAAKYSQSTYYAPKDGTPANSFNISMVPWLEFTGFNINVFDEGKFLLPVFTMGKFFERDGKRILPLAIQVHHAVCDGYHISAFVAKLQEYVNYLGNQNKR
>AHN92705.1|FEATURES|farme|chloramphenicol|cat20|antibiotic inactivation|1
MALKLIDLETWERREFYEHFIREVVCTYSAVVNIDITNLKGQKLYPAMIWLLTKTVNDMPEFRTVLTPDGPGIYDDMHPMYTVFKKENKNFSGIWSYFSKDYEGFLKSYEADAEKYSKSTRYAPKDGTPANSFNISMVPWLEFTGFNINVFDDGKFLLPIFTMGKFFERDGKRFLPLAIQVHHAVCDGYHVGAFVERLQEYVDGFHPV
>AHN92704.1|FEATURES|farme|chloramphenicol|cat15|antibiotic inactivation|1
CTYSVVVNLDITNLKKHRLYPAMIWLLTKTVNEMPEFRTSFTEEGLGIYDDMHPMYTVFNKENKNFSGIWSYFSEDYDTFLKNYEIDAETYSTSTRYAPKSGTPANSFNISMVPWMEFTGFNINVFDDGHFLLPIFTMGKFFERDGKRMLPLAIQVHHAVCDGYHVGLFVEKLQRLIDCFDC
>AHN92699.1|FEATURES|farme|beta_lactam|cepA|antibiotic inactivation|1
MNRKLTIIFSILLTVLTPLTCLSKQKDVNTSLQKQVEQLLEGKNVQVGIAVYYQGKMLCTKNADQSFPMMSVFKLHQAVAILHCLKQDSLTLKKPMLITKDMLSPDTYSPLRDKYPDGDIRLKVSQLIEYSVAQSDNNASNILFNLFDGTHYANQVIQDLGCTNTQIKWTEDEMAMDHSRAYFNSTTPNDAILLLEMLVDNRTQRQQDFLWLTEVMSGTQTGPNRLAKYLPTLGTKLYHKTGTGYVKDDGTIVAVNDIGFVILPNGKHYSIAVFCKDSKLSSEKTEELIAEISRLTYEYIHRKISNQ
>AIA10481.1|FEATURES|farme|beta_lactam|blaVEB-11|antibiotic inactivation|1
MQTPNIFKLSFSIANCSHSLGHLFMLRLLSPILIFILFLAPAISEAQLKSLAPSLLALQKESGGILGVSIQNMETGDTISLNGEKPLVMQSSFKFPIALAVFNEIENNRLSLEKKVKITKSKLPKETWSPLRDQLKENTSEVSVRELLVFMVSHSDNIACDYLLDIIGGPSTVQNFIHQKGIKNIAIKYSEAEMGKTWEAQYQNWVHPKAMSDLFIKLFHEELLSPEHTKHLIKLMEETTTGAGRLKGLLPENTIVAHRTGTSGRNKDGMIAAVVDAGVLFLPNGQHAAISVFVTGSGKETPEIEAVIAKIGRAVWDLYVK
>AIA10482.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MNNIKIKKATINDVDRLQKIGRETFYETFSAANTEENMKQYLRNEFTIEKLTAELSDLNSEFYFATLDNNVIGYLKLNFGQSQTELKDEKAVEIERIYVLKEFHGKKVGQILYEKAMWIARQTNADFVWLGVWEENPRAINFYKKNGFVEFDKHVFKLGDDEQTDIMMKLQLNDN
>AIA19113.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MAPVLTVADVRSAVAWYIEVFGFVEHVRIGDGHRSQLGLPDGPPAELVVAEVRPGRRTPEQERSHQVMLKVADVASVVETAVARNARLVDPPHDWEYGERQATIDDPFGHQWVLNQTLTDVAPEQWGGNTVTPREPSA
>AIA18887.1|FEATURES|farme|beta_lactam|CGB-1|antibiotic inactivation|1
MKKSIPFFIISMLLSPLGNAQTTQVRDFVIEPQIQPNFYIYKTFGVFGGKEYSTNAVYLVTKKGVVLFDVPWQKTQYQSLMDTIQKRHNLPVIAVFATHSHEDRAGDLSFYNKKGIKTYATAKTNELLKKEGKATSTELIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYKILDGGCLVKSNAAVDLGYTGEANVAEWPKTMTKLKNKYSQATLIIPGHDEWKGGGHVEHTLDLLNKK
>AIA18843.1|FEATURES|farme|aminoglycoside|AAC(3)-IIIb|antibiotic inactivation|1
MSSRVSTRSSLAEDLRAIGLADGDAVLVHAALRKVGKIVGGPDDILDAMRDVIGPAGTVLGYADWQLEDEIRDDPAMREHIPAFDPLRSRSIRDNGFWPELIRTTPGALRSASPGASMAAIGGEAEWFTADHALDYGYGPRSPLGKLVEAKGKVLMLGAPLDTMTLLHHAEHLADFPNKRILRYEAPILVDGEKVWRWFEEFDTSDPPDGLADDYFAGIVEEFLATGRGKRGKIGEASSVLVPADEIVAFAVDWLERWGRTARR
>AIA17452.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MKRRLPVYILLFVALVSACSGSATTQNNNSAGASAGSQQAKTADNQNRELQKELEQIAAAAKGRVGVQAVVIETGETVSLNPNEHFPMQSVYKFPIGMAVLQQVDAGKLKLEQRVRVEKSDFVREGQRSPVRDKNPQGVELSVGELLRFAVSESDGTASDVLLKLAGGAEAVNGYLKQLEVTDLVVANSEKEIGQDWETQYRNWASPESAVKLLRALYDGRGLSAQSQKLLLKLMTETPTGPKRLKGLLPVGTIVAHKTGTSGANASGINAATNDIGIVTLPNGRHLAIAVFVSDSPANEATREGVIAKVARAVWDKWSK
>AIA17081.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MPGIEGGKVRTIVNIDVPDLVPAIRFYRAALGLRLARLIEDDVAELSGASSTVYLLKHPAGSDATHGASPPRSYARHWTPVHIDFVVDDIEAAARQAIAAGAIQESELVEWRGSKCVTFSDPFGHGFCVIEFEGGTYR
>AIA17040.1|FEATURES|farme|aminoglycoside|APH(2'')-Ie|antibiotic inactivation|0
MPREETMRDVAALVREALAGRDVHTIVEIEGGSDHRTFDVNGALVARLRRRPDEGTASAIMREVRLLEVVSRVSPVPVPDVAGANPDRGLIVVTRLPGVPLLDSPPRHPMALIDPLARFLRAVHGLPIAELEDLVERDEYGFEDYLEDAAEDLRQVAAHLPSDQQRAVEAFLGAPPPAASDNRTFCHNDLGAEHMLASDDGSVLTGVIDWSDAAIADPARDVGRILRDLGPAVARAIVRQLECAEPHHLLARARFYARCALLEDVSYGLRTAHHRYAERALDHFRGVFEDD
>AIA16275.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MATPATLRPDPAIVCSACAEWNAPRQPFKVFGNTYYVGSLGLSSVLIAGDQGLILIDVALPQSAPLIDANITALGFRTADIKMILTSHAHYDHVGGVRSLQRFTGATVGGSARTVEALALGHPTPDDPQFATDSSVRFPAVTNGARVVKDGETLRVGNIAITAHYTPGHTPGATSWTWQSCEGTRCLAMAYVDSITPVSNDTFKYTAQPGLVDKFRKSIDVVSNLPCDVLLTTHPSASGMDEKVKQRAQASGADPFIEAGACKALAQQSLAAFEKRVTEERAR
>AIA15911.1|FEATURES|farme|aminoglycoside|APH(4)-Ia|antibiotic inactivation|0
MQSSEFDLTELVGLNHLVPALIEATGQDAWARTEVELITGGKSNLTFLLRSAAGELILRRPPTGHLLPSAHDMVREARVQQGLVGTDVPVARVVLADAGELIGLGCYVMEKVPGHVIRAELPDAYAERPEQRLTMGLAFADTLAALHAVDPAEVGLGDYGRPEGFMARQIRRWTGQWEASRTHEVLEIDELGRRLAAAVPGQQYASIVHGDFRLDNVVFDAADPGRINAVLDWELSTLGDPLTDVGLLMFFWAGADDPTFTLIPGVTHLPGFPTRDEMLERYAATSGADLSDMAFYQAFARYKFAIIAQGVQARAAAGSMGGQDFGNLDDEIRQLGQTGLELI
>AIA15217.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
MQRKIFDMRKILASLTALVATLSLFAPAMAGQPAAWSQPTKPFQILDNIYYVGTKGLASYLIVSNGKAILFDGTLAENAGYIEANIKALGFRLEDIKIILNSHAHYDHAAGIAKLKQDTGAQVMAMEEDRSALEHGKQEGDTNYGGARFPAVKVDRALHDGDVVALGDVKMTAVLTPGHTKGCTTWTTISADNGAPRQVVFPCSITVAGNILVGNKSYPGIVEDFRDSFERLGSMEADVVLTAHPEFADVFQRKARRDAGDKEAFVDKGLLHRMVEKARIGFDRDLKAAQK
>AIA14990.1|FEATURES|farme|beta_lactam|BL2a_III2|antibiotic inactivation|0
MVASLDQYGHELYRPGDDLGELELRTLISEYLYQSRGVNCLPEQVIVGAGNPALLQMLCKIFEVNLSIGYEDPGYPRAREIFKVNHMKIIPIPVDDEGVCIRKLNEERPRLVYVTPSHQFTLGTIMPVNRRIQLLKWAEEHQSFIIEDDYDGEFRSNGQPIPSLQGLDQHHRVIYMGTFSQSLLPSLRISYMILPLPLIEKGREIASLYKQTVSCHSQLTLAQFIKSGEWQKHINRMRKLYRKKRAVLLEAVRRELGQYVRIRGEN
>AIA14071.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MSIRTSRRIERVPASGIRRFFDIAAQMGNVISLGVGEPDFVTPEPFRQAGIRSIQEGRTAYTSNSGLLELRVAVADHIERRYGVRYDPETELLITVGVSEGLQNAMLATIDPGDEVIVPEPCFVAYPACVIFADGVPISVPSFVEDSFQVSPKAIEQAITPRTRALLIGYPNNPTGAVMSREGLLELAALAEKHDLLVFSDEIYDRLIYGVEHTCFASLPGMRERTLLMGGFSKAYAMTGWRLGWIAGPAEVISATRKVHQYGIMSAPTMSQYAGLAALREGEAACQEMVAEYDRRRRVIVNGFNSIGLKCFEPQGAFYAFPSVAHLGLSSEEFCERLLQEQRVAIIPGDIFGPSGAGFVRACYAASMDKIEAALDRIEHFVRTIT
>AIA13610.1|FEATURES|farme|macrolide-lincosamide-streptogramin|lnuD|antibiotic inactivation|0
MPSIRQFAETHGVSRFTVVEAYDRLVAKGYMESRRGSGFYVRERSPMIAAGNPRPAEMPPQQLDVVWLVRNMFRQYPAQHTPGSGLLPSDWLDGELIANGLRAISRQNLSLLLQYGNPQGFLPLRQQLQLKLAELEIAATPEQIVTTSGITQGLDLVARHFAQPGDTIFVDDPAWFLMFGSFATLGAKVVGIPRLPDGPDRILPSWPSWQQCTSRASMSSIPYCTIRRRLHCRPPRHSRS
>AIA13203.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
MRKILVFVAGICAVVAAVPVPAAWAAQPAAWSEPTSPFEIVDDIYYVGTKGLASYLIVSDGEGILLDGTLDENVGHIEQNIQALGFKLVDVKIIVNTHAHFDHAAGIAGLKRDTGAKVMAMEQERSALENGRHEGDNVYGATRFPAVKVDRALHDGDTISVGSVTMTATLTPGHTKGCTTWSMSAKDGEVTRQVVFPCSLTVAGNKLVGNAGHPTIVEDYEKSFELLKSMKADIVLPAHPEFGDIFERKAKRDAGDADAFVDTGLLQKLAETSRVAFEKELKAAQK
>AIA12985.1|FEATURES|farme|polymyxin|arnA|antibiotic inactivation|0
MPQARYKQLVDRLAADIRAGRLQPGTRLPTHRQLAAQEGLALVTATRVYAELDAMGLVSGETGRGTFVKETSLPHSGIDQQVVAADVVDLNFNYPSLPGQAELLRAALRQLASTGDLEALLRYQPHGGRQHERASVARHLAARGLSVTAPQVMLVDGAQHGLATSVMALLKPGDVVAADALTYPG
>AIA12885.1|FEATURES|farme|beta_lactam|PMI41_04644|antibiotic inactivation|1
MNLKLLAPIIATAFVSMTAASPGGAAENQRDKVGVWVNDAVRPVMSQYDIPGMAVGVILDGKSYVFNYGSMAKDGSKPITDKTLFEIGSISKTFTATLATYAQANGDLALTEPAGKYVPALQGSPFGDVEILHLATHTPGGFPLQVPDNVKNERQMLKYFKEWQPAYLPGTHRTYANPSIGMLGYITAHSMKGDFPTLVEQKLFRPMGMANSYINVPSDRMADYAQGYTKAGKPVRMSNAVLSSEAYGVRTTAADLVQFLKANMKLVPLDEKLARAIRDTHAGYFRVGEMTQDLVWEQFDYPAALPALLEGNSQRTSRPALPVKRISPPMSPRQDVLINKTGSTNGFGAYVAFVPEKRMGIVILANRFYPNEDRVKIVHQLFARFESGGVGHEPAPVE
>AIA12371.1|FEATURES|farme|beta_lactam|HMPREF1568_2704|antibiotic inactivation|0
MKLRRLYTFFALQLIAALLLSPLAAAQTASVAKPNQPATVVELPASPVGKLGRAFIEAVNSGDKTALANFIASSFSEIAMKNAPASEYIANLQKVYAQSGGFDVMEVMPTTDANMLRLKLRSKRGNRWVMLVTRLDKAQPDRLDGFGVRLLPDPEIEKADVWSEAKMDEAGAVKEIERHVEMAASQDRFSGVALVMKGDRVIFNKAYGIAERGFGAPNKLDTKFNLGSMNKMFTSVAIAQLVQAGKLSYDETLAHALPDYPNKQTAEKITIHQLLTHTSGLGDFFKPEF
>AIA10902.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MKRIAFLLSYALAALPAFAAAAEWEGPQDPFQLYGNSYYVGTQGLSSVLITSKAGHILIDGASPKSAVMIAAHIRRLGFRLEDIRYILVSHEHLDHAGGIAELQALSGATVITSPAAQPVLASGKADKGDPQAGNDMPDMKPVGAIRTVRDGETVELGTLSIKANYTPGHTQGGISWTWKAVENGRAMNMVYADSLNAIAGPGFRYSANTLYPTAKADIERSIARVAALPCDILVTAHPDAVDLIERQAKGKAALVDPGACQRYAETGRARLAKTLAEEKR
>AIA10555.1|FEATURES|farme|aminoglycoside|ERS370000_04144|antibiotic inactivation|0
MIRLAHADDLLIMQDIERAAGQVFRALGMDLVADDEPLTVDQLHGYAVAGRAWVYVDGLDYPVAYLLADIVDGAGHVEQVSVHPDYARQGLGRELLHAARVWTRGHGMQRQTLSTFRDVPWNAPYYRRLGFEVLDAGSWGPQLTRLTEHEAGLGLTHWPRVAMWRPAVPPT
>AIA19301.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPKISKKAQAMPASPIRKLVPFADAAKKRGTKIFHLNIGQPDMETPKQFWDKLKNLDMKVLEYCPSNGLESYRKKFAEYYNRIGIQVDASHFMITEGASEALSFGMMSCLNEDDEIIIPEPMYANYIGFATAGHIQVKPIPTSIESGFALPPIADFERAITPKTKAILVCNPNNPTGYFYSKEEIMTLREICLKHDLYLFVDEVYREFLYSDKTFFSALNLEGMDQHVIVFDSISKRFSACGARIGALVTRNKEVLQAVLKFGQARLSPPSLGQIAGEELFDLGKEYYDSIIAEYKKRRDVLVEGLNKIPGVYCPNPGGAFYAVASLPVKDTDVFCQWMLEKFSHNGATVMMAPASGFYSTPGSGKNQVRIAYVLNANDLKTAIACLEAGLKEYAAQKEVSAQVH
>AIA19165.1|FEATURES|farme|beta_lactam|SPG-1|antibiotic inactivation|1
MKIFQMLSVLLVSSLAFADGPANPVLTHDPSWSAPHAPYQITDNIYAVGTDGIGVYLITTPKGHILLDAATEQGAAVVEANIQSLGFKLKDIKYLIENHAHSDHAGGLAQLKKSTGAKLIASQGDRYSLEHGTLDSETNWEDKFPPVKVDKIIADGKDVILGGIHMQAIMTPGHTKGCTSWLTESEDKGVKRKVIFACSITTAGNKLIDNKIYPNIVNDFRNTFARLIKIQADILLTGHPSMAGLEEKYQAQKNGKKDAFVDPMGLQNLVENAEEKFEEELKKQREKGANNIVR
>AIA18441.1|FEATURES|farme|aminoglycoside|TO66_29130|antibiotic inactivation|0
MPNTIHSAHDITDQEWDALRTLYVEAFVAMSSTLSACDLALMDNHPEQFWAGVFDRDKPQSTAKNYTFSLTKEGERIIAYGLYTYVNGTQYLYIHHFVVHPDYQGQGLGKRLMCAIEELHSEAKKVGLLTRTYNVLAQNFYERLGFSATSDVPALIREYYSNDRVYMERSK
>AIA18079.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MKRLAALTAALCLSFSASANDPNHIDCGSCAAWNVAQKPFKIVGNTYYVGTKELSAMLVTTPKGHVLLDGALPQSAAQIEANIKALGFNIRDVKYILNSHAHWDHAGGISALQKASGATVLASEWGARVLRAGTVEADDPQYNPKHIEHFPKVANVRAVKDNEVIRVGDVAITALMAPGHTPGSTTWTWKSCEAGKCHDIVYADSLTAVSADDFRFTGGAGKPDLSDSFRSTIDRIGKLQCDVIVSTHPGFTDTLDKLAKTTPTHNGFLVGGCAEYAAASLKRFDERIATERR
>AIA17699.1|FEATURES|farme|aminoglycoside|ANT(6)-Ia|antibiotic inactivation|0
MYSSFQLAKKYLQYYLTASNSKGHGMHSPFVFQFILHVLNNKSGHRPPAEIERLRTLLLHDKRMLDIEDFGAGSRMASHKKRSVVQLAKYALKPKKYAQLFFRLVKHYQPQTILELGTSLGLTTAYLAAANPSARIITIEGSEAIAAVAKENFATLLLTGIHQQLGNFDVLLPAVLKEHSSFDLVYVDGNHRTV
>AIA17375.1|FEATURES|farme|peptide|vph|antibiotic inactivation|0
MEQGTITRILQLYGIEHDDILAPQKGYRNSSFAILRGGQPPLNLILYKNEPGMLARIIRTNAIGNFLHARGMPARRTFSPRIMQLKSAHQTRHAALYYYVSGSTIPWEAYTMERIKTLGKTMGNMHSILADYSGDLPDIADELIALNRRMVRYFVEPDVARAMSQKLNIKIKQPSFMRLLASCKNQPSQALHMDFVRGNILFEGDDITGILDFEKAGRGTPAFDIARTLAFLLIDCKYKSEDKTYKYFIQSGYTKRSASTFRAWQSVDRLVQFFLLHDFYKFLRHNPYEHLEQNEHFVRTKAMLLKHGIIERAHVK
>AIA17322.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRTNIIHPGAGHLKYEIRSIVEFANSLQKTGVDVIWENIGDPIAKGEEVPAWIKDIVVDAAKDSMSYAYSPTKGLNEARDYLAKTRSQSTGATLNSEDIIFFNGLGDAITKLYTWLNPTARVLGPSPAYPTHSSVEGAHGRSRHHTYDLDPENGWIPDVEDIKKKIEKNPNIAALLIINPDNPTGMVYPRHILEEFVALAKKNDLFLIADEIYANLAYEPDEFTSLVEIADGVPTVIMRGLSKEVPWPGSRCGWLEFYNTKRDSDFARYAQSIEEAKMIEVCSTTLPQTVLPKILSDHRYPDHLRHRTEQYKQRADIAEQMLADIEGVDVIKPKGAFYLVVNFKSGFLDESKKLTPANAAAADLLNKALAETEEDELDKIFCLQLLAHNGLCTVPLTTGFNSHIPGLRMTLLESDEKKFRHNLTLLAQALQNYQQQ
>AIA17323.1|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|0
MLDYKTSQVYLDGNLVPFKDANISIASSPVLYGLTIYTVFCLNWNDQQQKLYAFRLKDHFKRLVNSARIMDFGQFINDWTYEKFEQTMLELISKNNVREDALVRVAVYVDELIAGTKIHGLKNSVSAYIYPMGEILPLTGINACVSSWVRTQDNAMPSRAKINGSYVNASLMKNEAVLNGYDEAIALDHNGHVAEGTVANIFIVKNGTLITPDDSTDILEGITRSSILQIARDLDLRVKQCAIDRSELYIADEVFMCGSSARIAPILSIDKRPIGNGQIGKVTGELMKYYKEVQLGNNSAYTHWLHQV
>AIA17238.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSLTIRRAQKGEAGLVLSFVRELAEYEKLLHEMEATEADIDAALFCASPRLFCEIAEWNGEPVGFAVWFVNFSTFSGRSGIYLEDLFVRPAQRGNGIGKALLVHLAKHCVENGWSRLQWSVLDWNTPSIAFYKSLGAELMDEWTTCRVGGPALTALAQGKL
>AIA17184.1|FEATURES|farme|aminoglycoside|APH(9)-Ib|antibiotic inactivation|0
MKMHRITRWTRAVYVLWTLLTFALDVALEAKGWFGRKARREARLRQQAIQLRGRLIKLGPTFIKMGQMLATRADLLPLDYLKELSELQDRVPPFPDSQARAILEAELGRPIEKIFTELSEPPVASASLAQVYRGRLLTGEEVAVKVQRPLLEEQIRFDLDLLRGIGRWLDRHPNLLPGAEWLGAIDEFDRVIHEEMDYRREAASADEFRRNFRDWPGLYVPHIFHQLSTSRVIVMEFITGIKVTHLDQLRAAGHSPRRINELIYRAYFKQLLEDGFFHADPHPGNLLVMPDGRLAVFDFGMVGRVSDELQRQMINAFFHLYNRDVKAIVGDLVGLGFLAPAADVTAIGAIVAEVFERKLNLKLGEVRFKDLTYDLAPIVYEHPITTPARFTYLIRAIMTLEGISIVMNPEFNFFDVARPYVKEFLFRRESSHLRQMALQSLRDARTGRFSLDRLWSMAKMAYSLYIGD
>AIA16887.1|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|0
MPSLLYGDTEVVNNRAATRDARKRGIPYGQALEESTARFQADWEQWQSLYNLPNNLYQPGAQDHNGTPFYDVEIDVTHLAKDQTAEVLHQALLESGLVERRNVVEPVQIFPVPVNGLFF
>AIA16580.1|FEATURES|farme|peptide|vph|antibiotic inactivation|0
MTKTASKTPITEPMTLADKVLHAYGLEYSRILTPQKGYRNQSFPVVLASGEMRNLILYKREPGIVKRIKAANAVSDFLAGQNFPTRQTADERIIKLDSGSGRPAQYGALYSYLDGHTIPWEAYTQDHIKALGEMMGNMHAALAAFPPRAADSLPAVTDEYLAIVARMKRYFGEAPVQRSLGQKLQLAVGLERLEYFEQLLVGANMLPGQQALHMDFVRGNILFVREPVEESGPRITGILDFEKTAYGHPLMDVARTLAFLYIDCKYKPEEKVRKYFLGSGYAKRSAAPLPARLSAALLGPLVDLFLCYDFYKFLRHNPYESLRQNEHFVRTRDMLLARGVVTSSTP
>AIA16355.1|FEATURES|farme|aminoglycoside|sat-3|antibiotic inactivation|0
MISIHKGSPADFDQFYASFENSLASNFKHYSKKIISYLLKNDYPASWLKERVNIGKKVYFLATFEDQIIGYFLVSKPFAGVSLGDWLSVDKKFQKQGIATQLIQQWEDYAKNEGAHALQLWTTEENVDFYKKRGFLLAGKFPESWYGIDRYLFYKNIQKPLQQNYLKD
>AIA16099.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|1
MSEKTRQEVLELAHKHSLDIQADSLQFNESGLDFQVVLATDTEGERWILRFPRREDVLRSVAQEKRTLELIAPLLAVEVPVWIVSTNELIAYKALCGVPTATVDPEAKCYLWAIDENNVPEQFHQTLAEGIASLHHISVEKAHSAGLLIATAKEVRATMKQRMDVVRSEFGVDQQLWDRWQRWLENDVFWSHETVLTHGDLHAGHILINARTEVTGFIDWTEAAINDPAVDFVAHYRTFGEDALD
>AIA16095.1|FEATURES|farme|aminoglycoside|ASD83_19545|antibiotic inactivation|0
RKNMVEVVNTEMSDLEQIFELFEHSINYQEKKGYPVWRNYDKNAIIRDIADRNQYKIIIDSKTAMIFSVCYTDKIIWRDLDEGDSIYLHRIVVNPEFKGQKLFGTILDWVITHSKQKRLSSIRMDTWAANPTIIDYYKSFGFAFIENYTTPDSEELPVHNRNLALTLLEYKLQY
>AIA16029.1|FEATURES|farme|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|0
ETLTHTTSTAVIAAAEDVRSADAEQLMTELSAELAALYEVADGSAGFKASDVEVPRAAFVIARIDGFPVGCGALRPLDASTGEVKRMYTRRGFRRKGVAQAILAELERLAIEFGYTTIKLQTGPKQLDAAALYELVGYHRIPRFSGNWDLVLAYQKDL
>AIA15558.1|FEATURES|farme|aminoglycoside|AAC(3)-Ic|antibiotic inactivation|0
SRSTYDGVVAGTVALKKVSNDVYEFTKMAVDEAYRRRGIAEALTYASFEKARELGATKVILYSNRVLTPAITMYHKLGFTEVPMEKDVVYQRSDIKMEIDLASLRPQADSYTNANAPAQHFTTI
>AIA15252.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MKFPTASALALTSLALALGLSTSLAQAAEVSGVTEHTALATKAAKTDLLGALGLCKTATPQPAASFMDNYNKLKQKPPLEPMQVMDELYFLGNYWTSAWAVKTSQGIVIIDALDNADEAQHYIEDGLKKLKLNPADIKYVIVSHAHGDHYGGAAYLKKKFDPKIVMSDIDWKTFDDPKFDPKRIPLFDAPPKRDMAVNDGDTIKLGNTEFKLYVIPGHTLGTLATVFTVHDEGKAHRAVAWGGTAYNFGPLADRLQIYADTTAKYRDVMKKENADVLLSNHVSYDNAVAKMGTLKERKPNQPNPFVVGEDTVDRFLTVLGECALATKAYVEAGQPGKEQAEKKDAPAPAAEKK
>AIA15074.1|FEATURES|farme|aminoglycoside|APH(2'')-IIIa|antibiotic inactivation|1
MTDEREHLALPIFTLTNGHIPPVTTASWLGEGDFCFCYLVNGEYVLRFAKHATASAANVREACVLSVIAPLLSVAVPQPEARGINNETGEQLQYYPLVPGTILESEVLESLPPAVQASLIAQMADFMRQVHAIPLEAVSACGIPTFQTLTHFGEVMERARDTLRPHLTDAVWNHHEALLARATANPRFDHYTPVLLHGDLSPDHFLADLDTGKLTGVIDFGDVCIGDPAWDFVYILEDYGADVLTAFLAHYDSDNAAFLAEKVRTYQHLNNVAYGVSALAEGNDDDFAEAMAILTEQAR
>AIA14937.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MLATKVDRVADAVSRLGSESAFEVLARAKALEAEGKRVVHMEIGEPDFDTPAHIKEAGIQAIRENYTHYSPSAGIIQLRDVIAGYAAKFRGVEPFSAENVVVSPGAKPVIWNILSAILSPGDEFVYFDPAYPAYASCANYLGAKVVPIPLYEEKNWRMDLDELERRVSDKTRAIMINSPHNPTGGVLTKGDLERIAQMAIKHDFLVIADEIYSRNFYESSFASIVAVHGMRERTIIVDGFSKAYAMTGWRLGYAIMPPSLAKIVTLFNNNTFSCVATFVQQAGIAALLGPDEPVREMNETFRTRRDRLVNGLNNLPGVSCTMPEGAFYAFPNVKQITADDKALATFLLSEGGVACLGGSAFGSAGKGYLRFSYAASLEDIDYALEQMARCIPQFKG
>AIA14926.1|FEATURES|farme|aminoglycoside|AAC(3)-Ic|antibiotic inactivation|1
MGQNMEIDNFLKIERLAENDLPKFIQLIRLFEAVFEMKNFSIPDSEHLQKLLNQNNFYVFVALLENKIVGGLTSYVLEQYYSEKPLAYIYDLAVDTNWQRQGIGKKLITATNQFYTEKGFEEVFVQADKVDDYALDFYRSTKPTAEEQVVHFYYTLKN
>AIA14841.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MKMENPAPVQWQFSRRAEQLQSSVIREILKVTVRPEVISFAGGLPSPATFPVERMRAAYDSVLSKQGKVALQYGPSDGYAPLREWVAQSLSTDGARILPEQVLMVSGSQQGLDLLAKVLIDEGSKVLVETPSYLGALQAFSVYQPEFVSVPTDDHGLLPDQVASVGQGARLLYALPNFQNPTGRTLSVERRIALVETCARLGLPL
>AIA14581.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MTATLRPARPDDVPVIVDLIRGLARYEKLEDNVAATEDGIRSALFGPSPRVFCDLAEADGQVAGFALWFYTFSTFVGRHGIYLEDLFVRAEFRGQGIGKALIRNLARRCAVENLGRFEWSVLDWNQPAIQFYRSQGARLLDDWIICRVEGEALQALGGAA
>AIA14398.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MKKLFLAAIALASGLSAALAQDNPTIDKHMAAATKAAKADLLGALGLCKTATSQEATGFMENYTKMKAEPPLEPMQVMDDLYFLGNYWTSAWAVKTSKGIVILDALDNADEAKQYIEGGLKKLKLDPSDIKYVIVSHAHGDHYGGAAYLKKKFDAKIVMSDIDWKVFDDPSFNPKRIPLFDDPPKRDMAVKDGDTIKVGNTEFKLYVIPGHTLGTLATVVTVHDKGKSYRAVDWGGTAYNFGPLADRLQIYADTTEKYRPIMKKEKAEVLLSNHVSYDNAVGKMGTLKERKPNQPNPFLVGEDTVDRFLTVLGECALATKAYVEAGQPGKEKKDEPAAAAPAAEKK
>AIA14053.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MITRFKILSSCAVFACLVCACNASVSPTLQTSTTASPGAAVQTPTPAVCSATSLQKQFEEIASVAAGPVGVAVLEIETGELVTLSGKQHFPMQSVYKLPIGMAVLQQVDKGLLKLDQIVHVKPADLVPANLGSPLRDRHPQGADVTLSELLSLMVKDSDGTASDVLLNLIGGPDAATKYLRELGVEDIVVATSERDMAGDVQVQYRNWSTPEAMVGLLKLLHEGRGLTAASRTLLLDWMVKTQTFPTRLKGMLPEGTIVAHKTGSSGARDGVARATNDVGLITLPNGHHLAIAVFVSDTKADAKTRDAVIARSARAAWDCWVTSEKK
>AIA13479.1|FEATURES|farme|beta_lactam|AS202_10895|antibiotic inactivation|1
MNTRIGFLLLSLFIVGLNSAPAEAQDLSPYFKNTNGAFVLYDLKENHYIRYNEQRCRERFSPKSTFKIPNSLIGLDTGVIRDADFTIAWNRQKYPPQDNWNQEPFIHWAQDHTLRSAIKYSVVWYYRELALRVGKQKMMKYITAFNYGNKTISKDIDNFWLDNSLKISADEQVEFLKEFYAGRLPVSKLAIETVKDILVLENTPAYKLSAKTGGGSIAEGKYIGWFVGYLETKGNVYFFATNIEGASFAEIREKRVELSKEILAALGYLPK
>AIA12664.1|FEATURES|farme|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MKKSLFYLALFSLSASCVAADLSSQQVTSLVKAAIEPLMEQQEIPGMSVAVLYKGRAQFVNFGVADLESRRRVTENTLFELGSVSKTFTGTLAGVMIRNGEIRLNDPVQKYWPQLTGEQWRPVRMLHLATYTAGGLPLQLPDDVSDQASLLRFYQEWQPEAAPGTLRQYSNASIGLFGSLMVKGDYEQAMARNVFQPLRLTRTYITVPPSMMLDYAWGYKNGQPVRVSPGMLDAEAYGVKSTARDMLTFMQANVDPNRLSSGNAVLRNAIRTAQARYFKVGTLFQGLGWEIYDWPVTADTLMGDSDNGVALQPRPATLLNPVGPSQSASWVHKTGATNGFGAYIAFIPERNSGVVILANKNYPNPLRIKAAWQILQALQQEKPE
>AIA12645.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MRNYFPNPIPALALAIFLLAFASFASGQSNAPASSCADCPEWNKPQQPFRIYGNTYYVGPHGLTSILLTSKAGHVLLDGALPESVPQIVANIRALGFRIEDVKLIVNSHVHFDHSGGISELQRLSGAKVAASPWSVEVLTKSGVGKGDPQFGVVTPVALVPRADTLRDGQTLRVGDIKLTAHFTPGHTPGGTSWTWRSCEGKRCLNLVYSDSMTPVSADGFRYSDSREYPTAVQDFEKSFAFLKTTQCDILLTSHPDASGLWQRLEGRERGVRPNPMVSPDACKKLAERAAGQLRRRLESEKGR
>AIA12305.1|FEATURES|farme|beta_lactam|LRA-18|antibiotic inactivation|1
MIISSTLRAFLTGGALSALLAASACHAADANAALRAIVDRAVRPVIAEYDLPGVAVAVTVDGKASFFNYGLASLEDKTPVSENTLFELGSISKTFTATLASYAQVTGKLSLDDHPGKYLPELKGSAIDNATVLHLGTYAPGGLPLQFPDEVPDDGMLAYFKQWKADAAPGTQRRYSNPSLGLFGHVAALSMGSGFADAVESRILPGLGLKHTYLRVPAGAMGDYAWGYDKANKPGRMGPGPLAAETYGIRSSAADMIRYLQANIAPSRLDTPLRRAVEGTHVGYFKIDGMVQGLGWEQYPYPVSLKDLEAGNSQKMIWEANPASALVPPQTPPPATLFNKTGSTSRFGAYAAFVPAKKIGVVILANKNYPIPARVKAAHAILVNLEARRAD
>AIA11981.1|FEATURES|farme|beta_lactam|OXA-54|antibiotic inactivation|1
MRLKATLLTALFLLAALGCAKTTGRGSVVVEGQAQTAAPAAAQPDLAKHFKPYPAGAFVLYDLKRDSYLRYNEARCRERFSPYSTFKIPNSLIGLDTGVITDAEYVIKWDKQKYPAHDRDTLPFSAWWQDQTLRTAIKRSVVWYYRELALKVGERRMKEYVNRLDYGNEDASGPLNNFWLNSTLKISADEQVEFLKRLYKEELPVSKRSTSIVKEIITLEETPGYKLSGKTGGGSLEENSYLGWFVGYLETKDGTYFFATEIEGSTYLSIRDERIAVTKRILADLGHLRN
>AIA11789.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MLKTSKAFSGFSVTDIKIAKDFYGDVLGLEVSEQKGMGLDLHLGGGAHVFLYPKEDHKPATYTVLNFPVDDIDKVVDELTKRGIKFEVYADSEFIKQDGKGIARSDDPSRGPSIAWFKDPFGNILSVLK
>AIA11500.1|FEATURES|farme|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|0
MDAPLQPFILRPVMPADEPFLWEMLYQALYVAEGDLPFPRDIIGHPDIRRYVEGWGQPDDSGFIAVEETTGQPVGAVWVRLMTGAYRGYGYVDEITPELTIAVLPDYRGRGVGKRLLEELLAAVRPAYPAICLSVSAANPALRLYQRLGFEIVKSSADSATMRMAFAGESYDETKI
>AIA11213.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MRQKLNLITLGVDDFDRSVGFFEDGLGWNKSSASVPGLALFPLGGIVLALHPRKDLADDAMVPQEGSGFSGITLSYNAKSEKEVDEVLKKVEGLGATIIKPAQQVYWGGYSGYFKDFDGHLFEVAHNPFWEFDNQDNLILP
>AIA11008.1|FEATURES|farme|beta_lactam|SD53_15990|antibiotic inactivation|1
MKIKPLLLACFLIILSSFKFTGGDLQNKIETIISSTKADIGVAVMVPSSHDTILVNGMKPYTMMSVVKFPQAVYILSLVDRGKLRLSQKVNFDAAELQRKTHSPMRDKYGKDPFEVTLEETIMWAVSHSDNIACDRLFELGGGVAANEKYFQDLGYHDFAIGVDYKHLDEKTMRANNTSPLTMTRILERFYNGKLLAGSSRNLLLKFMTQSQNPEDRIKGNLPKGTVVAHKTGTSAAAENGTIQVFNDVGIITLPSGKQIILSVFVSASKEKSDDNAKAIAAIAKAVFDHYSN
>AIA11009.1|FEATURES|farme|aminoglycoside|AAC(6')-34|antibiotic inactivation|0
MDPEAYRLAFEMSDPGEQQEFFGYATRDRLEEERLRWQQGMVTFNKSFCWFTIFLKAEQTAVGWCGFHTWYIPHRRAEIGYEISGDDYKRSGLMTEALAAVIDYGFTELNLNRIEAFVEPGNEASIKLLEKSDFLKEGLLREHYFKNNEFQDSVVYGLFEKKDVNGLNQPGYHLQIKVTPY
>AIA10512.1|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MVWMRLAFCFLLGLTLCPSAVAQERVKIQLADDVFIEKLEPGVWRHVSYKTLPNLGPVPSNGGIITVGSDILLIDSAWNNEQTKLILDWSEKELRAAPSIAVITHAHEDRIGGIHELHRRGIRTVSSKLTAELAKQQGLEVPQQTFEGRRNLSLGGRSIEVYYPGPGHTKDNVVVWIPDKHILFGGCLIKAAQAQNLGNIKEADLEQWPKTVETLAHEFKEVRLVVPGHGDPSGSEAMTHTLELLEKAVPLKPPVKGSTSH
>AIA19152.1|FEATURES|farme|beta_lactam|CARB-10|antibiotic inactivation|0
MPNVHAAGGGCPSIRGSPLSKHAQLGALAVHIVNAGRARLGSSNVPTRTNIKCGLASASLKSGVPHAPQNRRRMRFPLSETLKYSLASPVLEKVDVRKHEFTVPLPAPRYWQSRHQHTRVTIGNSELVQRTNPQRHLPVIVM
>AIA19023.1|FEATURES|farme|aminoglycoside|AAT_like|antibiotic inactivation|0
WDQVANLCEANGLIPFVDMAYQGFGDGLEEDTYGLRMLSARLPEVIVATSCSKNFGLYRERTAALSFVFADEQQANAGLSNLLSVARSIYSMPPAHGSALVDIILHSSELTTVWSNELTTMRERIAGLRVDLVQSLNQLQSQRDFTFIAKERGMFSFLGLSVEQVHKLKNDYSIYMTDTSRISVAGLTKEKMDYVSRAIVSVL
>AIA19014.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MIRFARILVLILLFPILAFAQQAKLKSEIETISKDAKGIVGVGVMDLKTRETLLMNQEHKFPMQSTFKFPLAIAVLDLVDKGKYKINQKIHVKSAGLDPETHSPMRDKRPNQDFDITIGELLSYSVSESDNNACDILFELAGGTKKVNEYIHSLGVKDIAIVATEKEMKAGWDVQYTNYARPSAYLQLLQIAYERRKLSKASHDYLWKMMVEGPTGLKRIKGLLPKGTEVAHKTGTSGTNDKGISAATNDAGIIRLPNGKDIAVVVFVSDAAANMDTRELVIARIAKAVWDYYGSK
>AIA18968.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSDFIIRAAAPSDAPAIVSLLKELADYEKLLDHFTLTEAEAARDMLGAACHCDLAFQGGESVGIAVWYWTYKSFRARRGLFVEDLFVRRAHRGRGIGKALLVHLAAKARKAGGFLEWQVLDWNAPSIDFYKSLGAKPWENWLIYRLEGEALERLNP
>AIA18947.1|FEATURES|farme|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|0
MSAHFTNKGYRVSYLADCAAHIPALAKMWFQELGQQWIPNASCAKAEKNLAAHLNQNTLPLTFVVFNENSPIAMASLRKEDGLQSDLTPWLGSLIVSPNFRLQKIGEGLVNLIEHEALKLGHQKLYLFTLDLTIHQWYERLGFACIGTDKLYHHPIRVMEKLI
>AIA18948.1|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MKINFKSALYFLTTFLCMIPSFLLAAVDQKDMINKAVHTFMEKNQIPGVAVEVFNDGEPNSYYFGLANQEKKIPVSGKTIFELGSISKLMTSLLLAQEVDFANLQLNTPLREVLKDLPETFNNVTLQSLATHVSGLPFRPSQPINDRVELEKYLNGFPKITLPDKQWAYSNFGINVLGYALETSTHKDFYQLYRSHILAPLKMQNLSEPKRKVSGFIAQGYDKEGKPASAVGPGLLPAAGGLKASAEDMQRFLSAAIGLPKTPMRIFYPMRMTQSIYVKLSNHMQGLGWQIHPMDKSKIGNLFTEATNPLALGTLNVLEIEQRPMFDPNALIDKTGGTDGFRSYIAVIPNKKSGVVILANKFVPSDEIVKLGREILLKMTNIIDT
>AIA18942.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MPHTKKILVIGASVAGPALCYWLNHYGFQPTLVEKNQSTRKGGYAIDLRGIAVDVAKQMGIYDSVCAMRTSLQCVRYVDAAGNLLFEEHGEKGGFRQGDEVEIVRGDLVDILMKTITDIPCFYDHAIESLTQHDDHVTVQFKNGKTENYDLVIAADGLHSATRRMVFSKDDYHLRNLGCYISVFSIPNYLQLDHCETLLEAKQKLVSITSDKDSTKAFAGFMFRSSNSPNDIRDEASQKDFLRENFTNHGWESNKLLSLMNDANDFYFDAIMQVKMKDWTKGRIALVGDAGYTPSPLSGQGTSLALVGAYILAGELKTATDHVAAFARYNELLKPYVEANQAFGVWVSESFLADEPLSAEQAEERNNIVLGIMKKATHAIELPEY
>AIA18895.1|FEATURES|farme|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|0
MVNIEDIINDLQDPSITHFSAIKKGFSTATKYILHSKGNKSRYVLKIYGIEKADRRNAEFDLLKRHYSHNVSCQMPVKFGINEEQQICYMILSYLDGVSGDTSLPLKSVEEQYSLGISAGEELKKIHVITPQKPFNWYEKRMRKYHNKVDECKRQGLKFYKQECIESYIKDNIYLLKDSPIHFQHDDFHPQNMIVKDDGTISIIDFDSYDWGDPLEEFFKLPKFTIHISAYFAKGQVIGYFNHKIPDDFWRKYNLFVALNQHASKIAGAAANNLQAVEERTRFIIETHDFSNHGAPDWYQNTIL
>AIA18806.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSDFSIRAAAPSDAPAIVSLLQEFAVYAKLLEHFALTEEQVVRDMFGAACHCDLAFQGAEAVGIAAWYWTYKSFRARRGLFVEDLYVRPDRRGRGLGKALLTHLAAKARAAGGFLEWQVLDWNAPSIAFYKSLGAQPLEGWLNYRLDGDALESLTA
>AIA18768.1|FEATURES|farme|beta_lactam|blaOXY|antibiotic inactivation|1
ANAEMMNATLQQKLASFEKMSGTKIGAAAINTADNTYLQYRATQRFPLCSTFKVMVTAAILQKSMAESDLLQQKIYYKKQDFVYYSPVTEKHLADGMTVAELSAAAMMMSDNTATNLLLKKLGGPQAVTAFARSIGDQIFRNDRFEPDMSSSIPGDIRDTSTPLAMASSLRRLVLGDNLGLVQRQQLQTWLIGNTTGDKLIRASVPQGWTVGDKSGKGDYGTRNDIAIIWPLHGAPIVMAIYTTQSIKDAESRDAVVAGVARILLDELTQVNSGIKANIK
>AIA18722.1|FEATURES|farme|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MPSFDVKVLRPGSAGALREMLTVFGRAFADVATYTARQPGGDYLEGLLASSTFIGLAALADGQVIGGIAAYVLPKFEQVRSEIYIYDLAVDEEHRRRGVATALIAELRHVAAARGAYVIFVQADREDEAAISLYAKLGVREDVLHFDIAPIPGVAP
>AIA18668.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MGASSIGVRPELVERILRAYGLEWRRIHQPQKGYRNNSFPVEFADGQVLNLIFYKSELGILGLIQASNRVSDYLAAQGLPCRRTLGPIACLQPTGKTDQPVRKRYAGLYTYLTGQTIPWEAYTRDHIKALGMTMSNMHAALKPLPQGSLPDAAEIYLAILGRMEKYFKDPGVCQALTVKLQLGAPRPELFKHYAALLKACRRLPGQQPLHLDFVRGNILFRNRPDSAHGLKVTITGILDLEKTAFGHPLLDIARTLAFLLVDCKSKPAAKVRKHFLHSGYSKRGRAADLE
>AIA18615.1|FEATURES|farme|chloramphenicol|catA16|antibiotic inactivation|1
MKFELIDVSTWSRREYFDHYLNKIPCTYSMTANLDATHLLREIKKKDIKLYPTMLYLLSMVVNRHDEFRTAIDPNGDVGVFDLMHPIYTIFQKESESFTNIWTEYHVDFSEFYKAYLDDIQKYSDVKKFIAKPDGPPNVFTISSIPWVSFTGFNLNIAKADNYLLPIFTTGKYFEQNDRKWLPISIQVHHAVCDGFHAARFMNELQEAMNHFEC
>AIA18616.1|FEATURES|farme|streptothricin|sat-1|antibiotic inactivation|0
MNEHKPFLNLLEESFPGLKANISRCETLGFQWTSKPFLKGINEEILSHVGFLEYPILIEGRECKAAALHAICTRATHRGQGFASELIQEALKWAKDRYEFVMLFTEIPGFYEKLAFRSIQEYRFHLPCRHLNGSQSTQPVVSPKDDALFLRTFHERAPLSNLLWIKDTGTIAAFNTLFATYPTYWSLHYSPSINGMISYEIKDKTLHLYDVIASRIPSLDLILDQIPAAIEGIYFYFSPDLLTNAAVAEPYLYDHGQLMVYGDWPEVKPFMIQPLGRC
>AIA18617.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
PSTKGRIALVGDAGYAVSPIAGQGTSVALVGAYVLAGELAEAHGDYAKAFQGYEECLSEFVQINQKLAKTSLTLLEGGDVSWFKSAILWLHRNLMRFLPGCWIEFLKKRGLKQTAEAANAITIKDYQYGNTH
>AIA18582.1|FEATURES|farme|aminoglycoside|APH(2'')-IVa|antibiotic inactivation|0
MQDTETQSVLQVKLWGTRGSLPSPLSPDELYSHVRSLLSDFRVWTESNPIQNPTDMDRFLKELPRYRVSGYGGNTPCVEVKTKTNQVIIDAGSGIRKLGAELMKGPCGSGQGEVHLLFTHFHWDHLIGLPFFTPIFIPGNVIHVYAVQKDLERRY
>AIA18563.1|FEATURES|farme|aminoglycoside|BN77_3951|antibiotic inactivation|0
MLKQLPDGLILRSLSENIASDVERLPDFYASINAADDTDDIKEGVRVWTRDLMHGHATVTLDDIFVVVDPAKDDLLVSATLLIPQTWRYEDVVIPVGRPELVATHPDYRNRRLVRALFDALHERSAALGHNLQVITGIAHFYRQFGYTMSLDRHGVHFLTAYVAGV
>AIA18554.1|FEATURES|farme|beta_lactam|bla_2|antibiotic inactivation|1
MIHHNTIKNLFSLRPHFKRLLVCGIVFSCASWPLLANNNCFIAKENGRIIAEKGRCDQRHSPFSTFKIAIALMGYESKILVDTNHPRVAYDRHMQQLFKDYYHPKKYPVMLLAARDQTPFSWMRYSAIWYSQYVTMKLGKKQFQDYVTLLNYGNKDVSGDKTHRRGLLHAWLGTSLQISPKEQVNFIERLTRKKLPVSQSAQTNTMRIMTLQPIFDDWQLHGKTGGPVPSGWFVGWIEKNGRMISFAQYIEQPENSLLSGGRVAKEVAIDHLIALTLES
>AIA18522.1|FEATURES|farme|beta_lactam|NPS|antibiotic inactivation|1
MENIEERLDARVGLLIRDSGTGWSWGHRADERFLMNSTAKVPLCGAVLAQVDKGAMRLTDGLDVRAEDMVEYAPVTELRIGDTMQVGELCFAALDMSDNAAANILIDHLGGPQEVTAFMRQIGDDVSRLDRREPDLNRFETGDPRDTTSPAAVVDTPERLLVGDALSPSSRAQLTEWMTPGGVTGALLRAFTPDSWRVADKSGSGSVTRNIVGMIAPPQGGPYFVAIYLSEAEADFDTRNAAVVAISAAVVELIASR
>AIA18477.1|FEATURES|farme|bacitracin|uppP1|antibiotic inactivation|0
MHTQSKIIFLNGVGSVGKTSIAKMLQSLLDEAYLHVGVDQFIDMLPEKYINNSEGISFNPLKINQINNKPTIEITTGKIGKNALRGMRHAIAALADQGNNLIIDEVIIGNEMDEYKKLLSPFQVFYVGIFAPLEVIEERERSRKDRLIGLGRWQYNLVHQDKSYDLEIDTTTLSPLDCAKLIKNKFNLS
>AIA18457.1|FEATURES|farme|beta_lactam|Shewmr7_3328|antibiotic inactivation|1
PQARAFLQRPAAEAVVRVHKELKKQGLGIVIFDGYRPWSITKLFWEVTPDDKRKYVANPKTGSRHNRGCAVDLSIYDLKTGRLLPMPSDFDEFTERASPDYKGGTEEETRNRELLRKLMEAEGFTVNANEWWHFDYKDWQSYAIYDISFDDAGSLDKKPKKPKIEEKKEFKKIFDDAGISGGIYIYDLNRNKYTIFDRRRMDTGFVPASTSKILHSLIFLDSGAIKDENETLKWDGTLRSVEAWNQDQNLRSALKVSAVWFYVEVSKRVGQEKMQKYYDAVGYGNRDTNGFGADYWNKGNLRITPREQIEFLVKFQQNRLPFSPQVIAVVKDILIEEKTANYTLRAKTGWSDAFQPQVGWWVGYVERGADVYFFATEIDIKKDEDAAHRKEITKKI
>AIA18429.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MKRPIYTILLTVLISCTVAPANAQLTDLQTQITSISQSIIADIGVAVIDVQSNDTLSVNGNKHFPMQSVFKFHIALAALRQVDEGKLSLDQKYHVTKDHYFNTWSVLMREHPEANVDVTLRELITWCVMNSDNVACDLLFEILGGPSHVDKFIKSLNVNDIAITANERKMHTDWYEQFSNWTTPSATARLLRLFYDGKILKDDSNKFLWKLMADTPNAPNRLKGLLPEGTVVARKPGTGASSEDGVLGAANDVGILVLPNGKKIIVAAFVTNTKEPLSTAEMAIAQISKAVYDYFKK
>AIA18381.1|FEATURES|farme|aminoglycoside|ASE45_04665|antibiotic inactivation|0
MEAQEVIQFLNATQDDLSELISLLADDELGKVREQNAAEIDSAYQIAFQEITSDKNNELIVGKRNGKVIAVLQVTYIPGLTLRGSKRALIEGVRVSSQLRGQGTGRKLFYFAFEQAKKRGCKVVQLTTNKTRTDAHRFYESVGFKGTHEGFKFAL
>AIA18314.1|FEATURES|farme|beta_lactam|IIU_05946|antibiotic inactivation|1
TVILISLAGIILMNSCQQKESLQSRIEKEFSREQGEFALAFEDLATGEQLLINAGERFHAASTMKTPVMIEVYKQVAEGRMSLHDSVEVKNTFKSIVDGSAYSLDVADDSDTLIYKQLGHKRTLYSLMYDMIILSSNLATNLVIERVGAIHVTATMRGLGAKDIEVLRGVEDNKAYEKGLNNTITAYDQLLIMKKIALGKAVSKEASDAMMNILFDQRYRDIVPANLPPEVKVADKRGWLTGLEHDCAIVVLPNGHRYVLIILSRKLVDRDKAVKAMANVSRIIFDHVTAH
>AIA18223.1|FEATURES|farme|beta_lactam|SMB-1|antibiotic inactivation|1
MFEAISLLAWLAAASGAPVPAVDPLTQPITTSGSAEWLAPAPPEKIYGNSYLVGFGGMSVALIDTGDGLVLVDGALPQAAPAILANVRQLVFDPKDIKFILSTEPHFDHAGGLAALARDTGATVVASARGVEGLRTGRHAADDPQLAYGGSWPAVTTPMRVMADGEVLTLGKVGITAHATPGHTMGSMSWSWHACEGAACKAIVFASSLNPVSADDYKFSSAAGAPFVAAFAQSWRTMEALACDILISAHPDNAGEGRYNAKPGACRAYADRSRQALAKRLASEKAE
>AIA18220.1|FEATURES|farme|aminoglycoside|IP85_04510|antibiotic inactivation|0
FLRDATYKGEHFIKRGRTAYLERLIVDPAFQNKGIGTAFMIEVLDTLFYRSEFYDGKPADEVRLSIFNDKEASSVADEGRKGFDRNDYFFRQFGFENDEGTIDVDERTIQPYKLNIDRYELYRAKALATLTEKQPERKLILEEVWDELKDILRKKDPNYAKGR
>AIA18194.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MNIQIIYLNGPTSSGKSTLAKALQEALDSPFLHIGIDKIIGMMPDKVNNWVGCSAPLGFSWKESKDNDGNLIQELQMGPFAKQISDTYREVVALLVKLGHYVIIDDVSFGSEEMARWRKLLQNYRVLYVGVKSPLDVLELREKQRGNRMIGSAREQYHKVHLGNEYDVEVDTSKSPVKECVDLILKRL
>AIA18138.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MRNLFCSAASLTISFVFLAASEIYGQESLRKEIENLVRPVNGSIGVGVRHLESGDTLTIHGKDHFPMQSVYKFHLALAVLSDVDQGKLSMDQKVLIRKEEFIPNTVSPIADKYPDGNVALTVSELLSYTVSNSDNNGCDILFKLVGGPKKVEAYIRGLGVRDVAIVNTEREMHQDWDAQFNNWTTPQGMVQLLDLFYQKKILSPESRDFLVKIMEQAATGKKRIKGQLPAGTVVAHKTGMGGNDEVISAMNDVGVVTLPSGGHFAIALFVTNPKDSIEVVEAVMAKISKLVLDHYATAK
>AIA18098.1|FEATURES|farme|beta_lactam|CARB-14|antibiotic inactivation|1
MCSTFKALAAALVLVRVDEGEEKLDRRIKFSKKELVSGSPVTQARVGEPGMTVAELCDAAVTRSDNTAGNLLLASFKGPAALTAFCRTLGDDVSRLDRIETELNYHDRSDDIRDTTTAAVMLENLRKLLFTDILSGGSRSQLVAWLITSKTGDARLRAGLPKSWLVGDKTGTNGDKYGNANDIAVIWPPDRAPIIVTAYCEIPSIPADERDAVIADIGRIASEI
>AIA18074.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPGISHKAQAMPASPIRKLVPFAEAAKKKGTKIYHLNIGQPDIETPAVFLDAIKNAGMKIVEYSHSAGNESYRKKLCDYYREYNINIDPSEVIITCGGSEAIEFAMLACFNPGDEIIIPEPFYANYNGFSRAADVVVKPVRSYIDSGFALPPIAEFEKAITPKTRGIMICNPGNPTGYLYTKAELEALRDLVKKHDLFLLSDEVYREFCYDGKEYVSVMHLTGIEQNVVLLDSISKRYSACGARIGALISKNKEIMSAALKFAQARLSPPSYGQIGAEAALNTPKSYFEGVKKEYVARRNFLIESLNKMKGVFCPSPSGAFYCIAKLPIDNADKFCQWLLEEFSYNGQTVMLAPATGFYSTPGA
>AIA18046.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MIRYCFLNNTPVNALHHAFLRAFADYQVDMQMSLEDFEFRLRRDGVDTSISVGAFDDDQLVGFCLNGSGTWQGEPTVYDAGTGVLPQHRGKGIAAEMFRFMNPQLKERGFSRYLLEVLTSNEPAVNLYRRLGFEETRRLAVFRTTNSLSYRVNAVAEVRHVEVPEWKLYQTFWTGYPSWQNSIEAVQRVVDTTATVECLVDHRCVGYGVVSKTSGQLIQLAVDPSNRRRGLASKLLDELQNCVTGSASIKVNNVDENLKDATAFFEAVGFSLVLEQYEMILNL
>AIA18048.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MPLIRVILIITVFGAFALTSCNKSSSNTTPNSTVTQVSPTPKNQTELEKALEQKLTSICSRAQGSIGVTAVHVETGRAVSVNGNAVLPLYSVFKLPLAITVLKDVEANRLKVEQMVHVTPDEIVPGTPENTALWAKPVDRTVAELIEFSISRSDNTSTDKLLQLVGGPTRVTEQMRSLGFNNLDIHSTVMGYVKTRQSVNTGSADDLANLLTQLQQGKILQPAQSQLLVGYMRGTITGMRRLRGDLPPGTVVADKTGSGERNTQTNVPKTTNDVGLITLPNGKGTIAMAVLVTDSRLVDTAQEKIIAELARAAFDAYAKRE
>AIA18022.1|FEATURES|farme|aminoglycoside|aphA3|antibiotic inactivation|0
MKQPPPETALRFIHRDYHPVNVLWQEGKVSGVVDWANACRGPAGVDLGHCRVELAQLYDVATADAFLEKYQRLAGAEFSYQPYWDILALFDILFGPPQVYPGWPAFGFTGLTEQILMERLDLYLLSLLERAGVRP
>AIA18023.1|FEATURES|farme|aminoglycoside|YH67_08905|antibiotic inactivation|0
MAFIPNFSQPPADTLLQWVRAAVDPHSEIVEIRPLEGGSSSTLYSITLRTGEMLREVVLRQYDNLEWLAEEPDLARHEAAGLLWTEKTGLPTPRLLAVDKTGRVSGIPALVMTKLPGAVVLRPPDMAGWLEGLAETLARIHRFEVKYFPWNYLPLY
>AIA17953.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSKHIKILVIGAGIAGPAICYWLKRFGFSPVLIEKSPSIRKGGQALDIRGIATHIAKEMGIYDEICNIRTRIECGRFVDTAGNILHEEHGEKFGFRQDDEVEILRGDLVEILMKTIADVPCYFNQSITSMQQNDDNVIVNFKDGKIENYDIVIAADGIHSATRRMIFDKNEYQIIHLGSYLSTFTLPNYLGLHHMDLECEANHKLVSLNSDNDPEIARAGFMFRSQHVLKDIRDENEQKQFLRDTFHDFGWETQHILNRMSQSDDFYFDAITQVKMNSWTKGRIALVGDAGYCPSPLSGQGNNLALVGAYILAGELKTANGNYIQAFTRYNALLRSFVEANQQFGVWVSESFLVEDEVSKEVAEERSNKILAMIKSVSNAITLPQYE
>AIA17792.1|FEATURES|farme|aminoglycoside|WH87_16890|antibiotic inactivation|0
MIRTLTDRDFDAIHTAFLGAFSDYVIPMKPSADQLRSMFVRRGWVPELSLASFEGDVVTGFVINCVSGDQAYNTGTGTLPSHRRSGLARELMKRSMSLLSPRTYTLEVISTNEKAVALYRALGFEEVRKLDAWSLNGEWRTGDLACPDRQDCLSSTFHRETWFTSRPSWQ
>AIA17723.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MTMGYERIAERVAKVPPSGIRRFFDIVAQMPDVISLGIGEPDFVTPEHIRLAATRGLEVGSTAYTAYTSNSGLLELRLALAAHLEQLYGIGYDPEQELLITVGVSEALQNAMLATINPGDEVIIPEPSFVAYPASVVFAGGTPVTVPTSVADSFQVTAAAIEAAITPRTRAILIGYPNNPTGAVMPRARLLEIAALAEKHDLLVFSDEIYDRLVYGVEHTCFASLPGMRTRTVLLGGFSKAYAMTGWRLGWLAAPDDITAATRKIHQYAIMSAPTIAQYAGLEALRNGEAAVQGMLAEYDRRRRVIVGGLNQIGLPTFEAQGAFYVFPQISHLGLTSEEFAERLLHEQQVAVIPGDAFGPSGAGFVRACYATSMDKIEMALDRIDKFVHSIR
>AIA17711.1|FEATURES|farme|beta_lactam|TLA-2|antibiotic inactivation|1
HRYAQQAAQARAKGMAALSEVINHRGRDTQRKAMKTLLHGALILGISVMGLAEDHLAARYEQIAAQAKGRVGAASVVLEGGEETCIRCDEHFPMQSVYKFPIAMAVLARVDAGELKLDQKVAVSKNEYLADGAVSQLRDRSRDKDQTVELRELLELAVVKSDGTASDVLMRLLNNQAKAISGPYSVGAKEVMRFLASIGIDATSINVQDPEMALQKDWQVQYRNWMSPRGALKLLRAFHEGKGLSKQSHALLRDMLERSIRGEKRLKGLLPKETVMAHKTGTSGSRSGVTAATNDIGIITLPNGKHLAVAVFVSDSKGDQPMREGAIAALARLAWDEEVGKDPRVAFQKMYDEWLSLTKIVLYDGTELPKEKLRY
>AIA17691.1|FEATURES|farme|puromycin|pac|antibiotic inactivation|0
MSVDVSPLQRGDVRAAAGVLARAFYDDPVTTWLLPDDRTRLKALTRSFAPLARHHFLPRAGSEVGLRDGTVGAATLWDPPGKRKPSMVEQLITMPAMLWSFRSRIPASMRVMELMEKHHPEEPHWYLMLIGSDPAVRGAGFGHALMRSRLDRCDAEGAPAYLENSNPKNESYYVRFGFEVTGEIKLPDDGPTMWPMWRNPG
>AIA17680.1|FEATURES|farme|beta_lactam|OXA-54|antibiotic inactivation|1
MKQLLIIILFVIIVSAVAATKHVDNLQKPAPDLSPFFKDTTGAFVLYDLKNDRYIRYNEQRCRERFSPKSTFKIPNSLIGLESGVIRDADFVIPWNRLKYPPQDNWNQEPFSHWGQDHTLRSAIKYSVVWYYRELALRVGESRMKKLVSAFRYGNENVSGEIDDFWINGTLKISADEQVEFLKAFYAERLPVSKRSIDIVKDILVLEKTPAYTLRGKTGGGSIAEGKYIGWFVGYLETNGDVYFFASNIEGSNFNAIRDKRIEITKQILRQLGYLTT
>AIA17658.1|FEATURES|farme|beta_lactam|blaOXA|antibiotic inactivation|1
MNKLLTLILTATFISSTANAITTKEYSELFKNYNGCFILYNLNEHKVVNEYNPNNYCNQRIAPDSTFKVALSLMAFNQGIINQHTVFKWDGKKAELPDWNQDQTPASWLKYSVLWVSQQITPQLGYARIKRYLADFDYGNQDFSGDPDKNNGLTHAWLSSSLKISAMEQLHFLKAMLSNELPINSDAIKNTKENMYLGKLDNGADYYGKTGSGRHGRNERLTDPSLLRDGWFVGFVENKDKQYIFVSNLTDKTVQAIDRSNGGLKPYGSQLLKPITMKLLNDYFVK
>AIA17659.1|FEATURES|farme|aminoglycoside|SG34_20990|antibiotic inactivation|0
VLNHPSFEIPNFQPAGLPIVEIGWRLSSQHWGKGYATEAAKAVLHYAFTELNLNEIISFTVVANTQSRRVMEKIGLHHSEADDFDHPKLEENSPLKRHVLYRLTRDDYLTHEATINKRKK
>AIA17654.1|FEATURES|farme|beta_lactam|OXA-20|antibiotic inactivation|1
MFGGNGVAMRFWILVIFLTLGFCATASAQVWQERLDWAHFFADAGVKGTIVVSDERTHTHWVYGEERARTRFLPASTFKIPHALFALDGGIVRDEFQIFPWDGTRRDLESWNKDQNLRLSMRNSVVWVYQLFARQLGERRERNYLRRIAYGNADASGGIDRFWLEGGLRISAHEQVEFLERLYRNKLPFRVEHQRLVKDMLIVEAGRDWILRAKTGWGVRMDPQVGWWVGWVERPEGAIFFALNMEMPHQGDDLPKREAIARAVLRSIDALPSN
>AIA17651.1|FEATURES|farme|chloramphenicol|F938_04047|antibiotic inactivation|0
MKGEDCLQKKARIVFLNGVGSVGKTSLAKALQDVTTRPFLYVAMDAFMDMMPAGYFDHPDGFVFETIDDGGKPSVVIKSGIVAERTLRGMRQAVVAMAAAGNDLIVDEVLLGDEKAEYRQLLAPFDVHWVGVFAPLDVLETRERSRGDRLIGLSRWQYDKVHRDMTYDLEIDTSNATPLECAERIKQRFGL
>AIA17643.1|FEATURES|farme|aminoglycoside|Mmwyl1_0154|antibiotic inactivation|0
MVEIRRAVPGDEETIAALILEAFAPFRDEYTADAFEYTAAKADRIRERFDEGPMWIAEIDGQPVGTVSGLPEEERFYIRSMAIKPSAQRGGIGQRLLEVLETFARDAEFEKLYLYTTFVLPGAKRLYEKNGFYVLRETPPEEWYDMGGLEMEKILE
>AIA17632.1|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|0
MAQKITFTLALLALVLLTVFYFYPRELMFDYYADAAATPLSADEIKTLKSIHIECFADTYRKYLSTYYKERYELHQPGQLAALDSKMTEVMASYREYIDRKYKDIKNLYIVKLAGEVIGEFTCMTDNDFTDGNPILYDVCLDSTKRGHGYGSQMTEYAIEHCSKPGKPLVLTVYKDQSGLVKLYEKLGFEVVNFEHAPDESFKYYNKYLMRYKGKP
>AIA17624.1|FEATURES|farme|beta_lactam|BL3_l|antibiotic inactivation|1
MKNNLFRASFTSAVLLATAASAAEPVLPQLKAYETEDSWRQPVPPFALAEHSWYIGTAGLSVVLVKTPQGAVLIDGGLPQAAGMVLQRIKELGVQPGDLKLILNSHAHIDHAGPLAQLKRETGAKLVLSAESAVLLARGDSDDLHFGEGLTFPPASADRIVMDGEVLELGGVRFTAHFTPGHTPGSTSWTWDDQRAGRTLHIAYVDSLSAPGYQLIANPRYPRIVEDYGRSFATVRALPCDLLLTPHPGGSGWTPEATASPHPEPMTCHEYADNAERALDELLEKQRHGQKPSAP
>AIA17620.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MVFGLSCLVMAGCNRTNAPASANPTATANGTNTQAADADLSNRLTTLAKSLGDEVALSVVHVESGRAVAVEGAKKLQLYSVFKVPLAIAVLKAVEEKKLSLDQKVHVTPGDVAPGSQFNTDLWRQPVDKSVAELLEFSIVRSDNTSSDKLLGLVGGPAGVTQRMRALGYSDIDIVSTVRGYASKQGNPNVGAPVDLARLLTQLQKGELIQPANALLLLGFMERARTGGERRLRASLPPGTPVADKTGSGTAATNDIGVITLPDSKGHLAIAVLINGTKSKTEAQEKLIAEIARAAYDAFVANTAAVK
>AIA17614.1|FEATURES|farme|beta_lactam|SPM-1|antibiotic inactivation|1
MKNALLFAVLILAGCTHNEGLQPALSMEPAKETTPSASTALDDNLSAKLIRPDVWLVQDRSFYDTNVMLARMPDGTVVIASSFIDTPKTARLIAWIKKNLKPKEIRAINTHFHFDGTGGNEAYHREGVQTWSTQETLSLYKGRADSMRSSLAATLPDKQQGQDLRETKNTFADHIFSAAAGLEWDLQGEKVIVYYPGPAHSPDNLVVYLPAKKILFGGCMVRALDYDLGNTQDGDLKNYRKSVLSLRRFPAEIVIPGHGRMGGMDLIEHTIQLASMPTQKP
>AIA17610.1|FEATURES|farme|beta_lactam|PEDO-2|antibiotic inactivation|0
MSLFRIRCFGVGDGLASADRFHSSYLHHLGGSSLLIDCGEPVSRSFKAAGLDYDSVDAIFLSHLHSDHFAGFLMLMQSFWLEKRRRELSIYLPADAIPRVRELLTGVYLFPELLPFPVKYEALRAGEAIKVGGVRITPSPTTHLEQLRGRFQAKYPGDYQAFCFLLEADGLRVVQSCDLGAPEDLKPLLEQPVDMLVCEVSHFTPESLFDFLKGREIRRLSLVHISRPLWQKRDALLEQAKRALPKVTVSIAKDGDVFEG
>AIA17598.1|FEATURES|farme|aminoglycoside|AAC(3)-IIIb|antibiotic inactivation|1
MVHASLRAVGEVAGGPDEVHLAIKDVITDRGTLFMYASCPAYVDEVGRGNLTPAEEAEVLETLPAFDPHTARSARDNGALVEMFRTYPGSRVNVHVARFVVWGKHTDRLLTPQPWDYPFGHGSLLERFVELDGKVLLLGSDHDNVTFLHYAEHIADIPDKCIARFKVPVLENGVRVWREMAEVDTSSQGAHASWPDRFFAILVDSYLAATNNRGGRVGRAESYLFSARGLLEHALPKMEAIARPRR
>AIA17593.1|FEATURES|farme|aminoglycoside|AAC(6')-IIc|antibiotic inactivation|1
MKQAFRFRPLTRQDLPRIHEWLNRPHVAEWWEEPRDLESVVQEFGADLESPVIRMFLVCLDEEPIGYIQVYRVMGANPEWWTDETDPGARGIDQFLANAEQLGRGLGSSMVRQFVAELFADPEVTVVQTDPSPRNARAIRAYEKAGFRRIDEIVTPDGPALLMRVRRAEFG
>AIA17583.1|FEATURES|farme|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MTTKEDLVGDFGRLGICDGDTIMVHASLKAIGPVDGGPAMIVEALVDAVGQSGNLLAYVSWDRSPYEETLNGRRLSDAEREAWPAFDPATAGAYRGFGVLNDFICGYPGAWRSAHPDASMAAIGPRASELVRPHRLGDAYGPGSPLERFVSMRGRVLMLGAPLDAVTVLHYAEALADIPDKRLVTYEMPLLDSSGKKVWQTAKEFDSNGILDCFAVEGQPDAVEQIATDFVRLGRCRQGRVANADCFLFDAVQLVDFGVRWLERRFGATRQGSRAG
>AIA17459.1|FEATURES|farme|aminoglycoside|APH(4)-Ia|antibiotic inactivation|0
MPPEVIARILRAYNVPYSRVAAPQKGYRNTSYGINGIYNLILYKSEAGILARIKNANTVGAFVAAAGMSARTPRNPRILKLASGGRVRYAALYNYLPGSTIPWEAYTMDHIKALGQAMSDMHQTLSLYDTQSLPDVADENSALLKRMQRYFVDTHVAGALTSKLGIHSVRCHFFDVLAASKKLPGQHALHMDFVRGNILFEGSKITGILDFEKAAKGSPLYDVARTLAFLLVDCKYKQENKIRKYFLQSGYIKRGAAELRDYMVNGMSVLESLVDFFLLHDFYKFLRHNPYESLPQNEHFVRTKAMLLKRGLIECD
>AIA17425.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
YAIDLRGIATTVAKKMGIYERVCELRTSIEFVRYVDANGNLLFEEHGEKGGFRQGEEVELVRGDLVEILMQTIQDIPCYFNQAVQQINQQPDSVEVIFKDGRKEYYDLVIGTDGLHSTTRQLAFTKDEYKLHHLGSYICIFNVPNYLKLKRCEMLFEKDQKLTSVASDKDPSAAQAAFMFRSNHLLKDIRDSKEQKQFLRDTFSNLGWQANHLLELMEHSENFYFDSVTQVKMPSWTKGRVALLGDAGYCPSPLSGQGSSLAIVGAYILAGELKNAGENYTHAFDRYNELMHPFVEANQGFGEWVSKTFLMPEDLSKEAAAARADVILEKMKTVTNALTLPEY
>AIA17249.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPKISSKALRMPASPIRKLVPFADAAKKRGTKIYHLNIGQPDIETPSTMLNAIKSSNIKVVEYSNSAGIESYRKKLAEYYKSHRINVEYSDILITTGGSEALQFAFNTCFNPGDEVIIPEPFYANYNGFATAVDIVVKPVVSGIETGFALPPISDFEKVITPKTKGILICNPGNPTGYLYSRAELEALKALVLKYDLFLLADEVYREFCYDGREYVSVFHLDGLDNNVVLLDSISKRYSACGARIGAFITRNKEVLNAALKFAQARLSPPTFGQIGAEAALDTPKEYFDKVSKEYTERRNFLVNELNKIPGVHCPMPGGAFYCIAKLPVDDSDKFCQWLLESFSHEGQTVMMAPASGFYSGGGKGKDEVRLAYVLNRSDLEKAVTCLREALKKYPGSTLQGKN
>AIA17144.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MQLAVLLLCLLAVGCANGQGSVRKDARKDRPRDSERPARPDDVVRQKTGLEKQFEEIARKSGGRVGVRAMLLATGETFSLNENERFPMQSVYKLPIAMAVFGRIEAGTIKLEQMLRIGGGEVLKGSTALPAEKYPDGTERSVEELLGLMVSESDNTASDALLRLAGGPREVMNYLKKLGINDMVVANFEKEMHADWQAQYRNYATPSAAVELLRAIDEANGISPPNKTRLLKFLTESPTGPRRLKGLLPEGAVVAHKTGTSATRNNLTPATNDIGILTLPDGRRFAIAVFVADSSADQATREETIARITRAAWTYWSEK
>AIA17044.1|FEATURES|farme|polymyxin|pmrF|antibiotic inactivation|0
MADVKPIPEGYHSLTPYLIIDGAAEAMEFYKKAFGAVELFRMEHGGKVGHAEMKIGDSPFMLGDEMEQYKGPKALGGTPMMLMIYVDDVDTIYQQAIAAGGIEVKPLQDQFYGDRSGTLTDPFGHVWTIATHKEDVSPEEIEKRVAALHGQGAGA
>AIA16968.1|FEATURES|farme|aminoglycoside|IP83_02945|antibiotic inactivation|0
MNWYEKLSQYFPIEEMKSKKHIETLLQERSDIYHKNEGPHHVLMYVETDQFIVIDYLFVSKDARGQGLGGKLIDELKQHNKPIILEVEPVDYKDSDSAKRLHFYKRADFKHAQTIGYNRRSLATNEVNQMEILYWSPTSETEESILNKMKKTYELIHTYKDKEIYGASYQPADQVLKIDKNRKDGDILADL
>AIA16945.1|FEATURES|farme|beta_lactam|WS62_15880|antibiotic inactivation|1
GDPMNTKHLMALVLLAGAALPAASQDAIRCTLLVDAATGKTLVREGQCEQRVTPASTFKVALSLMGYDSGILLDEHTPLLPFRKGYVDWLPEWRTATDPAAWMKQSVVWYSQQVSTRLGAKRFQSYLDRFDYGNRDASGNPGKNDGLTQAWLGSSLKISPDEQAVFLRKLVNRTLPVSGKAVDMTASLMRYPRLRNGWELYAKTGTGSEPGALPHGWLVGWTGDGKRTVVFARLAQDAQREPGGRAGLRVRDAFIRELPTLLERI
>AIA16944.1|FEATURES|farme|beta_lactam|ASD05_04445|antibiotic inactivation|1
MRGFPARKKGNAEVSSLKLFALSLITSLLSSAVAAPTENTNPELRQFAELEARTGSQIGVAAIDISTKRGVDYRANERFLMCSTFKAMAVAAVLQRVDQKKEKLDRFVTYGEAQLLEYAPVTRAHVKEGGMTLEALCEAAIRQSDNTAANLLLNVLGGPKGFTEFARSLGDEFTRLDRMEPELNMGSAGDERDTTTPAAMAKDLQRLFTSDVLTVESRKRLEDWMAANETGTRMIRASVPAGWRVGDKTGRSGKGATNDIAILRPPTGEPIFMAIYTNAPNESSEGREKLVAEVARIALEALAK
>AIA16940.1|FEATURES|farme|beta_lactam|OXA-50|antibiotic inactivation|1
MARLFAVLIFLVASLHPLAAQTYREVPELAKVFNEKGVAGTFVLFDVPTNTMLVSNEARAKMRFVPASTFKIANSLIGLEVGAVKNVDEVLPYGGKPQPMKEWERDMSLRDAIKVSNVAIYQELARRVGLERMREGLKKLGYGNMEIGNVVDRFWLDGPLAISAVEQTEFLYRLVKGSLPISPNALRAVKEITLLEKTETYELHGKTGWLSSRTPPQTGWWVGWIERESKVYPFALNIDMMSDGDAAKRISIGRECLKVLGKL
>AIA16902.1|FEATURES|farme|aminoglycoside|AAC(3)-IIIa|antibiotic inactivation|1
MTDSNDHLVTHGQLVEELETLGVAAGQIVMVHASVKAIGRIMGGPNVVVQALLDTLTPAGTLMMYVGWENIPDFVSNLSPAVRQEYYAEHPPFDPRIARAVRDHGILAEIVRGWPGARRSLNPEASVAAIGARAEWITQDHPLNYGYGAGSPLEKLVAARGQVLMLGAPLDTLTLLHYAENRARMRNKRVIRYSCPILRMGERVWVEIEDYDTGEPHGDYTFDGIAREYLAQGKGRQGTIGHAPSYLFDAADLSTFAIAWLEERFGETT
>AIA16866.1|FEATURES|farme|beta_lactam|OCH-8|antibiotic inactivation|1
MGKISFPKLGILAIAFSLCGASAHAAESPAPGDLDRIVGEAIKPVMEEHKVPGTAVAVMVGGKRYFFNYGVASRESGQKVSENTIFEIGSISKTFTAILASRAQVAGTLSFSDNASKYFPALAGSSFDAISLLDLGTYAAGGLPLQFPDDVTTHEKMIAYFRNWRPAYAAGTHRLYSNPSLGLFGYLAASSMGKPFAELMEQQIIPALGLTRTYITVPPDRMDDYAWGYSKDDKPIRVSPGVLDAPTYGVKTTAADMIRYVEANIDGSRLDETLQRAIAATHTGYYKVGDMTQGLGWEMYAYPADLDRLLAGNSPQVVLKANDVSRLDLPQPSQQAVLINKTGSTNGFGAYAAFVPARGIGIVMLSNRNYPTPARVKAAHRILTALDGLAGPAGGR
>AIA16841.1|FEATURES|farme|aminoglycoside|AAC(3)-Ic|antibiotic inactivation|0
MRDFVIRTALPSDAPSILALLGELAAYGKAPEFNLNEAHVLRDMFGAACHCELALRDEEPVGIATWYWTYKSFRAVRGLFVEDLYVRAAFRGQGLGKALLAHLAGKAEDAGGFLEWQVLDWNSRAISFYKMLGAQAVPHWLNYRLEGEPLERLAQSRTDKR
>AIA16809.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKRMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGGFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE
>AIA16783.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MINNKTMSDYLTPLVRSIPSSGIRKFFDLVEGSKDIISLGVGEPDFATPWHVREACVYSLERGQTKYTSNAGLLELREAICEYLHHHFHTKYEPGNEILVTVGGSEAIDLALRALITPGDEILIPEPCYISYSPITSLSGGIPKGIETYARDQFKLTAEALKASITPRSKVLILCYPSNPTGGIMSYEDWLPIAKLVEENDLIVISDEIYAELTYGQKHVSFASLPKMLDRTIMVSGFSKAFAMTGWRMGYACGHREIISAMLKIHQYTVMCAPVMGQVAALEALKNGLDEKDRMIESYNQRRRLVVKGFRDIGLECHEPQGAFYAFPSIRSTGLSSEQFAQDLLKDARVAAVPGNVFGLGGEGYIRCSYATSVLQLNEALERMGRFIRTIG
>AIA16777.1|FEATURES|farme|beta_lactam|AS202_10895|antibiotic inactivation|1
MTQRTSLDFKILLQVLFISLIVLPATAQVGAQDLSRFFKETKGAFVLYDLKQNRYLRHNQTRCRQRFSPFSTFKIPNSLIGLETKVLTDADYLMHWEPQKYPEAKDWTDPPFVHWKQDQTLRSALKYSVVWYYRELAKRVGASQMKKYVAAFGYGNQDTSGGLASAQLFQAFWLNSSLQISADEQIEFLKKFYTGKLPVTERSTAIVKDILVLEKTPNYTLSGKTGGGSLPGGNSLGWFVGYLETKGNVYFFATNIEGANYAAIRDRRIELTKQILAELGYMPK
>AIA16725.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
MRKILSSVIAALFVAGMATAAMAGQPAAWTRPAKPFKILDNIYYVGTEGLASYLIVSDQGAILLDGTLAENAGHIEKNIRALGFKLSDVKIILNSHAHFDHAAGISQLKQDTDAKVMAREADRSALENGKQEGDTNYGGASFPAVKGDRALKDGDVVELGKVKMVAIATPGHTKGCTTWQTTATDNGISRRVVFPCSITVAGNILVGNKGYPGIVEDFRRTFEKMASLEADVVLPAHPEFADVFQREAKQEAGDKDAYVDTQLLPRLVKKSKIAFEKELKAAQK
>AIA16723.1|FEATURES|farme|aminoglycoside|APH(2'')-IIIa|antibiotic inactivation|1
MEIFWLKSMRGREIDDSPIQSAAELRVEISAKEAAELIVREFPELQIETIKKLGGGLDNLAFEVNGEYIFRFPKRDEDNQKLLREGKVLELVKDLSSVPVPEPTFKSTKFMGYRKIEGVSLLEGRETFDGYEELAETLAKFLSQTHSLSLEEARRIGVPENSQSFSEWLADAPQFFEQAKTRVPVELHAPIEKFLREESLDGNWQPFFSHNDLGIEHIIVKDNSVTGIIDWADAEITDPAYDFGKLLRDLGEDLVKEILARYTVEANNKEEIFRRAVFYAKCSALEDLAYTAGDGKDKLYWDNSRAALKRLFRSE
>AIA16696.1|FEATURES|farme|macrolide-lincosamide-streptogramin|srmB|antibiotic inactivation|0
MSLNYLGPSAHRRMQVSKKPLINKKPLEKSPIILLLNGPSSSGKSTLAELLQSKLKDPFLHIGIDKMIAMMPDKINNWEGGQSEQGFWWEEDTDSEGHQIYKIKMGPYAQKVSQTYKEVVVTLAKNGHNIIVDEVAFGNKEIEIWREKLSEFNAFYIGIHCPLPTLEEREIARGDRIIGSARHQFYTVHEDIKYDLEVDTETHPLQECAERIISLFQ
>AIA16670.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRNDLVEILIDSIEGVPLQFNQTIESIKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYFDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEVAEERSNNIMEQVKIASNMIVLQDYANPH
>AIA16668.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMGIYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVPCHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAYFSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAIAGFCFRAQNVLNNLRDENEQRRFLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQGSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSKEVAEERSNKIMQEIKIVSNMISLPNYE
>AIA16623.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPKVSLKGLSMPASPIRKLVPYAEKAKQEGKKIFHLNIGQPDIETPETMLNAIHTFSPKVVEYSHSAGIESYRRKLTEYYRRNQIELDYTEIMITTGGSEAIEIAMMSCLNEGDEVIIPEPFYANYNGFGTQAGIKVTPVQSHIENGFALPPVSEFEKVITPKTRAIMICNPNNPTGYLYTKDELESLRKIVARHDLWFFSDEVYREFCYDGKEHFSVLNMKGIEQNVVMLDSISKRYSACGARIGALISKNKEVMATALKFAQARLSPPTFGQVAAEAAIDTPDSYFKKVKEEYVARRNFVVEALNKMEGVFCPKPSGAFYCIARLPIDNADDFCQWLLEEFSYRNETVMLAPATGFYTHSNLGTDEVRIAYVLNINDLKKAMECLDEALKVYPGRKVIAEELKSQG
>AIA16588.1|FEATURES|farme|aminoglycoside|ABB27_14230|antibiotic inactivation|0
MTIEIRPIKPGEGPALLVLTRALAEAHDYLDKYTATAGDLERALFAPVPIVGCLIAFCDGEPAGCAFWHRSFTTARGREIMYLEDLSVLPAYQRRGIGRALLQRLAVEARDRGFPSIYWLTMGWNAKAQALYDQTGATCDEGMRYYRLADEALIRLAEAKP
>AIA16547.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MLDFSLQHPETIMKKIFAAASLFALSLPAFAGWDDPQEPFQLFGNSYYVGPKGVSSVLITSPAGHILIDAGTAKSHEQIIPHIRQLGFKVEDIKYILTSHEHHDHVGSIAELQRASGAVVVGSALSVAVMKTGEASKDDPQFGDLSKFAPAAGNARCRRWRGGDGRPLVGDRTLHAGPHAGRRELDLAVGGRRTHGEHGLRRQHYGLRRSGLQI
>AIA16544.1|FEATURES|farme|beta_lactam|blaA|antibiotic inactivation|1
MKFSPLKYSLLLTVIMGTFINICTTGFASTQQIKPTSIAKKLSKLETSFDGQIGILAINTANNQRIQYRADERFPIQSTFKVMAVSAILKQSMTDKHLLQQKVTYTKQDLVFWSPITEKHLADGMTISELCAAAMMYSDNTATNLIVKKLGGPSAVTTFARSIGDNTFRIDSWEPELNSNSSDPRDTSTPTAMEKSLQKLTLGNVLASPQREQLVTWMKGNTTGDARIRAGVPKGWIVADKTGAGDDYGISNDIGIIWPPSCAPIVVTIYSVHNNKDTARRDDVIASATRMLIHEFAQTDKCIKRKYD
>AIA16545.1|FEATURES|farme|aminoglycoside|AAC(6')-Ib3|antibiotic inactivation|1
MEKFTFKPLTISDLNLLCEWFDNPHVLEWWDDQLTPAEIKQKYGSRINDDVVHPHIAYLHNKPIGFIQYYWVNKVGNGWWPNEDNGTVGLDQFIGDENFIGKGYGTTMIKEFIQFLFHNPAITKIITEADPNNHRARRCYQKVGFHEEGEINTPDGKSLLMTMKRQK
>AIA16540.1|FEATURES|farme|beta_lactam|blaVEB-11|antibiotic inactivation|1
MLNPLLIVLSLASTGPTTASLQKDLQRVVTESDGKVGICSWSLAASEAVCINGLERFPLQSVMKLIVSAAVMDAIDQKRMKLEDLITVKPEHASPGPQEFADLVRKKGSLAVTVEELMRRSIVDSDSTSIDILIEKLGGMRTVQSFLKAKNITDIRIDRNERDLQSEFCGFPWQAAYADPQKFEATMKAVPPAKRDQALETYLKDPRDTATPLGMVKFLKALAEGKLLSRTSTEKLLSIMEMTVTGPDRLKAGLPPGWKIGHKTGTSFTWNGRAAATNDVGILTAPNAARIAIAVFVTDSRHSPDERALVIAKAAKAVTGSFAP
>AIA16516.1|FEATURES|farme|aminoglycoside|ASD14_09375|antibiotic inactivation|0
MHVTAARREDCLAIASIHVASWQAAYASLFPAEYLASLSVPERENSWLAILEASASRTLVVKRDGQVLGFISFGRCRDEGAAPNRGEVWALYVKPQAWSAGAGWALWEAARVQMLHAGFAEVSLWVLSGNDRGLRFYEAVGFRREPHSEQYFERGGAKLQEVRLLIHPRPH
>AIA16444.1|FEATURES|farme|macrolide-lincosamide-streptogramin|HDEF_0539|antibiotic inactivation|0
MESPTPIQWQFSQRAEQLQSSVIREILKVTVRPEVISFAGGLPSPATFPVDRMQAAFDSVLAKQGKVALQYGPTDGYAPLREWIANSLSTDGAKIAPEQVLMVSGSQQGLDLLAKVLIDEGSKVLVETPSYLGALQAFSLYQPQFVSLPSDEHGLLPEHDL
>AIA16438.1|FEATURES|farme|streptothricin|sat-1|antibiotic inactivation|0
MTTILNSTKEDIPEIFRLYGLATVFQATKGSFVWPAFERSLVEEEIAARHQWKMIDGDTVACVWATTFSDPQIWEEKNADPAVYIHRIATNPDHRGENLVLQIVGWAKQYAKANNKKYIRLDTVGNNLGLIKHYRRCGFEFLGLFKLKRRY
>AIA16430.1|FEATURES|farme|aminoglycoside|ABB27_14230|antibiotic inactivation|0
PDQIETARLLFREYEAWLGMDLCFQDFETEVATLPGKYAEPRGRLLLAYVDQKPAGCIALRGIDDGVCEMKRLFVRDEFRGHRLGLLLVEKVIGEARAAGYLKMRLDTFPPKMGKAVKLYESHGFREIAPYYNNPHTGVLFMELDL
>AIA16427.1|FEATURES|farme|aminoglycoside|sat-4|antibiotic inactivation|0
MSTITIVKYQPEHQPYFEKFNRAWIEKWFTMEPLDEWVLTNPEEAILKDGGEILMALYDGEVAGTVGLRKLQKAVYEFTKMAVDENFRRKGIAEALCYASFEKAKELGATKVILYSNTKNAGAIKLYEKIGFKHLPVENDVYERANVKMEIDINSFTIKHNAQPATS
>AIA16413.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MSNTVAEIFNVRSHNPSFFSVKESTVYKGPLLDFCIPVNLHFPPAQMVQRIGEHLPEILRYYPDYAEVHAKYIGEIAGVPPACIVPANGSTEIITRLCHLTRGPILTPIPTFSRWTDLPNELGIPLHTIEQDVRRNFRLEVAEIVSRATELGVRMLVISNPSNPTGTWFEFDEIKKLVLSLPEVELIVIDESFLDFSDLESAVSLIPRAQNLVVVKSLGKSLGWHGVRLGYAAMNSRGAALLRSELPFWNVNGLAAYILKSLSEFKDEFLQSLALVAQDRTYMLNQLEGVSGLRVFPSKANFLYVELPSNVPGRKLRDRLLEEYGLMVRECSNKIGSSERYLRLAVQTREAVDLLAQALRESLGRIH
>AIA16410.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MLDFSLQHPETIMKKIFAAASLFALSLPAFAGWDDPQEPFQLFGNSYYVGPKGVSSVLITSPAGHILIDAGTAKSHEQIIPHIRQLGFKVEDIKYILTSHEHHDHVGSIAELQRASGAVVVGSALSVAVMKTGEASKDDPQFGDLSKFAPAAATRVVGDGEVVTVGPLSVTAHYTPGHTPGGVSWTWQSAEGGRTANMVYGDSITAYGAPGYKFSAHPEVLASLRNTFARVAALKCDILVTAHPEAGGLWPRVEKRAQLGNAALIDPDACRKYAAKGTARLETVLAEEKAKP
>AIA16407.1|FEATURES|farme|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MMERETISQKAVTRQLLDLGVRPGGVLLVHCAFSKVRPVEGGPLGLIAALREALGPAGTLVMPSMADDDEHPFDARQTPCLHMGIVAQTFWQLPGVRRSDSPHAFAAAGSEAERITAPHPVAVPHGLDSPPGRVSEADGQVLLLGVGHGEDTTIHVAENMSGVRYRRKTHVLLHTDGQVTRFDYGEVDHCCENFSQVDGWLDAQSMQRRGKVGHADARLARSRDIIAVASAQLRENETVFLHPPGIDAECDEARASIPQESA
>AIA16333.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MDNNRYQKIADELATAIRSGELAPGTKLPPLRSIMRKHGVALATAVRAYNMLEAAGMVVGELGRGTFVRDTTVPGNDVLIQRSWPSAMIDLGFSYPLLPGQDELLRDGLRALASTGDLGSLLQAPPQGGRLHYRESAARHLRNRAIRVPASQVLIVNGAQHGLSVTLSALLKPGDVLAVDALTYPGLKALAKLHRLELSALPMIDGIPDLGALHVLCTQRRVKAIYCMPTIHNPLGSVMPLAARKRMADLAEQHNLLIIEDGAYAFLAEAAPEPVQRHAPDRTVYVSGLSKSVAAGLRVGFVVAPPSCIPALEQAIRVSIWNTPSLNVALSCRWIESGVIDSLESAKRRDAKQRQVLARKVLRNGKIRSNPSSYFLWLELPDEARAEEIARQLQEERILVATSEPFATTSHAPQAIRLALGTLPLAELRDALMKVDEAVSR
>AIA16286.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MAQPRYKELVDTLAADIRSGHLRAGTRLPTHRQLASAHGLALVTATRVYAELAAMGLVSGETGRGTFVREISLPPRQGIDQFALAAGMVDLNFNYPALPGQADLLRSALRQLAASGDLESLLRYQPHGGRQHERAAVARHLASRGLKVGWEQVSLVNGAQAGLAATVMALLGPGDVVAVDTLTYPGFKVLAEACRLELAPIQASGQGFDLDALERLCRTRRVRAVYVMPTLHNPLGWVTGAQWRRQLVSIARRHGLLIIEDAAYAFLADKPPAPLAALAPETAVYVSGFSKNIATGLRVGFVVASAESMKAIERIIRATTWNTPGVMTSIACAWLDDGTVERLEAEKRRDAKIRQSMAAEILAGLNCVRHPSSYFVWLPLSHEVRADQVAAALMREQISVSTAEPYATSHHVPHAVRLALGSVELDVLRESLETVRRVISGYAY
>AIA16281.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MVSNSAAATNSPIPPAADVALLSETLKKLCDTVGGKVSVAVVHVETGKLATVDASNELPLFSVFKLPLAITVLKRVEEGSLKLDQNVHIGPDELIVGTRANSQRWQNPIDFTIKQLLEFSIIESDNTSSEKLLQLVGGPQAVTERMLSFDLQQINIKTTIRDYVATRSNPNTGSAAALVKLLSKLQNGELLQRAQTDLVIGMMERAKTGLHRLRGNLPQGTKVGDKTGSGDPNPKTNFAISTNDVGLITLPNGRGHLAMAVLLHESTLSDEAQEKLIADLARTAFDAYSTVR
>AIA16279.1|FEATURES|farme|multidrug|farA|antibiotic inactivation|0
MAGMLFSPSWYRVAALKPRLRGHVEIHRHSYRDAIWFVLQDHSSGRSHRLAPAAYAFMGLMDGKRGVQNLWDLCNEHSGTDAPTQDDVVRLLGQLHAADALICDVPPDTRELFRRFQRQQRQTWRQRLWTPLAIRVPLFDPDRFLERTAFLVRPLFGWLGAVIWLSIVSAGLVLAGLNWSALSENVVDRALAPQNLLVLFFVYPLVKAVHEFGHAYATKIYGGEVHEVGVMFLVFVPVPYVDASAASNFPNKRERMVVGAIGIGVEMLLAAVAVFVFAYATIGTVHAVAYNVILIGGVSTLLFNGNPLLRFDGYYVLADALELPNLGQRANRYLGYLIERYAFGSRDASFPETDRRARAWFVFFGIASFGYRLFISVAIIISLGSRFFIIGVLLLIWAAASQLIIPIGKGFSFLSSSPRLQRNRPRAVALTALVVGFAGLFLFVMPFPLRTVAEGITWPSERSQIRAGTDGFIGRLLVANGSQVEPGQPLIEAYDPFLDARVEVLEAQLRGLRRQYTAVRATDQAEAGVLQEEINGVVSDLERARERRRELVITSRRAGVFVAPVEQDMPGRFVKKGQLVGFVID
>AIA16236.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MDFVRSLALTLVAATLVLAPPTSLASQKPRGDAALETELRRLAATLPGTVGIAVHHVGTGRLVTVDADRAFSMARVFKLPVAIAVLRRVQTGGLTLETPITIAPEAYYPGYSPLRDAKNRAEATVTVRDLVETMMVDSDNTAVDVLMARMGGADAVNAELRAAGVPDVSVHRTEGEVMADLDGLGAAPAGGWTYSALVAGEARATAEGKRAGRAKFLADSRDTATPTALANLLARLDRGEVLDAERTKILVGMLDRNKTGGRRFRAGLPAGVRIGDKTGTNPTVGTYNDAALVTLPSGARIALVVMTREAGDTGAAAEQLMASVARTVYAHFARP
>AIA16235.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MRFHWIYILLLFYVLASACTKTANTAEVKQSPAPVAAAQNVDHELEQRLKTISDGSQGTVGLSVVHIESGKTVSINGSSQLPLYSVYKLPLAVTVLKDVEEKRLRLDQKIHITPQNVVQGTTANSALWQKPVDYTVEQLLEFSISRSDNTSSDKLVELVGGPLQVTERMRSLGFQNLDIHISSGEFVKTRQNPNTGSSDDLVQLLVQLHRGKILQPAQVNLLRGFMQRATTGLHRLRGDLPRGTVVADKTGSGEADAVTKVAKVTNDVGIITLPRGRGHLAMAVLVNGSKLPDAAQEKLIADLARAAYDAYSKDVAK
>AIA16067.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MDDFIIRAATPSDAAAIVSLLRELADYENLLDHFTLTEAEVAREMFGAACHCDLAFQDGEPVGITTWYWTYKSFRARRGLFVEDLFVRASARGRGMGKALLVHLAAKARDAGGFLEWQVLDWNAPSIAFYQSLGAKPWENWLIYRLEGEALERITA
>AIA16054.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MNKTLRLKSSFIPHPSSVILSLLGRFWLWLFGWKIHGETPSYRKFVLIAAPHTSNWDFPFMLATAYAMRVRISWFGKHTLFIPPWGWFMRKLGGIPVDRGAPHTLVMQMAENFKNSEDLVLAVPPEGTRSKSTYWSVAQPVPPSHARVATFSYTLRAHQRNDPQFQAELDMLDREIRAASFAPRLADDAR
>AIA15995.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MPSRTALVFAAVVSLSACVNKGETSAQKPATAGTPAASSTSAPQVADAELSARLKDICERAGGRCGVAVTHVETGRGAAFEGATPLPLYSVFKLPLAVAVLKEVEEGRLQLDQKVRVEPEETVPGTEENSALWRQPSERPLRELLEFSIARSDNTSTDKMLELVGGPEAVTRRMRALGLDHIEVRSTVKEFLKSRDAHPNTGAPEDLARLLVLLRKGEVLAPPQSALLLGIMARTVTGDRRLRAGVPAGTPVADKTGSGPSTTNDVGVVTLPGDRGHLALAVLLDGSKLPSKQQEDLIAEVARAAYEAHVRGK
>AIA15996.1|FEATURES|farme|aminoglycoside|MED297_13282|antibiotic inactivation|0
MTRQDSAPHIRRASIEDAKLLADLGARTFAETFSQDNSPEDMAVYLAASFSVGRLTEELTDPLSVFFVAEVDGSAAGYAKLHPGEVSAGVEGQRPIELVRLYVLQEWLGRGVGPALMRRCIDEARALGFQTIWLGVWERNQRAQAFYRKWDFHEVGEHIFQLGSDPQRDVVMQRAI
>AIA15926.1|FEATURES|farme|aminoglycoside|AAC(6')-34|antibiotic inactivation|0
MHLDCGPCVVRDWNPNDKGALVEIANNRNIWRNLTHRFPHPYIDADADGWFALLEKIPERTHWAIAVEQEVVGGIGFERGEGVHARAGHFGYWLGQPYWGRGIITAAVRATSDHIFEHFDLERLEAAVFEWNPASMRVLEKCGFVREGVLRRSILKDGQLIDSVLYARVRGD
>AIA15845.1|FEATURES|farme|aminoglycoside|Mmwyl1_0154|antibiotic inactivation|0
MSAEPTIRLATIEDAETISQILREAFEPLKDGYAPEAFDVVRPSATEIVGRFDDGPQWLAQIDGTPVGTVSVVPEPEWLYIRSMAVLPSAQGFGIGGSLLDAVETYALDQGFKKLFLYTTYFSESALRLYEKKGFYWVRDTPADEWFDTPGLAMEKVVGRKAENAVGS
>AIA15839.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPLGLSNRAVNMPASPIRKLVPLADEAKRRGVHIYHLNIGQPDIETPSCMLARLGTIEDRVLAYTPSVGTPEFLAAMQHYYAAQGIPLDTKQIIATTGGSEALLFSFMACANPGDEAIVPEPFYANYLAFAQMSGVKLVPLATSVENGFHLPPIEAWKAAITERTRFIVLCNPNNPTGTVYEEHELRMVLELCREHSLYLVADEVYREFVYDGRRAMSALAFPEFSQHVIVADSLSKRYSACGIRLGVFVTRNLELYDAAYRMAQGRLSAPGIAQMIAAAATQLGPEYTDNVITEYQKRRDVLYEGLSTIPGVFLRRPEGAFYFVARLPVADADAFARWLLTDFSHDGATVMVAPASGFYATPGGGKDMVRIAYVLNEHDLRKSVEILRLALAAYPARVEAALQAT
>AIA15796.1|FEATURES|farme|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|0
MSPSAIRKARPDDAALVCKLLYELAEYEKLAANFALTEDMVRRDMLTPNTTCHCALGFAAGEPVGIATWFFTYRSFRARRNLYVEDLFVRPQFRGQGHGKALLAWLAREATAIGAGMEWQVLDWNLPAIAFYRGIGAAPLENWITYRLEDQAVAALAAT
>AIA15789.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MAKVIVLNGVGSVGKSSTAKALQALAKAPLLHVSMDAFLEMLPAAMFGDADGLLFEPLVEDGKPSIAIRTGPVVARTLAGMRHAVAAMAGQGNDLIVDEVLIGEGEAAEYRTLLSGHDLRFVGLFAPLEVLEAREKARGDREIGLARWQFQRVHAGVDYDLTIDTLESSPEQSARRIAEAFGL
>AIA15751.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MTLSIRPAVASDAALIFRFIRELAEYERLAHEVDATEADIAKALFGSNPRVFADIAEWEGEPAGFALWFYNFSTFRGRHGIYLEDLFVRPELRSKGIGRALLRHLARRCVAEGLARLEWWVLDWNEPALKVYRSIGAMPMDEWTVQRVTGEALQQLAEEP
>AIA15734.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MAGGTSDSAIQLKETVMVCGAVRMDGPASKADGSAPRIEAAMREIRRRIAARSLPTGAKLPSVRSFAKLMQVSTSTVVEAYERLVAEGAIRSRPGSGFYVASALAPLSLAEIGPKLDRAVDPFWVSRLALNGGADVAKPGCGWMPADWMPQDVLRRAMRTLSRGEPEQLTDYATPLGLLPMRQLLSRRFAEQGLHASTGQIILVDSGTQAIDLLCRFLLEPGQTVLVDDPCYFNFHALLRAHRVKVIGVPYTPTGPDVALFEQALSEHKPRLYITTSGVHNPTGACLSPVTAHRVLMLAERANLTIIEDDIFADFEEQRAPRLATFDGLNRVVQIGSFSKTLSASVRCGYIAAPKDRIEPLTDLKIAANFSGSQLSEALVYAALKDVQYRRH
>AIA15721.1|FEATURES|farme|beta_lactam|BL2a_III2|antibiotic inactivation|1
MKSWNTIFRISKFKKIVPALLLTCVTLAGCSEGNDQSVQAKQKNKESVIKHHFVKLEDKFDARLGVFALDTSTNQTVTYRADERFTYASTSKALAVGALLQQKTIEDLNQRITYTQDDLVNYNPITEKHVDTGMTLKELCDAALRYSDNTAMNLILKQIGGPNGLEKALRDVGDNATMPEQFEPELNEVKPGETHDTSTPRALATSLQSFTLGDVLPIEKRELLIDWMKRNTTGDSLIRAGVPKGWVVADKTGSGSYGTRNDIAIIWPPKGEPIMLAILSSRDKKDANYNDKLIAEATKEVINAYQANHK
>AIA15706.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MKTRMHTLALGLLLSTLGQPASAQDAITCSSCEEWNQPAKPFNIYGNAYYVGTAGLSAILVTGPEGHVLLDGALPQSAPLIQKNIEALGFKMKDVKLILNSHAHFDHAGGIAALQKASGATVAHSPHGAQVLRDGTPGLDDPQYDPKERFTIPKVAQVKEVADGDTLAVGPLRFTVHYTPGHTPGGTTWTWQSCEAGRCLDMVYADSLTAISTDGFYYTGGANYPDRSASFRKTIDTVANLKCDIVIAAHPSATDAFKKAAARTAQSNPFIDPEGCRKLAAHAGKNFDARLQREREEKAKAPGG
>AIA15681.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MYNLKFAGFKVKRIFVKQVFIAVFIFLTVSSTVGFAQKAEFAKNIEAIAKEARGVVGVGIMDLKSRETVVLNPSHKFPMQSVFKFPLAMAVLDQVDKGKFTLAQKIHVTKQDVSPKTWSPLSKKYPNGEVDLTLAELLGYTVSMSDNNACDILFKLLGGPKNVEDYIRTLGVKDIAIVATEEEMSKHWDVQFTNWCRPAAMLQLLDVIYKGKKLSQTSNDFLLKVMTETTTGPNRIRGLLPKDAKVAHKTGTSNTNEKGITAASNDVGIMTLPNGKQVAVVVFVSNAAADEKTRDAVIAKITKAAWDYYLK
>AIA15670.1|FEATURES|farme|beta_lactam|Lqui_2697|antibiotic inactivation|1
YSRILTSKLGMPKFQKYVTQFSYGNMDLSGGLTDAWITSSLKISPDEQTIFLQKVVEQKLPVSAASYAKTKKIMFIQEMAGGWKLYGKTGNGDQIDQDGNHTDLQQGWFVGYIEKDQRRIVFASHITDSEKQDTFASFRARNEALIKLWYVIDQLEKSVS
>AIA15655.1|FEATURES|farme|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MINFKGSLTGMLLMAATGCSVSAHAAFDQLTLKSQFETLENKSGGRLGVTVVDTSDGSEYSWRGNERFPLCSTSKVMAVAAILKKNESDHSLLDKKIHINKSDMVNYNPITQKHIGSSMTVAELSAAALQYSDNAAMNKLLAYLGGPQQATHFARTIGDKAFRLDRKEPELNTAIPDDVRDTTTPSAMADTLNKLVLGTALKGEQRAKLSEWMKGNTTGANSIKAGLPADWIVADKTGSGDYGTTNDIAVIWPKDQAPIILTTYFTQKDKDAVARKDVLASAAKLVVDAISK
>AIA15640.1|FEATURES|farme|beta_lactam|LRA-12|antibiotic inactivation|1
MLTSKLKIAVLAMGFLLVDFVAPAQKVFEPKDTPPEWSRPYKPFRIVGNLYYVGTYDLACYLVTTPEGNILINTGLAASAPMIKSNIEALGFKFADTKILLTTQAHYDHMGAMAAIKKSTGAKIMVDEQDAAVLLDGGRSDYALGGDTSVFAPVKPERLLHDRDVIKLGNMQLVMLHHPGHTKGSCSFLFKVKDEHKSYTVLIANLPTIITYEKFNNVAAYPSIAKDYAYTMNAMKKLSFDIWLSSHASQCDLHTKHKPGDAYNPAAFIDRKGYDAALNDLEQQYLKKVAEK
>AIA15626.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MTLSIRSATVADTDLIVKFVMDLAIYEKLEHEAKTSPDDIARDLFGANPKVFCDIAEWDGRPAGFALWFYTYSTFQGRHGIWLEDLFVDPELRGKGIGKALLAHLARRCATEKLGRLEWWVLDWNAPSIAFYKAQGAEMQDDWTKCRLDGAALARLGA
>AIA15582.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|1
GQFMPEARYHHLSVRNRPDYKDDTTARGRVSMTIKRRIGFVLCSVFTITCLSALSAHAAQQLQCTVILDAKTGDALHREGTCDQAFAPQSSFKLPLAIMGYDADILVDATTPRWDYKAEWKKPKREQKSVDPTVWERDSIVWYSQELTRKLGAQKFSDYVRRFDYGNADVRGVKGRTDGLTESWLMSSLKISPDGQVDFLRRFLNGKLPVSKAAYDKTIAIIPAFDAADDWKVHGKTGSGRMRTKAGKYDGNSWLGWFVGWADKGDRRVVFATLNIKDWKSEEPISFATRDKLIADLPKLVK
>AIA15579.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MVQPRYKVIVDAFAADIRSGRLSPGARLPTHRQLARREGVALVTASRVYAELEAIGLVVGETGRGTFVRETSLPAGLGIEQQAALSGLTDLNFNSPSLPGQGEMLRSALRELASSGDLEALLRYQPHAGRQHERAVFARHLLARGMEVAAEQILIVNGATHGLAAVVLGLFRPGDVLAVDALTYPGFKLLAETMRLDLAPVPIRSDGLDLTALARICKDRHVRAVYTMPTLHNPLGCVMTAERRQELVAIARKHELLIIEDAAYAFLVDDAPAPVAAIAPELTIYVSGLSKSVATGLRVGFVAAPAHYVPMIERAIRATAWNTAGVMTAIACNWIVDGTVSQLEAQKRDDARVRQQIAAEVLTGITRIAHPASYFIWLPFTEDVRADLVAMALIRENIAVSTAEPFATTEQVPHAIRLALGSVDLTSLRESLGTVRKAINAYTY
>AIA15552.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MMRRTPSLLVPLSAKMDGQDSDGLIRFRETVMVQKAVRMNEGRTRVEMVVSTIRQRIAGRSLTPGARLPSVRGLAATLKLSTSTVVDAYERLVAEGAILARPGSGFYVANQAAPFARAETGPKLDRAVDPFWISRQSLEADETDLKPGCGWLPPSWLPAEGMRRGLRTLARADGPALAEYGSPLGLPPLRQLISRRMGERGIEASPDQIMLADSGTQAIDLLCRFLLEPGDTVLVDDPCYFNFHALLRAHRAKIVSVPYTPSGPDIDLFAHVVAEHRPRLYITNSAIHNPTGATLSPVTAHRLLKLADQFDLTIIEDDILTDFEYTPAPRLAAFDGLDRVIHIGSFS
>AIA15550.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MNMGAMNMFNDFKFTDDRPVYIQVKDYLKRLIIKGSLQADQKLPSTRELGLLLAVSRNTVISAYAELEGDGFVYAIQGKGSYVAAASAPPGAAAPSCEFDWQSRINGYARQAIELDRMKRGIRADKSVISFTSIAPDEKLFDLDNVKRAFLERIAKEGGVLLNYGYAKGYKPLIDYLLKYMEQRGVDLSGKDMLITNGFTEAFDIVMSALRRKDGGSVICENPTHYTAIKNLRLNGFDITGIPMERDGINLTELERALTERAYDCAYFIPSYHNPTGIVTSPEKRLAIMQLMARHRIPVIEDGFNEELRYSGSHVSPLIATAGQGNGVIYIGSFSKVLFPGLRVGWVLADRRLIDSLESIKRARSIHTSTLDQSVLFQYLYNGNLEKYLKKARAHYKRKYEWTKHCCEIHLPYKRLSGDGGLHLFVEFDECFDTTALLNECSGQGVIFTPGDMFYTDGGGGHTMRLGFSRVPDDDIGKGLEIIGQTAKQLMR
>AIA15540.1|FEATURES|farme|beta_lactam|SD53_15990|antibiotic inactivation|1
MFCSLSSAPKEFVVKAHWHLASYIRHMRLLLLFGVLVSLLSCADSPQPGQQKSSDSVTENTPRESALEAQLLKNVINGKQATVGVAIKNFQSGEEHYILPDERFALMSVAKFPQVLLLLHLADEGKYDPKAPVSFDAEDLKQRTASSLRKDHPQSAFSLPLTEALRYCIGQSDNITSNKIFELEGGPRAVEDYVHSLGIADIGVTTDYAHMRPDSPRQNWGTPRAMLALLEKFHNGKLLSDSSKAMLWKAMVEATSGHNRIRGGVPAGTLVADKTGTSGRDEKTGVTAAFNDVGIVQLPDGGYYGLVVFVGDSKEPDSVNAAIIAGVSKTVWEHFNAAKR
>AIA15538.1|FEATURES|farme|beta_lactam|AIM-1|antibiotic inactivation|1
MPPVALADAAPGQRAWTQACADSDGWDKPGPPFRVYGGTYYVGTCGITSLLVVGPEGHTLIDSGTDAGAAVVLANIRALGFEPKDVRTILTSHEHFDHVGGMARLQAATGATIVTSAPAAAVLRSGKPAADDPQAASGHPPFPAVTGQIVVLDGERPQLIADREFTPLFTPGHTPGAMSWTWRECEGESCKSIVYVDSLNPISAPGYRFSDHPAMVVAFRAGIAKIAALDCDIVLAPHPGAAKLRERLLGEAPLIDRGGCRTYAASVTERLDKRLAAEAQEDTSGG
>AIA15535.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MKRIAALLSCLLAVPALSVAAEWEGPQDPFKLYGNSYYVGTAGLSSVLITTPAGHILIDGATPKAAVQIAAHIRQLGFKPEDIRYILTSHEHFDHVGGVAELQRLSGATVLTSAAAKPVLETGKTDKGDPQFGNNMPDMTPVSPVRAVRDGESVELGPVSIKAHYTPGHTKGGISWTWMAFENGRPMNMVYADSLNAITGPGFRYSGNTVYPDAKADIERSIARVAALPCDILVTAHPEANDLLERQAKGKLADANACQAYAETGRVRLAKTLAEEAAKR
>AIA15471.1|FEATURES|farme|aminoglycoside|AAC(6')-32|antibiotic inactivation|0
MKVLETERLVLRRMSGEDAEFIFDLLNQPSFIKYIGDRNVRTIEDARQYILSRFVASYKKFGYGFYLVELKQNKTPIGICGLVKRDTLPDVDIGFAFLPEYWSQGYAFESAQAVMDYARKDLKLERILAITTKDNHSSGKLLNKIGLKFERLISVNDEELKLFSTD
>AIA15468.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
PRLEVGQPPQGEQLSGLQASPQYRDGAFHNALPTPGYNGDKNMLVAMWEFLTKKTENARPAQPLPLVNTDLASLPLAQDTLVWLGHSSWYLQLAGKRILIDPVLGNYAAPFSFLNKAFEGDYPWRAASMPEIDLLIISHDHYDHLDYATIKALLPKVKRVVTPLGVGSHLRYWGMDPTIIDERDWNQSVRISEALTVHVLPARHFSGRGIKRNQTLWGSFMFVTPEQKVYYSGDSGYGPHFRDIGEQFGAVDLAIMENGQYDQDWKYIHMLPDETAQAAADLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASRDKGYRLLTPELGEPVRVNDTAQQFRPWWE
>AIA15459.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MKVKTLRRILLPALFVLPNLLFAQKSDFKSQLESITKQIDGIAGVAVKDLEGKETLILNADHKFPMLSSFKFPIAVAVLDQVDKGKLALDQKYHLTKEDIQLKTYSPLRDKFPDGNVDLTIADLLASMVSLSDNIACDILFKLAGGTKPVQDYVHSLGVKDIAIVANEEQMGQDWNVQYTNWCKPGAMLQLLDIFYKGKNLSKSSHDFLSKIMIDGPTGMNRIKGQLPKEAVVAHKTGTSGTNHKGVMAAVNDVGIVKMANGKSFAIVLFMSNSTAELKAIESVMAQVSKAAYEHYAAK
>AIA15405.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MANFSIRRAQSGDEDLVLALLRDLAEYEKLLDKFHITADVIARDYFREQPLLNCDLAFEGDTPVGCATWYWTYHSFAARRGIYLEDLFVRPQTRGKGYGKALLSHLARTAVENGGAQVEWEVLPWNTPSIEFYELIGAKRLSDWYVYNLSGDALKKMGS
>AIA15287.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MKLGAFSVSLSVKDLPVSREFYENLGFTVFAGSMEQKYLIMKNDNALVGLFQGMFQGNILTFNPGWDENAHNLESFEDIRTIQHHLKSKGVSLLSEADESTTGPASIMLTDPDGNMILLDQHY
>AIA15270.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MPVKKIAVALIALLPLGDVAQAQTVKDLLAALLVKWNTPTEPFKMIGNVYYVGTDGLASYLITSPQGHILVDTVMPESTSQIKASIEKLGFKITDIKYLLNTHAHIDHTGGFAEIKQASGGQLVAGEADKPLLEGGYYPGAQQDEALKFPPVNVDRTVREGDKVTVGDVTLTARETPGHSPGCTSWEFSVKDGDATRTALIFCSGTVALNRLVGNPTYSGIVTDYKKTFARARDMKVDVLLAPHPEMYKMAEKRAKLAEGGPNPFVNPGEFNAYAATLEKSFEDALAKQTAAAQEKKG
>AIA15268.1|FEATURES|farme|beta_lactam|PMI41_04644|antibiotic inactivation|1
MKYRTVRLMAAAVATTCVMMAATCHAADESHGRHIVNEAVRPAMEKYDIPGMAVGIAVDGASYIFNYGVASRETRKPVDAATLFEIGSISKTFTVTLASLAEVEGHLSWSDKTSQYLPSMKDTPFGDVRLLYLATHTPGGFPLQLPDDVTNDAQLTAYLEHWKPAYKAGTMRTYANPSIGMLGRIAARSMDGDFAALMEHRIFAALGLSGTYLHVPKSRMPDYAQGYTKRDEPARMTEAVLSSEAYGVRSTASDMLRFLTANMGQLPLQPALQRAITATHTSYFRAGVLTQDLIWEQYDEPVALDTLLRGNSSEMAYNATPAAPLIPPQAPRADAWINKTGSTNGFGAYVAFIPERRLAIVLLANKNYPNDARVALAHEILSRLARKNGSPSD
>AIA15264.1|FEATURES|farme|beta_lactam|OXA-50|antibiotic inactivation|1
MPRIIIVLSFLIASLGSLSARTYQEVPELAKCFAAQGVAGTFVLFDVANDTMFISDEARARKRFTPASTFKIANALIGLETGAVKNVDEVLPYGGKPQRIKEWERDMGLREAIKMSNVPIYQELARRIGLERMREGVRKLGYGNMEIGNVVDRFWLEGPLAISAIEQTEFLQRLVKGSLPFNPAAMRAVKEITLLEKTDTYELHAKTGWHVGPTPPEIGWWVGWIERDNKVYPFALNIDMPGDADPPKRISIGRECLKALGKL
>AIA15260.1|FEATURES|farme|beta_lactam|LRA-12|antibiotic inactivation|1
MFKRILKNTFVITLLLFCGTLSFAQQVKEPTGGNPEWSKPYDPFRIVGNLYYVGTYDLGCYLITTTKGHILINTGLAGSFDMIKSNVASLGFNFSDIKILLTTQAHFDHTGALATIKKATGASMMADEKDVDLIEEGGVSDYAFGGSVMFAPVKVDRKLHDKDVVALGDMKLTHLHHPGHTKGSCSYLFDIKDEKGSYRVLIANMPTIVTDKHLDAIPAYPDIARDYAYTLKELKSLTFDIWVASHASQFDLHVKRKPGDAYNPEVFRDREGYDRSLADLQAAYDKKMAAK
>AIA15256.1|FEATURES|farme|beta_lactam|HMPREF1562_2717|antibiotic inactivation|0
MKLLSVAVTLLFLSCASKAQVQPEYIHQIDSLLQVKQPRAFNGVLLIAQEGAILYSKAYGYSNFDKNTPLKIDDKFSTMSIAKQVTATLIMLEVEKGTIDLHVPIRRYLPDFKYTWADTVTMHHLLNHTSGLESFDIKKPLKFATGKDFSYSNIGYSIAGQILEKQSGKTFEQLVTSLFRHCGMSNSAYYTKQNQALLTKGHTLQNDGKHLVRNDISFNPADYFGCHLMVTAADLAKWNESLHNGMVLKPATNKLMINYSTKATHPLFGQDAIGYG
>AIA15255.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
PMLSTVKFPIALAILYKVEQGELAMKQKLLIKKAHLRENTWSPFRKLHPNGNVTITLEEAMTWMVAESDNNLTDVLLRLIGGTETVKEFMDSEGFIIKNNEADMHKDWAAQFVNKIRPTVAVQVLQEFDQQRILNPQHTKWLYTTMAGSKTGDKRLKGKLPENIVVAQKTGTSFTNDKGLTGAINDIGIIELPGNKKIYIAVYVRDCAEPFETGEAIIADIAKVTYDYYLQKGN
>AIA15243.1|FEATURES|farme|aminoglycoside|PSEEN3982|antibiotic inactivation|0
MAIELVRAMPEHIPQMARITYEAFKGIADAHNFPTDIPDVNVASMFIEMLVTRPDFYGVAAVEDGVVLGHNFVQISDPVAAVGPICVEPNRQAKGVGRHLMQHIVEWSLKNHGPMVRLLQEGYNMRSLSLYAALGFVVREPVVLMEVIPASKPDSTTRALTAADLDACDALCQKVQKASRKNELAAAIQFGPAMGCVPFGRFVGGPLKAFIVPGFFGFSAAVSDDELLDVMQEAARLSPPPLHRTLMPTRQGTLFPAAMRRGFRSIKPFNTMSIGPYETPRGAWTPSIGY
>AIA15199.1|FEATURES|farme|beta_lactam|LRA-3|antibiotic inactivation|1
MSDTDQKMRIFMRSKLLLAAALLALSASVPLQAATPQRIHPPITNKEWETPFPGFKIVGNMYYVGTYDLGCYLIDTGQGLILINSGAPGSYPLIKANIEKLGFKTSDIKIITSTHGHWDHVGDLASFEKDAPNAKMYMSERDAPVLESGGNLDYRRAEGRGIIYDPVRVDVKTKPGDHIKLGNVDMTVHAAYGHTPGATSFTFTQQDSGKTYNVLIVNMDGINAGVKLLGSPGYPTIVEDFANTLKDQATYKPDIWVSSHSGQFNLHTVYHPGDAYNPSRFGDLAAYQKKIADYQKAYEKQLTEERAAKKS
>AIA15196.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSAINKILVIGAGIAGPTVCYWLKRFGFSPTLIERSSKIRKGGQGLDVRGVAIDIVKRMGIYEKICNMRTQVELGRYVDARGNILHEEKGERFAFRQGEDVEINRGDLVEILIQTIEGVPCHFNQWIDGIKQSDNDVEVQFKDGRTEHYGLVIGADGLHSKTRRMVFNEDEYKLTNLGLYFSVFSIPNYLNLNHTEVQFEANQKLISLTSDKNPKMAEAAFCFRTQNVLNNIRDENEQQKFLRDTFQDFGWETSKILELMSDSDNFYFDSVTQVEMKSWTKGRVALLGDAGYSASPISGQGNNLALVGAYVFAGELKQAGGNYHRAFSRYNELLHSFVEANQKLGILVNESTLVYDEVSQEVAEERSNKIMQEVEIAANMISLPNYE
>AIA15153.1|FEATURES|farme|beta_lactam|OXA-54|antibiotic inactivation|1
MKRLLATLFVCLLLAPASGRAGSATQSASTPKDAASTPEAKIAELFGATPGAFVLYDRNADRFVRHNAARCAVRASPFSTFKVPNSLVGLESGVIKDADFVIPWDKKKYPADEAFLPEWNRDHDLRSAIQYSVVWYYRELALRVGKAPMNRYVEAMNYGNRDTSGPLDGFWLNSSIKISPDEQIAFLRALYDEKLPFSKRSMKIVKDILPSEKIGAATIRGKTGTGRIDGELWLGWYVGWVETGDNVVFFALQMDSPDVQTLMPLRKTTTKKILSALGYLPGAAAS
>AIA15145.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MIHRLPRGLLAAALGTALCGCASPPPAAQRPTEASIAAHVAAATRAAGSDLGEVLTLCKPAPAARPVQDETADRGLRALISRPAPPPGRAFDNLYFVGGDWSSAWAIDTPEGIILLDALNNQAEAAALIEGGMRKLGLDPARIRYIVVSHGHGDHYGGAPYLAQKYGARVVMSDIDWTMMETRLEFATPIWGAPPKRDISVKDGDKLTLGGTSLTLYVTPGHTWGTLSPVFDVSWQGRKHRVLLWGGTGFNFGADIPRMEAYGRSTQRMAQVARAEGIDVMLSNHSRVDGSQGKLARLRDAGGTQNPFVIGESTVERTLTVMNECSLAQRDRFALLP
>AIA15133.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MTKHIKILVIGVGVAGPAVAYWLKRFGFSPVLIEKSAAVRKGGQALDIRGIATHIAKEMGIYDQICNMRTQIKCGRYVDVKGNVLHEEQGETFGFRQDDEVEILRGDLVEILMKAIADIPCEFKQSVIKIEQNEDSVTVTYKDGRVENYDLVIAADGIHSATRGMVFSKNEYQLINLGSYVSAFTIPNYLGLDHMELLCESNHKLVTLQSDSQADKAMAGFMFRSKHVLEDIRDEQEQKHFLHASFQNFGWETQNILNRMPESDDFYFDAITQIKMKSWTKGRIALIGDAAYCPSPLSGQGNNLAFVGAYILAGELKKADGDYIQAFTRYNELLHPFVEANQQFGVWVSESFLLKDDEVSKEIAEARSNKILAMIKSVSNSINLPQYE
>AIA15119.1|FEATURES|farme|beta_lactam|SMB-1|antibiotic inactivation|1
MENRLKVLIAALCIVSTEAHAYPTDWDAPQKPFALYGNTYYVGTAGISAVLITSPQGHILIDGTGSKGAGIVADNIRSLGYKLSDVKYILNSHAHSDHAGGIAALQRLTNAPVLAGQANLATLASGKASRDDPQYGELPDFEQVTSLRGIGDGEVVAVGPLTVTAHATPGHTPGGTSWTWKSCVNGQCETMVFGDSLSANAATSYRYTDHPDTVASLRQGFATFEAMPCDILVTAHPEANDLFGRLQQRAQNGSAAFIDPNACRDLVASYRERLDKRLATEKR
>AIA15120.1|FEATURES|farme|fosfomycin|FosA4|antibiotic inactivation|1
MLSGLNHLTIGVLDVERSLQFYGSLLECRVRATWRSGAYLSIGSLWLCLSLDAKRSTEPAPDYTHYAFSVAQDKFDVLVRRLREHGVVEWKENCSEGNSFYFLDPDAHKLEVHVGDLDTRLAQCRLAPYDFMRFFD
>AIA15107.1|FEATURES|farme|tetracycline|otrA|antibiotic inactivation|0
MFTRVVPDIAKTYGLDVRAIGNVQKGYRNESYKLTLADDKLVNLICFKREHGIVDRIARADAVSSHAAAAGLPVRIRYDERILKLQENSYAGIYEYLPGVTVAWEAYTKKHLKLLGWAMSDLHTALQTMGADSPHLLADELASLNARMRRYFSDDNVVRALREKLSITLSFDVFDTFEALIVHSGRLDGKQYVHMDMVRGNVLFGGADTSDRWQLDDIALTGIIDFEKTAYGLPVCDVARTLAFLLVDCPKTRSDILNYFLNSGYRKRGTAKLENRELIAPFVRFFLVHDFYKFLRHTPYESLENNHHYVRTRDILLEYGMISITDK
>AIA15061.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MLGGVTSLLLLGQANAASIDCSYCEAWNKDQAPFQIYGNTYYVGPHGLSAVLITSAQGHVLIDGALPQSAPLIAKHVEQLGFKMSDVKVILNSHTHFDHAGGIAELQKLSGAKVIASDKAAPVLRSGQVGPDDPQVGHLLPFPGVGNVEALGRRASIAVGTLKLSVIHTPGHSPGGTSWLWQSCEAGRCLNMLYSDSLNAVADSQFKYSGDARYPTAAKDLISSMEAVAAAPCDVLITAHPELSGVWATIDEQGKGDRAKLNDPAACKRYVETTKQRLEQRLASEKADKK
>AIA15064.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MLHHLSFAVRDLERAASFYDAVLAPLGFVRVWSDNTAVGYGYPGGGDKLALKLVPEGIVIPGPGFHLAFAAQAHEQVDRFHAAALEHGGRDNGPPGLRPAYGPHYYAAFVIDPDGYRIEAVLNTAG
>AIA15015.1|FEATURES|farme|aminoglycoside|Q644_14880|antibiotic inactivation|0
MSDLHIRNAAPDDAPIILALLGELAAYEQQPFELSEAAIVRDMLGDKPVCRCDLAFWGGAPAGIASWYWAYKSFGAARGIYLEDLFVRPEFRGRGTGRALLAHLAAIAARESGFMEWRVLDWNASSIEFYKSLGGKPQEAWVTYRLQGEALLKLASP
>AIA14961.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSDFTLRKAMPGDESIIQALLKELAEYEKLQDRFHLTQSAITRDMFGDACHCELAFQDDIPAGIVTWFWTYKSFRAVRGLFVEDLYVKPEFRGRGLGSRFFAHLAARARQANGFMEWQVLDWNTPSIEFYKSLGAGLSPEWITCRLEGEALEKLS
>AIA14957.1|FEATURES|farme|beta_lactam|carB6|antibiotic inactivation|1
MIVPFLLASSAECTAKVLSAPGLKSVIESFEKNLGGRVGVALLDVRNASGWYYRADERFPMASTSKALVCALLLKSGPAALTKKVKVLESDILEYAPVSKTLTGQYVTASDLCAATMRTSDNTAVNKILDTLGGPKAVTAFLRQIGNTSTRLDRNEPTLNEGRPGDVRDTTTPRAMAKTLQELIFGDTLNQQARSTLINWLKGNEVGGPLLRAGLPNDWQIADRTGAGGFGTRGVVAAVWPTERSPVVIVIYLTNTKASMDQRNAAIARIGREIAATLKQQ
>AIA14878.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSLTIRRARHDEAGLVFSLIRELAEYEKLLHEVEASETDIHDALFGDQPRLFCEIAEWEGDPAGVAVWFNTFSTFTGRPGIYLEDLFVRPALRGKGIGKALLAHLAKQCVANGWRRLQWAVLDWNTPSIEFYKSQGAELVDDWTMCLVHGPALTALAQGKQ
>AIA14870.1|FEATURES|farme|aminoglycoside|N184_17645|antibiotic inactivation|0
MITVRPMQRGEGAALLSMVRALAESHNLLHTVLATPEMFETAMFSEAPIVGTLMAEYDGRLAGCAVWHRSFSTNRGAEVMYLEDLSVLPEFRRRGVARALLKAVARLALAKNYPSIYWLMMDWNKEASALYQSIGAEIEPGTTFCRIRDDALKALAA
>AIA14863.1|FEATURES|farme|aminoglycoside|AAT_like|antibiotic inactivation|0
MKARYKGIVDRYAGLIRSAQIPAGTRLPTHRTLAAREHISLATATRVYAELEKMGLVSGETGRGTFVREILLPSGQGIDQHAVATDVLDLNFNYPALPGQGELLREALRQVASGGDIESHLRYQPHAGRQTEREIIAAHLAGAHFQPTGDNVLIVNGAQHGLTITVMGLLRPGDVVAVDALTYPGFKALAALYHLELLAIPCTENGPDLAALRQLCQRRHVRAVYTMPTLHNPLGWVLSREQRRTLADIARQHDLLIIEDTAYGWLIRRPPPPVASFAPERTVYVTGFSKNVATGLRGRCSDLPTRSAPGAGAGYPGHHLEYPVGHDRHGVSLDPGRHRGPV
>AIA14826.1|FEATURES|farme|chloramphenicol|catA15|antibiotic inactivation|1
MIFNPIVIDNWSRKPYFEHYLNNVRCTYSMTANIDITRLLSELKKKGIKLYPALIHMITTVVNRHSEFRTCFDSEGRLGYWDSLSPSFTIFHDDDKTFSSIWTLYGEEFNDFYSRYLDDMKMYRSVKQFAAKANEPPNTFPISSIPWVSFTGFNLNVYNEGTYLLPIFTMGKYFHHDEKILLPLSGQFHHAVCDGYHAGLLYNELQLRADTCKEWLPNN
>AIA14820.1|FEATURES|farme|beta_lactam|OXA-129|antibiotic inactivation|1
MRKSVFISLLFLPLVGQAATTPMLSEEPSWQRYYEEAGVKGVFLLCDADASHCYTNDKARAETPFIPASTYKIPNLLIALETGVIKDPDQIFRWNGEPRRLKQWENDFTLRGAVQNSVVPIFQQFARDIGERRMSSYLHKFHYGNEAVEGGIDHFWLDGALRISATQQVQFLQRLNLGQLPASKINQLRVKDILISDATPDYVIHGKTGYSLGAPGYGDRNAPGVAWWVGWIEKGTATWYFAGNIDVARDTDVAARKSIPLKILQGRGILP
>AIA14757.1|FEATURES|farme|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MKVTSQAELVAQLRALGIREGGVLLAHSSFRAVRPVEGGPLGLIAALRAALGPEGTLAMPSATGDDDLPFDPTTTANREDLGIVPSLFWQQPGVVRSAHFDAVAAVGPMAEWITGGPFVVPPAAPGSAIDRIREAAGQILLLGVGHDANTMLHLAELMGGAPYRSDYHYTRADGVRVDYGENDSCCEKFALADDWLRAEGLQREGRIGNAHARLIEAEDLIRVAVPRLRADPLVFLHGADQGCEECGEARESLSR
>AIA14704.1|FEATURES|farme|beta_lactam|bla|antibiotic inactivation|1
MRPFLQCLLLCLLLPLLSAAAPADIFSGYSGTVILYDLQTKQYSGLNQAQWDVGALPASTFKIPNSLIGLESGVIPNIDFVIPWDRVKRPIEAWNQDHTLKSAFAVSCVPYYQELARRVGFARMQDLVGKLDYGSMDVRAGNLDEFWLRGYSRITPRQQLQFLTRLIERKLPFSQRSQDLVESIMLRESKPAYQYFGKSGWAFEGKHETGWFVGFVRRGPKAWAFASRLEADSPDAAKSGPASEAAAKSWLRGQGLID
>AIA14700.1|FEATURES|farme|chloramphenicol|catB|antibiotic inactivation|1
MAVHFKPIEISQWNRREYFEHYLNQVPCSYSMVLNLDLTALLKEIKKRDIKLYPTMIYLLSTVVNGHEEFRTAIDKDAGVGVFDFLHPSYTIFQNPTETFTNIWTEYNRSFLEFYRQYESDVKDYGATKGFMGKPDTPSNVFTISSIPWVSFTGFNLNLPKSTDYLLPIFTTGKYFYENDKTWLPIAIQVHHSVCDGFHLARFVSELQEAMNTFHMN
>AIA14681.1|FEATURES|farme|beta_lactam|XM57_27510|antibiotic inactivation|1
MISRRQLLQAASIGLAGFGVIGRAGFVRAAAMSQEQFATELQRLERDSGGRLGVVLLDTATGKRAGHRMDERFPMCSTFKVLAASAILHNVDAGKESLERRVYFNETDLVTYSPETKKHVGPSGMTIAELCKAAITLSDNTAGNLLLASIGGPKGFTDFARSLGDKMTRLDRIETALNEALPDDPRDTTTPNAMASDLQSLVLGKTLSAKSRAQLVEWLAANTTGGKRLRAGLPTGWHVGDKTGTGDRGTANDIAVIWPTGRAPVIVTVYLTGATASADQQSAVIAGVGRAVGAVLT
>AIA14682.1|FEATURES|farme|beta_lactam|UB46_32240|antibiotic inactivation|1
GVVLLDTATGKRAGHRMDGRFPMCSTFKVLAASAILHNVDAGKESLERRVYFNETDLVTYSPETKKHVGPSGDDTPVTKLDLAEYMEAVGDWLIGHIRGRPCSILRAPDGIGGETFFQRHAMPGMSDLVEMAKVSGDKKPYLQIDRIEGLIAVAQIGGLELHPWNCAPGQYDVPGRLVFDLDPAPDVEFSEVIATAREMKDRLEALGLETFCKTTGGKGLHVVTPLSTAKKDSVSWKEAKAFAQVVCQQMAEDAPERYLVNMSKKLRDGKIFLDYLRNDTKSTAVAPLSPRARPGATVSMPVTWPQVKAGLDPKRYTVRTAPALLKKSKAWAGYDKAAHSLKAAIGKLVG
>AIA14655.1|FEATURES|farme|multidrug|sav1866|antibiotic inactivation|0
MATVPPSGIRRFFDIAATMKDVISLGVGEPDFTTPDNIRQAGIQSIKEGMTRYTSNAGILELRELLAQHLQRLYGVTYDPLKEILVTVGVSEALQVACIATLNPGDEVIIPEPSFVAYAPSVIFAGAIPVSVATHMEQEFAPAIADIEAAITPRTRALLLGYPNNPTGAVLTLEL
>AIA14543.1|FEATURES|farme|beta_lactam|PMI41_04644|antibiotic inactivation|1
MKRKIATALAGSLLITGVSATLSHAADDANRIKSLVDAAIRPVMDKNAIPGMAVGVIADGKSYIFEYGVASKDTGTAVTPSTIFEIGSISKTFVVTLATYAQANGQISLSDPASNYLPAFRGTEFGKIPLLHLGTHTPGGFPLQVPDNVKNDDQMITYLKNWKPAYKLGTTRTYANPSIGMLGVITAKAMNKDFTSLMEGTLFPGLGLASTYIDVPKSKMKDYAQGYTSKDKPARVNKAVLSSEAYGVKTTAPDMVRFMQANMNMVKLESKLQQAIADTHKGYFKVGAMTQDLLWEQYSYPVSLSALRLGNSREISSKPVPVKQINPPTEPRSDVWINKTGSTNGFGAYVAFVPEKKIGIVILANKYYPNEERINAAYEVLTKLDSK
>AIA14521.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
PEPFYANYNGFAIQADVVVKPISSTIQSGFALPPIEDFEKAITPKTKAIVVCNPNNPTGYLYSAEEMETLKQIVLKHNLYLFADEAYREFCYEGKHTSAMHLKGAEQHVVLMDTISKRYSACGGRIGAFITKNKQVFDAAMKFAQARLSPPFYAQVLGEAAVDLPDNYFDTTKAEYKLRRDTIVKRLNAMPGVFCPNPGGAFYAMAQLPVKDSDAFCQWLLEEFSYEGQTVMLAPATGFYSTPGLGRNEVRLAYVLNVESINSAMDCLERALEVYPDKIVKLAEAQAGG
>AIA14507.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MINYPCNPTGTVMTEQDWLPIVELIIKHNLVVISDEVYAELTYGRKHVSIASLPGMKERTIVISGFSKAFAMTGWRVGYACGPHELIAGMLKIHQYTAMCAPTIAQIAALESLRHGLAAKDEMMASYNERRKLFVAGLNAIGLACHEPEGAFYAFPSIASTGMSSEQFARRLLEEAKVAVVG
>AIA14508.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MFSEEGIGQFLSSRVRDIRPSGIRAFFDLNAAGGDTIALGVGEPDFVTPEKVREACIQALREGQTKYTSNAGLMELREELSAYFASSFALSYDPEQEIIVTVGSSEAVDLALRAVINQGDEVLIPAPSYIAYEPITHLHGGKIVEVAATAEEQFKLTPQVLQAAITPHSRL
>AIA14501.1|FEATURES|farme|chloramphenicol|catA15|antibiotic inactivation|1
MIFNPIDLDTWSRKPYFDHYVNNVRCTYSMTANIDITRLLEAIKKKGIKLYPALIHMITTVVNRHREFRTCLDSRNRLGYWDSMSPSFTIFHDDDKTFSSVWTPYCEDYKEFYRRYLDDMEKYGCVKQFTAKTNEPPNTFPVSSIPWVSFTGFNLNVYTEGTYFLPIFTMGKYFKQDEKILLPLSVQLHHAVCDGYHAGLMFNELQARADTCKEWLPN
>AIA14456.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
DFVRALADYEKLSHEVLATEADITRDFFGPDPKVYAQIAEWEGKPVGFALWFYTYSTFQGRYGIWLEDLYVDPALRGKGIGKALLQHLAQRCVSEGLGRFEWWVLDWNEPSIAFYKSQGGVMQDEWTKVRVEGEGLLKLGRSG
>AIA14450.1|FEATURES|farme|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MDTLAIARNQAFNQLAEAAVRQYCKTVHEITYIEHGADNLIILVNHEFVFRFPRDDGASRRLFFETALLQKLAGKVTTVTIPSVVQVHHQPLFVVAPYTEGVHLDGRQIQSLSQEEQTAVGETIAQFVVELNQAISGAEVSQLRQQAGVVHADGAWEPYFERLFALQPLPNAKLQPLVNEFYPLWKDYLKHQDRTLAIHDDLHPVNLLFMGPRLTGVLDFGDANTGGIEEELRWLYLMGDVVLGSAIAKYQELTGKNINHDHVRVWAIMHELSSYVRGLARQETEQFPFKRAEANLKAWLPNFPV
>AIA14389.1|FEATURES|farme|beta_lactam|ATN06_17210|antibiotic inactivation|1
MKTLLILCISLLSWASALAQSPTIQVSKLEENFYVHTSYNTYQGQLVPSNGMIVNTPKGVILIDTAWGDEQTQQLLAWIKKELRRKVILVIVTHAHSDRMGGIRTITKEKIRIVSTPFIRERAGQINENYGEYRPEPALSSDTTLTFGSLKTRVFYPGKGHAPENVVVWFPAQKILFGGCFIKSVASTNLGNLSDADIPEWKLSLHRTEEKFPKPNIVIPGHGDPGGPELLTRTRELLDIGK
>AIA14386.1|FEATURES|farme|beta_lactam|blaA|antibiotic inactivation|1
YKKINIMKFLSFILILVCAQHIFANKYPSARKQLNKLEHSLDGKIGIFAMNTANQQTIHYRSKERFPIQSTFKLMVVAAILKKSATDPELLQKKIFYTKNDLVTWSPITEKRIDSGMSILELCDATMKYSDNTATNLLMKQVGGPAVITDFAHSLGDSVFNVLHYEAELNSNPNSTDDTSTPENMGINLKKIAFNPILPSSYIHLLLNWMKENTTGDAQIRAGVPKEWVVADKTGSSSFGTSNDIGIIWPTGCDPIIIAIYTVQNKEDATKRNDILKDATRTVINEFARADLCIKQALKNEKA
>AIA14350.1|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
TFPFFFMPEVPAFASARNGYQAAGDTVIGNDVWIGSEAIIMPGVHVGDGAVIGTRALVTRDVEPYAVVGGNPAKIIRKRFDDADIAMLLETKWWEWDDSELREVMPILSSGNIKALHEHWQKVK
>AIA14264.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MESDVQIRIASPDESDTIAAVIREAFAGFESFYTPEAFAATTPNAEKIRERFDEEGTIWAALKDKEIVGTVSAIVKGEKVYIRSMAVSPTAQGLGIGRKLLETVEKFAIENGSESLFLYTTPFLPGAIWLYEQSGFERGDIETDGFFGTFWFAMEKD
>AIA14255.1|FEATURES|farme|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MKRDYVLEQSLTFAATSRAMSAAEVSSQLLALGVRRGGVLLVHTSFRAVRPIAGGPTGLIDALRDALGPEGTLVMPSWSGLDDEPFDPLTTPSADDLGIVAQTFWRLPGVRRSNHFHAFAAVGPQAELVTADPLPLPPHIPASPVGRVHDLNGQVLLLGVGHDANTTLHLAELITSVPYRTESYITVLENGQRVQIRYGENNHCCARFALADTWLGDAGRQAEGQVGHAHARLADARDIVALAVERLVADPLLFLHAPEAGCPECVEARQSVSVGEPIRNMG
>AIA14148.1|FEATURES|farme|macrolide-lincosamide-streptogramin|MphC|antibiotic inactivation|0
MSWSSPIPLSATDGTGATWQILRAWPYTTPGDYTLEVRTSGRPGVRGARLRDGNFELVPPDDPRLPALRTAAEQGVIVRYMPYKRAVVRAEGRYIKVFRRGSAAVPAERCAQMDVLLEAGAFVAPEIISRSSQDVIVFGAIPGPTLYELGEDGSPAGDVPFARAWERWSQAWVAQVAGLHGPAQQAVLDSLPLRSAETQAEDAWRRVERWLRHYQDVPGLSFERRTLLARAEQVAANLLRTPPDPLVWAHADLHDKQIIASPGASPPGLLDFDGISRAEAALDLANIDAHLELHQRQGLLAPSRYLTAHTQVLAAAAELLVSPERFRAYSDALWLRLASSPLPGRLPLALGVLAERADQVPQNVR
>AIA14082.1|FEATURES|farme|beta_lactam|bla|antibiotic inactivation|1
MMKLLAITFLLLVSITETVAQAQDLSPFFKDTKGAFVLYDLKNNRYLRFNEARCRERFSPKSTFKIPNSLIGLDTGVIQDADFVIAWNREKYPPQDNWDQEPFKHWGQDQTLRSAIKYSVVWYYQELALLVGEKRMKKYVTALNYGNQNVSGGITQFWLNGGLKISADEEVEFLKALYANRLPVSKRSTDIVKDILVLEKAPTYTLSGKTGGGSIAAGTYIGWFVGYLETNGNVYFFATNIEGPSFAAVREKRIDVTRQVLSYLGYLPK
>AIA14065.1|FEATURES|farme|peptide|vph|antibiotic inactivation|0
MESGEQAIIRQVADLYGLEISRLLPSQKGYRNTSYPILLKDRSHVNFIMYKSEPHMLERIKRIHSVSRILEHQGLPVRHALNNKIVKLKSVHGTSYGALYNYLPGETIPWQSYTKDHIKLTGMAMSNLHAGFGHTPNVSVNVANEYEALVKRMHLYFGRLDVLEAMREKLSIVPTISFRRLAAILNICGNLAYKQNLHMDFVRGNLLFNTVKPQSTLRVGSVAMTGILDFEKVAYGHPIFDIARTLAFLFVDCPTKSPEKIEKYFLYSGYNKRGTSQFTRPVVSRDQIKMDLLIELVHLFLVHDFYKFLVHNPYDFLHQNEHFIRTRNILHERGMIQFI
>AIA14057.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MKKLVLLIVLLSLSIACSRIMSKRDEFRDKVSEFQEPKIEDQELADLTALIEKTAAPAKGRVGVFAVVLETGESVDLDPDGQYPMQSVFKLPISMAVLRQVEEGKLKLDQKVKVEKADYVRIGMRSPLRDKNPNGAEVTVEELIRLSIVESDGSASDVLTRLAGGAGEIQAYLTGINIGEMIVANTEKEIGQDWETQYRNWASPEGAAALLRALHEKRGISEPHQKLVLKFMVESVPGAKRLKGMLPAGTQVAHKTGTSGTNKDGITAATNDIGIITLPNGKHLAIAVFVSDSPADEATREGVIAGIAKACWDTWSK
>AIA14047.1|FEATURES|farme|beta_lactam|OXA-247|antibiotic inactivation|1
MQFLILLSLMLLPPVSHPAAPAQPQDLRPFFKNTNGAFVLYDSGRGRYIRYNERRCDERFSPKSTFKIPNSLIGLESGIIRDAEFVIPWNRRKYPPQDNWNQEPFVHWGQDHTLRSAFKYSVVWYYRELALRAGLQKMKGYVTAFNYGNKNISERVDEFWLGGSLKISANEQVEFLKAFYSGHLPVSRRSTEIVKDILVLEKTPAYKLSAKTGGGSIAEGVYIGWFVGYVETEDNVYFFAMNIEGASFAEVRDKRIKMTKEILTALGVLPK
>AIA14017.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSLTIRQAVPGDEQVVLDYVCKLADYESLRHEVAATVGDIRESLFGATPRAYCDLAFWKGEPAGFALWFYNYSTFRGRAGIYLEDLFVDDAMRGKGIGKALLKHLAQRCVKDGLPRLQWWVLDWNAPSIEFYKSLGAVPQDEWTVFRVSGDALDKLAAQ
>AIA14002.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MGLLLFGHLVNRRDILTQKPFLLRHQLAKLLSVVLLVLPSIAKAQSDETSRAWNRPVEPFRIIGNVYYVGATEVSSFLITTPEGHILLDSGFAETVPLIQANLKKLGFKIEDVKILINSHAHYDHAGGLADLKELTGAKLMTSEADAVLLANGGKGDFRWGDDLSYKPVKVDRLLRDNDKVELGGVTLTARLTPGHTKGSTTWTMKVKESGRQLDVIFAGSTSAPGYKLIDEPNYPGIAGDYDYTFRLLKSLHCDVFLGPHGSIFSLLDKAARLKQGEKNNPFIDPKGYRNFIEESEKNFLAQLEKQRQAKKTE
>AIA13995.1|FEATURES|farme|aminoglycoside|ERS370000_04144|antibiotic inactivation|0
MIRLARTDDLPRLQDIERAAGEAFRGLGMDQIADDEPFSLDEMNAYVTAGRAWVWVDGLDYPLAYLLTDIVDGNAHVEQVTVHPDQAHQGLGRELLHAARVWARGHGMQRQTLSTFRDVPWNAPYYRRLGFQTLDAGSWGPELAKLMEHEAELGLTRWPRVAMWRPVVPPT
>AIA13983.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MIPAIKKAWFYTFCLLLLTLGCTSVNSSNREDTPNNETSAPSGITISNADRTNELRDRIEQISQAARGRVGVTATVLETGESVTLNGDRQFPMQSVYKFPIAMAVLAQVDQGKLKLDRKIRVETSDVLQGSRILDEKSQGMEFSLAELLKYMVSESDGTSCNVLLRQVGEPRIVTEYLRSLGINDIVVANTEKELAQDPAVKYRNYATPDATVVLLRAFHEGKGLSKSSQALLLQLMTETTTGPQRIKGLLPDGTVVAHKTGTSSTVNGVTAATNDVGLVTLPNGRHMAIAVFVSDSGANNATREGVIAKVTKAAWDEWSK
>AIA13841.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MKAQSDETARSWNRPVEPFHIIANIYYVGATEVSSFLITTPKGHILLDSGFAETVPLIQTNFKKLGFKIEDVKILINSHAHYDHAGGLALLKELTGAKLVSSEADAALLANGGKGDFQWGDELSYKPVKADRLLRDNDKVELGGVAVTARLTPGHTKGSLTWTMKVEEAGKQFDVVFAGSTSAPGYKLVDNQKYPGIIKDYAHTFQLLKSLPCDVFLAPHGSIFSMLEKAGQLKQDEKHNPFIDPKGYRNFIERTEKAYLQQLEKERQATKTN
>AIA13819.1|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
DLSIYDLQTGKLVEMPSDFDEFTERASPDYMGGTEKERANRDLLRKSMEAEGFTVNANEWWHFDYKDWQSYAIYDIPFSAIGDLKTRFSEAKIEEHSDWKRFFDAAKAKGGIVIYDLRENKYMVYDRERMNRGFVPASTSKIIHSLIFLDSGAVKDENEVFKWDGVKRFSPDWNKDHNLRSAFQVSAAWFYVEASKRAGRETMQKYYDSADYGNRNTDGFGDAYWVKGDLRVTPKEQVDFLIRLYENTLPFSQRSIELVKDIMIVEKTDNYVLRGKTGWSDTYTPQVGWWIGYVERSQNAYFFALEMDMKNFADAEKRKIITKNILKSLKIIE
>AIA13817.1|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
MKKHFLRFTWCLFCFILFSSCAPAQNTPPKEENKREADLLELVKLDKTIKLDIRYARTDNFVGKVVYPEARAFLQRPAAEAVVRVNQKLKEKGLGLMIFDGYRPWAITKLFWEVTPDDKRKFVANPANGSKHNRGCAVDLSIYDLQTGKLVEMPSDFDEFTERASPDYMGGTEKERANRDLLRKSMEAEGFTVNANEWWHFDYKDWQSYAIYDIPFSAIGDLKTRFSEAKIEEHSDWKRFFDAAKAKGGIVIYDLRENKYMVYDRERMNRGFVPASTSKIIHSLIFLDSGAVKDENEIIKWDGVKRWVPEWNQDHSLKTALKASAAWFYVEASKRAGRETMQKYYDAAGYGNRSTEGFGEDYWVKGKLRITPRQQIEFLVKFYENRLPFSPKVPALVKDLLVYEKTDKYIIRGKTGWSQDFDPWVGWWIGYVERGSDIYFFATELDMKKNEDAQKRYEITKRVLRSLKVIE
>AIA13749.1|FEATURES|farme|beta_lactam|OXA-5|antibiotic inactivation|1
MRTLQVDRSCDITACDLANLLKFMNRISRAIALILIVLGCITAVLVQTQQSALTAPTPALESPPRPGDVAQTVNFGRHFQELGVEGSIAIYDLNSDRLYQHNPQRNATAFLPASTFKILNSLISLETGVISDEIAVLTWDGTQRQFPAWNRDLNMREAIKLSAVWFYQVLARRVGHEQMQKWVAKVGYGNQKIGNKDDIDKFWLEGELRITPKEQIQFLRRLYKNDLPFSERSLSLVKDIIIVEQTPDYTIRAKTGWANLGEQTKPQIGWYVGYLEKDKNVYFFATNIDIRNKNDPSARIELTRRCFKDLGLL
>AIA13740.1|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
MKRIFPITACALFLTLFSVVFSAAQGTYLNKKEADLIELIKLDNTIKLDIRYAASNNFVGKPVYPEARAFLQRPAAEALLKVHKLLKKQGLGLVIFDGYRPWAITRLFWDVVSLEQRKFVADPEKGSKHNRGCAVDLSIYDLKTGALLDMPSGYDEFTERASPDYRGGTELQTKNRELLRGLMEAEGFTVNPNEWWHFDYQGWENYGVYDIPFSVIGALDQDIAKAEIKENKTWKRIFDATGVTGGIYIYDLKKNKFTVYDRARFDTGFVPASTSKIFHSLIFLESGAVKDENEIIKWDGVKRWVPEWNQDHSLKTALKASAAWFYVEASKRAGRETMQKYYDAAGYGNRSTEGFGEDYWVKGKLRITPRQQIEFLVKFYENRLPFSPKVPALVKDLLVYEKTDKYIIRGKTGWSQDFDHWVGWWIGYVERGSDIYFFATELDMKKNEDAQKRYEITKRVLRSLKVIE
>AIA13737.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MQAKHSFVSSFEFKTKDQRPKFKNQIMKFLSFALCVAFSASGCSPSSSQTSDVGSQPAEASTPQAEGTTKTSALQNQIKEIAAEAKGKVGVTAVVLESGETVASLNPQEHFPMQSVYKLPISMAVMKAVDAGKVKLTDKVTISKSEFVGRAAHSPIRDQHPNGASLTVEELLRYALSESDGTASDVLMKLAGGPAAVQALTELSIKDLIVLDTEQTFTQDKTAQYRNWATPEAAVALLRALHESRGVSESSQSLLLKFMTESTPGAKRLKGMLPAGTPVAHKTGTSGTDKGVTAATNDIGIITLKNGKHVAIALFVSDSPADQVTREGVIAKIAKAVYDTVSGGR
>AIA13652.1|FEATURES|farme|chloramphenicol|catA15|antibiotic inactivation|1
MNFNPIDMDNWSRKPYFEHYLNNVRCSYSITANIDISRLLKELKRQGIKLYPALIHMITTVVNRHSEFRTCFNSDGTLGYWDSLSPSFTIFHDDDKTFSSIWTLYGEDFIGFYSRYLDDMKKYGSVKQFAAKTNEPPNTFPISSIPWVSFTGFNLNIFNEGTYLLPIFTMGKYFQQEEKILLPLSGQFHHAVCDGYHAGMLYNELQLLADACTEWLPN
>AIA13639.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
SCRLPKGGRHFFDQNHRQAEASVNARSTRRRRNKKKWRMPVKKIVVALVALLSVAGTVQAQTVKDLLETLKVKWNTPTEPFKMIGNVYYVGTDGLASYLITSPQGHILVDTVMPEATSQIKANIEKLGFKVTDIKYLVNTHAHIDHTGGLAEMKQASGAQMIAGEADKPLLEGGYYPGAQEDAALAFPPVKVDRTVREGDTVSVGDVTLTARETPGHSPGCTSWEFSVKDGDATRSVLIFCSGTVALNRLVTNPTYSGIVTDYRKTFARAKDMKVDVLLAPHPEMYRMQDKRAMLSDGAPNPFVNPGEFNAYAATLEKAFEDALAKQTADAQEKKG
>AIA13625.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MVRRFVSLCIGLSVVQGMLPGLAVVLAAPLVWNESAAQGRSVPSNWTEKVKPYQVMGNIYYVGTLDLSSFLITSPEGHVLIDTGVEENAVAVLDNIRTLGFSVKDIRVILTTQAHYDHVGAHARLKNESGARVLVAAGDAPLVAGGGEGDYLFGPEYHFPPTEVDATVKDGEVVKVGPIALTAHLTPGHTKGTTTWTATVRDSAGQDRKVVFLGSTTVNTGTKLVKNEKYPAIEADYKHAFEVEKALPCEVFLAAHASAFGGPEKTAAAAAKGDAVFVDPQGCRAAIERSEKAFLAELEKQRTGG
>AIA13621.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MRLRTLHLIAVLCAFALASLGFAGESQTIVAQNKMTPTSAVRAQESPLERAIKRLAESSGGIVGVSAIHIESGRRVSMNGGTRFPMASVYKLPIALQLLNKVDRGELRLQDSITLSAHDFRPGHSPIVEFANNKPVTLTLERLFELMLGESDNSASDALLRLAGGPAAVTNRMQALGITGINVSRPEGELILNHRGVRELPPESEWTIALLDALSAKVTPAQRDEAAAAYADDPRDTSTPDAMADLLVRVHRRDVLLEPASMERLLQIMTATQTGPARLKGLLPTGTIVAHKTGTMGGTTADVGIVTLPDGAGHMAIAVFVKASTKEVPERERVIAEIARTIYDYLVLRSQ
>AIA13592.1|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MKFKLIDTSKWDRKEFFNHYLNHVPCTYSMTLNLDLTILLKEIKKRDIKLYPTMIYLLSMIVNKHEEFRTAIDVNGNVGIFDFLHPCYTVLQKDSQKFTNIWTEFTSLFSEFYKQYLLDVQNYGEIKSFIAKPDMPLNTFNISSIPWISFTGFNLNLPKDTDYLLPIFTTGKYFEQNGKIWLPIAIQVHHAVCDGFHIARFVSELQEAMNTLKLDEIKG
>AIA13556.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MEEIKLGLANGSLIAGGKLPSVRRLSQHFSCSNNTVIKAYSELEKEHLIYSVPKSGYYVVAEFQYKTSENEVIDFLSAGPDKNVMPYLEFQHCINQAIEQYKEELFTYSDQQGSYSLRVQLVKHLQNLQVFTQAERLVVVSGSQQALHLLVSMPFPNGKNNILIEQPTYFGFIESLTLHQATTFGIQLSMKGIDLDRLEYIFRNNDIKFFYIIPRFHNPLGHCYTNFEKKKIVELAEKYDVYIVEDDFLGDLDPDAKSDPLFSFNPCGRVIYIKSFSKVFLPGLRIAAVVLPSLMNSNFLRYKFSSDFNSSALSQGALEIYLKSGMFTSHLKKIKEVYHTKMQILVEACDSLLAAHT
>AIA13538.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
LASGQNGAPVSSCANCPEWNKPQKPFRVYGNTYYVGPHGLSSILITSRAGHILIDSALPESVPQVVANIRSLGFRIEDVKLIVNSHVHFDHGGGIAELQRLSGAEVAASPWSVEVLTKTGVGKADPQFGSVLPVALIQRATTLRDGQTLRIGDIKLTAHFTPGHTPGGTSWTWESCEGKRCLSLVYADSMTPVSSDGFGFTDSRESPTAVQDFEKSFSFLRATPCDILLTSHPDASGLWQRLEGRQGGVRPDPLVSPNACKELAGRASEQLRRRLESEKAR
>AIA13524.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MHKLYHLPNPTRALTLACFLLILAALAWGQQQGAPQSSSCDNCPEWNKPQQPFRIYGNTYYVGPHGLSSILITSKAGHILIDSALPESVPQVVANIRALGFRIEDVKLIVNSHVHFDHGGGISELQRLSGAKVAASPWSVEVLTKSGVGKGDPQFGSIPPVALIPKATTRQALPEPRLCRQPDAGLSRRLSLLGQPRIP
>AIA13525.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MHTRNHLPNPTRALALATFLLVLAALASGQNGAPVSSCANCPEWNKPQKPFRVYGNTYYVGPHGLSSILITSRAGHILIDGALPESVPQVVANIRSLGFRVEDVKLVVNSHVHFDHGGGIAELQRLSGAEVAASPWSAEVLTKSGVGKGDPQFGSIPPVALVPRATTLGPSPPQAFGGVARKLVRPNPCRRSARQRGRA
>AIA13521.1|FEATURES|farme|multidrug|MexF|antibiotic inactivation|1
MSYINKILVIGAGIAGPAVCYWLKRFGFTPILIERSANLRKGGHALDVRGVAIDLVKRMGIYEKICTMRTQVEFGRYVDAQGNIVHEEEGERFCFRQGEDVEIVRGDLVEILIDAIEGVPC
>AIA13518.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFGIAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIEILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKEEYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDNIRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVAIQIKMKSWTKGRIALVGDSGYCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINETFLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK
>AIA13507.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MNTTNPHEKRKLIRISMRVIINLVVALMLPGVAGCNRAPSAAQSTTTQQASAVRSDSADRELTEQLRSLCDAVAGDIGVAVVHVESGKTVAVAGDKKLPLYSVYKLPLAMTVLRDVEAGKLRLDQKVKVTPADVAGTLFNTDLWRSAQEKTVRELIEYAIVRSDNTSADKLLGLIGGPPIVTQEMRTIGLANIDVVVSSREFTAHRDKPNTGTTTDLAQLLARLQKGELLQPANFSLLRDYMERAKTGGERRLRANLPAGTQVADKTGTGDVATNDVGLITLPENKGHLAIAVLISGSKLPVDKQEKTIADIARGLRLVRFPACATLITISTCR
>AIA13509.1|FEATURES|farme|aminoglycoside|PROVALCAL_00921|antibiotic inactivation|0
MTQEIRQTNSLTLAERAQLFEWGVNIFGVQNEALTWRHKDVHFILSVDGEDVSHVGVLKHEVSVAGERIPVGGVGGVVTIPTAQRRGYARELMSHVAQFFAGWEVDAGLLFCLQKRVPYYGSQGWELVHDEVVIQQPDGNINSPLEVMVLPLRRSWPQGTIELNSLPW
>AIA13505.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MVFRSLAAAALGVALMGQSGVFRPHPPMKCSSCDEWNAVREPFRVFGNTSFVGTAGLGAGLITSKDGHILLDGGLPQTAESIDRSVRALGFKTADIKLILNSHAHYDHAGGIAAIQRASGATVASSPSGAQALERGEPTDDDPQFAFGRAANAYPRVSKVRVVADGETLRVGELAIVAHFTPGHTPGSTTWTWRSCEGERCVNLVYADSLNAVSAPSFRFTDHKERLAAFRKSIATVANLPCDIILTVHPETSGLGDKFRRRGDKPAVDPFIDPEGCWKYAAAATTTLDKRLAEEKAVK
>AIA13500.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MTRISVLFLFIALIAGKVHGQTLSKEIVTLAKKYSADVGVGIITPEGDTVSVNGNRRYPMQSVYKFHLALYILDQVDQKKLSLRQEIILTKRDLLPATHSPLRDSSRIGMRVTLQKLLQYTVSYSDNIGCDILFRLAGGPSKVHDFIQAHGVSDVAVIYTEEEMHADWEKQFANYSTPKSMVLLLDKFRKGEILSPSSTKLLMELMQNTTTGTKRLKGNLPEGTIVGHKTGTSGYREGISPATNDAGIVTLPGGRTYSIAVFVSKSRETEETNERIIAEISRMVYDNLK
>AIA13495.1|FEATURES|farme|aminoglycoside|ASE98_04520|antibiotic inactivation|0
MQPYEITSDKSRMSVEAAHAFLSQAYWARGVPISTVRKAFDNSICFATLAGSEQIGFARVVTDKATFAYLSDVYVLPAHRGKGVAKRMVEAIQRHPELQGLRRFMLATRDAHDLYAKFGFAPLSAPGMFMELHNPDAYAQD
>AIA13473.1|FEATURES|farme|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
EQRMKQLVTAFDYGNRDISGGIDYFWLGGGLRISADEQVEFLKKFYAGRLSVSKRSTEIVKDILVLEQTPDYKLSAKTGGGPIAEGKYIGWFVGYVETKGNVYFFAINLEGASYPEIRDKRIDLTRRILAGMGVLPKEKE
>AIA13455.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MDHTCVASLPGMWERTVLLGGFSKSHAMTGWRIGYTAAPPAILAAMRKVHQYIIMSAPTTGQEAAIEALKSGEPFVESMRQEYDRRRRLIVDGFNRLGLKCFEPRGAFYAFPSIESTGLSDEEFCDRLLMEEKVAVVPGSAFGMSGTGHVRASYATAYERIEEALVRIERFLNKLK
>AIA13440.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MTDLTIRSAVAADAGLIINFIEALAAYEKLSHEAKADEADIVRDLFGPEPKVFCEIAEWQGKPVGFTLWFYTYSTFQGRHGIWLEDLFVDPSMRGKGVGKALLVNLARRCVQEGLGRFEWWVLDWNEPSIEFYKSQGGVMQDEWTKVRVDGEALLKLGAS
>AIA13432.1|FEATURES|farme|aminoglycoside|Y886_30125|antibiotic inactivation|0
MPLLLEIQQLAAQTDGTTTASPTDFAAWLSNPALEAAHNVFVVTDDDETNTWGQGDTLEGIEGEIIGYTALTLHQDERAYHFLCQGAVSPQYRRQNAGRALLICALNRARICAAEFEFEAEQEGKPLYLEALLPLADAASSRLAAKCDMQPADEPAPAGMQLYRRELYD
>AIA13398.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MIPAIKKAWFYTFCLLLLTLGCTSVNSSNREDTPNNETSAPSGITISNADRTNELRDRIEQISQAARGRVGVTATVLETGESVTLNGDRQFPMQSVYKFPIGMAVLAQVDRGKLKLDQKIRVEARDFVSDLQHSPIRDENPQGLELSLAELLKYMVSESDGTACDVLLKLVGGPEVVTQYLRDLGVNGIVVANTEKEIGQDKAVQYRNYASPNAAVVLLQALHEGQGLSESSQALLRKLMTQTPTGLQRIKGLLPDGTVVAHKTGTSRTVDGVTAATNDVGLVTLPNGRHMAIAVFVSDSGANNATREGVIAKVTKAAWDEWSK
>AIA13396.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MLPEIILAQKNSPKLAIKQIIQSSKGTVGVAVIGLEDNFSMTMNDHKRFTLHSVYKFPLALAVLDQVDKGQLSLDQKLHVTKKDLLPNTWSPLRDEHPNGGDISLSELLGYTVSQSDNNGCDFLFRLLGGTKNVQTYIRNLGIKDISIAATEEEVAKAWPVQYTNWSRPSAMLRLMVNAYRGKYLSQSSTDFLWKLMRETSTGPNRMKGLLPPGTVVAHKTGTSGTNDKGLAPATNDVGIVTLPNGKHFAIVVFVADSTDDQKTREGVIARITKVVWDYYLAKS
>AIA13376.1|FEATURES|farme|beta_lactam|OXA-129|antibiotic inactivation|1
MTLALRAFVLLIAFLSMSAAEAAAQNLDRVFGNTKGAFVLYDMKSNRYVRHNPGRARLRFTPASTFKITNSLIGLETGVVRDADFRISWDRQRYPNEDRPNTAPFIHWWQDHTLRSAIKYSVVWYYIEIARNVGAERMQKYVRQFRYGNGDTSGGIEQFWRNSSLQISAEEQVDFLRRFYTGKLPVSSRSTGIVKDILLLEETPSYRLSGKTGAAPFEGGTLAWFVGYLEREGNVYFFALNMDGANYEAIRDERINLTKRILVELGYLPRRY
>AIA13292.1|FEATURES|farme|aminoglycoside|PlsC|antibiotic inactivation|0
MICPNHQSYLDPFPVCSIYPRKVLQNIFHVGASMYFANFAMAHLAQLINVVPVDPDANLLRAMRAGAAGLRAGKILNIYPEGERSFDGRLHEFKKGAAILATELSVPVVPVALDGVYRIWPRKSWRVRLAKVKISFGEPIDVTTLADGMDKEALYEVITATLKERIQRMLDEMRRSR
>AIA13290.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MVLVTFLFLLAALASGQSGAPAPSCANCAEWNKRQEPFKIYGNTYYVGPHGLSSILITSKAGHVLIDGALPESVPQVVANIRSLGFRVEDVKLVVNSHVHFDHGGGIAELQRLSGAEVAASPWSAEVLTKSGVGKGDPQFGSIPPVALVPRATTLRDGRTLRVGDIKLTAHFTPGHTPGGTSWTWKTCEGKRCLNLVYSDSMTPVSSDGFRFSDSREYPTAVQDFEKSFAFLRSTPCDILLTSHPDASGLWERLEGRQKGVRPDPFVAPNACKDLAGRASEQLRRRLESEKGR
>AIA13260.1|FEATURES|farme|aminoglycoside|sat-3|antibiotic inactivation|0
MENINIKKATLKDIDQLHKISRQTFFETFSAGNTEENMKKYLDEVFSVEKLTDELNNENSTFYFAELDNNIIGYLKLNSGQSQTELKDDKALEIERIYVLQEFHGKKVGQLLYEKAMQIARQTNADYVWLGVWEENARAINFYKKNGFVEFDKHIFKLGNDEQTDIMMRLRLI
>AIA13229.1|FEATURES|farme|beta_lactam|VEB-3|antibiotic inactivation|1
MNKQILLTLLLVSGSVLPGCVQSPDPSRESVAICLQQRFAIAASTHTMDSVKSEADGRLGKAQVVAAQPNTTRLQERLNNLDLSSAQGDVGIGVLDLDTGERWFRNGKQRFPMQSVFKLPVGIVVLKLVDEGKLSLNQTVTITREQFVPAWSPILKEIKGDRGQFTVQYLLQRAVGDSDNTAADALVRLVGGTEQVTANLGRMNLRDIRVDRLEQQLQPDTVGLTNFRPELVDKQKYEEAVQQIPDAVKKAAMERYLTDPRDTATPEGMIDLLVKLQSRQLLSENSTALLLKIMTDSPTGQKRLKAGLPPGWSIAHKTGTGEDVVGIGIATNDVGLISSPTGKHIAIAVFIAGSKAPLEQRESVMSAVASAVVQAMQ
>AIA13168.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSTQLLLSALLNLTAHAGFSDILAVFPAAAALMVGLSKGRPSRQGQGSNGNQKMAHFILREAAALITGMSRSGFHFRTSPVWSSAMSELVIRAAEPSDTALILALLEEFAAYAKAPEFKLNETDVLRDMFGGACHCELAFREKEPVGIACWYWTYKSFRAARGLFVEDLYVREAFRGQGLGKALLAHLAAKARGAGGFLEWQVLDWNSSAISFYKMLGAQPLGQWLNYRLDGEPLERLAQSETR
>AIA13133.1|FEATURES|farme|aminoglycoside|AAC(3)-Ic|antibiotic inactivation|1
MLIYRRLTEADAEAMRQMNQMFGAAFKDTKTYRYDQGDDAYFQRILGKDHVIVLACFHAGQVVGGLVAYVLDKLEMARSEIYIYDLAVDESHRRQGIATELINELKAIAAKTGAWVIFVQADREDEPAIQLYEKLGVREEPLHFDINLEEGNG
>AIA13101.1|FEATURES|farme|beta_lactam|OXA-247|antibiotic inactivation|1
MKSMRAVLLLLMFMAGCAGVRAQDLSPFFKDTDGAFVLYDQKNDRYTRYNETRCRERFSPKSTFKIPNSLIGLETGVIRDADFVIAWNRQKYPPQDNWDQYPFKHWGQDHNLRSAIKYSVVWYYRELALRVGLQRMKRHVAAFAYGNEDISGGIDNFWLNGGLRISADEQVEFLKKFYAGRLPVSKRSTEIVKDILILEKTPEYTLSAKTGGGSIAEGTYIGWFVGYVETKGNVYFFATNIEGASYPAIREKRIDVTKLILAELGVLPK
>AIA13089.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
HTEVQFEAHQKVISMTSDKNPKVAEIAFCFRSQKILNNIRDKNEQQRFIRDTFQDFRWETPKVLELMSYSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNNLALVGAYILAGELKLAGGNYHQAFNRYNELLHPFVEANQKLGVLVNESFLIHDEVSKEVAEERSNKIMQEVKIAANMISLPEYE
>AIA13069.1|FEATURES|farme|multidrug|arpA|antibiotic inactivation|0
MKPDDLTPAFGWTLARRAARMNPSVIREILKVTERPGIISFAGGLPSPLTFPVDAFAAACRKVLADDGPGALQYAASEGYAPLREAVAAWLPWPVDPAHVLITTGSQQGLDLVAKVLIDADSEVLVETPTYLGALQAFAPMEPQVIGVASDSEGIDMSDLRRRRGSARFLYVLPNFQNPTGRTMSEPRRQALVNTARELALPIVEDNPYGDLWFDAPPPAPLAARNPEGTIYLGSFSKVLAPGLRLGYLVAPAALTPKLLQAKQAADLHSPSFNQRLVSEVLRDGFLDRHVPTIRALYRSQRDAMLAALQREMQGLDVSWNAPDGGMFLWARLPAGMDAAALLPHAVERGVAFVPGAAFYADAADTRTLRLSFVTATPQQIDTGMAALAAAIRSALRRPS
>AIA13062.1|FEATURES|farme|beta_lactam|oxaSH|antibiotic inactivation|1
QKNDRYTRYNETRCRERFSPKSTFKIPNSLIGLETGVIRDANFVIPWNRQKYPPQDDWADQYPFKHWGQDHTLRSAIKYSVVWYYRELALSVGPKRMKKYVMAFKYGNQDISGRIDNFWLGGPLRISADEQVEFLKKFYAGRLPVSKRSTEIVKDILVLEQTPDYKLSAKTGGGSIREGTYIGWFVGYLETHGNVYFFACNIEGKSYPEIRDKRIDVTKRILAELGLLPKQGAAQ
>AIA13040.1|FEATURES|farme|beta_lactam|Sputcn32_3157|antibiotic inactivation|1
MRLRAALLTALLLLPTLACAKTTGDGAARAAASPQTADTRAEGPKAREASPADLEPFFKQFPNGAFVLYDLKRDRHLRYNEARCRERFSPFSTFKIPNSLIGLDTGVITDADFLIKWDEKKYPAHDRDILPFSAWWQDQTLRTAFRRSVVWYYRELALKVGERRMKEYVQKLRYGNEDASGPVNNFWLGSSLRISADEQVDFLKRLYKEELPVSK
>AIA13037.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MRAATPADAPVIWQLLNDLAVYEKAPVFTLTEAEVARDMLGGACHCELAFRDGEPVGIATWFWIYMSFRARRGLYLEDLFVRPQARGHGLGKMLLAHLAAKARAANGFMEWRVLDWNEPALAFYQGLGAKPVAQWLNYRLEGAALDRLGT
>AIA13035.1|FEATURES|farme|beta_lactam|LRA-2|antibiotic inactivation|1
MRAAGWIDNKSTRVRQKIMAMRSRWSGQVKTGLAVLLGAGIAAGAAYAAAKSSCAECAAWNAPHKPFKIYGDTYYVGTAELSAILITTEFGHVLIDGGLPESAPVIKANIETLGFKLKDVKAIFNSHVHPDHAGGIAELQKESGADVYALRPAYEVLISGKPNADDPQAARKGGPGVPKVERAWVAQDDQQIGIAGVRMHVVATPGHTPGGTTWTWDACEGTKCLHMVYADSLSPVSADKYRFSDHPEVLQGFEKSFARIASLPCDVLLTPHPSASQLFERLDLGKENTEAVRDPEGCKKYVATARDALAKRLESEKTV
>AIA13033.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
ADLKELTGAKLMTSEADATLLANGGKGDFQWGDDLSYKPVKADRVLRDNDKVELGGVTLTARLTPGHTKGSTTWMMKVNEAGKQFDVIFVGSTSAPGYKLVDNPKYPGIVADYTYTFRLLKSFHCDVFLGPHGSFFALLDKAGRLKQGEQNNPFIDPKGYREFLEESEKDFLEQLEKQRQAGKTK
>AIA13030.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MLLPVVLLFLPSIAKAQADETSRSWNRPVEPFRIIGNIYYVGATEVSSFLITTPEGHILLDSGFAETVPLIQANLKKLGFKIEDVKILINSHAHYDHAGGLADLKELTGAKLMASEADAALLADGGKGDFRWGDSLSYKPVKADRLLRDNDTVQLGGITLTVRLTPGHTKGSSTWMMKVKEAGRQLDVIFAGSTSAPGYKLIDEPKYPGIIGDYEYTFRLLKSLQCDVFLGPHGSFFSLLDKAARLKQGEKNNPFIDPKGYRGFIERSEKDFHEQLEKQRQAKKTD
>AIA13028.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MNWRDILMQKSSLLRHQLIKLLPVVLLFLPAIAKAQSDETSRAWNRPVEPFRIVGNIYYVGATEVSSFLITTPEGHILLDSGLAETVPLIRANLIKLGFKIEDVKILINSHAHYDHAGGLADLKELTGAKLMTSEADAALLANGGKGDFRWGDDLSYKPVKVDRVLRDNDKVELGGVTMIARLTPGHTKGSTTWAMKVQEAGKQLDVIFMGSTSAPGYKLVDDPKYPGIVADYTYTFRLLKSLHCDVFLGPHGSFFSLLEKAARLKQGEKNNPFIDPKGYRAFLEDSEKGFLEQLEKQRQASKTK
>AIA12996.1|FEATURES|farme|beta_lactam|VEB-3|antibiotic inactivation|1
MTKILFTFFACTFLVGAVNVSELKKKLEHVDVSSVQSEVGIGVLDLSSGESWFLNGEQRFPMQSVCKVPVAIAILKLVDDGALSLGQSVTINPEQYAPSWSPLRDELKGGSGQFTVRNLLERSVADSDNTAVDVLIELAGGAGKVDAILKAMGIRGVRVDRRERDLQTESQGLEDFRPEQASTEQFDAVLAQVPEEKKRAAVRKFLSDPRDTATPEGMVHLLSQLYQNKLLSPSSTQLLLQIMTDTPYGQYRLKAGLPPKWSLAHKTGTGPDVLGVNTGTNDAGLACAPAGQCFALTVFIAGSKVPLQNREALMRDVAAAVTK
>AIA12956.1|FEATURES|farme|aminoglycoside|PKc_like|antibiotic inactivation|0
MLKDGTTVNVILYKSEPGILDKIKAANAVSAHLAAKGFPVRHTVDSRITKMTNGSHEKYAAVYTYLDGHTIPWEEYNQDHIKALGMTMSNMHAALADCDYLLPDVADEYLAIVARMRAYFADAPVQRALADKLLLAIKPEVFDGFEQLLVGSKLLPGKQPLHMDLVRSNVLFEDVEDNEDLKVRRPGGG
>AIA12941.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
SSDFYFSAVTQVKMNDWTKGRIALVGDAAYCPSPLSGQGNNLAFVGAYILAGELKTANGNYIHAFKRYNTLLRSFVDVNQRFGVWVSESFLVKDEISKEIAEARSDKILTMIKSISNAITLPQYE
>AIA12872.1|FEATURES|farme|beta_lactam|ampC_1|antibiotic inactivation|0
DPLRFEPGKGWSYSNAAFIVLGAVVEKVSGQNYFDYIREHIYKPAGMKDTDSYAADEVTPNLAYGYTRFGGDDPLGIEPRRANFMSLPLKGSPAGGGYSTAPDLLRFAQALRGHKLLNAEFTEKVTSAKVDTDFGAKYGYGFFDESVEGKVVRGHSGGAPGINSELKMFWDGSYTVIVMGNYDPPAAQGLAGKIARFLARQ
>AIA12849.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MGLIVRDAVRGDAPVILDFVRKLAEYERLTHEVAATPVDIERELFGAAPKVFCQLAEVDGAPVGFALWYYTFSTFQGRHGIWLEDLFVNPETRGHGVGKALLADLAQRCVREGLGRDEWNVLDWNQPSIDFYMSQGAVFLDDWRRCRVTGDALQKLGAAA
>AIA12844.1|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|0
MNPVKLVGPRITLREFNTDDIDAVHALIGDDRVTRWLSFDSRTREQAAAMIDGVLQRTQEQPRAEYYLAATLGDSSLIGFARLGLTGVKAAKLGYAIAADAWGNGYATEATQLIINFGFDELGR
>AIA12764.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSKHIKILVIGAGIAGPATCYWLKRFGFSPVLIEKSASIRKGGQALDIRGIATNIAKEMGIYDQICDKRTQINIGRCVDIAGNILHEEQGEKFGFRQDDEVEILRGNLIDILMNKISDIPCYFNQHIIGVQQNDNHVTVHFNNGSVENYDIVIAADGIHSETRSLIFDKNEYQLVNLGFYISTFTIENYLDLNHMELECEANHRLVSINSDNNPKIANIGIMFRSQHILADIRDEHEQKQFLCDTFRDFGWETQNILNRVP
>AIA12701.1|FEATURES|farme|beta_lactam|ThisiDRAFT_0902|antibiotic inactivation|1
MKKHFLTIGARLVWILVAAVCISAQSAPPKEENKREADLVELITLDKTIKLDVRYARTDNFVGKAVYTEARAFMQRPAAEALLKVHRKLKKQNLGLVIFDGYRPWSVTKLFWEVTPEDKRKFVANPKSGSRHNRGCAVDLSMFDLKTGKLVEMPTDFDDFTDKASPKYEGATETQKKNRDLLRQMMEAEGFTVNDNEWWHFDYKDWKEYAIYDIAFSQIGKLDVKVAEAAVEEKADWKQFFDAADVTGGIYIYDLQRNKFSIYDRERMNRGFVPASTSKIIHSLIFLDAGAVKDENEVFKWDGVERRVAAWNQDHNLRSALKTSAVWFYIEASKRVGREKMQKYYEQASYGNRDTDGFGADYWNTGDLRVTPKEQIDFLVRLYENRLPFSARSTEIVKDVLTLEKTDKYTLRAKTGWSDSFTPQVGWFVGYVEKGSEAYFFATEIDIKKDADAAKRAEITKNILKSLRIIE
>AIA12683.1|FEATURES|farme|beta_lactam|Shewmr7_3328|antibiotic inactivation|1
MKFIRSSLILLILAAGYAVSPVSAQDLSPFFKDIKGAFVLYDQKNDRYTRYDEARCRERFSPKSTFKIPSSLIGLETGVIRDAEFVIPWNRQKYPPQDNWDQYPFKHWGQDHTLRSAIKYSVVWYYRELALRVGEQRMKRFVTAFDYGNEDISGGIDNFWLNGGLRISADEQVEFLKKFYAGRLPVSKRSIKIVKDILVLEKTPEYTLSAKTGGGSIAEETYIGWFVGYLETKGNVYFFATNIEGKSYPEIREKRIDVTKLILTKLGLLPK
>AIA12657.1|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|0
MYKKILVPVDLADTDLAKPALTTAIEMVRASSGSVRLLNVLAMTPVMLAEYVPPDFDVQQRKSAEEALGIIARECGLDAMHVSATVRQGGIYHEVLEEAKAFNADLIVMSSHRPAMRTYFLGSNAGHVVRYAKCSVLVVRQ
>AIA12652.1|FEATURES|farme|beta_lactam|AF332_00150|antibiotic inactivation|0
MLKQVSFCLVLILLFSICISAQRTQPAPKNVVAPQTLDERINDAVKDFKGKVWIYAKNLDTQKTFSLRGDERVRTASTIKLPIMVETYFQISEGKLKWTDEIILTKEKKVGGSGILGEFSDNTKIDLRTAVNLMIVVSDNTATNLVLEKVTSDAVNARMESLGFNDTKSIRRIFGSEKDSRVATDPIIKNFGLGMSSPKDMVGILEMLELGQLVNSEASKSMLHVLKRQQYKDGIGRNALDTVPVASKSGTLDRLRADVGIVYTRRGRIAMAITVDDMQVVHYATDNPGSLLIWQLSQILQEGLAK
>AIA12640.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MKIQKLAVIALGIICPCGLGYATERENDSTTSLAELISSIQVKSGGKVAVSVRHIETNQGGSWRHGFEEMPLYSVFKLPLAVVVLKDVEAGKLQLDQRVSVKESDVAPGIAANTDRWRNVPLEMTVRQLLELSLIESDNTSSDKLLQLTGGPGALTKRIESLGFDKIKINVSVKEMSQNKKHLNVATAESIVRLLSGLQQGSVLKDEQRTVLFELMGKSRTGLKRLRGLLPAGTAVLDKTGTGPDGSAINDVGIVTLPGSGGHLAVAVLISGSKLPVEEQEHMIAEIALASYKLFTPQP
>AIA12636.1|FEATURES|farme|beta_lactam|LRA-3|antibiotic inactivation|1
MKKSIEDLGFKLTDIKIITSTHGHFDHVGDLAAFQKVSKARVLMSERDAPVLESGGNLDYRRPEGRGIIYDPIKVDQRLKDGDKFGLGGVQITTIDSPGHTPGSTSFSFPIQDGGRTYNVLIANMPGINNGVKLLGSPGYPTIVQDFPNTIHRLQGMNPDIWLSSHAPQFNLHTVYKPGDAYNPARFSDVAAFKAKLAGYEKAYNEQLAKERAEQKK
>AIA12595.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MTTTTSAVRAQQQPPLERAIKRLAESSGGIVGVSAIHIESGRRVSVNGDLRFPMASVYKLPIALRLLQRIDRGELRLDGPITLSTHDFRPGHSPIAEFANNKPVTLPLERLLELMLGESDNSASDKLLALAGGPAAVTARMRALDITGLDISRPEGRLALDFWGVREPPPESEWTLAFFERMSESGTPAAREAAAAAFADDPRDTSTPDAMAQLLVRVERREVLEPASMERLLQITTATQTGPLRLKGLLPAGTPVAHKTGTMGATTNDVGIITLPDGAGHVALAVFVKGSTLDVPSRERVIAEIARTIYDYYLLVG
>AIA12592.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MLRRIAALALALLLTPSLPWAQTRPVSSSWTARVKPYQVMGNIYYVGTEDLSSFLVTSSEGHVLIDTGVEQNAAAVLDNIRALKFDLKDIRIILTTQAHYDHVGAHARVKQESGARVLVAAADAPIVSSGGEGDYLFGPEYHYPPAKVDGLVKDGDVVRLGPIALTAHLTPGHTKGATTWTMTVKDAAGREHSAVFLGSTSVNPGTKLVNNEKYPTIEADYKRAFAVERALRCEVFLAAHASLFNGAEKAAAAAAGKGDAAFIDPDGCRAAIDRSQKAFDEELVKQRAAAGK
>AIA12585.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|0
MRLTSSKGQNDLRRFIKHSIIVLFTLALASLIFGKERNASIAHLPVMPDAFTSDALAQSSLERAIKRLAESSGGIVGVSAIHIESGRRVSVNGDLRFPMASVYKLPIATAPSRSPRTTSL
>AIA12586.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MTLPLERLLELMLGESDNSASDLLLRLAGGPAAVTNRMQALGIMGINVSRPEGQLILNHRGVRELPPESEWTMALLDSLSAKITPAAREAAAAAFADDPRDTSTPDAMAQLLVRVERREVLEPASMERLLQITTATQTGPLRLKGLLPAGTPVAHKTGTMGATTNDVGIITLPDGAGHVALAVFVKGSTLDVPSRERVIAEIARTIYDYYLLVG
>AIA12582.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MRIVLAIAAIACLGALTWAGFSARDGARRAEAGNPTTSSPENAVQQKGSDADGQLTERLKAITSSAGGVVGLAVTHIESGRTVNIQGTLPLPLYSVFKLPLAVAVLKDVEENRLRLDRKVLTTPAEIVPGSQENTDLWRKPVERTVTELLELSVMRSDNTSADKLLQLVGGASAVTERMRSLGYQNLLIHSSVREYVADRKKVNTGTASDLTRLLVDLHQGRILQPPQLSVLLGFMQRATTGQRRLRDLLPAGTQVADKTGSGAAGVATNDVGLITLPKGQGHLAIAVLVSDAKLPTEEQEKLIAEVARVSYDAHLSQAAPATP
>AIA12564.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MAGPIYYVGTRGLAVYLIKTKVGLILISGGPPKTENLIADSVKKLGFNLKDIRLLLSSHAHFDHIGTLAALKNLTGASVAIMDADVELLKSGGKTDYLYANRPELHFDGVTPDRILRDGETVNLGGTQLIAHRTPGHTRGCTTWEMNIAVGGRHHKVVFADGTGINPGTRFVKNPSYPGIREDYQSTFRVLESLRPDIFLSYHAEFFGFEAKRQGMAKEGFRAWLDAEGYRASILKKREAFEKLVRDEELPNG
>AIA12539.1|FEATURES|farme|beta_lactam|AS202_10895|antibiotic inactivation|1
MRLRAALLNALLLLSALACATPTDADSTRTASTRTADPQTQGAPAREASPADLEPFFKEFPNGAFVLYDLKRDRYLRYNEARCRERFSPFSTFKIPNSLIGLDTGVIPDAEFVIKWDEKKYPAHDRDTLPFSAWWQDQTLRTAFKRSAVWYYRELALKVGEKRMREYVRNLHYGNEDASGPVNNFWLNSSLKISADEQVDFLKRLYREELPVSKRSLAILKDIVKLEETPDYKLSGKTGGGPLAENRYLGWFVGYVETKDNTYFFATEIEGTTYLSIRDERIALTKRVLAGLGYIRG
>AIA12532.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|0
DPNGARVPIHLECWVEMFPFLEPVLVEAAKLQTARYDRYETTKLDVWTKGKVALVGDAAHAMCPALAQGAGCAMVNAYSLAMELEEIADLDEALPSWEKRIRPITDRCQAISGEYAANRSLSKGNQFTASALEAARYDPLRRVYSW
>AIA12322.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MSRRILSIVIALAVPVVAAPLAAQGAPKLERQIAAIAPLSGGTVGVAATHLESGRSVFVNADDQFPLASTYKVPIAIQAFKLVEEGKLSLDQMVPVLPTDIHIGSEWNKLFQAPGVSLSFRNVIEPMLIFSENSATDLALRLVGGGEAVTARLRALGINDMRIDRSTADVIAGPNGVPDVWANGVFSKEKWQAGTASVSRARRDSAAYYYANDPRDHGSPRAMLTILTRLWKGELLNKANTAYMLDIMYRCETGQGRIKGMLPPGTRVAHKTGTFPGTTNDVGVIDLPDGTHVAIAVYIKKSSKVPGADLEATIAQVSRAAYDYFLFTGEQRTGDRE
>AIA12314.1|FEATURES|farme|beta_lactam|SPM-1|antibiotic inactivation|1
MKNTLFIAALILASCAHDHGIQPSLSQNDAKEISSSASAAIPIDENLSATQLKPDVWLVQDKSFYDTNVLLAKMPGRTVVIASSFIDTPKTAKLIAWINQTLKPKEIRAINTHFHFDGTGGNEAYHQEGVQTWSTQQTLSLYKARADSMRSSLADSLNDKQHGKDLRATNNTLADHIFNAADGLEWDFQGEKLIVYYPGPAHSPDNLVVYLPSKRILFGGCMVRALDYDLGNTADADLKNYYKSALSLKRFPAEIVIPGHGQKGGMDLIDHTITLASKASQKP
>AIA12294.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MRTRNHLTHPARTLALATFLLLLAALVSGQTGAPQSSSSSCADCPEWNKPQRPFRIYGNTYYVGPHGLSSILITSSAGHVLIDSALPESVPQVVANIRALGFRVEDVKLIVNSHVHFDHAGGISELQRLSGAEVAASPWSVEVLTKSGVGPGDPQFGSIPPVALIQRATTLRDGQTLSVGDIKLTAHFTPGHTPGGTSWTWQSCEGKRCLNLVYSDSMTAVSAKDFRFSDSREYPTALRDFEKSFAFLRAARCDILLTSHPDASGLWQRLEGRERGVQPDPLISPNACKALAERASEQLGRRLAAEKGR
>AIA12285.1|FEATURES|farme|beta_lactam|HMPREF1562_2717|antibiotic inactivation|1
MRISTLARRLSCGTLAALLFACAVAPRADARQAKAFDPAELDKVVEAELKAGHTPGAAVAVVSGDRVVYAKGFGVTSAEEGGAPVNADTLFRMGSTTKMFTAAALVTLASEDRIRLDQPVGNYVKSLPPKIAALTAHQLLSQSSGLRDFAPSVTSDDDAALSKNIRAWTDDLFFTEPSRIYSYSSPNYWLAGFMVEEL
>AIA12281.1|FEATURES|farme|beta_lactam|BH160DRAFT_5418|antibiotic inactivation|0
MIGNRYLRAKRSLYVLWTLVSFALYVYLDSKGWFGKSQQKREMRLRRQAARLRERLIRLGPTFIKMGQMLATRADLLPLDYIKELSALQDQVPPFSDKQAIGIVESELGRPIKEIFAEMSERPIASASLGQVYRATLAGGEDVAVKVQRPGLSEKIRFDLDLLRWVGHLLDRYPKLFPGAEWMGAIDEFDRVIHEEMDYRRELANANEFRQNFHDWHSIHVPRVFDELSSERVLVMEFVSGTKVTDLEGLRAAGHDPRRVNELIYRAYFKQLLEDGFFHADPHPGNLLVMRDGRLAFFDFGMVGRISDELQRQMIDAFFHLYSRDINAIVSDLVGLGFLAPEADTEAFRAIVAEVFARKLNLKLGEVRFKELTYDLAPIVYEHPITTPARFTYLIR
>AIA12274.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MSIALCAFALMMTTSGAVRAQTPPLERAIKRLAESSGGIVGVSAIHIESGRRVSVNGSLRFPMASVYKLPIALRVLQRVDRGELRLNAPVTLSTHDFRPGHSPIVEFANNKPVTLPLERLLELMLGESDNSASDALLRLAGGPAAVTNRMQALGIMGINVSRPEGQLILNHRGVRELPPESEWTMAILDSLSAKITQAEREAAAAAYADDPRDTSTPDAMADLLVRIQRRDVLEPASMERLLQITTATQTGPARLKGLLPIGTVVAHKTGTMGGTTNDVGIVTLPDDAGHLAIAVFVKASTKDVPERERAIAEIARTVYDFFVLKGQ
>AIA12264.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MHFDHGGGISELQRLSGAKVAASPWSAEVLTKTGIGKSDPQFGSIPPIALVPKVSVLRDGQTLRVGDIKLTAHFTPGHTPGGTSWTWESCEAGRCLNLVYADSMTPVSSDGFRFSDSREYPTAVQDFEKSFAFLRSTPCDILLTSHPDASGLWQRLEGRERGTKPDPMVSPKACKELADDASEQLRRRLASEKGQ
>AIA12235.1|FEATURES|farme|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MTYRIQQVTPADLDLMNELLSVFGQAFDDEETYNGKRPGAGYMRRLLESDNFIALAALNDQKVVGGLAAYELKKFERERSEIYIYDLAVAKNHRRKGIATALIMELKKIAAARGAYVIFVQADTGAEDEPAIELYTKLGIREDVLHFDIPVENGDE
>AIA12232.1|FEATURES|farme|aminoglycoside|AAC(3)-IIIa|antibiotic inactivation|1
MSESNIPFTQTQLMDHLKALGLHAGQTVMLHASVKAVGPVMGGPNTILQAILDVLTPAGTLMMYAGWQDIPDFLYELPEDVRQVYYEHHPAFDPATSRAVRDNSILVEFFRTWPGTHRSLNPEASIVAFGAQAASITQDHPINYGYGAGSPLEKLVGLRGLVVMLGAPLDTITLLHYAEWRAKLRHKNVIHYPCPILQEGKKVWIEVEDYNTGDHHDDYTFEEIAHEYLAQGKTSHGTVGDADTYVFDAADLSEFAVQWLEARFGA
>AIA12202.1|FEATURES|farme|beta_lactam|OXA-247|antibiotic inactivation|1
MKLMRVALILLMLAAGYAVVPANAQDLSPFFKDTKGAFVLYDLKNDRYIRYNEARCRVRFSTKSTFKIPNSLIGLETGVIRDSEFVIPWNRQKYPPQDNWDQYPFKHWGQDHTLRSAIKYSVVWYYRELALRVGEQRMKKHVTAFKYGNQDISGGIDNFWLGGGLRISADEQVEFLKKFYAGRLPVSKRSLEIVKDILVLEQTPQYKLSAKTGGGSIAEGTYIGWFVGYLETQGNVYFFACNIEGASYPEIRDKRIDVTKRVLMELGYLPK
>AIA12122.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MLLTLLVISLVSACYGSANPQNTNSVNRPADSVGTKTNEKRDNELQKEIEQIAAAAKGRVGVEAVVLETGETASMNADAHFPMQSVYKFPIAMTALAQVDAGRLKLEQKVRVEKSDFVREGQRSPVRDQNPQGVELSLMELLRYAVSESDGTASDVVLRVVGGADVVNKYLSDLQVSGLVVLNTEKEIGRDWETQYRNWASPEGAVSLLRALYDRRGLSEQSRALLLKLMTETPTGLKRLKGLLPKDAVVAHKTGTSGANKSGINAATNDIGIITLPNGRHLVIAVFVSDSPADEATREGVIAKIARAAWDRLSR
>AIA12114.1|FEATURES|farme|beta_lactam|OXA-247|antibiotic inactivation|1
MKLIRMVALLLIVIGGLGLSEARAQDLSPFFKDTRGAFVLYDQNNNRYVRYNEARCRERFSPKSTFKIPNSLIGLETGVITDADFVIKWNREKYPPQENWNQEPFINWGRDHNLRSAIKHSVVWYYRELALRVGEQRMKKFVKGFDYGNEDISGGIDNFWLNGGLKISADEQVEFLKRFYAGRLPVSRRSIDIVKDILVLEKTPAYTLSAKTGGGSIAEGVYIGWFVGYVETRGNVYFFATNIESTSYQAIRGKRIEVTKQVLTSLGLLPK
>AIA12111.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MQEIASVTKGPVGAAAMIVETGEPVSINGGDHFPMQSVYKLPIAMAVLSRIDNKTLTFDQKVRVDPKDFVSRREFSIATKYPNGADISIRELLDYMISESDGTACDALMRMLGGPEVVTKYLRDLGVQDVVLATYEQDMFKTPSVSFQNWSTPEAMIQILKLLQVGKVLSEERRDILLSLMIKSRPGPQRIKGLLPAGTTVAHKTGTSATIKGVTTATNDVGLITLPSGQHLAIAVFVSNTTADQKTREAVIAKIARAATDCWVEPSRAELVRPQR
>AIA12062.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MKRILPAYILILIAFISACSGSGAVTQNAKPATTTATPSAPKTVEREDAELQKQIEQIAAAAKGRVGVRAVTLETGEAVSLNPQEHYPMQSVYKLPIGMAVLEQVDAGKIKLEERVRVEKSDYLKKEQHSPIRDNNPDGTELSVRELLRLAVSESDGTASDVLLRLVGGAEAVTKYLNRLKVTGIIVANSEKEIGQDWETQYRNWASPEGAVTLLRALHERRALSEQSTALLLKFMTESPTGPKRLKGLLPQGAVVAHKTGTSGVNASGINAATNDIGIMTLPNGRHVAIAVFVSDSPAGIATSEAVIAKVARAVWDKWGK
>AIA12038.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MKKLIVALVALISLGGAVQAQTLKDLLATLTVKWNAPTEPFKMIGNVYYVGTAGLASYLITSPQGHILVDMAMPETAQQIKGNIEKLGFKVTDIKYLLNTHAHLDHAGGLAEIKQASGAQLVAGEADKPLLEGGYYPGQREETALAFPPVKVDRTVREGDMVTVGDVTLTARETPGHSPGCTSWSFPVKDGDATRSALIFCSGTVALNKLVTNPTHPGIVSDYRKTFARAKDMKVDVLLAPHPEMYKMPEKRAKIADGAPNPFVDPGEFNAYAATLEKAFEEGLAKQTAAAQEKKG
>AIA11908.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MTTRNHLPNPTRALALATFLLVLAALGFGQTGTPQSSCADCPEWNKPQQPFRIYGNTYYVGPHGLSSILVTSRSGHILIDGALPESVPQVVANIRSLGFRIEDVKLIVNSHVHFDHGGGISELQRLSGAEVAASPWSVEVLTKTGVGKGDPQFGSIRPVALVPRATTLRDDQVLRVGDIRLTAHFTPGHTPGGTSWTWKSCEGKRCLSLVYSDSMTAVSAEGFRFSDSREYPAAVQDFEKSFAFLRSTRCDILLTSHPDASGLWQRLEGRERGVRPDPVVSPNACKALAERASEQLRRRLESEKGRQ
>AIA11905.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MAIFLFLLTLIGAGGFTPAAAQDLAPDNPWVKPAEAFKILGPIHYVGTEDLAVYLIATPEGHIVIDGGVKGSIPAIEGSIRALGFKPEDIKILLTTQAHYDHVASMAYFQRLSKARVEVMAGDAKLLESGGEADYLAAEWGAKARFERVKATRILKDGDKVTLGGVTLTARHTPGHTPGCTTFIMDVPAGGRAYNVVFPGSMTINSGTRLVGKESYPGIARDYARSLDFLESLKPDIILMAHASAFDLPAKRDRLKKDPSSNPFGDVAGYRAWIAANRANLQKQIKEQEASR
>AIA11895.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
RLSGAKVAASPWSVEVLTKSGVGKGDPQFGSIAPVALIPRASTLRDGQMLRVGDIKLTAHFTPGHTPGGTSWTWKSCEGKRCLSLVYSDSMTPVSAEGFRFSDSREYPTAVQDFRKSHAFLRSTPCDILLTSHPDASGLWQRLEGRQRGDLPDPIIAPNACRELAERAEEQLRRRLESEKGR
>AIA11823.1|FEATURES|farme|beta_lactam|PI87_26790|antibiotic inactivation|1
MKNKLYTFSFLLFHILFLIIVSCSAPVGDHRDDFKRYFDEFHVTGCFVMYDLENSKFTDYNPDRCAQRFIPASTFKIFNSLVALETKAIPDENYVIKWDGVLRNVPAWNHDQTMTEAIKNSTVWYYQEVARKIGEERMQQWLNLVHYGNRQMGSTIDSFWLNGDLRISADEQIEFLKNLYTYQLPFSKRSMEIVKKILVRQDSLGYKLSFKTGLAIQDTTAIGWNVGYIETKGNIYFFAMNIEAPKPLPENFAIARRMITERCLKELGVL
>AIA11706.1|FEATURES|farme|beta_lactam|LRA-18|antibiotic inactivation|1
MATIKLGLSTAILATLASSAFAEGGERAQIAAAVDKAIRPIMREHKVPGMAVAVTVEGRHYFLNYGVASKETNEPVTENTLFELGSISKAFAATLASYAQVTGKLSFDDHPGKYIPAFAGTSIDKATLLHLATYTAGGLPLQFPDAVKSDADMVGYFSTWKPEAKPGKTRRYSNPSIGLFGHTAALAMGGSFSAVLESEIFPKLGLKHSYVRVPDSQMGSYAWGYGKADKPIRVTAGTFDAEAYGVKSSAADMIRFVETNIQPERLDGAIRKAVEGTHVGYFDSGKMVQGLGWEQYPYPVSLERLLDGNSRDMALKSNPVKALDPPKRPDGSTLYNKTGSTNGFGGYVAFVPEKKIGIVLLANRNYPNPERIKAAHAILKSLEGGGEVKADRPRRFACRGKPATPGNDIHQQLCSESSISACLHIDAEYCHLHFAKARSDAVEFRRMWGCRCSNGW
>AIA11657.1|FEATURES|farme|fosfomycin|FosK|antibiotic inactivation|0
MHVVGLDHVVVNTQDVERAMHFYHEVLGLELLRLEEFRAGKVGFVSARISPETIIDIRPIAAGERVTPNMDHYCLVLGPTDMHRLHAELKAQGIQVEDTVRPAWGAQGYGQQFKLSDPDGNKIELRCYTGSQTA
>AIA11610.1|FEATURES|farme|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MSLDVHQLSPNEVALMETLLATFGEAFNDMETYTGNRPRGAYSRRLLESDYFIALAALEYGEIVGGLAAYELKKFEQERSEIYIYDLAVAKAHRRRGIATALIEKLKELGAARGAYVIFVQADTAIEDEPAIALYSKLGVREEVLHFDIPVSQNNVDA
>AIA11603.1|FEATURES|farme|beta_lactam|SPG-1|antibiotic inactivation|1
MIQKPSLLHQKLRVLLPVVLLFLPSIAKAQADETSRSWNRPVEPFRIIGNIYYVGATEVSSFLITTPEGHILLDSGFAETVPLIQANLKKLGFKIEDVKILINSHAHYDHAGGLADLKELTGAKLMASEADAALKKRAGNSMSSSQAAHPLPAIS
>AIA11580.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MTMTIRSAAPDDAALIIQFIEALAEYEKLTHEAKATEADILRDLFGADPKVFCEIAEWEGKPVGFSLWFYTYSTFQGRHGIWLEDLFVDPEARGLGVGKALLVNLAQRCVREGLGRFEWWVLDWNEPSIQFYKSQGGVMQDEWTKVRVYGEALAKLGAL
>AIA11440.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MALAAFMLVVATFASGQDGARPSSCDDCPEWNRTQQPFRVYGNTYYVGPHGLSSILITSKAGHVLIDGALPESAPQIVANIRSLGFRVEDLKLIVNSHVHFDHGGGIAELQRLSGARVAASPWSAEVLTKSGVGKGDPQFGSIRPVALVPRADTLRDGQTLRVGDIKLTAHFTPGHTPGGTSWTWRSCEGGRCLSLVYSDSMTPVSADGFRFSDSREYPNAVKDFEKSFAFLTSTPCDILLTSHPDASGLWQRLEGRQKGVSPDPMLSPNACKELAGRASEQLRRRLESEKER
>AIA11435.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MLLATFLLVLAALASGQGGAPASSCTACPVWNKPQQPFRIYGNTYYVGPHGLSSILLTSKSGHVLIDGALPESVPQIVANIRALGFRIEDVKLIVNSHVHFDHGGGIAELRRLSGARVAASPWSVEVLTKSGMGKGDPQFGGLVPVALIPRADTLRDGQTLRVGDIKLTAHFTPGHTPGGTSWTWESCEGGRCLNLVYSDSMTPVSAEGFRFTDSREYPTAVQDFEKSFAFLRSTPCDILLTSHPDASGLWQRLEGRQQGVKPDPVVSPNACKELAGRAAQQLRHRLEGEKGQ
>AIA11430.1|FEATURES|farme|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|0
MIITIRPEQQADIDDIFELNKVAFGQENEARLVDLLRTAPGYVPGLSLVATAENTVVGHILFSKIFVVSGDARHETLALAPMSVLPGYQKQGVGARLITQGLESARELGFGSVVVLGHEHYYTKFGFVPASRWGIRAPIDVPDDVFMAMELLPGSLKNISGVVQYPVEFSAI
>AIA11431.1|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MYIYSAMKNILLILAILMGTAAAAQDTLTRTRINQDLEIIALSSNAYLYTSWFTSPTFGRVGDNGLIYVNNNEAVFLDAPTNDTISNLLLDWFAKTFPGATIKAVVVNHFHDDALGGLKAFHQKGITSYANFMTNESIHNDSTEKPKQTFTKQLVFRVGKSIIINAYLGEAHTKDNIVTYIPAEKILFGGCMVKSLDAGRGFLGDANLKQWSATVTKVKNAFPEAKIVIPGHGDPGGIPLLDYTIKMFEGEAK
>AIA11428.1|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MVWMRLAFCFLLELALCLSAVAQERVKIQLADDVFVEKLEPGVWRHVSYNTLPHLGPVPSNGGIITLGADVLLIDSAWNNEQTKLILDWSEKQLRAAPSIAVITHAHEDRIGGIHEIHRRGIRTVSSRLTAQLAKQQGLEVPQQTFDGKLNLSLGGRTIEVYYPGPGHTKDNIVVWIPDKHILFGGCLIKAAQAPDLGNIKDADVERWPKTMETLAREFKQVKLVVPGHGDPSGGEAMTHTLELLGKAVPLKPPVPGSTSH
>AIA11412.1|FEATURES|farme|beta_lactam|SPM-1|antibiotic inactivation|1
MRCLIPALLLTLSSCSTLSHSGSDAFTQQFSVKEVAPKTFVVTDQSYHNSNVMVAVMPDQTVLIASSPFETEGAEQLVQWIHSQWNPKKIVAINTHFHADGTGGNEAYQKNGVEIWASDLTRKLQSEFGEAKKKGEAADFASKPELQARILKRKIVLADHTFKLQDGKTFEFAGKKVEVIYPGPAHSQDNVVVYLPERKVLFGGCMIRPTDTLGYTGDASIKTWAASATRLKPLAPKVVIAGHEVIGGPELIENTARTASKAAAQPM
>AIA11388.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSLVIRKAEAGDAGMIYEFIRELAAFEKLTHEVDASQRDIEEALFGPQPCVFAEIAEWNGTPAGFALWFYNFSLWFYNFSTFRGRHGLYLEDLFVRPDFRAKGVGKALLKNLARRCVTEGLPRLEWWVLNWNEPALRFYRSIGAVPMDEWTVQRVTGEALETLADL
>AIA11318.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MGWVHHIDITVTDLAVSTAFYDQVLKLMGFRRIRDESGVPLWAGARTEVGLQQARADHNRPHDRYSPGLHHLAFGAPDRAAVDRVYEALLKLNVKILDAPATYEQYSPGYFAVFFADPDGIKLEYVYTPVWPTE
>AIA11272.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MKFALKFSTATMAFFGLLTSIHVAYGQGQLKKDIVESINSIKADVGVAILHLENGDTLSFNGLHHFPMQSVYKFHLALAVLHAVDQGKLSLDHETFIAKSDFIPKTWSPIADKYPEGDVKLTVSQLLSYTISQSDNNGCDILFRLVGGPRKVDEYIKGLGIIDVAIANTEAEMHENPDLQFKNWTTPRAMVQLLSLFYQGKILASPTHNLLVEMMEQTITGNKRIKGQLPQGTVVAHRTGMSGQNEDGVRAALNDVGIITLPNGKHIAVALFVSNTRESIPASEELIAKISRIVFDYYSIDAGKKK
>AIA11267.1|FEATURES|farme|beta_lactam|OXA-10|antibiotic inactivation|1
MKIVKLLLLLAMSSSATASVVAQDLSQFFKNTNGAFVLYDLKQDHYLRYNEARCRQRFSPKSTFKTPNSLIGLETGVINDASFVIPWDRVKYPPQDNWNQEPLSHWAQDHTLRSAIRYSVVWYYKELALRVGGTRMQKYVRALNYGNKNISGGVDNFWLNNSLKISANEQIEFLKAFYTGKLPVSKRTTEIVKDILVLEEGPTYKLSAKTGGGPIADGTFIGWFVGYLETKGNVYFFALNIEGPDFSSIRDRRVLITKQILSELGYYPRN
>AIA11266.1|FEATURES|farme|beta_lactam|blaOXA|antibiotic inactivation|1
MKQLLTIILFAIVVSTLATSKGVEQPDLSPFFKDTTGAFVLYDLKDNHYIRYNEKRCRERFSPKSTFKIPNSLIGLETGVIRDADFVIPWNRQKYPPQDNWNQEPFSHWGQDHTLRSAIKYSVVWYYRELALRVGESRMKKLVSAFSYGNENVSGAIADFWLNGTLKISADEQVEFLKAFYAERLPVSKRSIDIVKDILVLEKTPTYTLRGKTGGGSIAEGKYIGWFVGYLEINSDVYFFATNIEGSSFQAIRDKRIEITKQILMQLGYLTR
>AIA11263.1|FEATURES|farme|beta_lactam|OXA-48|antibiotic inactivation|1
MKLLKLSFVCLVFICGTRAAVGRAQDLSPFFQNTTGAFVLYDSKNDRYVRYNDERCRRRFSPKSTFKIPNSLIGLETGVIKDAAFVIPWDRRKYPPQDNWDTEPFVHWAQDHTLRSAIKYSVVWYYRELALRVGPQRMKKYLGDFKYGDRRMGGRVDEFWLDNSLKISADEQVEFLKAFYAGKLPVSKRSTDIVKDILLLEQTPTYRLSAKTGGGSIAEGKIIGWFVGYVETGGNVYFFATNIEGPNYAAIRDRRIEITKQILASLGYLPNQ
>AIA11259.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MVNVDKLVLGGLLSIAAVAAFAPGAPLLQPDPPKSCKASDEWNGKQQPFRVFGNTYYVGVAGLSAVLIASDTGHILLDGGLPQSAPLIAENIRSLGFRIEDIRLIVNSHAHFDHAGGIAALQRASGAVVATSPSGARALEQGEPVPDDPQHGFGRESTGFPRVNAVRVVSDGEVLHHDGLAITAHLTPGHTPGSTTWTWRSCEDTRCLDIVYADSLNSVSAPGFKYTGLPGVVEGFRRSIAAVESLPCDVLLTVHPEFSDLSGKLRRRTAAANENPFIDPQACRVYAAAAARSLDRRLEEEK
>AIA11248.1|FEATURES|farme|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
MKFMRAVLLLLMMVAAASASAQDLSPFFKDTKGSFVLYDLKNDRYTRYNEARCRERFSPKSTFKIPNSLIGLETGVIRDADFVIPWNRQKYPPDGWDEYPFIHWKQDHTLRSAIKYSVVWYYRELALRVGPQRMKKFVSDFDYGNENVSGRIDDFWLGGPLRISADEQVEFLKKFYAARLPVSKRSVEIVKDILTLETTPAYKLSAKTGGGPIAEGKFIGWFVGYVETKDNVCFFAINIEGTSYPEIRDKRIELTKQILSALGYLPK
>AIA11249.1|FEATURES|farme|aminoglycoside|SG34_20990|antibiotic inactivation|0
MTAITIASTDQHLEEILALQRRYHTRTLSAEVQSVEGFVFAEHTLPLLRRMAAQSPQAIALSEGHVVGYCLSLPISLQAEVPALVPMFEQFRRCVYRGKPLSDYRLVVGGQVCVDREHRGQGLLARLYEQLRVSLGQDCDLCVTEIATRNQVSVRAHERMGFEIISAYNDAVEEWVIVAWDLSRPAVLERALII
>AIA11245.1|FEATURES|farme|beta_lactam|AS202_10895|antibiotic inactivation|1
MKFMRAVLLLLMMVAAASASAQDLSPFFKDTKGSFVLYDLKNDRYTRYNEARCRERFSPKSTFKIPNSLIGLETGVIRDADFVIPWNRQKYPPDGWDEYPFIHWKQDHTLRSAIKYSVVWYYRELALRVGAKRMKKYVTAFNYGNQDISGRIDDFWLGGPLRISADEQVEFLKKFYAGRLPVSKRSTEIVKDILVLEKTPEYTLSAKTGGGSIKEGTYIGWFVGYVETKGNVYFFACNIEGTSYPEIRDKRIDLTKRILAELGLLPK
>AIA11184.1|FEATURES|farme|fosfomycin|FosX|antibiotic inactivation|0
MIIPKIYNDPTTKIAVISIRIEGFTLSKMVYCCDIQKNDLFVNFLSVKPPLTYGLTHIAVAVKDLNATKQFYCGVFDMEVMYDTDDFVQLTTPGTFDILVFEKSGGPFGETGGIVHFGFRLKRPEDVEELTGRVKKFG
>AIA11150.1|FEATURES|farme|aminoglycoside|BN487_00430|antibiotic inactivation|0
MEANSMTFDYQSGEVYFQDKFVPFDDANVSIASSSVLYGLSIYTVFSVNWNEQEQKLHAFRFKDHYQRLINSARIMDFHSFCDEWTYKRFEQTMHELISRNTLREDALVRVTVFIDELIAGTKIHGLKNSVTAYIYPMGEILPLSGVNLCVSSWVRNADNSIPAKAKINGSYVNASLMKNEALINGLDDAIALDHNGHVAEGTVANLFIVRDGKLATPDTSTD
>AIA11076.1|FEATURES|farme|aminoglycoside|WN59_12960|antibiotic inactivation|0
MPSSSITQSKNRSLRAQALPALLEDVVKAYDLPVRRILPPQKGYRNRSFPIQLKDGAYVNFILYKEELGILEVIRSANRVSAYAADRGFPSRRPLGPIACLRGASGRTKYGALYDYLSGHTIPWEAYTMDHLKLLGKTLGDLHAVLRPLSRKALPAVTDIYAGIVDRMTRYLADPGVQAALQHKLGLRLAPAQFQKYRRLLDACAALPRQQALHMDFVRGNILFNDEPATTRPSDLKVTISGILDFEKTAFGHPLFDIARTLAFLLVDCKFKTGDKVRKHFLFSGYARRSQASLPNQPELLDALIDLFLTYDFYKFLRHNPYEALPANEHFVRTKQLLAQRGLLQLSR
>AIA11062.1|FEATURES|farme|beta_lactam|OXA-55|antibiotic inactivation|1
MKFIKLLFVQIMFLCSLPGAMPVQAQDLSPFFKDINGAFVLYDLKNDHYIRYNEARCRERFSPFSTFKIPNSLIGLESGVIKDADFIIPWDRRKYPPDDWTIEPFIHWGRDHTLRSAIKYSVVWYYRELAGRVGERAMKEYVSKLHYGNQDISGGVDRFWLNSTLKISADEQVAFLKALYKEELPVSSRSMKILKDILVLEETPQYKLSGKTGGGPNNGKGLGWFVGYVETKGNVYFFATNIEGADYLAIRDKRIALTKRILAELGHLPKS
>AIA11032.1|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|0
ATEGHRLLLAKRVRADPPSRQTRFGGMDGSMRIMRTHRWTRALAVTTAVLVGALLAAAPQAGQAPATAGKIVLASPERVGFSSESLKELDAAMQGIVDKKHLAGMVTVLARHGQVVQHKAYGLQDVDSQTPMQLDTIVRIYSMTKPIVGAAMMMLYEDGKWKPSDPIAKHIPEFANLKVFAGTDAAGTMILEPPAHAPTMGELMSHNAGFTYGLFGNSPVDKMYQADSPLDAPSLQVFINKMATLPLLYQPGEKWVYSVSVDIQGYLVQKMSGKSFPDFLRDR
>AIA11011.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MMKNVLLKICIVGLALSFHSACTPGQDVRTTEPAIPAVESGAADAELTKQIAALCNDSQGEIGVTVIHVESGRTVNFEGEKKLPLYSVFKLPLALEVLKRVAEKKISLDQKIHVAPADVAPGSQFNADLWRKPADKTVAELLEFSIVRSDNTSSDQLLQLVGGPAVVTERMRTLGFPNIDIVSTVREYATSQGKPNLATTANLARLLSRLQKGELLEPSHLSLLLGFMERARTGGERRLRASLPLGTTVAEKTGSGADSTNDVGLITLPDGKGHLAMAVLIHNSKLTAEAQERLIADLARKAYDAFVTSAATVPGR
>AIA11000.1|FEATURES|farme|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|0
MIITVRPEQQGDIDEIYALNKLAFGQDNEARLVDLLRTGPGYVPGLSLIATAENAVVGHILFSKIFVVSGDARHETLALAPMSVHPNYQKQGVGARLITAGLETARDMGFGSVVVLGHEHYYPKFGFVPASRWGIRAPIDVPDNVFMAIELMPGSLKNVSGIVEYPVEFSAI
>AIA11001.1|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MKNALLILAILISNIVAAQDTLKKIRVSDDFDIIPLSKNAFIHSTWTSTPSFGRFNNNGVIYINENEALILNTPPDDRLSKELLDWFSKTFPSVKIIGVVGNHFHGDGIGGLRVFHAANIPSYANALTNAQSDTIVKAQNTFTGKLDIKVGKKNVRCQYFGEGHTRDIIVTWIPDEKILYGGCLVKALGAGRGYLGDANLKQWSATVAKVKKAFPDAKIVIPGHGDYGGVELLDFTIKMFAGDAQ
>AIA10997.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MRRLSFLSALLITAAAVAAAQGRSNPSDWTTRVAPYKVMANIYYVGTLDLSSFLLTSPEGHVLIDTGVEENAEAILANIKTLGFNVKDVRVILTTQAHYDHVAAHARLKKESGARVLVSTADAPLVAGGGEGDYLFGPAYHFPPTPVDAMVKDGEVVTVGPTALKAHLTPGHTRGTTTWTTTVRDAAGKDRSVVFLGSTSVNPGTKLVNNDKYPGIEADYKRAFTVEKGLTCEVFLAAHASAFRGPEKAAAAAAGKGDAAFIDPEGCRAAIERSEKAFLAELEKQRAGR
>AIA10959.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|0
MSDDEDLKFTVQRPPAYGELTDVLPGLFWVRLPVPLRLNHVNCWLLDNGPGWTLIDCGMNTDDIFEIWDKLWRGLLRSRPLQNLTFTHAHIDHIGFAGYFVKEMKCAVRLPFAEWLNGWMMWHEREEGLSEQFASYMKRNGASDEDVAAVMGSQRPSKYLGSRPPREFSRIKDGDVVSMGQRDWRVITAGGHSPEHASFYCEEDKILIAGDQVLSHITPSVIVPSAQPDANPMQEYLDSLARFEELPTDTLVLPSHGLPFRALHTRLRQLREHHQARLDDMASFVTEKTTAFAIVQEVFPRVLHENPRQAFGEALAHLNALAAMGKLKREVDANGMITFAP
>AIA10950.1|FEATURES|farme|aminoglycoside|N182_21955|antibiotic inactivation|0
MITVRPMKPGEGGALLSMIKALAHSHNLMHTVLATPEMYEAAMFSGQPIVGTLMAEYNGVLAGCAVWHRSFSTNRGAEVMYLEDLSVLPEFRRRGVARALLKGVARLALEKNYPSVYWLMMDWNKEANALYESVGAEIEPGTTFCRIRDDALKALAS
>AIA10915.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MATLAAVSLVVSALAFVHVYAQDQPASWSEPQKPVRIFGNTWYVGTRGLSAILITSPTGAVLIDAAVREAADGIASNITSVGVRLEDVKLIVNSHAHNDHAGAIAELQRRTGATVAALPWSAEALKSGKKYAGDPQFESPTTPPERVAKVKTIRDGEVLRAGGVEITAHKTAGHTPGSTTWTWRSCEEGRCVDIVYADSLTAVSADKFRFTDNKTYPHVIDDFTRGYAFLRSASCDILVTPHPEASDFWPRIAKRDGGERDALIDRTQCARYADRADAQLQKRLATERAK
>AIA10911.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MLISTTPAAFAELKQASGAQMVAGEADKPLLEGGYYPGAREVKELDFPPVKVDRTVREGDTVTIGNVTLTARETPGHSPGCTSWMFNVKDGDATRSVIIFCSGTVALNRLVTNPTYSGIVTDYRKTFARAKDMKVDVLLAPHPEMYRMQDKRAMLSDGAPNPFVNPGEFNAYAATLEKAFEDALAKQTADAQEKKG
>AIA10888.1|FEATURES|farme|aminoglycoside|AAC(6')-Ib-SK|antibiotic inactivation|0
MSLALRRTTERDLDFVCAAETSEDNRAFVSVWTREQHINELYDEDIAHLIIEKDDRRVGYLIVAGLSNEHQSVEFRRLVVTEKGSGIGREVFRLVKRMAFEEFGAHRLWLDVKEFNKRAISLYESEGFIVEGVMRECMKNGDEWESFILMSMLRHEYEAKSKAANRI
>AIA10854.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MPVKKIAVALVALMSLTTAVEAQTPKDLIEALKVRWNTPTEPFKMIGNVYYVGTDGLASYLITSPQGHILVDTVMPESTSLIKASIEKLGFKITDIKYLLNTHAHIDHTGGLAELKQASGGKLVAGDADKSLLEGGYYPGAEDDTTLAFPPVKVDRTVREGDTVTVGDVTLTARETPGHSPGCTSWAFSVKDGDATRSVLIFCSGTVALNRLGGADPTYFGIVSDYRKTFARAKDMKVDVLLAPHPEMYRMQDKRAMLSDGAPNPFVNPGEFNAYAATLEKAFEDALAKQTADAQEKKG
>AIA10851.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MTILRPGATVAAAIVVLAPASFAMQNASADGPWTKAIEPSRIIQNVYYVGTEDLASYLVTSSQGHVLIDSGVAANAATIAAGIQKLGFKLEDVKYLLTTQAHFDHVAAHAELQKRTGAQVVASDGDAPLLETGGKADYHFGADYNFAAVKVDRRVKQGDTISIGDRAITAHMTPGHTQGTTTWVMPVKQETGETLNVVFVGSTSVNPGVKLVANAKYPQIADDYAASFARLKALKVDVFLTAHLSANEGLEKMAKLRAGATPNPFVDAAGFRAYLERSQANFEAELAKQRSGGQLLIW
>AIA10847.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MRRNRFKHLILLVGVLTATVGCSGRLFAQANDWTEPFPPFKIADNLYYVGSKGLASYLITTPQGHILINSDLKESVPLLRASVEKLGFKFGDIKILLISHAHWDHNAGSAAIKRLTGAKYLVMDADVPAVESGGKSDFHYGGDSSTYYPPTRVDQVLHDGEEVKLGGAVLVAHITPGHTKGCTTWTMKVQENGKTYNAVIIGSPNVNPGYKLVNNATYPGIAADYERTFRVLKELPIDIFLGAHGSYFDLETKYPQLKKRGLAAFIDPDGYAKYVADREKAFRTELAKQTAAQRQ
>AIA10836.1|FEATURES|farme|beta_lactam|LRA-2|antibiotic inactivation|1
NVGNIKAILQSHAHPDHIGGIAELQKLSGAAVYARRPADEVMRTGKLPAEDPQFTTKGPKIPTVPNVWVVHGDQLLGVGSNRLRVLATPGHTPGGTSWTWESCEEKLCLQMVYADSLAPVSGDKYRFSDHPEVLEQFETSFKTLEAQRCEVIISPHPEASGFFERIKKAGGKGDALKDAEGCKSYAKVFRERLAERLAQERAAGVKRKGK
>AIA10834.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MNLDKIVLSGLLSMAAVAFPAQGTPLLQADPPKSCKACDEWNGKQQPFQVFGNTYYVGVAGLSSVLIASDTGHVLLDGGLPQSASPIAENIRALGFRIEDIRLIVNSHAHFDHAGGIAALQRASGAVVAASASGARALEQGAPTPDDPQQGFGRESTGFPPVNAVRVVSDGETLRVEDLAITAHLTPGHTPGSTTWTWRSCEETRCLDIVYADSLNPVSAPGFEYTRSPGVVDAFRRSIATVESLPCDVLLTVHPELSDLSGKLQRRTAAANENPFIHSQACRVYAAAAARSLDRRLEEEQ
>AIA10832.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MKIFRGEKRVPLVAINLIVLILSGIGFTVHSRTPLGDAWVSAELFPPGVPLTLTQESDNVELSARLQKLCDRAGASIGLALMHVETGRTVEIQGKTSLPLYSVFKLPLAIAVLKDVEENRLRLDQKVRVTPADVAPGSQGNAALWRKPVEKTVAELLELSIGRSDNTSSDKLLQLVGGPDKVMQRMRSLGFQDIEIRSAVRELATRQGKPNTGTASDLARLLSGLQQGQVLQPPQRTLLLGFMERATTGLRRLRGDLPAGTIVADKTGTGEDGSVTNDVGLITLPEGKGHLAMAVLISGSKLPAEAQEKLIAELAKTAYDFHLSQVRQGSQKQSLSRP
>AIA10812.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MRQKLNLITLGVNDFDRSVAFFEKGLGWKKSSASVEELALFPLGGIVLALHPRKDLAADVTVSSEGSGFSGITLSYNAKSEIEVDEVLEKVRRLGASIIKPAQKVHWGGYSGYFKDFDGHLFEVAYNPFWDLDAQDNLKLP
>AIA10763.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MTKLISPSLLLLAFLYLLPYAAFSQKEALRKRMEEITQTAKGKVGVAVLGIEDRDTLSVFGKDRFPMQSVYKFPVAIAVLHQVDQRKLSLQQKIHLRPEDLLPNTWSPLREKYPQGNVDIPLSEVLLNTVALSDNNGCDVLFRLLGGPPKVDAYIRSLGVRGMAIAATEEQMHQEEQVQYTNWSEPTAMLRLLDVFYARKALSPASTDFLWKVMVETSTGPRRMKGLLPPGTIVAHKTGSSGTNSQGITAATNDVGIVTLPNGKHVALVVFVSDASADEATREGVIAQITKAVWDYFVAKP
>AIA10747.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
RSKVTIRTRISRPKLPYEQWCEHLMPLAIRRARPGEAGLVLSFVRELADYEKLLHEMEATEADIDTALFGANPRLFCEIAEWDGEPAGFAVWFINFSTFSGRSGIYLEDLFVRPAQRGKGIGKALLVHLAKECVANGWSRLQWSVLDWNTPSIEFYKSLGAVLMDEWTICRVGGSDLTALAQGAR
>AIA10715.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MVRARYKGVVDALAADIRAGRIPPGTRLPTHRELAAREGLALVTATRVYAELAEMGLVSGEAGRGTFVRESSLSSRDDIVKRAFSDDVVDLNFNYPSVPGQADLLRNALRALASSGDLEALLRYQAHGGRTHERASVALHLEQRGLTVPADRVLIVSGAQHGLAVAALAMLQPGDVVAVDALTYPGFKVLAQVLHLELVPLPPATDGPDMDALAQLCSTRRIRAVYAMPTLHNPLGWVTSQESRRQLVAIARKHGLLIIEDAAYAYLVERPPAPLAALAPESTLYVSGLSKNVATGLRFGFVVAPSEYVDVLERVIRATTWNTPALMTAIAAGWLNDGTVTRLEAQKRAD
>AIA10707.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
EKTVAELLESSIVRSDNTSTDKLLPLIGGPAGVTDRMRTLGVANINIKYSSREFAAHRDKPNTGTASDLAKLLAKLQKGELLQPAQLSLLLGFMEKARTGGERRIRANLPAGTQVAEKTGTGDGTTNDVGLITLPDGKGHLAIAVLITRSKVSPEAQEKVIAELARAAYDALVAPAP
>AIA10667.1|FEATURES|farme|beta_lactam|OXA-50|antibiotic inactivation|1
VERFTARSGYGNADVRDEAEQGSYWYDGSLRISANEQVRFLQRLHNGELGLSARTTDMIRQVALVEETPRWRLVAKTGACRGVGEQTTTHWYVGWVEKADNTYYFALRLAADSFEPALRDRVPIARDLLARLHILD
>AIA10658.1|FEATURES|farme|beta_lactam|oxaSH|antibiotic inactivation|1
YPNKIIFICIMNTSTIKFFTGTLLLTLALGLFSFMFKSNPEVRDDLKPFYDKYGVDGSFVLYDQKKQKYIIYNKDQVSKPFTPASTFKIFNSLVALETKVVADEYAVFKWDGQQRQVAAWNADTDMRNAFKNSTVWYYQEIARRVGGKRMNSWLNKAKYGNADTSGGIDAFWLTGGLRITPMEQIGLLRKLHDDKLPFSMRSMNIVKDIMIVKDTLGYVLRAKAGLGKQGNQYVGWYVGYITTRDNTYYFSNCVQTDRRNAEFANARLNIVYDVLDRLAIVKK
>AIA10654.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MHMRNHLPNPTRVLALAGFLLILAALAWGQTGAPPSSSCDNCLEWNKPQQPFRIYGNTYYVGPHGLSSILITSRAGHILIDSALPESVPQVVANIRALGFRIEDVKLIVNSHVHFDHGGGVAELQRLSGAKVAASPWSVEVLTKSGVGKGDPQFGSIPPVALIPRATTLRDGQTLRVGGIKLKAHFTPGHTPGGTSWTWNSCEGKRCLNLVYSDSMTPVSAEGFRFSDSREYPNAVKDFEKSFAFLRSTPCDILLTSHPDASGLWQRLEGRERGVRPNPVISPNGCKSLAERAGEQLRRRLAAEKGR
>AIA10642.1|FEATURES|farme|beta_lactam|oxaSH|antibiotic inactivation|1
DLLRRMMEAEGFTVNKNEWWHFDYKDWENYAIYDIAFSQVGANRVFQAEVEERRDWKQFFDAANVTGGIYIYDLRKNKFSIYDRQRFNKGFVPASTSKIIHSLIFLETGALEDENETLKWDGVKRQVAAWNQDHNLRSALKTSAVWFYVEVSKRVGREKMQQFYDKAEYGNRNTNGFGADYWNTGDLRLTPLEQIDFLVNFYENRLPFSKRSMEIVKDILVFEKTDKYILRAKTGWSNSFTPQVGWFVGYVEKGSETYFFADEFDIKKDEDAAKRIEITKNALKSLQIID
>AIA10612.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSLVIRRARPDDIGTVFSLIRELADYEKLSHEVAASEADIAAALFCEHPTLFCDLVEWNGEVAGFAVWFVNFSTFAGRHGIYLEDLFVRPAFRRNGLGQALLGHLARTCVERGWTRLQWSVLDWNLPSITFYKSLGAELMEEWTLCKVTGASLAALAEKAP
>AIA10554.1|FEATURES|farme|aminoglycoside|Mmwyl1_0154|antibiotic inactivation|0
MKLDVEIRFALPDESEAIAEVIREAFAEMQSLYTPEAFAVTTPNAEKVRERFREGKIWAALEEEKMVGTVSVVPEENGRLYIRSMAVLSSVQGLGIGRKMLEAIENYAIENGFENLFLYTLPFLEGAIRLYERN
>AIA10546.1|FEATURES|farme|beta_lactam|OXA-198|antibiotic inactivation|1
MKNLLSVFFVILLAQAFAFSQVDLQKPFQDCNLQGSITIYDYKNKKWIFSDEKDSQRETLPASTFKIINSLIALETGAVKDEKEVLKWDGLKRQVEAWNADTDMENAFKNSTVWFYVEMAKRIGKDKYKHYLSESIYGNGNLDTGQDNDFWNYGNFGVSPKNQIKFLRRLYLETLPFSKRSFEIVKRIMIEEKTDNYILRAKTGWTRFGGNDTGWWVGYVEQKDNVYFFATRVIKKLETQNPNFSPCRKEITRKILKELKII
>AIA10542.1|FEATURES|farme|beta_lactam|CTX-M-86|antibiotic inactivation|1
MLLAANRAKAGSADIPGSKGLSDAMAALERRSGGRLGVAVLDTGSGRRFDWRGNEMFPMCSTFKFLLAAAILKRVDEGRESLTRRIPVSPGDLIPYAPFAETRVNGTPPTVAELCEATMTLSDNVAANLLLPAVGDPAGLTAFVRSLGDERTRLDRNEPTLNSSIPGDPRDTTTPNAMVHSMDRLMVGDALRPSSREQLIGWMVGNKTGDKRLRAGLPRDWRVGDKTGTGNGSFNDIAIVWPGASPPILIASYVTQTPEGFKQGDAIHAEVARAAAGAFTG
>AIA10538.1|FEATURES|farme|fosfomycin|FosX|antibiotic inactivation|0
MFKFAIPVLHVTSSAAAEEFYCDRLGFSQTFAYRPFGRADPCYMGLTRDDVELHVSSFSGDGVAGGVVFLGVEDVDELHNELKAKGVTIDLEPTDQSWGNREMYVHDADNNSIRFVHRGR
>AIA10536.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MFKFAIPVLHVTSSIAAEEFYCDRLGFTQTFAYRPFGRADPCYMGLARDDVELHVSSFSGDGVAGGVVFVGVEDVDALHEELKATGVVVDLEPTDQSWGNREMYVHDPDGNSIRFVHRGE
>AIA10537.1|FEATURES|farme|streptothricin|sat-1|antibiotic inactivation|0
MIAIRPAVETDIDALYSLDLIARQENERREFIRREVVSGNCFVAVMNETVIGYGVLNYTFYRSGCIDMVYVDSEHRRRGVGAALLKHMESLCKTPKLFTSTNLSNLPMQSLLAKLDYVLSGVIHNLDDGDPEIVYFKRLRG
>AIA10499.1|FEATURES|farme|beta_lactam|WS68_16125|antibiotic inactivation|1
MAAPPAAGPEGQSRGPAHPEGQSRGPAYPEEPKRSPADPEGQSRKLAELERHAGGRLGVAAVDTATGQRLEHRGNERFAMCSTFKFLLAAALLQRVDKGVEHLNRRIEYGEADLLEYAPVSKQNVKQGGMALAEMCSAAVEWSDNTAANLLLQALGGPDRLTAFIRTLGDEVTRLDNNEPKLNVVLPGEVHDTTSPLSMVRLLSTLLFGQVLSPDSRTRLQGWMLDAKVGQHRLPAGLPPFWRIAHKTGTGSDQTNDVGVLWPPDRAPIVVAALYARGDIPQDRREAVLADVGRIVSSVF
>AIA10477.1|FEATURES|farme|beta_lactam|PEDO-2|antibiotic inactivation|1
MKLRYVRNAVVALALLSVQASAQEQPLTTKCESAPLTAAFTVFSETGQMPPNLVKFLGDAALQKIEPYKAFDNIYYVGICWVSAWLITSPNGHVLVDTLYGPYTGLMLDNIRSLGFDPKDIKLVVVTHGHFDHAGGIAQLKSELAPGTRFAMSKEGWREGAEVSAAKRPIPWTMIEPDIVLTDGETVSGGDIAIQAFETPGHTLGTVSFAFDARDGARTHRAITVGGLGLNAIRGPEQVEAFIASVKRIRTLTQDGARPVELHLTTHGFSTGLTEAKDQLKTRKPADPHPLVDLAGFRKQLDELQAGAEKRLVVERQKKAN
>AIA10467.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
GKPLLLVANHRSFFDMYTVSSVIFRRTPRPVTLFFPVRAKFFYDRPVGWLVNFVMGWWAMYPPFFREQKEIVKREFDKFSLRRLIQLASVGPGNVIGFHPEGKRNFGSDPYEFLPAQPGVGKVIYSAKPQVIPVFIAGLGNDLAKQVLGNWTGGEKVRIWFGEPIDFSEFYEKGDRLRTHKEIADFTMVKIGELGEKDREIFGTASSAS
>AIA10454.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MEEIARVSNGPVGAAAMEVETGEVVALNGKQRFPMQSVYKFPIGMAVLHQVDTGVLKLDQKVRVKPTDLAPKSLRSPLRDLHARGAELTVRELLTFMMVDSDSSASDVLLATVSGPQQATKYLRELGIEGINVATSEKQMATDDQVQYQNWSTPEAMLGLLKILQEGRSMSPASRDLLLELMRKTWTFPTRIKGLLPAGTVVAHKTGSSGTRDGLTRATNDVGLITLPNGHHLAVAVFVSDTKVDEKTRDAVIAKIARAAWDCWQ
>AIA10451.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MAIDEQAPAQKHATGEQFVSERVNNVPPSGIRKFFDIVATMKDVISLGIGEPDFVSPEPILNAGIDSLKAGHTAYTSNSGILELRELLSKHIERLYKVHYDAEREILVTVGVSEALLLAFMATLEPGSEVIVPEPCFVAYQPTVVFAGGVPVPVPTYVSQDFQVTVEDLEKARTPRTRAILLGYPNNPTGAVLERSRLEEIAAWAVKHDLLVVSDEIYDRLVYGMSHAMTGWRIGYTAAPPAILAAMRKVHQYIIMSAPTTGQEAAIEALKSGEPFVESMRQEYDRRRRLIVDGFNRLGLKCFEPRGAFYAFPSIESTGLSDEEFCDRLLMEEKVAVVPGSAFGMSGTGHVRASYATAYERIEEALVRIERFLNKLK
>AMJ38530.1|FEATURES|farme|beta_lactam|KS18_02580|antibiotic inactivation|1
MWMRNKSVWRGLLLAGLLNLSLGSTVALADNTALTQKLAALEKSTGGRLGVAWIDGDGLRYGYRADERFPMTSTFKTLAAAAILHNSVSQPNLLEKKIRIREADRVAWTPVTGNYFGKEMSIAALCAAAIEYSDNLAANYLLKELGGPQGVTAYARLLGDTLTRLDRQETELNSAAPGDERDTSTPAAMAENLSKLTLGDALPTAQRQRLISWLKQNTTGDQSIRAGVPAGWTVGDKTGAGAYGTTNDLAILWPEKGAPKILAIYFTQPQPDAANNKAVLASATRLAIDALGR
>AMJ38518.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
MKLTQIRNATLLLNYAGVKFLIDPMLADKEAWEGFPGTARSHLRNPLVALPLPLETLLDVDAIIVTHTHRDHWDEAAAAHISKDMLIFTQNAADAELIRAQGFTRIQVLEEHNTFAGITLIRTDGQHGSDEAYSNPEIAALLGDACGLVFQHPDEKTLYIAGDTIWVKSYIDSLNAWRPDVVVVNAGFAQVDHIGAIIMGKEDILRTHQALPQATIVASHMEAVNHCILSRDELREYASEQGLQACLRIPADGESCYF
>AMJ38479.1|FEATURES|farme|beta_lactam|ACT-27|antibiotic inactivation|1
MLNLTVCQAQSNPTDYACLTGPDIPLTRYYGRLLMMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGNAGCTSLWRENQRAGYGELGHGKHGAGEGCRCLT
>AMJ38348.1|FEATURES|farme|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MMKKSLCCAWLLTASFSTFAAAKTEQQIADIVNHTITPLMQEQAIPGMAVAIIYQGKPYYFTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQWQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWALGAKRLYANSSIGLFGALAVKPSAMRYEEAMTRRVLQPLKLTHTWITVPQSGTKGLCLGLSRREARARLSGPA
>AMJ38298.1|FEATURES|farme|beta_lactam|blaR1|antibiotic inactivation|1
QIKRRILNIASYENPTYWKRIKGLIAFFMTAILLFGCSPMLSTYASEECYTWDTSSKKITLVDLSSYFDGYKGSFVLYDLQKDNWNIYDIEQATIRISPNSTYKIYDALFALEENIITSENSFISCPQQNYPFESWNEDQTLFSAMNSSVNWYFQALDAKLGKSNLQSYIEQIGYGNQNINGELSSYWMESSLKISPIEQV
>AMJ38291.1|FEATURES|farme|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MMKKSLCCAWLLTASFSTFAAAKTEQQIADIVNHTITPLMQEQAIPGMAVAIIYQGKPYYFTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQWQGISLLHLATYTAGVCRFRYPTTLQIKRHCCAFIKTGSRNGL
>AMJ38288.1|FEATURES|farme|beta_lactam|ACT-27|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQIADIVNHTITPLMQEQAIPGMAVAIIYQGKPYYFTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQWQGISLLHLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDAYLD
>AMJ38222.1|FEATURES|farme|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|0
MKLPLTTPRLLLRRFRTEDLPSFSHYRNLSEVARFQSWTHYGMTEATAFYEQQRSQAFAEDESWFQLAVEIQANGALAGDVGIHFLDHGRQAELGMTFSPAYQHQGYAREAMRAVMALLFEQLAHHRLTAVVDTRNTGAIKLLEGLGFRREAHYRQNIFFKGEWGDEYLYALLRSEYQ
>AMJ38198.1|FEATURES|farme|aminoglycoside|AAC(3)-Ic|antibiotic inactivation|0
MEIRVFRQEDFEEVITLWERCDLLRPWNDPEMDIERKVNHDVSLFLVAEVNGEVVGTVMGGYDGHRGSAYYLGVHPEYRARGIANALLNRLEKKL
>AMJ38141.1|FEATURES|farme|beta_lactam|OKP-B-6|antibiotic inactivation|1
MRYVRLCLISLIADLPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTTPSLSARSQQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AMJ37958.1|FEATURES|farme|beta_lactam|ACT-15|antibiotic inactivation|1
INEKILQQGIQLAQSRYWQTGDMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYPNPARVEAAYHILEALQ
>AMJ37953.1|FEATURES|farme|beta_lactam|OXY-6-2|antibiotic inactivation|1
QLITIKESEMLKSSWRKSALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQTLYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGMTLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKRDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AMJ37837.1|FEATURES|farme|beta_lactam|EBR-1|antibiotic inactivation|0
KSLKDINVTMDSIRAVFITHDHADHIKAVGHLGEKLNIPVYTTARVHAGINKSYCMTEKLHGSVRYLEKEEPMLLEDFRIESFEVPHDGTDNVGYCIEIDGKVFSFLTDLGEITPTAARYICKAHYLIIEANYDEEMLRMGPYPTYLKERISSKTGHMSNIDTANFLAENIMEHLRYIWLCHLSKDNNHPELAYKTVEWKLKSKGIIVGKDVQLLALKRNTPSELYEFE
>AMJ37738.1|FEATURES|farme|beta_lactam|TEM-112|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIRRTEGANRFFAQHGGSCNSP
>AMJ37732.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
SSMSNTFTFLNAGILISIFLNAWLMEIVPLKTQLRFGFLLMVLAVAGLMFSHSLALFSAAMFILGVVSGITMSIGTFLVTQMYEGRQRGSRLLFTDSFFSMAGMIFPMIAAFLLARSIEWYWVYACIGLVYVAIFILTFGCEFPALGKHAPKTDAPVEKEKWGIGVLFLSVAALCYILGQLGFISWVPEYAKGLGMSLNDAGTLVSNFWMSYMVGMWAFSFILRFFDLQRILTVLAGLAAILMYVFNTGTPAHMAWSILALGFFSSAIYTTIITLGSQQTKVPSPKLVNFVLTCGTIGTMLTFVVTGPIVEHSGPQAALLTANGLYAVVFVMCFLLGFVSRHRQHNTLTSH
>AMJ37621.1|FEATURES|farme|beta_lactam|LRA-13|antibiotic inactivation|0
MEDKLVTLAIHTFEKAQILKTILETEGIEVYIHNVNQIQPVVSAGVRVRIKESDLPHALRIIEDNKWFEEPKEEEAKVNAVKKVLIPIDFSDYSAKACELGINYAHAVGAEVMIMHAYFSPYFPSAIPMGDTLAYQVNEEESVQHILQRVRIDMENICTHINRKMSSGELPKVKYDYVLREGLPEEEIIAYSKEYHPTLIVMGTRGKSQKDMDLIGSVTGEVIEVNRVPVLAIPENVPFTDLRDAKNIAFATSFNQRDLVAFDEFMEIIKGFDFNIHLFNISTSKDEWNEIRLTGVREYFKKQYPHAHISHTVLADGDLLLAIEKFVRDKQIDVIALSTYRRNILARMFNPSIARKMLFHTDTPLLVIDSKK
>AMJ37452.1|FEATURES|farme|beta_lactam|BL2a_pc|antibiotic inactivation|1
MIYKNYNCNIGGFILKRLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALNTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETSKSVMKEF
>AMJ37049.1|FEATURES|farme|quinolone|PLPDE_IV|antibiotic inactivation|0
MFLINGVVQDTLAANDRATQFGDGCFTTARIQQGQVALLDAHLQRLQTTCEKLHIPFNDWLTLSEEMQRLARPHAQGVLKVTLTRGVGGRGYSTAGCVSPTRILSFSPYPAHYARWREEGITLTQSPVPLGRNSWLAGLKHLNRLEQVLIRSHLEQTDADEALVLDSDGWLTECCAANLFWRQGRDVFTPRLDCGKAR
>AMJ37020.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MKKPLFICVVLIMIIASAASLPFVLNAGFGQPPQGERLTEVEASPQYREGKFHNTLPTPGYNGDKNMLVAMWEFLTKKTENARPTQPLPLVKTDLASLPLEQDTLVWLGHSSWYLQLAGKRILIDPVLGNYAAPFSFLNKAFAGEYPWRAEIMPAIDLLIISHDHYDHLDYATIRALLPKVKRVVTPLGVGSHLRYWGMKPEIIDERDWNQSVRISDALTVHVLPARHFSGRGIKRDRTLWGSFMFVTPEQKVYYSGDSGYGPHFRAIGEQFGEVDVAIMENGQYDQDWKYIHMLPEETAQASADLNAKAVVPGHNGRFVLAKHAWNDPLIQLAKASQDKNYRLLTPELGEPVRVSDTAQTFRAWWE
>AMJ36677.1|FEATURES|farme|beta_lactam|IND-5|antibiotic inactivation|0
MQGIKIYTILASSLISGSIFAQTEISTANSSTVNASYVEPSAEKIISPSDKLNNLFERNMSQPYILQKIGERTYYVQRYFYSTTFYVGDKGVLLFDAPEGRGKYLLQAIRDVTPLPVTALVYSHYH
>AMJ36594.1|FEATURES|farme|beta_lactam|bla|antibiotic inactivation|1
QQKLADLEKRSGGRLGVALINTADDSQTLYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRKIGFSGLEPDYRKTSAKRNDPGGTQRGGAAVQRQYRDE
>AMJ36422.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MSDYLLIIKLRASPSRSEALFMKILITCVVLMILAAAGGVISALVPSMGRSPDTEQRHKFAKSPQYRDGKFHNEALTPMVSGSKGRMAVMWDFLFKKSRLAKPDHALPYVNTDLVSIDTDKDVIVWLGHSSWYLQLDGKRILIDPVLSDHAAPFSFMNKSFIDDYPWQAQRMPKLDYVLISHDHYDHLDYETMQILQSRIGQIITPLGVGTHLLRWGFVPEQIVEADWNQQVVLDETLTLHVLPARHFSGRGFEGNPTLWASFLLQSSQRRLYYSGDSGYGTHFKKIGDRFGPIDVAILENGQYDSDWQYIHMLPEETAQAALDLNAAAVLPSHAGRFVMAKHSWNEPFIRLALTSRDKPYRLLTPKLGEVVWDDGKTQQFDVWWN
>AMJ36101.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MKRLTVCVVVIMLIGAAASLPFLLNAGFGQAPKGAQLSQVEQSPHYRDGQFHNQVPTPGYTGNKSMLAAWWEFLVAKRENARPAHPLPLVATDLAGLSPEQDTLVWLGHSSWYLQLAGQRILIDPVFSNYAAPLSFLNKAFAGDYPWSAQTMPEIDLLIISHDHYDHLDLATIKALMPKIKRVITPLGVGSHLRYWGMRGEIIDEMDWNQSIRVTDSLIVHALPARHFSGRGIKRNQTLWASFMFETPEQNVYYSGDSGYGPHFKAIGEQFGSVDLAIMENGQYDHDWKFIHMMPEETAQAAVDLHAKAVLPGHAGRFVLAKHTWDDPYKRLALASRRYDYRLLTPMLGEPVILSAPDQLFTAWWQQVTQ
>AMJ35851.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
MLNLTVCQAQSNPTDYACLTGPDIPLTRYYGRLLMMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHYYTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMGYERAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILDALQ
>AMJ35595.1|FEATURES|farme|chloramphenicol|cmlv|antibiotic inactivation|1
MTTHTVSRRVAWLRVVTLAIAAFIFNTTEFVPVGLLSDIAASFHMETAQVGIMLTIYAWVVALMSLPFMLLTSQMERRKLLIGLFVVFIASHVLSFMAWNFTVLVISRVGIAFAHAVFWSITASLAIRLAPAGKRAQALSLIATGTALAMVLGLPIGRIVGQYFGWRTTFFAIGMGALITLVCLIKLLPKLPSEHSGSLKSLPLLMRRPALMSIYLLTVIVVTAHYTAYSYIEPFVQVVAGFSANFATVLLLILGGAGIIGSILFGKLGNKHASALVSSAIGLLLACLLLLMPAAGSESHLAILSLFWGVAIMIIGLGMQVKVLALAPDATDVAMSLFSGIFNLGIGAGALVGNQISLHVSMSAIGYLGAIPALIALIWSVLIFRKWPVAMEEQTSHG
>AMJ35461.1|FEATURES|farme|beta_lactam|ACT-32|antibiotic inactivation|1
VHRTITPLIEQQKIPGMAVAVIYQGKPHYYTFGKADIAAN
>AMJ35435.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
FIRDVAKSSVDDPLNARYTPFDGKPAFLQAAANWYRNVHGVELDWRSQLFAVEGAVDGLAGLFAILIDRGDAVAFADPYYPSYHCMSVMHGAEEILLPARAELGWLPDLDAVDESVWRRLRMLILNYPNNPTGAQAPASFFEHAVELAKRYGFLIVHDFAYTGLGVSDQQVSLLTVPGASDVSVEVDSLSKMYA
>AMJ34936.1|FEATURES|farme|aminoglycoside|aminotran_1_2|antibiotic inactivation|0
RDIAEQYKRRRDVLVKGLHEAGWMVEMPKASMYVWAKIPEPYAAMGSLEFAKKLLNEAKVCVS
>AMJ34766.1|FEATURES|farme|beta_lactam|SHV-33|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMATTLRKLLTSPLSERPFAAAAAAVDGGRSGRRTVDPLRAAGGLVYRR
>AMJ34471.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
LGIVISFVWLKVIHDPNNHPGVNQKELDYIAEGGALINMDQKSSAQKVPFSVKMGQIKQLIGSRMMIGIYIGQYCINALTYFFITWFPVYLVQARGMSILKAGFVASIPAVCGFVGGVLGGVISDWLMRRTGSLNIARKTPIVLGMLLSMTMLMCNYVNVEWMVIGFMAMAFFGKGIGALGWAVMADTAPKEISGLSGGLFNMFGNISGIVTPIAIGYIVGTTGSFNGALIYVGIHALVAVLSYLVLVGDIKR
>AMJ33973.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
LQLAGKRILIDPVLGNYAAPYSFLNKAFAGEYPWRAESMPEIDLLIISHDHYDHLDYATIRALLPKVKRVVTPLGVGSHLRYWGMNPEIIDERDWNQSVRISDELTVHVLPARHFSGRGIKRDRTLWGSFMFVTPEQKVYYSGDSGYGPHFKAIGEQFGEVDLAIMENGQYDQDWKYIHMMPEETAQAADDVRARAVLPGHAGRFVLAKHTWDDPYIRLAEASTGRPWRLLTPMLGESVWVADKTQSFNAWWR
>AMJ33499.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MVGRIYHVGLTVSDLDRSIAFYRDILGLEFQGEIFMEGEETDKMFRKENCKARVAYLNGSKALEAPPVELIQFVDSKIHKEQSDLFTTSISEVCFYTDDIDSAYKTLIENHVECLSEPQYFDFRTDGFGESRAFYFRDPDGIILGLMQPL
>AMJ33498.1|FEATURES|farme|chloramphenicol|catD|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEYRTVINQAGELGTYDEMIPSYTIFHKDTETFSNLWTEYMPNIEEFSRAYENGIQRYGSNHGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYKEDKKTILPLAIQVHHAVCDGFHICRFVNELQELINS
>AMJ33430.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MPEINLYGQTVGDVVPDWNGAAVLPRETLVGQYCRLVPLDADSHAADLFDAYAQAPDDRDWTWLASSRPTSVEAAACWVEGKSTDASLVPYAVIEQRFGRAVGLVCFMAIEREHGSVEIGHVTWSPRMKNTVLGTESIWLLLRQAFALGYRRVEWKCDSLNTASRRAAERLGFIFEGRFRQKIVRKGRNRDSDWLSMIDGEWPQCDAVLQRWLAAENFDEHGRQRRSMADFVTKSLHTE
>AMJ33247.1|FEATURES|farme|beta_lactam|OXY-2-4|antibiotic inactivation|1
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQILYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQYSDNTAMNLIIGYLGGPEKGHRLRPQYRRCHLSSRSYGAHAEYRHPGR
>AMJ33064.1|FEATURES|farme|beta_lactam|TEM-17|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AMJ32985.1|FEATURES|farme|beta_lactam|AmpC|antibiotic inactivation|1
MGSHYYISQPTPLAALPLQVPDEVKSSSDLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADASLKQGIGYNWHNLATGVSGQCIRVWAGRCSTGPWRPTRWSRAATVR
>AMJ32974.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MGSHYYISQPTPLAALPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ32734.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
VWKPNPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAGIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPQSGRGALRLGLS
>AMJ32642.1|FEATURES|farme|macrolide-lincosamide-streptogramin|msrE|antibiotic inactivation|0
ILIDPVLGNYAAPFSFLNKAFAGEYPWRAEIMPAIDLLIISHDHYDHLDLATIKALMPKIKRVITPLGVGSHLRYWGMDGAL
>AMJ32516.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
VMNRVTFSVVAIMLLASATTLPFVLNAGFGQAPQGAQLSLVEQSPHYRDGQFHNQLPTPGFTGQKNMLAAWWEFLVAKRENARPAQPLPLVNTDLASLPLGQDAMVWLGHSSWYLQLAGQRILIDPVFSRYAAPFSFINKAFAGDYPWHAEGMPEIDLLIISHDHYDHLDYATIKALMPKVKRVVTPLGVGSHLRYWGMESAIISEADWNQAVPVSDELTVHVLPARHFSGRGLKRNQTLWASFMFVTPQQKIYYSGDSGYGPHFKAIGEQFGAVDLAIMENGQYDQDWKYIHMMPEETAQAADDVRARAVLPGHAGRFVLAKHTWDDPYIRLAEASTGRPWRLLTPMLGEPVWVADKTQSFNAWWR
>AMJ32429.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
FPHAGLNKPPILARLTRSLQRRNAKIENRLDDFHRFPNNECVLTHNQVYPAHAIGWGLLSGQDMNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGFTGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKRILIDPVFSDYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALLPKIKRVITPLGVGSHLRYWGMDGALITEADWQQAVPASDELTVHVLPARHFSGRGLKRNQTLWASFLFVTRQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQAADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQSFNAWWR
>AMJ32322.1|FEATURES|farme|aminoglycoside|SG34_20990|antibiotic inactivation|0
MTVEYTVIEKVPSAEAFCHLRVAAGMSPRPLEGARAGLPHSCYGVHILWQETPIAMGRIVGDGAINFDIVDVAVDPAHQGKGLGRLVMEKLIAWLDANAFDGAYVTLVADVPALYAKFGFESVRPESEGMARVWRTRSR
>GU720999.1_1015|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|0
MRNKLFLALFSFGFFSSSAQTTYYPDSIWQVKTAAEMMMDKTLLDSAVRFAVANENKFDRDLRIATLKAYGNEPDFKIIGPTKDRGGPAGLIIMNGYIVAQWGDVNRVDMTNSVTKSFLSTIAGLAIDEGLIRNVSDKVYNYVWDGTFAGEHNSKISWEHLLTQSSDWSGTLFDLADWADRPPKEGGIDDWKNRKLNEPGSFFKYNDVRVNVMAYSLLQVFRKPLPMVLKEKIMDPIGASTTWRWYGYDNSFINIDGLMMQSVSGGGHHGGGLFISTLDQARFGLLFLRKGKWRTQQLISEKWVRAVHQPSSAFKDYGYMWWMNNSKKWKDVSPDIYYANGAGGNYIVIDNEHGLVVVTRWMDDSKMGELMKIIEQSIKNN
>JX009353.1_1033|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
LGLSNTHVRVPTGKSEQYAQGYDKDQKPVRVTPGALDSEAYGIKTSTQDLARYVIANLHPETLEKLAEVR
>JX009351.1_1034|FEATURES|farme|beta_lactam|AK972_2544|antibiotic inactivation|1
TYTAGGLPLQFPEESDNTGKMISYYQHWKPDFAPGTQRLYSNPSIGLFGHLAAQSLGQPFDRLMEQTLLPKLGLKHTFINVRVPTGKSEQYAQGYDKDQKPVRVTPGALDSEAYGIKTSTQDLARYVIANLHPETLE
>JX009349.1_1035|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
VASRQTGKPITNQTLFEIGSLSKTFTATLATYAVSEGKMSFADPASRYLS
>JX009327.1_1053|FEATURES|farme|beta_lactam|UCMB321_2366|antibiotic inactivation|1
MFKKNLAKLEVLVTSLLLVGASNSFAADTPQDKVKSIIDAAIEPIMQEQNIPGMAVAVLVNGKPYHFNYGLASKANRQAVTDDTLFEIGSVSKTFAATLAGYAQAQGKLVPSERVSHYLPELKGSAFDNITVLQLGTYSAGGLPLQFPDAFDAQDKMLDYFKQWKPIYPAGSHRQYSNPSLGLFGYVAAKSLGAPFDELIEKTLLPALGMKHTYLHVPPAQMPHYAEGYTQDDKSVRVGPGALDAEAYGIKTTSTDLLRFVEANLQPETLEAPLHKAIDLTQSGYYQIDGTTQGLGWEFYPYPVKLEPLLTGNSSEMAYEAHKITTQFNPAQPPQKNALFNKTGATRGFGAYVVYVPAKKIGIVMLANKNYPNPVRVKAAYQILNALEAVK
>JX009325.1_1055|FEATURES|farme|beta_lactam|Rahaq_4870|antibiotic inactivation|1
MMKNTLRKIVLMAAAVVPMLAFSAVSWAQTATKMTSVQQQLAALEKDSGGRLGVMLINTEDNSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLKKSDLVNYNPITEKHLDTGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAIPGDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDKTGSGDYGTTNDIAVIWPDNKAPLILITYFTQPEKDAKSRRDVLASAAKIVTQGY
>JX009323.1_1058|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MKRIHKLAVALLTALAIPAGHAADKVDIDAIVQPLMQKYGVPGMAIAVSVEGKQQFYHYGVASKQTGKPITNQTLFEIGSLSKTFTATLAAYANDEGKLSFAEPASRYLPELRGSAFDHVSLLNLATHTSGLPLFVPDEVTNDAQLMAYYKQWQPSQPAGSTRVYSNLGIGMLGMITAKSLNQPFAQAMEQRLFPALGLTHSYINVPTGQMANYAQGYNKKDQPVRVTPGPLDAESYGVKSNAQDLIRYLEANMQVAKVGDKWRKALDETHTGYYRAGVFTQDLMWESYPYPVALARLTEGNNAGMIMNGTPATAITPPQREQGAAWFNKTGSTGGFSTYAVFLPKQKIAVVMLANKWFPNDDRVAATYRIVQALEKP
>JX009321.1_1061|FEATURES|farme|beta_lactam|M992_2411|antibiotic inactivation|0
LLLDSSGGPQGLTDWLRLTGDQVTRLDRREPDLN
>JX009313.1_1065|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
TIIVLDGRTGGYQAYDSTRANQRMSPASTYKIFNSLLALESGALDNEREIIPWDGKPRSMKRWERSNESARCVPGVVSAVLSGCVAQDCADLCAGQARCGG
>JX009307.1_1068|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
TVRSYSNVSIGALGWLTARAMQGDFATLMAEHVFKPLDLRHTFIRVPEAEQANYAWGYKDGKPVRVTPALFEPDRCAAILPPTTVNSLTCCASSKPISDSRYPIANCAMRSTPRAPAITSMPP
>JX009301.1_1073|FEATURES|farme|beta_lactam|AV650_28380|antibiotic inactivation|1
MKKNFNKVLAITSLMVSMAPFAAQKSLTAEQISQIVNGTVKPLLEAQSIPGMAVAVIYQGQPYYFTYGQADIKKNLPVTKKTIFELGSVSKTFTGVLGGDIITRGEMKLSDPVTKYWPQLTGSQWKGINMLHLATYTAGGLPLQVPDSVTDDASLLNFYQNWQPQWKPGTMRLYANASIGLFGHLAVKPSSMTFEQTISQRVFQPLQLTHTWINVPKSAEKEYAWGYSNGQPVRVSLGMLGAESYGVKSTIEDMTVWLKANMTPQHLNDSTLKQGILLAQSRYWRVGNMYQGLGWEMLNWPVNADTLINGSDNQVALAPHPSIAIIPPDPAENASWVHKTGATEGFGAYVAFIPEKQIGIVMLANKNYPNQERIKTSYAILEALQ
>JX009297.1_1077|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MAATDLRQVVDSTVAPLMQQHGIAGLAVATIKNGQVQYFNYGVMSKTTQRPVTEDTLFELGSVSKTFTATLGGYAQATGALKLTDKASQHLPALKGSAFDRISLLQLATYSAGGLPLQFPEAADSAKTMLGYFQHWKPTYAPGVQRLYSNPSIGLFGYLSAQSLGQPFNVAMEKTLLPQLGLKHTYITVPADKADQYAQGYDKQQNPVRVGPGALDGEAYGVKSSTQDMARFVIANMHPQTLNAPLQQAIATTHTGYYTVNGMTQGLGWEYYPYPVKLQALLDGNSTLIALQPNKAHWLQPAQTQPGNVMFNKTGSTGGFGAYVAYVPGKDIGVVILANKNYPIADRVTAAHGILSAMDQ
>JX009295.1_1079|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MPQLSLSGVRNLGALALFLATGHCLAADDLRAVVDASVKPLMQQQSIPGLVVGVVKDGKTQYFNYGVASKDAKQPVSENTLFEIGSVSKTFTATLAGYAVASGKLTLTDPASQYLPALRGGKFDHISLLNLGTYTAGGLPLQFPREADNTQHMISYFQQWKPDFAPGTQRLYSNPSLGLFGYLAAQSLKQPFDALMERTLLPKLGLKHTFVNVPASQMNLYAQGYGKDGKPVRVGPGAMDSEAYGIKTSAADLLHYVSVNMNPAGLEKSLQQAIATTHTGYYSVNGMTQGLGWELYPYPITLAALVEGNSSQMALEPHTVDWLTPPQAPHADTLVNKTGSTNGFGAYVAYVPSKGMGVVVLANKNYPNGERVKVAHAILSALDH
>JX009237.1_1129|FEATURES|farme|beta_lactam|farB|antibiotic inactivation|0
MPTGASAPSSPLVIRLDAPQHVGDQPVRYQSLWLLMRLYYAARFETASVPLAALKSRFAQAGDLRMLVSRAFADFAEWGVSAGWGDDHQADARLLPTRGRG
>JX009235.1_1130|FEATURES|farme|beta_lactam|BL1_sm|antibiotic inactivation|1
MKRIHKLAVALLTALAIPAGHAADKVDIDAIVQPLMQKYGVPGMAIAVSVEGKQQFYHYGVASKQTGKPITNQTLFEIGSLSKTFTATLAAYANDEGKLSFAEPASRYLPELRGSAFDHVSLLNLATHTSGLPLFVPDEVTNDAQLMAYYRQWQPPHAVGSYRVYSNLGIGMLGMITAKSLNQSFTQAMEKQLLPALGMNHTYIKVPAEEMANYAQGYNKKDQPVRVTPGPLDAEAYGIKSNAQDLIRYLDANMQVVKVGDPWRKALAATHTGYYRTGVFTQDLMWESYAYPEKLATLTEGNNAGMIMNGAPATAITPPKQDQGAAWYNKTGSTGGFSTYAVFIPSQKIAVVMLANKWFPNDDRVAATYRIVQALDKR
>JX009324.1_1201|FEATURES|farme|beta_lactam|AK972_2544|antibiotic inactivation|1
MYTSLFPTVRNTAIFALLLGAGNCMAATDIRQVVDSTVEPLMQQQDIAGLSVAVIQNGKAQYFNYGVANKDSQQPVTENTLFEIGSVSKTFTATLAGYALANGKLKLSDPASQYLPALRGDKFDHISLLNLGTYTAGGLPLQFPEESDNTGKMISYYQHWKPDFAPGTQRLYSNPSIGLFGHLAAQSLGQPFDRLMEQTLLPKLGLKHTFITVPKAQMNLYAQGYDKAGKPVRVGPGALDAEAYGIKTSTSDLIQYVEVNMHPAKLEKPLQQAIAATHTGYYTVDGMTQGLGWEMYPYPITLDALTEGNSAQMAFQPHKVSWLTPPQAPHADTLVNKTGATGGFGAYVAYVPSKGVGVVILANKNYPNAERVKVAHAILSALDH
>JX009300.1_1219|FEATURES|farme|beta_lactam|PMI39_02504|antibiotic inactivation|1
VKLISQTLIATALTSACSLAFAETADVQATVDQAIKPLMQQQAIPGMAVAVVVKGQPHYFTWGMADVKQQRPVTQDTLFELGSVSKTFTGVLGGVAVNKGEIALSDPARKYWPALNTPQWRDITLLQLATYTAGGLPLQVPDAVTDEKALANFYQQWQPQWAPGNTRQYANSSIGLFGWLATKPSGLTFEQAMQQRVFMPLQLKHTFITVPNTAKENYAWGYREGKPVRVSPGMLDAEAYGVKSSIKDMARWMQANMNPQQINDKTLQQALDFAQTRFYRTDALYQGLGWEMLDWPAQAEMAVKGADNKVALGPQPVRDAKSHPRVTASWVHKTGATGGFGAYVAFIPAKQVGIVILANKNYPNTERVKAAMQILKALQ
>JX009294.1_1229|FEATURES|farme|chloramphenicol|cmlv|antibiotic inactivation|1
QHWGWRITFGLVAVLVFICLLALVRLLPAIAAGRTLKMAEEIKAFKNKAYWKACTTSCLILGASFAAFSYFVPVLVDVSGFSMQTVPFILMLYGLANIVGNMITGRLAYRHSLAIMVVGLSILSLSLFGMALFAEYPLIAICAVILIGLSGVPMNPAMMARIVSVAHPGPMVNAVHTSVINIGLGGGSYLGGMAIASGYGLRSALWIGMALAVLALLSILPYLRRGQQGWR
>JX009232.1_1282|FEATURES|farme|beta_lactam|OA39_00246|antibiotic inactivation|1
LSLFILCLSIMPSAYAINLHEKVKQYERDGWKVGVSVLFSDKKSVSINGSQRFPLNSTVKAISCANVLSKVDNGSLSLNREMKVTEKNIESYSPVAKDYIGRPFSLSQACKAATEYSDNTGANFSISSGGGPKGLTNFMRSIGDDITRSDRYEPDLTVNPESDLRDTTTPDAMSASIKKLLTGNVLSDKSKTQLKEWMIDNKVADNMLRASLPPGWKIADRSGASDYGIRGITSMVWSDNHEPVFISIYVRKKDTSLDERSEVIRVLGAHIFSEYLTK
>JX009202.1_1311|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MPQLSLSGVGKLTALALFMAAGQCLAAADLRTVVDASVKPLMQQQSIPGLVVGIVKDGKTQYFNYGVASKDAQQAVSENTLFEVGSVSKTFTATLAGYAVATGKLSLTAPASDYLPALRGGRFDHISVLNLGTYTAGGLPLQFPAEADNNQRMISYFQHWKPDFAPGTHRLYSNPSLGLFGYLAAQSLKQPFDQLMEKTLIPKLGLKHTFVTVPKSQMNLYAQGYGKDGKPVRVGPGAMDSEAYGIKTSASDLLHYVEVNMRPATLDPVLQQAITTTHTGYYTVEGMTQGLGWEMYPYPIKLDALVEGNSTKMAVEPHPVNWLTPQQAPHADTLVNKTGSTNGFGAYVAYVPSKGMGVVILANKNYPNGERVKVAHAILSALDH
>KF630348.1_11349|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MKQPELSPYMMARKPSGIRIGQIKFLERKNPPILVNGSIGNVMRPMHPAMQRRLFDLGGVNSPFHNGIVPYVPTTGTDECREAFLHILRSQGFDTTGLDVLVTDGASMAMEIIMLGVCGGAGEEERPLLMFNPSYTNYDAVGLRIGRKTVTVERELNENGEFELPSVETVEQRIIETKPGALLIIPYDNPTGQLFSKETLIEYTKLCVKHNLWIISDEAYRELAYEKGKETSSIWALTDKDVPGIEGRRISLETASKVWNACGLRIGAIITDNKLCYEKSVAEYTANLSANTLGQYIFGALKHESYAQLHNWYEQQRDYYRQMIFELHKGFKEVEPDFIVSRPEASIYFVIDVRKVAKPGFDGVEFASWCAEHGAVSLDDGKEYTLLMAPLNGFYSGKNGDNNPGKTQLRVSFCENPELLRLAPELLSKLFRAYEAQRNV
>KF630336.1_11379|FEATURES|farme|beta_lactam|CTX-M-95|antibiotic inactivation|1
MRLRIGKKRAVLFLLFVFSMNTEWTRDNTDRGFSMMTLGVRRTMLMMMATIPLLLGSTALYAGTSSVQQKLEALEKSTGGRLGVALINTADDSQIVYRADERFAMCSTSKVMAAAAVLKQSESDKTLLNQRVEIKKSDLINYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAHLGGPEKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLRNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPTSWVVGDKTGSGDYGTTNDIAVIWPEDHAPLILVTYFTQPEQKAESRRDVLAAAAKIVTEGL
>KF630322.1_11410|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MDLTEFNEIRPYNDEELPQIFEELIADPAFRKAATGAIPNVPFELLAQKMRTCKTKLDFQKAFCYGILWKIAEEHTNGLTLDHNALPNKKKAYTYISNHRDIILDSGFLSILLVDQGMDTVEIAIGDNLLIYPWIKKLVRVNKSFIVQRALTMRQMLEASTRMSRYMHYTIAEKNQSIWIAQREGRAKDSNDRTQDSVLKMLAMGGEGDLIDRLKEMNIAPLAISYEYDPCDFLKAREFQLKRDIEGYKKTTQDDLINMQTGLFGYKGKVHFQVASCINDELERIDRSLPKPELFAAISACIDQRIYRNYRMYPGNYVAYDWLNGTTEFTGIYSQEEKQQFVGYIDG
>KF630311.1_11445|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRNPLSRKIVEIQPSGIRKFFDVANEMKDAISLGVGEPDFDTPWRIREEGIFSLEKGRTFYTSNAGLKELREEICSYLERKIGVSYDPMQETMVTVGGSEAIDVALRCMLDPGDEVLIPQPSYVSYLPCTIMADGVPVIIPLQYENEFKLTVEDLKKAVTPKTKVLVMPFPNNPTGSIMTKADLEPVAEFIKEHDLYVLSDEIYSELSYQGDHVSIAALPGMRERTIVINGFSKGFAMTGWRLGYCCGPKLIIEQMVKLHQYAIMCAPTNSQYAAIEGLRHCGDEVEEMRKSYNQRRRFLMHEFKRMGLECFEPFGAFYVFPNISEFGMASEEFATRLFDGRKSCGGAGNCIWRVWRGILAYFLCIFSGRSERWRWEDWSALLKN
>KF630293.1_11486|FEATURES|farme|chloramphenicol|catA13|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTILNRHEEFRTALDKNGQVGVFSEMLPCYTIFHKKTETFSSIWTEFTADYTEFLQNYQKDIDAYGERKGMFAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYHIPLSIQVHHAVCDGFHICRFVNELQELINS
>KF630292.1_11490|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRNPLSDKIVKIPPSGIRKFFDIVSEMKDAISLGVGEPDFETPWHIREEGIYSLEKGRTFYTSNAGLKPLKVEICEYLKRRCGVTYDPDQEILVTVGGSEAIDIALRAMLNEGDEVLIPQPSYVSYMPCVTLADGVPVTIELEEKDQFKLTPEKLLEKITDKTKILVLPFPNNPTGAIMEKEELEEIVKIVLEKDLFVISDEIYSELTYNGKRHVTIASFPGMKERTVLINGFSKAYAMTGWRLGYAAAPHIILEQMLKIHQYAIMCAPTTSQYAAVSAMKNGDPDVSMMRES
>KF630274.1_11532|FEATURES|farme|beta_lactam|LRA-2|antibiotic inactivation|0
VEEMEKLIVLGTGNAMATKCYNTCFSITDGEEYFLVDAGGGNGILSMLDKANIKVSKIHNMFVTHEHTDHVLGVTWIIRKIGTMILNDKYEGNFNIYCHEDLENTIVTIAKLTLQKKITNLFGKRIIIYPVKNGEKKKILDYNITFFDIYSTKAKQFGFTMKLKNQKTLTCMGDEPYNSLCESFIRNSNWLLSEAFCLYGDREKFKPYEKHHSTVKEASELAEELNIENLVLWHTEDSKIEERKELYTNEGKEYYRGNLFVPNDLEVIEL
>KF630271.1_11538|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
PPPEVDFSMGNPDGATPPHIVEKLCTVAQRPDTHGYSTSRGIPRLRRAISRWYQERYNVEIDPESEAIVTIGSKEGLAHLMLATLDHGDTVLVPNPSYPIHIYGAVIAGAQVRSVPLVEGVDFFNELERAIRESYPKPKMMILGFPSNPTAQCVELEFFEKVVALAKRYDVLVVHDLAYADIVYDGWKAPSIMEVPGARDVAVEFFTLSKSYNMAGWRIGFMVGNKTLVNALARIKSYHDYGTFTPLQVAAIAALEGDQQCVHDIAAQYKRRRDVLVKGLHEAGWMVDMPKASMYVWAKIPEQYAHMGSLEFAKKMLQDAKVCVSPGIGFGDYGDTHVRFALIENRDRIRQAIRGIKAMFRADGLLPSEGKSAG
>KF630228.1_11623|FEATURES|farme|aminoglycoside|KONIH1_14625|antibiotic inactivation|0
VAKFKVQGTVEEIKPLGAGLINDTYKVNTKETDAPDYVLQRINHAIFQNVEMLQSNIAAVTSHIRKKLTEAGESDIDRKVLSFLSTEEGKTYWFDGDSYWRVMVFIPRAKTYETVNPEYSNYAGQAFGNFQAMLADIPETLGETIPDFHNMEFRLKQLRDAVATNAAGRVAEVQYYLDEIEKRADEMCKAERLYREGKLPKRVCHCDTKVNNMMFDEDGKVLCVIDLDGS
>KF630214.1_11658|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MNNIFAERLKKAMEQKNMKQIDLVKKAAEQGVKLGKSHVSQYLSGKTTPRSEILNFLATTLGVETEWLKGTDVSVDTLKKETNEAGIQMENMKFDYNYNNMKENTRETVEEVQVREFKKSSKLNNVLYDVRGPVVEEAARMENAGTQVLKLNIGNPAPFGFRTPDEVIYDMRQQLTECEGYSPAKGLFSARKAIMQYAQLKKLPNVSIEDIYTGNGVSELINLCMSALLDNGDEILIPSPDYPLWTACATLAGGKAVHYICDEQAEWYPDMDDIRKKITSRTKAIVIINPNNPTGALYPREILQQIVDIAREHHLIIFSDEIYDRLVMDGAEHISIASMAPDLFCVTFSGLSKSHMIAGFRIGWMILSGNKAVAKDYIEGIKMLSNMRLCSNVPAQSIVQTALGGHQSVESYIVPGGRIYEQREFIYNALTDIPGITAVKPKAAFYMFPKIDTKKFNIVNDEKFALDLLKEKKILLVHGGGFNWHQPDPFRVVYLPRIEVLKEAAGKIRDFLEYYQQEI
>KF630095.1_11961|FEATURES|farme|fosfomycin|FosA2|antibiotic inactivation|0
MSPIEKSSKLENVCYDIRGPVLKEAKRLEEEGNKVLKLNIGNPAPFGFDAPDEILVDVIRNLPTAQGYCDSKGLYSARKAIMQHYQARGMRDVTVEDIYIGNGVSELIVQAMQALLNSGDEM
>KF630068.1_12023|FEATURES|farme|tetracycline|tetC|antibiotic inactivation|0
MTGGRYIMEKKNIDWGSIGFGYIPTDYRYVANFKDGKWDEGQLTTDPNVTLNECACVFQYAQTVFEGMKAYTTEDGHIVTFRPDLNAERLANSARRLEMPVFPEDRFVEAVVQTIKANEAYVPPYGSGATLYVRPYMFGSNPVIGVKPADEYQFRILTTPVGPYFKGGATGASRG
>KF630051.1_12064|FEATURES|farme|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|0
PETLGETIPDFHNMEFRLKQLRDAVAANAAGRVAEEQYYLDEIEKRADEMCKAERLFREGKLPKRVCHRDTKVNNMMFDEDGKVLCVIDLDTVMPSFIFSDYGDFLRTGANTGDEDDKDLDRVNFNMEIFKAFTKGYLKGAKSFLTPIEIENLPYAAALFPYMQCVRSLADYINGDTYYKIKYPEHNLVRTKAQFKLLQSVEEHTPEMVAFINECLVNG
>KF630010.1_12172|FEATURES|farme|beta_lactam|YBT1518_18690|antibiotic inactivation|0
VYRKTLSFRKTDISNSNVIIMEDKKTQLTNEAGIPVGDNQNSRTTGPRGPELLENVWLLEKLAHFNRERIPERIVHAKGCGAFGTFTVTNDITRYTKAAMLA
>KF629983.1_12248|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKSRSLLSKAVVSSLLLFQVLSVSASDLTSDIQEVIKGKKAQVGVAVLYKDDAFTANNDDQYPLMSVFKFHIALAVLKKMEKEGIPLTAVVTLGPSDIDTKTWSPMYKKYKSKKITLSYGDLINYMVSQSDNNACNWLINFVGGIQNVNDFIKNLGIDRIQLIETEKSMEQDIRKSYNNWSTPLSVTQLLRKVYTEKVLSDEHFAFLGRAMLASASGKDKFRAGLPKEVEVGHKTGMSYRTPEGIRICDADVGVIYMPGGEKCYLAVLVKDSKESDAANAKIMADIAKKVYSHYTENAGKNSAAAK
>KF629962.1_12308|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MFSKLFFCLIFLTALTPLYSQEPLAQQLKSIIENKKATVGIAVLYNGKILVTVNDKAGYPMMSTFKFPLALAVLERLDKQGLPLETELFISKPDLHPDTYSPLREARPEGNFKITIGELLKYSVALSDNNACDILIDYLGGTSALQKYVRRQGIKQMKITATEDRMHKSGDPYLNHTRPSSAVRLLEKFIQQELLSPVYQKFLENTMIATSTGSDKLKGLLPAETIIGHKTGSSDRDSTGMKAGDNDMGFVYLPHGGDHYTIAVFITDSMEDDKTNAAIIAQISKAVYDYINEISS
>KF629944.1_12362|FEATURES|farme|beta_lactam|blaR1|antibiotic inactivation|1
MKKHIIGTLFALVLLASVARASETVERTDLADIFQGFDGTFIMYDEGADRYTVFNKALSETRLPPCSTFKVFHALIGLDSGVLDRDDARTLMKWNGKPSSIAAWNHDQTLASAMRHSVVWYFQRVATGIGEERMQRGLDRIGYGNRDISGGLTRFWLQSSLKISPREQVGLLRALFNGSLPFAAEDIAVVKRDITLSSGKGLRFMGKTGSGSDDADRGIIGWFVGGVETPHNRWSFAVNIQGPDASGVRARGIAEAALERLSILP
>KF629898.1_12504|FEATURES|farme|peptide|EdeQ|antibiotic inactivation|0
MEKLMTQSFPSEEYRELEELRKYTDTKTHFYNNIIFHNNTPVGLITYWDFGHFYYIEHFAIDPAQRNGGYGKSVLNHLCQLLKHPIVLEVEIPEEEMAKRRINFYQRQGFSLWEKPYQQPPYKTGDNYLPMLIM
>KF629893.1_12522|FEATURES|farme|beta_lactam|BL3_l|antibiotic inactivation|0
MKLQFIGANHEVTGSCHYLQAGDSYMLVDYGMEQGVNQFENCPLPVPESQINFVFLTHAHIDHSGMLPLLYAHGFRGKIYTTEATADLCSIMLRDCAHIQQQEAEWKSRKAKRHAGIEVEEPLYTMEDAIGTINCIVPCPYGKELEINDNVTIRFTDVGHLLGSASIEVWLKEEGCSRKLVFSGDIGNKNQPLIKDPEYTKTADYVVMESTYGDRLHGSTRPDYVRELTQIIQETLDKGGNVVIPSFAVGRTQEMLYFIRKIKADGLVSNHADFPVYVDSPLAVEATGIFKQNERTCFDEEAMELVRQGINPITFPGLRLAITSDESKAINFDETPKVIISASGMCDAGRVRHHLKHNLWRPECTILFVGYQSVGTPGRALIDGVKEMRLFGETVDVNAQIRVLTGISGHADKNGLIDWIEGFESKPKKVFIVHGEDLVTMSFADCLKDEHGLDAFAPYSGTVFNLTTETFEKITEPVAVKKKTAAASGGQSSAYNRLVAAGQRLMALIGHCKGMANKDLAKFADQINSLCDKWN
>KF629871.1_12591|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MFKIIDRNNWKRNPYFDHYFDKIPCTYSITVNIDISRVIRFKTEQNTKLYPLLVYALSKAVNCYDEFRTDINENGEVGVWETLHPCYTVFHKESETFSNIWTEWDKDLNTFLSNYNRDIELYGNNTAIDAKPQAPKNVFPISSLPWTTFTGFNLNIKPDTGYLLPIFTFGKYFKQEDKFYIPLSIQVHHAVCDGFHVSRLVNTIQKICTEI
>KF629854.1_12631|FEATURES|farme|chloramphenicol|catQ|antibiotic inactivation|1
MKFNLIDIEDWNRKPYFEHYLNAVRCTYSMTANLEITSLLREIKLKGLKLYPTLIYIITTVVNRHKEFRTSFDQNGKLGYWDSMNPSYTIFHKDNETFSSIWTEYDENFPRFYYNYLEDIRNYSDVMNFMPKAGQPANTINVSSIPWVNFTGFNLNIYNDATYLIPIFTMGKYFQQDNKILLPMSVQVHHAVCDGYHTSRFFNEVQELVSNFETWLGEK
>KF629840.1_12671|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQAEYSSTRDKLSWIFSAMQWKPANGISPR
>ACN58929.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MNWHAVWSIYYFEMARAWRTLSQTIVSPVISTSLYFVVFGAAIGSRITEIEGVSYGSFIVPGLIMLSLLTQSIANASFGIYFPRFTGTIYEILSAPVSYVEVLLGYVGAAASKSIILGFIILATAALFVPVHIAHPFWMIAFLVLTAITFSLLGFILGMWADGFERLQIVPLLIITPLTFLGGTFYSINMLPPFWQKVTLANPVVYLVSGFRWSFYEISDVSVSLSLAMVAAFLAVFLGIIGWIFKTGYRLKT
>ACN58930.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MQPILSVSNLSKTYKSGLQALKAINLEIQKGEIFALLGPNGAGKTTLISIICGIVNPSGGKVSVAGHDIIAEYRAARVQIGLVPQELTLSIFETVQDTVNFSRGLFGKKPDPVYIEKMLKELALWEKKDTTIRALSGGMKRRVLIAKALSHQPQILFLDEPTAGVDVELRKQMWNIVRHLRETGVTVILTTHYIDEAEEMADRIGVINRGEIILVEDKRELMHKLGKKQLTLDLQEPLAAIPTSLAAYQLERTKDGNELVYTYDTQATRTGITALLKDLGDAGIRFKDLHTKQSSLEEIFVSLVKHK
>ACN58864.1|FEATURES|farme|multidrug|mexE|antibiotic efflux|1
MNILAALASSRWFKLSLLFALLAGCGKHEEGAPQGGPPAVSVAPAVKRDVKEFDEFTARLEAPDTVDIRSRVAGTLMQVHFREGQMVHKGDPLFTIDPRPFAAEAARVEAQLVAARTSGELSKTELARAEKLVAVRGVSQQELDQLKAALANANSNVKAYEAALVQARLNLEFTRIVAPVTGRTSRANVTAGNLVNIGDPVLTTVVSNDRMYAYFDASEAIYLKYMRSARDGSRPSSRDVPNAVRLGLANEEGFPHEGHMDFVDNRLNPATASMRGRAVFDNKDGLYTPGLFARIQLVGSGSYAATLVSDRAITTDQTRKVVLVVGKNNIVEQREIKPGALIGGMRVVTGINAGELVIVDGLLRAFPGAPVAPQVLKVDEQGLPIPAPPPGAAPVAKG
>ACN58871.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MADYLLEMKNIVKEFGGVRALNGIDIKLKAGECAGLCGENGAGKSTLMKVLSAVYPHGTWDGEILWDGKPLRAQSIRETEAAGIVIIHQELMLVPELSVAENIFLGNEIKLPGGRMDYAAMNRRAEELLAELDIRDVNVVLPVKQYGGGYQQLIEIAKALNKNARLLILDEPSSSLTASEIKVLLRIIHSLKAKGVTCVYISHKLDEVADICDTIVVIRDGQHIATTPMADMNIERIIAQMVGREMNQLYPERSHVPGEVIFEARNVSCYDADNPQRKRVDNISFKLRKGEILGIAGLVGAGRTELVSALFGAYPGPSEAEVWLNGVKLDTRTPLKAIRAGLAMVPEDRKQHGIVPDLGVGHNMTLAVLNDFVRATRIDQQAELATIHKEIKSVKLKTATPFLPITSLSGGNQQKAVLSKMLLTKPKILILDEPTRGVDVGAKFEIYQLMFDLAAQGMSIIMVSSELAEVLGISDRVLVVGEGKLRGDFVNDNLSQETVLAAALDHTQPALH
>ACN58788.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MQPILSVSGVSKTYKSGLQALKNIDLEIKPGEIFALLGPNGAGKTTLISVICGIVNATAGKISVAGHDIVTDFRAARSLIGLVPQELTLGMFETVLDTVGFSRGLFGKKANPAYLEKMLKDLSLWDKKDTTIRALSGGMKRRVLIAKALSHEPQVLFLDEPTAGVDVELRRHMWNIVRRLRESGVTIILTTHYIDEAEEMADRIGVINRGEIILVEDKKELMHKLGKKQLTLDLQEPLDAIPASLAAYGLERIKDGNVLVYTYDTQASRTGITALLKDLGEAGIRFKDLHTKQSSLEDIFVNLVKHP
>ACN58991.1|FEATURES|NCBI|multidrug|cmeB|antibiotic efflux|1
MKNDRGEMVPFSAFMTIKKKQGANEINRYNMYNTAAIRGGPATGYSSGEAIKAVQEVAAKNLPNGFDIDWAALSYDETRRGNEAVYIFLIVLAFVYLVLAAQYESFIIPLAVVFSLPAGVFGSFLLIKGMGLANDIYAQVGLVMLVGLLGKNAVLIVEFAVQKQQQGATVFEAAIEGARVRFRPILMTSFAFIAGLIPLVFAHGAGAIGNKTIGSSALGGMFFGTVFGVIVVPGLYYVFGSWAEGRKLIRGEDHDPLTENLVHQMDNFPQSDDK
>ACN58964.1|FEATURES|farme|quinolone|qacB|antibiotic efflux|0
MRHIDVHKLADEAKFNRFHGGILLWCALIIICDGYDLAVAGIALPSIMKGMGVTAQNAGFMVSSALFGMMFGAIFLGTIADKIGRRKAIAICIGLFSVFTAAAGCTSDPYTFSAMRFLAGLGIGGVMPNVVAQMTEYSPKKIRATMVTLMFSGYAVGGMVAALLGKGLIEAYGWSSVFLAAGLPVLMIPFVLKSLPESMPFLIRENRLDELKAIVTRMEPGYRADRGDRFALPSKDQAGGAPIGKLFQDGRGFSTVMFWVAFFMCLFMVYALSSWLTKLMASAGYSLGSALTFVLVLNFGAVIGAVGGGWLADRFHIKYVLIGMYALAAVSITLLGYKVSTEVLFILVGLAGASTIGTQIVTYAYAGQFYPMAIRSTGIGWASGVGRSGAILAPIVIGTLVGMALPLEQNFMAIAIPAVIAVIAVSLIRHGRSASAFELRAATA
>ACN58844.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQNDKEIVIDIKGLYKSFGNNHVLRGVDLQVERGENVVVLGRSGTGKSVLIKMICGLLTQDKGDIIVLGEDVKNITHKKLEELRLRVGFSFQLSALYDSMTIKENIAFPLKRNFKHLSKKEVNDRVDEMLNAVSLIKSKDQYPAELSGGQKKRIGIARTLVLRPEIMLYDEPTAGLDPISSIEINSLIHNIKEEFNVSSIIITHDLVCAKTTGDRLVMMFDGVVQKQGTFEEVFDSDDERIKSFYEYNFI
>ACN58767.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|0
MQGTTAYAPFRHRAFAVLWGATLLSNIGSWMHDVAAGWLMTTLAATPFMVALVQAATTAPVFLLALPAGALADLMDRRRLLIVVQSTMLVLAAILGVVVLRGAVTPALLLGFTLAIGCCTAVLSPTWQSILPKLVPRADFPPAVALHSVGINVSRAIGPALGGAIIVALGIAWPFFLNAVSFLAVIAALVWWKPPADPPPPAGTQPRPAENYWRAIGSGLAHVRSSFSLRATLARCLLFFFFGSAYWALLPLVAREHLHGGAPLYGLLVACIGVGAVSGALLLPKLRTSIGSDGVVLAGTVGTVLAMTAYALATAPLLGLIASLIAGASWIAALSTLNVAAQLALPDWVRARGMAMFSAVLYGSLAAGSVTWGQIANHAGLSTTLLIAAGGALACLALARKLPLQH
>ACN58777.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MDMLAATAAPDTARDAPDGDDTPLIELQGVTKTYFNGDLSVEVLHGVDLKIYAGELVAIMGASGSGKSTLMNLLGCLDRPTTGTYKFMGHDVSDFDRDELAELRREAFGFVFQSYNLIATGTAAENVEVPAVYAGLLPAERHTRAKELLERLGLSDRAHHRPNQLSGGQQQRVSIARALMNGGRVILADEPTGALDSKSGADVMRLLDELSAQGHTVILITHALEVAQHARRIIEIKDGDIVADPGPSKPAAGELARHWTPRKGKESHLAEGLEAAKTALRALKANVFRSILTLLGIVIGVASVIAMLAIGDGAKQAVIDRISAMGSNLLLVRPGAPNQRGFNGTATLVLADVKAIDEEVPNVLAAVPEQQSNATLRYEGRDYSTQVNGTSAKFPLARQWKVAKGSFFTEDDEEDYATVAVLGRTVADALFPDGEDALGKFVVVNNVIFQVIGVMSVRGASPIGQDQDDVVFVPYATSQLRLSGQRFLRNATVAVNDVTRIDATQSAMESLLAERHGTVDFQVRNMASIMETATETQNTMTILLGSIAAISLLVGGIGVMNIMLVSVTERTREIGIRMATGARTRNILQQFLIESLVVSSMGGAIGVVIGLSVAALIAAFGTPVEYSVGPVLLAFGCAFATGLVFGYLPARKAAYLDPVVALASE
>ACN58741.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|0
MTQPAQGGGAAGGAWAPLRHAEFALLWFAALISNTGSWMHDLAAGWFMTTLDPTPYMVALVQAANTLPVCLLAIPAGTLADRMDKRRLLLLVQVVMLVLAGLLGALVLAGRAGETTLLLATLGIGSCVAVMSPTWQSIIPGLVPKPDLQQAVALHAVGMNISRAIGPAIAGLVIATVGIAWPFLINAASFLAVILALWWWKPRTSAPVVHADSYLSALRIAFTQTRTNQALRHTLWRSVLFFLFGSCYWALLPLVAREQLQGGPKLFGVLVGCIGAGAVMAALGLPSVRARWGLDRLLNVGTLATAAALAGYALLRLPVLGMLTSLLAGAAWLASLSTLNVAAQLAVPDALRARGMALFTAVLYGSLALGSLFWGQVATHLDLTSALLIAAGGLLLALTIARRLPLRA
>ACH58982.1|FEATURES|farme|multidrug|farB|antibiotic efflux|1
MAEARTAPLPPGEYPPLRGIALVLLSIAIGVSSFMEILDMTIVNVSIPAIAGSMGVSPSEGTWAISSYLLAAAVVQPLAGWIGRRFGEVRTFVISNLLFIVFSALCGLATSMPMLIACRLLQGLVSGPMMSVAQALLLRNYPVHLRGLAMGLWAMVVIVAPIMGPILGGWITDNYSWPWLFYINVPVGLGSAAITWFLLRRRETLRVKVPIDAIGLSLLVIGVGALQFMLDNGNEKDWFQSTEIVTAAVIGVVALVFFIPWELTDKHPIVDLALFRRRNFRVGTITLAIAYFAFTGVNIIFPLWLQTAMGYTATWAGLAMAPIGLVAIVMAPIVGRNLHRINLRAAPTIGFMVLAFALLWFSQQNDQASFSQMATPRFVMGIGLALFFLPLNQIIMSGLPSSQIASAAGLSNFLRTFAGSASTAICVFYWNDRSEHHYARLTEHIRPDSPAWIDYQAQLAAQGITGDTAYAATSQVLSVQSMTMGANDIFLMIAVMFIVLIPVIWFAKGPFRAVGTGSSH
>ACS83748.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MPPSHHMLRPIEQCSILWNDVRYSNSVRLKEAGMTATTQASAPAARTYLSLRAAWIPLFALCLAFFVEMVDNTLLTIALPTIGRDLGASVTSLQWVTGAYSLTFGGLLLTAGSLADRFGRRRVLQIGLLAFGLISLTVIAVATAGQLIAVRAALGLAAAAMAPITNSLVFRLFEGEDLRRRAMTLMIVVGMSGFILGPLLGGTVLAHASWQWLLLINAPIALIALIGVRLGVPADDAEGLTKDRLDVKGSALSIAAIGLACYTLTSGVEHGWMSAVTWACGIGAAAALMGFVWHERRTDHPMLDLDVFRNRTVRGASIAQVGTSIAMASLMFGLILHFQGAYGWSPMRAGLANLPLILTMILATPVSEGLAKRFGHRIAMLIGAGLLAGSLAGLAWGVGHGYLVIAVFMVTFTLGLRTVMTIAAVGLVGAMPENRTSLGAALNDTAQEVGTSLGMAVIGTLIAVLXTTTLPNGDXSLDLATSYFAGERIAYLFLAVVVGVIAGWGALTLSNSKEMEDVH
>ACS83695.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MKITVDNIGKKFVREWIVRGATFDLEPGSKYTFVGPNGSGKSTLLQLLTGMLPVSEGSIVYTSTDGTPVGVDDWYKHLVIAAPYLELIEEFTLRELVNFHSEFKKLKNGMNAADFEDFIELAHVKNKIIRHFSSGMKQRVKLGLAFMSDVPLIFLDEPTTNLDSTGINWYLKNVIENTKGQMILLGSNVKQEYEFCENIISVSAFK
>BAG82729.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
MGAESDLLALYMAQTYLGSILTSLSLVLMRGRRTKTFAVWCWMAARSLFLVFAFVSEVYWVMVVMAFFWLLEAFPNPAYTRIIQAIYPAGVRGKALSLVRLGMTGAILLTTPFAGWMLDHWGFRVIFPVAALLGMLSTWQFNRLDVEEGTLPPRETRSVTSLVGLVRSNRNFAIHLLSFTFFGLGGLIGVAFYPIVQVDRLGLSYTTIGLLGMAQSVTWLLGFVYWGRAVDRLGGVWVMRVNLAIGVLVPFSYIWAENAWMLLPAFIAQGIISAGIDLGLINTTIQLAEPEKLVEYAAVQATVIGIRGMIGPFIGVALVNLGVEQSVIFALGAGLTAVAWWVSGYIQLPLSPEEMRAKRERLRFRWPLRFRHPRV
>ACT97620.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MSTNLSVIKNPRVQSDQRRLVRRPDVKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR
>ACT97454.1|FEATURES|farme|multidrug|cmeB|antibiotic efflux|0
MTSLAFVLGVMPLLFATGAGAGSRVALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFGKNKGK
>ADI87846.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MEKNQHISLHKVSTNNLKQIDVTIPLNQLTVVTGVSGSGKSSLVFDTLYAEAYRRFVDSLSSYARQYLKTLPKPDLQSVSNLPPAVAVKQGRSPANQRSTVGTLTELTHLIQTLFMHLGKIQCYKCGRPVQKDHARSIVDNLLQDISTDTQLAIMAPLKGWSGLKGSALKKQLQEQGFVRVSLDSEIFSLEDIDLKKIHSSNVIIDRLKCKPDEKTRLTEAVELALKVGRGLCLVGLPKEELRFSNALECTHCRINYLPASMVLFSFNHPLGACDSCHGYGRIANLDWDKVIPDKNSSIAQDGIAPLNFGSHAEYYSEIKKSAKKLRIDLKKAFHQYTEREWQWLREGSGADFGGMKAYFEWLNSKKYKAHYRIHAAKYNKYEICPSCNGRRYCRDALVYKIEGKNISDVHEMAIKDFKTWLSVFNNAQEASKSSPEPIAGLSEALEEIESRIRYLVKVGLSYLNLNRVSGTLSGGELQRIHMASCIGSSLTDTMYCLDEPTAGLHARDSQNLLDVICELRDQGNTVVIVEHDKQIMNGSDFLIEIGPGSGHLGGHISYEGKAKSRSSAMPYPERPARKFGSYLKLEGAKTHNLKNIGVEFPMGGLSVVCGVSGSGKTSLIQHTLFPMLESALGNRPMETIPAKSIGPKSVLDKIAQVLFIDQKTLARSSRSNIATYLGIFEAIRKLFSSQERAKELKLGPGSFSFNVPGGRCETCKGLGTVIEDLSFLGEVQVTCPQCEGKRFSSQVLSVTVRGQNLLQILSLTVHQAFELFYDHGEIRDVLKPIIDLGLGYLTLGQSTNSFSGGEAQRLKLLSLLKETHSKSKSMLLIFDEPTTGLSDKDVYNLWKHLDFLTQKGHTVIVIEHHLDMIRHADWLIEIGPDAADLGGQVVYQGSPGGIFSAPLSKTAPFLKS
>ADI87853.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKKFVLFCERNGIALIPIVLILLGCGLWPEMELLVPSLPDMQRAFNIQDAQIQQLLTANFVGFLIGVLFAGPLCDSAGRRTVMMIGTIGYLVSSVLCPFCNDFVLLMIARFFQGLFMTGPVIAGGVLLMEATEGVKQIFWMSIGNAAITFCMAAGPIVGSWINTGFGYVGNLWSILILGLIGCLPALFLVPESLPVEKRAAFHPKLLFKGYFALLKDFRFMCLAIPMCALAAAYWIYVGVSALYMVNQLGIAQEMFGRYQGPIVGCFSIISLGSSKLLQRFGLMKCLRAGIVSMFTGMLLLLGMSILSLDHAVATTVFMMFFVGGMAPICSMLFPYALGHLPVDLKGNAQAMVQAIRLFFASIGTSLVGVFYKSAFLPVALIMFAILLFSCYFLWKGRRYLKEGLGADHILSVGH
>CBI71192.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MNPTILRAALVLGLLSAIGPFAIDMYLPALPAIGASLGADTAGVQASLMAFMAAIAVCQLFYGPVSDMVGRKPPLYFGLALFTAGGIACALAPSIEWLVVARFVQGIGACAAMALPRAIVRDGYTGADAAQLQSLLMLVFSVSPILAPLGGSLIVQFGDWRVIFYAVAGIGLLGILLVAFFLKETRPASARLESSVGSAIKGYGVLLRDRNFLGLSMIGAFGMASFMAYLANSSFILIDHYGLNPTQYSIMFSINAVSFIGVSQLTGVLTRRYGLNAVVRTAVNGFILVMVALAAVFALGVDRLDVLAALLFVGYGFLGLVIPTTAVLALEEHGAIAGTASALMGTLQLVTAAVVMGIVGSFFDGTARPMVLGIAACAIVAFALTRLTIKRSRAPLAAAAE
>ACI02017.1|FEATURES|farme|tetracycline|tetC|antibiotic efflux|1
MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCAPVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYIADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFLMQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDRFRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVCLAFATRGWMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSIIGPLIFTAIYAASASTWNGLAWIVGAALYLVCLPALRRGAWSRATST
>ACI02048.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MDTANENKMGIMPVGKLLITMSLPMMISMVVQALYNIVDSVFVSRVSEDALTAVSMAFPLQALCIALGAGMGVGVNALLSKSLGAKDNDMVNKSALNGLFMTFVSYLVLLVIGIFAVKPFYMIQTDSADIIQYGTDYLSVICCFSFGMFFQFTFERLLQSTGRTFQTMITQTVGAVTNIILDPIFIFGYFGVPAFGVKGAAIATVIGQIIAAILALIMNIKVNTDIDFSLKGFKPDIKIIGMIYKVGLPSIIMQSIGSVMVFCLNKILIVFSSTAVAVFGVYFKLQSFVFMPVFGLNNGLIPIMAYNYGAKKKDRMIKTIKCGLLIAFSIMSVGMVVFELFPDAILALFEASDNMLAMGKVALRTIAIHFPIAAICIVLGSAFQALGNAVYSMFVSIARQLVVLIPVAYALSKLGNVNYVWWCFPIAEIMSLTITVIFFIKLKREVIDKI
>AGC09627.1|FEATURES|farme|multidrug|mdtc|antibiotic efflux|1
MAAAHSGSAQRSVDDGGWVGIFVRRPILALVLNLLIIIAGIAAYQGIEVRELPDVDRPVVTVRATYAGATPESIDSQITAVLESAVSRVQGVTSISSNSSYGSARISIEFSSSTNLDTAAMDVRDAVAGVVNQLPKDMEDEPRVVKADADATPIMQMSVSAEKLSEGELTDLVTNVIEDKLAAVEGVAAANSYGLRAKTIEVRVNQTALASRGISLADLIAAIGKASVTAPSGALENATQQLLVRAEAPVATPEDVADLEINPQTKVKDVAFVRWGFQEATAMTRLDGKTAIGIDIIRQAQANTIDISEGVHQAVDELRRTLPAGV
>AGW01015.1|FEATURES|farme|multidrug|MdtL|antibiotic efflux|1
MPLILLLVLLVLFSPLAIDIYLPAIPQMAEQLGAEVTLMQGTITWFLFSMGLGQLLVGPLADRYGRKPIALGGVLLYGLSALAAGFAASLGELMLARVLQGFGACATSVAAFSVVRDSYGPKKSGQMISYLNGAICFIPALAPLLGGWLTAKAGWSANFWFMAGYAAIVGSWLLWRMPETRPGETSSSGPLISWSRYSPVLRSPSFLFNACLCMLAMAVILAYVTAAPVQLMVKLGLDMSGFSYWFTANAALNILACFLAPRFIARVGPRRTLRIGLLVITLSAMALTLVQHIDHPLAMMGPVFFSSIGFAMVLGAAAGMALAPFGHCAGTAAALLGLFQMSGSGALVGITGWLMPDPLNQLALHMWLLLPPLLLLLTRQGRRLCLQ
>AIA18796.1|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
MTVEVSGLGKRYGDQWALRDLDLSVPKGTILGLLGHNGAGKTTTIRILTTLSEPTEGTASVAGFDVAKHPGDVRRRIGVAAQQQTVDGLLSARLNLEMVGRLNGFTKKEARARAEQLLVQFDLVESTNKLAKALSGGMRRRLDLAASLITRPEVLFLDEPTTGLDPRSRNDLWAMLRDIVRDGSTIILTTQYLEEADRLADDVVVLDHGRTVAHGTPLELKQQIGNDRIDIKVRSEEELSQVQKVGASFATNAISADVDLLVATVPVAADARLIDIVRLLDENGIDAVDINRRQASLDDVFLSLTTPKGMTR
>AIA16595.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSSSYLRNAVVLGLLSAIGPFAIDMYLPALPSISTDLGTTTAATQMTLMAFFIAFGLCQIVYGPVADMIGRKPPLYFGLSVFALGGIGCGLAPTVEWLIFFRFVQGIGAAAGMVIPRAIIRDLHTGVEATRLMSLVMLVFSVSPILAPLTGSGLIAAFSWRAVFVAVTIAALLGIVLLALLLPETRPVAARIRSGLGSVLAGYGGLIRDLRFLGLTFIGGLGMASFFAFLASSSFIYIDHFGLTPTEYAFAFSVNAVGFIGASQFSASLATRFGISRVVSAAVSCYAATAVLLFVVTLAGVDSLPVLMAMLFFAFACLGLVIPSTMVLALEEHGSIAGMASALGGTLQFLTGALMIVVSSAFFDGTSFAMVATIVICAIGAFTLSRLTLGGRREAEAQPEPAE
>AIA15168.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MFRLFEDKALRMRAMTVMIVVGMSGFVLGPVLGGSVLTHVRWEWLLVVNAPIALIACVGVRLGVPADRPEDLTDDVLDLPGALLSVTTIGLACYSLTSGVEHGWLSALTLASIVGAVLAAVAFVRHERRSASPMLDLGVFSDGIVRGASIAQIGTSIAMASVMFGLILHFQYAYGWSPMRAGLATLPIIVTMIAATPLSEWLAQRFGHRIACLVGAGFLGGSLAGLSWGVDHGYLAIAVCMVAMTIGLRTVMTICAVALVDAMPSNRTSLGAALNDTAQEVGTSVGTAVVGTLIAALVTTRLPAGVWSSELVASFFHGERITYAVLAVVVGLVAAGGALTLTDSRAVEEHPEP
>AIA14791.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MSSRSARPASSSPCAPHSAWPWLLVVNAPIALIAFIGVRLGVPADRPEDLTNDKLDLPGAVLSIITIGLACYAATSGVEHGWLSPITLASIVGAVAAGIAFVRHERRTASPMLDLDLFSNGTVRGAAIAQIATSIAMASVMFGLILHFQYAYGWSPVRAGLANLPLIVTMIAAMPVSEWLAKRFGHRVACLVGAALLAGSLGGMAWGVSHGYLAIAVCMVVMTVGLRTVMTICAVALVSAMPDNRTSIGAALNDTAQEVGTSVGTAVVGTMIALLVTTRLPAGTWSTDLVASFFHGERITYAVLAVVVGVIAAYGALSLTDSHAVEEPA
>AIA14672.1|FEATURES|farme|puromycin|pur8|antibiotic efflux|1
MSVETGVVPAAEIVSGSEVVNRERSASLAQTIGLIVLLAWQLMVVLDGTIVNIALADIRQSLGFSQTSLSWVVNAYALAFGGLLMLGSRAGDMFGRRRLLVVGVLVFTVASALGGIASNQEMLIIARVLQGVGAAMAAPSTLSLIVTNFEAGSPRNRALSLFASVSGVGASMGLILGGVLTSGLSWHWIFFVNVPIGIAV
>AIA14412.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|1
METTTTSEARGYRYRWYVLAVVLIADVMDLLDATVANLAGPSIRAELGGSESTLQWILASYTLTFAIGLIISARLGDLIGRKQMFVVGMAGFTLASLLCGLAPTPGLLIAARVLQGLLGAVMIPQGFAMVKQAFHPDDLQKAFIPFGPIMALSAVAGPILAGVLIDGDLFGTGWRMIFLINVPIGLVGAYLSWRYLPDIERDSSARLDVSGSLILALASGLLVYPLVQGRELDWPLWTFGMIAAALVLFVVFARHERRSAHPVIEPSLFGHRGYVAGLFFLGVFFVAMTGFSLVSNLFIQIGLGYSPFDTGLAQTPLALGMALGAVVSGAVLGPRLGRHVLHLGLAVAALGLAWLALVVGRGTGIDGWDLAPALFLSGFGVGLIFAPLFDIILADLGDREVGSGSGLLNAVQQFAGAFGVAVLGTLLFGWVPDAGWFVATQHLIWVCVGCYAAAFVAVFALPMRARGDAVV
>AIA13712.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|1
METVTERGYRYRWYVMAVVIIADVMDLLDATVANLAGPSIRAELGGGESTLQWILASYTLTFAIGLVISARLGDIVGRKQMFIIGMAGFTIASLLCGIAPTPGLLIAARVLQGLLGAVMIPQGLAMVKQSFHPDDLQKAFIPFGPIMALSAVAGPILAGVLIDGDLFGTGWRMIFLINVPIGLAGAYLSWRYLPDVERDPAARLDLPGSLILAVASGLLVYPLVQGRELDWPAWIFGMIAASVVLFVVFARHERRSSFPVLEPSLFKHRGFVAGLVFLGLFFVAMTGFSLASNLFIQIGLGYSPFDTGLAQTPMAFGMALGAVVSGALLGPKLGRHVLHLGLAVAALGLAWLGVVIGGGAGIDGWDLAPALFLSGFGVGLIFAPLFDIILADLGDREVGSGSGLLNAVQQFTGALGVAVLGTLLFGWVPDAGWFVATQHLIWVCVGCYAAAFAAVFALPMRAREDVLV
>AIA13140.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MQARFVRNAVVLGLLSAIGPFAIDMYLPALPTIGKSLNADIGAVQLSLMLFFVSFGAFQLVFGPISDMYGRKLPLYAGLVLFAIGGVGCAFAPDIATLNTFRFIQGIGACAGMVIPRAVVRDLHTGIDAARMMSLLMLVFSISPILAPLTGSLIITLADWRAVFWVVTIAAILGLAMVATLLPETRPKALRVASGVRSALEGYRLLLRDRNFLALSLIGGFGIASFFVYLANSPFVLIEHFGVTPVLFSVFFSINAVSFFAAAQFTGTLASRFGLRRVVRIAVIGYFTALAVLFALTAAGVERLDVLATCLFIGYGFLGLVIPTTAVLAMEDHGEIAGTASALMGTLHFVTGALAVAAVGLVADGTVLPMVGGIAACALATFILAQITLRQGQAVEVPAE
>AIA13097.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MAKHAISVKNLYKSFGKVEVLKGVTFNVEPGTILALLGPNGAGKTTTVRILSTLLKADKGDVNVSGYDVRKDADKVRTVIGLTGQSAAIDELLTGRENLVMMGRLYRLTKNSAVERADELLEEFDLVKAADRPAKTYSGGMRRRLDLAVSLIATPPVIFLDEPTTGLDPRSRMAMWEIIKNLVAKGTTILLTTQYLEEADQLADQIVVIDNGVVIAQGTATELKSKIGNDRLELTFRNEKTLNEAKKALGKSVIDDGDKELTAVVLIKDTNSDVRNTLDVLSKNKISIASMDIRKPTLDDVFLSLTGKQKKSEDSEEEK
>AIA19161.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MFYYRTRFDQRTSFDTPGATAMTTLPATGARTYPSLRAAWIPLAALCLAFFVEMVDNTLLTVALPTIARDLHSDTTSLQWVTSAYSLTFGGLLLTAGSIADRFGRKRVLLYGLAAFGIISLGVAMVSSSGELIALRAALGLAAAAMAPITNSLVFRLFDSPTLRMRAMTVMIVVGMSGFVLGPVLGGTVLAHFQWQWLL
>AIA19111.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MFDNRTPFEAEEEAMTTTNPATAPRTYPSLRAAWIPLAALCLAFFVEMVDNTLLTIALPTIGRDLGGSTTALQWVTGAYSLTFGGLLLTAGSTADRLGRRRVLLVGLAAFGVISLGVVAVTTSGELIALRALLGIAAAAMAPITNSLVFRLFDEQVLRMRAMTVMIVVGMSGFVLGPLLGGTALAHVSWEWLLLVNAPIAVLACIGVRLGVPADRPEDLTQDRLDLPGAGLSIATIGLACFALTSGVQHGWLSATTIASALGSVLALIAFIRHERRTASPMLDLTLFSRGTVRGAAMAQVGTSIAMAGVMFGLILHFQYAWGWSPMRAGLANLPLIITMIAATPLSEWLARRFGHRVACLIGSACLVASLVGLAWGVEHGYLAIAVCMVVMTIGLRTVMTICAVALVEAMPANRTSIGTALNDTAQEVGTSVGTAVVGTMVAVLVTKVLPSGTWGADLLETFFRGERITYLVLALIVGVVATWGASTLTNSRAVDEHGTEPRSAEEATEELVTSADPAR
>AIA18885.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSADDDRQATPPSGSKVPEDSEQATAEPGDQPRDGDDVPTPWELKEQERAEAAGDDGDSDAAVTWESPPGAHDDEEYKWHTAKRTRSETAETDAVEFIDVKKAFGRNTVLNGLNLGIPEGQISMILGPSGTGKSVCIKHMVGLLYPDEGDVLVHGESVPNMRDDDLFEMRKKFGVLFQDGALFGSLNLLDHVAFPLRQHTDKGEDEIMEIVTRRLKEVGLGGAGDKMPNELSGGMRKRAGFARALVLDPQIVLFDEPDSGLDPVRTALLCELIKEIHEENGGAYVVITHDIMSARRVAEYIAILWKGRIVESGPASELFNSDNQFVRQFLSGEARGPLGME
>AIA18361.1|FEATURES|farme|multidrug|mdtG|antibiotic efflux|0
MKKHYIEHWDAEDVDAWEAGGKDIAKRNLIWSVVAEHVGFSVWSIWSVMVLFMPTDIYGIDAAGKFFLVAVPTLVGSILRIPYTVATARFGGRNWTVFSALVLLVPTLFTLYLMMNPGASYTTFILVAALAGVGGGNFASSMTNINAFYPQRLKGWALGLNAGGGNIGVPMIQVIGLLVIATLGNTEPWIVCAVYLVFIAVAAVGAALFMDNLGNQKSDLRSMAKALKFSDSWVISFLYIGTFGSFIGFSFAFGQVLQINFLAGGATPAAAALHAAQIAFIGPLLGSIARPMGGKLADRIGGGKITLYTFVAMALAAAVLVTAGTIDDGTPGAATAGVLVAFVFGFITLILLAGIGNGSVYKMIPSIFEAKAQGLEGLSRDAKAAWSRAMS
>AIA18362.1|FEATURES|farme|tetracycline|tetZ|antibiotic efflux|0
MISLVTLLRGRLLVFCAIAMSALVLRLAVTSFTPLASQIREDIGFSPTVVGVFGMVPTAMFALFGLGTPLIAKRWGLERTALVAMLMAAVGMLTRALMSDTWSLLALSALALAGMGIGNVVIPPLVKRYFSDRLAVMSSVYIVGVQLGTIAPAFVAVPLAEAFGWRFSIGVWALLGFAAAVPWIFLLARERRRAVVVTAQPPADVPAERPHGKAWRSPVGWGMAGMFGMTSMITYSMFTWIPDILSDAGASEAFGGAMVGLFSFMGLVAAFGAPTLCARMRNPFPIVIGCAVCYLVSFSGLLLAPMSAPILWIVLLGLGPSTFPMSLTLINLRTRSHLGSATLSGFTQGVGYAVACLGPLLFGVFHDASGGWTLSFGFLTCGVVILLIAAFQACKPRMLEDSWHVDSEPQDALRHV
>AIA17532.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MTSLNPSPSTRGTQRAWVMLVVLTMLTVIGMTVVLPVLPFVILRYVGNENDLAIWVGVLEAINGLCAFLVAPFLGRLSDRFGRRPVIIVAAFGAAFAMTLFGIGGAIWVLVLARAIQGVTAGDLPALFAYLADITPPEERAKRFGILGALSGIGMMVGPAVGGLLAAVSLELPVFLTAGISLLVAVLSIFLLPESLKPENRISTISMRDVQPFAVFKAAFGRKELRGLLIGFGLLALSFGFFVNNFSVLALDSITWGPTEIGLMTASIGIIDILIQGVLLGILLPRIGERGVIISGIVGQAIGLVALALVASVLAQPWVFIVGALMLAAGQGAAQAAMDGA
>AIA16277.1|FEATURES|farme|multidrug|mexV|antibiotic efflux|0
MSRAPSFVVLAASLAAGACGANATGTRAAAEPAAVSVSAVTVAEQPITRFIRVSGTLTAQEDAQVAAEIAGRVVATPVERGTLVNEGDNLIRISADEVEAQAHEAQANAAQIEARLGLTGGIAFDAERVPEVANAKAASALARIDFGRAEKLHAGKLLSQSEFDQRAAQLDAAERQYDVAKNGAAQQYQALLGARARVALAQKAVADTVVKAPFAGAVGERFVSVGDYVTRGMKVATVMRINPLRVELTVPEQYVSAVAPGRAVSFDVDAYPGESFSGQVRYVSPSVTAATRALMLEAVVPNPNGRLKPGFFAVARIEEAGKQSAILAPAAAVRTTAGTARVFVLSGDRAEERIVTTGQAVGDQLGRY
>AIA15648.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MTSPINSIKSANRAWIMLIVLTMLTVIGMTVVLPVLPFVVLQYVSEEKDLAIWVGVLEAVNGLCAFLVAPFLGRLSDRFGRRPVIIAAAFGAAFAMALFGIGGALWILVLARVIQGLTAGDLPALFAYLADITPPEKRAQRFGLLGALSGIGMMIGPAIGGLLAAISIQLPVFLTAAVGLTIAILSIFLLPESLKPENRITAIRLRDVQPFGVFKNAFGRKELRGLMIAFGLLALPFGFFVNNFSVLALDSVQWGPTQIGLLTAAVGIIDILIQGVLLGILLPRIGERGVIVSGIIAQMIGLLGLAVVASVFAQPWVFIVGALMLAAGQGASTAAMDGAMSNAVGDDEQGWLGGATQSLNAAMGTVAPLIAGALYVTVSHAAPYWLGAALMVVAAIVVGRAHIANTAKKQPADADAPAEQVAVAG
>AIA15446.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTPTTTSPIRTYSSLRAAWIPLTALCLAFFVEMVDNTLLTIALPTIGRDLGSGTTGLQWVTGAYSLTFGGLLLTAGSAADRLGRRRVLLVGLAAFGLISLCVVAVSTVGELIGLRALLGVTAAAMAPITNSLVFRLFDDQALRMRAMTVMIVVGMSGFILGPLLGGTALAHVRWEWLLVVNAPIALIAFIGVRLGVPADHPDDLTHDALDLPGALLSIAAIGLACFSLTSGVEHGWLSALTLASILGAVAAGIVFVRHERRTASPMLDLALFSNGTVRGAAIAQIATSIAMAAVMFGLILHFQYAYGWSPVRAGLANLPLIVTMILATPVSEWLARRFGHRIACLVGAGFLAGALAGLAWGVSHGYLAIAIAMVVMTVGLRTVMTICAVALVSAMPDNRTSIGTALNDTAQEVGSSIGTAVVGTMIAVLVTAQLPAGTWSSELVASFFHGERITYAVLAAAVGLIGVLGARTLTDSRAVEEH
>AIA15297.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
MLAIWVKETLPPEKRIKPDIKAMGDAWRTLFADRAFIGMTFIGAFAITGVFIYLGNSAFVLSQHYGLSPRQYSLAFSANALAFFAATQLNGYLGNKYGMARLPIPAAAGFALTMCILAGLFVAGFDGFWVMACVLFVGFSFIGILLPTIMVLALENHGDIAGTAASLMNTVQMMIGATAIGVSGMLIKGSPTMMIVCIAGLSLATLACTFGTFKKK
>AIA15298.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MHSAHYLRNAILLGLLTAVGPFAVDMYLPALPAIGTSLDAPANTVMLSLTSYFVSFGLFQLLFGSLADVYGRKLPLYGGIALFVLAGIGCALANSIEALIVLRFLQGIGGAAGIIVPRAIVRDMYSGVEEVKMMSMLMLVFSVSPLLAPLAGSFLIQDFGWRAVFWVLTAIGIASPWHAGHLGQGNVAA
>AIA15005.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTTPASPSPQVDQSAPSDASVEPQPIPTGSRVYPSLRAAWIPLAALCLAFFVEMVDNTLLTIALPTIGRDLQGTTTSLQWITGAYSLTFGGLLLTAGSIADRFGRRRVLQVGLAAFGLMSLAVLAVTSTGELIALRAGLGIAAAAMAPITNSLVFRLFDDQALRMRAMTVMIVVGMSGFILGPLIGGTALAHVSWEWLLLANAPIALIAFVGVRFGVAKDRPEDLTADVLDIPGAALTILGIGLACYTLTSGVEHGWTSLPTLLSAAGAVVAIVGFVLRERSAAFPMLDLRLLRNRTVRGATLAQIGTSIAMAGVMFSLILHFQYASGWSPIRAGLANLPFIVTMLAASPLTERLVTRFGRRMACLAGAVALTVGLGWLSWAVDQGYLAIAIGMVVMTIGLRTVMTICAVGLIDAMPSNRTSLGAALNDAAQEVGTSVGTALIGTLIAALVVTALPSGAWSPALVTSYFHGEHVAYLVLTVLVGVVAVLGALTLDDSRSTDEHHEEQAG
>AIA14797.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNASAIIRTENISKAYGKTTVLKNIDLSVMAGEFTAVMGPSGSGKSTLMNVLSTIDRFTGGDVWLEGQSLLALDKKELRRFRKERMGFIFQEYNLLDTLTVKENILLPLSLRKVKAGELNGKLMPIVQALNIADLLDKYPSELSGGQKQRTACARAIITQPAIVFADEPTGALDSRSATQLLEELTSLNRLFGTTLLMVTHDVYAASYCKRVIFLRDGAIVNELYAGEHSQQAFYDRILETQRP
>AIA14798.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MVKESTNKTLIMIGLLLGLVFSELDQTAVSTALPTIIRELHGLSLFGWVAGIYMLAITVFMPIFGKMADLYGRKRIYLGCVALFMVGSILCGLSDSMTQLLIGRCVQGIGAGGLMPLAMIIIGDSFPLEQRAKVQSLIGPMLILPQLIGPTIGGYFVSHINWHWIFLINIPVGLVAALFVAKGLRESVSPEKKQIDWAGAATLVLAILSLLFAPVLIDVKGYAWSSPIIIGLLVLSALFVLLFIRIEARAAEPIIPLSLFRNRSVVVLSIIVFITMLGVMGGMSGMPFFAQIVMGLTPTASGYLSLGFMAGAIPMSIVCGFLITRVAYKYLFIGSFVLPIVGYFLLSRVAVDTTVLYILAAFFILGLGIGVLFGSDNLIVQETVSPEHTGVGVATVQLFQSLGATLGFSIFGSLLSRRIHDGIAGLSDQFPADAADSIMNGGLPSGLASGLVLQIKTVFADAFQEMFLIGAIFAAAAFLACWFMKREVLTPKPEAKAEQAAVIQG
>AIA14563.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTPTTTSAPAHTYPSLRAAWIPLAALCLAFFVEMVDNTLLTIALPTIGRDLGSGTTALQWVTGAYSLTFGGLLLTAGSMADRLGRRRVLLVGLVTFGVLSLCVVTVSTAGELITLRAALGLAAAAMAPITNSLVFRLFEGQALRMRAMTVMIVVGMSGFILGPLIGGTALAHVSWEWLLLANAPIALIAFVGVRFGVAKDRPEDLTADVLDIPGAALTI
>AIA14435.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MNARHDSADWAIEAHGLVKTFGDNRAVDGVDLLVRPGTVYGVLGPNGAGKTTTISMLATLLKPDAGTARIFGHDVMKEAQVVRQLIGVTGQYASVDETLSATENLVIFSRLLGLGRKESRQKADELLEPSGP
>AIA14436.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRGQMWDTIRELVATGSTVLLTTQYLDEADQLADRIAVIDRGRVVAEGTADELKASVGTTSLQLRIEDPEDTEDALTVIERVLGVRGSLSPEAARITAPMADADRVTDLLVTLREAGIHLTEMSVRQPSLDEVFLTITGHDAADQSMPEPEDGAGEKEKVNA
>AIA14437.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MSAIAPSPAAPGRIVPPSERRLKNHTSARETLRNTFTMAYRGLVKIRRTPEQLVDVTVQPIIFTLMFAYLFGGAIAGNVQNYLPLLIPGILVQTVITTSVVTGVQLREDMDKGVFDRFRSLPIARIAPLSGALLADTVRYAIATTITFVVGYIIGYHPAGGFWNVVLAGLLVIACSWAISWIFAFFGVIARTASSVQGISMLVLFPLTFLSNAYVPVKSLPDVLQWFVNINPISHLVTAVRDLANSGTIGADLWISLLGAAIIVAVFAPLTVRAYMRKA
>AIA13723.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MAHIQSDLAVYRTAFYYRTTFDHRTTYEKEAIMNTTTTATTTSRTYPSLRAAWIPMTALCLAFFVEMVDNTLLTIALPTIGRDLGSGTTALQWVTGAYSLTFGGLLLTAGSMADRLGRRRVLLVGLAVFGTLSLAVIAVSTAGELIALRAALGLAAAAMAPITNSLVFRLFDDKALR
>AIA13690.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|1
MAQPAPAPQPVAPAASSAWSPLRHTLFRSVWIATIASNVGTYMQDVGAGWLMTSLSSSPALVALVEAADSIPVMLLAMPAGAMADIVDRRRLLIGTQIYLMIVTAILGVLTLTGAMSAWLLLGFIFVLGLGSAMMMPAWSAIVPDLVPSQELSAAVGLNSVAVNISRAVGPAIAGVLVAAVGPWLVFVLNALSYVGIIAVLMAWKHEHRKSTLPAERFLSAIRMGLRFVMHTRPLQAVLIRGVAFFVFASATWSLFPLVVRNELRRGPEIYGLLLTCIGIGAVSGAILLPRVRARFSRDVLVAGASVLYALAALVLGYSENISLLIVAMLATGVAWIAILAALQVSAQTTLPPWVRARGLAAFVVAFMGGMAFGSILWGQVATRYGIPYALSAAATGMVIAATLTWRFKLGQHELLDFTPAMDIPLPVLAETPETDLPVMVSIRYTVQSDKRAEFVEAMQAVREMRRRNGAYLWQLFHDSENPTRYVEVFMDESWIEHLRQHERASVADREVLNHAKVYLVKGTSTQSSHWLGDREN
>AIA13100.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MSSTRVTTPTAPTRTYPSLRAAAIPLFALCLAFFVEMVDNTLMGVALPTIGRDLGGGTLSLQWVTSAYALTFGGLLLTAGSAADRLGRRRVLLVGLAVFGGVSLGVLAVDSTGQLIGLRATLGVAAAMMAPITNSLVFRLFDDDVLRRKAFTVMITVGMTGFILGPVLGGSALAHLDWQWLLIANAPIALIAWVGVRIGVPADHPEDLTHEKLDLPGALLSIAAIGLGCFTFTSGVLYGWTSWQTLGSAIGALLALAGFVIHERRTPQPMVDLSLFSRGTIRGASLAQLATAVAMAAVMFGLILHFQYAYGWSPMKAGLANLPLIVTMLVASPLAENLVTRFGHRVACLIGSGFLAGSMAGMAWAVGHGYLAIAVFMVTFTIGLRVVMTTCAVALVDAMPSNRTSLATSLNDTAQEVGTSIGTAFIGTMIAVLVTKVLPDGVWSDDLASSYFHGEQVAFLALAVIVGTIAAWGSLTLTDSHATDEH
>AIA12241.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|0
MNRLPARLLCIALCLITAAVNLPAPLYPVYAQLSGAGAGATAIAFAGYVVGVVPVLLLWGGLADRVGRRPLIVTALALSMLATVLLLRAPGLYSLAIARCLLGLGTGLASATGIAYMTELLALEGQEPARAASWVTASTSLGFGLGAAATSVCLLHTPGLAPASFWIQLVLAGLALVSMLKLPDPAPRRASAMVRLPCYPVGCVRYGLAILLAWATTGVVIAILPSVLQVAGLGAWAGFSTFSVISCGLMFQPLARRMPARRAVALGLAILPPSYALIAWGALNGQLALVLVGTVAASSACYGFIYLGGLGAIAAQAGAEMPRASAGFFLLAYAGFSVPVVFTGLIADRFTPSTGLWAFAGALTLGTLALLAAMARRPPLRASIANKA
>AIA19300.1|FEATURES|farme|multidrug|floR|antibiotic efflux|1
MAPFDLLASLAMDIYLPVVPVMPDALGTSATVVQLTLSVYMLGLGFGQILFGPVSDRIGRRPVVLGGAAVFALASAFLPLIVWAPGFVALRLVQALGASAALVATFATVRDLYADRPESVVIYGLFSSMLAFVPALGPILGALLAENWGWHAIFWLLALGTTPPFLHAVARWHETLPPGQPQVRSAWPILKSKPFWFYTLAFGTAMGTFFVFFSIAPRILVDRVGYSELEFSFAFASVALVMTVTARFAKCYVERWGIYGSIQRGMWLLLIGAAILAVVWTIADPGFATFILPMWIMAVGIVFTVSVTANGALASFGDRAGLAVSIYFAGQSVIVSVIGTFAVAALDGSTPWPLVVFSTVLGLSVLCAMRLK
>AIA19267.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MIIAGRQCRPINLKKERFMNAQLIRAAIVLGLLSVIGPLAIDMYLPALPAIGQDLNASVGAVQQSLMAFMLAFAVGQLVYGPLSDMFGRKPPLYAGIGIFLAGTIGAAFAPSIEWLVFFRFVQGLGACAPMSLPRAIVRDNYTGAPAAQLMSLIMLVFSVSPILAPLSGSFVIQFGDWRTLFYVMTGTGILGLLLVAFVLKETRPKAARTGSTLSSALGAYWQLLRDWKFMGLTLIGTFGMSSFMAFLGNSSFVYIQHYGLTPTQYSIAFSVNAVSFFAVSQATGFLVGRFGLNRVVRIAVGGFVAAMVGLLAVYLAGIDSVWVLGGFMFVAFGFLGLVLPSTSVLAMEEQGEIAGSASALMGTVQMVVAAVIMGIVGAFADGTAKPMVIAFAACALAAFLITQLTLGRGRQRSMAEVPAE
>AIA19224.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MSRSLLVIICVVCLDAIGIGLIFPILPSLLEELTGSGQVSTIYGLILAAYAAMQFVFSPILGMLSDRIGRRPVLIVSLAGAAIDYLIMAFAPMLWVLVVGRIIAGITSASMSVAGAYIADISDEKDRAKRSSWMSAAFGVGFIVGPVLGGLLSTYFLRAPFLVAAGLNGLNLVLALTVLKESRVPSREKLDLASLNPFAPLKWAFSFRTLAPLLAMFLIFAINGDIPGTIAVLYGTAKFHFDGMTVGLWLAAFGACHFLAQAFVTGPLAERLGERWTLVVGIGADVLAFLGFGFATQGWMAFALSPLSAIGGVGLPALQSLMSAQAGEDRQGELQGVLASAQSLTSIIGPLLGTTIFALTPGFPGAVWLVAAALYLLAIPVLARLFRQGRAVPAT
>AIA19157.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKTQHDQAKGRSAISANRFIILMLGALVTITPFSIDMYLPAFSQMAKDFGTTPAKISLSVTSYFIGMAIGQMIYGPLLDRYGRKKPLYYGLGIYLLTSVGCLLSGSVNMLIALRFLQALGGCVAWVAAMAMVRDFFSNEDMPKVLSLLILLIGSSPLLAPTVGGFITDSLGWQWVFIVLICMVVVDMIVTALFLPQKYQPDPSVSLKMKPMLATFYSILKHPQFAVYTWSGAFGFASMFIYVAGSPVIFMEIFHVSPKLYGGIFALLSVGFIGSGQVNILLLKKYTSAQIYRVAIYVQVLTSAIFLYGTLQGWYGLVATIVLFFIILSCLGFMYPNSNALALAPFKKNAGSASALIGCLQIGLAGLASGSVGLFNAKNSTPIVVMLFVTAVIGLLILVAGKRKAELTTGMA
>AIA18727.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSCPLLPARALIPDFEHCGRKLGAAPRGFDKMNSTMLRAALVLGLLSAIGPFAIDMYLPALPAIGVGLNASTAEVQASLMAFMVAIAACQLFYGPISDMVGRKPPLYFGIALFTLGAVGCALAPSIEWLIAARFVQGVGACAAMALPRAIVRDGYTGADAAQLQSLLMLVFSVSPILAPLAGSLMVQFGDWRTIFWAISIIGVLGLLLLAFFLKETRPASERLESSVGSAMRGYGVLLRDRNFLGLSLIGAFGISSFMAYLANSSFILIDHYGLNPTLYSVMFSINAVSFIGVSQLTGVLTRRFGLSNVVRVSVSGFITVMVALAALFVLGVDQLPVLAVLLFVGYGFLGLVVPTTAVLALENHGSIAGTASALMGTLQMVTAAIVMGVVGAFFDGTAKPMVIGIAACAIIAFALTRLTMKSETGQPVAAE
>AIA17997.1|FEATURES|farme|aminocoumarin|novA|antibiotic efflux|1
MLLEIKNLHAGIEGKEILKGLSLNINKGEVHAIMGPNGSGKSTLSKVLAGHPSYEVTTGEVIYEGKNLLELEPDERAKEGIFLAFQYPVEVPGVSNAQFLRLAYNEKMKHLGEEELDPLEFNDYLKEKAKIVEMSSDFFKRSVNEGFSGGEKKRNEILQMAVLEPKLAVLDETDSGLDIDALRIVAGGVNKLRSSENAIILVTHYQRLLNYIVPDYVHVLANGRIAQSGGKELALALEEKGYDWIKEATAGK
>AIA17877.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MENISNVGEQVLNNKNNKILVMTGLMIGIIFSELDETVVNTAMPTIIRDLGGLSMYGWVAGIYMLALSAFMPILGKLADLFSRKKVYFASMAFFIGGSIICGLSHSMIMLLIGRGIQGLGAGGLMPLAMTISSDLFPVEQRAKVQAFMGPVMFIPMLLGPLMGGFFVDQASWHWIFFVNIPVGLIAVIFLASGLKEVHERKKVTIDWAGAILLVAAIISLLITPVLVENEGYTWSSPFIVSLLCVGVILIGLFIWVESKVIEPIVPLHLFRNRNILVLSLLVFTVGCGLMGSFSSFPYFAQNVLGLTPTESGYLTLPMMVGAVATSIVSGFLLTKVRYRELFVISFIMPVIGFYLFSKLDISTTTLQVIIFFFITGLGLGVMFGGDNLIVQESVEKEHKGIALATVPLFQSIGATVGVSMFGTLLSSTLTSNLSSLGDELPKSMANNMNSLAAGGIPSGLTPELFMKIKVLFIESFQHIYTYAFVLTIIAFVLCFFLKKEVLSSKSEE
>AIA17854.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MEFPRGELSAVMGPSGCGKSTLLRCINFLEIFDSGRITIGNVSVAWSAGETAALSEEKKLALQQLRLKTGMVFQGFNLFPHLTVLDNVTLAPMLVKRTPASQAKELGRAILDRVGLGDKTDRYPSTLSGGQQQRVAIARSLAMQPEVMLYDEPTSQLDPRLVDEVFQVMRELANEKMTQIVVTHHEHFAREAAGRALVLEEGRAVWRKL
>AIA17696.1|FEATURES|farme|multidrug|MFS|antibiotic efflux|0
MISYKEALRNERWHAFEVFLATPSLVVIQQYVPVLVTRLGASPLLLGILTSGAAVMLVIASSLGPLWLQHMPSWRPAMFIPLMLWRSALLIIPLMLLLPAKQAEAIVLVVVALNFAAGFSNYTFTSYLPRMTLPDRLARLVSTRWTMLGIGMALFTVVLAAMLDFFAIPLNYAIVCALAFVIGLAGAWCLMQTKPEPISRTGKGKPRASVREILSHGPARKYLLITLLAQIALNAPGPLITLQMVRVLGATNVE
>AIA17522.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MSDTVEIPSAEAVNNSVWNVLREAFVGTQRDFTKGSIPAALIILAIPMILEMSMESLFAIVDTFFVSKLGTEAIAVVSLTESILVLTYAVAIGLAIGATATVARRFGEQDKEGAARTATHVVYLGIIVAVVMGAAGVIFAPQLLHLLGAEPHVIELGTPFMRIMLGTNAVIVFLFLLNGIFRGAGDAAIALRVLIIANLLNIFFCPMFIFGIGPFPELGVTGAAVATVCGRGIGVMYAAWALFIRKNGRLHVRGDHWKFDSTLLWSLMSLSSTAVLQFLIATLSWTGLVMIVAGFGSVAIAGYQIGLRVIMFVLLPAVGLANAAATLVGQNLGAEQPDRAERSVWTAGFLNAGILGIAGLFFIIFPGLVINIFTQDPEVAAYGRDCLRIVGYGYAFYGLGMVMESSFNGAGEHLDAYISQLFRFLAF
>AIA17492.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MKFKIQSLFFPFLLAGYEFSTYLSNDMYLPALPDMMREMHLTTQQVQFTLTSWFLGLASMPLFLGVLSDRFGRRPILLIGGIIYIIATVICALTHNHQVLLIARFLQGGMTSSMLVAGYATVHEMYDHKEAVRMIALMGSISVLAPTLGPLLGSIVLLFTSWRGIFWFIAIWATIAILLLIKIMPETLNKEQQNKINIPTLLKSYKKIISNYRFMALTSVLGCIFAGFITWIAAGPLLVIEVFQHSAIAFGLFQLAIFIAYIIGNYLVRYLVEKIKVVHLLHWGMSIAQIGVFMMLMSSFFFPQFLYGFIFSMMVFSFGTAFCFPLLNRMIIESSQETMGIRVSLFTVFLTLFSSLGSAASGLFFSGTIFSLACLVTGFVVLAYLFYFFVK
>AIA17488.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MIHTEKLTRTFTTGKQVVEAVKGIDLDVQKGELVALLGPNGAGKSTTLRMLTSLLPPTSGTARVAGIDVTKNPAGVRQKIGYIGQNPGAGYNYRVWDELRMQGRFYGLSKDEVSERGKELLSTLALEGMELRKVSTLSGGQKRRLDIALGLIHSPELLFLDEPSTGMDPQNRANLWEHITRLREERGTTIVLTTHYLEEADSMAERIVIIDHGRIIADDTAERLKAQQAGDRITVTVDESDVQLASEVVANAGTILDTTSNTINVRVDAGDRTLPKLLNALHNKGIDVLSATLHQPTLDDVFLNLTGRSLREGGDA
>AIA17423.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MSLPNEAPQPNENNSFLSILRESVWGSTRDFTKGPLGTAIFILAVPMIIEMFAESLFALVDIFFVSHLGARAIAIVGITESMMYLVYSIAIGVSIGATATVARRIGEKDPDGAARAATHSIYLGLAASTVMGAIGVIFAPEFLALMGADADVVAQGTAFTRIMLGGNVVVMGLFLLNAIFRGAGDAAIAMRVLWFANILNMVLGPCFIFGLWIFPEMGVTGAAIGTTIGRGCGALYASYELFFANRRFTVNREHWALQPDRLWRLVKVSAPAVFQFFVQTASWIGLVRVMTGFGTTAVAGYQIAIRVVIFALLPSIGLANAAATLVGQNLGAGKPERAEKAVWQACLYNAIVQTAIGLAFVIFAGTIAGVFTSDGEVLTYASDALRIIAYGFLFYAIGMVLETAFNGAGDTWTPTYLALGIFWAFEIPLAYILAYHFELGPYGVFWSITIAFSLLAIAAALLFRRGKWKTKLV
>AIA17341.1|FEATURES|farme|multidrug|PmpM|antibiotic efflux|0
MKVKDLGEHTGQQVPGGTDKAKDLKLFYLTWPIFLEVALFMMMGIADTFMLSEISDNAVSGVGASNHYLHIAILLLEVIGNGASIVVAQYIGSKKFFEAAKISALAVTLNLVVGIVLSVAFVAFNSHLLSSLNLQGEVYDYAQSYLQIVGGAIFLQAIINSLAAIIRVHGYTKEAMFVALGMNVIHIIGNYALIFGNWGMPALGVEGAAISTIGSRLIAVVVFFWLLYRVMKVRIAFRYYFNLSKEFVGKILKIGIPSALEQVMYHSCQIVFLAYTTYLGEASLAAKQYASNISMLIYLFAFAVGIGTSIMVGRFVGAGRPDDAYRRVWMSVRSASMGTLLVVVLVMVFREQLVGFFTDDPEVLRLGAQVLLYSFILETGRTINIVIVNSLRASGDAKYPLFIGMFSMLGMSLPLGYLLVFHWNMGLPGVWLAIAADEWVRAVIFYFRWRSRKWEKHALVKPDAPSPVEGNATSVQA
>AIA17122.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
ATIGGATKMPRWEFIALAAALMALNALAIDIMLPGLQQIGASLGVENENHRQYVISAYISGFGLAQLVYGPVSDRFGRRGPLLFGLVIYVAAALTAAMAPSFGFLLAVRFIQGIGAASTRVIAVSVIRDTFGGRAMAEIMSLVFMVFMVIPVIAPSVGQLVMLFSEWHMIFLFMATIALLITIWTAVRLPETLPPEYRRPFPAKSVMGGFAIVLTNRVSLCYTLATTIVFGALFGFINSAQQIFVGLYRLGVWFPIAFACMAGMMAVSSFANSQLVGRFGMRRLSHAALLGFASMSTLMFILSLFGPVPLPIFFLLFMLAMVQFGWIGSNFNSIALEPLGHVAGTASSVTGVVQTIGGGIIGAGIGQAFDGSVRPLTGGFCAVSLLAVLIVLYAEHGKLFQAHSKPLR
>AIA17038.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
FFLKRLPRGGVGGSVPVFTRPAPGQSDFYMTDTVATSREPSRVEFIVLVAALMALNALAIDVMLPALPYMGEALGIANENERQLVVGFYMFGFGIAQLAFGPLTDRFGRRGPLLVGLAIYLFCAFAATFAPNFGALLALRFVQGMGAAGTRVIATAVVRDRFEGREMAEVMSLTFMIFMAIPIIAPGIGQVILLTGPWQYIFLFMGGLASLIGLWGYFRLPETMHPEYRRALSFKSVVEGFRIVVTNRPALFYGLAGTFLFGAMFGFITASQQIFVELYGLGPYFPVAFAVMAGTIAIAQFINSRVVRRVGMRRLAHTANLVYLAAAAIWLILALAGPVPFAVFFGLFMVIQFFFGWAASNMNSLSMEPLGNVAGTAASVFGFTQTVGGALIGTYIGQQYNGTLVPNAIGYASMGALVLICVLIAENGRLFGVGVQYARGAGTGR
>AIA16999.1|FEATURES|farme|puromycin|pur8|antibiotic efflux|1
MVILDGTVVNIAMPHIQQALHFSPSSLSWVQNAYALAFGGLLLLGARAGDLLGRRRVFITGISVFTLASLLGGLAPNAELLLAARVLQGIGGAIAAPAALTLLMLTYREGPERMKALGYYSLVSSGGGSVGLVLGGMLTEWASWRWGLFVNVPIGIALVFAARRVLTETEPETGRFDVAGALTSTLGITSLVYGFIRVAEAGWTSAEVLAAFAVGVVLLVSFVLIERRVSHPIVPLRLFKSAARSTSYLTMLLVVGTMFGMFFFLTQYLQGVLALSPLSAGLAFLPMTGLLFTASRVVPRLVARIDGAKLMLAGSTLVVLGTVWLTRLDAHSTYLHDVVGPLLLFGGGAGMIFIPLVGRAISGVAPQDSGAASGMLNVVQQVGGALGLGILVTIFGTASRNSTSVIPREVLVDGVHAAFIGALVYAGLSLTMIVISVRPWNWFRTEPAPVESLTQMEAAPSTTST
>AIA16973.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MPQTDWAIEAKNLKKSYGKVEVLKGLNLQVKRGTMLALLGPNGAGKTTTVKILSTLLSFDGGTARVEGFDIVSDADKVRSVIGLNGQSAAVDELLTGRENLIMMGRLYRLTKASATARAEELLEEFDLVKAANRPAKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRLAMWNIIKKLMESGTTILLTTQYLEEADQLADKIVVIDDGRVIAEGTAAELKSKVGKDRLELIFANPKTFEKAQTVLGKSVADSNPKTNAVGVVIQDNN
>AIA16815.1|FEATURES|farme|multidrug|efmA|antibiotic efflux|0
MEVSIAYQNEDENGYGNLFLQRLMLIDLSPLKASRDYRLLFTGQLVSFFGTMMTFIVVPWQMYQLTHSSAMVGSIYLAEFVPMVILAFVGGAMADFLDKRRLLRLTEIGQTTATVVLLVNSLLPDPQVWILFLAVAVHAGFAAVQRPAFESFIQKVIPAEMMSAVMALNSIRYSVGAIVSPAVAGIIATQFSASIAYAFDLVTFTASLWAVFLIRAVPPPENAEKPSFQSIKRAWKYAFGRQELVGTYFIDIAAMFFAMPQALYPALAVVYGPQYVGFFPASIAAGALVAGLTSGWTKKINRHGLMVTIAAVLWGVAIIFFGLADSIVPALLFLGAAGFFDMISGIFRGSIWNQTIPNYLRGRLASIEMMSYLTGPMLGSAKMGIVAESFGVKTAIVSGGVMCIAAVLGSAMFLPKFIGYDGREGRRQREAEEAERAEMA
>AIA16619.1|FEATURES|farme|multidrug|mepA|antibiotic efflux|0
MLSIQRSTNRISHIFSIIRLSLNGEQQDYTTGSIRRAVILLAIPMMLEMCMESVFAVVDIFFVSHLGKHATSTVGLTESVITIVYSLAIGISMAATAMVARRVGEKDAQAASKAGMQAIFVSIAITLAVSIPGFIYAPGILRLMGAEEAAVEMGTGYTRIIMGGSMVIMLLFLINGIFRGAGDAMMAMKSLWLANICNIILCPLLIRGWGPVPAFGLTGAAMATTLGRGIGVAYQLYHLFNGKRLVQFTLKHLTPDWKVIRSLIDIAWPATIQFLIGSGSWIVLASLVVTTGHSEASAGYQIAIRIVMFFLLPAWGLSNAAATLVGQNLGAKQPGRAELSVIRTAKYNAIFMAAVSTILLGFTPYIISFFTKEEAVANYAILAVRIVSAGYLFYGIGMVMANAFNGAGDTRTPTIINLFGFWFFQIPLAFILSKALGMGPTGVFIAIPVAETAITIAAYILFKQGKWKLKQV
>AIA16465.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKNKNTLTIILLGMLTAVVPFSIDMYLPGFTDIAKTYNTQVSKVALSLSSFFVGMGIGQLLYGPLLDRFGRKGPLYVGLLIYCLASIGCAFAPSIEMLIGLRFVQALGGCAATIAATAMVRDLFPPQENARIFSVLILVLSVSPMLAPTAGSLLAVCFGWRSIFFVLTILIVLIMAGSFFYLPESKGVDKTYSLKPSAILTSYRNVLRQSYFIVYAFACSLAFAGLFTYIATSPGIFMQHFGLTQKQYGLLFAFLASGLIVASQVNTLLLKRFRSEDIVKAAFLSQLVVTAVFLFLILSGVNTLVTTIALLFLFLAAAGLIMPNATSLAMKPFDSNAGSASALLGFIQMGLGSIITIVIGMLNIQSVLPMVLCMMGSSVVGMLLLLLSGSLFREKRMNEWAIN
>AIA16358.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAIHAENITKRFGDFVALDDVSLEIDDGSLTALLGPSGSGKSTLLRVIAGLEQPDSGVVLLGGRNVTSLPAHRRGIGFVFQHYAAFKHMTVAKNVAFGLDIRKRPKAEIKQRVAELIELVHLDGLGDRYPSQLSGGQRQRMALARALAVEPDVLLLDEPFGALDAQVRKDLREWLRRLHDEIHVTTVIVTHDQEEAMEVADSVVVMQRGRIEQEGPPRELYENPVNRFVMSFVGPVNELGEALVRPHDVEITLSPNGTTIAATVERVVHLGFEVRVHVVLEDGTPMTAQLTRDEANRLRVESGADVFVRPRAVREFGEDDGSMAAVEEDVPAPVPSVTDPERRAPEPL
>AIA15915.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MVKHTNNTDFAVEARGLVKVFGENRAVDGVDLLVPTGSIYGVLGPNGAGKTTTINMLATLLKADDGAAKIFGHDIQEEPQIVRQLIGVTGQYASVDESLSATENLVIFSRLLGLNKAEAKQKAKDLLEEFGLTEAAKRPLAKFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRNQMWDTIRRLVSTGSTVLLTTQYLDEADQLADRIAVIDHGRVVAEGTPDTLKKSVGVATLQLRVVAKKDVLSAIEVVQKVLKVATQNPDATLITAPMADPERVTDLLIALRTNGIHLAEVSVQKPTLDEVFLTLTGHATTEEKGEKA
>AIA15916.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MTTEAIIPGAKRELKNHTSIGMTISNSLTMARRGLLKIKRTPEQLFDVTIQPVLFTVMFTYLFGGAISGDVASYLPLIIPGILIQTVITTSVVTGVQLREDMDKGVFNRFKSLPIARISPLAGALLADTLRYAIATIITFAVGYLMGYRPGAGLGGVVAGGLLVIGFSWSVSWIFAFFGVLARTAASVQGISLLILFPLTFLSNAFVPTNTLPDWLKWFADVNPLSHLIAAVRDLANSGTIGSDFWMSLIGAVGIVAVMAPLTVKAYMRKA
>AIA15465.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MRKGEFIALAAFLMAINSLAIDIMLPALQQIGASLNVESENHRQFVVSSYLLGFGFAQLIYGPLSDRFGRRIPLLAGIGIYICSSLGSALIPTFEGLLILRFVQGLGSAATRVITISIVRDIYGGRQMAEVMSLIMMVFMIVPVIAPGSGQIIMLFGSWHLIFLFIAVMAAIIAGWAYLRLPETLRPENVRPFTAKSVLGGFKLVLTNRIALCYTIASTFIFGSLFGFINSAQQIYVGIYGLGVYFPFAFAGVAVFMSMSSFLNSRLVGKFGMRRLSHGALLGFITINTIWLLALVFGPHPMPFFLFIGFFGLAMFQFGWIGSNFNSLAMEPLGHVAGTASSVLGFMSTVGGALIGAGIGQAFNGTALPMVAGYFTVSIIGLVFVLIAEKGKLFQPHNPAV
>AIA15451.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MALNALAIDVMLPALPYMGEDLGVDNENERQLVVSAYMIGFGLAQLAFGPLTDRFGRRAPLFFGIGLYVVCAFAATFAPTFAILLGLRFVQGLGAASTRVIATSIVRDRFSGREMAEVMSLTFMVFMAIPIVAPGIGQIILLTGPWHYIFLFMAGLSAAIWVWAWFRLPETLHPEYRRELKLSVIVEGFRMVFTNRVAFFYGLAGMFLFGAMFGFIISTQQIFVGIYGLGPWFPLAFATMAGFMAVSSFLNSRIVKHFGMRRLSHTAMLVYVTCAVILLVLSLTMSVVPFWLFFLLLMIIQVSFGNAASNMNSLSMEPLGAVAGTAASVFGFCQTVGGAILGTFIGQQFNGTLTPNATGYVVMGTLVLCCVLIAEKGKLFGVGKEYEPTGVVAHAD
>AIA15441.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAAELVFEKRSRLYLAISDSLIMIKRSGRHIIRNRDQLLGAFFQPIMFLVLFSTVFGGAISKALPPGVSYLNFLMAGIIVQTAAFGSTTTAIAVCNDLQKGIVDRFRSLPMSNLAVLNGHVISDLFRNSISTIVMLLAGLAIGFRPHTNFVEWLQIAGILFLFTLAFSWLSAIVGILAKSVEGVQWLTFVLVFPLTFASTAFVPAQGMNRVLRAFAENQPITQVVDAVRALILGTPLGNHGWLAVAWSVGTLVVAMPLASWLFRRKTTS
>AIA15442.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MTQSKYVVAAEGLAKSYGSNQVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLKFDSGTVTVEGHDVRTEPDKVRSVIGLTGQSAAIDDLLTGRENLQMMGRLYRLTPASATARAQELLEEFDLVAAADRPAKTYSGGMRRRLDLAVSLIAAPPVIFLDEPTTGLDPRSRLAMWEIIKGLMAAGTSILLTTQYLEEADQLADRIVVIDGGKVIAEGTATELKRKVGKDRLELTFKDSTALARVKQILGTDIIDTNGKEYTATVIVQDTSVDIKRTLDLLAQEKVAIQSMAIHKPTLDDVFLSLTGKQKEAEEEKV
>AIA15390.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MPARLQGVGKVEFIAMMASLMALNALAIDIMLPGLQQIGESLGVENPNHRQYVVSAYLFGFGVAQLFYGPISDRFGRRKPLLIGLGIYILSAVAVVFVPSFAGLLLLRFAQGIGSAATRVISISIVRDVFGGRAMAEVMSLIMMVFMVVPVVAPGTGQIILLFGNWHLIFVVIALAALIVSLWVIKRLPETLDPADVRPFTVASVANGFLIVLTNRVALCYTLASTFIFGALFGFINSAQQVYVGIYQLGAWFPLAFAAVAVFMSISAFLNSRWVGKLGMRRLSQTALLGFVGITFLWLVVQLLSSTPMPFLLFLAFFAVAMFLFGLIASNFNSLAMEPLGHVAGTASSVLGFMGTIGGAIIGAAIGQAFNGTATPMVAGFFTVAVIGLMFVLLGERGKLFRTQNAPV
>AIA15371.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|1
MTTAHPTHSAHHHASKFTSRQKTIALIIVALAFVMDLLDNTIVNIAIPSIQSNLGASYSTIQWLIAGYSLAFAILLITGGRMGDVFGYKKMFLLGVGGFTITSLLCGLAWNSEILIVARLLQGSMAALMVPQVMSLMQVLYKAHERGQVMGLFGALAGVAATLGPVIGGVLIHLNIAGLDWRPIFLINIPVGIFALAAGWKYLPTGKSPHPLRLDVIGTAIIVVALFLLIFPLIEGRELDWPAWTFGMMVAAAPVLVLFAWWQFKKDKKDRSPLIVPALMKTSTFIKGIVINLTFESAMLGFFLPFTLVIQVGLGYDVIKAALTGIPTAIGISVVMAVFSQKLIPKLGRYSLTIGTVVMAAGLVLLYFMTRSLGLDMTPWEFIPGLLIIGAGMAMIMTPIFAVVLTDVDPKHAGSASGVLNAVQQLGGSIGIALIGLFFFSQLATNAPASFDKVEPQLRNDLSSLQVPATMQDQVLASVKTCYTDRAEAKDMSQTPESCKKLESSKAGNGHMSQAQAAINQKMTESITKSVTQANANNFTNAFGVAVI
>AIA15369.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVELIFETRSKASLALSDSYIMIKRSGLHIIRNRDQLLGAFFQPIMFLVLFASVFGGAISKALPPGVSYLNFLMAGIIVQTTAFGSTTTAIAVCNDLQKGIVDRFRSLPMSNLAVLNGHVVSDLFRNGISTIVMILAGLIIGFRPHASFTDWLVIAGILILFTLAFSWLSAIVGILAKSVEGVQWLTFVLVFPLTFASTAFVPSEGMNPVLKAFAVNQPITQVVEAVRALILGTPIGSHGWLAAGWSVGILIISMPLASWLFRRKTAS
>AIA15370.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MAANKYVIEAQGLTKSYGSTKVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLAFESGTVTVEGHNVTTESDKVRAVIGLTGQSAAIDELLTGRENLVMMGRLYRLTVPSAKARAQELLEEFDLIDAAERPAKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRLAMWGIIKNLLAAGTSILLTTQYLEEADQLADRIVVIDDGKVIAEGTASELKSKVGKDRLELTFKDSRTLANAVKALGKKVIDADEKEFSATVIIKDTNADVRETLDVLAREKISIHAMTIHKPTLDDAFLSLTGKQKSLKKERSN
>AIA15315.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefC|antibiotic efflux|0
RGIDDTDFQLPHQTAARPMTANILARMPRGWILLASIGLIALNMRGPFVAVAPVVGPMQQDLGFSPVELGLLTGIPVLCFSLAAPLASFAGRKFGAEFAIMLTLLGVLAGVIVRSAGNGALVLVGTVIIGVAITIGNIAVPLIIRRDFSPRRQGTAMGIYTAALNIGSFLTSVVTAPLAELAGWRLALAASGLFAVAATGFLGDVRGTRCLRSGRRR
>AIA15098.1|FEATURES|farme|multidrug|norb|antibiotic efflux|0
LEVVFYGLGAVTGPVVASIMLDWQHTAIPTIWGGAVLATVLIPGVFVMTLPPVVAREHITGSRATSLYRSPILWTLAAIFLLYVGLEVGTGGWIAVYIHITTPLSLSVGALIASGYWLALTGGRLLATLFGGRLSPARLLLVCLCGAVVGGFLLALSTGDAPLTIGAVVVLGVSFGPIFPTAFAITTAEFPRAPGQAASTVVALGSIGGVVFPWLQGLILTRISPQTSVVFVAALALLLLLVSRAIPAKHRPHPLAPSPF
>AIA14981.1|FEATURES|farme|bacitracin|uppP|antibiotic efflux|0
MKSPESSDNPQRAASDASAAHAMAPHDSRARSIALAASLALIAFSLRTPITSVGPILLEAVQATNLSRTGASLLTTLPSLCFGFFGPLAPLLARRLGSERALLALLALLTAGTALRVVPVWQVLYLGQIVACFAIGLMNVLLPGVVKRDFPHHVALMTGIYSAAMCAGAAAAAAATVPAAHALGHLLGGASDHAWAWALALWALPVALATVVWGARLPARSTSTGRRVHVVRGLWRDPLAWTVTVFMGSQSALAYIVFGWLPTVLRTRGMSAVDAGFMLSLSVVTQAVASLLLPFLLARRRDQRAVNVGALLLTGVGLMGCFFAPLSILWIWALLLGAAQGASFTLALTVIGLRSYDSHVAAQLSSMAQGIGYLIASCGPFIAGSLLHATGSLSSLAALCAGICIVSAWFGYAAGRPEHVNAHVE
>AIA14919.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MAIGEDISTKTKGDATGEEFVSARINSVPPSGIRKFFDIVATMKDVISLGIGEPDFVTPEPILNAGIESLRAGHTAYTSNSGILELRQLIAAQLKHHYNVKYDPDTELLITVGVSEALLLALMAVVEAGSEVIVPEPCFVAYQPTVIFAGGVPVPVPTYVSQDFQVTVEDLEKARTPRTRALLLGYPNNPTGAVLDRSRMAEIAAWAEEHDLLVVSDEIYDRLVYGIEHTCFSSLPGMWKRTILLSGFSKSHAMTGWRIGYAAAPPAILAAMRKIHQFIIMSAPTTGQEAAIEALKSGEPYVESMRQEYDRRRRLIVDGFNRLGLTCFEPRGAFYAFPSIESTGLDEEEFCERLLMEEKVAVIPGSAFGASGKGHVRASYATSYANLQEALVRIERFLGKLK
>AIA14787.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MNLETEKSMSRSEISTTPKRTAELEELLIDAEADDEQVQQSHPLVRRPWLLLLGLILVALNLRPALSSMAPLLSDVSKSLGLSAAQAGLLTTLPVLCLGLFAPLAPILARRFGAERVVLGILLTLAGGIILRSNFGEIGLFAGSVLGGASIGIIGVLLPGIVKRDFAKHAGTMTGVYTMALCLGAAMAAGSSVPLSEHFGHSWAMGLGFWVIPALVAAVFWLPQVGQKHGAHNVAYRVRGLLRDPLAWQVTLYMGLQSSLAYIVFGWLPSILIGRGLTPTQAGLVLSGSVIIQLASSLAAPWLATRGKDQRLAIVVVMALTLGGLFGCLYAPIEGLWGWAILLGLGQGGTFSLALTLIVLRSRDSHVAANLSSMSQGFGYTLASMGPFAVGVVHDWTGGWNAVGWIFGIIGTGAIIAGLGAGRALYVQVQSERI
>AIA14781.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MASADNVISVKGLKKSYDKLQVLKGVSFDVQRGQILALLGPNGAGKTTTIRILSTLLESDGGSASINGFDVGHNAGKVRESIGLTGQYAAVDEYLTGEENLYMMGRLYRLSKKDTKRRTQELLEQVDLVEASKRPVKNYSGGMKRRIDMAMSLIASPPVLFLDEPTTGLDPRSRAGMWSLIKKLAKAGTTILLTTQYMDEADQLADNIVVIDKGKVIAEGTSTQLKAKVGSDRLELTISSKSEFSDAISAVKGEKAEIDEEARTISVVASKGGVQKLKQVLQNLETAKIQVDNVSLHRPTLDDVFMSLTGHVTAKTEPEKANKKVKK
>AIA14754.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MSFESQSPLNGDKNSSFLSILSEAVWGTERDLTAGSLGTAIFVLAVPMIIEMFAESLFALVDIFFVSHLGAGAIAVVGITESMMFLIYSIAIGVSIGATATVARRIGEKDPHGAAQAATHSIYLGVAASIVLGLIGAIFAPTFLHWMGADADVVAQGTTFTRIMLGGNIVVMLLFLLNAIFRGTGDAAIAMRVLWFANILNMILGPCFIFGVSFFPELGVTGAAVGTVIGRGAGAAYAAYCLFLKNTRFEIRREHWTIDTKKLWKLVNVSAPAVFQFFVQTASWIGLVRVMTGFGTTAVAGYQIAIRMVMFALLPSIGLANAAATLVGQNLGAERPDRAEQAVWRACLYNAIVQTAIGLLFVIFSGTVAGVFTSDPEVHRYASDALRIIAYGFLFYAVGMVLETAFNGAGDTWTPTYLALGIFWVFEIPLAYVLSYNVGMGPYGVFWSITIAFSVLAVVAALLFRRGKWKHKDV
>AIA14653.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MGRTEFIALAAALMALNALAIDIMLPGLQEIGASLGVDNENHRQYVISAYLIGFGISQLFYGPIADRFGRRKPMLFGLGIYIISSIAVIFVPSFAGLLVLRFIQGIGSAATRVITISIVRDIYGGRQMAEVMSLIMMVFMVVPVIAPGTGQIVLFFGDWHLIFGFMAGIAAIVTVWMYLRLPEPLHAEDVRPLTVSSVLAGFKIVLTNRVALCYTIASTIIFGALFGFINSAEQVYKGIYGLGPWFAAAFAGVALFMALSSFLNSRLVGRFGMRKLSHGSLIGFICITFVWLVLQIVGPQPMPFFLFILMFALAMFQFGLIGSNFNSLAMEPLGHVAGTASSVIGFMSTIGGSLIGAAIGQAFNGTALPMVAGFFVVSVLGLVFVLIGEKGVLFQPQNKPTH
>AIA14601.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVKLEFDKRPKAVLALNDSLIMIKRSGTHILRNTDQLLGAFFQPIMFLVLFASVFGGAISKALPPGVSYLNFLMAGIIVQTAAFGSTTTALAVCNDLQKGIVDRFRSLPMSTLAVLNGHVISDLFRNGISTLVMILAGLVIGFRPKADPLEWLLLVGILLLFTLAFSWMSAILGILAKSVEGVQWLGFVLVFPLTFASTAFVPSEGMNSVLKAFAVNQPITHIVEALRALILGKPLGDHGWLAVVWSLAILAVSVPLATIMFKRKTSN
>AIA14602.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MANNRYVIEVKNLTKSYGSNNVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLSFDDGEVLVDGHNVKTEADRVRESIGLTGQSAAIDELLTGRENLVMMGRLYRLTPESAKARAQELLEEFNLLDAAERPAKTYSGGMRRRLDLAVSLISTPPIIFLDEPTTGLDPRSRIAMWDIIKRLMENGTTILLTTQYLEEADQLADRIVVIDGGKVIAEGTANELKGKVGNDRLELTFKDAKVREQATKILGNSVVSSDEKEHSVTVVIQDTNKDVKDTLELLSQKQLTLTSMAIHKPTLDDVFLSLTGKQKQAAEEQA
>AIA14509.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTLGHQLQKRSVVMNAQIVRAAIVLGLLSVIGPLAVDMYLPALPAIGIGLGANSAAVQASLMAYLAAIAVGQLLYGPLSDMLGRKLPLYFGIGIYVLGSIGAALSPNVEWLVTFRLVQGIGACASFTLPRAIVRDEYTGAPAAQLMSLLMLVFSVSPILAPLAGSAVIAFGDWRLLFWVMSLGGVLCLLLAIFALRETRPKQARLNSGVGSAVSAYWTLLRDGRFMGLSLIGTFGMSAFMAFLGNSSFVYIQHYGLTPTEYSLAFSVNAVSFFAVSQATGYLVGRFGLNRVVRTAVGGFVVSMVALLAVYLGGVDSVWVLGIFMFIAFGFLGLVLPSTTVLAMEEQGAIAGSASALMGTVQMIVASVVMGVVGAFSDGTARPMVIAFALCSIAAFAITQMTLGKGDGSRMIEVPAE
>AIA14487.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MATKLVFQQKPKWILALNDSLIMITRSSRHIIRNTDQLLGTFFQPIMFLVLFSTVFGGAISMALPKGVSYLDFLMAGIIVQTVAFGSTTTAIAVCNDLQKGIVDRFRSLPMANLAVLNGHVISDVFRNAISTLVMILTGLAIGFRTHASFVDWLLITGILLLFTLAFSWLSAIMGVVAKSVEGVQWLGFVVVFPLTFASTAFVPAEGMNRVLRAFAENQPITQIVEAVRALMLGTPTGNHVWLAIVWCLGLLVISVPIASWLFRRKTTS
>AIA14488.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MAQSTYVIEAKNLQKSYGTNNVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLGFDGGSVTVEGYDVIKQADKVRGVIGLTGQSAAVDELLTGRENLIMMGRLYRLTTESAKTRAQELLEEFDLVKAADRPAKTYSGGMRRRLDLAVSLIATPPVIFLDEPTTGLDPRSRLAMWDIIKRLMENGTTILLTTQYLEEADQLADKIVVIDGGRVIANGTANELKSKIGNDRLELTFADQETFKKALQTLGKAVIDTNDKEHTVTVVIKDTNADVKAVLEKLSQANIVITSMDIHKPTLDDVFLSLTGTQKAATSEETK
>AIA14453.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
VVEVKNLKKAYGSNKVLKGINFKVPRGSMLALLGPNGAGKTTTVRILSTLLKYDEGTVSVNGFDVKTDPNGVRSTIGLTGQSAAVDEMLTGRENLVMMGKLYRLTAKSAKARAEELLKEFDLIKAADRPLKAYSGGMRRRLDLAVSLIATAPIIFLDEPTTGLDPRSRLAMWNIIKKLMESGTTILLTTQYLEEADQLADNIIVIDGGKVIAEGTAKELKSKIGNDRLELTVSDLKTYEAAKSSLGKKVVESNEKEYTVTTMLKNTNKDIREVLDILEKAGISLQSMNVHKPTLDDVFLSLTGKQATKLDTKKKKEKK
>AIA14414.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MANNRYVIEVKNLTKSYGSNNVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLSFDDGEVLVDGHNVKTEADRVRESIGLTGQSAAIDELLTGRENLVMMGRLYRLTPESAKARAQELLEEFNLLDAAERPAKTYSGGMRRRLDLAVSLISTPPIIFLDEPTTGLDPRSRLAMWDIINRLKEQGTTILLTTQYLEEADQLADKIVVIDGGRVIANGTANELKSKIGNDRLELTFADQETFKKALQTLGKAVIDTNDKEHTVTVVIKDTNADVKAVLEKLSQANIVITSMDIHKPTLDDVFLSLTGTQKAATSEETK
>AIA14383.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MAEKTVIEVRGLKKSYDKTEVLKGVNIQVQRGTMLALLGPNGAGKTTTVRILSTLLKFDGGTVKVAGYDVKTESDRVRSVIGLTGQSAAVDELLTGRENLVMMGRLYRLTPKSAKERAQELLEQFDLVKAADRPAKTYSGGMRRRLDLAVSLIAAPPIIFLDEPTTGLDPRSRLAMWQIIRKLMDDGTTILLTTQYLEEADQLADQIVVIDGGKVIAEGTATELKRKVGNDRLELTFKDQKTLEKAVKALQKDVVDTNEKEYTATVVIKDTNTDVRKALDKLSNQKVKIESLEIHKPTLDDVFLSLTGKQNKDKKGQSNGG
>AIA14200.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MSDKKSEYVIRAKGLTKSYGDNHVLQGIDIDVRRGTMLALLGPNGAGKTTTVKILSTLLKHDEGSVTIEGFDVQNEADKVRQVIGLTGQSAAVDELLTGRENLVMMGRLYRLTKASAKARAQELLEEFDLVEAAERPVKTYSGGMRRRLDLAVSLIATPPVIFLDEPTTGLDPRSRLAMWDIINKLKQGGATILLTTQYLEEADQLADRIIVIDGGKVIAEGTAAELKSKVGKDRLELTFDDAKAMQAARRALGKGVVDVDERENSVTTVINDTNQDVKRALELINGAGVSLRSMSVHQPTLDDVFLSLTGKQKKTDTEKSEDK
>AIA14185.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MSSQRRWAVTAGVITGMFLAALEATVVGTAMPTVIASLGGLNHYSWVFSAYLITATVTVPVWGKLSDLYGRRLLYQIGIAIFLLGSALSGMSTSMMHLVIFRAIQGLGAGALVPLGMTIIGDIYTVTERAKMQALFSGVWGLSSVIGPVVGGFITDQLSWRWVFYINLPVGLLTALILGLALKEPKRTERPAIDYAGAALLIAAITLLMLALVEGGAKLSTLFAARNLMLFAGAVVLTAIFIRVERRAADPVVPFKLFRNRVVLISVVAGFLAGVAMFGAISFVPLFAQGALEMTATQAGSLLTPLMLSWVGMSIIGGRILIRVGYRPLCIAGFTLLTLGFVLLSMFQRATPRVWLYVDLILIGAGLGLTMLTLLIAVQQAVSRAQLGIATSLNQFSRSIGGAVGVAVMGAVLSAGLASQLSEVASRGNTALTPERAAELSENPNALIDPHARAVLPPNVLDALQGSMAGAIHNVFWVGTAFAVLALLVSFYLPRKGESTFERPEEEACSSETGERMMMAELTTIDPEHEPVVTQGD
>AIA14173.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MASKYAITVKNLKKSYGKTDVLKGVTFNVERGTMLALLGPNGAGKTTTVRIMSTLLKYDSGSVTVEGIDVSKQSDAVRNVIGLTGQSAAVDELLTGRENLIMMGQLYRLTKASAVARATELLERFDLVKAADRPLKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRIAMWDIINELKKEGTTILLTTQYLEEADQLADRIVVIDGGKVIAVGTAKELKAKIGNDRLELTFATDKAYARALDVLGVSLIDQNHSERTVTVLIKDTDKDVERTLGRIHDAKLKIEAMAIHKPTLDDVFLSVTGRAKQTKKEDK
>AIA14174.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MATALEFTKRPKVISLLNDSLLMIKRSSTHIIRNTDQLIGTFFQPIMFLILFTAVFNVVGTSLPPGVTFINFLMAGIIIQTVSFGSTTTAIAVCSDLQKGIIDRFRSLPMSNIAVLNGHVVSDVFRNGISTAVIVLAGLLFGFRSNASLIDWLAIAGIIVLFTLAFSWLAAIMGVLAKSVEGVQWMSFVVVFPLTFASSAFVPADSMVSWLRPFAENQPLTHIIEAIRALMIGAPIGNHGWLAFAWCVGILIVSIPLASYLFRRKTTS
>AIA14157.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MRDMVVETERAGATKGTGEGFVSARINAVPPSGIRRFFDIAATMKDVITLGIGEPDFVTPQPIVEAGVESLRAGHTSYTSNSGILELREGISRQLDKLYNVNYDPETELLVTVGVSEALLLALMAVLETGDEVIVPEPCFVAYQPTVIFAGGTPVSVPTYVSQDFQVTVDDLEKARTPRTRAVLLGYPNNPTGAVLERSRLAEIAEWAEKHDLLVVSDEIYDRLVYGIEHTCFSSLPGMWERTVVLGGFSKSYAMTGWRIGYAAAPPAILAAMRKIHQYVIMSAPTTGQEAAIEALKSAEPYVESMREEYDRRRRTIVDGFNRLGLECFEPKGAFYAFPSIKSSGLSDQEFSERLIMEEKVAMVPGSAFGQSGAGHVRASYATSLQNIEEALNRIEGFLKKLRA
>AIA14121.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTSKRYFLLVLILGTLSAIGPFSIDMYLPGFPGIAASLNTTVANVSLSLSSFFIGISAGQLVYGPLLDRFGRKKPLYFGLTLYLAASLGCAIAGSIESLIIFRFLQALGGCAGMVAARALVRDIFPVEENARVFSLLMLVIGVSPMIAPTVGGYVTDNFGWHYIFLILTAMGLLILTAVHFTLPEGRQPDGTFSLRPSQIMKNYVEVLVNPQFYTYVLTGSLAGAGLYAYISGSPYVFMEL
>AIA14009.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MIAAGLSFLNFFYGLFILPESLPKDQRRSFDWKRANPVGSVVRLRRYPQILSLIISMMLIYIAGHAAQSTWTYYTMLKFNWSVRWVSYSLAFVGLSIAAVQGGLVRLIIPKIGQRNAVYAGLGLYIVGFLLFAFATKGWMMFAFLIPYALAGISGPAMQGIMSSQVSASEQGELQGALTSLVSLTSILGPLLMTGLFHHFTDKNTPVYFPGAPFAMGAVLTGVSLILAIRSFSLHRNT
>AIA13719.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MNKKYAIEVKGLTKSYGSNDVLRGIDIQVEEGTMLALLGPNGAGKTTTVRILSTLLKHDSGTVRVAGYDVAEDADKVRTVIGLTGQSAAVDELLTGRENLVMMGRLYRLTKASAQARANELLQEFDLQKAADRPTKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRLAMWDIIKKLMAAGTTVLLTTQYLEEADQLADQIVVIDGGKVIAQGTASELKSKVGKDRLELVFQDTSTLKAARKALGASAVDIANNSLALSMTIEDI
>AIA13683.1|FEATURES|farme|aminocoumarin|novA|antibiotic efflux|0
EILRGLNLQINKGEVHAIMGPNGSGKSTLAKVLAGHPSYEVTMGEVFYEGVNLLDLEPDERAREGVFLAFQYPVEVPGVSNAQFLRLAYNEKMKHLGQEELDPLEFNDYLKEKAKVVEMDKSFFNRSVNEGFSGGEKKRNEILQMAVLAPKLAVLDETDSGLDIDALRIVAEGVNKLRSADNAIILVTHYQRLLNYIEPDFVHVLAGGKIVKEGGKELALELEEKGYDWVKAAGN
>AIA13616.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MKHDDYSIVVQDLRKSFGKLDVLKGINLTVKRGTILAVLGPNGAGKTTTVRILTTLLEADSGIATIEGYDVAKQADEVRSVIGLTGQNAAVDEFLTARENLLMMGRLYHLSKKDSQMRAEQLLEQFGLVEAADRVAKTYSGGMRRRLDLAASLIATPPVLFLDEPTTGLDPRSRLAMWDIIQKLADHGSTILLTTQYMEEADQLANRIVVIDGGKVIAEGTPDELKEQIGKERVEFTFDSDTQFQKAHKALADG
>AIA13263.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MSRNRIILVTAGIMLSLFLASMESTVVATAMPTIVGQLGGLEHFSWVFSAFLLASTTTVPLYGKLSDIYGRRKLYVFAMALFLIGSVLCGLANSMTQLIFARALQGIGAGGIMPLAFILIGEMFSLEQRTKMQGVFSGVWGVSSIAGPLLGGFLVAQLSWRWIFYINVIPGLLAAALVAFAWRDQIHSQKRPAVDYMGAALLTVSVVLLLLGLMEFGTSRSWIYIGVAIILFIALWWVERRAVDPILPIPLFRDTLFATATAHGLLTGWAVFGSISFIPLFVQSVLGTDALQAGITITPMLLGWVGASIVGTRILLRVGYRNLSVIGTALFAVGAFLMTLVGANSNQIMVMVFVTMMGIGMGLSIPAFVIAVQTSVERRHLGTATSMLQFSRSMGGTLGVSVMGAMLSARLASNLSASGLDTEMVAQLLDPIPGSEVVIDAGVRLAMANAIHVVFLVAFVAAALGLVSAFFTPRKELTENLPEPTPMSAD
>AIA13253.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MNQDMKHIQPNNGDWAVEAQGLVKIFGDNRAVDGVDLKVRAGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQKESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRAESRRKAAELLEEFGLTEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVKTGSTVVLTTQYLDEADQLADRIAVIDVGRVVAEGTVDELKASVGTSSLHLRVQDSQDIEKARRTIEQVLKVPSSVTSELAKITAPMADADLVTDLLIALRAEGIHLTEMSVQKPTLDEVFLTITGKGVKQDEVQESEEWNKKEVARV
>AIA13247.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTNEHTSQKEFIFLVALLTALVAMSIDTMLPAIGTMASEFGVSDPNKRQYIIGAFFAGMTIGTLLSGPISDSTGRKPAIFAGLLIYVAGSLLSLFSTSFEMLLAGRALQGVGASSPRIVSLAMVRDGQGGAAMARIMSFVMSVFMLVPILAPSIGQLVLFVASWRMIFVGFLAMALIAALLLQFRQEETLPKEKRVAFSAGTLFRSAIEFFRFPSAWGYTVSVGFVFASFICYLGTSQQIFAEQYAQGEWFAVWFGVFAIAIAFAMIFNGRMVMRPRHAYACQMGGARLHRVFRHLPCCSLELRRPSAALDPRSLHVRHLLLFRHPIRQLQRHGHGACGPHCRHGGGHFRHPLNPRGALHRHLVRPAV
>AIA12928.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTNDTSQKEFIFLVALLTALVAMSIDTMLPALGTMASEFGVSDPNKRQYIIGSFFAGMTVGTLLSGPISDSTGRKPAIFAGLLIYVAGSLLCLFSTSFEMLLAGRALQGVGAASPRIVSMAMVRDGQGGAAMARIMSFVMSVFMLVPILAPSIGQLVLFVASWRMIFVGFLFMAIIAAIFLQIRQEETLPKEKRVAFSSGNLFRSAVEFFHFPSAWGYTVAVGFVFASFICYLGTSQQIFAEQYAQGEWFAVWFGGFAIAIAFAMIFNGRMVMRHGMRLLSKWAVRGCIVFSAIFLAVALSFAGHPPLWTLGLYLFGTFFCSGILFGNYNAMAMEHVGHIAGMAAAISGTLSTLVALSIGTWFGQQYDGTVMPLVYAFLSMSVAAMLVSEGVEWAKRRR
>AIA12926.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKDKVMTASFYRPAIILGLLSAIGPFAIDMYLPALPAIGRDLGSDTAVTQLSLLAFFISFALSQLVYGPLSDMWGRKLPLYLGIGIFALASIGCALATDIETLIAFRFLQGIGGAAGMVIPRAVVRDMHTGVEAARLMSLLMLVFSISPILAPLSGSAVIEFYGWRGVFWAVMIAALIGLVLLATQMKETRPVEQRRESSIKAAMSAYGLLLRDKNFLTLTFIGGLGISSFLVYLANSPFVLIEHYGLTPAQYSIAFSINAVSFFSVSQLTGFFGARYGLVRVMRVAVTAFALTMVVMAAVMASGFDSLPVMAVFLFIGYGFLGLVIPTSAVLALEEHGEIAGTASSLMGTLHFVAAAFAMVLVSTVFDGTALPMVAGIALVAALAFILTQVTIGRRAAAVSAAE
>AIA12845.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MNAKILGTAVILGLLSVVGPVAIDMYLPALPEIGGQLGASTSAVQLSLMSFMAAFAVGQLFYGPVSDMVGRKPPLYFGLGIFMLGSIGCALAPSIEWLIVARFVQGIGACASASLPRAIVRDQYTGAEAAQLFSLIMLVFSVSPILAPLTGSLVIAFGDWRLLFWVMTVVGLLGLALTVFALRETRPAHLRTESSIGGALRSYGTLLKDWNFIGLVMIGAFGMSSFMAFIGNSSFIYIEHYGLTPTQYSFAFAANAISFFAVSQSTGYMVKRFGLQRLVRWAVTGFASAMVLLAALFVAGIDSMWVLSGLMFVAFGFLGLVIPTTGVLAMEEHGAIAGTASALMGTLQMISGAVVMGIVGAFHDGTAIPMVLGFAICALAAFLIAQVTIRTTTTQVVGAPAE
>AIA12814.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MEGTSKAEVQKQDTEKPRLEMSSRRRWAVTIGVMTGMFIAALEATVVGTAMPTVIATLGGLNRYSWVFTAYIVTSTVTVPVWGKLSDLYGRRLLYQVGIGVFLLGTLLSGLSASMNQLIVFRAIQGLGAGALIPLAMTIIGDIFTLKERARMQALFSGVWGLSSVIGPIIGGFITDNISWRWVFFINLPIGVVAAIIIGFALKEPKLDEKPKIDYAGAAILMAAISLLMLAMVEGGTSIATLLAPLNLLLFGASVLLLGLFVWVEKRAADPIIPFALFSNRTVSVSVIAGFLAGFAMFGGISFIPLFAQGGLGATATEAGSLLTPLMLSWVTMSVIGGRVLLKIGYRTISIIGFIILSAGFLMLTQFERTTPYFWLYFDLVLIGSGLGLTMLTLLIAVQQAVERTKLGIATSLNQFTRSIGGAFGVAIMGAVLTAGLATQLHNVALSGTTSLTVEQAEVFASNPNALIDPEAKASLPPGTLVILQDAMAAAIHPAFWVAAFISVLALIATFFLPRDQHDMYSEIHRTDGNAGERMIMAEQTTINARNQPVAEQDSSG
>AIA12808.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MTSKDTAISVTGLKKSYGDNHVLKGVSFSVKRGTMLALLGPNGAGKTTMVRILSTLLRHDAGKVSIEGYDISKDSDKVRGVIGLTGQSASVDELLTGRENLVMMGRLYRLTKASATARAAELLTDFDLNDAADRQVKTYSGGMRRRLDLAVSLIAAPPIIFLDEPTTGLDPRSRIAMWEIIRKLMTDGTTILLTTQYLDEADQLADNIIVIDGGTVIAEGTANDLKSKVGKDRLELVFPNAKSLEQAVKALSEDKLDANTKLHSASLPINNTNHDIKRVLDRLSQQSVSIESLSVHKPTLDDVFLSVTGKQKPKEDEEADT
>AIA12799.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MSNEADVSREETHDNSFWAVVNEGLRGSTRDFTKGPILVALIILAIPMILEMSMESLFAIVDIFFVGKLGAEAITIVALTEAIMALIYAVAFGLAIGATATVARRMGEKDEKEAARTAAHVIYLGMIISAVISVIGIILAPRLLGWLGGSPEVVRDGTLFMRIMIGGNAAVLFIFLLNAIFRGAGDAAIAMRVLILANGLNIVLSPLFIFGVGFFPELGVTGAAVGTTTGRSCGVLYAAWHLFRPGGRIHVSSESWKLDPSLLWKLLRLSSTGMLQMLIATASWSVLIPIIAGFGEVAIAGYQIALRVVVFVLLPALGLANAAATMMGQNLGAGKPERAERAVWTAAGINMAVYFVMGVILWLFSGQIVSIFTNDPEVFAYGAACLHTVAYGFAFYGAGMALETAFNGAGDTWTPTLINVVIFWMVEIPLAYLLAYYFGWGPSGVFWSITISFSLLAIMSALLFRRNKWKEKMV
>AIA12768.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB_3|antibiotic efflux|0
EIKDLHAGIEGREILKGLNLTVNRGEVHAIMGPNGSGKSTLSKVLAGHPTYEVLSGEVLYEGKNLLELEPDERAREGIFLAFQYPVEVPGVSNSQFLRLAYNQKMKHHDMEELDPLEFNDYLTEKAKVVEMDKSFFKRSVNEGFSGGEKKRNEILQMAVLDPKLAILDETDSGLDIDALRIVAEGVNKLRSSENGIILVTHYQRLLNYIKPDFVHVL
>AIA12759.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MSKNSAVSSAVAQSPTLSMSVRRRWAVTAGVLTGMFLAALEATVVGTAMPTVISSLGGLNHYSWVFSAYLITSTVTVPVWGKLSDIYGRRMLYQVGIAIFLIGSALSGMSVSMTQLIIFRAIQGLGAGALVPLGMTIIGDIYTVAERAKMQALFSGVWGLSSVVGPVVGGFITDQLSWRWVFYINLPVGLAAALIIGIALKEPKLTERPKIDYAGAALLMAAITLLMLALVEGGASLTTLLSFRNVALLTGAALMTALFVWVERRAADPVVPFKLFRNRVVTVAVIAGFLAGVAMFGAISYVPLFAQGALGATATQAGSLLTPLMLSWVGMSVISGRLLLKVGYRPTTIAGFALLTLGFVFLSTFQREMARVWLYVDLVLIGAGLGMTMLTLLIAVQQAVSRTQLGIATSLNQFSRSIGGAIGVAVMGAVLSAGLASQLNNLARGGNTALTPESAAELSANPNALIDPHARAALPANVLDALQGAMAAATHNVFWVGTVLAGLALLVSFYMPRSGHDATAPLTEDECSAETGERMVMAELTTIDPEHEPSASPGD
>AIA12661.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MPKSAIVVKNLHKSYGKLKVLEGINLTVETGKVFALLGPNGAGKTTIVRILSTLLKADSGTIKVNGLDVREAPEKVREVIGLTGQYAAVDEYISGRENLEMMGRLYRLSKEDAAQRAQQLLEQFDLVKAADRIAKNYSGGMRRRLDLATSLIATPPIIFLDEPTTGLDPRSRIAMWDIIKDLVAGGTTILLTTQYLEEADLLADKIVVIDGGKVIAEGTADQLKQKVGNERLELTISKKSNFKKAKQIVDGETLQVDEDQRKLSIANNGGATQVKNLLIELEKAKVDVETLALHKPTLDDVFLTLTGKQTQDAEAEPDDESETRRKK
>AIA12662.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAKTTATAFKPQKHSELYWAFSNCATLIVRSTKHIIKNPDQLMSVAFQPIMFMLLFRYVFGGAINTGGTTYVNFLVAGILIQSAAFGASYTALGIATDMQRGIVDRFKSLPMLPSAVLVGHTVADLIRNTVSSIIMILVGLAVGFRPVANVWEWTLVFGILLLFTFAMSWLSSIMGLLAKSVEAVQWMTFVFVFPLTFASSAFVPTDGMPKYLRIFAENQPVTQVIEAIRALLVGTPIGNYGWNALAWCLGILIISIPVSAHLFRTRSPN
>AIA12415.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
SVVDIYFVSRLGANAVAVVGLTESLMTIVYVIAMGLGIGASAVVARRIGEGDEDGAAHSAAQAVLLGVTFSVMISVAGVLLAPALLRVMGGEPSVVSLGTPYTTLMLGGNMVVVVLFLVNAVFRGAGDAAVAMRALFIANIINIVLCPCLILGIGPFPDLGLVGAATATTIGRGIGAIYAFVRLRQKSGRLRVSAAHFALDPALMLRILRIAGSGMFQLFIAMASWVGLVRIVSGFGSDAVAGYTIGIRIIIFALMPSFGMSNAAATLVGQALGAGRPERAEKSVWTAALWNMCFLGAVGLLFIVIPDALVGIFTHDPAVMPYAVDCLRIVACGFLFYAYEMVITQAFNGAGDTRTPT
>AIA12299.1|FEATURES|farme|puromycin|pur8|antibiotic efflux|1
MAQTIGLIVLLSWQLMVVLDGTIVNIALADIRQNLGFSDTSLSWVVNAYALAFGGLLMLGSRAGDMFGRRRLLITGVVVFTVASALGGIASNQEMLIIARVLQGVGAAMAAPSTLSLIVTNFEAGAARNRALSLFASVSGVGASIGLILGGVLTSWLSWHWIFFVNVPIGIAVAVLAPRFVAEAPLQPGRLDIGGAIASTLGVTALVYGFIRAAEVNWTDPLTIASFVAAVILLGAFVAIERRVAQPILPFRLFNERKRSIAFINQLLVPATLFGVFFFLTQYLQVVLGMSAVQSGFAFLPFSATIVIGSRLVPRAVARFGPRTVMIFGGLAVATGLVLMSRLDETASYFPLVFISMVIMASGAVASFVSLSLAIMGTISPEDSGPASGLMQTNQQIGGAIGLAVLVTVFGTVNANALADGSNRIEAMVAGMQRGFLTAAGIALLVTVIAAVGYRSSNRDQQLGS
>AIA12080.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MSFDGQNPPVEAVDNSFRSVMREAFVGTSRDFTKGSILIGLIILAIPMILEMSMEALFAIVDTFFVSKLGAEAIAVVGLTESVLALIYAVGVGLSIGATATVARRIGEKDADGAARTATHAVYLGVMVSLIMAAIGVALAPTLLGLLRAEPQVIEMGVPFMRIMLGTNVVIVFLFLLNGIFRGAGDAAIALRVLIIANGLNILFCPLFIFGVGPFPELGVTGAAVATVCGRGVGVIYAAWMLFGRNNGRLNVTREHWTFRPELLVSISRLSMTAVLQFLVGTASWSALVTIVAGFGTVAVAGYQIGLRVIIFVLLPAVGLANAAATLVGQNLGANQPERAERSVWTAGFLNAGLLGLAGLSFVIFPDLVVSIFTTDPGVARYASDCLRIVGYGYAFYGLAMVMESAFNGAGDTWTPTYLNFFIFWLFEIPLAYVLANYYGFGPQGVFWAITLSFSSLAVVSALMFKRGKWKLKAV
>AIA12076.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSGLSPESAQRLKGMGKLEFIALAAFMMAVNSLAIDIMLPALQQIGASLGVENENHRQYVVSAYLFGFGLAQLFYGPLSDRFGRRIPLLIGLCIYVVAAFGIAVVPTFAGLLALRFIQGLGSAATRVITISIVRDVYGGRQMAEVMSLIMMVFMVIPVMAPSIGQVVMLFGNWHLIFAFMAVVAMIVWSWMYFRLPETLHEDDVRPFTVRSVLGGFRIVLTDRVALCYTLASTFIFGALFGFINSAQQIYVGIYGLGVWFPVAFAAVAAFMALSSFVNAKLVGRFGMRKLSHGALMGFLTVNTLWLVLTLVWPGHVPFPIFIVLFALAMFQFGWIGSNFNSLAMEPLGHVAGTASSVLGFMGTAGGTVIGAIIGQSFNGTALPLVTGFFSLSIIGLIFVLLAERGKLFQAHNKPV
>AIA12024.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MTESKYVIEAQNLTKSYGKTEVLKGINLSVKRGTMLALLGPNGAGKTTTVRILSTLLPFNGGTVTVEGHDVAADADNVRRVIGLTGQSAAVDELLTGRENLVMMGRLYRLTHASAKARAQELLEQFDLLDAAERPAKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRIAMWSIIKDLKAAGTTILLTTQYLEEADQLADRIAVIDGGVVIAEGTADELKSKVGKDRLELTFENEESLQRATKVLDGAATASTDESFTLMLVIQNIDKDVKDTLTKLATAGVSVTALAVHKPTLDDVFLSLTGKQKATEPDAQAEEK
>AIA12025.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAAKTTTNLAFDRRPKWLLAFNDSLIMIQRSSMHILRNQDQLLGTFLQPIMFMVLFATVFGGAIAMALPPGVPYLNYLLAGIIVQMLAFGSTTTAIAIANDLQKGIIDRFRSLPMNNLAVLNGHVVSDLFRNGISTIVMIIVGVIMGFRSGASFTDWLLIAGMIALFTIAFSWVSAVLGVVSKSVEGVQWLSFLIVFPLTFASSAFVPTEGMNKYLKAFAENQPITHIIETLRALMLGKPVGDHGWWAVGWCLVMLVVAVPLAGWLFRRKTAQ
>AIA11787.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MANTANDSVISVKGLKKSYKDLQVLKGITFDVKRGKITALLGPNGAGKTTMIRILSTLLDSDGGSAAINGFDVVKQAGKVRENIGLTGQYAAVDEYLTGEENLRMMGRLYRLSKKDTKRRTAELLEQVDLIEASKRPVKTYSGGMKRRIDMAMSLIASPPVLFLDEPTTGLDPRSRAGMWDLIRKLSDSGTTILLTTQYMDEADQLADDIVVIDNGKVIAEGTSTELKAKVGSDRLELTISSKSDFSTAVSAVKGEKAEIDEEARTISVVASKSGVQKLKQVLQKLDTAKIQVDNVSLHRPTLDDVFMSLTGHTTVKAEAEKTSKKGKK
>AIA11785.1|FEATURES|farme|multidrug|PmpM|antibiotic efflux|0
MSGPITNAPVADNTEKLATESLWQALKDAIRGTSADYTKINLKRAIFLLAVPMIIELVGESLFALADIYFVGRLGSWAVETVGLTETYMFLLYSIGMGVSFAVTATVARRIGEKNKEEAGKAAVQAIFLAILISLPFAIAGIFFAKDMLTIMGGKPEVIEKGYHFTQWMLGGNMVIMLLFIINAIFRGAGDAAVAMRVLLIANAINIFLDWVLINGVGPFPELGIQGAGIATTTGRGIGVLMQLWILFRAGKHIRVLATHVKANWKLLGSIIKTSLGGVGQMIVAMTSWIFIMRILASDNAVAGATIALRIMMFTMMPAWGLSNAAAALVGQNLGAGQPDRAEQSVWKIGFYNMYFMVAVSVLYFFANEWLVSIFTNDPNDLKVGSTWLRILSYSYFVYGWWMVSVQAFNGSGDTRTPTWINIIFFWLIQIPLAYLLAVHWNGGYKGVFWAVFVSETGVGLFTLYLFTRGKWKQAKV
>AIA11746.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTPRRYFLFILILGTLSAIGPFSIDMYLPGFPAIAADLNTSVARVTLSLSSFFIGISAGQLLYGPLLDRFGRKKPLYFGLSLYVLASIGCALATTVDTLIVLRFFQALGGCAGMVASRAMVRDLFPVEENARVLALLMLVIGVSPLIAPTTGGYVSAAFGWHYIFIILTVIGAAILAGVHFVLPETANAGRVFFS
>AIA11499.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MEIEFDKKSERPIELFDDQPHVVLSTVSRRMVTAGILLGSFLAALETTVVGTAMPTIIASMGGLNVYSWVFSAYLLTSTVTVPVWGRLSDLLGRRNLYLAAIIIFLVGSGLSGAATNIWQLIIFRAVQGLGAGGIIPLGMTINGDIYTWKERARVQGLFSMVWGVASILGPLAGGFITDHFSWRWVFYINIPFGIAAMLFVVLALKEPAKTGKPAIDYAGASYLTIAITLLLIVLVETSDARAWTNPLMLVAAASVLLFSWLFVRAEQRAAEPIVPFAIFRNRIVAIGSLTSFLVGTAMFGCISFVPLFVQGTFGGSATESGSVLTPLLLGWVVLALIGGRLMIKVGYRPTVLAGLILVFVSFAILSRFGTWTPRWMLLADIGLLGSGMGLVMLALIIATQNSVGRSQLGIATSLNQFARSIGGAIGVAVMGTVMTIGLASQQEAIQAASGLPEAEVAAIVHNPSALIDPAARSALKPELLHSMEKALASALHDVFLVGAIFAGLAVVAGFFLPKSWDAPAANQTKDRENDEMKCPATVEASEKFLLAEMTTIDPDNEPSIH
>AIA11487.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MHSSLFRTALVLGLLSAIGPFSIDMYLPALPQIAEGLSVTETDVQMTITLYFLAFGVSQFLWGPMADAYGRKLPLVLGILIFAVGAVGCAFAPTIGWLVAARFVQGIGGAAVGVVPRAIIRDRFTGLEATRLMAMVMLVISVSPMLAPLAGSVVLQFGGWRVIFGVLVLVAAMSLLVTLFALPETLARQDRFPVNLRSMGSGCRRLLGSFSFMGLTLVGAFGFGSFFVFIASASFVYTETFGLTPTQFSLAFALNALGFFAASQAAAPLGMRFGMVRVMRIALWGFAAANVLLLALTLGGAGTLPVLMACLFVGNAFMGLVMPVTFVMALEEHGDIAGLASSLGGTIQMVTGSILVAATAPFFDGSALPMVATICFCAVAALVVGLAVLRRGIQMAPAPAAAE
>AIA11486.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
AGAACPWLADGRLRQNEANMQSQIFRVALVLGLLSVIGPVAIDMYLPSLPAIGDQMGATTAEVQLSLMAFMAAVAICQLAYGPVSDMVGRKPPLYFGIVLFTVGSVGCALAPSIEWLIAFRFVQGIGACASMALPRAIVRDNYTGAEAAQLMSLLMLVFSVSPLLAPLSGSLVIQFGDWRLIFWVMAAIGVLVTLLAVFALEETRPAALRVESSVGSAIRAYGVLLKDWNFLGLSFIGAFGIGSFMGFIGNSSFVFIEHYGLTPTLYSLAFSVNALSFFAVSQSTGPLVRRFGLNRVVRVAVAGFAVSMLALFAIFAVGIDSMWVLSALMFVGFGFLGLVVPSTAVLAMEEHGEIAGTASALMGTLQLVSGAVVMGLVGAFFDGTAMPMVAGFAGCALLAFVLTQFTIRGESRPVAAPAE
>AIA11229.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB_3|antibiotic efflux|1
MLLEIKNLHAGIEGREILKGLNLSVNKGEVHAIMGPNGSGKSTLAKVLTGHPGYNVISGEVLYEGKNLLELDPDERAREGVFLAFQYPVEIPGVSNSQFLRLAYNEKMRHTGQEELDPLEFNDYLKEKAKIVEMDKSFMNRAVNQGFSGGEKKRNEILQMAVLQPKLAVLDETDSGLDIDALRIVAEGVNQLRSPENAVILVTHYQRLLNYIVPDFVHVLAGGQIVKDGGKELALELEAKGYDWVKTAANGK
>AIA11224.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTVISNIEVRGARVHNLANIDVSLPRNQLIVITGLSGSGKSSLAFDTIYAEGQRRYVESLSSYARQFLQLQDKPDVDLIEGLSPAISIEQKTTSKNPRSTVATITEIYDYLRLLFARIGMPHCYHCHKPITQKSATAITDEIMSLGQGVRISILAPIVRAKKGEHKLELSKLSKEGFVRVRVDGELRYLEEDIELNPKTKHSIDLVVDRLVVDIQERPRLSDAVELSLKKSGGLVLVLKHLADDTMVEELFSEHFGCVDCGTSFPEIEPRMFSFNAPQGACQTCNGLGNFLHFTEEKVIKNQSLSLDQGAISPYAANQKGYYYSQINSVAKAYDAPLDLPWKKLSKKVRDFILFGSDKRINFVFKSEKSGRTHRASRVYEGLINQLKRRYEETDNDTIRLELETYMSRDFCPDCQGARLNLFARSVKIEGKAIYELTDMAIKESVQFFNDLKVLERQQKIADPILKEIRARLSFLEAVGLDYLTLSRAARTLSGGEAQRIRLATQIGSALVGVLYVLDEPSIGLHQRDNEKLLNTLKNLRDLGNTVLVVEHDEDTILASDYVVDMGPGAGALGGQVVAVGSPKAIMKNKASLTGRYLSRELAIKTPKTRRTGTGKVLSIKNAKGNNLAGVDLNIPLGVMTAITGVSGSGKSSLIIDTLYAELASQLYASSIDVLP
>AIA10927.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MSQSKYVIEVEGLRKAYGSNQVLKGIDFNVERGTMLALLGPNGAGKTTTVRILSTLLPFDEGSVHIEGNDVRADADKVRSVIGLTGQSAAVDELLTGRENLVMMGRLYRLTPESAKARAEELLEDFALVEAADRPAKTYSGGMRRRLDLAVSLIATPPVIFLDEPTTGLDPRSRIAMWEIINKLKAQGTTILLTTQYLEEADQLADRIIVIDGGKVIADGTAKELKGKVGKDRLELTFADAAALKAGAKVLGKRVADTNEKEFSVSVVMQDLNVDTKEALTLLFDAGVQIAAMTVHKPTLDDVFLSLTGKQKQTEESEEETK
>AIA10751.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|0
RQLSVVGVIMLLIGELAGTFVQQVLHRPAEDMWIILAPAGIGLVSASIFMPHITQRFGRIRLTVIGFIVLAAGFLLLPASEWVALHLNPQHGAESPLLLWTTVILVFFLGVAMAVVNIPTQTLMQERAPEAGRARVLSLQFMIYNTGSIPVLLFAGIISQVLGFGLLIVLLSSSLLLFCWWGVSYTRDADKQPEGQKEDDIVSSSSR
>AIA10442.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MIIVFGILNALTPFTIDLYLPAFPQIAADLGVAVSRMSLSVSVYFIGFALGQVIYGPLLDRFGRHRPIYGGLAIYVLATLGCMTTTSFEGLLVFRFISALGGSAASVGAIALVRDHIPAEKAARAFATLMLVLSVSPLLAPTIGSLITTAASWRAIFAVLAVLAIANLALVMFAVPRTYSPDPSVSLRLAPILRTFRDALAQPQFRTYTLAGSLSFAGLFVFVSGSPAVFMDGFGVGPSGFGAIFAILAGGMILGGQLNHLLLKHFASEQVFRRALFVQVISGVTFLALSLTLDLGKWPTVVLLFAFLHCAGITYPNAAALALQPFTKNIGSASSLLGFLQLGMGAIAAALVGVLDLTGPTPMAFVMAVCSTAGWILLNSARRLGEASAVEQTSTQ
>AIA10436.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MQPGFLRTAVILGLLSAIGPFAIDMYLPALPSIGADLGAEPFTVQMSLLIFFLSMGFAQLAVGPLSDMYGRKAPLYAGLAVFAIGSVGSALAPTIESLIAFRFLQGLGASAGMVVPRAVVRDMHTGVQAARLMSLLMLVFSISPILAPLTGSFIIAAAGWRWVFWAVLIAAAIATVLLSFGLDETRPVEERSGSSLSSALKGYAFLMRDRNFLGLALIGGFGISSFFVYLANSPFVLIGHYGLSPSVYSLFFSVNAVAFFAVSQMTGYLTERFGLKRVVWVAVSAYAAVMAVLFAVTLAGFESLAIMAPLLFVGYGFLGLVIPTTSVLAMEDHGEIAGTASALMGTLHFAAGAAAMIISGLLADGTPLPMITGITACALIAFGLGAVVLGRRRETAEMEENAVPAE
>AIA19235.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTATTVPASSRTYPSLRAAWIPLAALCLAFFVEMVDITLLSIALPTIGRDLGSGTTALQWVTGAYSLTFGGLLLTAGSMADRLGRRRVLLVGLAVFGLLSLCVVAVSSAGQLIALRAGLGIAAAAMAPITNSLVFRLFDDQALRMRAMTLMIVVGMSGFVLGPLLGGTALAHVSWQWLLVINAPIALIAAIGVRLGVAADRPEDLTQDRLDLPGAALSVL
>AIA19232.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
MVMSPLGDMLMKSMGLTTKQFGFAVSAYAFSAGISGLLTAGFADKFDRKKLLLFFYIGFIAGTLCCSLATTYPLLLAARIVTGIFGGVIGSISLAIVADLFPLQQRGRAMGFMQMGFGASQVLGIPISLYIANHWGWQSPFMMIVGLATIIWLAVVFKMQPINKHLEVQSDKTAIKHLWHTVRQRHYRIGFLSTALLSLGGFMMMPWGSAFAVNNLGVTYNQLPILFMVGGVASLFIMPLVGKLSDKFDKFKIFTIAAVWMMIVVVIYTNLAMVPFWFVIIMNIVMMIGIMSRMVPAMALTSALPQMQDRGAYMSISSSLQQIAGGIAAVVGAMIVAQNTKTSPLQHYDTLGYVIVVIIIVSIIMVYRVSKIIKSRMHAEKL
>AIA19223.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTSGVEHGWLSAITIGSVLGAVAAGIGFVWHERRSAAPMLDLRLFSNGTVRGAAIAQIGTSIAMAGVMFGLILHFQYAYGWSPVRAGLANLPLIVTMIVATPLSEWLAKRFGHRIACLVGAACLAAALAGLAWGVDHGYAAIAVCMVVMTIGLRTVMTICAIALVDAMPANRTSIGTALNDTAQEVGTSVGTAVVGTMIAALVTTQLPAGVWSSSLVQSFFHGERITYAVLAVVVGVVAAGGALTLTDSHSVEESA
>AIA19220.1|FEATURES|farme|quinolone|qacB|antibiotic efflux|0
VVNAKVLTTLLIIVAVINWRCGKLIGGFVDRFGEQKVLTVGYALHGVTFLGFALSQNVWMLYGFYILYNFLFLFSVGTTTYLRKICKREDLAPSLAMGVSLSHVTAIVVPIVGATLWKQLGYQFPFLFGTVFVALSLIATQKINKSKEALAHHAT
>AIA19142.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
LGGVLGDIWVRAPFLAAAALNGLNLLLALFVLPESRPGSRNARFDANTLNPFVPLAWAVSLKGLLPLIAVFFILNFVGNMYGTVWALFGVDAFEWNGLMVGLSLAGYGLFHALVQALLPGLIVKRIGERNALLVGMAFESAGLLLTAVATQGWVVFAVLPLYALGGVGV
>AIA19116.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MNKALIVILAAVTLDAVGIGLIFPILPRLLEDVTHTGEVTTLIGIMLALYSAMQFLFSPVLGVLSDRYGRRPVLLLSLAGAAIDYLIMAFAPELWMLVLGRAIAGVTSANMAVATAYITDISVEEERAKRFGYFHAMFGIGFIIGPVIGGILGDIWVRAPFLVAAGLNAVNFALALFVLPESRKGDSSSKFDFKTLNPFRPLGWAFSFTALLPLMAIFVIMNFVGTMYGTIWALFGQDMFQWNGLMIGLSLGAFGLFHAGAQALLTGPVAARLGERWAMILGMACELTALLILGFATQGWIVFALAPLFALGGIGMPALQSLTTQQVDADNQGKLQGVLASLVSLSAVFGPLFFSMVYFALKPTWPGLIWIVGGGVYLLALPLLLGIRRTPLATVTPEG
>AIA19101.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MIIPVMPELISSLKHIPANEASAEGGWLLFVYALMQFIFAPIMGNLGDRYGRRPVILFSLFGFGVDYLFLALAPTYGWLFVGRTIAGITGASFTTASAYIADVSTAENRAKNFGMVGAAFGLGFIIGPAIGGLLSGFGLRAPFYAAAVLTLLNWLYGYFILPESLSLEHRRPFDWRRANPLGALMHLRKYPAISGLIFSLVLVYLAVHAVQSNWNYFTVYRFNWTPKTVGISLAVVGLLVAAVQAGLIRIITPKIGNERSIYFGLAFYSLGLFLFAFATQSWMMFAFLVPYCLGGIAGPSLQATMTGHVPPNEQGELQGALTSLMSVTSIVGPPLMTNLFAYFTSTKAPIHFPGAAFLLGGILMLISTFIAYNSLKTERAQ
>AIA19095.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MKKALSVVYATVVLDAAGIGLTLPIFPRLLRDVGHTDDLGWRFGAFLALYALMQFLFSPVLGSLSDRFGRKPVLLVSLAGAAIDYVFMALAPALWMLFLGRAIAGLTGASNAVAAACVTDVTEEHERARRFAQLSACFGVGFIAGPAIGGILGEYSVRLPFIAAAVLNALNFAVAIFLLPETRKRSEGEEGQPLSPFTHFKWLFSFKPLLTLMAAYFLLAFIGEVGGTVWVLYGQDKFAWSAMMVGISLAAFGFFHAVVQAFVAGPVSERWGERRAVLIGVIADSIAYVTIAFLSEGWMVFFLMPLFCLGGIGAPALQSLVTANVDAEAQGRVQGLLASMVSLASIAGPLAISTIYFASRDVFPGLVWVLGAAVYLGLLPLIFSRRPAVSS
>AIA19083.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MKKFYNVLINTLIANVTTSFLWFALTFWVYLETRSVLATAIIGGTYMLFVALFSIMFGTIVDHNKKKKVMLISSGITLAAYLIAGFVFLSFSKAQLTDYTTIAFWLFGLIILIGGVVENMRNIALSTTVTLLVPEKDHARANGLVGAVQGVAFLVTSVFSGLSIGFLGMGWTLTIAIILTAVAFIHLLFVPIPEEKILHDPELANKKIDIKGSIAAIRAVPGLFGLIIFSTFNNLIGGVYMALMDPYGLNLFSVQIWGVVLGITSIGFIAGGILIGKLGLGKNPIRTLLIVNIAIGALGMLFTIREFWLLYVVGIFVFMMLIPFAEAAEQTVIQKVIPFKRQGRVFGFAQTIETAAAPITAFLIGPIAQFGLIPYMNSDAGKSQLGWLLGDGSARGIALVFLIAGFIGIIITIFAFYTKSYKHLSESYQKKS
>AIA19084.1|FEATURES|NCBI|multidrug|salA|antibiotic efflux|1
MIADISISEKSFGPKSLMTNVRFTINDAEKIGVIGRNGVGKSTLFGVLAGTDKDFSGEVNYKPGTVVVATQQEYHDVGDKTVLQYILQGLPEYTDLSHIIETYPETMGDNLKKINEYTEALQRFDDKGFYQIEEQIERELNNFQLDGIAHREFTTLSGGQKRLVEVVKIMHSDAHLALIDEPTNHMDYIAKQQFIDWIKQAREAVLVITHDRDVLREVDRIIELKDGGSASFKGNYDGRY
>AIA19050.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|1
MNDVKQTAMHHARKLTDKQKKIALLIVAFAFVMDLLDSTIVNIAIPSIQVNLGASYSTIQWLIAGYSLTFALLLITGGRLGDVYGYKKLFMIGVGGFTAASLLAGIAPNAGFLVAARLAQGAMAALMVPQVMSLMQVMYEPKERVGVMGMFGMLGGLAASLGPIVGGLIIKANFFGWDWRPIFLINLPVGIFALVAGAKFLPEGKSPHPLHVDVKGTLLIILALSMFVFPLIEGRDLGWPLWSIGMLAASIPVFAIFGWYEVRKDRRDKSALIVPALFKIKTFISGLGLNVLVESLMVGYFLTFTLVLQAGLGYSPLKAALTGVPTAVGMTIGFTVLGQKLMARYGRAVISMGATIFGAGLVGVAWVFTHYTLTTHPWQFSLPLLLLGIGLSLIMIPMFSAALQDVDPGHAGAASGALNAVQQVGAAVGIAIIGVIFFGQLSSGATKSFAQIVPEMRQELSALHVPQAAQVEIIRQTGTCFYDRSTAKDDTKIPASCQQAQASVPVDENGQKIVDVVAASAKAANAHNFASAFRSSVVYILIILVVVCGISLTLPRKLRVVEEAA
>AIA19015.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|0
MRITVEKIGKKFIKEWIVRNASFELAAGEKYVFVGPNGSGKSTLLQLLTGVIPVSEGKIAYTDVTGKEIETDHWYKHLVIAAPYLELIEEFTLREQIEFHNKFKPFKNGISARDFEDFIQLPHASGKIIRHFSSGMKQRVKLGLAFLSDVPVVFLDEPTTNLDVQGINWYLDHVMDNTQNQLVLLGSNVQQEYEFCKNIISVSAFK
>AIA18941.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MADLQFEKRPKLLFALTDSFIMIKRSSLHIIRNTDQLLGTFFQPLMFLVLFTAVYSGAINTGGTNYSDYLMAGIIVQTIAFGSTTTAIAVANDLQKGIIDRFRSLPMSNLAVVTGHVISDLLRNGISAVVLILVGILLGFRPNADLGEWLMVILLLALITMALSWLSAILGIVAKSVEGVQWMTFVIIFPLTMASSAFVRPETMTSWLRGFAENQPVTQIVDAVRGLLLGTPMSENAVVLAIFWCLVVMAVSIPVAAFLFRRKTNQ
>AIA18937.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
NTLLSIALPTIGRDLGGGTTSLQWVVGAYSLTFGGLLLTAGSMADRFGRRRVLLGGLAVFGLLSLCVIWVTTTGELIALRAALGIAAAAMAPITNSLVFRLFDDNQLRMRAMTVMIVVGMAGFVLGPLLGGTALAHVSWEWLLLVNAPIALIACLGVRLGVPADRPEGLTHDPLDLPGAVLSVCAIGLACYSLTRGVEHGWLSVATIASVVGAVAAAVAFVWHERRSASPMLDLSLFANGTVRGAVIAQVGTSIAMASVMFGLILHFQYAYGWSPVRAGLANLPMIVTMIAATPFSEWLVHRFGQRIACLVGAIFLAGSLAGLAWAVGHGYLAIAVCMVLMTIGLRTVMTICAVALVGAMPSNRTSIGTALNDTAQEVGTSVGTAVIGTMIAALVTAQLPAGVWSSNLVHTFF
>AIA18851.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MEKLIVLKAREVVKTYGKKENTFVALKGISLAIKEGESVAIIGKSGSGKSTLMHILAALDRPDSGELEFNGKNVDNFKDRDLDRLRNHDFGFIFQQFFLNYRETVLENVMLPLKIAGVGRRERKKRAMEALAEVDMTNKADNKASDLSGGQKQRVCIARALVTNPKVIFADEPTGNLDSENGQRVEGMLFDLNRKKGMTLIIVTHDDDLAAKCDRRLYMKDGILTEGNDNEAARPRANRKPKPVTL
>AIA18826.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefC|antibiotic efflux|1
MSNQTPETTEVNSTSTEDKAQSPAFKTLMRNRNFRSLWLAQVVSDFGDGLTNIALLFLINSLTGSAAAIATMFVVLTIPQVTIGLVAGVYVDRLDRKKIMIFSDLTRGLLVLALIFAGSRDLLWLMFVIAFLQASVGTFFTPARAALLPNIVPADTLLSANSLSQVSRIIFGLLGTAAAGLLIGAFGLYWPAFLVDALTFFASMLLVSRIVAQTRAKGVNTEATARAIFAQLVDGIKLVVRTRTLLGTLVAAGVAMLGVGAVNVLLVPLIVNDLHVSPAWFGAVEFAQTSSMVLSGGLVAILARRLKPTGMLSTSMVVLGVVIASLSLVTDVWHILVILFAAGWAVTPMQASIATIMQTYVDDNLRGRTAASLNTMISTASLVSMGAAGVLASAIGVRTVFVAGGALVIVAGIASALVFRGIVQTRQNKPQAAIAGESLSGGTV
>AIA18803.1|FEATURES|farme|multidrug|qepA|antibiotic efflux|1
MATTEPKANFTNPITPARAGRREWIGLAVLMLPTLLIVMDLTVLHLALPHLSADLKPSSTQMLWIVDIYGFMIAGSLITMGTLGDRIGRRRLLLIGAGAFGVASVIAAFSTSAGMLIAARALLGIAGATLMPSTMSLIRNMFLDPRQRTVAIGIWVSGFSVGSAIGPLLGGLLLEHFWWGSVFLLGVPVMVLLLIAGPLLLPEYKDPNPGHFDLISAGLSLVGMLSVIYGLKQIAQNGVAWLPILFIVAGLSLGVIFVRRQRTLADPLIDLRLFRVPAFSTSLITYTFGIFFAFGSFLFIAQYMQLVLGLSPLQAGLWTVPGAIASIIGSNIAPRLVRRVRPAFVIGGGLALATVGLGLLTQASVNSLAVVVIGWVAMSLGFGMTFTLTADLVVGTAPPERAGAASALSETGAEFGGALGLAVLGSIGIAIYRSQVAATLPAGIPPEAAAAARETLAGAVAAAGQLPDQLGAALLNSAHLAFVHALQLVALVGVVGFIGLTILAPVLLRDVLIHAEPEDHPEKAHAVPNVTARPLHDAQVGD
>AIA18802.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MPATASSKKSAMGFIFVTLLIDIMGWGLIIPVMANLIAELKHIPVNQASTYGAFLLSVFAIMQFLFAPVMGNLSDRYGRRPILLLALLGLGIDYIVLAVAPTYGWLFLGRMIAGMTGASFTTASAYIADISTDETRAKNFGMIGAAFGLGFVLGPALGALLATWGIRAPFYAAAALCLLNCLWGYFMLPESLDEAHRRPFEWKRANPFGSLKFLTKHPEIGELAFCFFLIYLAAQAVQGNWNFFTIYRFGWSEKMVGISLAVVGVLVGAVQAGLTRVVNPKIGDEKSIYLGLGLYTLGLVLFAFASETWMMFAFLIPYCLGGICGPSLQSVIAGHVAKNQQGELQGALTSLMSVTTIIGPLIMNNAFSYFTSDKAPIHFPGIHFLIGAVFMLTSLFIIYRVLSREKKEHPEMISVIEGSAKKEEAAP
>AIA18800.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MASSRPAALGFIFITLMIDVTGLGIIIPVFPKLIQEMIHGDLSRASEYSGWLTFAYAIMQFLFAPLLGNLSDQYGRRPVLLGSLLGFGVDYLFLALAPSIGWLFLGRIIAGITGASFSTATAYIADISTPEKRAQNFGLVGAAFGLGFIIGPVVGGLLGQFGPRIPFYVAAGCSLLNALYGYFILPESLAPENRRRFDWKRANPLGTLLQLKKYPATLGLVSSLAILYIASHAVQSTWAFYNMQKFGWNSAWVGYSLGFVGLMVALVQGGLIRLVIPRIGQEKSIYAGLFLYSAGMLLFAFATKGWMMFAFMVPYALGGISGPAMQGMISNKVPPNEQGELQGALASLMSATSIVGPLIMTYLFGYFTSNRAPFYFSGAAFVVGSVLILIGIWVAARTIKRHR
>AIA18790.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|1
MKYLLNFSLLIRNRNYGLLFIGQFISFLGTMITGVALPYQIYHETQSTLIVGLLGFFQLMPLIVTALLGGVFADRYHRRMLLLVTESILALGSVLLAFNATLATPHIGFIFVVAVLMSAVNGLHRPALESITQQIVSKADYPAVGALMTFKYSIAMIAGPAIGGLIIAHFGLVVTFIVDFISFGISLMALCLMTHIPKPERSAEDLSTWSSVKQGFVYAASRQELIGTYMVDFVAMIFGMPTALFPAIAQSYGGVKTLGLLYAAPAVGALVISFFSGWSQKVKRHGAAVAISAGFMVVFNYLFWLSK
>AIA18573.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
QINPHFCEPISIMPTNKKAAITFIFFTLLIDVMGFGLIIPVMADLIAQLKHIPMNIASNYGAILLSVFAITQFLFSPVIGNLSDRFGRRPVLLCSLLGFGVDYIVLAIAPAYGWLFIGRVVAGITGASFTTATAYIADVSTNETDRAKNFGLIGAAFGIGFVLGPALGGFLAHWGIRAPFYAAAALCLLNCLYGYFFLPESLDAQHRRPFEWKRANPFGSLRFLTRHPEIGGLAIGFFLIYLGAQSIQGNWNFFTIYRFGWSEKMIGISLALVGVLVGGVQAGLTRVINPKIGNENSIYLGLSLYTFGLLLFAFANQSWMMFAFLVPYCLGGICGPSLQSVISGHVPVNQQGELQGALTSLMSLTTIIGPPLMSLTFSYFTTDKAPFYFPGMQFLIGAVCMLLSVIIIYKVLNKEKKEHPELRTVIDNENV
>AIA18568.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MRSASLLFIFVTIAIDAIGMGIIIPVLPDVIRRFLSDEAAISRVYGYFIAVYALMQLVSSPLLGALSDRFGRRPVLLVSLLGAAVDYFFMALAPTLPLLFLGRIISGVSGASFTVASAYIADISNDENRSKNFGVMGAGFGLGFILGPAIGGLLAAYGPQYPFLAAGAFNLLNFLYGAFVLPESLGTHQRRAVQWRSLNPLRSLHALSKMPAIRALVLVHVLIQLAGQTHPSIWTLYTEHRYGWSASEVGLSLAFVGVLSALSQGLLTGVIVKRFGERKVLTMGCLGEALSFTLFGLAVNGTMLYLVLLFSSVFWAAHPALQSLVSREVPPSEQGELQGSLMSLTSLMSILNPLIMTTLFAAFSVRGTGHYVPGAPYLLAGALYLAAWGMAARWERKHPEHG
>AIA18567.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MDRTQPITQATPARTYPSLRAAAIPLFALCLAFFVEMVDNTLMSIALPTIGRDLGGDTLSLQWVTSAYSLTFGGLLLTAGSAADRLGRRRVLLVGLAIFGVVSLGVLAVDSTGQLIALRATLGIAAAMMAPITNSLVFRLFDDDVLRRKAFTMMITVGMAGFILGPVLGGTALAHVHWQRLLIVNAPIALIAWMGVRIGVPADHPEDLTHDALDLPGALLSVAAIGLGCYTFTSGVVHGWLSWQTLGSAIGALVALAAFVVHERRTAEPMLDLKLFSRDTVRGASLAQLATAIAMAAVMFGLILHFQYAYGWSPVKAGLANLPLIVTMLLASPLAENLVTRFGHRVACMIGSAFLAGSLVGMAWAVEVGYPAIVVFMVTFTIGLRVVMTTCAVALVDAMPSNRTSLATSLNDTAQEVGTSIGTAFIGTMIAVLVTKVLPDGVWSDALVSSFFHGERVAFLALAGVVGVIAGWGSLTLTDSHATEEH
>AIA18551.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MLLLGRLIQGLGVSGPTTVCVAVIADIYTGDRQVKLLSFMNSAITVVMASAPILGAYLSAAFGWRANFLVIFASAVLATLLIAFTVPEGHPVEHRKPFAVKQLIKNYGTLLRSKLYMTTVVGLIFLITPYFVFIATIPFLFIETLKLPISEYVYYQGSVVGMFALLSLIVPSLVGKFDADKMTIRSTIVSLLASLALCLVGLLLPDNALTITVLMCVLVLGQVWPCSLLFPATMEFFPELRGSAAALFQSMRMLVMAAAISISGHIYNDTFMPVGVLMFILVAIGVPILAIALR
>AIA18546.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MTQRKAAIRFIFVTLLIDIIGWGIIIPVMPELLKQMEHVDTGTASSLNGWLLFAFSITQFLFAPVIGNLSDKYGRRPILLMSLFGFGLDYIMLSWAPSVEWLYVGRIIAGITGASFTTASAYIADISTNENRAQNFGMIGAAFGLGFILGPILGGLLGTLGPRVPFIAAAILCFVNCLWGYFILPESLDKAHRRPFDWKRANPVGSLLHLRKYPDLNYLIFAMILVYLASHAVQSNWSFYTIERFHWGEGMIGISLGVVGFLVGGVQAGLTRVVNPKLGNARSIYIGLILYTIGMFLFGIATEGWMMLVFLVPYCLGGIAGPALQATISSQVNVKEQGELQGALTSLMSATSIVGPPMMTNLFAWAVRPGNPIYLPGAPFFLGSILMAASAVIAFISFHKGKGAKKTVDAG
>AIA18543.1|FEATURES|farme|tetracycline|tetPA|antibiotic efflux|1
MFRKFDAYKLYLGLQFFTGLFFSMIFVVASLYEATIAGLTGTQLVLVGTTLELTVLLFEVPTGIVADAYSRRLSIIFGYLLMGLAFLVEGYFPVFSMILLTQLLWGIGYTFTSGATQAWLSDEIGEENANRAFLRGNQYDLAGSLIGMLLAIPLGNIAVNVPILVGGAAVASIGLFLLPFMPENGFKPVRPEDRNSFQHMGDIFKKGISVVRSRPVLLSVLGIGFIYGLYSEGWDRLWVKYLVDNFTLPSIFGMNEVAFFGLLRAGGMLLSILATRQVEKRLDANHAPSIARAMLWITVLLSAAIFTFAFSPALAISILAVTAVSILRNVMGPLYSAWVNQRLDSDARATVLSMSSQVDAIGQVMSGPIAALISLASVQAAITMASLLLLPAIPLIKRANRLHAEDESRITPEIQSAD
>AIA18369.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTTLPATGARTYPSLRAAWIPLAALCLAFFVEMVDNTLLTVALPTIARNLHSDTTSLQWVTSAYSLTFGGLLLTAGSIADRFGRKRVLLYGLAAFGTISLGVAMVSSSGELIALRAALGLAAAAMAPITNSLVFRLFDSPTLRMRAMTVMIVVGMSGFVLGPVLGGTVLAHFQWQWLLLINAPVALIAWLGVRIGVPGDRPEDLTHDRLDLPGAVLSMATIGLACYSLTSGVQHGWAAPLTIASMIGAGAALVGFILRERTADSPMLDLTLLSRGPVRGAAVAQAGTAIAMAGVMFALILHFQFAWGWSPMRAGLANLPLILTMIAATPISEGLTKRFGHRIACLVGAGFLVAGLIGLAWGVEQNYLAIAASMVVMTIGLRTVMTICAVALVGAMPENRTSIGTALNDTAQEVGTSVGTAIVGTMVALLITTTLPDGVWTSELVASFFHGERIIFVVLAVVVGVVAALGALTLTDSRNVEEHDEPEDAAALAVAAR
>AIA18174.1|FEATURES|farme|tetracenomycin|tcmA|antibiotic efflux|0
MHSRRTKRKVFVLEALNSMATSYYFYYLFFFLRAEFKFGDLGNLVFCASNGFVYMFAAWFGGRFAQKHGYLFALRLGFSIAALALGVGSQVANVPAHLIVMVGWTIGVCFIWPTLEALVSERESGRQLQRMVGIYNIVWAAANAVAYFTGGAMLEHFGLRSIFYVPLGLHVLSLVLLFNLERRVRAFPTAPPSDLVSGAETSTVVERLASPVHPKVFLKMAWIANPFAYIAINAVVPVIPRLAHRLDLSATFAGFLCSVWFFARAGAFVFLWLWTGWHYRFRWLATAYVTMIL
>AIA17989.1|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|1
MKKSIYIMALGAFGIITTEFGIIGIMPAIAKHFQVSIDTAGWLLSGFALTIALTGPFSVLLTAKINRKWMMCLVLFTFVLSNILSAVAPNFTVLMIARILPAFLHPVFWAVSTVAAARQVEPKDAPKAVSVVLAGLSIATVLGVPLTTYVSELINWKASFWVSGVINLIAFAALAAFVPSMPVTEKQSTKSQLVILRKGQMWVNLIATMIMIAGIFATYSYLAEYLGKISSMDGKQTSLMLLLFGTTGIAGNWITGLALSRNVMITTRFFLLSLIAVHVMAYLFGGLFIPMTAIVGIWGFIHTGGFLIGQTRSTSEAPEAPELAASLMVSFGNAGVTLGTFLGGIIIARFGVHQVIWISILLLLVSLALTFVFIGRRSVTPERETALPSAGLLEI
>AIA17987.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MDAPPTEELFAMHTRFVRNAVILGLISAIGPFAIDMYLPALPTIGKSFTADIGTVQLSLMLFFVSFGTFQLIFGPISDMFGRKLPLYLGLVLFAAGGIGCAFAPDITTLNVFRFIQGIGACAGMVIPRAVVRDLHTGIDAARMMSLLMLVFSISPILAPVTGSLIINFAGWRAVFWVVTAAAVLGLILIATMLPETRPKLARVESGIGSALSAYRLLLGDWNFLGLSFIGGFGIASFFVYLANSPFVLIDHFGLTPTLYSIFFSINAVSFFAVAQFTGKLADRFGLRRVVRVAVIGYFAAMTVLFALTTSGFDRLDVIAACLFVGYGFLGLVIPTTAVLAMEEHGEIAGTASALMGTLHFATGAVAIAVIGLFADGTVLPMVAGIAACALITFILGQVTLRQRQAIEVPAE
>AIA17964.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTNQSLAARALSRPEFIALIAALMAMNALAIDVMLPALPYMGEALGVDNVNERQLVVSAYMLGFGAAQLAFGPISDRFGRRAPLFVGLVIYVLCAFAAVFAPTFAILLALRFAQGLGAAATRVVAISVVRDRFSGRDMAEVMSLTFMVFMVIPIIAPGIGQIILLTGPWHYIFLLMGGLATVITAWAYLRLPETLHPEYRRSLSLSSVTDGFRIVFTNRVAPCYGLAGMLLFGGMFGFIISSQQIFVDIYGLGPWFPLAFAFMAITMAIASFLNSRLVQGLGMRRLSHGALVIYLATSAVWLVASLVGPIPFWMFYALFLVIQFMFGFMASNMNSLSMEPLGKVAGTAAAVFGFTQTVGGALIGTYIGQHLNGTLTPNALGYVVVGALVLGCALIAERGKLFGVSPEYAHAPAAID
>AIA17961.1|FEATURES|farme|tetracycline|tet(30)|antibiotic efflux|1
GFIVGPIIGGLLSVYLLRAPFIVAAGLNALNLILALTVLKESRVPSREKLDLKSLNPFAPLKWALSFPALAPLIALFLIFAINGDIPGTIWVLYGTEKFAWDGVTLGLSLATFGLCHALAQAFITGPLTKRIGERWTLVVGIASDMIAFVCIGLATQGWMAFALSPLFAGGGVGLPALQSLMSAQVGEDRQGELQGVLASAQSLTSIAGPLIGTTVYFFTKPVFPGAVWLIAAALYLLAFPILSGLLRRPKAVAA
>AIA17962.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MNRPLIIILAAVTLDAVGIGLIFPILPRLLEAVTHVDNIAPYVGIMYALYAAIQFVFSPVLGVMSDRFGRRPVLLISLAGAAIDYLFMAFAPELWMLVVGRAIAGLTSANMAVATAYITDITPEAQRAQRFGMFHAVVGIGFIIGPVLGGLLGDIWIRAPFIAAAGLNALNFALALFVLPESRPGQKGVKFDFKALNPLVPLGWALGVKTLLPLIAVFFILNFVGNMYGTVWALFGVDAFQWNGLMVGLSLAGYGLFHAIVQAVLPGPVAKRIGERNALLVGMAFESAGLLISAVATQGWIIFAVLPLYALGGVGVPALQSLTTQQVGEDKQGQLQGVMASIVSLASIFGPLFFSAVYFGIRDSWPGIVWAVGVGIYLLVIPVILTVRARPAAEKTA
>AIA17951.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|0
MGSAALNQGARYSALRSRNFSLLWIGLIVSNAGTWMQNVASGWLVLQLTDSPLWLGLLGLSFALPMIVLPVVGGAVVDRVHRIRLLYVTQTGSMLLAFTLALLTWLNLVNVWHLLAVSFLGAALLAFDNPARQALLPELVPPADLMNAISLNSATYNGAALVGPAIAGALLGPLGAGTLFFLNGVSYLAVIFALLAMRDVRSHGGGKTTSLRASMWAGLAHAANHRFILALLALSALAGIFGRSYQNLLPVFARDIWNGGPAGYGILLSSAGGGALLGALGMASVKSPSKPERVMLASGLLFGLALFAFALSPNLILGALLLFVSGTASTVFGTMIATFVQLSTPNELRGRVMSLYAITLIGLPSLGALGSGAVAEWLGGIVGAPRAVLAGALVVCLILIGVTPYFARRPMARHTNPSFRG
>AIA17949.1|FEATURES|farme|tetracycline|tetC|antibiotic efflux|1
MQKKNTKAALSFIFITLLIDVMGWGLIIPVMADLIAELKQIPVNIASTYGAALLSAFAVTQFLFAPVIGNLSDRFGRRPVLLCSLLGFGIDYIILALAPVYGLLFIGRVVAGITGASFTTGTAYIADVSANETDRAKNFGLIGAAFGLGFVLGPALGGLLASWGIRAPFYAAAALCLLNCLYGYFFLPESLSKENRRPFEWKRANPFGSLKFLTRHPEIGGLAMGFFLIYLGSQSVQGNWNFFTIYRFHWSEKMVGISLAIVGVLVGGVQGGLTRVVNPKIGNEKSIYLGLSLYTLALVLFALATQSWMMYVFLIPYCLGGICGPSLQSVISGHVQANQQGELQGALTSLMSLTTIIGPPIMSFTFSYFTTDKAPFYFPGMHFLIGALCMFLSIVIIYKVLSKEKKEHPELRNVIEGSEGEQKS
>AIA17650.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MAAVEIRDVRKAFGPTQILHGVSIDIADGEFVILVGPSGCGKSTLLRMIAGLESVTSGEISIADRVVNNVPPKERDIAMVFQNYALYPHMTVADNMGFSLKLKKAPVAEIGQRVGQAAEILGLTPYLDRFPRQLSGGQRQR
>AIA17637.1|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|1
MKKSIYIMALGAFGIITTEFGIIGIMPAIAKHFQVSIDTAGWLLSGFALTIALTGPFSVLLTSKINRKWMMCLVLLTFVLSNILSAVSPNFTVLMIARILPAFLHPVFWAVATVAASKQVEPKDAPKAVSVVLAGLSIATVLGVPITTYVAELINWKASFVVSGVINLIAFAALLAFVPSMPVTEKQSVKSQLVILKKGQMWVNLVATMIMIAGIFATYSYLAEYLGKISSMNGKQISIMLLLFGATGIAGNWVTGLALSKNVLLTTRFFLLSLIAVHMLAYMFGGLFIPMTAIIGIWGFIHTGGFLIGQTRSTSEAPEAPELAASLMVSFGNAGVTLGTCLGGLVITRFGVHEVIWISILLLVVSLALTWVFIGRRRAVAEEQQIAAVETAEEELPEEAMLGI
>AIA17635.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSGMGFIRVKGARVHNLKNIDVSIPRDKLVVLTGLSGSGKSSLAFDTIYAEGQRRYVESLSSYARQFLEMQDKPDVDLIEGLSPAISIEQKTTSKNPRSTVATVTEIYDYLRLFYARVGKPFCYNCGDPIEG
>AIA17629.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|0
MNRKEKILLGILACLNFTHILDFMIMMPLGNFLMPYFGISARFFSWIVAAYPVTAFFAGLIAAFYVDRFDRKKVLLFGYSGFLIGTICCGIAPDEYWLMAARVLTGLFGGLIGAQVLSIIADVFPYEMRGRAMGTVFMAFSIASVFGVPFSLYLAKLISWHAPFLFIGILGVVVIPLIIRFMPPIRGHLVNVGERKSVVSVLKSILSNKSQVMALSLTAMLMFGHFLVIPFINPYLEFNVGFTKEQTPLIYMVGGTGAMISSNIIGRMADRFGKLRIFMVCMLCSLIPIFLITNMPPINFYLVLAVFGFWFIFSTGRNIPAQAMISTVVDPTQRGQFMSFNSSFQQLFTGMASIVAGLIVKQDLQGRILHYNWVGYLSAAVVFSTLFLANKLAKRQQIR
>AIA17490.1|FEATURES|farme|tetracycline|tap|antibiotic efflux|0
MKIDISPLTKNKNFRYLFLGQFVSYFGTLISVTVVPLQVYNLTHSSAMVGLISIVELVPMLLAAFLGGALADHFDRKKLLVVCEFLMAVGIGILMINSTFSQPSLVVIFIVSALMQAINGFHRPSMDSLGQALLLRQEIPAAAALQSFKFGFVTLFGPSIGGILISTAGAHVAYAFDLATFVFSIIMLCSLKTQHLVREKNKLKLASSLIEGLKYAVKRQEILGTYIIDLVAMGLAFPVALFPALSHEWGQTKKIGLLYSALAVGSLAVPLFSGWAAKVQKQGQVIIVAAALWGIGIALFGMVENFWLALVFLALAGFADTVSGLFRSMIWNQTIPNEIRGRMAGLEMMSYMTGPLIGNARAGWIASVTSNHFSLIFGGFMCVVFVSLTAVLLPHFWKYANREVRIDAISIAKDG
>AIA17441.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTVHTSTISAKAAEVHAGRLVLILGGLAALGPLSVDMYLPAFPTIARSLETTLPSVEVSLASYFAGLSLGQLFYGPLADRYGRKVPLLVGLIIYALASVACALAQSIEAVITLRFIQALGACGGMVIPRAIVRDRFGHQESARIFSLLMLIMGVAPILAPLLGGYLGTHLGWRSIFWFLVMFSSLAMAASALFLRETHGSHPEFKMSGSFATFGRLLRDREFLRYTLAGSIAQAGMFAYITGSPFVFIELFGIPAESFGWVFGGNALGLIAVSQLNARLLRTYSYERILTVAIRILAISGSF
>AIA17437.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|1
MLLDLSPLKVSRDYRLLFFGQLVSFFGSMMTFIVVPWQMYQLTQSSAMVGYIYLAEFVPMVALAFVGGALADYLDKRKMLRITEIGQTSVTAILLLNSLLPQPRVWILFLSVALHAGLAALQRPAFESFIQKVIPPEMMSSVMALNSIRYSVGAIVSPAVAGIIATQLSSSVAYSIDLVTFLASLTAVFMLRHVPRPENAERPSWEGIKKAWRYAFSRQELLGTYFIDIAAMFFAMPQALYPALAVIYGDKYVGFFPASIAAGALVASLTSGWTKKIQRHGLMVTIAATLWGVAIIFFGLVDSLALALFFLAAAGFFDMISGIFRGSIWNQTIPNYLRGRLASIEMMSYLTGPMLGSAKMGIVAEKFGVKTALVSGGVLCVVSVVGAAFFLPKFLRYDGREGVKEREREEAARAELMRVSESEF
>AIA17435.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MRYFSKKSPAEARNRKRSFRHLNNHNQQINRSTNKMARKKSALIFIFITLLIDIIGLGIIIPVLPRLITELTGGTLSDASVYGGWMSFAYASMQFLFAPIMGGLSDRFGRRPVLLASLFGFGLDYIFLAFAPSMAWLFVGRVIAGIMGASFTTAAAYIADVSTPETRAQNFGIIGAAFGLGFIIGPLLGGFLVEYGSRVPFMFSAGLSLINWLYGFFILPESLKPENRRKFEWSRANSVGTLLRLKRYPVILGLVVSLILVYIAAHAVQTNWAYYTMEKFDWTEKTVGISLAVVGFMFAIVQGGLIRIIIPKLGQERSVYVGLGFSAMGFVLYALATQTWMMFTFTAVYCMGGIAGPALQGIISTQVPPNEQGELQGGLTSLMSATSIVGPILMTTIFAIFTKPGASVYLPGAPMLLGAVLTLTATLLARRSLKRTMHKAAPAGSAAS
>AIA17433.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|0
MVGLLINLTFESAMLGFFLPFTLILQIGLGFSVIKAALVGIPTAIGISVTMAVFSQKLIPKLGRYTMVLGTFLMAGGLILLYELLNRQVLNISPWTFIPGLLLVGAGMALIMAPMFSVALADVDAQHAGSASGILSAVQQLGGAIGTALLGLVFFSHLTTHATPSFNVVAPQIHQQLSELNLPVSAQEHIVQTAKVCFVDRSKANDASGTPESCKQTENTKSLAPASTQRIGSIVQNGVKQANSNNFISAFKASIIFELCILAAIIVLSFLLPRHIKISAEPEAL
>AIA17430.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MLPVILTTIVLDAAGIGLTLPILPRLLQEVGHTSELGWLFGAFLSLYALMQFLFSPVLGGLSDRFGRKPVLLVSLGGAAVDYLFMAFAPSLWLLFIGRAIAGITGANMAVASAVITDLTPEDQRARRFGQLSACFGIGFIAGPAIGGLLGEVSIRAPFVAAAFLNAVNLALAFFTLRETRRRDTEASESKNSFSPLGTLRWVSGLGGLLPLIGAYIVLAFVGEVGGTIWVLYGQDKFAWSPITIGISLAGFGLFHAGIQAFVAGPISERWGERRALLISITTDSIAYILIAIATEGWMVFALLPLFCLGRHRRAGAAIAADIRRALRPARQAARRAIQHDQPCLYRRSAIDQHRLFHEPIELSGPGMDCGRSTLLALPARLSQPLKGGRGIAEPALRKRPSDVFRRTASR
>AIA17366.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MTLKKHIAAHVREIPKSGIREFFDIVAQEKEVISLGVGEPDFDTPWHIREAAIYSLEHGRTHYTSNLGLPELRSSICRYVHKHFGVAYDPRTEVIITVGVSEAIDLALLSVLNPGDDVLYHEPCYLSYSPSVNMAHGKAVAVPTRAEDNFRLTADALKAHITERSKVLMLNFPCNPTGATQTRAELEKIARLCIDHDLIVLTDEIYSELTYDGAEHVSIASLPGMRERCVFLHGFSKAFAMTGWRIGYACAPAILTDAMMKIHQYAILCANTTSQDAAIEALEHGARGVETMRREYERRRNYIVRAFNDLGLECLKPVGAFYIFPKISSTGLTSREFSLGLLEKKKVACVPGPAFGASGEGFVRCCYATSLDQIKIAMERVAEFISEVKKK
>AIA17211.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MVKIEGLTKAFAGHCIFKDLSVEFPRGELSAVMGPSGCGKSTLLRCINFLEMFDSGRITIGDVSVSWNAGETARLSEDKKTALQQLRLKTGMVFQSFNLFPHLTVLDNVTLAPILVKRIPAAQAEDMGRAILERVGLGDKTDRYPSTLSGGQQQRVAI
>AIA17153.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MPSEFGVSDPNKRQYIIGAFFAGMTIGTLLSGPISDSTGRKPAIFAGLLIYVAGSLLCLFSTSFEMLLAGRALQGVGASSPRIVSLAMVRDGQSGAAMARIMSFVMSVFMLVPILAPSIGQLVLFVASWRMIFVGFLAMALIGGSFASVSSGWKTLPKEKRVAFSAGNLFRSAVEFFRFPSAWGYTVSVGFVFASFICYLGTSQQIFAEQYVQGEWFAVWFGGFAIAIAFAMIFNGRMVMRRGMRMLAKWAVRGCIVFSAIFLVVALELRRPSAALDPRRLHVLHLLLLRHPSSAITTPWPWSMWATSPAWRRPFLARFLPSWRSPSAPGSASSMTAR
>AIA17126.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
DNKKAAIGFIFITLLIDITGWGLIIPVMPKLIEQLIQGDLSHAATYSGWLGLAYAGTQFLFAPLVGNLSDKFGRRPVLLCSLFGFGVDYLFLTFAPTIGWLFVGRIIAGITGASITTASAYIADISTPENRAQNFGMIGAAFGVGFILGPVIGGLLGSFGPRVPFIVASGLCLLNWLYGYFVLPESLSKENRREFSRAKANPLGSLRFLIRYPAIGELAISFLLLYIGGQAVQSTWAFFGIEKFQWDSKMIGISLGVVGLLVGVVQGGLIRVINPRLGNEKSVYTGLILYAIGLVLFAFAGATWMMFVFLIPYCLGGIAGPALQSIISGHAPANEQGELQGALTSLMSATAMIGPPVMTNLFAFFTKKNALVHFPGAPFLLGAIAMLASAVIAWYVLRTEHYTEPAASTAKE
>AIA17005.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVELVFERKPKWLAAINDSLLMIKRSSTHILRNTDQLLGAFFQPIMFLVLFATVFGGAISKALPEGVTYLNFLMAGIIVQTVAFGSTTTAIAVCNDLQKGIVDRFRSLPMSNLAVLNGHVISDLFRNSISTIVMLVTGLIIGFRSHASVVEWLYIAGLLLLFTLAFSWLAAIVGVYAKSVEAVQWLTFIIIFPLTFASTAFVPAEGMNSVLKVFALNQPITHIVEAVRALILGTPMGDHGWLAIVWCVGILIFA
>AIA17002.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MQSTSKKRSLWIIVGITVLNAIGMTIVLPLFPFLLEKYVPSTSVAVVMSALVSVFAVATFLAAPIFGALSDRYGRKSILLISLLGSAIGYLLLGVGGALWVLFLGRIIDGLTAGNQSTLFAYITDSTEPHERGKWFGYLGGAIGLGFMIGPSIGGLLGSASITLPFYITAGITLVSMLCIMLLVPESLPAEKRSTRLTLRSFNTFSHFRDIFSLKEARALFLMGAFFYIGLNIWQFNAAIFLKDVFLWGPSFIGGVFVLVGVCDILSRVIVLPQLLKRWSEQTVGTIGLSGLAVGLGLLFLSAYIPSAFLIIGAVACIVLGEGLFDPSYNARLSLAVDESKQGLLQGANQSLQALYHAIVPLGAAAIYTFNHGAVFGVAALFMVCGLILFIQLKTKQQERN
>AIA16994.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|1
MNYLINFSIFRRNRNFALLYIGQFVSLFGTMITGVALPYQIYTLTHSTLMVGLLSLCQLIPLVFTALLGGVFADRYHRRRLLMIAETMLVMGCGLLAWNAHLAEPHLWIIFAAAMFMSAFTGLHRPALESIVQQLVAKADFPVVGSLGTFKSSVCMIAGPAIGGVIIASAGVVITYVVDCLTFAVSLTTLLLMTHIPKPVLTVPDDSAWTSLKASLLYAKSRQELLGTYFVDFVAMIFGMPTALFPAIAMSFGGAKTLGLLYAAPAVGALIVSLFSGWAKDVKRHGAAVAISAVLWGVSIIFFGLSTHLTAALIFLAFAGGFDAVSGIFRSVMWNQTIPIALRGRMAGIEMISYISGPRLGDTEAGLMAAAFGITFSVISGGVLCVLGVGICCWYLPKFWHYEAKEFASTDEVVAG
>AIA16964.1|FEATURES|NCBI|tetracycline|tetZ|antibiotic efflux|1
MIGTVQRKVRAHADARLKGKLTVLMITAFVDMLGLVMVLPLLPFYATKLGGSATMVGGLIAAFSLAQLASAPFWGSFSDRYGRRPALLSGLILSAIAYVIFAFASTLWLLLLSRIVQGFGGGTIGVVQAYVTDVSDPKERAKSLGWLSAVTSLGAVIGPAIGSALVQLWGRHAPGLAAAAFSLLVSLFAWEFLRESKQAPTTDEMALPPAPASAVMWNVLVHPGEAAPRLIWIYTIAIGAFYGMAPTLPLVLQRYLPITESNVGYFVMYLGGIGFLVRSLILGRMIEVLGEARLARLGLILLGLGLALVSAIR
>AIA16939.1|FEATURES|farme|bacitracin|BcrA|antibiotic efflux|1
MGLILPDRLINCERSLVTFRQDFGVYPNLNAIEFLEYLAAAKGLDRKTARQRIQELLQVVNLVEAQKRPLGSYSGGMRQRVGIAQALLNAPELLIVDEPTAGLDPEERVRFRNLLSELSGARIVILSTHIVSDVEAAATNIALIARGHLVTCAAPEELLQSVEGKVWERVVPSAELPALRQRYLTSSTMRRSDGVP
>AIA16935.1|FEATURES|farme|bacitracin|uppP|antibiotic efflux|0
EIVFQRGASGIGLLWAAAGIGLVTGALFAHALARRIGYHAYKRTISIAYLIHGGSYVLFSQAGTFERAMFWIGMSRAAMGVSSVLNTGQLLRHVSNEYRGRVFATVESWSWTTMIVSMAIAGIASEHVSARVIGAWSGVLSSTTAVWWAWANWRGHLPEPPVEGVDPDTVEIEEASPNI
>AIA16906.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MTEKTDHLATPTHLRAFYHLLTNTLITSVINFTLWFAITFYVYLETKSVFAVSLIAGLYLVATASTGIWFGSLVDHHKKKTMMIVSNIASLFLYITSFAIYQSAEPGAFKDPASVSLWALVVTLMLGVIAGNIRGIAMPTLVTILIPESKRDKANGLVGTASGVSFLVTSVISGFLVAAGGMLYALLLGLGILVVSLIHLFLVSVPEKGIAHLEGAPKKIDLKGTYKIVRGVPGLMALILFSTFNNFLGGVFMALMDAYGLSLVSVQVWGLLWGVLSTGFIIGGLVIAKVGLGKNPVRALLLSNIVLWAVSIIFPLQASIILLAGGMFIYMCLIPYIEASEQTILQKVVPFERQGRVFGFAQSVEQAASPLTAFLIGPIAQFIFIPFMTTGFGVQAIGSWFGTGPDRGMALVFIIAAVIGLIATVIAFRSKQYKQLSKRYTEGHGDDSSPPALDQPVQEGLVQ
>AIA16900.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MATMPQATSAESAIQIEHLVKRFGQLRAVDDLTFNIAAGETFGLIGPNGSGKTTLIRLLLGLLAPNSGSVHILGRKIPNRRVAAQIGYMTQSSALYNELSIRENLAFFGKLYGLRGA
>AIA16882.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MSTKTASVRFIFATIFLDALGIGLLIPVLPDVIRRFNSDPQFVSDHFGYFVAVYALMQFLASPVLGSLSDRFGRRPILLISLLGAGLDYILMAFAPNLTILYLGRIISGLTGASMTVASSYMADISDDKNRSANFGLIGAGWGLGFICGPLIGGLLGDMSPTMPFLGAAVLNLLNFFFGLFVLPESLPATMRRNVEIKRLNPFKSLAKVLQPSPILVLVWIYVLLFLSGQSHPSIWTLYTEYKFGWTPRQVGFSLAFVGAVIAAAQGGLTRVIIPKTGEIRALFLGIMMYVIGFALFGLAPAGWMMYAIMLLFSISGIAMPSLQSMLAKRFPSQEQGELQGTLVSLASLTAIIGPLFYTKVFSYFTDEKAPIHFPGAPYIGASLFAVVALVLYAVALHRSESEPPTNS
>AIA16766.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MSGKRNAALGFIFVTLLLDVIGFGIIIPVLPTLISHLIGGTLSEAAQYGGWLMFAFSVMQFLFSPVLGNLSDKFGRRPVLLFSLFGFGLDYLLLAFAPNIAWLFIGRILAGITGASMTTATAYIADISEPEKRAQNFGMVGAAFGLGFIIGPVIGGVLGQFGPRIPFYAAAALTLLNWLYGYFILPESLSQENRREFSWKRANPVGSLKQLKRYPVIAGMVGSLITIYIASHATQSTWAYYTMEKFKWNEDWVGYSLGFVGLMVAIVQGGLIRIINPKLGSKNSVYLGIALYMVGFLLFAFATKGWMMFAFLVPYCLGGIAGPALQGIISNQVPGNEQGELQGALTSLVSATSIIGPPIMTNLFAYYTDPKNEIYFPGAPFLAGAICSLVSLILAVRSLANYQTTKEPEVAPVEIQSH
>AIA16721.1|FEATURES|farme|multidrug|msbA|antibiotic efflux|1
AEAQEFIKHMPKGYDTLVGDRGVKLSGGERQRIAIARAILKNAPILVLDEATSSLDSVSEVAIKKALDELMKGKTAIVIAHRLSTIQKMDRIVVLNKEGNIEEMGSHAELLANNGLYANLWNHQVGGFIDEDAVE
>AIA16666.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MAPIQPEFALYRTLFYVIEHRSILERRSIRRFIMTTTTISRSSSRTYPSLRAAWIPLAALCLAFFVEMVDNTLLSIALPIIGRDLGSSTTDLQWVTGAYSLTFGGLLLTAGAMADRLGRRRVLLVGLAVFGVLSLAVVAVSTSGELIALRAALGIAAAAMAPITNSLVFRLFDDKALRMRAMTLMIVVGMSGFVLGPLLGGTALAHAGWGWLLIVNAPIALIACLGVRLGVPADRPEDLTHDALDLPGAVLSVATIGLACYSLTSGVQHGWLSAITIATVLGAVAAGAAFIRHERRTAAPMLDLDLFSNGTVRGAAIAQIGTSIAMASVMFGLILHFQYAYGWSPMKAGLANLPLILTMIAATPLSEWLAKQFGHRIACLIGAGLMAGSLAGLSWGVQHGYAAIAVCMVVMTIGLRTVMTICAVALIDAMPGNRTSIGAALNDTAQEVGTSLGTAVVGTLIAVLVATQLPTGSWGNDIVTSFFHGERVIYAVLALIVGLVTAGGALTLTDSRSTEEAH
>AIA16566.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
VSAAFSLIRQSLNGEQQDYTSGSIRKAVVLLAIPMMLEMCMESVFAVVDIYFVSHLGKHATSTVGLTESVTAIIYSLAIGISMAATAMVARRVGEKDQKAASRAGMQSIFISLAITIAISVPGFIYSADILRLMGAEEAAIIEGVGYTRIIMGGSLVIMLLFLINGIFRGAGDAMMAMKSLWLANICNIILCPIFIRGLGPIPAFGVTGAAMATTAGRAIGVIYQVYHLFNGQRLIQFTLRHLAPDWKIIRSIYTIAWPATLQFLIGSGSWIVLASLVVTTGHSDASAGYQIAIRIVMFFILPAWGMSNAAATLVGQNLGAIQPERAEESVLKTAKYNAVFMGLVSIVLFTFAPLIISFFTREPSVAGYAILAARIISAGYLFYGVGMVMANAFNGAGDTRTPTIINLFGFWCFQIPLAWVLSKPLEMGATGVFIAIPVAETAISIVAYIVFRQGRWKLKKV
>AIA16462.1|FEATURES|farme|multidrug|mdtL|antibiotic efflux|0
SLIMLVFSVSPILAPLSGSFVIQFGDWRTLFYVMTGTGILGLLLVAFVLKETRPKARAHGLDSIRCARCLLAAAARLEVHGADADRHVRDVELHGVPGQFELRLHPALRADADAVFDRLFGQCRELSFFAVSQATGFLVGRFGLNRVVRIAVGGFVAAMGSRH
>AIA16381.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefC|antibiotic efflux|1
MNDVTTVTKEKPAGLRDLLRNRNFRYIWTGQIISDFGDSLTNLALLIVINQLTGSTAALATMLIVLTIPQITFGLVSGVYVDRWNRKHIMIVSDLLRGALVLGFVFVHSADQLWLLY
>AIA16287.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MSVPVEKEKEQRRSTTSLIILIVGIIFLATNLRAPITAVGPVVALIRDSLGISNAGIGTLTTIPLLAFAILSPFAPRLARRFGMEMVLFVVLAVLSIGLVLRPLGGFSTLYLGTILMGAGIAIANVLMPAFIKMKFPNNIGMMTGVYSISMNLTGALAAGLSIPIATSSSFGWKGSIGIWAILAIIALVIWIPQIRNRKNGALPGQNGGKGKSLWRSKLAWKITIFMGLQSLLFYCMVAWLPVILQSRGMESTQAGWMLSAIQFSQLPFTFIVPIIAGRMKNQVPLVWITFVLMTAGLSGILFGGTFLVLPSVIVIGIAAAFAFSLAMMFFSLRTQNSYEAADLSAMAQSFGYLLAASGPPIFGLLFDLTNGWTFPLLLLIAATCVILFVGLGAAKDEYVSEK
>AIA16256.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|1
MLLDLSPLRVSRDYRLLFFGQLVSFFGSMITFVVVPWQMYQLTRSNAMVGYIALAEFVPMVSLAFVGGALADYVDKRKMLRFTEIGQTVLTGGLVLNSILSQPSITVLFIIVALHAGLAALQRPAYESFIQKVIPPEMISSVMALNSIRFHIGMIVGPAVAGLIATQFSPTDAYLIDLITFAASLAAVFMIRFVPPPENAERPSLEGVKRGLKYAVSRQELLGTYFIDIAAMFFAFPQALYPALATVYGNEYVGFFPASIAVGALAASLTSGWAKNVQRHGLMVVIAAVLWGVGILFFGLSTSIAPALLFLGAAGFFDMISGIFRGSIWNQTIPNYLRGRLASIEMISYLTGPMLGSAKMGIVAEYTSVRFALVSGGATCIVAVLLTAIFLPKFLKYQGREGLIQKQFEEAVREQGFEGDREKWEELNRLTQSEF
>AIA16254.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|1
MSRFIDLSIYRRNRNFAFLFTGQFISFAGTMITSVALPFQVYHETRSTLMVGLLSLVQLIPILFTALLGGVFADRYHRRVLLFTAESVLAVGCLLLAWNATLTTPYIWLIFCVAALMSAFNGLHRPALESIVQQIVDEKDFGTVGSLSTFKYSISMIGGPALGGLLIATHGIAITYFVDMMTFLFSLFCLFMMSHIPKPDRTHDDTTLQSLKAGVRYAMSRQELIGTYVVDFIAMIFGMPSALFPAIAHSYGGVKVLGLLYAAPAVGALVISFYGNWTRFRRHGLAISIAAVLWGLSIIAFGLVSNLYAALFFLAAAGAFDGISGIYRSVMWNQTIPNHLRGRLAGIEMISYLSGPKLGDTEAGLVAAAFGITASIVSGGALCVAGVGICCLFLPKFIQYRAK
>AIA16251.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MNKALVVILAAVTLDSIGIGLIFPILPSLLRDVGHVSEVATLLGVMLALYSACQFLFSPVLGVLSDRFGRRPVLLVSLAGAAIDYLIMAFAPELWMLVLGRAISGVTSANMAVATAYITDISTEEERARRFGLFHAMFGIGFIIGPVLGGVLGDYWVRAPFIAAALLNAVNFALALFVLPESRPGQPGARFDLDTLNPFKPLKWALTFSALIPLMAIFVIMNFVGTMYGTMWALFSEDAFAWNGLMIGLSLGAFGVFHAGAQAFLTGPAVARLGERWALIVGMACELTALVIMGLATQGWILFALAPLFALGGIGMPALQSLVTTQVGADKQGQLQGVLASLVSLAAVFGPLFFSFAYFSIRSTWPGLIWIIGAGIYLLALPLMLGIRRKSAAAPMPGE
>AIA16152.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
TLVHDVLYAGIKKKRSEWNAHVGLFKEITGAELIDDVMLIDQSPIGRTPRSNPVTYIKAYDAIREVFAATQTAKSKGFNSSHFSFNVPGGRCETCQGSGVVTVEMQFLADVELTCEDCRGTRFRDEILGVKYKGRNIDEVLDMTVREALLFFKDVKKLVTRLKMLEDVGLGYLRLGQSATTLSGGEAQRVKLAAHLAQKTRSNTLFIFDEPTTGLHFDDINKLLAAFRALIDNGGSLVVIEHNLDVIKTADHVIDLGPEGGVGGGEIVAIGTPEEIAKSPKSHTGKYLKQLLS
>AIA15920.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
RLYGDEGWRGIKGFFKWLETKKYKLHVRVFLAKYRGYTRCPECDGARLRQEARDVKIGGKSLPEIVEMSISDAAAFFEDLKLSEEREKIAEKILLEIRRRLKFLVDVGLDYLTLSRVAATLSGGEAQRIQLATNLGSLLVGTLYVLDEPSIGLHPRDNARLIKILENLRDIGNTLLVVEHDEDTMRAADHILDIGLFAGELGG
>AIA15919.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MGFIFITLLIDITGLGIIIPVFPKLIGQLTGGNISQVSQWGGILTVVYALIQFFCAPLIGNLSDKYGRRPVLLTSLVGFGIDYLFMAFAPTIWWLFISRVIAGVTGASFTTASAYIADISTAENRAKNFGLIGAAFGLGFIIGPSLGGLLAHFGLRVPFFVAAGCCLLNALYGYFVLPESLSKENRRQFEWKRANPVGSLTHLKKYPSVVGLMGSLVLVYIAAHSLQSTWTYINIERFNWSEEKLGYSLGVVGIMTFLVQGILIRYINPKIGNEKSVYIGLSIYALGMLAFAFANQSWMMFVFMIPYCLGGIAGPALQAILAGHVPKNEQGELQGALTSMMSLTSIIGPLVMTTLFAWFTRPGASVHFSGAPFLLGSVLLMGSALIAYSVLKTEKQHIQKESEQFSFEKTEV
>AIA15906.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MPAISFVHVAKTYASARGDVRALDDVSFDIEEGEFFGLLGPNGAGKTTLISILAGLARATAGSVAVLGHDVYSDYAAARRKIGVVPQELVFDPFFTVREALRIQGGYFGVHANDAWIDELLANLGLADKGDANMRQLSGGMKRRVLVAQALVHRPPVIVLDEPTAGVDVELRQTLWQFVARLNKEGHTVLLTTHYLEEAEALCSRIAMLKQGRVVALDRTSALLAGTASTMLRFKLDKPLPPALTANSRVAGRIVQITAHDAREVESILAVLHAAGCEPEDLEIGRADLEDVFIEIMRGETPQRVAA
>AIA15907.1|FEATURES|farme|bacitracin|uppP|antibiotic efflux|0
MSTTATAVPPAKVETGILAGTRTLLYKEVLRFWKVSFQTVAAPVLTAVLYLLIFGHVLEGRVKVFGSVGYTSFLIPGLVMMSVLQNAFANSSSSLIQSKITGNLVFLLVSPLSHWAWFLAYVGASVVRGLVVGAGVFLVTIWFAPLQVANPLWIIFFTVAGAALMGALGLVAGLWAEKFDQIAAFQNFIIMPMTFLSGVFYSVQSLPPVWREVSHLNPFFYMIDGFRHGFFGTSDVSPWLSLGVVSVALAVVCGVCLH
>AIA15900.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|0
QILFGLFGEIVFKMGSVGIGTIWSFAGVGLVTGGVFAHWLGPRLTFRSYKRTISLCYLIHGASYVIFSQMEQFWAALLFIALSRAAVAVSSVLNMTQLMLHVHDDFRGRVFATLETLTWGVMMLSMMAAGGASEHYSPRTIGAWAGLLSSTTAIVWAIANVRGRLPEPPVVGRSPEEVEVHGEPTV
>AIA15795.1|FEATURES|farme|bacitracin|BcrA|antibiotic efflux|1
MTALEQNSTQNVSVIDIRLLSTAYGKVKVLHDIEFSVPAGICCGLIGLNGAGKTTLIKVLLGLRDATSGTASILGYAPGHAEAKAQIAYLPEKFDPPPFLTGYEFIRFTQKLYGRSISQDAILEAASLLQLQAEALPRRVTSYSKGMRQKLGLMAALLTDCQLVILDEPMSGLDPRARSLVKEAILTFQKRGRTVIICSHILADLDEICAQIAVIHEGYLAYNGSPEGLKEQTGQNNLERAFLSCIDQRQAA
>AIA15782.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
AGSIVIGFGAWPLLFWVMGVVGALGLLLLVFALKETRPKHRRTESSVGSALRGYGTLLLDMNFMGLVLIGGFGMSAFMGFLGNSSFIFIEHYGLTPTLYSLAFSVNAVSFFAVSQSTGYMVKRFGLPRVVRVAVTGFTVTMLLLGAIFWAGVDSLWVLSSLMFVAFG
>AIA15743.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKKERFMNAQLVRAAIVLGLLSVIGPLAIDMYLPALPAIGRDLGASSGAVQQSLMAFMIAFAVGQLVYGPLSDMFGRKPPLYAGIGIFLVGTLGAAFAPSIEWLVFFRLIQGMGACAPMSLPRAIVRDNYTGAPAAQLMSLIMLVFSVSPILAPLTGSFVIQFGDWRTLFYVMAGTGVMGLLLVAFVLKETRPKSARTGSTLGSALGAYWQLLRDAKFIGLTLIGTFGMSSFMAFLGNSSFIYIQHYGLTPTQYSVAFSVNAVSFFAVSQATGFLVGKFGLNRVVRIAVGGYVASMIGLLVVYLSGIDSVWVLGGFMFVAFGFLGLVLPATSVLAMEEQGEIAGSASALLGTIQMVVAAVVMGIVGAFGDGTARPMVIAFAACAIAAFVITRRTLSKGDGTRMVSVPAE
>AIA15741.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
EILTFRVSKSDGMRRPTVTPPLPVPAGGEPEIQKEPAIMNAFFYRTAVVLGLLSAIGPFAIDMYLPALPPIGADLHAGTPAVQMSLLIFFLSMGFAQLAVVPLSDMFGRKAPLFAGLALFMVGGIGSALAPSIEWLIAFRFLQGLGASAGMVVPRAVVRDLLTGNEAAKLMSLLMLVFSVSPILAPLTGSFIIGGFGWRGVFWAVTIAAAIATVLLATALKETRPAEERVGSSFGVALAGYRQLMGNAKFLSLASIGGFAISSFFVYLSSSSFILIDHYGLSPRVYSLFFSINAVSFFAMSQLTGTLADRFGLTRVVKVAVTGYATTMVVLLALFASGVDHLAVLAVLLFVGYGFVGLVIPSTSVLAMDDHGEIAGTASALLGTLQFAIGAVAMGVSGIFFDGTPLPMVVGIALCAVIAFTLAQVSLGRVRGVAQVPAE
>AIA15675.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|0
MQISVEKIGKKFVKEWIVRNATFELAAGQQYTFVGPNGSGKSTLLQLLTGIVPVSEGTIRYIDQSGKEIEVDHWYKHLVIAAPYLELIEEFTLRELIQFHSKFKAFKNGISFKDFEDFIQLPHASGKTLRHFSSGMKQRVKLGLAFMSDVPVIFLDEPTTNLDVPGINWYLDHVVHHTQNQLVLLGSNVKQEYEFCENIISVSAFK
>AIA15597.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MTDNNAYASEFLKKSTLMFFPVFLIMYELVVNLSNDMYIPASTYLVDYFHTNAYYIQLTFTSWFAGSMIVNPILGVLSDNLCRKKILLFSGLCFMAASLYCAVSADIYLFLLARFIQGVTVTTIVICGYALVHDIYDDKRAIILISWMSGVLITAPMLGPLMGGYVIYFLNWQAIFVILAFVAAVSLVGIKFVMPERQVISQEPINWGQELLTYVKILCHTEFMLLTMISAMLFGGIIAWITASPFLLIGKYDFTPVQFGLAQMPIFGSYIVGTFVLKFFLKLDIKETRIITIGIVVAALTSALMFLTRQTGISNVTHLLALVSLYSFVFGLISSPLNRVAVKAVDYGLGKTMAMFDFMIGLSATVATILINVSAGDVLSLFYVTIGSFALLSCVFFTFNEVRSNVRKCR
>AIA15584.1|FEATURES|farme|multidrug|mexY|antibiotic efflux|0
LAGLSSLLIGILIRSIPMAFFLFTGTLFIGVGIAIGNVLLPAIAKDKFPDQFGLMTSVYSTSMGLVASLASGVSVPLAVGMNLGWKGALNVWGIPAVAAILVWIFLSKFNQGNQKEIKKVTPSSNHIWRSPLAWQIAIFMGFQSFLFYVTISWLPEILHSHGLSMETAGWLLSFSQIVGLPASFFIPVIAGRYRSQIWISFVLSMCSIIGYGGLLLGSS
>AIA15568.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MKLLREIYLFYARKIKESSRNPAFLVMGISTPILYLTLFAPLLKNFAVSMGAPSEGIYDMFVPGMLVMNAFFGGFFSGFGVIDELRGGVIERFRVTPTSRFSILAGPVFHDLTAVIVLSVLFIGLAVPFGFHIHVTGLLSLFVLLALLLVTSSSFSHALGLITKSEDSLAPIVHGINLPIMLLSGMLLPIDFAPNWMKIVAHFNPVYYVVEAGRALAVGDFAKPIVTQAFCVMIPVAALTMTWATRIYRKAVM
>AIA15569.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MKTIVETKALKKSFGSFQAVKGVNLSVYAGEIFGFLGPNGAGKTTTLRILTTLLSPDSGEATVAGFDLLKAQHEVRRRIGYVSQVGGADRQATGRENLLLQGRLYGMHQGEASKRAERLIEMFTLGECANKITSTYSGGQRRRLDIALGMMHKPLVLFLDEPSTGLDPQNRVNLWEQIRQLKGEGMTIFLTTHYLEEADALSDRIAIMDHGQITTVGTPAELKGVEALSLHDVFLQKTGKGLRE
>AIA15508.1|FEATURES|farme|tetracycline|tet(30)|antibiotic efflux|1
MTRSLFVIILIVALNAIGVGLIFPILPDLLRELTGSAEISTTYGLILAAYAAMQFLLSPILGMLSDRFGRRPVLLVSLLGCTIDYLVMAFAPTLAVLVIGRLIAGATSANMAVASAYIVDITEEKDRAQRFSWMSAAFGVGFIVGPMLGGVMSTWWLHAPFLAAAVLNGGALLLAWFMLKESRVPSGEKLDAKALNPFAPLRWAFSFPALAPLLAMFLIFAINGDIPGTIWVLYGAEKFNWDGVTVGISLTFFGVFATLAQAFITGPLTKRLGEKRTMMVGVCADAIAFLLIGLATEWWMPFALAPLFALGGVGLPALQSLMSAEVSEDRQGELQGVLASAMSLTSIIGPLLATGVYFWTKPFFIGAVWILAAALYLLAIPVLGWIGRRRVQPA
>AIA15502.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
AILLGLRFVQGLGAAATRVIATSIVRDQFSGREMAEVMSLTFMVFMAIPIIAPGVGQIILLTGPWHYIFLFMAGLSALILIWAWFRLPETLHPEYRRPLRLGVIAEGFRLVFTNRVAFFYGLAGTFLFAAMFGFIISTQQIFVGIYGLGPWFPLAFASMAGFMAVASFVNSRIVRRYGMRRLSHTAMLVYVTCASILLILSVSGPVPFWLFFALLLVIQVAFGTAASNMNSLSMEPLGAVAGTAASVFGFFQTVGGALLGTYIGQQFNGTLTPNATGYVVMGLLVLCCILIAEKGRLFGVGQEYEPTGVVAHAD
>AIA15466.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MTKQLAIILATVALAATGIGLTMPVLPDLLRDVGRSGDLGWQYGSFLALYALMQFLFAPLLGALSDRFGRRPLLLLALAGATVDYLFMAFAPTLPLLFLGRAISGITGAGSAVAAAYITDITSEPERARRFGQLSAAFGVGFIAGPAIGGLLGGHWIRAPFLAAALLSALTLAAAILALKEPKRPAVSAEPLPLNPLAPLRWALRFSGLLPLIGAFMVVSLVGEVGGTIWVPYTQERFAWDPVTVGISLTLFGLFHALAKAFLIGAISERWGERRAFIYGIGFDSAAYILIALATKGLMAFGLLPLFCLGGMAAPALQSMLTARVPQDRQGRLQGVLASLASLVSVGGPLVISLSYFGTRGTFPGIVWIGGAALYLLCLPLAAGRFSGPTPVGDNR
>AIA15464.1|FEATURES|NCBI|multidrug|mexN|antibiotic efflux|1
MGGVVGRLFNEFGMVVALAIVASAVVSLTVTPMLGSRLSGAEHHPGLMVRIFDAGFSRTLRGYDRAVGWCLRNRAIILLVFLASVGASVYLFRTLPTSFFPQEDIGRLTISTRAREDISYPAMRDLQAQVAAAVQKNPAVKHVTSIVGSNGRSSLNNGTIWVELKDRGERPPLDQTLRELRQATSKFAGMKTFITPQQSLRFGGRATASQYQLVVQALNASQTSEWSDKIQTAMRADRTHFTDVTSDAQNDAIEANIKVDPEKAASFGITDDELRKTLQMAFGGYTAAEIQSTGDSYDVITEFEQWNDQMLQGVRVMSSNGSLVPLSNFATIVRQTAPITINQTGQLVSTTVSFNLPAGVSLSDATAAIDQIKANLQMPNDVFTSYGGTAQIFQQSQGNTPLLILAAVLTIYVVLGVLYESFIHPLTILSGLPAAAFGALLALKLFGFDLSIIALIGLLMLIGIVKKNAIMMIDVAVETMRSKGETAAAAIHEACVRRFRPIMMTTFCALLGALPIALGTGASSELRQPLGVAVVGGLIVSQALTLFITPVIFVEMDRFGRFLGRLWTKKDKDLHEANDDAPTQIAAE
>AIA15422.1|FEATURES|farme|multidrug|mdtL|antibiotic efflux|0
RGESEMIPAAKEETAHLSIIPFIFVLFGLFMITTAVNLQVPLYTLYAEQAGYGKAATALVFAAYVFGLIPVLLFLGGISDRAGRKPVLLVALSFSLCATLLMIVHPTIQILFLARLLQGVGLGLSVGTCTAYLIALYPEKSSWIPTFIALCSSVGFGGGALFTALLSFQYVTLAPLSYWIVMGFLILTIVGVFFFVPPVQGDADKPMMNMPTFPKGTMPANAAIAVAWSVCGLVISVLPAQLKLNGYELWVGPALFLINMSGVLMQPFVRKMNSTAALLAGFICLPCGYGLLLFGANGGSIILVLAGTMLAGTACYGFTYLGGLQLIVERGKKEAARAVAGFYLFAYLGLGLPSVFVGLFADLFGTQVVLTVFFLVVLAACLILLMSSVRQKQK
>AIA15420.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MSRERISRRVRSVPPSGIRRFFDIAATMPDVISLGVGEPDFVTPGDIREAAMASIEQGKTAYTSNSGLLELRYALAAHLSSLYGVSYDPEDELLITVGVSEGMQNAMVALIDDDDEVIIPEPCFVAYPASVIFADGVPVNVPTRVENQFQVTGAEIEAAITPKTKAILIGYPSNPTGAVLSRERMQEIADIAERHDLVVISDEIYDRLVYGVEHTCFASLPGMRERTVLLGGFSKAYAMTGWRLGWLAGPSEIVQAVRKVHQYAIMSAPTASQYAGLEALRFGEESVQAMVAEYDRRRRRIVDGFNAMGLPTFEPQGAFYAFPYVGHLGLSSEAFAERLLMEEQVAVVPGDAFGQSGAGYVRACYATSMEKIEQALERIERFVRRVEQTG
>AIA15396.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MTVILFTLLLDAVGMSLVFPILPGLLRELSGGADATTFHYGGLLAVYAAMQFLFSPVLGALSDRFGRRPVLLASLAGAAADYVLMALAPNLAWLYLGRVLSGITGASMAVGTAYVTDVTPEADRAKRYGQMGAAMGLGFVVGPLIGGALGEWSLRAPFVAAAAMNALNLAFAWVALPESNQHRTARLEAGKLNAFSALHRLQGRPPLLPLIGVFAVVALVSQVPGSLWILYGQQRYDWSAWIAGLSLACYGGLHAISQAFVTGPMVARLGERRALLAGLTADGLGFVLMGVATAGWMPFALLPLFAAGGLALPALQAMLARQVSPQHQGELQGTLASLTSLIGIGGPLVVTAAFAATQLSWPGSVWIAAAAFYLLALPLLFSARASRG
>AIA15394.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MTTSKKSAMGFIFVTLLIDVMGWGLIIPVMADLIAELKHIPVNEASTYGALLLSVFAIMQFLFAPVVGNLSDKYGRRPILLLALLGFGIDYIILALAPTYGWLFLGRIIAGMTGASFTTASAYIADVSTDETRAKNFGLIGAAFGLGFVLGPALGGLLATFGIRAPFYAAAILCLLNVLYGYFFLPESLDKEHRRPFEWKRANPFGSLKFLTRHPEIGELALCFFLIYLGAQSVQGNWNFFTIYRFHWSEKMVGISLAVVGVLVGAVQAGLTRVVNPRIGDEKSIYLGLSLYTVGLILFAFATQSWMMFLFLIPYCLGGICGPSLQSVIARHVPSNQQGELQGALTSLMSVTTIIGPLIMNSTFAYFTSGKAPFHLPGVHFLIGAICMTISIMVAYKVLSRERRAATA
>AIA15365.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MSKREPKEKKPAGLAFIFVTLLIDVIGFGLVIPVLPNLVGQLAGGTAQHQVLVYGWLLSLYGLMQFICAPILGNLSDRYGRRPVLLISLLCTGIDYIIQATAGTIGLLFVGRIIAGIMGASFTPATAYIADVSKPEDRAKNFGMVGAAFGLGFMIGPALGGLLGQYGNRIPFYAAAVAALLNVLYGYFVLPESLSKDKRRKFTISNANPFKSIGILGRKKWVLLLSISTSILWLAQQVPPSTWILITEYKFHWDPHANGLSMGLLGACSMVVQLWLIRVLQEKWGDVGLVWISLIFNIIGFVAMGLSPTGPFMLVSMVVWTVAFVGGPGLQSLISHQYDETEQGAVQGALTGIQSLTGVIGPLIFTAVFGYFTARGHVNLPGAPFLLGAVFIVFATIIAYSALRHHKFSRGGEELAPAPDPTT
>AIA15361.1|FEATURES|farme|bacitracin|bcrA|antibiotic efflux|1
MNVVNAVEIEGVSQRYGSMTVLHDLTLSLGEGEVLGLFGHNGAGKTTVMKLILGLLKTSTGQVRVLGCRPAQAEVRRQLGYLPENVTFYPQLSGRETLRYFARLKGTPLTQVDELLDQVGLTAAADRRVKTYSKGMRQRLGLAQAVLGQPRLLLLDEPTVGLDPIATQDLYGLIDRLRQQGTSIILCSHVLAGVEAHINRAAILATGRLQAIGSLARLREDADLPARIRANGLARREHWLQRWNAAGHTAIAVGGNGVEVMAVNGHKVDLLRQLFHEDQPQDIEILQPSLEDLYGYYMSRAPGGTEGIHP
>AIA15265.1|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
MKLSLKGVGKLYQGKVQALQDFTLDVSPGILGLLGPNGAGKSTLVRILATITKPTGGTVTWNDVDIVRSPNRLRAVLGYLPQDFGVYPNLNAVEFLEYLAAAKGLDRKTARQRIQELLEVVNLVEARKRPLGGYSGGMKQRVGIAQALLNDPELLIVDEPTAGLDPEERVRFRNLLSELSGERIVILSTHIVSDVEACATNIALIARGRLITCAAPEELLQSVEGKVWERVVASAELPILRQQYLTSSTLHRSDGVHLRIVAEEAPGPGAIPQPPTLEDAYLYWISGRKGETE
>AIA15197.1|FEATURES|NCBI|tetracycline|tet41|antibiotic efflux|1
MNKALVVILAAVMLDAVGIGLIFPILPALLRDVGHTSDISVLLGIMLALYSACQFLFSPILGVLSDRFGRRPVLLVSLAGAAVDYLIMALAPHLWMLVIGRAIAGVTSANMAVATAYITDITTEEERAQRFGLFHAMFGVGFIIGPVIGGILGDWWLHAPFLAAAMLNGVNFALALFVLPESRKGQADTRFAWTVS
>AIA15198.1|FEATURES|farme|tetracycline|tet(30)|antibiotic efflux|1
MNKALIVILATVAIDAIGAGLIFPILPELLTQLTEGGDIGFLYGAMLAVYAVMQFVFSPVLGALSDRFGRRPVLLLSLAGTLIDYLVMALSPLGWILVVGRAMAGITSANMAVASAYITDITPPEQRAARFGLVGAVMSMGFIVGPVIGGVMGAWWLRSPFLIAALFNGLNLAVALFVLPESRKASDEPFDFKQLNPLAPLMWLWNFKPLLPMVIVSIVFGLIAAVPGTIWVLYGAERFGWDSVHMGISLSVFGVSGALSQAFLVGPLTKRFGDLGTLMIGVAFDTLAYTLMAFAYQSWMGYAVAPLFALGGVAMPALQSLLTSRVNDEQQGQLQGVLASLMSLAGIVGPVLTTAIFFSTKDIWIGTIWLVGAALYLLATPLFATVRQCKPAMA
>AIA15192.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MNKALIVILSAVLLDAIGMGIIMPILPGLLRELSHTSTTSSTHYGALLAAYALMQFLFAPILGALSDRFGRRPVLLISLAGAAADYLFMAAAPSLAWLYVGRILAGITGANLAVATAYITDITAEPDRAKRFGQMGAVMGIGFIIGPLLGGTLGEWSLRAPFVAAAALNAANLVLAYFVLPESRAPQAAPARRISFNAFASLHRLQGKPALLPLTSIFIIIALVGQVPMTLWIIYGQDSFGWSTTVAGISIAGYGAFHALSQAFMIAPAVRWLGERGALLLGLLADGTGLLLLALIMRSWIPFALLPLFAMGGMTLPALQAMLSRQVDESRQGELQGTLASIASLIGVAGPLAATAAYAASRSTWPGMVWAIAAALYLPVVPLLYSRRLREI
>AIA15152.1|FEATURES|farme|bacitracin|BcrA|antibiotic efflux|1
MGLPMSRVDEMLELVSLSQSEAKRRVKNYSLGMRQRLGIAPALLGDPSILILDEPANGLDPAGIHWMRGLLREYAEHGGTVCLSSHLLHEVERIADELLLIGHGKIVAQGTKQELLHTRGAYVKAVEHEQLLDALHREGITAVPSGDGLRSDAEAIQIGKVAVTHHITLVELRPADGAGLEELFLELTAETQRDTTPTAVPTEGAVA
>AIA15137.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
VDNTLLTIALPTIGRDLGSGTTALQWVTGAYSLTFGGLLLTAGSAADRLGRRRVLLVGLAVFGLISLAVVAVDSAGELITLRAALGIAAAAMAPITNSLVFRLFEEQALRMRAMTVMIVVGMSGFILGPLLGGTALAHVRWEWLLGVNAPIALIAWVGVRLGVPADRDEDLSGDRLDVPGAVLSISTIGLACYTLTSGVEHGWLSLATFGSATGAVLALCAFVWHERRTPQPMLDLDVFDNGTVRGASLAQIGTAIAMAGVMFGLILHFQYAYGWSPVKAGLANLPMILTMILATPLSEWLAKRFGHRIACLIGAVLLSGSLAGLAWGVSHGYLAIAICMVVLTIGLRTVMTICAVALVDAMPSNRTSIAAALNDTAQEVGTSVGTAVVGTLIAALVTATLPSGAWSNDLVASFFHGERVTYAALAVIVGLVAGWGALTLSDSRSTEEPH
>AIA15130.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTATTTPLSPHTYPSLRAAWIPLAALCLAFFVEMVDNTLLTIALPTIGRDLGSGTTALQWVTGAYSLTFGGLLLTAGSMADRLGRRRVLLVGLAVFGSLSLCVVAVTTAGELIALRAALGLAAAAMAPITNSLVFRLFDSQALRMRAMTVMIVVGMSGFVLGPVLGGTALAHVRWEWLLVVNAPIALIACIGVRLGVPADRREDLTDDALDLPGAVLSITAIGLACYSLTSGVEHGWLSAATLASIAGAIAAAVAFVQHERRSAAPMLDLGLFSNGTVRGAAIAQIGTSIAMASVMFGLILHFQYAYGWSPVRAGLANLPIIVTMIAATPVSEWLARRFGHRIACLVGAAFLAGSLAGLSWGVEHGYVAIAACMVLMTVGLRTVMTICAVALVDAMPSNRTSIGAALNDTAQEVGTSVGTAVVGTLIAALVTTQLPAGTWGSDLVASFFHGERITYALLAIVVGVVAAGGALTLTDSHATEEPV
>AIA14832.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MIVFAAGCLERIVWPTIKTIKKLSWIHLEMPRSRYKSLVDTFATDIRCGRLPPGTRLPTHRQLAESEGLALVTASRVYAELEAMGLVSGETGRGTFVRETSLPPGHGVDQPEVAAGVMDLNFNYPSLPGQADLLRNALRQLALSGDLESHLRYQPHGGRLHERASVASHLRTRGLSVEAGQVLIVSGAQHGLAVTMMALLKPGDVIAADALTYSGFKVLAQALHLEIVPIPVTETGPDLDALDTLCRRRSVRAVYTMPTLHNPLGWVMDAAWRNQLVSIARAHDLLIIEDAAYAFLATDPPPPV
>AIA14752.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
FGRRPVIIAAAFGAAFAMSLFGIGGALWVLVLARAIQGMTAGDLPALFAYLADITPPEQRARRFGILGALSGIGMMIGPAIGGLLAAVSLNLPLFITAAISLIVAVLSIFLLPESLKAEHRIDSIALRDVQPFTVFKNAFGRKELRGLLIGFGLLALTFGFFVNNFSVLALDSIHWGPTEIGLMAASIGVIDILIQGVLLGILLPRIGERGVIISGFIAQAIGMIGLALVASIFSQPWLFIVGALLLAAGQGASQATMDGAMSNAVGDDEQGWLGGATQSLNAAMSTLAPLIAGALYATVSHAAPYWIGGAIMAVAVVVVSRAYIARPPRFLVDSQPLEP
>AIA14749.1|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
MISLRGASKSFGTTEVLRDLDLTVERGSVFALLGPNGAGKTTLINILSTLVSPDSGTATVAGFDVVTQREQVKRVISVTGQSAAVDEVLTGEENLRMMGRLSGLSAAESARRATELLERFDLVDAARKRVKTYSGGMRRRLDLGISLLLTPPVVFLDEPTNRPRHPQPTGPVGCHPLARRERDDDPAHHPVPRGGGPARRPHRGARARADRRGGHSRRAQGPRGR
>AIA14747.1|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
MANNRYVIEVKNLTKSYGSNNVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLSFDDGEVLVDGHNVKTEADRVRESIGLTGQSAAIDELLTGRENLVMMGRLYRLTPESAKARAQELLEEFNLLDAAERPAKTYSGGMRRHFNLAVDSLIPEYCHQRPVWIVAA
>AIA14742.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
LYREMSSCTSRIKLLLPEPGIGRGYSMAATGRLGDMDAMIEAKGLKRTYTARGKSIEAVRGIDLTVQKGEIVGFLGPNGAGKTTTLKMLATLLEPTGGKATVAGSDLRTDAVGVRRKIGYVSQAGSTSPEARAGEEIMSHAELYGIDRATARKRGEKLLAALDLSDVWDRACGSLSGGQKRRLDIVMGLIHEPTLVFLDEPSTGLDPQSRANLWKHIRSLRDELGTTVFLTTHYMDEADSLSDRILIIDNGTIVAEGTPAELKKRVSGDAITLTLRHEEDARRAGEIAAGLEGADTPKTEAHVVRLHVPDGGRALPVLLAELTRSDIDAIGVDVNRPTLDDVFLTLTGRSLRD
>AIA14686.1|FEATURES|farme|tetracycline|tetJ|antibiotic efflux|0
MLQKEKTMPAGQNYRPGPWLLVLGIILIASNLRAPITSVGPVVKNIRQDTGLTNTLTGLLTTLPLLAFAFISPFAPRLARRFGMEKTLLGGLVVLGSGILLRAIPSEAALFSGTILVGMGIAIGNVLLPGFVKSEFPHQAGIMTGVFIVCMGVGAALGAGLSNPLAAGLGWRGMLAGWAVLSVIAIVVWLPTLKFSKRAPGVRADSLIPVSPGGNLWRSGLAWQITLFMGLQSLIFYVIVAWLPEMLTNWGMDTATAGWMLSLFQLVGLPASFIMPVLAGRSHSQRWLVIITALAMFTGYTGLLLFNTTLLPLWILLGGFGSGATISLALTFFVMRAHNTHQTAELSGMAQSVGYLMAAVGPTLFGFIHDQTGGWSITLFLLIVFTILFLLVGLRAGSPGFVSEAPAPPAD
>AIA14685.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MAIEEAAKTPTKSDGASYVSERVNNVPPSGIRKFFDIVATMKDVISLGIGEPDFVTPAPILEAGIESLRAGHTAYTSNSGILQLRQLISKQLDRLYAVQYDADTELLVTVGVSEALLLALMATCEPGSEVIVPEPCFVAYQPTVTFAGGVPVAVPTYASQDFQVTVEDLEKARTPRTRAILLGYPNNPTGAVLDRSRLAEIAEWAAANNLLVISDEIYDRLYGTEHTCFSSLPGMQDRTILLGGFSKSHAMTGWRIGYAAAPAAILAAMRKVHQYIIMSAPTTGQEAAIEALKSGEPYVEAMREEYDKRRRTIVDGFNRLGLTCFEPRGAFYAFPNIESTGLTDEEFSERLLHEEKVAVVPGSAFGKSGMGHVRASYATSLPNIEEALNRMESFLGKLKK
>AIA14678.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
RLQSDPLLKDDKMNAQIIKAAVVLGLLSVIGPLAIDMYLPALPAIGADLGADVAQVQLTLMAYMAAIAVCQLLYGPLSDMYGRKPPIYFGIGLYVVASLGAAWAPSIEWLTVFRFLQGVGACASMSLPRAIVRDGYTGAQAAQLMSLLMLVFSISPILAPLSGSIVLQFGDWRVMFYVMAVVGVLSLLLLVFGLKETRPKEARLESSLRGALSAYWKLLRDWRFIGLSLIGAFGMASFMAFLGNSSFVYIEHYGLTPTLYSLAFSVNAVSFFAVSQATGFLVGRFGLPRVVRVAVTGYVTAMLALLALFLAGFDSIWVLATLMFVAFGFLGLVLPSTGVLAMEEQGEIAGSASALMGTIQMVIASVVMGIVGAFTDGTARPMVVAFAACAVAALVITLVTLRGSSRRNIAGAMAAPAE
>AIA14674.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MPNNPYVIEVENLTKSYGSNNVLKGIDLKVARGTMLALLGPNGAGKTTTVRILSTLLSFDGGKVTVEGQLLTGRENLVMMGRLYRLTAESAKARAQELLEEFNLVDAAERPAKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRIAMWEIIKRLMANGTTILLTTQYLEEADQLADRIVVIDGGKVIAEGTANELKSKVGNDRLELTFKTEKERTEAGKVLGKTVVSTDEKENSVTVVIKDTNTDVKDALEALAKKRILVQSMAIHKPTLDDVFLSLTGKQKQPSTEGEEA
>AIA14570.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|1
MDHNWKKNIILFLSGQTISLFGTALVQYAIMWHITLTTQSGVMMTISIVCGFLPTFFLSPFAGVWADRYNRKKLIILSDSFIALSTLILAILFMNGYNALWLLFLISAIRALGTAVQTPAVGAILPLLVPEDKLTKVNGVNGSIQALVMLTAPMLSAALLTMASIDVIFLIDVVTAAIAVAVLLLFVRVKTHAKAAEQQTTSYFADMRKGFDYVKEHSYVKKFFVFMTFFMLLVAPAAFLTPLQVTRTFGEDVWRLTAIEIAFSIGMMLGGALIASWGGFSNKIHTMTLSCLIFGLCTVALGVVPNFWIYIAFMGLAGVSMPLFNTPATVLLQEKVEVDYMGRVFGVMGMISSVTMPMGMLVFGPLADVVDIEWLLIVSGALLFIQAFFLLGNKSLVEAGKPVAKPETEGGV
>AIA14533.1|FEATURES|farme|tetracenomycin|tcmA|antibiotic efflux|1
MQNVHGYSPVQAGVRLLPLSISMMVGSPLGGVLTEKFGPRPPLVAGLALLGAALLLMTGLEPDSGYGALWPPLLMVGLGLGFVITASAEAIVGNAPVDDAGVASGLQSTAIQVGGVMGTAILGSILSSQVGTVLYEKLTNAGVPDAVAKQLEGREGAGRPGPGPGPRRPRQPPERRRHRQPRSLHGGPPHPSMLVGGVLALLAAAAALFVQRTENPGTATATV
>AIA14511.1|FEATURES|farme|chloramphenicol|cmx|antibiotic efflux|1
MPVALYMLAVAVFAQATSEFMLAGLVPEIAAELAISTAAAGSLTSAFAVGMIVGAPGMAVVCRRFPPRAALLVFLTVFVAVHIVGALTPSFTVLFATRVISALANAGFLAVALAVAVRMVPAERTGRATALLLAGTTLACIVGVPAGALLGQAWGWRSAFWAVALISLPAIIGVVLGVPATAGRHRVGGVAGELGVLRRPNLSLTLLVGALVNGATFCSFTYLAPVLTERSGLDPSWVPIGLALFGIGSFVGVTAAGRLADHHPGSVIVVGGIMLVLGWTIFALTAVHPTAALIAIGVQGALSFAVGSTVIARALVMAADAPTLGGSYATASFNVGAAVGPALGGLALDVTESAQTPIWISAALGAAGLLTAACAASASRRDSAVGVRSL
>AIA14510.1|FEATURES|farme|multidrug|floR|antibiotic efflux|1
MSDIRPSWAHTLPAALLLMAPFDILASLAMDIYLPVVPSMPGSLNTTPSVIQLTLSLYMVLLGLGQVAFGPISDRIGRRPVLLSGAILFAAASLGAALSSTAFAFVCFRLLQAIGASAALVATFATVRDVYANEREGVTIYGMFGAILSFVPALGPIAGAAIADSFGWRAIFFVLTLLAVPAILNAATRWPETRPCGATSKPPSILPIFASAPFWTYTWGFGAGMGTFFVFFSTAPRVLIGRAGYSEFAFSLIFATVAVVMIVTTRFAKAFIDRWGIAGCLARGMVLLLCGAFALALGQLFGSPSFVSFILPMWIMAVGIVLTASVTANGALAEFDEIAGAAVAFYFCVQSLIVSVFGT
>AIA14496.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MFMWIDLSPLRRNRDFRLLFTSQVGSFLGPMMTYVAIPVQVFEITKSSKMVGFVSIVQLIPLVAFGLFGGSIADRLDRKKLLVTAELAMSVCALVLTANAFLASPSFVAIVVASFFLQAFSAFHRPAMDALTQNIVSREDYASMGALGSLRHSGGAIVGPALGGILTGKWGAQSVYLFDAVSFFFAAFCISRMSADLRKIEAKTSESLQHMWEGVIYAWRNPVLLGTYFVDMIAMAFAFPVAVFPALALRLGSTEDAGHMFAAMALGSLIMTTFSGWTKSTVFKGRGVVFAAMAWALGILGLGFAPNLWTALGCLVFAGAFDMLSGLFRGIIWNESIPNDMRGRMAGIEMISYMSGPLIGGARAGWMADLYGIGFSLSFGAVLAFIGTFIVGIAIKGFWNYRSETIPEPRPQPQDFPE
>AIA14492.1|FEATURES|farme|tetracycline|tet(30)|antibiotic efflux|1
MNKALIVILATVTIDAIGGGLIFPILPGLLAEVAGSGDIAWLFGAMLAAYAIMQFVASPVLGALSDRFGRRPVLLLSLAGTLVDYLVMAFAPYGWVLVVGRTLAGITSANMAVASAYITDITPEDQRAQRFGLVGAVMSTGFIIGPIIGGVMGAWWLRSPFLVAAVFNGLNLALALFVLPESRKAAAGKFALKELNPLAPLVWLWNFKPLLPLVVVSVVFGLIAAIPGTIWAFYGAEKFGWDSLHLGLSLSVFGISGALAQGLLVGPLSRRFGDLGTLMIGIGFDTVAYTLMGFADQSWMGYAVAPLFALGGVAMPALNSLLTRRVGEDQQGQLQGVMASLMSLAGIVGPVLTTALYFSTKNVWIGTVWLVGAGLYLLATPLFATVRSPKAVAA
>AIA14478.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MADIAQQRRQDRKDQADPNRIEGHGGENDDIAWLFGAMLAAYAIMQFVASPILGVLSDRFGRRPVLLLSLAGAAIDYLIMAFAPELWMLVLGRAVSGITSACSMPCSALASSLGLCSVACWAISGCERHLLPRPCSTPSISPWRFSCCQNRGPA
>AIA14454.1|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
KNGSGGNVAKTEYAIVAKDLHKSYGKNEVLKGVNLQVERGTMLALLGPNGAGKTTTVRILSTLLRADSGNVTVGGFDVHSAADDVRSVIGLTGQSAAVDELLTGYENLEMMGRLYHLPKSVAVQRANDLLEQFDLVKASKRTVKTYSGGMRRRLDLAVSLIATPPIIFLMSQLPALTPDPAWPCGKSLRN
>AIA14408.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|0
MFGAAALVLTAFVANQRRTERLTQSSLLPMHLFANRGFSAGIVTQAAFSAAMAGFVLALVIYVQSGLGFSAIHSGLVLLPFSLGAFIGVGVSAPLGLKLGKVIPFAGAICQAAGIWWLARVVADQRSGFGAWDATPPMLLAGTGLGLLVVPLIDIALSTVSTDDAGAASGTYSTFQQLGSALGIAIIGAVFFHVVGDNFTEVGLRDGFTQASWWAVGGYLLSAAATLVPARPQRSAAARA
>AIA14409.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|1
MFAAFMDLLDVTIVNVALPAIRSDLDASPAHLEWILGGYTLTFAVLLITGGRLGDIFGRQRIFVIGVAGFTIASLAACLSGNGDTLVAARVVQGGFAALMVPQLLSTVQVMYAPKERANVFGIVGAVSGTAAVVGPLLGGWLITSDAFGVGWRSIFLINIPVGIVLIVLALRYVPNTVSERATRLDLPGVVLATAGVFLLVFPLIEGP
>AIA15556.1|FEATURES|farme|macrolide-lincosamide-streptogramin|vgaALC|antibiotic target protection|0
MEAIIDIPVTKAKTSGLHEVDWKHLEFGKYVSDHMFICTYKNGEWQEPEIKPFQNISISPTALALHYGQSIFEGMKAFRMQDGSINIFRIEKHFERINASLDRMCMPPVPYDLFATALQQLVQVDRDWVPQGEDVALYIRPFVFASEARFGVKVSDEYTFIIVTGPVPTLYQKPIKVKVERKYIRAAKGGVGYAKCAGNYGGAFYPTQKAREEGFDQVLWTDAFEHEYFEESGTMNLMFVIDEKVITPPLSDSILDGITRDSLLTIAKDLGYQTEERKIGINEVLQAINEGRSVEAFGAGTAAVVAPISVIGVDGDLYHLPTYSNASVMFKLKKELETIRTGRKEDVHGWNNVV
>AIA11445.1|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic target protection|0
MAKGMPDSASKFNSSRAEEYGQQSRIALAGYDACHELSACMLAAALGPQSAAKILVVGAGGPAQEITIGGLLEPNWRFTAVDPSEPMLAIARARIAEAGMADRTEIVLGRVHDLPNEPLFDAATLIGVLHHLPGDEAKQDILHAIASRVRPGAPLILAGNHYSYASEPLMLEAWGQRWRMHGATPDEVKAKLGKILQGADPPHSEAAVFALLADGGFEAPKRLFASLFWGAWIAFRVGQSS
>AMJ38195.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKNNIGIDNLIEVITNKFYSSTHRGQSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQPRRPNIRIDKVRYMFNKIT
>AMJ36754.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|tlrC|antibiotic target protection|1
MCIQVQQITYIHPDKEVLFRNLSFTVGKGRQLALIGNNGCGKSTLLQIMAGKLQPSSGNVLRPDDLYYVPQHFGQYDEMSIAQALGIDRKQKALHEILNGNASIDHFNILDDDWNIEEKALAALNGWGLGNRSLSESMHTLSGGEKTRVFLAGLELQEPPAVLMDEPT
>KF630163.1_11786|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
MEKKNIDWSSLGFGYVQTDYRYVSKFKDGAWDAGELTTDPNVTLNECAGVFQYAQTVFEGMKAYTTEDGHIVTFRPDLNAERMANSAKRLEMPVFPEDRFVDAIVQTVKANAAYVPPYGSGATLYVRPYMMGTNPVIGVKPADEYMFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLIGIQMGRIQAPEGWLKVIE
>KF630148.1_11822|FEATURES|farme|macrolide-lincosamide-streptogramin|vgaA|antibiotic target protection|0
DDDGNLMHLNNTITKVAVGSDESKWGLKALEIAANFAAAWDAELDVISAVPNMKGSDDEGVMASFKDDLEVRIKPLEEAHPDLKINKQIVPGPAVGALTKASYDHDVVVVGSRGRGGFTGLLLGSTSQGLLQHAVGPVYVVPRKYVEAAETRLDTVPSSPAEVKPKALDDIKGVEEVPVSKAEPDVVEAIETKIDPDRQ
>KF630147.1_11829|FEATURES|farme|tetracycline|tet32|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLTEAYRALSVLDGAVLVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQNGIDLQRVYQSIKDKLTSDMIVMQEVSLSPQISMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAVTETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKKKIKITEMCIPSNGEIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTWIDNPMPLLRTTVEPQKPEQREALLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF629965.1_12301|FEATURES|farme|multidrug|ABC_transporter|antibiotic target protection|1
KTLLFPGVTDLTKTVGDGKVLGHVSFTIRPNEKVAFVGSDTVAKTTLFQILAGELEPDEGSYKWGVTTSLAYFPSDNSAFFDGCELTLIDRLRQFSREQLETDIRGWLGRMLFAGEEATKKAKVLSGGERVRCMLCKMMVSGANVLILDEPTNHLDLESITALNNGLISFPGTLLFTSHDHQFVQTIADRIIEILPDRVIDRKETYDEYLASLAEEDLKKLR
>KF629879.1_12568|FEATURES|farme|tetracycline|tet32|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAVTSFYWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMDIPTIIFINKIDQNGIDLQCVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAIIETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPQKKASCTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEGVRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYLSFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM
>KF629717.1_13020|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic target protection|0
MAGNRNEEMVYCSFCGKNQEEVKKIIAGNGVFICNECVALSQEIIREEMAEEVLADLAETPKPKELLDILNNYVVGQDRAKRALAVAVYNHYKRINFTESREDNDVDLQKSNILMIGPTGSGKTFLAQTLARSLNVPFAIADATSLTEAGYVGEDVENI
>KF629145.1_14584|FEATURES|farme|quinolone|mfd|antibiotic target protection|0
CHGTRLKPEAGYVRVDGKSISELVDLPITELKEFFDHLNLNEHDSNVARRILIEINSRIRFLIDVGLGYLTLNRLSNSLSGGESQRINLATSLGSSLVGSLYILDEPSIGLHSRDTDRLIRVLRQLKVNVDTLTMSATPIPRTLQFSLMGARDMSIMRTPPPNRYPIRTGLVTFSSEVICDAINFEMSRNGQVYFVCDRISK
>KF629024.1_14891|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
QDISIMENMGLENWDTVIADCDELLEKYIAGEPMDKEELLREENRRIQSVSLFPVYHGSAKVNLGIRQLIEAVTDTFQSPTGQNSSELCGTVFKVEYANQSQRLAYLRLYSGTLHLRDSVALAGKEKLKITEMRIPSKGEIVRTEIAHAGEIVIVPCDSLRLNDVLGNKLLLPRETWSDNPLPLLRTTIAPEKPEQRERLLNALTEIADTDPLLRYEVDAVTHEIILSFLGRVQLEIISDLLVEKYQLNTTAKEPTVIYMERPLKAVSHTIHIEVPPNPFWASIGLSVTPLPLGTGVQYESKVSVGYLNQSFQNAVLDGIRYGLEQGVYGWKVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQVLKKAGTQLLEPYLSFTLYAPQEYLSRAYHDAPKYCASIETTQVKNSEVIFTGEIPARCVQEYRNGLTFYTNGRSVCLTELKGYQIASGEPVFQPRRPNTRIDKVRHMFNKILPSMMDL
>KF628590.1_16029|FEATURES|farme|bacitracin|BcrA|antibiotic target protection|1
MDIALQINNLSKAYGKHQVLENISFTVVKGEIFALLGTNGAGKTTTLECLEGIRRYDTGKILINGKLGVQLQSSSLPADITAKEAIMLFAKWQDLEVTDDYFIYLGIKAFLKKQY
>KF628201.1_17037|FEATURES|farme|multidrug|ABC_transporter|antibiotic target protection|1
MLARDNLLLLDEPTNHLDIGSREALEEALAGYDGTIFIVSHDRYFINRLATRVLRLTNEGCQSFEGGYDQYLERFQEAERTKTEQAPPKENAYKKRKEQESVRRRLQGRIRRTEEAVAAAEEAVASLHRQLEDEAVAADYTRVLELTAELEEQNRRLEEQMALWEELQLEAEAMEEETPL
>KF627773.1_18161|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
NQQQNQGNYNAYQQQNYNPNFNPSGKPLKSKMVAGLLGIFLGGFGVHSFYLGYTGKGVAQIIVSLVTCGVGSLWGFIEGILILTGNISQDANGNPLAD
>KF627729.1_18277|FEATURES|farme|multidrug|ABC_transporter|antibiotic target protection|0
MALITCENVSIGYEGQTVVKELNFSIERGDYLCIVGENGSGKSTLVKSLLGLKGTSRG
>KF627615.1_18587|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
LSHRSPTVSFLLSHVVLLIYVAQHCLGLEAEEREVTLEEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMTEMGPVTKKLYEALTGIQMGRLEAPEGWLQVIE
>ACT97592.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKNPKRNIAIVCGGDSSEHDVSMRSAQGLYSFFDKERYNVYIVDVKGLDWNVHFEDGTTAPIDKNDFSFLVNGKLVVFDYAYITIHGTPGENGIMQGYFELLHIPYSTSGVLVEAMTFDKFVLNNYLRGFGVNVADSLLLRRGEEDKYSEAEIASRIGWPCFVKPAADGSSFGISKVKNADQLAPALRVAFMESDEVMIERYLKGTEISVGCYKTKNKSVVFPATEVVTSNEFFDYDAKYNGQVEEITPARLNPETAERVAEETSKIYDILHCNGIIRIDYIISQDQNGRDVINMLEINSTPGMTATSFIPQQVRAAGLDIKDVLTDIIENQMS
>ACT97572.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKLAVLFGGISSEHDISCLSAASILRNLNKDKYEIYPVGITRDGEWFYCPDCDPDRVESGAWERMTGKVKVVLAPDRGMHGMVLLREGEIEVVRLDCVFPVLHGVGGEDGTMQGLLELAGIPYVGCGVAASANTMDKALTKKVIEGTGVRQARYYLALRYDFERNAEAVVAAAAETLGAFPVFVKPCSQGSSVGVAKANNLLELAEGLTEALKLDTKVLVEEFIDGHEVECAVLGNLEPQASTVGEIAPTQEFYTFDAKYKDESSRLYIPAHITEEQLATVRQDAVRVYTALGCRGLSRVDFFVTHDSGEVVFNELNAIPGFTSISMYPKLFDYEGIGYAELLDRLISLALEEHNG
>ACT97570.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPVDRNDFSFTNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFTCNQYLKAFGVRIAESLLLRQGQSVSDEEVVEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQPAIVKAFGEAEEVIVEAFMDGTELTCGCYKTKEKSVIFPPTXXXTHNEFFDYDAKYNGQVDEITPARISDELTKRVQMLTSAIYDILGCSGIIRVDYIITAGEKLNLLEVNTTPGMTTTSFIPQQVRAAGLDIKDVMTDIIENKLEVLSIKYKVLTMLEWTQSNT
>ACT97564.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MLYSIRYAQENYTIRDCVWKRGLIMNIVVLAGGTSTERDISILTSTKVCESLRRNGYNANIVDVFFGIDSENVDNFFNNDNDLEKLCKYLKNQTPDVEKELEARKALGKGFFGDNVLELCQKADIVFMGLHGSNGEDGKIQAAFELMGIKYTGTDYISSAISMSKELTKKVLVPEGIPMPKGIALHKGHKVEYVPFPCVVKPCCGGSSVGVSIVNSEEEFKRALTDAFSYEDNILVEEFIKGREFSVGVLNGKALPVIEIEPLDGFYDYKNKYKAGATKETCPANLPKEISEKMQRWAEKACETAGVTTYARVDELLNEDGDIYCLEINTLPGMTGTSLLPQEAAAVGMSYDELTKKIIEISLEKYN
>ACT97558.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MCLIKPKHDNSIKEKRTKMNIVVLAGGLSTERDVSFKTGSMVAKALKENGHKVILLDVFMGYSDREEDLTGIFDRADEISVQVSDIPTEAPDLAKVKASRKDQSPCFFGPNVIKICQMADIVFMALHGENGENGKIQAAFDLFGVKYTGSDYLSSAIAMNKETSKQFFLANGIPTPKGISMTRATRQDDITKLDLTLPCVVKPCCGGSSIGVTIVRDAAEFKAALDDAFKWENELVIEEFVQGREFSVGVIEGKALPIIEIAPKEGFYDYKNKYKAGSTVETCPAELPEQVTKDMQHYAEEVARVIGLDTYSRSDFLLNDKNEMFCLEANTLPGMTPTSLLPQEAAVIGMSFNQLCEHLIDISRKNMRCSMSDKYMKSLTFAN
>ACT97556.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSELVVSLRSAQGLYSFIDKERYNLYIVEMEGHRWEVVLPDGSKTPIDRNDFSFMENGEKKQFDFAYITIHGTPGENGILQGYFDLLGIPYSSCNVLVSAMTFNKFTCNQYLKGFGIRVAESLILRKGFEITDEEVINKIGLPCFIKPNAGGSSFGVTKVKTKEDIQPAIEKAFEESDEVMIEAFMKGTEITCGCYKTSDKEVVFPITEVVSANEFFDYGAKYNGESQEITPARLPEDTAERVRLLTSAIYDILGCSGLIRIDYIITEGEKVNLLEINTTPGMTATSFIPQQVRAAGLDIKDVMTDIIENKF
>ACT97549.1|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MELSMKITVLAGGFSPERDVSLLSGALIANSLCRSGHLVALTDVFYPYRGALSDDAFTSDGNFMYTVPKEPPDLKALRAEVPGSALIGDGVLELCRLSDIVFLALHGGMGEDGSIQAALSSMGIPYTGSDFAACLVAMDKSLSKLLFRAHGIPTADFTLLKKGDSTDGIPLPCVVKPCSCGSSVGVSIVDTKEALAGALETAYQYEEKVLAEDKICGREFSVGVLLGRALPAIEIRPKDGFYDYERKYQSGMTEEICPADLPEAEAASLGALALKVHRALGLGSYSRIDFIREEKTGKFICLEANTLPGMTPMSLLPQEAAAAGIGYDALCLAIAQAAKNGQK
>ACT97547.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMKETIAVLFGGQSSEHVVSCMSAANVIDQIDKDKYDLLLIGITEEGEWILTPSVEEIRNDTWRDGRTHAVLSPDATRKCVIISEGDATKEVRVDVVFPVLHGLRGEDGTVQGLLELARIPYVGCGVLASAVSMDKLYTKLIVDSLGIRQADYVPVRRSQLQDMNSVIASVENKLSYPVFVKPSNAGSSRGVNKADNREELVFALNEAAKHDRKILVEETIIGHEVECAVFGGGLQEVKASGVGEIMAAAEFYDFDAKYYNAESKTVVDPELPGHAAEDEKKAAVEIFKAVDGYGLSRVDFFVTDAGEVVFNEINTLPGFTAISMYPMLWEARGISKSRLVDDLINHAKERYDV
>ACT97541.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MENSKRTIAIVCGGDSSEHDVSLRSGQGLYSFFDKERYNIYLVDVKGTDWHVALDNGETIEIDKNDFSFVMNGKHVYFDYAYITIHGQPGENGVMQGYFDLIHLPYSTSGVLVEAMTFDKYVLNNYLRGFGINVADSILLRRGEAYDEEEIAKRIGMPCFVKPAADGSSFGVSKVKNADQLAPALRVAFMESNEVMIEGFLDGTEISQGIYKTAEKTVVLPATEVVTTNEFFDYDAKYNGQVQEITPARLSPETAEEVAKTTSRIYDILHANGIIRIDYIISKDKDGKDKVNMLEINTTPGMTVTSFIPQQVRAAGLDIKDVLSEIVENQF
>ACT97537.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSEHGVSMKSAEGIYSFIDQDKYTLYIVELTKARWEAILSDGSRAQVDKNDFSFMDHGQKIIPDFAYITIHGTPGENGILQGYFELLGIPYSTCDVLVSALTFSKFTLNQYLKGFGVRVAESMLVNKRHGISDEDVIAKIGLPCFIKPNASGSSFGVTKVKTKEQIQPALEAAFKESDDVMIEAFMDGIELANGCYKTKKNEVVFPITEVVSQNEFFDYNAKYKGEVTEITPARLSPELTSRVQQLTSAIYDILGCKGIVRVDYIITEGEKINMLEINTTPGMTATSFIPQQVRAAGLDIKDVMTDIIEDHFN
>ACT97535.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEFKMNIVVLCGGNSTEREVSINSGSMVCEALRKKNHNAILMDVYFGLEDIDIFEKSASKYDVESVKKNIQSLSDKVSEDRRSFFGNNVIEICQKADIVFMALHGKNGEDGKCQAAFDLYGIKYTGSGHLASAIGMDKGVTKQIFMSKGVPTAKSVWIKKGESTDLKDYGMKVPVVVKACNGGSSVGVVLVHQESEYEDAVKTCFELDNQILVEDFIKGREFSIGVINKKALPVVEIIPRDGWYDYKNKYNGATEEVCPANLNDELTKKIQKVAEDACNAIGCEPYARADVMMDADGNMFCLEVNTLPGMTATSLVPQEAKAVGMDFPTLCDYLVELSLKKNN
>ACT97596.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKNIAILMGGYSSEAEVSLKSAATVVECLDKNKYRPYPILIAKDRWVYTDPKGQEFPIDKNDFSLTIGGEKITFACAFNAIHGTPGEDGHLQAYFSFVGIPITGCSMYASALTFNKRDMLSVLKPYGIPRAKAYYLNRGEHFSTREIIKTVGLPCFVKANRSGSSIGVFKAYNEKDIDEAIEKAFEVDSEIIIEEFLKGTEVSVGVITYRGKKRVLPITEIVSENDFFDHEAKYEGKSQEITPARLSEEERKKVEEIALRVYNLLQMKGFSRSEYILVNGQPHLLEMNTTPGLTKASILPQQAKAAGITLANLFDNAIEEAMNSD
>ACT97593.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MTEKKTVALLCGGRSSEHPISLITAAGVLGAIDRTAYDVITIGITRDGRWYLTDEQQLAELTAGTRGTAEFPEGTQQVFLPMGAGDSRLTLVDAEGNVTRTAPVDVVFPLLHGPFGEDGTVQGLLEMADLHYVGCGVTASAVGMDKHFMKVAFESAGLEVGPYEVVTNRQWEHEDREQILERVLKLGFPMFVKPTRAGSSFGITKVDSVEELVPAIEEARRHDPKIIIEAGIVGREIECAVLDGHHGEMPRASYPGEIEVVDQDHGFYDFEAKYVSESSAVTVCPANLPQDVQDRLRELAVKAFLALDGEGLSRADFFYTEDGRLVINEVNTMPGFTPISMYKTMWENTGISYTDLISELLTLAMERPLGLR
>ACT97573.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICRTLLERGHDAFLLDVFLGLENAPEDLEDVFTMPGHGLEIAKNISEEEPDLAAVKASRPDQSDCFLGPNVIELCRLADITFLGLHGGEGENGKLQATFDLLGIRYTGPDSLGCAVAMDKGFTKQVFLQAGIDTPDGVCLHKNDADRSLASLGLSLPVVVKPCSGGSSIGVYIVNTEDEYKDALEKSFRYEDEIVIETFIKGREFACGIIDGEALPPIEIIPKTGFFDYANKYQDGATDEVCPADIPKDIEERMMELTVRAFHALKLNVYSRADFLLDDQGSLYCLEMNTLPGMTAASLLPKEAKVAGIEYGDLCELIIQKSIEARYSD
>ACT97571.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKNLKRTIAIVCGGDSSEHDVSLRSAQGLYSFFDKERYDVYIVDVRGTDWRVQLPDGEEAKIDRNDFSFVKTDGTAVVFDYAYITIHGQPGENGPMQGYFDLIHVPYSTSGVLVEAMTFDKFVLNRYLGSFGIHVADSVLLRRGETYNEEEIAKRIGMPCFVKPANDGSSFGVSKVKNADQLEPALRVAFMESSDVMVEAYLDGTEITQGIYKTRERSVPFPITEVVTTNEFFDYDAKYNGQVDEITPARISPETAERVTEITSRIYDILHANGIIRIDYIITHDAEGNEVINMLEVNTTPGMTTTSFIPQQVRAAGLDIKDVLTEIIENQF
>ACT97566.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVCGGDTSEFEVSLRSAQGIYSFIDKERYTLYIVEMRGTDWHVQLPDGTKTPVDRNDFSFRLDGAKVVFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAAALTYDKFACNQYLKAFGVRIADSLLLRQGQSVSDEDVIGKIGLPCFIKPSLGGSSFGVTKVNVKEQIHPAIAKAFAEAKEVLVEAFMDGMEITCGCYKTKEKSVVFPITEVVSHNEYFDYKAKYNGESDEITPARIPDELRDRVQKLTSAIYDILGASGIIRVDYIITEGEKINLLEVNTTPGMTATSFIPQQVRAANLEIKDVMTDIIENQS
>ACT97555.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLSDSEHKMCVVVLFGGMSSEHEVSRVSAGTFVDQLDRQRYELLTIGITKDGRWLYTEATSAQMADGSWEELPGNMPCVVSPDRADHGLILFTPAGQVEKVRADVVIPVLHGLWGEDGTVQGLLELAGIPYVGCGVLASAVCMDKAVANAMFDASGIPHTKWLSATRWEIECDPEGVCDGVIAKLGWPIFVKPANAGSSVGITKAHDRTELKEAIRLALANDRKVVFEAFVDGHEVECAVIGSDPAVSTRPGEILAGAEFYTYDDKYKNGVSQVVIPAKLPEEKLDEVKTYAAMAYTALGCEGLARCDFFVEKNTGRVLINEINTLPGFTPISMYPKLMEHEGIPVPALIDRLIALALERTEKQHG
>ACT97550.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIAVLCGGRSSERDVSLSTGIQVARALRETGHDVVLVDACVDFPLDCRPEEVFEKALPIENHAIGAAAPCVERFFDRASGFFGKNVLEICKSADIVFNALHGDEGENGKLQAVFDLLNICYTGSGAQGCMLAMNKSLSKQLFRTHGIPTPEAVILSESDKCRAAELCEKLGLPCVVKPASLGSSVGVSIVRTIDEFFTALDSAFSLEHTVIVEKYIKGREFAVGIVGSRVLPAIEIIPKHGFYDYKNKYQPGCTVEICPADIDSDTAERMAEATRKVFRVLGLGAYARADFMVDENGIYCLEANTLPGMTPVSLLPQEAAADKLDFPALLEAIIKESLLLRATERRH
>ACT97530.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKRIIAIVAGGDSSEHDVSMRSAEGIYSFIDKDKYTLYIVELTKEKWEALLPDGSRAQIDRNDFSFSHDGQKVKPDFAYITIHGTPGENGILQGYFELLGIPYSTCDVLVSAMTFSKFTLNQYLKGFGVRVAESMLVNKHHGISNEDVIEKIGLPCFIKPNASGSSFGVTKVKTAEQIQPALEKAFAESDDVMIEAFMDGIELANGCYKTKDKSVVFPITEVVSKNEFFDYNAKYNGEVTEITPARLSPELTDRVQKLTSAVYDILGCKGIVRVDYIITEGEKINMLEINTTPGMTATSFIPQPGSCSRYRYQRGYDRYYRRFVSEITRNYVYLNCD
>CBI71203.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRHVMETGTDRGDRTGKGTRSIFGYQMRFDLAEGFPVLTTKKLHLRSIIHELLWFLKGDTNVAYLTENGVSIWDEWADEKGELGPVYGYQWRSWPAPDGRHIDQISQLIEGLKVNPNSRRHIVSAWNVGQLDEMALPACHCLFQFYVADGKLSCQLYQRSADVFLGVPFNIASYALLTMMVAQVTGLKPGDFVHTLGDTHIYSDHFEQAKLQLTRTPKALPTMRINPAVKDIFSFRFEDFALEGYEADPHIKAAVAV
>AET35510.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MNRKTAVVLFGGQSSEHVVSCMSVVNVINHMNREKYDLLLIGITEEGHWIKVESVEAIESGRWREGTVNAVISPDATKQCVILTEGDRVEFVKADVVFPVLHGLYGEDGTVQGLLELARIPYVGCGVLASAVSMDKLYTKIVVDDLGVRQAAYVPVMRSDLNDMASVVGRVEAKFSYPVFVKPSNAGSSKGVARADGREELEAALREAANHDRKILVEEMIRGREIECAVFGGGLIPVEASGVGEILAAAEFYDFDAKYYNSDSRTVVNPDLPGDAVNQVREAAKAIFQAVDGYGLARVDFFVKDDGTVVFNEINTLPGFTAISMYPMLWEAAGVTKDQLVDRLMEHAFDRFRL
>AET35496.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLAGGLSTERDVSFKTGDMVSKALRENGHNVILLDVFMGYSDKEENLTGIFDRTEEVSVQVKDIPETAPDLAKVKASRKDQSDCFFGPNVINMCRMADIVFMALHGENGENGKIQAAFDLFGIKYTGTGYLSSALAMDKGMAKQLFIAGGIPTPQGISTKKENRKDSAKELGLKLPCVVKPCCGGSSIGVTIVRTEDEFKSALDEAFKWEDNLIIEEYVEGREFSVGVIDYKALPIIEIAPIQGFYDYKNKYKAGSAVETCPAELPEEITEQMQHYAERVAEVLGLNTYSRSDFLLNKNNEIYCLEANTLPGMTPTSLLPQEAGVLGINFNQLCEKLIEISLKKYEK
>AET35507.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGLSTERDVSFKTGDMVAKALRENGHQVILLDVFMGYSDKKEDLTGIFDRSEEVSVKVSGIPEIAPDLAKVKASRKDQSDNFFGPNVIELCQMSDIVFMALHGENGENGKIQAAFDLFGIRYTGTGYLSSALAMDKEMSKKLFLSAGIPAPKGASMKKADCSDDITKLGIQFPCVVKPCCGGSSIGVSIAHNAEEYKAALDEAFRWEENLIVEEYVKGREFSVGVIEGKALPIIEIAPVQGFYDYKNKYKAGSAVETCPAELSEAVTEKMQHYAEQVAQVLGLDTYSRTDFLLDENENIYCLEANTLPGMTPTSLLPQEAQVVGVNFNELCEKLIQISLDKYEK
>AET35501.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKKKIAVLFGGQSSEHVVSCVSAANVIDQINKEKYDLLLIGITEEGHWVKAESVEDIRSGAWRESSVEVVISPDATKKCALITENGVTREERIDVAFPVLHGLYGEDGTVQGLFELAKIPYVGCGVLASAVSMDKLYTKIIVDTLGIRQAKYVPVMRWEMEKDMDIAVAAVETHFQYPVFVKPSNAGSSRGVNKAETRKELIGALKEAAKHDRKILVEETIVGHEVECAVLGGGQNPVKASGVGEILAAAEFYDFDAKYNNAESRTVIGPELPGDSAERVREAAAKIFNAVDGYGLSRVDFFVTSDGEVIFNEINTMPGFTAISMYPMLWEAAGISKPELVDRLIDLAFER
>AET35492.1|FEATURES|farme|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFFPPPTVKSALLNIKRKQLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWVNCFLEMLEVVPEKFHPS
>AET35511.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MSKLTAAVIFGGQSSEHIVSCMSAANVIEHIDRTRYNVLLVGITEEGHWIKADSLDDVKTGAWRGGTVTALLSPDATRKCMILMDGDKIEEVKLDVVFPVLHGLYGEDGTIQGLLELARIPYVGCGVLASAVSMDKLYTKIIVSDLGIRQAEYEAVYREELSAMDQVAERIEKHFPYPVFIKPSNAGSSRGISKADNRRELMDGLTEAARHDRKILVEETIVGREIECAVFGGGASAVEASGVGEILAAAEFYDFDAKYFNEDSRTVTDPELPDGAAQRVRRAAMDIFRAVDGYGLARVDFFVKDDGEVVFNEINTMPGFTAISMYPMLWEARGISKDQLVEKLLSHGMERYA
>AHN92695.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKKVAVVFGGRSTEHDVSRISAYSIIKNIDKTLFDVVMIGITKNGEWLPYSGSIEALPDGSWEKFVNPTGRISLEKGIAALEECDVILPVLHGQNGEDGTVQGLFELLDIPYVGCGILASAAGMDKAYTKIILNDAGIPQCRHIVAYRHVLEENPDAYADVVAEKIGFPCFIKPSNRARQLAFISQTLQ
>AIA18391.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRSRGHVVTALDPARGVISAAEERELSTGKVGTEPPSLETLSKFAEGAFLPNLTSMKEVKDADVAFLALHGGQGEDGTIQALLDMANVKYTGSGHLSSALAMDKDLSKKLFRSEDVKTADWLMAPVTVEQVEGMLGLPVVVKPSKQGSTVGLSLVKKREDLAKAIEEASKYDDEVMVESFVPGRELTVGILGDVALPVGEILPKHEIYDYECKYTAGMATEEFPAKLSPEATEKVQQQALAAFRALKLRGYARIDFRLTSEGEFYCLEANTLPGMTELSLIPQGAAAMGISFPELCEQIVRLALG
>AIA17871.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTKVLSQIKTNPQSRRLVVSAWNVAEIDKMALPPCHAFFQFYVAGDKLSLQLYQRSADIFLGVPFNIASYALLLMMVAQECELKPFEFIHTLGDAHLYSNHVEQARLQLTREPKKLSVMKLNPSVKSVFEFRFEDFTLERYESHPTIKEEISV
>AIA17720.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MHAYLDLMRYVMQHGVTKTDRTGTGTLSVFGYQMRFDLSKGFPLVTTKKCHLTSIIHELLWFLKGDTNIKYLTDNKVTIWNEWADANGNLGPVYGKQWRSWPDKTGKVIDQITQLIHNIKTNPDSRRLIVSAWNVAEIPDMALPPCHALFQFYVANGKLSCQLYQRSADIFLGVPFNIASYALLTMMVAQVTNLAPGEFVHTFGDAHLYSNHKEQAKLQLTRTPLALPQMRFKRKVSNIFDFQYEDFELVEYNPHPSIKAEVAV
>AIA16594.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMRRVLDQGVRKCDRTGTGTLSTFGHQMRFDLADGFPLVTTKKLHLKSIVHELIWFLSGDTNIAYLKANGVSIWDAWADEAGDLGPVYGAQWRSWPTGDGGSVDQIRQVVDQIRTNPDSRRLIVSAWNPAEVDRMALPPCHCLFQFYVAEGRLSCQLYQRSADVFLGLPFNIASYALLTMMMAQVTGLQPGEFVHSLGDTHLYLNHLDQARLQLERDPRRLPTMRLNPEVNAIVDFVYEDFVLEGYDPHPHIKAAVAM
>AIA16098.1|FEATURES|farme|macrolide-lincosamide-streptogramin|chrB|antibiotic target alteration|0
MPTEFTIARALVEAAQILRRAGVEEARREAASLLEHITGHDRTFLITSAETALAPSDVSRLRGLVERRAAGEPLQYITGHQEFYKLDFEVTPDVLIPRPETELLVETALDLLDEWDGPTFICDVGTGSGCIAVSLLHELPLARAIGLDISQPALRVAARNAARAGVNERLSLVVSDGLAALDPARARFTMIVSNPPYIAEDALAGLQREVRDHEPRVALTPGGDGLRIIRALVADAPRFLDSGGHLLIEIGFDQHEAVKKLIDPRVWELLDIHEDLQGIPRTVALMKI
>AIA15512.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLGKVRNSGARKGDRTNTGTLSIFGHQMRFDLADGFPLVTTKKLHVKSIVHELLWFLQGSTNVRYLNEHGVTIWDEWADANGELGPVYGRQWRSWPAPDGRHIDQISNVVEALKRDPDSRRHIVSAWNVGELDQMALLPCHCLFQFYVVDGKLSCQLYQRSADIFLGVPFNIASYALLTLMMAQVTGLEPGEFVHTFGDAHLYLNHLDQADAQLTRKPRALPRLEINPDIRSLFDFAYEDFKLVGYDPHPAISAKVAV
>AIA14205.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDGGTKKDDRTGTGTLSTFGYQMRFNLDEGFPLLTTKKLHIKSIIYELLWFLRGDTSIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRASDGRTIDQISQVIEQIKSNPDSRRLIVSAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQMKINPSVKSIFEFDYSDFELSGYEPHPHIKAEVAV
>AIA12623.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFNFSEGFPLLTTKKLHVKSIIYELLWFLRGDTNVNYLREHGVRIWDQWADERGQLGPVYGAQWRSWRSADGRAIDQISQVIEQIKSNPDSRRLIVSAWNVGELDRMALMPCHLLFQFYVAGGRLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLRPGDLVHTLGDAHLYSNHLEQARLQLSREPRALPQMKINPQVTSIFQFDYSDFELSGYEPHPHIKAEVAV
>AIA17256.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MPKKQAPIQVQNSYPEQQFIDILKKILDQGVWRPVKQRLAGETVPEAKTVTGVQMRFQPEDGMPLTTLRSMKGAFYMFLGEMLWILSGHTDVDMLHKFNVRYWDDWCDAEHCGWYDLPVGQFGRTYGAQWRSFNAGGPEPVDQIKRLFNAIKKNPYDRGLLVNPWNPYDVDHIVIKPCHGQFRLLLVDDKWTMIVTQRSGDVPVGIPSNVVMYKFLQQLICMKTGFAEGELIYDIHDAHYYSDQEKGVEELISREPRAYPTCTINPILVEILDAMLEGDDDPFANKRFNPDNKPYSDLLKEWVVLENYNPHPPVPRDILPVAI
>AIA19280.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MRQYLELLEDIKTNGVKKPNRTGVDQITVFGRQLRFDLSKGFPAMTTKKLFMRSITHELIWFLKGSTNIKYLVDNDVHIWDEWPYKHYLMVRGKAVPDSSSDEWKKGIQKFTEKIKKDYKFADKWGELGPVYGYQWRKWPTTDGKHIDQIANAIDLIKNNPAPAG
>AIA19238.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MSTVQSPVKLTHETRIGVLYGGFSSERKVSLISGQNCFDALRRLGYKNAELIDVDHQIARTLADKRIEVAYIALHGKFGEDGCIQGLLELMGLPYTGCRVAASALTMNKALTKSVLKDAGLPVIDSVVIKAGTVNGKPIEIGLSYPVMVKPINEGSSIGMSKVNRAEDLKEALHTAFNYADEVMVEEYVPGKSLTVGVVEVDGKPQVTPILELRPTQSEWYDLEAKYTEGGTEFILPAELSQAVTEAIQAATLQAHIAAGCRGVSRVDFVVDGEGRFYILEINTIPGMTPLSDLPAQAKAMGIDYDQLVECILKTAVTDL
>AIA19215.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQAFHQLLKTVLADGVRKEDRTGTGTLSIFGYQMRFNLNAGFPLLTTKKLHTRSIVHELLWFLKGDTNIQYLKDNKVTIWDEWADENGELGPVYGKQWRSWQAPDGRQIDQISSVISEIKSNPNSRRLLVVAFNPGEIEKMALPPCHAFFQFYVAQGRLSCQLYQRSADIFLGVPFNIASYALLTHMIAQVCDLQVGEFIHTLGDAHLYSNHLEQAQLLLTREPKPLPQLVLNPEIKNIFDFKYDDIKIENYESHPAIKAEVAI
>AIA19208.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTEMNSSKKHGEYQYLDLLDEILKNGERKVDRGTDVVLYSLFGRQTRYDLSEGFPLLTTKKVYWKGVLHELYWFMSGQTNIKYLVDNNVHIWDDYPFKIYNWKRESDKKLPELTKEEFVEKIHTDAAFAEKWGELPRIYGEMWRHWPTRSGRTIDQLKWILQEMKDDPDAKNLIVNSWNPEYLYTMATYEDASRFPICHNMYQISNRNGKLSLQLYQRSADIFLGVPFNIASYALLTIILAQISGLEPGEFVHTFGDVHVYENHIEQAKEQLSRKPRPFPTVTIDPAVKNLDDFRPEHVMLENYDPYPVPKGELTVAGGFYEKKK
>AIA19190.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKKKFVTSELQYLNLLKDVMKNGKYKENRTGVGTVSVFGRQIRFNLKEGFPLLTTKKVFLRGIIHELLWFLNGDGNIKYLVDNDVHIWDEWPYRFYAQKVEKKGETPLSQKDFIQKIKNDTKFAKKWGNLGPVYGVQWRHWKGADGKETDQIAELVEHIKEVKKNPFASYGRRLIVSAWNPSEIEEMAKAGLPPCHSLFQFYVIENKLSCQLYQRSADLFLGVPFNIASYALLLMMVAQVTGLEVGEFVHTFGDAHIYSNHMDQVKEQLSREIRPFPKMVLNSEVNDIFTFNFDDFKLEDYDPHPAIKATVAV
>AIA19188.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKHQEYQYLDLAREILKDGITKVDRGTDIKLKSLFARQMRFDLSKDFPLLTTKRVYWKGVIHELYWFMSGQTNIKYLVDHDVHVWDDYPYKIYMGKVKKGIVKDNKNLTKDEFIGRVKEDKKFAKAFGDLPRIYGEMWRHWPTRKKGRTIDQLKWVMQELKDDPDAKNLIVNSWNPEYLYTMAQFEDASRFPICHNMYQVSNRNGKLSLQLYHRSADLFLGTPFNIASYSLLTAILAQVAGLKPGEFIHTFGDVHIYNNHIDAIKEQLKRKPKPFPKIKIDKSVRSIDDFRPELVELIDYEPHPSIKAELTIAGGLYDPKTGKMAS
>AIA19137.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGKPRAELQYLSIARQILEEGEPTDDRTGVGTLDLFGEPQMAYDLRKEFPLLTSKNVATKAVRSELAWMLHGDTNLKYLAKHDNHIWDEWPFVAYLKKTDQAIPEQGSEEWKSAKDDYLQKIKDDANFAEEYGNLGPIYGHQWRAWADYDGKPIDQLRIAQDQIRSGKASRRIIVSAWNVSDLDEMSKAGLPPCHTLFQFNASNQTDPKTGKKYLDMKMYQRSADWFLGVPFNMVQYAMLLSAMAQTTGRTPRYFYHTFGSAHIYKNHTEQIKEQLSREDNLYEAPRLKLNPEITDIGDFEAEDFKIVGYKHHPSIKGQVAI
>AIA19085.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKKRLGLVYGGKSAEHEVSLSTARAVSQAVDFKRFEVIPVYITYDGEWRKGKPLEKPVETIEELRLQGDGTTKPDSIHDFLNGGESLPDVIFPLLHGTNGEDGTVQGLFEVMNIPYVGNGVLASSAGMDKVSMKQLFAQVGLKQVPYVHFNRSGWMEEREPLIEQMEKELGWPMFVKPANLGSSVGISKAEDRESLITAIELALKFDRRIIVEQGVTAREIELSVKGNDDPVCSVPGEIKPVTDFYDYEAKYKDGNTELIIPAEVTPEVLETMEDMAIRAFKVLDCSGLVRADFFVTAENEVL
>AIA19046.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDMLQHILDNGVDGDDRTKTGTRSVFGYQNRYNLADGFPLVTTKKIFLRAVIIELLWFIRGDTNIAWLNENRVNIWNEWADENGDLGPVYGEQWRSYQAADGRTIDQLSLVIDQIKSSPKSRRLLVDAWNVGELDRMKLAPCHCLFQFYVSGGKLSCQLYQRSADSFLGVPFNIASYALLTMMIAQVCDLEPGEFIHTFGDLHLYSNHFEQAKLQLTREPLPLPRVLINPERRSIDDFVYEDFTLEDYQAHESIAAPIAV
>AIA19007.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRHVLDKGATKTDRTGTGTVSVFGYQMRFDLQEGFPMMTTKKVHMKSILHELLWFLKGDTNIKYLKDNGVSIWDEWADENGNLGPVYGSQWRSWPTADGRHIDQITQVINQIKNTPDSRRMIVSAWNVGEIEKMKLPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIASYAILTLMVAQVCNLQPGEFIHTLGDAHLYSNHIEQAKLQLSRDLRKLPVLKINPDVKDIFGFKFEDFTLEGYDPHPHIKASVAV
>AIA18988.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FDLRKGFPIVTTKKVPFRWIAEELFWFLSGDTDEANLRARGVDIWAEWADAEHTTKFGRQAGDLGPVYGYLWRSFGGNYPNRDGVDQVARLIDEIKNNPDSRRLIITGWDPRQADNVDLPPCHTLFQFKVENHKRLHCQLYQRSADAFLGVPFNISSYALLIHLVAHVTELEVGEFVYTLGDYHIYQNHMDQVDELLAREP
>AIA18979.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FMGNCGVDGRPEPIEQSINSKWVISELTEDPYARNAIVTSWNPEYLYTMATNKDASRFPICHNMYQVSVKANKVNLQLYQRSADLFLGVPFNIASYALLTIILAQVLGYKPGEFVHTFGDAHIYENHIEQAREQLKRDPKPFPKVTIDPSVKTIDDFRPEHVVLENYDPHPILKGELTVAGGLYEG
>AIA18961.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMKHVLEQGAKKHDRTGTGTLSVFGHQMRFNLAEGFPLLTTKKLHIKSIVYELLWFLRGDTNVKYLQEHGVNIWNEWARENGELGPVYGAQWRSWKTPDGRAIDQISQVIDQIKSNPDSRRLIVNAWNVGEIPSMALPPCHLLFQFYVADGKLSCQLYQRSADIFLGLPFNIASYSLLTMMVAQVCDLEPGEFIITLGDAHLYSNHFEQTRLQLSREPLKLPQMRINRSVRSIFEFDYDDFELAGYEAHPHIKAEVAV
>AIA18924.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYIDLLRHVMEHGTEKSDRTGTGTKSVFGYQMRFDLADGFPLLTTKKVHTKSIFHELLWFLKGETNIRYLKENGVSIWDEWADEDGNLGPVYGSQWRSWQAADGNTIDQITEVISQIKKNPDSRRLIVSAWNVGEISKMKLPPCHAFFQFYVAEGKLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLKPGEFVHTLGDAHIYSNHFEQVALQLSRTPKALPTMKLNPDIKNIFDFKYEDFTLENYEPHPGIKAPVAV
>AIA18878.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTNTQHPEYQYLNLLQDILDHGIDKKVFNAETTIRSVFGRQIRFDLSQGFPLLTTKKVFLRGIIIELLWFLQGNSNIKYLVDNNVHIWDEWAYKPYKKLMEKGLVQHLDQPAFIEKIKAEGEFAAKWGDLGNVYGVQWRNWKTSDGRTIDQIKWLLSELRTTPFRKSLVVSAWNPDFIYEMAAPGKSMALPPCHTLWQVNVNEGRLSLQLYQRSADMFLGVPFNIASYSLLTMMLAAVAGFQPGEFVHTFGDVHIYSNHIDQVHEQLRREPRPFPTMKLTPGVKDIDSFKLEDFTLENYDPHPPIKGQVTVVGGF
>AIA18848.1|FEATURES|farme|aminoglycoside|Krm|antibiotic target alteration|1
MARSPENDITELIASVRGSSKYGSISEAMIRSIGLRELAARRNLKEAIKATKNKLHQVAGAYLDGRLPYDDWLALLDEARQADGVIDAGGSPTLHAQFRLACRQIMRNHASTRERLPILEDFYAATLASLGQVSSVLDLACGLNPLTLPWMPLAPDARYYACDIYADMIAFLNGFFTRAGLEGQTEECALAAGAPNVQVDLALVLKALPPLDQQAKHAGRDLLRALNARHILVSFPAQSLGGRGKGMAENYEQRFRTLADSEGWAIERFVFPTELAFLVRKG
>AIA18838.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMRHVLEQGAKKEDRTGIGTLSIFGYQMRFDLQQGFPLVTTKRLHLKSIIYELLWFLRGETNVRYLREHGVTIWDEWADANGELGEGIYGSQWRAWPNPDGTHIDQISQVIEQIKRNPNSRRLLVMAYNPSFADKTPLPPCHSFFQFYVANGKLSCQMYQRSADIFLGGPFNIASYALLTMMIARVCDLQPGDFVHTFADAHLYLNHLEQARLQLAREPHPLPQMKLNPEVKDIFAFKYEDFELVNYQFHPHIKAAVAV
>AIA18831.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLALVKDVLENGRPPSGGVRQDRTGVGTYSVFGRQLRFDLSEGFPLVTTKKVHLRSIIHELLWFLRGETNVQYLRDNKVTIWDEWADKDGELGHIYGKQWRSWEGPKGVVDQIKNLIENIKKNPTSRRLLVVSYNPADLPDVAPPACHTLFQFYVSGDKLSLQLYQRSADLMLGVPFNIASYALLLMMVAQVTGLEAHEFVHTFGDVHIYSNHLDGAKEQLKREPRTLPKMKLNPAVQEIFGFKYEDFTLEDYAPWDHIKFDIAV
>AIA18816.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRAYLNLIQHVLDHGIQKDDRTGTGTLSIFGYQMRFNLAEGFPLVTTKKCHLRSIIHELLWFLQGNTNIKYLNDNKVTIWDEWADAQGNLGPVYGKQWRSWPDINGGSIDQISQVIHDIKNNPNSRRLIVSAWNVAQIPQMALAPCHTIFQFYVIEGKLSCQLYQRSADVFLGVPFNIASYALLTMMIAQVTNLKLGDFVHTFGDAHLYSNHLNQARLQLTRTPYPLPKMQINPAITSIFDFTFEDFVLQNYQSHEAIKAPIAV
>AIA18811.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YLNLLQDIIDNGSDKPLFFTPEVLEEYKKKGQEPPFIRSVFGRIMRFDLSKGFPLLTTKKVFMRGITHELLWFLKGDSNIKYLVDNNVHIWDEWAWKRYHKAALKSEGKIKDMAQDEFIAKLKEGDVKSTFVKKWGDLVTIYGRMWRKWPASDGREIDQLGWVIQGLKDKPFRKSYVVSAWNPDFIYAMASKGNANEVPPFCHTTYQFAVVDGKLNLGLYQRSADSFLGVPFNIASYAMMLLMVSQVTNIPPGEFVHFFGDVHIYSNHFDAVKEQLSRKPKPLPTLKLNPKIKDIDDFTFEDITVENYDPHPPIKAEIANIGGF
>AIA18804.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKPYHDLLEKVLVDGHKKLDRTGTGTLSIFGHQMRFNLEKGFPLLTTKKVHFKSIAHELLWFLSGSTNIAYLKENGVTIWDEWADAQGNLGPVYGYQWRSWPSEDGKTVDQISRVIEEIKHNPDSRRLIVSAWNVGMLEQMALPPCHSFFQFYVAGGKLSCQLYQRSADLFLGVPFNIASYALLTHMIAQVTGLGVGDFVHTLGDAHLYLNHIEQTKTLLAREERALPKLRINPSVKNIFEYRYEDFSIEGYDPHPALRAPVAV
>AIA18749.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAIAGLPPCHTMFQFNVRGDYLDCQLYQRSADLFLGVPFNIASYALLTSMMAQVTGLKPGEFVHTFGDTHIYNNHIDQVNEQLSREPLPLPKLVLNPEVHSIFDFKFEDIQLADYQSHPAIKAPIAV
>AIA18714.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRTYLDLLQHVIDHGVEKSDRTGTGTLSVFGHQLRFDLTEGFPLLTTKKVHVRSVVAELLWFLQGSTNVKWLHEQGVTIWDEWADDSGELGPIYGYQWRSWPTPDERHVDQIAAVIHGLKTNPDSRRHLVSAWNVGDLEQMALPPCHTMFQFYVAPAPADSADRRGRLSCQLYQRSADIFLGVPFNIASYALLTHLVAQVCDLAVGDFVHTLGDAHLYLNHLDQARRQLAREPRPLAPLGLDPGVSDIDGFGLEHIVFEGYDPHPGIKAPIAV
>AIA18703.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGEREGPGIDQIREAISLIKKDPTSRRIIVSAWNVADLPHMALPPCHAFFQFYVNRGRLDMQLYQRSADIALGVPFNIASYALLLMMMAQECELTPGVFVHTLGDAHIYLNHVEGLKQQLTRAPLPPPRVEIAKKPLDEIQFEDIRLLEYQHHPFIRFEVSV
>AIA18679.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLELLEDIKKNGVKKADRTGVGTISVFGRQLRFDLSQGFPAMTTKKLFMRGVIHELLWFLQGSTNIKYLVDNDVHIWDDWPYKAYLMKQGKKVPTPNSDEWKKGITEFTDRIKKDADFARWHGELGPVYGYQWRSWPAPDGRHIDQISQAVNAIKHSPDSRRIIVSAWNVADVEEMAISGLPPCHLLFQFYVANGKLSCQMYQRSADTFLGVPFNIASYALLTLMMAHVAGLKPGDFVHTLGDTHLYANHLKQVEQQLKRKPRPLPKMKLNQDVKSIFDFTIDDFELSGYNPDPAIYAPIAV
>AIA18665.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVNVFFQRGLPVKQYHDLLKHVLAHGEKKNDRTNTGTISVFGYQSRYNLAEGFPLLTTKKLHTRSIFYELLWFLRGETNIKFLKDNKVSIWDEWAAENGELGPIYGKQWRYWETADGRTVDQNVIQQIKTNPDSRRHLVIAFNPGDVDKMALPPCHAFFQFYVANGKLSCQLYQRSADIFLGVPFNIASYALLVHMVAQVCDLEVG
>AIA18662.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MSGDRSKKIGVLMGGLSREREVSLRSGQAVLEALQRLGYAVVGIDVDATVAKALEREKIEVAFLALHGRYGEDGCIQGLLEILSIPYTGSSVLASSVAMDKYLTKEIAARLGLATAPDHFWDGHRDGFEALQGKIDESATWVVKPSREGSTIGMAKVQGREQLEAALRQASQFDSQVLIEQFIAGREVTVAILGEELFPIVEIAPKHGFFDFAAKYQSNETEYHCPADLPEALAARLRQDLRRLYQRLGCEGVARADFIIDAAGTPYFLEINTLPGMTATSLVPKAAKAAGVSFDQLVEKILLTARLKNRED
>AIA18651.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NVIQQIKTNPDSRRHLVIAFNPGDVDKMALPPCHAFFQFYVANGKLSCQLYQRSADIFLGVPFNIASYALLVHMVAQVCDLEVGDIHTLGDAHIYSNHMEQVHTLLAREPRPLPKLVLNPAIKNIFDFKYEDIQIVGYDPHPVIKAEVAV
>AIA18628.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKPYLDLMRHVLEQGTPKTDRTGTGTLSVFGHQLRFDLRQGFPLLTTKKLHMRSIIYELLWFLRGDTNIGYLQEHGVRIWNEWSDEQGELGPVYGRQWRSWQAADGRCIDQISQVVEQIKTNPDSRRLIVSAWNVGELERMALMPCHLLFQFYVANGRLSCQMYQRSADIFLGVPFNIASYALLTMMMAQVCGLEPGEFIHTLADAHLYSNHLEQARLQLEREPRPLPRMRINPAVTSIFDFDYSDFELTGYDPHPHIKAEVAV
>AIA18623.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLEDIKTNGTEKSDRTGTGTKSVFGRQMRFDLSEGFPAVTTKKLFLRGIIHELLWFLQGDSNIEYLVKNDVHIWDEWPYKAYLQSTGQEVPASGSEAWKTGIKEFTEKIKVDHEFAKKYGELGPVYGSQWRHWPARDGGEIDQIQEAIDTIKNNPDSRRIIVSAWNVADIQEMAKAGLPPCHSLFQFYVNDGKLSCQLYQRSADTFLGVPFNIASYALLTMMVAHVTGLKPGEFVHTLGDAHLYLNHLEQVDLQLSREPKPLPKMILNPEVKSIFDFTIDDFTLEGYESYPSIKAPIAV
>AIA18619.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYLGLLQHILESGVTKTDRTGTGTTSVFGYQMRFDLSEGFPLVTTKKLHVKSIIYELLWFLQGDTNVKYLNDNGVRIWNEWADENGDLGPVYGKQWRSWQGANGKVTDQVSDVIKQIKTNPDSRRMIISAWNVGELGEMALMPCHALFQFYVAPGKVGGKGKLSCQLYQRSADVFLGVPFNIASYALLTMMIAQVCDLEYGEFIHTFGDAHIYSNHMEQVKLQLTRTPYPLPQMRINPEVKDIFSFRFEDFALENYHSHPHIKGEVAV
>AIA18610.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYLDLVRHVLDKGIKKANRTGVDTLSTFGYQNRYDLSAGFPLVTTKKVHTRSIIHELLWFLQGNTNISYLKENKVGIWDEWADENGDLGPVYGHQWRSWPNKRGDAIDQIAQVVNEIKTNPDSRRLIVSAWNPADIPEMALAPCHCLFQFYVAEGKLSCQLYQRSADVFLGVPFNIASYALLTLMMAQVTGLKPGEFIHSFGDTHIYTNHLEQVKLQLTRTPYALPRMELNPYVKDIFSFKYEDFELLNYQHHAAIKGEVAV
>AIA18597.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
FARAFIALHGRGGEDGSIQGLLDSMNIPYTGSGVLGSALSMDKVRSKRIWQCLGLATPPFALWEPGTGADDYVKIFGLPLSVKPVFEGSSIGVTRVNSASRFDAACELAARYGAVMIEPWIIGDEYTVGILGTQALPSIQIASSEIFYDYHAKYLAEDTQYICPSPLSLQEEENLQLLSLQAFRAVGAAGWGRVDFIRDLNGDFWILEVNTVPGMTSHSLVPMAAKVAGLSFDELVLEILSLTVGVAAKVDYAKGANA
>AIA18520.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKITVLMGGPSAERNVSLASGIRIVLALRSRGHDVIAFDPSRGLISAEEEQRLASSKVGTEPPSLDSLAETTGGAFVTGLERLPEIKDADVVFLGLHGGMGEDGTIQALLDTAHVKYTGSGHLSSALAMDKDLSKKLFRFGGVQTANWLMAPASIEEVEQTLGLPVVVKPSKQGSTVGLTVVKRREDFDAAVTEAWRYDDEGMIEQFIPGRELTVGVLGGQALPVGEIKPKHEIYDYECKYTAGMAEEEFPAKLTGEQTMRVQEQAVAAFKALKLSGCARIDFRLAVTDDGEGDFYCLEANTLPGMTELSLIPQGAQAAGISFPELCERIAEEAHRMQGRG
>AIA18503.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LLRHTLEHGIKKDDRTGTGTLSTFGYQMRFNLAEGFPLLTTKKLHTRSIFHELLWFLKGDTNIKYLHDNQVTIWDEWADKEGNLGPVYGKQWRRWEGPDGKVYDQIKQVIEQIKTNPNSRRLIVNAWNVADVSKMALPPCHLLFQFYVADGKLSCQLYQRSCDIFLGVPFNIASYALLTHMIAQVTGLAVGDFVHTLGDAHLYLNHLDQAKEQLTRQSRPLPQLKLNPAVKDIDWFKYEDIEILNYDPHPAIKAPIAV
>AIA18469.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNRKIRVGVVFGGKSGEHEVSLQSAQSVVENLNLDLFEVLPIGISKEGTWHVGIGAYNALGAPVPAQLLTDGISEEEIKHIQPITQGPVLPEMSLSSIDVVIPVLHGPFGEDGTVQGLFELMNIPYVGAGVLASAVSMDKAMMKAVFAQAGLRQCKYEVVLRSNYERDAAPILEHIENSLGYPCFVKPANLGSSVGISKAKDRSELAQAIEVAAGYDRKIVIEEAVDGREIEVSVLGNDNPQASLPGEIISGNEEFYDYNAKYVDGSSTMVIPAPLSSEQTEEVRALAMQAYRAVDGSGLSRVDFFLDRKTGEFLINEINTFPGFTKYSMYPKMWEVSGLPYPELIETLIHLAIERHEDKNRNR
>AIA18444.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MSNLIQNLETFTEKPRVCSGPKTTQAQATLFGKVGVLYGGRSSERAISLQSGENILNSLLKQGIDAHGIDVDQNLAAKLIEAKFDRIFIALHGKEGEDGVIQGLLQMLGIPFTGSGVASSALAMDKARAKLVMHGLQIPTPIFGVAKTVENAESIAQKIGFPISIKPVAEGSSIGVTRVADAKGIALAYAKA
>AIA18420.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MRQYLELLEDIKKNGVKKADRTGVGTTSVFGRQLRFDLSKGFPAVTTKKLFMRGIIHELIWFLQGSTNIKYLVDKDIHIWDEWPYRAYLMKQGKKVPDSGSDDVISCFSSMLQMVN
>AIA18318.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLGLLEDIKANGIKKMDRTGTGTLSVFGRQIRFDLSEGFPAVTTKKLFMRGIIHELIWFLQGSTNIKYLVDNDVHIWDEWPYRHYLMERGKEVPASDSDEWKKGIKEFTEKIKADEGFAKEWGELGPVYGYQWRSWPTPDGKHIDQIKNVIESIKNNPDSRRHLVSAWNVADIDEMAKAGIPPCHTLFHFYVADGKLSCQLYQRSADTFLGVPFNIASYALLTMMVAQVAGLKPGDFVHTFGDTHLYVNHLEQVDLQLSRKPKPLPKMKISPKIKNIDDFKFEDFELTGYDPHPAIWAPIAV
>AIA18263.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MTTQLTKQTRIGVLYGGMSSERDVSLISGKNCYEALKRLGYENTVLIDVAPNVAQRLKEENIEVAYNALHGKFGEDGCIQGLLQIMGIPCTGCGVEASAITMNKAVTKSILKDAGLPVLPSLLYRKIVKPVTVPASNNTEWEVAGSVQKPERFPVMVKPISEGSSIGMSKVDREEDLNAALEEAFKYADEVMVEVFVKGKSLTVGVVDIEKKPKVLPILELRPVKSEWYDLEAKYTKGLTEFILPAELSENTTRQVQDATLKAHIAAGCSGMSRTDFVVDSDNNFYILEINTVPGMTPLSDLPAQAQAVGISYDELVEYILKSAF
>AIA18259.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MIEQIKTNPDSRRLIVSAWNVAEISKMALPPCHLLFQFYVACHLLFQFYVANGKLSCQLYQRSADIFLGLPFNIASYSLLTMMVAQACDLQPGEFVLTLGDAHLYSNHFEQARLQLSREPLKLPAM
>AIA18249.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKKTVKARHPEYQYLDLLKDILDNGFEKKEFNSGIAIKSVFGRSMRYDLSKDFPLLTTKKVFMRGIIHELVWFLRGETNIKYLVDNDVHIWDDWPYKEYKKKMEAGEVPALTQDEFISKIKNDASYAKKWGELGPVYGRQWRKWPASDGREIDQLAWAIEKTKKYPDRKHVVISAWNPEYVYEMARPGTSMAIPPCHTMFNLNVTNGKLSLALYQRSCDMFLGIPFNIASYSLLALVLAQICGYKPGEFVHMLGDTHLYGNHYDQAKEQIKRKPRPFPRIKINPNLKDINAIKFEDFELLDYDPHPPIKGEITVVGGFNEKDRKDFSFKKKEAKGKKPAKKGKK
>AIA18209.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELCRHVLENGTEKDDRTGTGTISTFGYQMRFDLNEGFPLITTKKLHLRSIIHELLWFLNGDTNIQYLQDNGVRIWNEWADENGDLGPVYGKQWRSWEGADGKVVDQISELIMQIKTNPDSRRMIVNAWNVAEIDNMALAPCHCMFQFYVADGKLSCQLYQRSADLFLGVPFNIASYALLTLMVAQVCDLKPGEFVHTFGDVHIYKNHIDQVNEQMSREPRKLPTMAINPEVKDIFSFKFDDFTLEGYDPLPHIKGAVSV
>AIA18199.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMRHVMENGTQKHDRTGTGTISVFGYQMRFNLQDGFPMVTTKKLHLKSIIHELIWFLSGDTNIKYLKDNGVRIWDEWADENGNLGPVYGYQWRSWPTPNGGHIDQISQIIDQIKNNPDSRRIIVSAWNVADVNQMALPPCHSLFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALLTMMVAQVCGLQYGDFIHTFGDAHLYNNHLEQTRLQLSREPRPLPTMKINPDVKDIFSFKFEDFTLDNYDPWPHIKGEVAV
>AIA18186.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIAVLKGGPSAEREVSLRSGAAVGKALREAGHEVEEIDVHGPDFLVPEKTEVVFLALHGTFGEDGQIQAILEKRGLPYTGSGIESSRLAFDKTATKKKFEASGVPTPPCRIMKKGDREVPRLKEPFPWVVKPSKQGSSVGVTIVQKEEDLEKAVKLGFESDDEVLIEAFIDGREMTIAVLGEEALKIVEIKPKSGWYDYQNKYTKGATEYLVPAPLTKHQELCLQTLAVQAHKCLGCRDVSRVDVRMDPNENNFVLEVNTLPGMTETSLLPKAAAAAGISFSQLCDSLAKMAAKRGARS
>AIA18164.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLELIKTILEQGERREDRTGTGTISMFGMQAKYDLRDGFPLLTTKKVLFGSVVRELLWFLRGSTNINDDLTQHTPIWDAWADDNGELGPVYGYQWRSWPKYIKQENGLYARGHVYQISNIIETIKTNPDSRRLIVSAWNVADLDEMALPPCHMMFQFYVINGRLDCQLYQRSADMALGVPFNIASYALLMMMIAKECNLTPGIFTHTLGDAHIYLNHLDGVMKQLERTPKGLPTVEIADKPFFELRYEDFALHNYDPYPFIKFPVSV
>AIA18151.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMKHIVDHGTRKDDRTGTGTLSIFGHQMRFDLSEGFPLLTTKKLHLKSIIYELLWFLKGDSNVKYLRDHGVNIWNEWADEAGDLGPVYGAQWRSWRTADSGAIDQIALVIDQIRTNPNSRRLIVSAWNVGEIEKMALPPCHVVFQFYVAGGRLSCQLYQRSADVFLGVPFNIASYSLLTLMVAAVCDLKPGEFIHTFGDVHLYLNHLEQARIQLRREPLVLPRMKLNPSVKSIFDFDYPDFEITGYEAHPHIKAEVAV
>AIA18119.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTQYLDLIRLVLGQGKFKGDRTGTGTYSVFGAQARFPLRDSFPLLTTKKLHLRSIIYELLWFLRGERNIRYLKDNKVSIWDEWADKKGDLGPVYGKQWRNWTKASRTRKSGSIASQMAFDLGESEDEDEGVIPPGPRVRRSEHGIDQIAAVIEQIRRNPDSRRLIVSAWNVADIDSMALPPCHALFQFYVSDGELSCQLYQRSADLFLGVPFNIASYALLTMMVAQVTGLKPGDFVHTFGDLHLYSNHLDQAHEQLTREPRLLPKMKLNPKVKHIDRFKFEDFELVGYDPYPSIKAPIAV
>AIA18070.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LSLLEEVLKQGIKNVDRGTGAVSYSVFGRQTRYDLSQGFPLLTTKKVYWKGVLHELYWFMKGDSNIKYLVDNNVHIWDDYPYKIYTNKEKEDITKEEFVEKIKTDNTFAKKWGELPKIYGESWRRWPTRTPGRTIDQLSWVLQELKDDPDARNLIVTSWNPEYLYTMATHEDASRFPICHNMYQVSQKGGKLYLQLSAECGFIFRCAI
>AIA18054.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MKLRVGVIFGGRSGEHEIAIRSARTVIEQIDKSKYEVVPIAISKDGRWLSPSEAVTLLPDERRMSLGSDTTHNEAEPIALVGDTTRRGLTVFKENGSDSLPLDVIFPVLHGTFGEDGTIQGLLDMADIPYVGCGVLASSCGMDKAVMKILFRDAGLPICKHIWFLRNEFETNPAAVTAAVGDQLGYPCFVKPTNLGSSVGVSRATDMSSLKDAIAIAAQYDRKIIVEEALDMREIECAVLGNDDPQASQPGEYLIRDQAKAFLDYTEKYSGTGNNEFVVPAPISPELTAKIQKMAVAAFKAVDGSGLARVDFFLRNDTGELLVNEINTMPGLTDASGYPKMWAGTGKNFPAVIDELIRLAIERHDDRSRNKTSR
>AIA18053.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQRKVALLFGGESPEHEISILSASKVGAALDQLIGTQTIPIYVTKTGMWHWSRPSGDIPSEELIQAVTNDEAFARNYSPSGISFAQALLHLSVDEFATVLIIMHGANGEDGRLQGAFELAGICYTGSGSAASALAMDKSRCQAYLEARGLPIPKFMPLPRGAYSDADAVGIVANEIGLPCVVKPSGCGSSVGVTIVRDREQLDAALKMAFEYGELVQVEEFIQGREFTCGVLDSGKTTALPVTEIIVPKATFFDYKAKYTPGVTREVTPAEIDAALARRIQELAVEAHRAVGCEGFSRVDFMADADGPKILEINTIPGMTQTSLLPQAAVVAGIQMPELMNIIIEHSIRRAGGVEVSA
>AIA18030.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTQLIHNIKTNPDSRRLIVSAWNVAEIPDMALPPCHALFQFYVANGKLSCQLYQRSADIFLGVPFNIASYALLTMMVAQVTNLAPGEFVHTFGDAHLYSNHKEQATLQLSRTPLALPTMQINPTIKSIFDFSFADFALQNYHCHEAIRAPIAV
>AIA17995.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLTLLDDVLKNGTEKTDRTGTGTLSVFGRQVRYDLAEGFPLLTTKKLHIRSILHELLWFLKGSTNIKYLQENGVKIWDEWATPDGELGPVYGYQWRFWPDGKGGHVDQIAVLMEGLKNRPDSRRHLFHAWNVAYLPDETKKPWENAASGRMALPPCHLLYQFYVAQNKLSCLLYIRSNDLFLGNPYNTASVAFLTHMVAQQCGFEPGEVIISMGDLHLYKNHLEQAKLQLTREPRPLPKLVIKRKPSSIFDYKFEDFEIVGYDPHPHIPAPIAV
>AIA17941.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRYVLENGEERQDRTGTGTIAAFGLQAKYDLREGFPLVTTKKVLFGSVVRELLWFLRGSTNINDDLTQHTPIWDAWADENGELGPIYGYQWRFWPKYVPEEGQPGLYRREHVDQIKDIIHRIKTDPTSRRLIVSAWNVSDLDKMALPPCHAFYQFFVSNGRLDCQLYQRSADMALGVPFNIASYALLMMMVAQECNLTPGIFTHTLGDAHIYANHLDGVKAQLEREPKALPTVKIAQKGIFDLRFEDFELLNYNPHPFIKFPISV
>AIA17934.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FGHQMRFDLSEGFPLVTTKKLHLRSIIHELLWFLKGDTNIRYLKENGVSIWDEWADENGDLGPVYGKQWRSWAKPDGGSVDQIRWVLDEIRRNPDSRRLIVSAWNPAELDKMALAPCHCLFQFYVAEGRLSCQLYQRSADVFLGVPFNIASYALLTHMMAQATGLQPGDFVHSFGDAHLYLNHLEQARLQLSRDPRPLPKLRLNPAVRSLFDFTFDDIAIEDYDPHPAIKAPVAV
>AIA17880.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNQYLQLCQHILDHGTVKSDRTGTGTISVFGCQMRFDLSKGFPVVTTKKLHLKSIIYELLWFLRGETNVAYLQEHGVRIWNEWADENGDLGPVYGKQWRSWPTEEGGAVDQIAEVLNQIRDNPDSRRMIVCSWNVAQLPEMALAPCHCLFQFYVADGKLSCQLYQRSADVFLGVPFNIASYALLTMMIAQVCGLMPGEFVHTLGDAHIYANHIEQVKLQLSRDPKPLPEMKINPDVKSLYDFQYEDFVLAGYDAHPHIKGEVSV
>AIA17874.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VLSSTAQYPRLTTLSEEIKNAVSEVHPIIAERLAEAAQTTSQNTKTALTVSHSKGIETSEMEYLNLLRDIRDNGQGKDDRTGTGTRSIFGRQLRFDLSKGFPAITTKKLYTRSIVHELLWFLAGDSNIEYLVQNNVGIWNEWPYRNYVQKTEKRTVTPEETHSEAWAKGMKKFTDKVATDHDFAMKWGDLGPVYGYQWRHWPDGKGGEIDQIQRVIDTLKNNPTSRRNIVSAWNVADIDEMAIAGLPPCHTMFQFNVRGDKLDCQLYQRSADTFLGVPFNIASYALLTAMVAQVVGLKPGEFMHTFGDAHIYNNHIDQVNEQLSREPFPLPTLWLNPDIKNIFDFKFEDIELRDYQSHPPIKAPIAV
>AIA17855.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSEFKKTRVGVIFGGRSGEHEVSLRSAESVIRSLDPSKYEVVPIAITHEGRWLGTRDAMKLLSPGEAIQAALKTGEPMAVVPEPQRNGAVDVFFPIVHGTYGEDGTIQGLLELAGVPYVGAGVLGSAVGMDKDVMKRLLREAGLPVGDFWVTRAKDIDAFIREFGKQLPYPVFVKPANLGSSVGITKVHNAGELPAAIAFAAEFDRKIIIEKGIDAREIEISVLGNDELKASIPGEIIPSREFYDYQAKYVDDDSRLIIPAPLSEQQVRQAQDLAIRSFQALDCSGMARVDLFLEKPTGKFLVNEINTLPGFTSISMYPKLWEATGLAYPDLVDRLITLAVERHAEKKKLRTKV
>AIA17851.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRFPTMNVIKGVRLKARGSGLGGTMKQYLEHAVKILSDKYTGYKPNRTGIDTISRFGHENEYDLSEGLPLLTTKKLFSKGIIHELIWFMRGDTNLKYLVDNNVRIWDEWGYKRYLQSLGKDKEITPNTPAWDEGMNAYRARIKSDENFAKDHGELGPVYGRQWRKWEGPNNKVVDQFGDLINGLKKSPSSRRLIVSAWNPIEVPNMALPPCHTIWHVNVQDKDLTLKLYQRSCDMFLGVPFNIASYAMLAHVLAQEANLNPGRFVHSFGDAHFYCGKGERGAWYGKNLDELKERVRNVETLETLEGYLDVKDWIERNAPPEPQGYELMDHIPLILEQLSREEKPLPTLQLAAKPYDQLTVDDFKIENYNPHPAIKGKVAV
>AIA17826.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MPQKLKAVLIYGGQSTEHEVSRRSAAYIWKNIDRQRFDAYAIAVDKQGRWHAQNRQALEGSQPKEMPLESGDRADADSAAVLKKIWTQGADTSDLVGFDIAHGTTGEDGMMQGFFDLQRIPYVGPGILGSAVAMDKVVAKQLVEYAGVPVVPYVALRLHDWLERKSALLQECSSKLKFPMFVKPSSLGSSVGISKVENVTALEKAINHALEFDDRVLIETGVSAREIEYACLGGYAPKLTFPGEVGVPEGFYTYDEKYSNASKAEVLVPAPLSKELADQGREISRKVFQALNLYGLARIDLFLEKSTNTFYFNEANTLPGMTAISQYPKLWEHEGMTGKDLISQLLDTALERRKLQLGLKRSI
>AIA17810.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMEQYHDLLKLILDHGTEKSDRTGTGTFSVFGHQMRFDLEKGFPLVTTKKVHLKSIIYELLWFLRGDTNVKWLQENKVSIWDEWADKETGDLGPVYGAQWRSWKTPDGRTIDQITEVINQIKTNPDSRRLMVVAFNPGDLDKMALPPCHAFFQFYVANGRLSCQLYQRSGDVFLGVPFNIASYALLTMMVAQVCGLRAGEFIHTLGDAHLYKNHIDQAKLQLSREHRALPRMKMNPDVKNIFDFKYEDFTLEGYDPHPPIKAVVAV
>AIA17756.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FKVENHKLLHCQLYQRSADAFLGVPFNISSYALMIHLVAHVCELEVGEFVYTLGDYHIYQNHMDQVDELLGREPLPLPELQINDSEGRLRGLEGLLSFNYEHLNLVGYKSHGKIGAPVAV
>AIA17751.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MTKREELPRKIAVLMGGPGSEREVSLATGRGVAKALRSLGTEVVEIDVRDENFQLPDDVDLAFITIHGTFGEDGQLQKILERRGIPYTGEGVNGSEIAFDKIRTKEKFREHDVTTPPSEVIEPGQRPTIALPMVVKAPRQGSTVGVVIVKDESELESAINEAGKYGRELLIEKFVSGRELTIGILGDQALPILEIIPKGGFYDFNNKYPFLNPQAGGGAEHVCPANIDAGKTKEIQELALRAFRAAGLQVYARVDAILSDSGKPYILEINTIPGMTEASLLPEAAAAAGIGYANLCARIIALSRARTEGKR
>AIA17726.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKKIALITGGYSGEAVISYKSASTIEKNLDTEKWETYKIDINPQGWYYMAPGDEKIPVDKNDFSIIVGGNKINFDAVLVGLHGTPGEDGKLQGYFDTLNIPYTSCDTATSALTFNKRYTVAVASFAGMHVARSMHLFKHIPVTPQTILNELKLPVFVKPNNGGSSIGMSKVKEAGALQAALDKAFREDDQVLVEEFITGRELTIGVFKSKGEVIALPITEIIAKNEFFDYEAKYEGASEEITPAQVDGSIAEKIRSEARKAYSIFNCNGLIRIDFIYDEASGNPYMLEINTVPGQSEASIVPQQVVAMGWTLKQFYSALLEECFR
>AIA17714.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDGLRAIMEKGEDVLEDRTGVGRRKLFAYQMRFNLKEGLPVLTTKSVHTKSVFHELIWLLSGSTNIKYLVDNGVRIWNEWPYENWLQKNGWSKDFPKYSESWTEKMKEFVELMKTDSAFAKQWGELGPTYAHQWRNFGATLGPDGSYNHDGFDQIANVINLLKTNPASTRIIVTGWHAVEATQVALPPCHTLFQFNTVGKKIITHLYMRSADAFLGVPFNIASYATLANMIAQVTDMEATELVITFNDFHIYLNHFDQVKEQLTREPKALPILKLNPAINNIFDFKFEDLTLENYEPMPAIPAPVAV
>AIA17580.1|FEATURES|farme|beta_lactam|ampC|antibiotic target alteration|0
KNNMEKQHSEYQYLSLMKKLIDSGDKQTDKGTGVVTYSSFGDQMRYDLSEGLPLLTTKKVYWKGVLQELYWFMSGQSNIKYLVDNNVHIWDDYPYKIYNEKVGKGEMEAMTKEEFVAKIAADSDFAKIHGELPHIYGESWRRWQARDGREVDQLGWVVSELTKDPDA
>AIA17578.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MREERFLASMIKPVSDRTPDAQYQNLLRSILEKGVRTNSQQGVDALTLMGPGPMHFKFDNGFPIINERNMAPQESERLPVTVWKQAVAEICAFANGVRTQEGLEQFGCTWWKSWVTKEKCEKRGLAEGDLGPGSYGAAFHDFPTSEGGTYNQFQNIIEQIREFPHLRTHFISPWIPQYIIRGTGKQQKVVVAPCHGWIRLRVLDNKLTLHMFQR
>AIA17547.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYHELLQHILDHGTPKTDRTGTGTMSWFGYQMRFDLGKGFPLVTTKKIHLKSIVYELLWFLRGETNIAYLKENGVSIWNEWADENGELGPVYGKQWRSWLTSNGETVDQISDAVKQLKNNSDSRRIIVSAWNVADLPDMALMPCHTLFQFYSAPDENGKRKLSCQLYQRSADVFLGVPFNIASYALLTMMMAQVCNMEPGDFVHTFGDVHIYNNHIEQVKLQLSRTPYHLPTMKLNPAVKNIFDFKFEDFTLENYQCHPAIKAPVAV
>AIA17501.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLVRDVLDNGKPDENEARSDRTGVGTYSVFGRQARFNLEEGFPLVTTKKVHLKSIIYELLWFLNGDTNVKYLNDHKVTIWDEWANSEGDLGSIYGKQWRSWQGPDGVKVDQIANVVEQIRTNPHSRRMLVIAYNPGDLPKIAPPGCHTLFQFYVAHGKLSLQLYQRSADLMLGVPFNIASYALLLMMVAQVTGLKPYEFVHTFGDLHIYANHVEGAREQLKREPKALPTMKINPEVRDLFSFTYEDFTLEGYDAHERIKFDIAV
>AIA17496.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMCHVLEQGVKKEDRTGTGTLSVFGYQMRFDLQQGFPLVTTKKLHLKSIIYELLWFLRGETNVGYLREHGVTIWDEWAEANGELGEGIYGRQWRAWPNPDGTHIDQLSQVIEQIKHKPNSRRLMVVAYNPSFADKTPLPPCHSFFQFYVAAGKLSCQMYQRSADIFLGVPFNIASYALLTLMVAQVCDLQPGEFIHTFGDAHLYLNHLEQARLQLTRAPLPLPQMKLNPTVKDIFAFTYDDFELVNYQFHPHIKAAVAV
>AIA17410.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDKIKIGIVFGGRSGEHEISVRSAKSVIEQIDKDKYEIVPLAITREGKWLNPVESLGLLPPPTQELLINDIGSFPRNSVALVGDTNYKGLLKLEAEKGEARVERLDVIFPVLHGTYGEDGTIQGLLEMAGIPYVGCGVLASSCGMDKAFMKILFRDAGLPICKYVWFLRSEWETDNEATIRQIEQQLGYPCFVKPANLGSSVGVSKAADEISLREAITLAAEYDRKIIVEECLDMREIECAVIGNDEPRASLPGEYIIRDESKKFLDYTEKYSGTGNNEFVVPAPISEELAKKIQQMAITAFKAVDGSGFARVDFFLRKDNGALLVNEINTIPGLTDASGFPKMWAGSGLEFSQVIDALVALAIERHKDKSRNKTSY
>AIA17401.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLEHVMEHGVEKSDRTGTGTRSVFGYQMRFDLQKGFPLLTTKKLHTKSIIHELLWFLKGETNIKYLKENGVSIWDDWADANGELGPVYGSQWRSWQTTDGRTIDQIEQVIEQIKRNPDSRRLIVSAWNVGEIKMKLPPCHAFFQFYVANRKLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLEPGEFVHTLGDAHIYSNHFEQVNLQLSRTPRGLPAMKLNPSVKNIFDFRFEDFALENYDPHPHIKGTVAV
>AIA17355.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNTKHPENQYLDLMREILEKGDRKVDRGTGDASYSLFGRQIRFDLSKDFPLLTTKKVFWKGVVEELYWFMSGQSNVAYLANKGVHIWDDYPYRIYNKKNPGLTKDEFVEKLKDPEFAKAHGELPRIYGELWRRWPTRSGRTIDQLAWLVQELKDDPNAHNLIVNSWNPEYLYSMATLEDASRFPICHNMYQVDMIDGKLNLQLYQRSADLFLGVPFNIASYALLTIILAQITGYQPGEFVHTFGDVHIYENHLEQAREQITREPKQFPKIELDQSVKSIDDFRPEHVKLIGYDSHPALKAELSVSGGLFEKKL
>AIA17324.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKVLVIGGGISDEREVSLRSANAIFEGAKSAGHEVEFYDWDGSKDWLNKNIQDFDVCLPILHGKGGEDGQIQSILEKSGSHFLGSSSDVSRVCFDKRLVLDTLKRNQIMIPEGVLVNHDQYKKHKLINRPHILKPNKGGSSLGVVFVRDPSHIDSTMVDRVFSEWREMLLEEIIEGTEITVPVLDGLQMPIIKIIPPEAGEFDYENKYNGATKEIVNPEEIDQKLKDESQKLGKKIHNLLKCRHLSRTDMILTAEGELYVLEVNTMPGMTNQSLFPKAAGIAGLSFDQLADYFIKLAAGKL
>AIA17315.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EDRTGTGTISTFGYQMRFDLQEGFPMVTTKKLHLKSIVYELLWFLAGDSNIQYLCKNGVGIWNDWPYAKYQKSAEFAGETMKEFAQKIANDDAFAAKWGELGPVYGHQWRHWPDGKGGEIDQIKQLIHQIKTKPDSRRLIVSAWNVADIEALLMLYLR
>AIA17281.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYLNLLKHVMDNGAEKSDRTGTGTKSAFGYQMHFDLAEGFPLLTTKKLHTKSIFHELLWFIKGDTNIKYLKENGVTIWNEWADENGELGPVYGSQWRAWKTSDGRTIYQLSNVIEQIKKNPDSRRLIVSAWNVGEIDKMKLPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIASYAAFTMMVAQVCNLKPGTFVHTLGDAHIYSNHFEQVNLQLSRDPRPLPKLILNPEVKNIFDFKFEDLQIVNYDPHPHIKGAVAV
>AIA17276.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLREIRTTGTRKAQRAALRSDGRRPEVLSVFGRQIRFDLAAGFPMVTTKRMPWNAVVHELLWFLSGSTNVGYLREHKVSIWDEWATSEGELGPVYGKQWRCWEGPQGKVDQIANLIAGIRKVIENPHASEARRLILSAWNPADMPDPKVPTGCHTLVQFNVTEGRLSSQLYQRSADMFLGVPFNIASYALLTHILAKLTGLGVGEYVHTFGDAHIYDNHLDAVDEQLRREPMPLPTLQIVGEIASIDDVKAEQLKLIGYQSHGRLPGEVAV
>AIA17214.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLWHILENGVQKNDRTGTGTLSVFGYQMRINLQEGFPLLTTKKMATKAIIHELLWFLQGNTNIKYLVDNDVHIWDEWPFQDYLIAQKLTEQYPMYSDSWKEQKTQFIQKIKDDAAFAQQWGDLGPVYGKQWRRWEGADGNTYDQLAAAIETIKKNPDSRRILVSAWNVSDVYGHTKTAPPLCHTLFQFYVANGKLSCQLYQRSADVFLGVPFNIASYSLLTHMIAQVCGLEVGDFIHSFGDTHLYSNHLEQAKEQLSRVPKKLPILKLSPAIKNINDFRFEDIEIVNYDPYPPIKAPIAV
>AIA17204.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYQQLLQFILDNGVQKTDRTGTGTISYFGYQMRFNLAEGFPLVTTKKVHLKSIIYELLWFLRGETNIKYLKDNGVRIWDEWADENGELGPVYGKQWRSWEGAKGETIDQISDAIKQIKNNCQLYQRSADVFLGVPFNIASYALLTIMMAQVCDLEPGDFIHTFGDVHIYNNHIEQVQLQLSRTPYTLPTIKLNPAVKNIFDFKYEDFTLENYQFHPAIKAPVAV
>AIA17169.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHELMRHVLKHGSTKTDRTGTGTLSVFGYQMRFDLQEGFPLLTTKKLHVRSIIHELLWFLKGDTNIKYLKDNNVTIWDEWADENGNLGPVYGYQWRSWPTADGRHIDQITQVINQIKNNPDSRRMIVSAWNVGEIEKMKLPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALLTMMVAQVCNLKPGDFVHTLGDAHLYSNHIEQTKLQLTRDIRKLPVMKINPAVKDIFSFKFEDFTLEGYDPHPHIKAAVAI
>AIA17164.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MINVALLCGGDSSEREISLKSARAMHSALDAQRFNVRLYDVSQVQSISTVLPLDESLLAAEEVASLRDWWQGAANAQSVAWGNLTAQLKADETAVVLSSLHGGWGEDGTVQTLLQIADIPFAGSPARASMIAMDKRLCKALVRESGVVAPRGVVVSSPDAPMFDGACVVKPNGGGSSMGVSFLREFDEVQWRTAIKNALSDGSDALVEELIEGVEVTAAVMGEGESAQALPIVEVVPQDATFYDYKAKYAAGGSEHICPARLDEATTQRIQRDALAVYRALGCRGVARSDFLVKADGMPVFLEINTLPGMTQTSLVPDAARAAGISFSALVENLVVGALQ
>AIA17075.1|FEATURES|farme|beta_lactam|AO353_20470|antibiotic target alteration|0
MMDEPLEQPYLELMKYVLAHGARKDDRTGIGTLSIFGHQMRFDLGRGFPLLTTKKLHLKSIIYELLWFLRGETNVKYLRDHNVTIWDEWADAEGELGPVYGAQWRRLARGGWPDDRPDQRID
>AIA17065.1|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MSNKIRVAVLYGGRSGEHEVSLMSAANVIQYLDRSRFEVVPIGIDKQGVWFLGDDTLRKELNAPKTLELLRDSDRMLFNPDYIGRNFQAVQASQLISHLKKSERLFDVIFPVIHGTLCEDGTVQGLLELAEIPYVGCGVLASAVGMDKDVSKRLVMNAGMQVAPFVVIKRGQWNCEPKHFCDLVTQQLKYPVFVKPANTGSSVGVEKIKSADELHDAINRAFQYDTKVLVEEGINAREIEVAVLESLEYGKDPILSIPGEVRPTHEFYSYAAKYLDEKGAELMIPAPLSEELQARVQQFAKNIFAVLECEGMARVDLFLEKNTNEIYFNEVNTIPGFTQISMYPKLMAATGVSYPELLTHLVMLAINRHKLKSELSRECQETFVS
>AIA17063.1|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|1
MKQKKIVFLFGGPGAEHEVSVATAKSALPKFDAQYSILPVFITKDNAWVASQEYMPPAESWAVAQKLITQSGIAQDVAIDMIEHTDPYVVFIGLHGTYGEDGTLQALLESHGLAFTGSNAEASSLAMDKPKVLQILQDEEITVPEFLELTSEMPEGAALEFGHYHGFPVVVLPADSGSSVGVTIVRNQEQLPMAIDTARQYSDRILLSQFIPGREVSCGMLVTDKNELTALPPTELIPNENYEFFDYDAKYKPGATKEITPPHMDDAIIAEIKSLARRVHHLLEADGYSRTDMIVGEDGKIYVLELNTLPGLTETSILPQQAAAFGLNFTDFLTTICENVDRSSREYLTAV
>AIA17025.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLNLMQHILDNGVSKEDRTGTGTLSVFGHQMRFDLSAGFPLVTTKKAHLRSIIHELLWFLRGDTNVGYLNENKVTIWDEWADENGELGRVYGAQWRHWRRADGTELDQIAAVVKSLRENPNSRRHMVVAFNPGELEQMALPPCHAFFQFYVASGRLSCQLYQRSADVFLGVPFNIASYALLTMMMAQVCNLQPGEFVHTLGDAHLYSNHLDQARLQLSREPRRLPEMKINPAVTDIFSFKYDDFELVGYDPHPPIKAKVSV
>AIA16951.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGLQPYLELLRDVMTNGVNKTDRTGTGTLSVFGRQLRFDLAEGLPLVTTKKLHMKSIIHELLWFLSGDTNIRYIRENGVTIWDEWADEAGQLGAVYGSQWRSWKTPDGRVVDQISQVLRQIQSYPDSRRHLVNAWNVAEVDSMALPPCHYAFQFYVAEQKLSCLFNMRSVDTFLGLPFNLASYAILTHMVAAQCGLGVGELIWSGGDVHIYLNHLEQVKLQLTREPYPLPQLHIKRKPDTIFDYVYDDFEIVNYQAHPRIKAPIAI
>AIA16921.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MHQYLDLLARIRNTGTRKDDRTNTGTLSIFGHQMRFDLAEGFPLVTTKKLHVKSIIHELLWFLQGSTNVRYLREHGVTIWDEWADENGDLGPVYGRQWRAWPTLDGRHIDQIARVVESLKGDPDSRRHIVSAWNVGELDKMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIASYALLTQMMARVTGFEPGEFVHTFGDAHLYLTHLDQARLQLEREPRALPKLVLNAGVSSIDEFTSDDIAIEGYDPHPGIRAPIAV
>AIA16916.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQAYLNLLSHVRQHGIEKTDRTGTGTLSVFGYQSRYNLREGFPLLTTKKMHLRSIIHELLWFLSGQTNVRALQAEGASIWDEWAAANGDLGPVYGKQWRSWPDEAGGVIDQISNLIQEIKTNPDSRRLIVSAWNVGQIPLMALPPCHCLFQFYVSKGELSCQLYQRSADVFLGVPFNIASYALLTLMIAQVCELEVGEFIHTLGDAHLYLNHLEQADEQLSRAPHALPKMHLNPKINNIFDFRYEDFSLRDYISHPRIQAPIAV
>AIA16912.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRNEQQYLDLLTHVINHGTRKADRTGTGTLSTFGYQMRFDLNEGFPLLTTKRVPMRLITSELIWFIRGDTNIRYLLEHNNNIWNEWAFKRWTKSAEYDGPDMTDFWLRAEQDEAFAVEYEEQMERFKQRVLSDDAFAAQYGELGDVYGKQWRAWRTTRGETIDQLQDVIQTIKTNPDSRRLIVTAWNPEDVPTMALPPCHTMFQFYVADGKLSCQLYQRSADSFLGVPFNIASYSLLTHLIAHECGLGVGEFVHTLGDAHIYLNHIEQIGEQLSREPRPLPELVLNEEVKSVFDIEVSDVRVEGYDPHPTIKAPVAV
>AIA16889.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNKHQEYQYLDLLKDILKNGDKNVDRGTGVTSYGVFGRQTRYDLSEGFPLLTTKKVYWKGVIAELYWFMSGNSNIKYLVDNNVHIWDDYPYKIYKAKSEKLKTKNILSKEEFIEKIATDDAFAKKWGELPKIYGELWRRWPTRSGRTIDQLRWVINELKEDPYAHNTIVNSWNPEYLYTMATYEDASRFPICHNMYQVNIKNNRLNLQLYQRSADIFLGVPFNIASYALLTVILAKVLKLEPGEFVHTFGDVHIYENHIEQVKEQLKRKPRPFPTVKIDKAVKDIDDFRPEHVILENYDPHPIIKGELTVAGGLYEGKKKKK
>AIA16873.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MTDLPKKIAVLMGGPGSEREVSLATGRGVAKALRSLGAAVVEIDVRDENFQLPNDVDLAFITIHGTFGEDGELQKILEDRGVRYTGDGVEGSRNAFDKILSKKKFLEHNVATPESEVIDAGRRPKMPVPLVVKPARQGSTVGVVIVKNESERDAAMKEAAKYDRKLLVEKFVSGRELTIGILGDQALPIIEIIPKGGFYDFNTKYPFLNPTAGASAQHVCPANIEATLTKKIQELALQAFRALGLGVYARVDVILSNTGEPFVLEANTIPGMTEASLLPEAAAAAGIGYPDLCARIIALSQVRQRSGEQARVKTKGKR
>AIA16851.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MTTREKLPKKIAVLMGGPGSEREVSLATGRGVAKALRSLGAEVVEIDVQNEDFQLPNDVDLAFNTIHGTFGEDGHLQTILEGRGIAYTGEGVVASEIAFDKIRTKEKFQEHGVTTPPSEVIHAGQRPTIPLPIVVKAPRQGSTVGVVIVKNESELESAIAEASKYGRELLIEKFVAGRELTIGILGDQALPILEIIPKGGVYDFNNKYPFLNPQGGGGAEHVCPANIDAGKTKEIQELALRAFRSAGLQVYARVDAILSDDGQPYILEINTIPGMTEASLLPEAAAAAGIGYPDLCARIIALSSLRQGYGGQAGAGTEGKR
>AIA16823.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLQDIKDNGTVKSDRTGTGTKSVFGRQLRYDLSKGFPAVTTKKLYLRTITHELLWFLAGDSNIEYLVKHGVHIWDEWPFKAYLQATGQDIPQTGSDEWDQKLKTFTDQIKTDHQFAKKYGKLGPVYGHQWRHWPDGKGGEIDQITEVIDTIKNNPDSRRIIVSAWNVADIKEMAKAGLPPCHTLFQFYVADGKLSCQLYQRSADTFLGVPFNVASYALLTMMVAQVTGLKPGEFVHTLGDAHIYLNHQEQVDLQLSREPRPLPTLKLNPNIKNIFDFTIDDFTLEDYDSYPPIKAPIAV
>AIA16807.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLQDIKDNGTIKTDRTGVGTKSVFGRQMRFDLSEGFPLVTTKKVFLRGIIHELLWFLQGDSNIEYLVKNNVHIWDEWPFRAYLVATNQPLPEQGSEAWKQRLSEFTENIATDHEFAKKYGELGPVYGYQWRHWPARDGGEIDQITEVIEAIKTNPDSRRHIVSAWNVADIKEMAKAGLPPCHTLFQFYVTDGRLSCQLYQRSGDTFLGVPFNIASYALFTMMVAHVTGLKPGEFVHTLGDAHIYLNHQEQVDLQLTREPRGL
>AIA16786.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRSYLNLLQDILDHGVEKGDRTGTGTISVFGRMLRFDLSQGFPLLTTKKMHLPSIVHELLWFISGETNIRYLQENNVRIWNEWADENGELGPVYGSQWRAWPTPEGDHIDQISRVVESIRHNPDSRRHLVVAWNVAEVDRMALPPCHYAFQFYVAEGKLSCLLNMRSVDTFLGLPFNIASYSLLTHMMAQQCGLEVGEFVWSGGDVHIYSNHLEQVKLQLTREPYPLPKLNIKRKPETIFDYKYEDFEFVGYECHPSIKATIAV
>AIA16754.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKKLKIALIFGGTSQEREVSLRSGQTIAENLSKAKYEMIPVEISQNGKWLISSPTIKQIEASTKSKKVSTNRDIIPVDKNTESKIDLAFLALHGPGGEDGTIQGVLESLGVKYTGSGVLASALAMDKAKTKRMVASEGILVAPHILLSKTDYKKNPKKLLNKLKGKLVIKPNRIGSSIGVTISSDKAEIKKGIEAAFKHDDELLIEPYVSGRELTVPVLGNKSLKALPVIEIVPKVSEFFDYRAKYETGGSDEIVPAPIPKSLALKLQDIAVLVHKLIGGRGVTRSDFIVTKEGKIYFLEINTIPGMTPNSLVPKSAKAAGMSYSQFLDKLIQLALNKE
>AIA16739.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MPGSINITHHTRIAVLCGGLSSEREVSLRSGNNCFEALKRLGYQNVVLIDMDRQVAQRLTEEKAEVVFLALHGQYGEDGCVQGMLEILGIPYTGNRLTASAMTMNKDLTKKILAAEGLPVLPSVTVYRNGKASDSLDNVSRLNFPVMVKPLSEGSSVGMSKVNQPEDLETAVATAAECGPWIMIEQFVKGRDLTVGVFNRNGKPVVTPILEIRPKPGKAEWYDYNAKYTEGMTEFILPAELPDDVTRLVQEKTLEAHQAMGCYGVSRVDWVMDANHQAYILEVNTIPGMTNLSDLPAQAKAMGVSYDELVECLLHTAALGMTATRG
>AIA16706.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLKSILLHGKEHEDRTGVGTISHFGFQTRFDLREGFPIVTTKKIPFRWVAEELFWFLSGDTNEANLRARGVDIGAEWADEAHTKRFARKPGDLGPVYGYLWRSFGGHYPEHDGVDQIARLVGEIKNNPHSRRLIVTGWGPREADNVDLPPCHTLFQFKVENGSTLHCQLYQRSADAFLGVPFNISSYALLLRMVAHVCELAVGEFVYTLGDYHIYKNHLDQVNELLSRDPLPLPRLEIVDPTKRLRGLQGLLDMRYEDLNLSGYQSHGKIAAAVAV
>AIA16683.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMPSAALHRDSAPRYNPVMRPYLDLMQRILDEGVAKGDRTGTGTRSIFGHQMRFDLADGFPLVTTKKMHLKSIIYELLWFLRGDTNVRYLNDHGVSIWDEWADAEGELGPVYGYQWRSWPTSNGQTIDQISEVIEQIRTKPDSRRLIVSAWNVGDLPKMALPPCHLMFQFYVADGRLSCQMYQRSADVFLGVPFNIASYALLTMMVAQVTDLEPGEFIHTFGDAHLYQNHLEQAQLQITREPRPLPTMSIEPRVRSIFDFEYDHFRLENYQPHPHIPAPIAV
>AIA16657.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMQHVLSHGTPKSDRTGTGTLSVFGAQLRFDLNAGFPLLTTKKVHLKSIIHELLWFLKGETNIKYLKDNGVGIWDEWADERGDLGPVYGYQWRSWPAADGRHIDQIRLVLDQIRENPDSRRMIVSAWNVADLDKMALMPCHAFFQFYVADGRLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCGLKLGDFVHTFGDTHLYTNHLEQARAQLSRGPRKMPTMRLNPNVKNLFDFKYEDFTLENYDPHPAIKAPVAV
>AIA16645.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MIFGGRSGEHEVSLRSAESVINAIDKTKYEVVPIAITTEGRWLTSGDAAALLPAAVMASNSHRQVAIIGDPTRHGLTRLDEREHVLPSEPLDAIFPVLHGTYGEDGTIQGLFEMAGVPYVGCGVLASATGMDKIAMKQLFERAGLELIDYDWFPRSEWEKNRDAVIKRVNRLLGFPVFVKPANLGSSVGISKAANKLELCDAIDDAARYDRKVVVERAVNGREIEVSILGNENPIASLPGEIITGHEFYDYEDKYIDTTSRTEVPAKLPKKIISRIQRDAIRAFQAIDGSGLARVDFFVERGTNRVIINEINTMPGFTSISMYPKLWEASGIPYSDLIDRLIQLAIERHADKSRNLTSYQPRQQKK
>AIA16638.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MSVLPKKIAVLMGGPGSERDVSLATGRGVVKALRSLGCDVAEVDVKGADFTLPDDVELAFLTIHGTFGEDGQIQQILEDRGVPYTGEGVAGSALAFDKISSKKAFRQHEVATPYWQTINVGQRPTIPIPLVIKAPRQGSTVGVHIIRNEREIDAAITDASTYDRELLVEKFVPGRELTVGILGDQVLPIIEIIPKGGFYDFTNKYPFLNPSAGGAATHVCPAEIGAAKTEEVQQLALRAFRALGLQVYARVDVLLPEDGEATVLEANTIPGMTEASLLPEAAAVAGISYPELCARIIELSGKRAK
>AIA16627.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MTTREELPKKIAVLMGGPGSEREVSLATGRGVAKALRSLGAELVEIDVRDENFQLPDDVDLAFNTIHGTFGEDGHLQKILEGRGIAYTGEGVAGSEIAFDKIRTKEKFQEHGVTTPPWEVIHAGQRPSISLPIVVKAPRQGSTVGVVIVKNEGDIDSAIAEATKYGRELLIEKFVSGRELTIGILGDQVLPILEIIPKGGFYDFNNKYPFLNPQGGGGAEHVCPANIDAGKTKEIQNLALRAFRSAGLQVYARVDAILAEDGRPYILEINTIPGMTEASLLPEAAAAAGIAYPDLCARIIALSGLRQGASGQVRGRTEDKR
>AIA16572.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MTTREKLPKKIAVLMGGPGSEREVSLATGRGVAKALRSLGAEVVEIDVRNEDFQLPNDVDLAFNTIHGTFGEDGHLQTILEGRGIAYTGEGVVASEIAFDKIRTKEKFQEHGVTTPPSEVIHAGQRPTIPLPIVVKAPRQGSTVGVVIVKNESELESAIAEASKYGRELLIEKFVAGRELTIGILGDQALPILEIIPKGGFYDFNNKYPFLNPQGGGGAEHVCPANIDAGKTKEIQELGAPRISLSWPAGVCACGRNSIRRRTAVHFGDQHHSRNDRG
>AIA16522.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
RKIALVTGGYSREAEISYQSVITVNNNVDRNKFDVYVIDINPEGWFYEDANAEKIPVDKNDFSITVNDSKINFDGVLMCIHGTPGEDGKLQGYFDCIGLPYTTCDAATSALTFNKRYTVAVAGFAGINVARSLHIFRNDIIDEETIINKLKFPVFVKPNNGGSSIGMSKVNQPSEEIGIALQKAFNEDDQVLVEEFIEGREFTIGVFKTKGEIITLPITEIKSKKDFFDFEAKYKGMSEEITPAQADEAVLDKVRAAARKIYSVLNCRGVVRIDFIYNEEKGEPFMLEVNTVPGQSAASLVPQQVKAMGWTLEQFYTALIEECWN
>AIA16513.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MHQYLDLLARIRNTGTRKDDRTNTGTLSIFGHQMRFDLAEGFPLVTTKKLHVKSIIHELIWFLQGSTNVRYLREHGVTIWEEWADENGDLGPVYGRQWRAWPTLDGRHIDQIARVVESLKGDPDSRRHIVSAWNVGELDKMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIASYALLTQMMARVTGFEPGEFVHTFGDAHLYLTHPDQADEQLKRSPRALPRMEINPEVRSLFDFAYEDFKLAGYDPHPAISAKVAV
>AIA16467.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNYVLHNSNKGKYANAAFCAGSARITRDLYSEKFLGVPFNISSYALLTHLVAHVTNLEAGDFVYTLGDYHIYKNHLEQVQQLLSREPLPLPKLTINDPDNKLRGLEGLLAAKYENLSLIGYQSHGKIAAPVAV
>AIA16454.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKLRVGVIFGGQSGEHEVSIRSAASVIQAIDRKKYDVLPIAISREGKWLSPPEAYRLLPAKAQQLLATETATKPEANVAILGDPSHQGLIAINEPGDAQPSERIDVVFPVLHGPFGEDGTLQGLLEMANVPYVGCGVLASSCGMDKVAMKLLFLQAGLPMCRYIWFLRSHWGKNRDQVLARISREIGFPCFVKPANLGSSVGISKAVDKQSLVKAIELANQYDRKIIVEEGVDGREIECAVLGNDEPRASLPGEYVVHDNSAGFLDYAEKYNSTGHVDFIVPAQVSKAMTAKIQRMAIRAFQAVDGSGLARVDFFLKRDTKELLINELNTMPGLTDVSGYPKMWAASGLNYTRMLDSLIQLAFERHREKSLNKATL
>AIA16450.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRGKGHEVTPMDPARGVINSAEERELSTGKVGAEPPSLESLSKFAEGTFLPNLTGMKEIRNADVVFLALHGGQGEDGTLQALLDMAHVKYTGSGHLSSALAMDKDLSKKLFRMEDVKTADWLMAPATTEQVEGILGLPVIVKPSKQGSTVGLSLVKKREDIAPAIEEASKYDDEVMIEQFIPGRELTVGILGDIALPVGEIFPKHEIYDYECKYTAGMASEEFPAKLSKEATEKVQQQALQAFKALKLRGYARIDFRLTTEGEFYCLEANTLPGMTELSLIPQGAAAMGIGFPELCERIVKLALG
>AIA16422.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLSNGVPKGDRTGTGTLSTFGYQMRFDLSAGFPLLTTKRVHTRSVIAELLWFIQGSTNVKWLHEKDVTIWDEWADADGELGPIYGYQWRSWPAPDGRHIDQLAGVIDSIKENPDSRRHLVNAWNVGELSQMALPPCHTMFQFYVAPPVDGDPDGRGRLSCQLYQRSADVFLGVPFNIASYALLTHLVAQVCGLDVGDFVHTLGDAHLYLNHLDQARLQLTREPRALPKLIIDPTITAIDDFGLEHVSIEGYDPHPGIKAPIAV
>AIA16395.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSMKKHPEYQYLELCKDILDNGADKELFFNDVVLEEYKKKGEQPPFIRSVFGRQMRFDLSDGFPLLTTKKTFWRGIVTELLWFLSGSSNIKPLLDVKNHIWDEWAWKHFQMWSSDDEKKMLPEMTQEALIAKLTELPATDPFVLKWGDLITIYGRMWRRWPAKDGREIDQLAWVIKGLKTKPDRKSYVVSAWNPDFIYEMASEGQKSHVPPFCHTMFQFQVANGKLNLGLYQRSGDLFLGVPFNIASYALLLIMVSHVTKIPPGEFVHTLGDVHIYSNHFDQVKEQLLREPYPFPKVTLNPAIDDIDKFTAEDITLENYQSHDSIKAAIANIGGFVEKKT
>AIA16354.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MTSSKAFQITNTILASKKYQDLYPQTVERIVIDCIKRYGEKRAEKEARNKLHQIWGAYWSTRPDFTKLFEKVLPQIQENPSQALKELMALQSSTKERTPLLETFYTQIFMTIGEAINSVSEYGCGLNPLTYLWIPNAQEKEFIAYDIDLAEVSFLNTLFEEFTLNITARPNDILQGCDKYTDVVFMLKLLPCLEQQQKNVSKTILAQLQCKYAVISFPTKTIGGKPKGMDEFYSGQFEEVITELKLNTKKIHFSSELVYIIKFH
>AIA16247.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRHVMNHGTEKSDRTGTGTKSVFGYQMRFDLKEGFPLLTTKKVHTKSIIHELLWFLKGDTNIKYLKENGVSIWDEWADENGNLGPVYGSQWRSWQAADGRTIDQITQVIEQIKKNPDSRRLIVSAWNVGEIDKMKLPPCHAFFQFYVAEGKLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLRPGEFVHTLGDAHIYSNHFDQVELQLSRDPRPLPTMRLNPSVKNIFDFKFEDIELLNYNPHPAIKAPVAV
>AIA16174.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RKENRTGVDALTVAGVMFEHDMAHGYPLLTTKKMPFKTMRVELEFFIKGLTDKQWLQDRRCMIWNEWANPKKAPYGHDEESKKRMMEERDLGPVYGFQWRHFDATYQNYDTEYTGTGIDQLANVIETLKKNPNDRRMIVMAWNPKALPEQALPPCHYGFQVTVINGKLNLLWNQRSVDTMLGLPFNIASYALLLHLLAKESGLQEGKLIGFLADTHIYVNHIDGAKEQLAREPRALPKITTDPFTSIFDWTGEHTTLEGYDPQDKIDFPIAV
>AIA16167.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQGKKVPDSGSDEWQNGIKEFTERIKKDADFAKWHGELGPVYGYQWRKWPTPDGRHIDQIKSAIETIKSNPDSRRIIVSAWNAAEVEEMAISGLPPCHLLFQFYVSDGKLSCQMYQRSADTFLGVPFNIASYSLLTMMIAQITGLKPGEFVHTFGDTHLYINHMKQVNEQLKRRPKPLPTMKINPAVKNIDDFKFEDFELLNYNPHPAIWAPIAV
>AIA16141.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKIYNDLLQRIMDEGVDRQGRNAVTRSIFAHQMRFNMADGFPAMTTKKLAFKAVKSELLWFLEGSNDDNRLKELNGSERTIWTANAQADYWKPKAKFDGDLGRIYGVQWRSWQKTDGTTVDQLKEAIEKIKKDPSNRRIIVSAWNPGEIDQMALPPCHMLFQFYVANGKLSLHMVQRSCDMFLGVPFNI
>AIA16134.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRERGHEVIALDPARGVISAAEEKELSTGKVGTKPPSLESLSKVAEGAFLPNLTSMKEIRNADVVFLALHGGQGEDGTIQALLDMAHVKYTGSGHLSSALAMDKDLSKKLFRAEDVKTADWLMAPVEIEQVEGILGLPVIVKPSKQGSTVGLSIVKKREELLPAIEEASKYDDEVMIERFVPGRELTVGVLGDIALPVGEIISKHEIYDYECKYTPGMAREEFPAKLSPEATARVQQQALDGFRALKLRGYARIDFRLTEEGEFYCLEANTLPGMTELSLIPQGAAAMGISFPDLCERIVKLALA
>AIA16116.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLNPTDQQYHDLLRHIMENGSGKEDRTGTGTRSVFGYQMRFDLAKGFPLITTKKVHLKSIIYELLWFLKGDTNVKWLNDRGVTIWDEWADENGELGPIYGKQWTAWEAKDGTKINQIANAVDLIKNNPTTRRIIVSGWNVGDLQTLIRGQKSAPPPCHTMFQFYVVDNKLSCQLYQRSGDVFLGVPFNIASYALLTMMMAQVTGKELGDFVHTFGDVHIYNNHVDQVNLQLTRDSRPMPTMKINPEVKDIFGFKFEDFTLEGYDPHPGIKAPIAI
>AIA16108.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VGEIPQMALPPCHAFFQFYVADQKLSCQLYQRSADLFLGVPFNIASYALLTHMMAAQAGLGVGEVVWTGGDCHIYDNHVDQVALQLGREPRPYPELVLAHRDSIFDYQYEDIAILNYDPHPAIKAPVAV
>AIA16082.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MHKEDRHPEYRYLDILQDIMENGFEKTDFATGTKLKSVFGRQIRFDLSKGFPLLTTKKVFYRGIIHELLWFLRGSTNIKYLVDNDVHIWDDWPYREYKKAAEKGEVPPMTQQVFIEMLKSLPVEHAFVKKWGELGPVYGRQWRK
>AIA16064.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GVRIWDEWADERGELGPVYGAQWRRWPTADGQTIDQISQAIEQIKSNPDSRRLIVNAWNVGELSRMRLAPCHLLFQFYVAQGKLSCQLYQRSADIFLGVPFNIASYALLTMMIAQACDLEPGDFVHTLGDAHLYSNHLEQARLQLAREPRRLPQMKINPQVKSIFEFDYSDFELSGYDPHPHIKAEVAV
>AIA15981.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MFNQLDLTWVHSILKKTHILKQNKMQQYHNLLKDILDYGVVKSDRTGTGTISIFGYQMRFNLAEGFPLVTTKKIHVKSIIHELLWFLKGQTNIAYLKKQGVSIWDEWADEYGELGPVYGKQWRSWEGPDGVIIDQITDVIEQIKKNPDSRRLIVSAWNVSDLPKMALSPCHAIFQFYVAEEKLSCQLYQRSADVFLGVPFNIASYALLTLMVAQVCNLEPGDFIHTFGDVHIYNNHMEQVKLQLSRTPYPLPTMRLNPDVKTIFDFKYEDFILENYQYHPAIKAPVAV
>AIA15909.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MQPVKLPIDSSFKQRLGRVGVLLGGTSSEREVSLQSGGAVVAALAEANVDHVAIDIGANAIQDIQSAKIDRAFLALHGAGGEDGRMQALLEFLNIPYTGSGVQASALAMDKLRTKQLWRGVNLSTPDFAVLSKNTDWQKTLAELGGEAMVKPAHEGSSIGMARVKTAQELESAFAEAAKYDGSVIAERLIVGSEYTVAILDDEALPPIKLETDHAFYDFNAKYIADDTRYICPCGLSPEKEAELKALALDAFNSAGCEGWGRVDVMADKSMNFYLLEVNTAPGMTSHSLVPMAAKARGLSFSELVLTILQSSL
>AIA15885.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKQPEKITKQTRIGVLYGGLSNEREVSLRSGSNCHAALKRLGYENAELIDVGHDIAIVLQQKKIEIAFLALHGKYGEDGTMQGLLEFMQIPYTGSGVLASALALSKPLTKAVLKAQGLPSAETIVIDQHDAKNFRQMIGDIKWAPAMVKPLSEGSSVGVSKVDDSSALVATVEETITKYGGAIVEKYIKGQEITVGVLEELGASKNGKGIFALPILELRPKSKAGFYDYEAKYTKGMTEFVLPAELSPEVTALAQDLAIKTFRALQCCGYARVDMMVDASGQPFVLEVNTLPGMTDTSDLPAMCEEYGISYDELVERIVQSSGLDK
>AIA15883.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKTRVAVIYGGRTGEHEVSVRSAKAILAGLDRAKYETTEYFIDKQGKWSPSPILPEPGAHPEIDVVFPVLHGTFGEDGTMQGLLELADLPYVGAGVMASAIGMDKEMMKRVCKERMLPVVEYVTAFRHTGSILDVCRKMPFPVFVKPANLGSSVGISKAHDAAELEAAFALARQYDRKVIVERAIEGRELECSVLGNAEPVASLPCEILPSREFYDYEDKYLLDMARTQVPADLPADRTEELRRLAVECYRAVECEGMARVDFFLEKETNQLYINEINTIPGFTSISMYPKMWEHSGIAFSDLLDRLIALALDRDKLKKATRFTR
>AIA15871.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTEKKKTRIGVIFGGRSGEHEVSLRSAESIIRSLDTSKYEVVPLAITHEGRWLTAAPAVAMLPAGKAIEAVLKEGKPMTLTPEPGANGVVDVFFPIVHGTYGEDGTLQGLLELAGVPYVGAGVLGSAVGMDKEIMKRLLREAGLPVGDYWVTRSKNIDAFVRQIGSELPYPVFVKPANLGSSVGISKAHDIGELPGALGLAAQFDRKIVVEQGIEAREIEISVLGNDDPRASVPGEIVPAREFYDYQAKYVNDDSKLLIPAPLTEGQVRDAQDLAIRSFQALDCAGMARVDLFLEKSTGKFFVNEINTLPGFTSISMYPKLWEASGLAYSDLLDRLIVLALERNAEKKKLKTKYS
>AIA15852.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HGVTIWDEWADAQGELGPVYGCQWRSWPGRHGETIDQISEVIEQIRTKPGSRRLIVSAWNVAEVPRMALPPCHLMFQFYVADGRLSCQMYQRSADVFLGVPFNIASYALLTMMVAQVTELEPGEFIHTLGDAHLYENHLEQTQLQLTREPRPLPTMSIDPSVHSIFDFQFEHFRLDNYQSHPHISAPIAV
>AIA15840.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MIFGGRSGEHEVSLRSAESVINALNPEKYEVVPIAINKQGRWLKSGEATQLLPSVVIKTADRHIALLGDPTDRGLTSVSNSVPTEGREQIDVLFPVLHGTYGEDGTIQGLFEMADIPYVGCGVLASSAGMDKVVMKRLFREAGLPIVEYTHFLRTQWENNPEQIAERIAEEIGYPCFVKPANLGSSVGISKATDRASLDKAIGLAAKFDRKIIVERGIDARELEVSVLGNDEPQASFPGEIVPQTAEFYDYIAKYVDAGGARLVIPAEVSRETTLKLQ
>AIA15772.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLENGATKQDRTGTGTASVFGYQMRFNLAEGFPLLTTKKLHLKSIIYELLWFLRGETNVKYLQEHGVNIWNEWARENGELGPVYGAQWRSWTGSDGRSIDQISQVIDQIKTNPNSRRLIVSAWNVGEIPRMELPPCHLLFQFYVANGKLSCQLYQRSADIFLGLPFNIASYSLLTMMVAQACDLEPGEFVLTLGDAHLYSNHFEQARLQLSREPLKLPRMKINPAVHSIFDFDYNDFELVGYEAHPHIKAEVAV
>AIA15769.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRDIKDNGVKKEDRTGTGTVSVFGRQVRYNLNDGFPAVTTKKLYFNSVVHELLWFLQGTGNIEYLARNNVHIWDEWPYKAYLQKNNLPVPSSDSTEWKTGIKEFIARIASDHEFAEQWGDLGPVYGVQWRKWPDGKGGYIDQIATAIDTIKHNPSSRRIIVSAWNVAEIDEIVSIGGLPPCHSLFQFNVADGKLDLHLYQRSADTFLGVPFNIASYSLLLAMIAQVTGLKPGEFVHTLADAHIYLNHFDQVDEQLSRTPKELPQLWLNPDVTSIDKFTFEDIRLEGYDPYPPIKAPIAV
>AIA15759.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLQHVIDHGVEKSDRTGTGTLSVFGYQMRFDLRAGFPLLTTKKVHIRSVVAELLWFLQGATNVKWLHEQGVTIWDEWADDSGELGPIYGYQWRSWPTPDERHVDQIAAVIGGLKADPDSRRHLVSAWNVSDLEQMALPPCHTMFQFYVAPAPAGSDDPRGRLSCQLYQRSADIFLGVPFNIASYALLTHLVAQVCDLAVGDFVHTLGDAHLYTNHLEQARLQLTREPRGLPTLRLDPSITAIDDFGLEHISIEGYDPYAGIKAPIAV
>AIA15606.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MTKRIKLRTLLMGGFITLLFVGLMFRIYWVQVVKADFWAKQAMNTWITNEKIPQERGMLLDRDGKVLAADAMAYTVAVGPKTIALLEKKNPDWKLTDRIVSKLHLVLGTSESTLREMITSKKASDGTYLDQREIHPDGWKIDKAVKDRLETFRSELQKLTNEKNVGLYFMEEQKRYYPNGSLASHILGYENKEGMAVMGLEKTLNDQLSGQPGSITYLKDGARTQLPNGQVEYKQAVNGKNVTLTIDRDIQFYIEEALRKAYAEYKPISITAIAADPQTMEILGMASLPDYNPNNYWDFMKDPNSFRDNAIQSVYEPGSTFKIVTLAGAVQEGLFNPTATYKSGSIKYSAKDKPVYDHNRVGWGEITYLDGLKHSSNVAFVKLGYEMLGKDRLVKYITDFGFGQKTGIELPNEVSKSISLNYPSEVATAAFGQGKVLVTPIQQVAAVAAVANGGKLMQPHIVKSITDPTTGQKQVTEPKVIRQVISAETSRKVGDYLETVVSDQAIGTGKSAYIPGYRIAGKTGTAQKVTKSVDTNISGYSKDKYVVSFIGYAPVENPKVVLYIVVDEPQIPNAGGGAVAGPIFKDIMGKSLLHLGIAPNLPKTPDASATASASSSASKGVVVTATVPDVTGMTVSQAQTQLKQRSFPVGVLGNGGKVLQQLPKEGSVLPATQQIYLLTDTKPGNVPDLKGLSLRDALEMCSLLKVVCTVDGQGYVTSQKAVKVGGKWILQLKLASPGG
>AIA15607.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MYFVLIFAVLAFAALVVRLGYVQLWKGSEITKKAEDSWRRDIPFQAKRGEILDRNGTRLAYNISSPSIMAIPVQVKDVRETARKLAKPLGMSEEQLVKLLSKRESSVELKPGGRKITTEKALEIRKLELPGIVVSEDNKRFYPYGSLASHVLGFTGSYNQGLTGLELQYDQRLTGLRGSVSYLSDAAGRKMPQSSDQFIPPQDGLSLELTIDQTIQSIVERELDQAMLVHQANSIIAIAMNPNTGEIYAMGSRPTFQPDKYQEVSSEVYNRNLPIWMTYEPGSTFKIITLAAALQEGKVDLEHEHFYDPGYIEVAGAKLRCWKKGGHGSQTFLEVVENSCNPGFVALGQRLGKDKLFSYIYNFGFGKKTGIDLKGEENGIMFKPKQVGPVELATTAFGQGVSVTPIQQITAVSAAINGGKLFKPYVSKSWIQPGTGMILEEAKPQFVRQVISPETSKLVREALEKVVAQGTGGKAFLDGYRVGGKTGTAQKVVNGRYSKDEHIVSFIGFAPADDPQLIVYVAVDNPQGIQFGGVVAAPIVRNIMADALPYLGVKPRTKQVEKEYKYGSGEPPIVTVPNLVGKTVSDLYEDMNANFQLATSGSGSTVIRQAPAAGARVDKGSVIRIYLGAAD
>AIA15599.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKRDLPKKIAVLKGGPGSERNVSLATAAGVSKALRSAGIEVVDVDVRDENFQLPKDVDLAFDCIHGTFGEDGTLQKILEDLGVPYTGEGVEGSRIAFDKFLTKEKFIEHQIATPDSETIEVGQRPKMSTPLVVKPARQGSTVGIVIVKDESELDAALKEAAKFDDKLLIEKFVSGRELTIGILGDQALPILEIIPKGGFYDFNTKYPFLNPQAGASAEHVCPAKIAPALTKKIQELALRAFRALGLEVYGRVDVLLSESDQPYVLEANTIPGMTEASLLPEAAAAAGINYVDLCLRIIELSRARTERARQ
>AIA15575.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MASAATMTTLPENIAVLMGGPGSEREVSLATGRGVANALRSLGATVTEVDVRGPDFVLPEGVELAFISLHGTFGEDGQVQKILEERGVAYTGEGVEESRLAFDKIESKNRFRAAQVATPYWQIILAKQRPTIPPPFVVKAPRQGSTVGIYIVHSDREIEAAITSASQYDEQLLIEKFVSGRELTVGVLGDLALPVLEIIPKGGVYDFTNKYPFLNPGAGGGAQHVCPAAISEEQTATIQKLALQAHRALGLQVYSRVDILLPEEEEPTVLEVNTIPGMTEASLLPEAAAAAGIPYPHLCARIIELSAKARPSKG
>AIA15566.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAPPRQFEVNLPNQAIPEQGSEEWKTAKDAYLQKIKSDADFAKEYGNLGPIYGHQWRAWADRDGNPIDQLRIAQEQIRSGKASRRIIVSAWNVGDIDEMSKAGLPPCHTLFQFNASNQTDPKTGKKYLDMKMYQRSADWFLGVPFNMVQYAMLLSAMAQTTGRTPRYFYHTFGSAHIYKNHIEQIKEQLSRANNLYDAPRLKLNPDVTDIGDFEAEDFKIIGYKHHASIKGQVAI
>AIA15529.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTNSTFDAASFGKVGVLFGGRSAEREISLISGNGVLAALKSRGIDAHPFDPGTHSLSELAAQNFDRVFIALHGRYGEDGSLQGALELLGIPYTGSGVMASSVGMDKITTKKIWLMEGLPTPKYLSIDAASDLSSVVADLGLPMIVKPPLEGSSIGITKVTKADELQGAIDLVASMDEAVLAEEFVTGREFTVAVLGQGASARALPIVEIVAPGGKYDYQNKYFTDDTQYHCPAPLPESLTQEIQRHAVNAFRALGCEGWARIDVLVRESDMRPFLLEVNTSPGMTTHSLVPMAARAVGIAYEDLCIEILRSARLKMGNKSSKAKG
>AIA15516.1|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MKIAVMFGGTSEERDVSIASGSQVVRALRSRGHEVIPTDTAVGVLDAAAEEKLLSSDVRSAPPGSEQLDVLRTGDATSITRAPEMQGVDVIFLALHGGAGEGGTLQALLELTGLPFTGSGMLGSAMAMDKDVAKRLFEIAGVPTPAWPMAPVGIHDADAQIGWPAVVKPSKQGSTVGLTIVKKPEDLAKAIELAYQFDDEVMIERFIPGRELTVPVMGDDVLPVGEIFPKNEIFDYESKYQAGGAEEVFPADLTGPETVAVQMLAMKAHRALKLRGFSRIDFRLDEHGCFWCLEANTLPGLTAASLFPKGAAAAGIPFPDLCERLCQLAIEEHAGRRRV
>AIA15496.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLAHVMEKGTNRGDRTGTGTRSVFGYQMRFDLSEGFPVLTTKKLHLRSIIHELLWFLKGETNIAYLKENGVSIWDEWADEDGNLGPVYGAQWRSWPAPDGSHIDQIALLIEGLKTNPNSRRHIVSAWNPALVDDMALPPCHCLFQFYVADGKLSCRLYQRSADIFLGVPFNIASYALLTLMVAQVTGLKPGDFVHTLGDTHIYSNHFEQAELQMKRTPKALPTMRLNPDVTSIFDFKFEDFTLENYEADASIKAPIAV
>AIA15488.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VIDHGVEKSDRTGTGTLSVFGYQLRFDLTQGFPLLTTKKVHIWDEWADDSGELGPIYGHQWRSWPTPDDRHIDQIAAVISGLKTNPDSRRHLVSAWNVGDLDQMALPPCHTMFQFYVAPAPPGSADQRGRLSCQLYQRSADIFLGVPFNIASYALLTHLVAQVCDLAVGDFVHTLGDAHLYLNHLDQARRQLAREPRPLPTLRLDPAITDIDGFGLEHIVIEGYDPHPGIKAPIAV
>AIA15481.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MADKVAVLMGGTSAEREVSLNSGQAVLAGLREMGIDAHGIDTRDVSVLTLKEQGFTKAFIALHGRGGEDGTLQAVLEFLQLPYTGSGVMASAVTMDKLRTKLLWQGRGLPSGKFVWLTRQQFDAGLDAENNAAIAALGLPLFVKPACEGSSVGISRVNDLSALPAALDMAFKHDNDVLVEAFLSGAEYTVAIVGDRILPSIEIKSASEFYDYEAKYISDDTQYVCPADLSAEREAELQQLVLAAWRALGCRGWGRVDVMTDGEGRFQLLEANTSPGMTSHSLVPMAAKQAGMSFPQLVAHILELAD
>AIA15463.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AVGPGRSDAKLTRSKNANTMNQYHDLLERILGDGAEKHDRTGTGTLSIFGHQMRFNLASGFPMLTTKKLPLKSIVHELLWFLKGDTNIKYLKDHGVSIWDEWADENGDLGPVYGSQWRSWPAPDGQSIDQIANVIDLIKRNPDSRRLIVSAWNPADVDKMALPPCHCLFQFYVANGKLSCQLYQRSADVFLGVPFNIASYALLTTMVAQVTGFEPGDFVHSLGDAHLYLNHLEQARLQLTRPTRPLPTMTINPEVKDIFAFHFEDFKLENYNPHPHIKAEVAV
>AIA15437.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRAYLDLVQRILDEGVAKGDRTGTGTLSVFGHQMRFPLSEGFPLVTTKKVHLKSVVAELLWFIKGDTNTSYLRDNGVSIWDEWADENGDLGPVYGYQWRSWPAPNGEHIDQLAQIIEQIKVNPDSRRHIVSAWNVADLDAMALMPCHAFFQFYVADGKLSCQMYQRSADVFLGVPFNIASYALLTHMVAQVVGLEAGDFVHTLGDAHLYVNHLDQAREQLTREPRALPELWLDPAVTSIDDFTLESIKVTNYDPHPGIKAPIAV
>AIA15402.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMRHVLEHGAQKHDRTGTGTISVFGYQMRFNLEEGFPMVTTKKLHLKSIIHELIWFLSGDTNIKYLKDNNVRIWDEWADENGDLGPVYGSQWRSWPTADGRHIDQISQIIKTIKENPDSRRIIVSAWNVGEIEDMALPPCHAFFQFYVANGKLSCQLYQRSADIFLGVPFNIASYAMLTMMVAQVCGLQYGEFIHTLGDAHLYNNHLEQARLQLSRDPKPLPVLKINPEVKDIFAFTYEDFTLENYDPHPHIKATVAV
>AIA15364.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKKPGKLRIGILFGGRSGEHEVSLLSAASILNAINKSKYEVVPIGITKQGHWIASTAAERLLAGSSKPAPIQHKSMQLSTSLAQQNGPLARQLDVIFPVLHGTFGEDGTIQGLLELADIAYVGSGVLGSATGMDKVAMRQLFTAANLPQTPHLALTRSEWKSDPKRCAKLIEKKLTYPIFVKPANLGSSVGISKVHDRSELAAAMELAASFDRKLMIEQGVGGPGVKPREFEVAVLGNDNPEASVVGEIVPGAEFYDYEAKYVSDTSVPIIPAKLTKQEAKQIREMAVAAFRTCDCAGLARVDFLMEPARKGKKSRIYLNEINTMPGFTSISMYPKLWQASGLSYTKLIDRLIELAIERNQEKQQTAFSRS
>AIA15342.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NAIETIKNNPNSRRIIVSAWNPAEIDTIVEIGGLPPCHSLFQFNVSGDWLDLHLYQRSADTFLGVPFNIASYSLLLAMVAQVTGKKPREFVHTLADTHLYLNHAAQVDEQLSRTPKELPTLWLNPDVKNLDDFTFDDIRLENYEPYPPIKAPIAV
>AIA15331.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MNGQNRIAVLMGGPGAERAVSLATGAGVAKALRSLGAEVTEVDVRGPDFQLPPDVDLAFIALHGTFGEDGQVQKILEERGMAYTGEDVEGSRLAFDKILSKEKFKAQNITTPEWEILKAGQRPSLPRPFVIKPPRQGSTVGVYIVRQEQEIDDTLKKAAEFDQELLVEEFVEGRELTIGILGDQALPVLEIIPEGGFYDFQTKYPFLNPGAGGGAQHICPAPLQDEQTRAIQDLALRAHRSLGLKVYSRVDIMLPENGAPSVLEINTIPGMTEVSLLPDAARAAGIEYPELCARIIELSQAARPKK
>AIA15330.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MPTKNIALIAGGFTGEYEVSINSAKNIAANLDPAKFKVYTVLITRADWFYDTGHEHISIDKNDFSLTLNGEKIKFDFAFITVHGTPGEDGKLQGYFDMLGIPYNTCDATTSAITMNKAFTKTLVHGIHGLNAAKSMQLHRKDGHDVATIAANLKFPLFIKPNNGGSSVGMSKVHNIAGLPEALERAFHEDDQVLVEEFIKGREYSRGIARLNGEIMVLPATEIISHKEFFDYEAKYTAGASDEITPADLSNEQNEKIANILTEIYLRLNCKGMVRIDFILLEGSQDFYFIEVNTTPGQSSASLIPQQVRAAGMDLMKFYGDLIEGTF
>AIA15327.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAEKKVKTPGGPLKITVLMGGASSERDVSFASGTRVAAALREKGHTVTAFDPAGDVMTREEETRYLSGAVKTAPPTPEFLATLRIPGTLGDHPAVRDADVVFLALHGGQGEDGTVQALLDLAGITYTGSGHLASALAMDKDLSKLLFRAGGVRTADWLMAPAAEDEIVSALGLPVVVKPSKQGSTVGLSVVKRREDLAAAIELAYKHDDEVMIEAFVPGRELTVGILGDEALAVGEIIPKHEIYDYERKYTAGMAIEEFPAKLDRAQTGAVQQQAVAAFRALKLGGYARIDFRMSPEGHFYCLEANTLPGMTETSLIPQSAQACGISFADLCERVVRLALEQRRPVAGAGAGA
>AIA15099.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQRKLRVGIVFGGRSGEHEVSVASARSVMAAIDQTKYEVIPIAIARSGQWLPGVAPQALMAPTDIAPAEAVSSDTPQAVISDDTPTGFALLPQLRDEQHATEVDVIFPVLHGTYGEDGALQGMLEMAGLPYVGNGVLGAALGMDKDKAKLLFQVAGLPVVPWITVTRKEVESALDASITAIAARFGFPVFAKPANMGSSVGVTKAHDAAELRAALTMAARYDRKIVVEPAINCREIECGVLGNDDPEASVVGEILPSNEFYDYQAKYLDGASQLLIPAPIADAIALDVRRMAIVAFRALDLNGLARVDFFLDRDTDQVYLNEVNTMPGFTEISMYPKLWEVSGLTYPALIDRLIMLGIERHQERARNEIGVDF
>AIA15018.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKSVIATPYEDLLRETLEHGSTKSDRTGTGTRSVFGRQLRFDLADGFPLITTKRVHFKSIAYELLWFLRGDSNVGWLRENGVTIWDEWADESGDLGPVYGVQWRSWPTPDGGHIDQIAQVIETLRTNPDSRRMIVSAWNVSEIPAMALAPCHALFQFYVADGKLSCQLYQRSADLFLGVPFNIASYALLTLMVADQVGLAPGEFVWTGGDCHIYDNHVEQVTEQLRREPFPAPTLRILRQPASIFDYRFEDFALVDYRHHPAIKGAVAV
>AIA15010.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGGGNVQAYLDLLSHVLEHGALKEDRTQTGTKSVFGYQMRFDLSKGFPLVTTKKCHLKSIIHELLWFLKGETNIRYLNENGVTIWDEWADQDGNLGPIYGKQWRSWSTPSGETVDQIASLIHAIKTNPNSRRLIVSAWNVQDVDKMKLPPCHCLFQFYVANGKLSCQLYQRSADIFLGVPFNIASYALLTLMIAQVTGLQPGEFVHTLGDAHLYLNHVEQAKTQLTRTPFPLPTMLLNPDIKAIDDFRFEDFVLKDYQSHPAIKAPIAV
>AIA14986.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MAINEEKIKVALVSGGDSSEREVCFMSAKAMANALSPERYAVTVFDVASTETRAHSFNYGGDVLGKKPRHAVAAVEWNQLVTTLYTTGYDVVLPALHGGRGEDGTLQALLEVAGIPYVGSAQHTSAIAIDKQICKAVLAEHGIPVPRGQVFNSLGEFDAAKPALEPCVVKPNGGGSSVGVTIFREVPTAG
>AIA14921.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAAAPRMASCRRCAKCAAFPLPGPARRRRTWPSTSSRRKDSRRIAGVPAPAGVALENLDAAFAEYGRLIAKPARDGSSYGLIFVNAKQDLVAVRNAARTEEYLIEPFVAGVEATCGVLEQSDGTLMSLPPIEIVPGEGAFDYTAKYLLKSTQEICPGRFTPEITAQLQDQALRAHKALSCSGYSRTDFIVSANGPIYLETNTLPGLTAASLYPKALKAQGIELPDFLRDQITLAERRSRERS
>AIA14916.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKSLEPYGQQTMNKEGFPSMSSVQTPVKLSSQTRIGVLYGGLSSERKVSLISGQNCFDALKRLGYENAELIDVNHHIAQTLAEKRIEVAYIALHGKFGEDGCIQGLLELMGIPYTGCRVAASALTMNKATTKSVLKDAGLPVIDSVVIKAGTVNGKPMDIGLSYPVMVKPINEGSSIGMSKVNRAEDLKEALHTAFKYADEVMVEEYVPGKSLTVGVVEVDGAPKVTPILELRPTQSEWYDLEAKYTEGGTEFILPAELSDEVTRAIQDATLKAHVAAGCRGMSRIDFVVDAQNRFYILEINTIPGMTPLSDLPAQAKAMGIDYDQLVECILKTATADF
>AIA14883.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLVKHVLEHGNEKGDRTGTGTKSVFGYQMRFDLSEGFPMVTTKKLHLKSIIYELLWFLNGDTNIKYLNDNGVRIWDDWADENGNLGPVYGAQWRNWDGREIDQITELIDTLKANPNSRRMLVSAWNPRVLPDTSQSFADNVADGKVALPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALLTLMIAQVCGYQPGDFIHTFGDAHIYNNHMEQLELQLSREPRPLPKMTLNPEVKNIFDFTFEDFTLTEYDPHPHIKGVVAV
>AIA14848.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAEKKLRVGVVFGGRSGEHEVSLASAKAIMENLDRNKYDVVPIGITKAGTWLLGTNPEQLLAAGQDVSQSAAEEQHETTTAVTLTGDPTVRRLIPLQGSEQLRNNGALDVIFPVLHGTYGEDGTLQGLLEMANVPYVGCGVLGSALGMDKEKMKMVFQAVGLPSADYLVYRRNQWERRPEEIMDAIEQRLGYPNFVKPVNLGSSVGISKAHNRSELHHAINLAGEYDHKIIIEKNINCRELECAVMGNDEPLASVVGEVIASNEFYDYNAKYIDNKSQVIIPANIAAETASAVRSQAVQAFLALDLSGLARVDFFLEKETGQVYINEVNTMPGFTQISMYSKLWQASGVAYPELLDRLIELAQERHADRQRNRTSL
>AIA14816.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEQYLKLLQHIIDQGSVKTDRTGTGTTSCFGAQLRFNLQEGFPLVTTKKLHLKSIIYELLWFLNGDTNIKYLKDHGVSIWNEWADENGELGPVYGKQWRSWETKDGRVIDQITEAVKTIKNNPDSRRIIVNAWNVGDLPQMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIASYAILTMMMAQVCDLEPGDFVHTFGDVHLYSNHIEQAKLQLSRQPFELPTLKINPAVKDIFGFKFEDFEVLNYQHHPHIKAPVAI
>AIA14728.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MGKIDDKVAGRVVFGGKSAEHEVSLQSAKNILEAIDKTRFDVVLLGIDKQGHWRLNDASNFLLNAENPALIALNHAAEDVALVPGTTQQQIITRHNAHPLSQIDVIFPIVHGTLGEDGSLQGLLRMASLPFVRFRRAGLCGQHG
>AIA14725.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKSSKHPEYQYLNLAKEILESGIKQTDRGTGVSDYSLFGRQSRYDLSEGFPLLTTKKVYWKGVVEELYWFFSGQTNIKYLVDNNVHIWDDYPFKIYKEKNPKSKMTKDEFIENIRTDAKFAKEWGELPRIYGEMWRKWPTRKKGKTIDQLQWAVNELKADPNAHNAIVNSWNPEYLYTMADRQDASRFPICHNMYQISNRNGRLSLILYQRSCDLFLGVPFNIASYSLLALVLAKVLDLEPGEFIHDYGDVHIYENHIDQFKEQLMRKPRPFPTVKLVGKIKELSDFTPDKVVLENYDPHPTIKAELTVAGGYYESKKKKK
>AIA14723.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSATTLTQSEIKELGKVAVLFGGRSAEREISILSGTGVLQALQSKGVDAHAFDPAERSLGELAAEKFDRAFIALHGRYGEDGSLQGALEQLGIPYTGSGVMASSVGMDKITTKIVWLANGVSTPKYAVIDTDTDLDQVVADLGLPLIVKAPLEGSSIGITKVTRREELQAAVELSRKYDARVLAEQFIEGREFSVPLLGTGPTARALPIVEIVAPEGKYDYQNKYFTDDTKYHCPAPLDAATTGAIQREVEKAYRALGCEGWSRIDVLLRESDQQFFLLEVNTSPGMTTHSLVPMAARAEGTSYEDLCVAILRSASLKIGQNKKEKA
>AIA14699.1|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
TSEVTPRKIRVGVLYGGKSSEHEVSLRSATNVIQQLDRSRFEVIPIGIDKQGAWFLGQDLNALEQSPVIALEQDLEKELFNPNRIGQAQNLTAKSFADHTDRLFDVVFPVIHGPLCEDGTIQGLLELADVPYVGCGVLASAVGMDKDVAKRLVMQQGLPVAPYQAIKRGEWNKNSNAFCDSVNETLRYPVFVKPANTGSSVGVHKVKQPADLIAAIEDAFQYDTKILVEQGIDAIELELSVLESLDYGAEPIVSIAGEVKPQNGHEFYSYASKYLDDHGAETLIPAPISSALQQSAGKIAQQIFSLLECEGMARVDLFLERDTHQIYFNEINSIPGFTQISMYPKLMMASGMSYPDLLTHL
>AIA14691.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MGCVVEKKLSILVLCGGQSTEHEVSILSSKNVVAGLDPNKYSVNVVYITHQGVWHYLSDIPSYLSHGPEVLVKQGKTIPVLCHLGAKVPTLVAFSSPNKAFTMDCIIPILHGTNGEDGSIQGLFQLMNVAYVGSDVLSSSMCMNKAITKQLLRANGIPTTPWNLLSRDQIIKGTYSKLVEQLGAELFVKPVSLGSSVGISRVASEAEFLQAAHQVLRYDHQVLVEQSIRGREIECAVLGNENPVASLPCEIISHRDFYDYDAKYLDPKGATTVVPADLSPVAVDRICQMSRDAFRIMQCRGMLRVDFFMINEEAILVNEVNTIPGFTNISMYPKMWQASGITYSELLEQLINLALQRQAMQNQLERVYVRLGAVEAVNRDSLSS
>AIA14666.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MKKSVAIVFGGQSSEHEVSLQSARNVINAIDRERYALTLIGVDKLGHWLHFDEADYLLNATDPARIKLSASGKPLSLLPGSIGGQFVEVESGQPLAAIDVVFPLIHGAFGEDGALQGLLRMLAVPFVGADVLSSAVCMDKDVTKRLLRDAGIAVAPFRVLSRGESLSFTEAADQLGLPMFVKPANQGSSVGVSKVSDEAGFAAALALGFEFDHKLLIEQGIVGREVECAVLGNVDVQVSVCGEVIANDEFYAYDTKYLNGDQARIAIPAELPADLSDQVREVALQAYKVLGCAGLSRVDFFVTEGRDIIINEVNTLPGFTSISMYPKLWQASGLSYAELIHRLIVLALERADQARLLKTEIFA
>AIA14659.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSAAELKNEFGKVGVLFGGRSAEREVSLMSGNGVLTALRSKGIDAHPFDPAERSLAELAAEKFDRVFIALHGSYGEDGTLQGALEQLGIPYTGPGVMASAIAMDKIMTKRICMSHGVPTPKFVALDASATSAARLQEVASELGLPLMLKAPHEGSTIGIARVEDAAGLQAGFDLCAKYDSVVLAEQFVKGRELTVPVIGSGRNARALPIVEIRAPQGNYDYQHKYFSDDTQYLCPAPLDEAFTKRVQKLAVDAFNAVGCTGWSRVDFMVRESDNEPFLLEINTSPGMTSHSLVPMSAKVAGTVYEDLCVEILRLARLDLKPAQHVKKD
>AIA14613.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KSAEHEVSLQSAKNIYDALDKDKYDVELIGIDKEGKWHLNHAGSYLTNEHDPKLISLNKSNEGIAVVPGEDQKQLVNLSSKEALSSLDVIFPILHGTLGEDGSIQGMLRLANIPFVGTNVLGSAVCMDKEITKRLLRDAGIPNAKYVTATTWNRDSLSFSDIEKELGTPLFIKPANQGSSVGVSKVSDEKAFKAALDTAFKFDHKVLIEECIIGREIECAVLGNENPKASIPGEILPQNDFYSYEAKYIDESGALLAIPADLTEEQSNAVRELSVSAFRTLNCEGMARVDVFLKENGEIVVNEVNTIPGFTKISMYPKLWEISGISYKSLIDELIQLAIERHERDNRLHHNAFE
>AIA14596.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLVRDILEHGRPEDGGVRSDRTGVGTYSVFGRQLRFNLEEGFPLVTTKKTHMRSIIHELLWFLSGDTNTKYLTDNKVSIWNEWADKNGELGPVYGKQWRRWEGPRGERIDQIQRAVDTIKKSPNSRRILVVAYNPADLPEVAPPACHTLFQFYVSGNRLSLQLYQRSADLMLGVPFNIASYSLLLMMVAQVTGLKPYEFVHTFGDVHIYSNHIQGAELQLTREPRPLPKMILNPDVKDLFKFRYEDFKLVGYEPHELIKFDIAV
>AIA14586.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKKQRIGILFGGRSGEHEVSLLSAASILKAIDKKKYDVLPIGITKQGQWLGAGDAQALLAGESKQPLQLSAGADLVQQSGNLTQTVDVIFPVLHGTFGEDGTIQGLFELADIAYVGSGVLGSAAGMDKDVMKKLFAAAGLPQTPYLALTRSEWKADPKRCTRLIEKALQYPVFVKPANLGSSVGISKVHGRSELAAAMDLAAGFDRKLVIEQGVGGPGAKPRELEVAVLGNDAPEASVVGEIVPNKEFYDYESKYADSPDDPSVPIIPAKLTAAAVKEIRTMAVAAFRACDCAGLARVDFLMEPARKGKKARIYLNEINTMPGFTSISMYPKLWEASGLPYKQLIDRLIALAVERHQEKMQTSFSRN
>AIA14582.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMRHVLDHGAVKTDRTGTGTRSVFGYQMRFDLGEGFPLVTTKKLHLKSIIHELLWFLSGDTNIRYLQEHGVRIWDEWADADGNLGPVYGAEWRSWPTPDGGSIDQIAHVVDQIRRTPDSRRLIVTAWNPADVDRQALPPCHCLFQFYVADGKLSCQMYQRSADIFLGVPFNIASYALLTLMMAQVTGLRPGDFVHTLGDAHLYANHLDQARLQLGRDPRPLPAMRINREVNSIFDFVYSDFVLEGYDPHPHIKAEVAV
>AIA14579.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLQDIIDNGVDKNDRTGTGTRSVFGRQVRYNLADGFPAVTTKKLYFNSVVHELLWFLKGTGNIEYLAQNNVHIWDEWPFKAYLEKNNLPMPEVNSDEWKSQMKEFIQKIATDHEFALKWGDLGPVYGVQWRQWPDGKGGHIDQIANVVEMIKKSPDSRRMIVSAWNVAEIDEIVEIGGLPPCHNLFQFYVANGKLSLHLYQRSADTFLGVPFNIASYSLLLAIIAQVTGLEQGEFVHTLADTHIYSNHFEQVKEQLSRTPKELPTLWLNPDIKSIDDFTFDDVKLENYDPDPAIKAPIAV
>AIA14574.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MNNLPKKIAVLMGGPGSERDVSLATGRGVAKALRSLGTEVSEIDVRGPDFEMSDDVEMAFVAVHGTFGEDGQLQRILEERGVPYTGEGMRESETAFDKISSKERFDAAGVATPEWEIIKAGERPTLSLPFVIKAPKQGSTVGVYIVRTDAELEHALTEAAKLEHALTEAAKYDERLLVEKFIPARELTIGVLGERALPIIEIIPKGGFYDFTNKYPFLNPSAGGGAEHVCPAHISEEQTRAIQELALQAHRSLGLKVYSRVDIMLPENGAPTVLEINTIPGMTEASLLPEAAAAAGISYPALCARIIELSQAARKAA
>AIA14552.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MGTERSLPKKIAVLMGGPGSERDVSLATGRGVSKALHSLGADIVDVDVRDENFALPKDVDLAFITIHGTFGEDGQLQKILEERGVAYTGDGVEASRMAFDKILSKEKFREHSVATPEWEVIEVGQHPTISIPLVVKPARQGSTVGVVIVKNASELDSALEEAGKYDRKLLIEKFVSGRELTIGVLGDQALPILEIIPKGGFYDFNNKYPFLNPQGGGGAEHVCPAKIEPNKTKEIQEEALRAFRALGLVVYGRVDILLSDAGDPFVLEVNTIPGMTEASLLPEAAAAAGINYVDLCARIIALSRVRTERRRR
>AIA14515.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MNARAYESLKSNVAPSDFGRVAVLYGGTSAEREVSLKSGAQVLGALQAAGVNAFGIDVGPDLLQILLREKIDRAFIILHGRGGEDGSMQGLLECLNIPYTGSGILASALAMDKLRTKQVWQSQGISTPRHAVLASEEDCVNAVTELGLPLIVKPTHEGSSIGMAKVTSSNELVSAWKDASAYDSQVLVEQWIDGPEFTVAVLRDQVLPAIALGTPHTFYDYDAKYLANDTQYRIPCGLSPEKEEELMELSQRACAAIGISGWGRVDVMQDATGTFWLLEVNTAPGMTDHSLVPMAARAAGLDFQQLVLSILTDSLQARG
>AIA14363.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEKKHPEYQYLDLLQDIIDNGSDKELFFTPEILKQYEEKGEKPPTIRSVFGRQMRFDLKDGFPLLTTKKVFTRGIIVELLWFLRGDSNIKYLVDNNVHIWDEWAWKRYNKVGKTRGLPEMSQENFIAKLKEEPAESEFVKEWGDLITVYGRMWRRWPASDGREIDQLAWVIDGLRDKPFRKSYVISAWNPDFIYSMASGNNSNEVPPFCHTTFQFAVTEKRKLNLGLYQRSGDVFLGVPFNITSYALLLQMVAQVTGLEAGEFVHMLGDVHLYSNHFDQAKEQLSRTPRPFPTLKLNPERKDINDFVFEDIVIEKYDPHPPIKAEIANIGGFEKKDNTLFTLKDKK
>AIA14331.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLELMRRVLETGADRGDRTGTGTRSVFGHQMRFDLADGFPMLTTKKLHLKSIVHELLWFLRGDTNIAYLNDNGVSIWNEWADENGDLGPVYGYQWRSWPARDGRHIDQIENLLNGLRRSPHSRRHIVSAWNPALVDEMALPPCHCLF
>AIA14323.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRTYLNLLQHILDHGVKKADRTGTGTLSVFGYQMRFNLAEGFPLVTTKKCHLTSIIHELLWFLQGDTNIKYLNDNKVRIWNEWADANGDLGPVYGKQWRAWSAADGQFIDQISQLIHDLKTNPDSRRLIVSAWNVGQIPQMALAPCHTLFQFYVAEGRLSCQLYQRSADVFLGVPFNIASYALLTMMIAQVTNLQLGDFVHTLGDAHLYLNHREQANTQLVRTPYQLPTMQLNPAINNIFDFKFEDFSLQNYVCHESIKAPIAV
>AIA14315.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MKAYLDLLQHLLDNGTRKTDRTGTGTLSCFGYQMRFDLADGFPLLTTKKLHTKSIIHELLWFLQGDTNIAYLKENGVRIWDEWADADGDLGPVYGKQWRSWAAPDGRVIDQISDVLAMIKKNPDLEPRRRAHHGPAAMPLPVPILRCGRKAQLPALPAQCGYLPRRTLQHRQLCAAHIDDRAGLRSAAR
>AIA14297.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MVLYGGRSGEHEISLRSAASVIRYLDRTRFDVIPVGIDKKGVWRLGDFNLIEESLSNKLQESLVIYENAPVVVVGDFKSLAIDAVFPVMHGPLCEDGAIQGLFELAEIPYVGSGVLGSAAGMDKDVSKRLARDGGLKIVPYISLKRGRWQGGSSVGDSDPASGISASTSSGLSSGSFSKTPSDVPAGASVGSPEVFAEVSKQVVSQLGYPVFVKPANLGSSVGVHKVKESNGLRAALKDAFRYDTKVLIEKAINAREIEFAVLEASHYGDPAKVSLAGEIAPTHEFYSYEAKYLDEQGAKLMIPAELEPKQMALGQKIAREAFELIECEGMARVDLFLDKDSGEFYFNEVNTIPGFTSISM
>AIA14250.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYNDVLKRIMDQGVDRQGRNAVTRALFVEQMRFKMSDGFPAMTTKRLAFKAVKSELLWFLEGSNDDNRLKELNGSEKTIWTANAQASYWKPKAKFDGDLGRIYGVQWRSWLAPDGRVIDQIAQAIDKIKNDPSNRRIIVSAWNPGEIDQMALPPCHMLFQFFVANGKLSLHMVQRSCDMFLGVPFNIASYSLLLHMVAQVTGTTADECILTLNDAHIYHPHFDAVNEQLSREPMKLCSLWLNPEIKDINDFTMDDIRLENYESHPTIPAEMIE
>AIA14220.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MRASINDAARYDRRIIVERAVVGREIEVSLLGNDHPMASLPGEIITGHEFYDYEDKYVDTTSRTEVPARLPKKILERIQRDAVKAFQAIDGSGLARVDFFVERETNRVIINEINTMPGFTSISMYAKMWEASGISYAELIDRLIQLAIERHGDRSRNLTSYKPRQ
>AIA14211.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLEHGAAKDDRTGTGTLSTFGYQMRFNLDEGFPLLTTKKLHIKSIIYELLWFLRGETSIKYLQEHGVNIWNEWADEHGELGPVYGAQWRSWHTADGRTIDQITQVIDQIKTNPDSRRLIVSAWNVGEIPKMALPPCHLLFQFYVANGKLSCQLYQRSADFNIASYALLTMMIAQVCGLKAGEFVHTLGDTHLYSNHIDQAKLQLTREPLTLPRMRLNTSVRSIFDFDYDDFELVDYDAHPHIKAEVAV
>AIA14207.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MDQIAQLIQSLKQNPDSRRLIVNAWNVGEIDKMALAPCHCLFQFYVANGRLSCQLYQRSADVFLGVPFNIASYALLTQMIAQVTGLKCGEFIHTLGDAHLYLNHLEQAETQLKRTPFPLPTMVLNPDITSIFDFRFEDFQLQNYQSHARIPAPVAI
>AIA14127.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKIRVGVIYGGRSGEHEISLRSARSVIESLDSEKYDVVPIAITKEGKWLGPAQAVGMLPEETKQLVPGKVIKHANRDVAIIGDPSRSGLVTLETENEGTSSQPLDVVFPVLHGTYGEDGTLQGLLDMAGIPYVGCGVLASSCGMDKVAMKALFREAGLPLCKYIWLLRSEWERDPASIMRRIKREIGFPCFIKPANLGSSVGVSKAIDKGSLEKAIELAARYDRKIMVEEGLDAREIECAVLGNDEPVASLPGEYVVYDEAAKFLDYTEKYSSTGHVEFVVPAPLSKSLIKKIQQMATLAFKAIDGAGLARVDFFLRRDTNELLINELNTLPGLTDVSGYPKMWEASGKSFPQVIDSLIELAFERHKDKSRNQTSR
>AIA14118.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTHTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELLWFLRGDTNIKYLKERGVNIWNEWADESGDLGPVYGAQWRTWRACDGQTVDQISRVIEQIKSDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGRLSCQLYQRSADIFLGVPFNIASYSLLLAMVAQVTGKQPGDFVHTLADTHLYLNHLEQVEEQLSRKPFPLPTLKLNPDIKSIDGFKFEDIELVGYQSHPPIKAPIAV
>AIA14088.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TGTLSVFGYQMRFNLGDGFPLLTTKKLHTRSIFHELLWFLKGDTNIKYLKDNKVTIWDEWADEKGDLGPVYGKQWRAWETADGRTIDQISNVIHQIKTNPDSRRLLVVAFNPSEIERMALPPCHAFFQFYVANGTLSCQLYQRSADVFLGVPFNIASYALLIHMVAQVAGRCAPLFKSY
>AIA14080.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
YGEDGSLQGALEQLGIPYTGSGVMASSVGMDKITTKIIWLAHGVPTPKYAVIDSVESAGLDARLDAVVADLGLPLIVKPPLEGSTIGITKVTEAAGLKAAVELAHQYDKQVLVEQFIEGREFSVPLLGSGPGARALPIIEIVAPEGNYDYQNKYFTDDTKYLCPAPLDAQVTAAIQADVVKAYRSLGCEGWARVDVLIRESDGKHFLLEVNTSPGMTGHSLVPMAARAEGTSYEDLCVQILRTASLKIGQSKQKAG
>AIA14061.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HVLDNGTKKDDRTHTGTLSTFGYQMRFNLSEGFPLLTTKKLHTRSIIGELLWFIQGCGDLGPVYGAQWRTWRACDGQTVDQISRVIEQIKSDPDSRRLIVNAWNVGELSKMRLAPRHLLFQFYVADGHLSCQLYQRSADVFFGVPFNIASYALLTMMIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQMKINPSVKSIFEFD
>AIA14060.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLVRYILDNGERKADRTGTGTLSVFGYQSRYDLRDGFPLLTTKKVLFDAVVRELLWFLKGSTNINQGLKQFTPIWNAWADPSGELGPIYGYQWRKWERFVWDESTQTYRKEHIDQIQTAIDTIKTNPDSRRIIVNAWNVADIDRMALPPCHSFFQFYVANGRLDCQLYQRSADVALGVPFNIASYALLMSMVANECRLTPGIFVHTLGDAHVYMNHVEGLRTQLERSPKPLPRLKLADKPVLQMNFEDIELTGYQHHDFIKFPIAV
>AIA14044.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RTGVGTYSVFGRQMRFDLSEGFPAVTTKKLAMRAIIYELLWFLRGDTNIKFLVDNDVKIWNEWSYQVYLEKNDLDKKYERYSDKWKSEMDKFVENMKSDDEFAKKWGELGPIYGKQWVRWQAADGSEINQIQNVIDLIKNDPTSRRLLVSGWNVGEIQELIKNHHHAPPSCHSLFQFMVINGKLSCQLYQRSGDFFLGVPFNIASYALLTMMVAQVTGLEPGEFVHTFGDAHIYTNHVDQVTEQLSRKPKSLPKMKINPKVKNIFDFKFDDFELVDYDPHPAIKAPIAV
>AIA13998.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIRIGVIFGGRSGEHEISIRSAKTVIEQIDRDKYDVVPIAISEEGKWLNPIEALALLPSPTQELLTKEVGNFPREAVALLGDTSFKGLTRLEAVDGEERTSLLDVVFPVLHGTFGEDGTIQGLFEMADIPYVGCGVLASACGMDKAVMKTLFRDAGLPICRYVWFLRSEWERAGEAAVEQVKAKIGFPCFVKPANLGSSVGVSRADDEISLREAVELAARYDRKIIVEEALDMREIECAVMGNDEPRASLPGEYVIKDESKKFLDYTEKYDGTGNNDFVVPAPISEELTRKIQEMAIRAFKAIDGAGLARVDFFLRN
>AIA13965.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KLANPDRTRRSHMKQYHDLLHSILEHGKEHQDRTGVGTISHFGYQTRFCLSEGFPIVTTKKIPFRWVAEELFWFLSGDTNEASLRTRGVDIWKEWADLEHTSRFGRAAGDLGPVYGYLWRSFGGHYPERDGVDQIARLIHNIEHEPNSRRLIVTGWDPAQSELVDLPPCHTLFQFKVEEDAKLIHCQLYQRSADAFLGVPFNISSYALLTHLIAHVCDLRVGDFIYTLGDYHIYQNHLTQVEELLAREPLPLPQLEIKDEDGRLRGLPGLLSFRYEHLNLIGYKSHSKIAAPVAV
>AIA13949.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QWRSWPTADGRHVDQIGEVVERIKNDPDSRRLIVSAWNVGEISKMALPPCHVMFQFYVADGRLSCQLYQRSADVFLGVPFNIASYALLTLMVAQATHLAPGEFIHTFGDAHLYTNHLEQARLQLSREPQREPHPLPQMKLRPGVESILDFRFEDFELVGYQPWPHISAPVAV
>AIA13901.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKHVLDNGTKKDDRTHTGTLSTFGYQMRFNLGEGFPLLTTKKLHVKSIIYELLWFLRGDTNINYLQAHGVNIWNQWADETGDLGPVYGAQWRAWRAADGRTIDQISQVIEQIKTSPDSRRLIVNAWNVGELDKMRLAPCHLLFEFYVVHGKLSLHMVQRSCDMFLGVPFNIASYSLLLHMVAQVTGTTADECILTLNDAHIYHPHFDAVNEQLSREPMKLCSLWLNPEIKDINDFTMDDIRLENYESHPTIPAEMIE
>AIA13852.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHELLKHLLEHGARKEDRTGTGTLSVFGYQMRFNLQEGFPLLTTKKLHTRSIIYELLWFLRGETNTAYLKENGVSIWDEWADEQGNLGPVYGYQWRSWPNPDGSHTDQITNLITGLKKNPDSRRHIVSAWNPSFIDQMALPPCHCLFQFYVANGKLSCQLYQRSCDTFLGVPFNIASYALLTLMVAQVCGLQPGDFVWTGGDVHLYSNHLEQARLQLTRDLRPLPLMMINPEVKDIFQFRFEDFTLLNYDPHPHIRAAVAV
>AIA13834.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELMQHVLEHGTPKDDRTGTGTLSVFGYQMRFDLGAGFPLLTTKKLHVKSIIYELLWFLRGDTNINYLQAHGVNIWNQWADETGDLGPVYGAQWRAWRAGDGRTIDQISQVIEQIKTSPDSRRLIVNAWNVGELDKMRLAPCHLLFQFYVANGKLSCQLYQRSADIFLGVPFNIASYGLLTMMIAQVCNLEPGELVHTLGDAHLYANHLEQARLQLTRQARPLPQMQINPAVKSIFDFDYADFELTGYEPHPHIKAEVAV
>AIA13786.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLGKVRNRGAKKGDRTNTGTLSIFGHQMRFDLADGFPLVTTKNLHVKSIIHELLWFLQGSTNVRYLNEHGVTIWDEWADERGDLGPIYGRQWRSWPTPDGGHIDQIANVVEGLKRDPDSRRHIVSAWNAAEIDEIVETGGLPPCHTLFQFNVRDDKLDLHLYQRSADTFLGVPFNIASYALLTMMIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQMKINPSVKSIFEFDYSDFELSGYE
>AIA13781.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRDIRDNGEEKGDRTGTGTRSVFGRQVRYNLSEGFPAVTTKKLYFNSVVHELIWFLKGTGNIEYLAQNNVHIWDEWPYKAYLQKNNMEIPDPNSGEWREGMKEFINKIATDHEFAKKWGNLGPVYGVQWRHWPDGKGGEVDQVARAIDMIKNSPTSRRIIVSAWNAAEIDEIVETGGLPPCHTLFQFNVRDDKLDLHLYQRSANTFLGVPFNIASYSPLLAMVAQVTGKQPGDFVHTLADTHLYLNHLEQVEEQLSRKPFPLPTLKLNPDIKSIDGFKFEDIELVGYQSHPPIKAPIAV
>AIA13771.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMKHVLDSGARKDDRTGTGTLSVFGHQMRFDLSEGFPLLTTKKLHVKSIIYELLWFLRGDTNIRYLKEKGVNIWNEWADESGDLGPVYGAQWRGWRAADGRVIDQISQVVEQIKSNPDSRRLIVSAWNVGELDRMALMPCHLLFQFYVAGGKLSCQLYQRSADIFLGLPFNIASYSLLTMMMAQVCGLKPGDFIHTLGDAHLYSNHLEQARLQLAREPRRLPQMRINPSVKSIFEFDYSDFELSGYEPHPHIKAEVAV
>AIA13754.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MIGKSVSPITYHLSPITYHYFQECRLVKKLRVGVIFGGRSGEHEVSVRSARAVIDAMDAGKYDVVPIAITKEGKWLSSAEATRLLPEETKRLLTDEVVSEERRPSILVGDVAGNGLVAQSKDEPHAPVKQLDVVFPVLHGTYGEDGTIQGWLEMVGMPYVGCGVLASSCGMDKVTMKALFREAGLPICNHTWFLRKAWDDDRQSILRRVAREVGFPCFVKPANLGSSVGVSRATDKASLEQAIELAARYDRKIIIEEGLDAREIECAVMGNEAPQASLPGEYVVRDQAAAFLDYTEKYSNTGHVEFVVPASLSKALIRRIQRMATRAFQAVDGTGLARVDFFLRRDTHELLINELNTMPGLTDVSGFPKMWAASGIPFPQVIDRLIQLALEHHQEKSRNETSI
>AIA13707.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYYIYNQVGGEVRQYLDLLQDIKVNGAEKADRTGTGTRSVFGRQIRFDLNEGFPAVTTKKLFLRGIIHELLWFLQGNSNIEYLVKNNVNIWNEWPFKAYLKATNQSIPEQNSDEWKEKLAAFIENIKNNADFAKKYGELGPVYGYQWRHWPDGKGGEIDQIQEAIDTIKNNPDSRRIIVSAWNVADIKEMAKAGLPPCHSLFQFYVNDDKLSCQLYQRSADTLLGVPFNIASYALLTMMVAQVTGLKLGEFVHTFGDAHIYLNHLEQIDIQLSRTPKALPTMVINPNVTSIFDFTIEDFTLEGYDPYPAIKAPIAV
>AIA13668.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MKEMNALPKKIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFELPKDIDLAFLAIHGTFGEDGQLQQILENRGVPYTGDGVEQSRTAFDKIESKKRFEAAGITTPRWQVIDANEKPTLPVPLVIKAPRQGSTVGVYIIKEAGKLETVLAEARKFDRQLLVEEFVPGRELTIGILGDQALPILEILRSFPKAAFTISPTSIHFSTRKPAAARNMFVRRKLKRN
>AIA13666.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
SGEHDVSLMSARSVLNALDAERYEVIQIGITLDGDWLTGANTLDAFEKGNIKDLDRVVPPLQPSHQSLYVLRSTKTGDKLETLADVDVFFPVLHGPFGEDGTIQGLLELADVAYVGAGVVGSAVGMDKGIFKDVMRANDIPIVNSLLVLRSEIEKNIDTVIEKTEKMGAYPFFAKPANLGSSVGISKCNSRSDLAEGLMEASRYDRRVIIERGAGDVREIEVSVLGNEEPQTSVCGEVLPSREFYSYESKYIDGTSGLEIPAQIPADVSDKVREYAVRAYKAIDCAGMARADFFVENNTNKIFLNELNTLPGFTSISMYPKLWQASGLTYPQLVDRLIELALERKAQRDHTEHRRTA
>AIA13600.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MRHELVSDTNNRKSEIGNRKLRIAVLYGGKSGEHEVSLMSSASVMEELDDGKYEVTPVFINRDGCWDLPLETLRQFDVVFPVLHGPMGEDGTVQGLLVLLGVPFVGADVVGSAVGMDKAIFKDVMRAHGLPVARCVVVLRHEWSRGQQAIIAQVEQELGWPVFVKPANMGSSVGINKCKTPEQLPDAMNEALKWDRKVLIEAAVPNARELEVSVLGNDEMQASVVGEVRPRREFYDYAAKYLVKGEEESELIIPADISDSLSQRVREMAVQVARLADVRGMTRVDFLMNGVSGDIYINEINTIPGFTSISMYPKLWAASGLPYPDLLDRLIELALEK
>AIA13596.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKTREELPKKIAVLMGGPGSERAVSLATGRGVAKALRSLGAEVVEVDVRSDEFQLPNDVDFAFNTIHGTFGEDGQLQKILERRGIAYTGDGVSASEIAFDKIRTKQKFQEHGVTTPPWEVINPGQQPTIPLPIVVKTPRQGSTVGVVIVKNENELESAIGEASKYDRELLIEKFVSGRELTIGILGDQALPILEIIPKGGFYDFNNKYPFLNPQAGGGAEHVCPANINAGKTKEIQELALRAFRSAGLQVYARVDAILSENGQPHILEINSIPGMTEASLLPEAAAAAGIGYADLCARIIALSRLRQGYGGQARARTEGKR
>AIA13585.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MSALPKRIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEVDVHDENFELPQNIDVAFLTIHGTFGEDGQIQQILEDRGVPYTGDGVNESRTAFDKIESKKKFEAAGVTTPRWQIIGSNERPTLPLPFVVKAPRQGSSVGVYIIKNADLLENGLAEARKFDRRLLVEEFVPGRELTVGILGDQALPIIEMIPKSGFYDFTNKYPFLNPQAGGGAEHVCPARIEEALTRQIQDLALRAYRSIGLRVYSRVDVLLPENAAPTVLEVNTIPGMTEASLLPEAAAAAGISYEDLCLRIIELSRARRGSGK
>AIA13548.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKIAVMFGGTSEERDVSIASGSQVVRALRKKGHDVVPIDTAIGVLDAAAEQKLLGSDVQSAPPGAEQLDVLRTGDSTKIMRAPEMAGVDVIFLALHGGAGEGGTLQALLELTGVPFTGSGMLGSAMAMDKDVSKRLFEIAGVPTPAWLMAPVEVQDVDTQIGWPAVVKPSKQGSTVGLSIVKKPEDLAAAIELAYRFDDEVMIERFIPGRELTVPVLGDDVLPVGEIFPKNEIFDYESKYQAGGAEEVFPADLTGPETVQVTMLAIKAHRALKLRGFSRIDFRLDEHGGFWCLEANTLPGLTAASLSPKGAQAAGIPFPDLCEKLCQLAIEEHANRRRV
>AIA13450.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAVKKHPEYQYLNLLQEVLDTGIKKVDRGTDITLYSLFGRQVRYDLSQGFPLLTTKKVYWKGVLHELYWFMSGQTNIKYLVDNNVHIWDDYPYKIYTKKHESRGTNQELTKDQFVEKIKIDEKFAKKYGNLPRIYGEMWRHWPTRSAGSGQGRTIDQLKWVMQEMKDDPDAKNLIVNSWNPEYLYTMATNKDASRFPICHNMYQISNRNGKLSLQLYQRSADLFLGVPFNIASYSLLAIILANIAGLEPGEFIHTFGDVHIYGNHIEQVKEQLRRKPRPFPTISIARKLKDIDDFKTDDVILENYDPHPMMKAELTVAGGLFDKKTGKMAG
>AIA13437.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLSTGVVKDDRTGTGTISTFGYQMRFDLAAGFPLLTTKKLHTKSIVAELLWFLRGSTNVAWLREQGVTIWDEWADDNGELGPIYGYQWRSWPTPAGEHVDQIKTVIDAIKTNPNSRRHVVSAWNVADLGTMALPPCHTMFQFYVAEGRLSCQLYQRSADIFLGVPFNIASYALLTALVAQVCDLEVGDFVHTLGDAHLYQNHVDQAKRQLEREPRSLPKLVLNPDVRDIDGFTLADIGIESYDPHPGIKAPIAV
>AIA13427.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLTHGVEKSDRTGTGTLSTFGYQMRFDLGEGFPLLTTKKLHTRSIIGELLWFIQGSTNVKWLHEQGITIWDEWADPDGELGPIYGYQWRSWPTAAGGHIDQLAGVINTIKTVPDSRRHIVSAWNVGDLADMALPPCHAMFQFYVAQGRLSCQLYQRSADIFLGVPFNIASYALLTEMVAQVCGLEVGDFVHTLGDAHLYLNHLDQARLQLSREPRPLPRLVLNPSISAIDDFTFDDIAIEGYDPYPGIRAPIAV
>AIA13418.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
HEVSLVTAREVATALRESGYEVIELELDEHLPEKLLQTQPATVFPAVHGAPGEDGSLQGMLEIMGISYVGSDVLASALAMHKATAKQLFQMAGLPITGSHLMREGDDLEATVAAIKEKLGEPPYMVKPNTEGSALGATRVFDAGELRPAIERAVSPGKEVLIEEFIEGREMTVGILEEDDGYRTFPLIEILSKKDWYDYEARYTPGMSEHICPAEVPPEVAAELARISLEAHKVLGCRDLSRADLILTSSNDAYLLEVNTLPGMTPTSLFPDAAKVAGISFNSLMDHLIKRALRRRQS
>AIA13336.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKRVGIIFGGRSAEHEVSLQLAMSIIANIDNEKYEVVPIGITKTGQWALVPGPQNLIDTEQPKPLEVNDDNDKPGVLVRGQAATLTEAVDPLKVLSSVDVVFPVLHGPYGEDGTIQGMLKVANIPFVGPSVLGSAVAMDKDVMKRLFKASGVPTPKLLVFHKADEDSIQFSKISAELGTLVFVKPANLGSSVGVSKVTNEEQLKRAVDEAFKYDTKILIEEGIDGREIECSVLGNENPIASVPGEIVVHADFYSYDAKYLNETSSSLIIPAELSPELTKKVQDLSIAAFEALCCEGMARVDFFLRGKELLVNEVNTIPGFTKISMYPKLWEASGMPYSELIDRLIELAIARFEQDIFKV
>AIA13333.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVSAWNVGELDKMKLPPCHAFFQFYVANGKLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLEAGEFVHTLGDAHIYSNHFEQVALQLSRDTRSLPEMKLNPSVKNIFDFKFEDFSLLNYDPHPVIKAPIAI
>AIA13327.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSSSQSRLRIAVLFGGRSSEHDVSIMSATNVMRALDPERYDALPVYVSKDGRWLQSRFADGELDKPSSGTELCLVPGGRGRLLAVTPDGKAAEAGRIDIVFPVLHGLHGEDGAVQGLCQVARVPLAGCGILGSATALDKDIAKQLLKAAGLPVARSVTLDQEAPPALEALEGALGLPLFIKPARQGSSVGVRKVSGSQEFAPALAEAFSHDRKLIAEEFIAGREIECSVLEDTKGGLFVSRPGEIAPAESHGFYSYTAKYLDENGAALKVPAELPADVEARIRDMAARAFRALGCDGMARVDFFVMEDMRFVVNEVNTIPGFTDISMYSKAMAASGVAYAEVIDRLVEHGLARGA
>AIA13325.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKEMNALPKKIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFELPRDIDLAFLAIHGTFGEDGQLQQILENRGVPYTGDGVKESWTAFDKIESKKKFEAAGVTTPRWQVIGANEKPTLPVPLVIKAPRQGSTVGVYIIKEAGKLETALAEARKFDRQLLVEEFVPGRELTIGILGDQALPILEIIPKGGFYDFTNKYPFLNPQAGGGAEHVCPAKIEAKLTRKIQDLALRAYRSLGLQVYSRVDVLLPENAEPSVLEVNTIPGMTEASLLPEAAAAAGIKYDELCLRIIELSCARREGAK
>AIA13279.1|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MTHKQRIGVVFGGRNSEHEVSLKSARSVMAALDQAKYEIVPIGIDKLGRWVMGGDPLFALEQAADPHLLSRDPEPGVINSSTALVMSEGRLPGAQPSELDVIIPVLHGMYGEDGALQGLLELADVAYVGCGVLGAAVGMDKGIAKAAFAAASIPQVPYVLVRRTDWEQDRAAVIAEIEQTLTYPVFTKPANAGSSVGVAKCANQAELHAGLDLAAQHDRRLLIEQGVRPREIEVAVLGNDAPEASVPGEVIPANEWYDYADKYLEGKTGYVIPADLSPEQTAAVQALALAAFKAIDGAGLARVDFLLDRETGALYLNEVNTFPGFTAGSMYPKLWAASGLPYPALLDRLIALAVERHQDRRVRA
>AIA13199.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSQVIGQIKSDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLFVAEGHLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLKPGEFVHTLGDAHLYSNHLEQARLQLTREPRALPQMKINPSVNSIFEFDYSDFELSGYEPHPHIKAEVAV
>AIA13188.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKKLRVGVIFGGRSGEHEVSVRSARAVIDALDARRYEVVPIAITKEGKWLSPARATRLLPEETKKRVADKVASEERQPSALIGDPSSNGLVARESSGEDDALAPLQPLDVVFPVLHGTFGEDGTIQGWLEMVGMPYVGCGVLASSCGMDKVAMKALFKEAGLPICRYTWLLRKDWDEDRGAILRRVVREIGFPSFVKPANLGSSVGISKASDKSSLERAIDLAARYDRKVIIEEGLDAREIECAVIGNEKPEASLPGEYVVKDPAAAFLDYTEKYSGTGHVEFVVPAPLPKSLTERIRRLAVRAYQSLDCAGLARVDFFLRRDTRELLVNELNTIPGLTDVSGFPKMWEASGLPFPRVLDRLIELALDRHKEKARNETSI
>AIA13172.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PSSRSDQLANVIEQIKTNPNSRRHIVVAFNPGDIDKMALPPCHAFFQFYVANGNLSCQLYQRSADVFLGVPFNIASYALLTHMVAQVCGLGVGDFVHTLGDAHLYSNHIDQAKLQLGRNEFPLPKLKLNPNIKNISDFKFEDIEIVGYESHPAIKAEIAV
>AIA13108.1|FEATURES|farme|aminoglycoside|Krm|antibiotic target alteration|1
MPNEEMVSELVTSITNSKKYRSVYPKTIERIVQQAVAKQPNEKQAQHYARNVLHQVWGAYWGTRPNFKKVWQKFEENIQDGMSVQEAVLKILVLQSSTRERAPIVTEFYNQIFAITGQPETILDHACGLNPLSFFWMDLPNTTQYQAYDIDIEQIELLNKIAQTTGISNQLTATVADIVTDSYGYADVVFLLKTLPCLEQQEKGISLDILRKQQCKYIVVSYPIKSIGGKEKGMAAFYTQQFQELTKHEKWQTEKLNFETELVFVVQK
>AIA13077.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRVGVIFGGRSGEHEVSLRSAESVINAMDKSRYQIVPIGITQEGKWLVSGDAKTMLPHTVMASNNHQQVAIIGDPTRQGLTRLDAGTSEPLDVVIPVLHGTYGEDGTIQGLLEMAGVPYVGCGVLASATGMDKVVMKQLFTQAGLTVIDYEWFLRSSWEENPQAIIKQISRKLGFPVFVKPANLGSSVGISKAKDKAELRASINDAARYDRRIIVERAVVGREIEVSILGNDHPMASLPGEIITGHEFYDYEDKYVDTTSRTEVPARLPKKILERIQRDAVKAFQAIDGSGLARVDFFVERETNRVIINEINTMPGFTSISMYAKM
>AIA13025.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLQDILDNGTDKNDRTGTGTRSVFGRQVRYNLAEGFPAVTTKKLYFNSVVHELLWFLQGTGNIEYLAQNNVHIWDEWPFKAYLQKNNLPIPEVNSDEWKTQQKDFITKVATDHTFAEQWGDLGPVYGVQLRKWPDGKGGYIDQIANAINMIKTTPDSRRIIVSAWNVAETDEIVAMGGLPPCHSLFQFYVANGKLSLHLYQRSADTFLGVPFNIASYSLLLAMVAQVTGLKQGEFVHTLADTHIYSNHFDQVKEQLSRTPKALPTLWLNPDVKNLDDFTFDDIRLDNYDPDPPIKAPIAV
>AIA13016.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTHPELQYLNLLNEVLSKGYRKVDRGTGDASYSLFGRQLHFDLAQGFPLLTTKKVYWKGVIHELYWFISGKSNIKYLVDNNVHIWDDYPYKIYNLKRAKDKELREFTKQEFIEKIKTDHKFAKQWGDLPRIYGELWRRWPTSVPLSGTTTGKPIKKRTIDQLKWAIKEITEDPNAHNAIVNSWNPEYLYTMARYEDTSHFPICHNMYQLNVIDGKLCLQLYQRSADLFLGVPFNIASYALLTLIIAKITGYQPGTFVHTFGDVHIYEIHKEQVREQLKRKPKALPQIKFIKDFKTIDEFKPEYLELINYDPHPPIKASLSVSGGFFKKK
>AIA12992.1|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
MAKLKVGILFGGKSGEHEVSIVSALSIYQALDKSKYDPTLIGIDKTGRWLLPDQSRILAERQNARLIKLNKEHQTVSLLPFDTDKNLVPVVEDAVPTAQRGLHFDVILPILHGTYGEDGTVQGLLELANLPYIGSGVLGSAVSMDKETAKRLLRDAGIPVVPFMTVHRNDFKKQAANILAEAKRRFGLPYFVKPANMGSSVGVNKVKTEAEALAKFEDALLYDTKVLVEQAIDARELEVSVLGNHDPQASIVGEIIPNHEFYTYEAKYLDENGADLAIPARDLSAATTKRVQEVAIAGFRALECAGLARVDFFLDRKTSEIYLNEVNTIPGFTQISMYPKLWAASGLPYPQLLDRLIELALERHREKNSLKTTYEPK
>AIA12969.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SEKGDRTGTGTLSVFGHQMRFDLSKGFPLITTKKLHVRSIVHELLWFLKGDTNIKYLTENKVSIWDEWADEQGNLGPVYGKQWRSWETTDGQTIDQIAQVVEQIKTNPNSRRLMVIAYNPGEVHKMALPPCHAFFQFYVANGKLSLQMYQRSADVFLGVPFNIASYALLCMMVAQVCDLAPGEFIHTLGDAHLYSNHLEQARLQLTRESKPLPMMSINPAVKNLFDFKFEDFQLIGYDPHPAIKAEVAV
>AIA12953.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYLSLLKWVLEKGAPKSDRTGTGTVSVFGHQMRFDLNAGFPLVTTKKCHLKSIIHELLWFIKGDTNIGYLKENGVKIWDEWADENGNLGPVYGKQWRSWPTHKGETVDQLAKVIEDIRTNPDSRRLIVSAWNVADIPDMALAPCHCLFQFYVVNGRLSCQLYQRSADVFLGVPFNIASYALLTMMIAQVTGLQLGEFVHTFGDVHLYSNHIEQAKTQLERTPFALPKMLLNPDIKHINDFRFEDFVLTDYESHPAIKAPIAV
>AIA12947.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMRHIMENGVQKTDRTGTGTLSVFGYQMRFDLSKGFPLVTTKKCHLRSIIHELLWFLRGETNVRSLQAENVKIWNEWADENGNLGPVYGAQWRSWPTPDGRYIDQIAQLIHQIKTNPDSRRLLVNAWNVGMLDKMALPPCHCLFQFYVANGKLSCQLYQRSADVFLGVPFNIASYAILTSMIAQVTGLEVGDFVHTLGDAHLYLNHMEQVAEQLSREPYGLPKLRLNAEIKQLEDFKFEDIEVLNYESHPTIKAPIAV
>AIA12854.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FQFKVEEGRVLHCQLYQRSADAFLGVPFNISSYALLTEAVAHVCGLRAGEFIYTLGDYHIYQNHLKQVEELLSREPLALPRLEIRDEEGGPQKQQLLRGLEGLLSLRYEHLNLVGYKSHGKIDAPVAV
>AIA12853.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DRTGTGTKSCFGYQMRFNLQEGFPLVTTKKLHVKSIIYELLWFIKGETNIKYLTDNGVTIWNEWADENGELGPVYGKQWRSWEGAEGKVHDQLSDVIRQIRTNPDSRRIIISAWNVADLPKMALMPCHTMFQFYVAEGKLSCQLYQRSADVFLGVPFNIASYALFTMMIAQVCDLQPGEFIHTFGDVHLYNNHFEQAKLQLTRKPFPLPTMRINPAVKNIFDFEYDDFTLENYQFHPPIKAPVAV
>AIA12782.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MMNSFLVDKKIAVLCGGPSSEREVSLRSGSAVTKALRSLGAEAFEIDVRDENIHLPAGTELAFNALHGAFGEDGTVQAILEKKGVPYTGEGEEGSRLAFDKIASKERFVECGVPTAPYITLRKGEVPALPLPYVVKVPCQGSSVGVYLVKAMSERCAALEEAFKLAETVLVEALVSGRELTIGILGDTPLPIIEIRPQGGFYSYENKYTWTNRGGAAEHECPARLSRAEKKIVEAAALAAHRSLELEIYSRVDIILDAHRGPQVLEVNTIPGMTETSLLPEAAAAAGISMSQLCESIVRLSLERRLANNR
>AIA12777.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSDTITNFGKVGVLFGGRSAERDVSIMSGTGVLQALKSRGIDAHGFDPAERSLAELAAENFDCVFIALHGRYGEDGSLQGALEQLGIPYTGSGVMASSVGMDKITTKIIWLSKNIPTPRYATVAPGDDLDAIVLDLGLPLIVKPPLEGSTIGITKVEAAEQFEAAVALALGFDETVLAEEFVTGREFTVAVLGTGKHARALPIVEIVAPQGNYDYQNKYFTDDTKYLCPAPLDAALSAEIQKHAVDAYRALGCEGWGRVDVLVRESDMRPFLLEVNTSPGMTSHSLVPMAARAEGISYEELCVEILRSARCKMVKAQG
>AIA12748.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAQGENEFIFRIKYFLMSKKKKVAILYGGRSVEHAVSVNSARNIYEYLDKNQFEPIPMGINKSGQWFLTNGVSKDMEQGKALGLMLDPVSPGFVLLSSGDRFKVDIVFPVLHGTDGEDGSIQGLIKAMDMPMVGTGVLGSALSMNKIVAKRLMRQAGLPVTDFLTFRYAEKDKITFTSISKKLGTPFMVKSASLGSSVGVTKVKNKEDFKKAVEEAFKYDDEMLAEEFVTGREIECAILGNTPGEASYPGEIVISKNYEFYTFDAKYVDPKAVEIHVPAKLSKAVAEKIRAVSIRAYEALHCQDFSRIDLFLDKKGKVYINEINTIPGFTNSSMYPMMWKERGISFSDLITRLLNLAQERYNRGKRIERDFQSALKF
>AIA12576.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNNPTDQQYHNLLRHIMENGTGKDDRTGTGTRSIFGYQMRFNLAEGFPLITTKKVHLKSIIYELLWFLKGDTNIKWLNDHGVTIWAEWADENGDLGPIYGKQWTAWEANDGSKINQIAVAEEKIKTNPKDRRIIVSGWNVGDLQSLIKAEKAAPPPCHTMFQFYVADNKLSCQLYQRSADVFLGVPFNIASYALLTMMMAQVTGRELGDFVHTFGDAHIYNNHVDQVELQLSRDSRPMPTMKINPDVKSIFDFQFEDFTLENYDPHPGIKAPIAI
>AIA12550.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLARIREHGIRKDDRTNTGTLSIFGYQMRFDLADGFPLVTTKKLHVKSIVHELLWFLQGSTNVRYLNEHGVSIWDEWADDKGELGPIYGRQWRSWPAPDGRHIDQIANVVEGLKRDPNSRRHIVSAWNVGELDRMALSPCHCLFQFYVGEGRLSCQLYQRSADVFLGVPFNIASYALLTLMMAQVTGLETGEFVHTFGDAHLYLTHLDQADEQLKRTPRALPRMEINPEVRSLFDFAYEDFKLVGYDPHPVIGAKVAV
>AIA12519.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHELMERVLKEGVKKEDRTGTGTLSIFGHQMRFNLNEGFPLITTKKCHMKSIIHELLWFLQGDSNIKYLKDNGVSIWNEWADENGNLGPVYGVQWRSWKTHDGRTVDQIKNLIEMIKKNPDSRRLIVSAWNVSDVDKMALPPCHTMFQFYVANNKLSCQLYQRSADIFLGVPFNIASYALLTHMVAQVCGLGVGDFVHTFGDAHLYVNHLEQTQEQLKRSFFALPTLKINPEVKDIFGFKYEDFELLNYQAHPHIKAPVAV
>AIA12516.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HVLTRGAEKSDRTGTGTLSTFGYQMRFDLREGFPLLTTKKLHTKSIIHELLWFLQGDTNIKYLQDNGVKIWDEWADAEGNLGPVYGYQWRNWPTPNGGSIDQITKLVEMIKRNPDSRRLIVTAWNPADVDRMALPPCHCLFQFYVAEGKLSCQLYQRSADTFLGVPFNIASYALLTLMVAQVCGLKPGEFIHTFGDVHLYADHLEQARLQLTRAPSPLPKMELDPTVTDLFAFRFEHFALKDYDPHPHIKAAVSV
>AIA12512.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLRHILDNGTRKSDRTGTGTLSTFGYQMRFDLAEGFPALTTKKLHLRSIIHELLWFLQGDTNIKYLKDNGVGIWDEWADADGNLGPVYGHQWRSWPAADGRTIDQISDLITQIKKNPDSRRLIVSAWNPADIPNMALPPCHCLFQFYVADGRLSCQLYQRSADTFLGVPFNIASYALLTLMVAQVCDLQPGEFVHTFGDVHLYLDHLEQAKLQLTRDLRPLPTMAIDPSVKNIFGFRFEHFTLKDYDPHPHIKAAVSV
>AIA12467.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MARFDEIYQQMLQRIMTEGYREVNQRTNHETAALPGLSFSLDIQKEGFPLLGLRKIPTKIFIAEQIWFISGARKPDDFLRDFTKIWDDFTNPGDVVTVAYGYRWRKYFGRDQLGLLVNLLTKDPSSRHGVVVTWDPAGAGLGGVARGNVPCPFSFTVNIIGGRLNLMNVVRSNDMILGFPHDVAGFALLQCILAQKLGVEPGTYTHTIANAHVYDIHYEAAETMIKRPATHTKVTLKLPKEAYERAQQKDATLVEEINNALTTQYEPGEAIKGLRIVL
>AIA12460.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNDIKTNPNSRRLIVTGWDPRYADQVDLPPCHTLFHFKVQNERVLHCQLYQRSADAFLGVPFNISSYALLTHLVAHVSGLEVGEFVYTLGDYHIYKNHLTQVEELLSRQPLSLPTLQINDGDAPLRGLEGLLSARYENLALVGYESHGKIAAPVAV
>AIA12461.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MQQYHDLLRSILSNGTEHQDRTGVGTISHFGYQTRFDLRAGFPIVTTKRIPFRWVAEELFWFLSGDTNEANLRARGVDIWAEWADEDHTRRFGRESGDLGPVYGYLWRSFGGHYPSRDGRSQDS
>AIA12360.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DQLKSFPMKQYLDLMRHVLENGTDRTDRTGVGRRCIFGHQMRFDLREGFPLLTTKKVFTKGIFHELLWFIRGETNIRYLVQNDVHIWDEWPFQNYLKANKLEEKSPMYSPEWEEQKKMFVGKIKEDEVFANQWGNLGPVYGYQWRHWQGADGSQHDQLKNVLEQLKKNPYSTRHIVCAWNVADVSKMALPPCHCLFQFYVANGELSCQLYQRSADIFLGVPFNIASYALLTHMMAHVLGLKVGDFVHTTGDTHLYLNHLEQAKEQLSREPRPLPQIKLNSNVKDLFDFAYEDIEILNYDPHPAIKAPIAV
>AIA12359.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTVDTQYERLLRKVLETGTPKGDRTGTGTVSLFGERLRYDLSAGFPLITTKRVHFKSVAVELLWFLRGDSNTAYLKEHGVRIWDEWADENGELGPVYGYQWWNWPTPDGGHIDQVAKLLETLRGNPDSRRMIVSAWNVADLPGMALEPCHAMFQFYVADGRLSCQLYQRSADMFLGVPFNIASYSLLTRMIADQVGLLPGEFIWVGGDCHIYSNHVEQVREQLTREAYPFPRLSLSPRPTLFDYAWDDFELVDYHHHPTLKAPIAV
>AIA12329.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VGTISHFGYQTRFDLRQGFPIVTTKKIPFRWVAEELFWFLSGDTNEANLRARGVDIWDEWADEEHTSRFQRSAGDLGPVYGYLWRSFGGDYPKRNGVDQIANLINEIQTRPNSRRLIVTGWDPRQADNVDLPPCHTLFQFKVENESVLHCQLYQRSADAFLGVPFNISSYALLMHLVAHVCKLEVGEFVYTLGDYHIYQNHLAQVEELLQREPYPLPQLEIAGEGERKQGLDGLLAMRYEDIKLVGYQS
>AIA12309.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTDTRHPEYQYLDLLQDILDNGVEKKDHNTGNSLTSVFGRQIRFELSQGFPLLTTKKVYWNGVLHELVWFMTGQSNIKYLLDNNVHIWDDYPYKDYQKLVADGKAEDLSKDDFISRIKEDDTFAKQYGELPHIYGQQWRNWPRTNGGGIDQLAWALNNIKEFPQRKHSVVSVWNPEHLYSMALPGEALSFPLCHIFFHFNVADGKLSCQLYQRSADMFLGVPFNIGSYSMLTLVMAHLAGLQPGEFVHTFGDAHIYGNHVEQVKEQLKREPRPFPTLAISDELQDLDSAKAEHFSLENYDPHDTIKAELTVAGGFQEKDRRDFAKPSKS
>AIA12249.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTKMRIGLLFGGRSGEHEVSISSARAIARALAAEENASKYEVLPFYIQKNGRWLSGTLPQQVLATGKPLEIEEQPGQDDSPASGQFPNFNAVDVWFPVLHGPNGEDGTVQGLLKLMQLPFVGSGVLGSALGMDKIAMKMAFAHAGLPQVKYIAVNRSEIWSNPCVFPKLCDKIEAALGYPCFVKPANLGSSVGISKARSRAELEAALDSAASYDRRIIVEAGVVAREIECAVLGNDNPKASTVGEITFQSDFYDYETKYTEGQAEWSIPAKVSGAIASQIQEMAVQAFLAVDAAGLARVDFFYIESTGEVLINEINTFPGFTATSMYPQMWAADGISFPELVDRLIQLALERHGEKG
>AIA12228.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VVWRLPCRLAARCHNIPLNSIDQETPMKQYLDLMRHVLEHGTPKDDRTGTGTLSVFGYQMRFDLQEGFPLLTTKKLHTRSIITELLWFLRGDTNVRYLQEHGVRIWNEWADENGELGPVYGAQWRSWQAADGRRIDQISQVIEQIKTNPDSRRLIVSAWNVGELDRMALMPCHLLFQFYVANGKLSCQMYQRSADIFLGVPFNIASYALLTMIIAQVCDLEPGEFVHTLGDAHLYANHLEQARLQLTREPRPLPRMRINPAIKSIFEFDYSDFELAGYDPHPHIKAEVAV
>AIA12188.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLATIRERGTSKDDRTHTGTLSIFGHQMRFDLAEGFPLVTTKKLHVKSIVHELLWFLQGSTNVRYLREHGVRIWDEWADPKGDLGPVYGRQWRSWPAPDGRHIDQITQVVEGLKRDPNSRRHIVSAWNAGELDRMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIASYALLTLMMAQVTGYEPGEFIHTFGDAHLYLNHLDQADEQLMREPRKLPRMEINPEIRSLFDFAYEDFKLVGYDPHPAIKAPVAV
>AIA12175.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MQALREKGHEVVPVDTARGVLSASDEKALLGKGVSQVPPDMAALDMLRTGDPTAITRAPELKGVEVMFLALHGGAGEDGTLQGLLDLVGLPYTGSGRLASAIAMDKDISKRLMLDAAVPTPEWLMAPAPFDEVEKKLGLPVIVKPSKQGSTVGLTLVKTREQYEPAVREAFLHDDEVMIEGYVPGREFTVPILGDEALPVGEIIIASEIFDYESKYQPGMAQEVFPADITPAQAAEMQELALNTHRALKLSGYSRVDFRMSEDGTFYCLEVNTLPGMTANSLFPKSARAAGISLAELCERICHLALEEHGSSQRV
>AIA12167.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTRVGVIFGGRSGEHEISVRSAKSVIELIDKDKYDVIPIAIGKSGNWLSPAESVGLLPSTSGAALGNSVESYPQDAMVVAGDTSYKGLTRLGGGGDEERIGLDVIFPVLHGTYGEDGTVQGLLEMAGIPYVGGGVLASACGMDKVVMKTLFRDADLPICKYVWFLRSEWERAGDAVIKQVEIKLGYPCFVKPANLGSSVGVSRADNAASLRAAIELAAEYDRKIIVEEALDMREIECAVMGNDEPEASLPGEYIIRDDSKKFLDYTEKYAGTGNNEFVVPAPISGELSDKIRKMAVTAFKAVDGSGLARVDFFLRNDNGMLLVNEINTMPGLTDASGFPKMWAGTGKSFAEVIDNLIDLAVERHKDRSRNKTSY
>AIA12099.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRGVEKGDRTGTGTLSTFGYQMRFDLREGFPLLTTKKLHTRSIIGELLWFIQGSTNVKWLHEQGVTIWDEWADADGELGPIYGYQWRSWPTPTGGHIDQLASVISSIKAVPDSRRHMVSAWNVADLGDMALPPCHAMFQFYVAQGRLSCQLYQRSADIFLGVPFNIASYALLTHMVAQVCELEVGDFVHTLGDAHLYLNHLDQARMQLGREPRPLPKLVLNPSVRSNRRLQL
>AIA12001.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEPYHQLMREILAHGARKEDRTGTGTLSLFGYQMRFDLQKGFPLVSTKKLHLRSIIHELLWFLKGDTNIQYLKENKVGIWDEWADENGNLGPVYGKQWRSWEAADGRTIDQISNVIEQIKKNPDSRRLLVIAFNPGDVDKMALPPCHAFFQFYVANGKLSCQLYQRSADVFLGVPFNIASYALLTHMVAQVCNLEVGVTLGDAHLYLNHLEQTKLQLTREHKAMPQLKLNPNIKNIFDFKFEDIEIVGYEAHPAIKAEVAV
>AIA11984.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDALRQILADGVRHEDRTGVGTTSVFGEVQMSFDLEKNFPIMTTKKVPLRWIFEELMWFLGGRTDNQWLNERKISIWDEWSTVEQTARFGRKEGDLGPVYGYLWRSFGGDYPKRNGVDQIANLINEIQTRPNSRRLIVTGWDPRQADNVDLPPCHTLFQFKVENESVLHLSALSAIR
>AIA11964.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MREYHELLRLVLEKGRRKNDRTGVGTISYFGAQTRFDLSKGFPLLTTKRVHLKSVLFELLWFIRGGTNIRFLTNHGVTIWNEWADANGDLGRIYGAQWCDWRTADGRSINQLKDVLSAIRKNPDSRRLLVTAWNPGEIDQMKLPPCHAM
>AIA11926.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTRGVREVNKRTGHETAALPGLSFSIDLEKDGFPLLALRKIPTKLFIAEQIWFVSGARKPEIFLREFTHIWDDFTNPGDVVTVAYGYRWRRHFGRDQLGKLVELLAKDPSSRHGVIVTWDPSSDGLGGVSKSNVPCPYTFTINIIGGRLNMMNVVRSNDMILGFPHDVGGFALLQLMLAQKLGVKPGVYTHTIANAHIYDTHYAAAEELMARPTDSQKIALKLPKDSYDRAEAKDASLVTEINDVLSAQYNPAEAIKGLKIVL
>AIA11869.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQEYLKLLRYVRDHGTEKHDRTGTGTRSVFGYQMRFDLNQGFPLLTTKKVHFRSVAHELIWFIAGDTNIEYLHKNGVTIWDEWADERGNLGPVYGSQWRSWATPDHQTIDQFANVIQEIKRNPDSRRLIVNAWNVADIEKMALPPCHTMFQFYVANGRLSCQLYQRSADIFLGVPFNIASYALLTMMVAHVCDLGVGDFVHTLGDAHLYLNHFEQADIQLAREPRPLPHVELNPNVKDIFAFTYEDIVLHDYHPYPGIKAVVAV
>AIA11858.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLRSILANGNEHRDRTGVGTISHFGYQTRFDLRQGFPIVTTKKIPFRWVAEELFWFLSGDTNEANLRARGVDIWAEWADEEHTSRFQRSAGDLGPVLWLSVAVFWRRLSEAQRRGSNCEPHQRKIQTRPNSRRLIVTGW
>AIA11803.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLELLQDIKDNGKLRPTRQGQEVVGVFGRQMRFNLQEGFPLLTTKKVFLRGIIHELLWFLQGDSNIEYLVRNNVHIWDEWPFRAYLQATAQAIPEVGSTEWQAKLAQFTNQIATDHKFARKYGELGPVYGHQWRHWPAGDGGEIDQITEVIEEMKHNPASRRLIVSAWNVADIQEMAKAGLPPCHTLFQFYVNDGQLDCQLYQRSADYFLGVPFNIASYALLTMMIAQVTGLKPGDFVHTLGDAHLFTNHFEQADLQLSRQPRTLPKMALNPKVTSIFDFAIDDFTLEGYDPHPGIKAPIAV
>AIA11765.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HELVWFMTGQSNIKYLVDNNVHIWDDYPYKDYQKLVEAGKAPELSKEDFIERIGSDDKFAKKYGELPHIYGQQWRSWPRTNGESIDQLAWILNNIKNFPERKHSVLTVWNPEHLYSMALPGEALSFPLCHILIHFNVADGKLSCQLYQRSADMFLGVPFNIGSYAALTQIMAHLAGLKVGEFVHTFGDAHVYSNHIDQVKEQLGRKPRAFPTLTIDPKLKELDAVKAEHISLEGYDPHPMIKGELTVAGGFQEKDRREFAKQKA
>AIA11690.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PSSRSKIWDAFTNPGDVVTVAYGYRWRKHFGRDQLQLLIDLLRNEPGSRHGVIVTWDPSQDGLSLAKKKNVPCPYTFTVNIIGGRLHLHNIVRSNDVILGVPFDVLGFALLQCLLAQELGVRPGIYSHSISNAHIYDSHFEAAKELMSRKNNHKKITLELPENAFKEIEKRNRNVVDAIIENLTKQYEPSQAIAGIKIVPY
>AIA11651.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KSNPDSRRLIVSAWNVGELDRMALMPCHVLFQFYVAGGKLSCQLYQRSADVFLGVPFNIASYSLLTMMVAQVCDLEPGEFIHTLGDAHLYSNHLEQARLQLTREPYKLPRMNIDPKVTSVFEFGYEDFELVGYEAHPHIKAEVAV
>AIA11612.1|FEATURES|farme|aminoglycoside|Krm|antibiotic target alteration|1
MATSTELTEITGRIIKSKKYSHLSQQTIHRIVEWAAVRFNKLKEIEDNSRKKLHQVYGAYMQVYTPKVFSEFTGAGDLNNDDLKTVCKNILLRHNSTKERMGFIDDFYAAIHSAIPSAQKIIDIGCGFNPFSYPWLATHLGQIEYAGFDIDVLLTEMMNNAWKQVGLPVSVQYNDVFFGLPGHTENDVLFFLKFFPCLEQQEKGISAKIFNAVKSNAFVVSFPSVSLTGKNKGMRENYDGFLNQLTAGMNLHSEYFDFPTERVYILKRAK
>AIA11606.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLTTGVAKGDRTGTGTLSTFGYQMRFDLSQGFPLLTTKKLHTRSIIAELLWFLRGETNVSWLRDQGVSIWDEWADDDGELGPIYGYQWRSWPTPDDGHVDQIADVIRAIKSNPDSRRLIVNAWNVGDLDQMALPPCHAMFQFYVADGRLSCQLYQRSADIFLGVPFNIASYALLTQMVAQVCSLDVGDFVHTLGDAHLYTNHIEQARLQLTREPRPLPKLILNPTITDIDRFGMDDITIEAYDPHPGIKAPIAV
>AIA11408.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRPQQTIQPKEPTVQQYHDLMKRILDTGTAKSDRTGTGTISVFGHQMRFDLQNGFPVITTKKLHLKSIIHELLWFLSGDTNIQYLKDNQVRIWDEWADADGNLGPVYGAQWRSWRTPDGHVVDQISNVIQQIKTNPDSRRLLVVAFNPGEIDKMALPPCHAFFQFYVADGRLSCQLYQRSADVFLGVPFNIASYALLTMMVAQVCKLAPGEFVHTLGDAHLYNNHIDQARLQLSREPKPLPQMIINNKIDDIFAFRFEDFQLINYDAHPHIKAEVSV
>AIA11391.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSGADENGDLGPVYGSQWRSWPTPDGRYVDQISQVMEQIKRNPDSRRHLVVAWNPGEVDHMALPPCHYAFQFYVAGGKLSCMFQMRSVDTFLGLPFNIASYALLTHMMAQQCGLEAGELIWTGGDVHVYLNHLEQVQRQLTREPFPLPKLVIQRKPESIFDYKYEDFVIEGYQSHKGIKAPIAI
>AIA11349.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDKIRVGVIFGGRSGEHEVSIRSAKTVIEQINKDKYEVIPIAITKAGNWLNPVESLGLMPESVQNLLMADIGKYPRNAIALIGDTQYRGLTKLEAAVGEERTTIFDVVFPVLHGTYGEDGTIQGLFEMAGIPYVGCGVLASSCGMDKVVMKVLFRDAGLPMCKYVWFLRSEWEKASDTVIDQVKTKLGFPCFVKPANLGSSVGVTMAHDDLSLRQGIELAAEFDRKIIVEEGLNMREIECAVLGNDEPRASLPGEYIIKDESKTFLDYTEKYAGTGNNEFVVPALVSEELSKKIQQMAIQAFKAVDGSGLARVDFFLRNDTGALLINEINTLPGLTDASGYPKMWAGSELHFTQVIDTLITLARERFDDKARNKTSFSEA
>AIA11302.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQLLGRQQREAFAEIEAHLVAKCAERASASPIVREGFPLLTTKKLHTRSIIGELLWFIQGSTNVKWLHEQGVTIWDEWADERGDLGPVYGAQWREWRAAGAADGRVIDQISQVVEQIKSNPDSRRLIVSAWNVGELDRMALMPCHLLFQFYVAGGKLSCQLYQRSADIFLGLPFNIASYSLLTMMMAQICGLKPGDFIHTLGDAHLYSNHLEQACLQLAREPRRLPQMRINPSVKSIFDVG
>AIA11274.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDHGTKKDDRTGTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELLWFLRGDTNIGYLKEHGVNIWNEWADERGDLGPVYGAQWRTWRACDGRTIDQISQVIEQIKSNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVAGGHLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLKPAEFVHTLGDAHLYLNHLEQARLQLTREPRALPQMKINHRSNPYLNSTTLISSFQATNRIRT
>AIA11232.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKEMNALPKKIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFELPQNVDIAFLTIHGTFGEDGQIQQILEDRGVPYTGDGVNESRIAFDKIESKKKFDAAGVTTPRWQIVAADERPTFSPPIVIKAPRQGSSVGVYIIKSADQLENGLAEARKFDRRLLVEEFVPGRELTVGILGDQALPVIEMIPKSGFYDFTNKYPFLNPKAGGGAEHVCPANIEETLTHQIQELALRAYRSIGLCVYSRVDVLLPENGVPTVLEVNTIPGMTEASLLPEAAAAAGISYEDLCLRIIELSRARREDAK
>AIA11228.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSQEKRKLRIGVIFGGRSGEHEVSIRSARSVIEAIDKSKYDVVPIAITKEGNWLGPAAAVKLLPEDTQRKLSINAQKQSTEDVAILGDPSRRGLMRLDSSDQSRDKLDVVFPVLHGTYGEDGTLQGLLEMAAMPLVGCGTLASACGMDKVTMKALFKEADLPICAYTWFLRSSWEDDPDKITRRVMREIGFPCFVKPANLGSSVGVSKATDKASFARAADLAARYDRKIIVEELVDGREIECAVMGNDEPQASLPGEYVIHEESARFLDYTEKYSSTGNVEFIVPARISKSVIKKIQGMAARAYRAIDASGLSRVDFFLKKDGELLVNEINTLPGLTDVSGFPKMWEATGVSFTRVIDQLIQFALERHRERARNETSI
>AIA11225.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MIMSTDNLIKQLGKVGVLYGGRSAEREVSLMSGSGVLKALKDKGVDAHGFDTGEKDIAELAAQQFDRVFIALHGRYGEDGTLQGALEQLGIPYTGSGVMASSIAMDKIMTKRVWLSHGLPTPRFKVLDAKTTTPEQLRLVPDELGLPLMLKAPHEGSTIGISKVTGYSELNGGFADCAKYDEVVLAEEFVTGREFTVPVLGKGRDARALPIVEIRAPEGNYDYQHKYFSDDTQYLCPAPLDAALTQRMQAIAVQAFNALGCVGWARVDFMLRAADNEPFLLEINTSPGMTGHSLVPMSAKAAGVSYEDLCLNILKTAALEMTPVKK
>AIA11053.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MSKIRIGVVFGGRSGEHEVSVLSARSVINGLDPEKYEVVPLGITREGKWLPPAGARAALEAGVVNGNGSTLAVLPGGEQALMSLKGGAAEAGLPRLDVIFPVLHGTYGEDGTIQGLFEMAGLPYVGAGVSGSAVGMDKALMKAIWTAHGLPQLAWQQVTRIDLEVRREKTVEMLLQKPGLPCFVKPANLGSSVGISRATTREELEKALDHAAEYDRKLVVEEAAKKPREIEISVLGNDRPEASLPGEIVHGHEFYDYKAKYLNTKGQETIIPADITPEQTARIKELAIEAYLALDLNGLSRVDFFLDETGAIYLNEVNTMPGFTPVSMYARMWEKSGLSYGQLLDRLIELGLERYSDRQRNRVDRGV
>AIA11048.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MDTLAGLKVAVLKGGPGSEREVSLRSAQTVERSLKEAGASEVIPVDVRDAGFDLPDGVDIAFVIIHGTFGEDGEIQKALELKGVKYTGEGVDVSRCAFDKLLSKDAFIAAGIPTPGYEKVAAGARPAMKLPLVVKAPREGSSVGVYIIKTEAELAPALEGVKNYAQEFLVEEYIAGRELTVGIVGDLALPIIEICPKEGFYDFRNKYPWLSPGGAADHYCPADLPEETTRKLQELALKAHRALGCQVYSRVDFILTEAGDPYVLEINTIPGMTDSSLLPEAAGVAGIALPELVTRIVNLSLRRWNA
>AIA11022.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKRFQHVAVLMGGWSSEREVSLRSGKACADALERKGYRVTRIDVKRDIATVLEALKPDVALVMLHGRPGEDGTIQGVLETLGVPYSHSGVLASSLAMQKDLAKTVMATAGVPVAQGLTLSRAEVAKGHVMAPPYVIKPVADGSSVGVFIVTESHAHPPQELFRGDWPHGEQLLVEKYVAGKELTCAVINGEPTGVIEIVPLIKFYDYEAKYSPGASNHILPAPILPFVYQEVRRLTLAAHVALGCRGVSRADFRYDDRIEGTGGLICLDVNTQPGMTETSLVPELAAHAGVTFDELVQWMVEDASLGR
>AIA10930.1|FEATURES|farme|beta_lactam|mrdA|antibiotic target alteration|0
MTLADSLAVSNNVVAVEAATGKMASCDDRNRLTDIKDYAVSPETVAKLIHEAGADASMVPGKTDEIKIGKEPRLAIGATLGLSPLKLAVMAATLANGGEYHKPHLVSRIDAPNGDNIFEHEDESRRVIDEKYAKIVNQVLVGVGTNPNGTGHKLLVDNHPLMMKTGTTDEELGDSWYFASNAVNPDHKNESAYVCAGWAGKNANRQGADVGGVCQSFYQSQLKGRPRVDFPAADMDAGKLVGIVQAAPPPPPPPPVQTQQPEPTKVETPTVVPPVPTRHTEPSATPPTPQGTPTASSPPTAGESTPRETPPAEEPGGGVEDPNAGEAPVPGVQPTG
>AIA10892.1|FEATURES|farme|tetracycline|tet34|antibiotic target alteration|0
MSDKTTVYGMHDFDWLHDHAADTKTKQLVDRIVAIEKSHKAGKPLPVGTDLMKLKLDDMVVWTRENTAHSIPHGYVQIFKLLDEILPAEFRQPMEGLIVDVGANEGHWSMYMHQHHPKARLVAIEPNPTALDLLRRNFEANGMQDVAVRAVAVSDKNELQQMETT
>AIA10893.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MASAHPEYEYLKLLAEILKNGRSKPSRGVHDLKSIFGYQAHFDMRHGFPLLTTKKMPFKILMHETLWFISGSSDVDYLHDHKIFYWDGFLHEGSNDLGRVYGVQWRHWKRPDGSEFDQLQWAIDQLKTNPDSKGIIVSAWNAGELGDKRWNPDDYGDMRLPPCHTMFQFDLTKGKLRLHLYQRSWDVFLGAPFNIAQYALLLHMVAHLIGAEPRELIISAGNAHLYKNHLDMAKEQVKRKPYPFPKLKIVGNPKTIDDFTEENFVLEGYQSHPHIKAPLVIL
>AIA10755.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MLKTNKDVELARLVQDIQQSGKYGDICLALIEHVGRQELSKRRNVKEALKATKNKLHQIGGAYLDGREQYQQWLRMLAEAQAEQGTDNETFKAVSLQLMGKHASTRERRSILPDFYPRIFAELPPIHSVIDIACGLNPLAHPWMPLAPAATYDAYDIYQGMMTFLNDYFALRNIRGTASACDVIQSCPTQEVDVALLLKVLPCLEQLEKWAAHHLLHTLNARYLIVSYPIQSLGGKSKGMSTYYESHFRSLISDTPWTIKKLEFANEMVFVVAK
>AIA10753.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MSRLNDPHALDLLVSDVQGSAKYRDMSLDLIRTIAAQELTKRRTHKEAVKATKNKLHQVSAAYLDPRENYTAWLQELREAQQTGTAEANKQTCKQIMSHHASTRERLPLLEQFYSTLLAELPAPHSVLDLACGLNALTLPWFPHMEAITYYACDIYRPMIDFLNATMEIMHIRGCAEVRDILQSCPTQEADLALVLKTIPCLEQIDKQAGTRLLRAINARYMIVSFPAQSLGGRNKGMVTNYEARFYQLVEGENWEIQKYEFATELVFVIKK
>AIA10677.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MIAWSVVLRRLGFTKRKLATLLDQSLVVNIRGVARGRGSAVLWRQIFTVQKRGHEREMMSEPLEQPYLNLMKDVLAHGARKDDRTGTGTLSIFGHQMRFDLERGFPLLTTKKLHLKSIIYELLWFLRGETNVKYLRDHNVTIWDEWADAEGELGPVYGAQWRRWRSADGRTIDQISELIDQIRRNPDSRRLIVSAWNVAEIERMALPPCHAFMQFYVVDGKLSSQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLAPGHFVHTLGDAHLYLNHLEQAQLQLARQPYPAPQMRLNPAIKSIFEFNYEDFELVGYEAHPHIKAKVAV
>AIA10604.1|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
SYAAFDKILSKEKFREHNVATPKWEVIEVGERPTIPIPLVVKPARQGSTVGVVIVKKASQLDAALAEAGKYDRKLLIEEFVSGRELTIGVLGDQALPILEIIPKGGFYDFNNKYPFLNPQAGGAAEHVCPAEIDPKKTKQIQELALRAFRAVGLVVYARVDVLLSDSGDPFVLEANTIPGMTEASLLPEAAAAAGINYVDLCAHIIALSRARTERSRR
>AIA10551.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTRVGVIFGGRSGEHEISIRSAKTVIEQIDKDKYDVIPIAIGKNGNWLNPSDSVGLLPATSGEALGDAVDGYTQDSVVVAGDTSYKGLTRLGGSDDEERTLGLDVIFPVLHGTYGEDGTLQGLLEMAGLPYVGGGVLASACGMDKVVMKTLFRDADLPICKYVWFLRSEWERDNDAVIRQVEAKLGYPCFVKPANLGSSVGVSRADNADSLKAAIELAAEYDRKIIVEEALDMREIECAVMGNDEPEASLPGEYIIRDDAKKFLDYTEKYAGTGNNEFTVPAPISGELTDKIRKMAVNAFKAVDGSGLARVDFFLRNDNGMLLVNEINTMPGLTDASGFPKMWAGTGKKFSDVLENLIELAIERHKDRSRNKTSY
>AIA10518.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMQHVLADGTHKSDRTGTGTLSVFGAQLRFDLNAGFPLLTTKKVHLKSIIHELLWFLKGDTNVKYLKENGVSIWNEWADAEGNLGPVYGYQWRSWPAPDGRHIDQISQVLEQLKSNPDSRRIIVSAWNVADLDRMALMPCHAFFQFYVAGGRLSCQMYQRSADLFLGVPFNIASYALLTMMTAQACGLKPGDLVHTLGDTHLYMNHLDQAREQLSRSPRKLPTLRLNPAVQNLFDFKYEDFTLENYDPHPAIKAPIAV
>AIA10517.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLKSILANGNEHKDRTGVGTISHFGYQTRFDLRDGFPIVTTKKIPFRWIAEELFWFLSGDTNEANLRAKGVDIWAEWADEDHTRRFSRAAGDLGPVYGYLWRSFGGNYPQRDGVDQIANLISEIQTNLNSRRLIVTGWDPRQADQVDLPPCHTLFQFKVEAGRVLHCQLYQRSADAFLGVPFNISSYALLMHMVAHVCGLEAGEFVYTLGDYHIYQNHLEQVQELLGREPYPLPKLELLDEGGQLRGLEGLPAIRYENLKLVGYQSHGKIAAAVAV
>AIA10497.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MSASQVTKSADLDELVIAIRASKKYAHISEATLRHLGQIELSKRRTLKDAIKETRNKLHQIGGAYQDAMHYAAWLGELEAAEPGARTTILSRIMHHHASTRERLPILDPFYTTIFEALRENPGEVHSILDVACGLNPLAIPWMPLLPDTTYHALDIYADMIQFVGRCLALMQVKGTADTCDVVAALADPTSEAAQVLRRPVDVAFVLKTIPCLEQVDKRIGSSLLDILGAKQLVVSFPIQSLGGKRKGMLQHYSAHFAELMAGRPWPVQRLEFESELVFIVRKM
>AIA10452.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
EVYPVFISKEGEWRKGQKLLGPVETVETLQFGDDTGKANDITSFLPAENSAQELDASTGNEGLDVIFPLLHGPNGEDGTVQGLLEVLNLPYVGNGVLASAAGMDKVVMKQLFAQAGLKQVPFVHFIRKEWKNNQALLLEKIESSLKWPLFVKPANLGSSVGITKANNREELIKAIDLAFKYDRKILVEQGIVAREIEMSVLGNDTPRCSVAGEVLPTKDFYDYSAKYIDGTTNYAIPAKVSDRLQKSLEDAAIRAFKVLDCSGLVRADFFVTDTEEVLINEVNTMPGFTPISMYPKLWMASGLSYSDLIEELISLAIERYEEKQQLEHSKDGE
>AIA19295.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RPLVEQGVHIWTDWPLDRYRRETGEAIDRDAFEARIIADDHFAREWGDLGPVYGKQWVAWPDGKGGTIDQIAQLVDGLRNNPASRRHIFTGWNVAELDRMALPPCHMTYQYHVADGRLSGILYQRSCDLGLGFGFNIFEAALLLRMLAQQCDLEPGEIVWMGADVHVYLNHEHLVAEQVARTPRPFPKLEFTRRPDSIFDYRLEDVAITGYDPHPHIAAPVAV
>AIA19175.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KPQNERGSRMRQYLDLIRTVLADGEKREDRTGTGTISLFGTQAKYDLRQGFPLLTTKKVNFGAVVRELLWFLKGSTNINDDLHEHTNIWDAWADENGELGPIYGYQWRSWPAYDLDEKTGLYKKRHIDQIQNAIDLIKTNPDSRRIIVTAWNVADVPKMALPPCHMMFQFYVINGRLDCQLYQRSADLAVGVPFNIASYSLLMIMMAQECGLTPGIFTHTIGDAHIYQNHLEGLQKQLDRKPGSLPEVEIPNKSLFDLKFEDFTLKNYDHQGFIKFPVAV
>AIA19168.1|FEATURES|farme|glycopeptide|Usp|antibiotic target alteration|0
MKIPIMLRVLIPTDLSRGAANALRYAMQLTQGMDVELILFQGNVIPVPMAEMPIVTDMPNKDDTVKSMNEEVQKVAASLQQKDNKNISCMVSAGLSLAPMIEDAAAQAKADLIVMGTHGATGIIKVLIGSNTVSVIETSKHPVLIVPEHYE
>AIA19076.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|1
MEHIPANKFQYIQEYLHLFPGFYGELRSARGYFENHSAHILGYMSEVDQNKIDQSGGIYVPGDYCGSTGVESNYENLLRGTKGAQYILKDNLGREIESLDGGKHDSLAISGDNVILSLDHVLQEYGQALLQNKRGSIVAIEPSTGEILAMISSPGYDPNELSISRLRGDVFAKLQKDTLNPLFDRSVMAMYPPGSIFKPILALAAMQEGVLDENKTVFCNGSYNLGGFRRGCHNHPAIHNVSQAIQYSCNTYFFTVYKDVIDDAGYTLPEIGMRKLNSFLTEFGFGRKISVDLPAEKSGNLPGPDYFDELYGSGKWRSSYILSMGIGQGELQLTTLQMAHAAAIIANEGTYTDPHILKAKVPAGGEPKSEFYPRRRVSIDYRYFDPVIEGMAGAVRAGTATLASHPDYEVCGKTGTSENPHGADHSVFFGFAPRNQPKIAIAVYIENAGWGGSFATPVGGLMMEKYLKGEIIEAHKAIEKRMLETDLIHKEKS
>AIA19072.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTNNQASQPVTVAVLAGGTSAEREVSLRSGAAVQAALEAKGYAVLMLDPHDGLSQSLLEQADVAFPVLHGIGGEDGSIQSLLDELKIAYVGTGAKESALCFDKWQYKQLLREHNLPVPDGALVNREEFAASPLTERPFVLKPNDGGSSVDTIIARDGLSGVDEHLRDDIFARHGRMLLEELIPGTEITVAVLDGHTLPVIEIVPPESGEFDYDNKYNGKSQELCPPQTVDPVVQQKAQALAAQIHTLVGCRDFSRTDMMIDSDQNLYVLETNTIPGMTDQSLFPKAAATAGIPMSELTDMLVRAALARRTAKS
>AIA19040.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKIYNDVLKKIMDEGVDRKGRNAVTRALFSIQMRFNLENGFPAVTTKKLAFKAVKSELLWFLEGSGDDNRLKEINGSERTIWTDNAAAPYWTPKAKFPGDLGRVYGVQWRTWKTPDGKEVDQIATLISKLKTDPNDRRLVVTAWNPGELDQMALPPCHMIFQFFAANGKLSLHMVQRSCDMFLGVPFNIASYALLLSMIAQVVGMKPHECILTLNDAHIYHDHFEAVKEQLSREPFPLPELWLNPDVKDINCFKMEDIELKNYQSHPSIKAPMIV
>AIA19031.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MALPPCHCLFQFYVANGKLSCQLYQRSADIFLGVPFNIASYALLTHMIAQVTGLGVGDFVHTLGDAHLYLNHLEQAKLQLTRETKQIPTLKLNPRTSIFDYVFDDIVIEGYDPHPSIKAPISV
>AIA18925.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|0
VPSEKTGNLPGPSYFDQVYGSGKWRSPYILSMGIGQGELQLTTLQMAHAAAIIANEGTYTDPHILKARVPAGELPQQEFYPRRRVSIDYRHFEPVIEGMSGAVRAGTATLAYIPDIEVCGKTGTSENPHGGGSLSVLWICTKGSTEDCYCCVH
>AIA18691.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTVDRAAELHPRAPHPEYQYLDLLGEIKDKGRDKGSLSSGQAIRYVLGRTHHYDLQTEGFPLLTTKDVFWKGVRVELEWFLKGDTHIKFLVDNNVTIWNGDVFEKKYQPAVKKGLTPNLDRKDFDAKLKEDEEFLMRWGDAGPIYGHQWRRWKRPDGVEVDQLEWIVEKLRKEPHRKHLVFTAWNPANIYEMAASEEDEMALVPCHMISQVDVSSDGELSLMMTQRSCDMFLGVPFNIASYALFTHLLAESAGLKPGTFVHTLNNTHLYHKHFAAADLQRTRTPYPFPKLEFRRKVSEPWDFKWQDAKVVDYKHHPKIEEELITVGGKSGRIARRS
>AIA18638.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLELMRNVLEHGARKEDRTGTGTLSIFGYQMRFDLSEGFPLLTTKKLHLKSIIYELLWFLRGDTNVKYLQDHGVKIWDEWAEENGDLGPVYGAQWRSWKDPNGGSIDQISQLIDQIKTNPDSRRLIISAWNVVDIPRMHLAPCHCLFQFYVSEGRLSCQLYQRSADIFLGVPFNIASYALLTMMVAQVCDLKPGDFVHTFGDAHLYLNHIEQAKLQLSRRPYSLPQMKINPAVKSIFEFKYEDFELIGYQAHPHIKAEVAV
>AIA18631.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHELMQRVLKEGTRKDDRTGTGTLSVFGHQMRFNLAEGFPLVTTKKCHMKSIVHELLWFLMGESNIKYLKDNGVSIWDEWADEEGNLGPVYGVQWRSWKTHDGRTVDQIKNLIEMIKRNPDSRRLIVSAWNVSDVDKMALPPCHTMFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCGLKPGDFVHTFGDAHLYINHIDQTQLQLSREPFPLPTMKINPEVKDIFDFKFSDFELVNYQAHPHIKAPVAV
>AIA18599.1|FEATURES|farme|beta_lactam|PMI39_02504|antibiotic target alteration|0
MNQYSVAGLSLAVIRNGQLDEVTAFGTLEAGTTRAVTTNSLFNSCSISKFITTMLVLTLSEQGIVYLDENVNDKLTSWNIPTNLFTSQKSITLRNLLSHQSGLIDPPNSFEHYTPAKGLPNMSELLSGKTLYCPVPIEVTYKPESEFHYSDASFCITELLLEDITGRSFSQLLEEHIFQPLQMKYSTLFSPKDIDKTDVFACGHNKDRTVTNEKYPFYPFAAASGIWTTPTDLSALVIEIIHSLQGKGKLKLSQKLVIDMISPQGCSKWTGLGVFLDDSNEELQVYSLGWGVGFQCMMVCYPYCGNGAVIMTNSDLGVHQMEGIIGEVVKTLSL
>AIA18535.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MCIDGKDFFVSILRDNVLPSVEVHTPGGFYDYQAKYESDETKYLCPAPISVDKERELRELSYKAFCALGCEGWGRVDLIQDEAGKFWVLEVNTIPGMTSHSLVPMSAKAAGIGFDEVVMTILASTIREENFSTIVGEVAQA
>AIA18519.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|1
MKDNLGREIESLDQGRHDSLAISGDNLILTLDHILQEYGQQLLQNKRGSIVAIEPSTGEILAMVSSPGYDPNELSISRSRGIAFTRLQSDTLKPLFDRSVMAMYPPGSIFKPILALAAMQEGVLDADRTIYCNGAYYSGGLKRGCHNHPSAHNVSAAIQYSCNTYFFTVYKDMIDISGYTMPEIGMRKLNGILTEFGLGHKISIDVPSEKTGNLPGPSYFDQVYGSGKWRSPYILSMGIGQGELQLTTLQMAHAAAIIANEGTYTDPHILKARVPAGELPQQEFYPRRRVSIDYRHFEPVIEGMSGAVRAGTATLAYIPDIEVCGKTGTSENPHGEDHSVFFGFAPRDQPKIAIAVYIENAGWGGSFATPVGGLMIEKYLRGEISEPRKYIETRMLEADLIHKPKS
>AIA18488.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRLSALKQYLDLIRYVLENGERREDRTGTGTISVFGLQAKYDLREGFPLLTTKKVLFGSVVRELLWFLRGSTNINDDLTQHTPIWDAWADEHGELGPIYGFQWRHWPKYVMDEAHGGLYRKEQVDQIADVLHRIKTDPTSRRLIVSAWNVADLDRMALPPCHSFFQFYVSNGRLDLQLYQRSADMALGVPFNIASYALLLMMVAQECNLTPGVFTHTLGDAHIYLNHVEGLQSQLQREPKALPEVKIAKKPLFDLRYEDFELLNYNPHPFIKFPISV
>AIA18455.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MRDKTKGNGVPKIGIVLGGMGSEREVSLNTGAAFEKAVKSLGYSYILIDAKEDFPKKISESKIDCALLALHGKYGEDGTVQGILEYLKIPYTGSGVMASSLAMNKVATKQILTHWDVPTAEFGILDLTITKNSEIKSEVQKIVKKTGIPLVVKPNQEGSAVGVTIVHNEKEIAAAVKLASQYDKVIIIEKYIPGMEITVPIWFGEALPIIEIRPKSEFYDYKRKYTAGQTEYILPAPLNNTRGQPFCFRNQYVTWLYRDQSFS
>AIA18436.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYHDLIQHILDRGEERTDRTGTGTISVFGLQAKYDLREGFPLLTTKKVLFSAVVRELLWFLRGATNINDDLTQHTPIWDAWAGPNGELGPIYGYQWRSWPRYVRIEGTDHYAREHVDQIRNLIDEIKTNPDSRRLLVSAWNVADLPQMALPPCHLLFQFYVINGRLDCQLYQRSADMALGVPFNIASYALLMIMVAQECNLTPGVFTHTLGDAHIYLNHVEGLRKQLQREHRDLPTVQVARKPVLEVQFEDVTLLNYDPHPFIKFPVAV
>AIA18397.1|FEATURES|farme|aminoglycoside|Krm|antibiotic target alteration|1
MRSSQKYAAISEAMIRSIGLRELAARRNLKEAIKATKNKLHQVAGAYLDARLPYDEWLALLESAVADDRRMTNDERRVASDGEPPANSVLGTQSSALARACLTIMRHHASTRERLPILESFYATTLASLGPVRSVLDLACGLNPLALAWMPLAPAVRYYACDIYADMIAFLNGFFAQAGIRGQARVCDLVAGAPDEQVDLALVLKALPPLDQQAKHAGRDLLRALNAQHILVSFPAHSLGGRGKGMTENYEQRFRALADAEGWSIERFIFPTELAFLVRKE
>AIA18356.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MYQISNRNGKLSLQLYQRSADLFLGVPFNIASYALLTIILAQIAGLEPGEFVHTFGDVHIYENHVEQVKEQLSREPRSFPTIKIDPSVKTLEDFTPDKVELINYDPHPTLKGDLTVAGGFYEKK
>AIA18305.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAVFDGIYQGLLRDIMDKGIREVNQRTGHETAALPGVSFSIDVEKDGFPLLSLRKIPTKIFIAEQIWFISGARKPEVFLRDFTRIWDDFTNPGDVVTVAYGYRWRRHFGRDQLGMLVSMLEKDPSSRHGVVVTWDPANDGLGGASKANVPCPYTFTVNIMGGRLNMMNVVRSNDVILGLPHDVAGFCLLQLILAQKLGVKPGVYTHTIANAHVYDIHYDAAKEMIGRKSDMPKVSVTLPVDTFARAEAKDTQLVEDINGPLTEQYQPGEAIKGLRIVL
>AIA18256.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLRSILQYGTTHDDRTGVGTISHFGFQTRFDLRRGFPIVTTKRVPFRWVAEELFWFLSGDTNEENLRARGVDIWAEWADDAHTAKFGREAGDLGPVYGYLWRSFGGDYPQRNGVDQIARLMDQISSNPDSRRLIVTGWDPLQADNVDLPPCHTLFQFKVESRRTLHCQLYQRSADAFLGIPFNISSYALLTHLVAHVSGLEVGEFVYTLGDYHIYRNHLEQVNELLSRAPLPLPELKIDDPEKKLRGLDGLLNVKYEDLNLIGYQSHGKIAAPVAV
>AIA18248.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRKVTKIWDAWADADGNLETAYGRYWRRFPRPIQKSHAPLSVTGEQVAPVEEIDQIQYVVDEIRRNPFSRRLVVTAWEPGNAERSKLPPCHYTFAFNVSPDETGQPRRLNCHLTQRSGDIALGIPFNLACYATLTQILAQEVGLEVGHFAHTIIDAHIYCADAGSTMAAYDHVAGLKEQLARAPRPLPRLVVAKKPMKELTFEDFRVEGYDPHPAITFKVAV
>AIA18241.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLSDIMTNGVKELSERTGLETSALPGVHFKIDPAKDGFPLLTLRKIPIKAIVAEQIWFLTGSRKPEDFLRDYTKIWDPFTNPGDVVTVAYGYRWRKHFGRDQIKLLIELLQQEPSSRHGVVIAWDPAQDGLSLVKKKNVPCPYTFTVNIFGGKLHLHNIVRSNDMILGNPFDVAGFCLLQFILAQKLGVEVGTYSHSISNAHIYSNHYEGAHELMKRKSDHPPIMLHLPENAFARAEERDTTLLDEIVADISGQYNPQEAITGLKIAL
>AIA18230.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAHPEYEYLKLVAEILKNGKSKPTRGVHGIKSIFGYQMHFDLRKGFPLLTTKKMPFKILLHELLWFVSGDSNIKYLQDHNIHYWDEFADKDLNLGPVYGVQWRHWKDHDGSEIDQLAWVIKQIKENPHSKAILVSAWNVADLEAMRLPPCHTFFQFDVTKGKLRMELYQRSSDVFLGLPFNIAQYAMLLHMVAYLTDLEPRELIVSIGNAHLYQNHLEQAKEQLQRKPYPFPTLKISGKVKTIDDFTADNFELLNYEAHPHIKAPLVIL
>AIA18219.1|FEATURES|farme|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|0
MKVSDVMSRQIDFVRPTDRVQRVAVLIFGRGVNGVPVCEGKKLVGFVSENDILQKFFPSLRELDEDRVKESNFEMMEEKASTILSLPVSKIMSTQPLTVKADTPLLRAQSMMKVNEVGRLPVVDSEKNLIGVISKGDVFKALIGQQISFTENEDYNDFLSKTYYSTVDWDDRIKKEIPDLVKLLEKHKVKTILDVGTGTGDYAIELASRGYNVVGTDRSKAMIDEANIRKIALSSKNYGNIHFWNKDTEDFLYEMDIKFDAILIMGNSLSHNPENYRRLIKKCADSLSENGIMIFQTTNFEKILKVKKRMWSVNFVPVADEPVKEYSFIQFYDKPIKEKTILKTFAILSFDGKRWSWSGIRNSIMAYTNEARIKSILKNEGFTKIETYGGSFDGRTWDHLFRKQFKPMESDWLNVVATNKK
>AIA18203.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGPYEALLAAVLATGEDRPDRTGTGTLSLFAPQPLTFDLRGMHVPLITSKQVAWRMALKEYMWMLSGSTSTVDLGGSSTQMANIWNNWADERGDIGPTYGAQYRDAGGTLLTEAPDDGGWTYSKAGVDQLGEVIHRLAETPDTRRALISLWSVPELQDMALEPCMVLFQFSLRGPNLDQLHLHIHQRSADMMLGVPFDLFQGGLLAHLVARELSYYTDRFIDATNLTWSAGDVHVYNTHLPAAFEQLLQAQNAPKPAARLVLPPHQAPLRLLGGSLTAAHIDVIDYHSAPRITAGAIA
>AIA18172.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ENLNKYDVHYWDAWADEEHAGWYDLPAGQFGRTYGAQWRSFNAGGPEPIDQIKRLFTIIEKNPSDRGLLVNPWNPYDVDHLVIKPCHGQFRLLLMDDRFDMVVTQRSSDVPLGLPSNVVMYKFLQMLICMKTGYKEGDLIYDIQDAHYYSDQEEGIKILIEREPKPYPKVTIDPIMVKVLDAMLDGNDDPLSDKQFNPEGKPYKELLREWIKLEGYDAHPTIPYEVLPVDI
>AIA18146.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FYKVNLADGFPLLTTKKVNFNACLHELLWYLSGDDHIRNLRKVTKIWDAWADEKGDLETAYGRYWRRFPHPVQKSHAPVAQTGEAAAPVQEIDQIQCVIDEIKRNPFSRRLVVVAWEPGNAEVSKLPPCHYSFAFNVSPDETGKPRRLNCHLTQRSGDIALGIPFNLACYATLTQMLAQEVGLEIGTVAHTIIDAHIYTADANSTMAAYDHAAGLREQLNRAPRPLPKLTIAKKPFNELTFEDFKLENYDPHPAIQFKVAV
>AIA18111.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MQQKLAFAFQFDHKVLIEEYIKGRELECSVLGNDDPIASLPGEVIPQHEFYSYEAKYLDENGALFEIPAKLSESEIACIQALSIKAFQVLCCDGMARVDVFMQEDGRIVLNEINTIPGFTKISMYPKLWAVSGLPYADLIDRLIELALERFKKTQSLKTIFTMLDAEMSPVPAVLG
>AIA18112.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSNKIRVGVLFGGKSAEHEVSLLSAKSVVEAIDKEKYEVVLIGINKSGEWYLHENMDECLVNCEDPKLIQLKMAKENVTVVPREKGNPLVNLSGSALNKQLDVVFPVLHGTYGEDGTIQGLLKLVNVAFVGSGVLASAVGMDKDVMKRLLRDAGVPIAKFMTLHSHSYQSNSFEEIVATLGLPFFVKPANLGSSVGISKVKNKQEFAAKISFCISIRS
>AIA18101.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRGRGHEVIALDPARGVLSAKEEQELSTGKVGTKPPSLEDLTKVAEGAFLPNLTSMKELREADVAFLALHGGQGEDGTIQALLDMARVKYTGSGHLSSALAMDKDLSKKLFRSDEVKTADWLMAPASTEQIEGILGLPVIVKPSKQGSTVGLTLVKKRQELVPAIEEAFKYDDEVMIERFVPGRELTVGVLGDVALPVGEIISKHEIYDYECKYTAGMAREEFPAKLTPEATERVQNQALAAFRALKLKGYARIDFRLTSEGEFYCLEANTLPGMTELSLIPQGAAAMGIDFPELCERIVRLALE
>AIA18092.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYLGLLEDILENGVDRGDRTGTGTRGVFARQLRFNLSEGFPLVTTKKIHFKAVVYELLWMLGGHTNVKWLQERGITIWDEWADENGELGPVYGAQWRKWLAFRKVADGDQHGLNGSFLWEPKAIDQIAKVVRDIRENPNSRRLMVTAWNPADVDKMALPPCHCLFQFFVADAKLSCQLYQRSADVFLGVPFNIASYALLTMMMAQVCGLAPGEFIHTFGDVHLYLNHFDQAREQLTREPRPLPLLELNPERRELDDFVYDDFRLLGYDALPNIKAAVSK
>AIA18069.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FHELLWFLKGDTNIKYLVDNDVHIWDEWPFQDYLIANNFTEKFPMYSEAWKLEKATFIERIKTDAEFAKKWGDLGPVYGKQWRRWEGPDGIVYDQLGKAIEMIKKNPDSRRILVSAWNVSDVYTHTKTAPPLCHTLFQFYVNDGKLSCQLYQRSADTFLGVPFNIASYSLLTHMIAQVCDLDVGDFIHTFGDVHIYSNHIDQVKEQLNREPKSLPTLKLNPDVKRLEDFT
>AIA18067.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVCQFRASVLFSLPMTQYLDLLRLVLKDGKFKADRTGTGTYSVFGAQTRFPLANGFPVLTTKKLHLKSIIYELLWFLRGDTNVKYLNDHGVTIWDEWADQDGNLGRVYGAQWCDWRTADGRSINQIDQVIEQIKKNPDSRRLIVSAWNAGEIEKMALPPCHTMFQFFVQEGELSCQLYQRSADLFLGVPFNVASYALLTLMVAQVCDLKPGTFVHTFGDLHLYANHLEQAKLQLTREPRPLPQMKVNPAVRNIHDFKFEDFELIGYDPHPGIKAPIAV
>AIA18050.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
GGTSAEREVSLWTAKSVANALTLLKEEFAEIDAADADWLDQVVGYNPKVVIIALHGPFGEDGTVQKALEEKGIRYTGSNSATSKVAINKNRTKEIAQSLGINLATSRLFKKGEEVVWNREFPVVVKPNGDGSSFGVTIVKNSEDLQKAAENAFAYGEEILLEDFIPGVELSCGVVQKGTELTALPLVEIRPGEEFFNFEAKYNESKC
>AIA18039.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSVDYIPYEQRTPDTQYRDRLVLIRDHGIAAKSFHPIGSQTYMGLPAMRFDLRNGVPSPPSATWKGSWRSAIGEILGFINGVRTQEALVGEFGVNEKFWGPTVTEAKCKIFGLQTGDLGAGSYGAAMGAFPTPWGTTVSQMRNVLDQMRSMPDVRTHWIDPWIPFYTMKGGGGAESKGVVAPCHGWMHFRILNAELHLQMHQRAADMPAGSVFNTFQYAALTIAVAHVMDIKAAGFYHSFSDAHYYDNQLDPWVNDLIDREPRRLPTLTLTEDAPDDLFAFRPRHFVLTDYDPHPAMNDIPVAV
>AIA17977.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MRSFNMTKNFNDCVILFGGSSEERLVSVASAQNISVVIPEAPLWFWTKDGKIHEVTSAELGAHAEAFTKEFSPKSPVKASTLEEALKVNTGKTIIIALHGTEGEDGTLQRMLERMKITFTGTGAAASEKAFNKAMTKAIARDNNLSVAPELVVENVEPANVKKLEHFLEQNKKIVLKPLANGSSVGLHIIASKADLEKALPAIKASGYLPYVSEPFITGREITVGVREDKDHKLSPLPCSEVRVIQGRQFDYQGKYLGSGVEELTPAPLTKEESDACQKLALAIHKAIGCKGYSRTDMILTEKGPVMLEINTLPGLSKASFIPQQLKVAGMTLRDFFLEQINL
>AIA17919.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DDQGELGPIYGKQWLSWSTPSGDTIDQISRAVDLIRRNPDSRRIIVNAWNVGELEQMSLTPCHALFQFWVANGRLSCQLYQRSADIFLGVPFNIASYALLTHMFAQQCDLQVGDFVWTGGDCHLYANHLTQADEQLRRAPYPLPRLVINRKPPSIFEYEFEDFTIADYQAHPSIKAPIAV
>AIA17915.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MARFDELYQGLLSDIMERGVREVNGRTGHETAALPGLSFSIDLEQDGFPLLTLRKIPTKIFIAEQVWFVSGARKPDIFLRDFTKIWDDFTNPGDVVTVAYGYRWRKHFGRDQLGKLIELLTKDPSSRHGVIITWDPSSDGLGGIAKGNVPCPYSFTVNIIGGRLNMMNVVRSNDMILGFPHDVAGFAFLQLMLAQKLGVKPGVYSHIIANAHVYDIHYDAAKEMIGRKTDHKPVHITLPKNSFDRSEAKDASLVEEVNENLLEQYVPQEAIKGLRIVL
>AIA17884.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLVKDILDNGRPGDGLVRSDRTGVGTYSVFGRQLRFNLDEGFPLVTTKKVHLKSIVYELLWFLRGDTNVKYLRDNKVTIWDEWADQHGDLGPVYGKQWRRWETPDGRKIDQIQNAIDQITNNPTSRRIIVIAYNPGDLPEVAPPACHTFFQFYVSGGKLSLQLYQRSADLMLGVPFNIASYALLLMMVAQVTNLEPHEFVHTFGDVHIYANHLAGAREQIKRDPKPLPRMTINPKVKDIGAFCFEDFQLSGYEPWEHIKYDIAV
>AIA17823.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
QALPIPEIIPKGGFYDFTNKYPFLNPEAGGAAQHICPASIEPEKTKEIQELALRAFRSLGLRVYARVDVILSRTGEPFVLEINTIPGMTEASLLPEAAAVAGISYVDLCRRVIALSRARIEGAS
>AIA17801.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTSFDLQYQQLLKEILEDGIEEISERTKHGVKALPGKTLELEAGSGFPLLTLRKIPLKIFIAEQIWFLMGSRRPAEFLNNFTKIWDDFTNLDGVVSTAYGYRWRHHFGRDQITLLVELLEKEPSSRHGVVITWDPSNDGLSATRKKANIPCPYTFTVNIIGGMLHMHNIVRSNDMILGCPHDVAGFALLQRILAARLGVKVGKYTHSISNAHIYDIHYDAAREIIKRT
>AIA17794.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MFFAIHSYKSPISIAIVPRIAYNQQVMAKFDEVYQQLLADIMDKGIREVNQRTGHETAGLPGVSFSIDVEKDGFPLLALRKIPSKIFIAEQIWFISGARKPEVFLREFTKIWDDFTNPGDVVTVAYGYRWRRHFGRDQLGLLVNLLQKDPSSRHGVVVTWDPAGDGLGGANKANIPCPYTFTVNIMGGRLNMMNVVRSNDVILGLPHDAAGFCLLQLILAQKLGVKPGIYTHTIANAHVYDIHYDAANEMVQRTPDSPKVILALPENAYERAEAKDVTLVEDINAPIVKQYQPGEAIKGLRIVL
>AIA17787.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VATAQSMARTLGNPLCWFQASYGAVYDVPVNELLAHERPFEIDCDPKRPAVWPDLQQAFDTMPVEDPVVILGFHGGAGEDGTVQRMLEQRGIPFTGSGSAASAAAFDKGRAKEMLKGKVKVAESRTVGVSDADTIRSAVESMLSSHERIVLKPLAAGSSRGLFFVNRGEPIDDIIRKIVKLKLPYIIEQFIKGRELTVGVFDRGGDVIPLPVVEIEVDAGHTFDYEGKYLGKGTREICPAKIPASVAGAAQEMAVAAHRGLGCEGYSRTDIMAADDGPYFLETNTLPGLTKSSLVPQELRTAGIEFREFLEAQIALARKRAATTPRKVSAAGSRS
>AIA17786.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MASFDSIYRSLLEDLVNKGVKEVNNRTGHETASLPGVSFSIDLEKDGFPLLALRKIPVKLFIAEQIWFISGTRKPEIFLRNYTKIWDDFTNPGDVVTVAYGYRWRRHFGRDQLGSLIKLLENDKSSRHGVIVTWDPSSDGLGGVSKSNIPCPYTFTVNIIGGRLNLMNVVRSNDMILGFPHDVAGFALLQSILAQKLGVKPGVYTHVIANAHIYDTHYKAAEELIRRPVDSAPTKLKLPKDSFERAEAKDDSLVEEIYDSLASGYKPGEALEGLRIVL
>AIA17764.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DDDLFGGEPFDQIDGVFQQMRERPELRTHRITNWLTPYLLRQHQKVVVTPCHGDLHFRIHVAEGSLSLFHTQHKMDMLVGGINNICQYAALLMAAAQVLDLRADKLIFSISDAHYYKMQKEMLQEVLSREPRHFPTVYLTEKLTSVKDLRPHHFQIEDYHPHGDFRIPTPV
>AIA17755.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MKAETYLTPVLYLPVAERTVDTQFQDMLRDVRDNGYWDQSAQDDPARMKLGYQLHYNLRNGFPLMTERDMTAPILRDGKEPWPSMAEQSIGEIAAFLNGARTHKEYQSYGCYWWGRWLTAEKCEKRGLLKGDNGPGSYGAAWTHFPTL
>AIA17754.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
ASVPGEIVPSREFYDYQAKYVSDDSRLIIPASLNEAQVRNAQALAVQAFQALECSGLARVDLFLEKPTGKFFVNEINTLPGFTSISMYPKLWEASGLSYADLLDRLIALAIERHAEKKKLRTKV
>AIA17729.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VSRRSAAYIWKNIDRQRFDAFAIAIDKDGRWHAQNRQELEKSQPKEMPLQAGDKADAESAALLKKIWTQGADNSDIVICDIVHGTTGEDGMMQGFFDLQRIPYVGPGILGSACAMDKVVAKQLVEYAGVPVVPYVALRLHDWLERKSAVLDEAVRKLKFPMFVKPSSLGSSVGINKVENQAALEKAISHALE
>AIA17634.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MASIRDKGQTMQRKVILLFGGESQERFVSVATAQNLSRFLPNALCWFWAPNDAVYEVDAAFLQEHKDPFNAAFEPQIPVLFETLPSALDCPDYKGHIFLLGLHGGRGEDGTVQKWLEDRDLTFTGSHSEACGKAFDKVWAKSVLADFPIKMAPTLVVRGNDKLSLEALRTLFETHSKVVVKPVHDGSSVGLCIIESDRALQAALDMVCSQLDRPFIAEPFIAGTELTVGVVDEAHGPRALPATEIRAQAGRTFDYNGKYLGHGVQEITPAEVSAEWVKKAQEMAVLAHKALGCVGYSRTDLIMHEGEAYFLETNTLPGLTRASLVPQQLAAEGTTLTSFLEHVLDMAEKHREQK
>AIA17545.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRITILFGGTNTERLVSVASAQALHRALPEADLWFWDVADTVHAVTSKQLLSHTRPFEDEFKPGNRGLPLEAALDKARTEDRVLVLGLHGGRAENGELQAMCELRGIAFTGSGSASSNLAFDKVAAKRFAAYAGVAVPAGVALENLDAAFAEHGRLIAKPARDGSSYGLIFVNAKQDLVAVRNAARTEEYLIEPFVAGVEATCGVLERPDGEVLSLPPIEIVPGEGTFDYTAKYLLKST
>AIA17543.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRSLDPSKYDVVPIAITHEGRWLGSKDAVKMLTPGDAIQAALKGAEPMAVLPEPRQNGAVDVFFPIVHGTYGEDGTIQGLLELAGVPYVGAGVLGSAVGMDKDVMKRLLREAGLPIGDYWVTRSKDIGNFIREIGPTLPYPVFVKPANLGSSVGISKAHNLAELPAALAMASEFDRKIVVEQGIDAREIELSVLGNDDPQASIPGEIVPSREFYDYQAKYVDD
>AIA17530.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|0
MGIGQGELQLTTLQMAHAAAIIANEGTYTDPHILKARVSPGGQPRAEYYPRRRVHIDYRYFEPVIEGMSGAVRAGTATMAAHPDIEMCGKTGTSENPQGKDHSVFFGFAPRHQPKIAITVYIENAGWGGSFATPVAGLMMEKYLRGDIIESRKWIETKMLETDLIHDPKS
>AIA17514.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKIYLDAVKKIMDEGNDREGRYGPTRALFALPLRFKMKDGFPAMTTKKLAFRTVAAELLWFISGSGDNRELNRLGCHIWDANGNADYWKPKAKYEGDLGRIYGVQWRHWKRPDGKEVDQLKDVIERIKSNPYDRRLVVSAWNPGELDQMALPPCHMIFQFFVSDGKLSMHMFQRSADMFLGVPFNIASYALLLHIVARLTNLEADELVMTLGDAHVVHNHFDAVKEQLARESFPLCQLWLSPDIKSLEDLNTEQFKEPDDIFKIIKLENYQSHPTIKAPMGV
>AIA17507.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DFPGVTTHLATSWMPAYALGNKSRRRKVVVAPCHGTAVRVIVNDGRLTLQHVQRSADMPVGSVLNMVGYAGVALELARVLDVEPYRYVHCFMDAHTYENQIPWVKRLIRRRPRAFPTFKILDSAPRDLLAFRSEHFELSDYDPHPAMDDIPVTE
>AIA17498.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHELVQRVLDQGERREDRTGTGTLSVFGTQTRYDLREGFPLLTTKKVLWAGVVRELLWFLRGSTNIKEDLAQHTPIWDAWADEQGELGPIYGHQWRKWGAPFRTHARDKQPETAARSGAGIDQIQEAIQLIRKDPTSRRIIVSAWNVADLPHMALPPCHAFFQFYVQQGRLDMQLYQRSADIALGVPFNIASYALLLMMVAQECGLTPGVFIHVLGDAHIYLNHVEGLKVQLTRQPYPLPRVTIAQKPLDEIGFEDIQLHDYQHHPFIRFAVSV
>AIA17478.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEVYLKAVREALEKGTRKENRTGVDTISTFNINYEIDLREGFPLLTTKEISWKNIVVENLWFLSGDTHIGLLQKHKCKFWDPWADESGRVPSAYGNFWRHFPVHGPGGEPAFNDQLAWVLAELKRNPMSRRLVVSAWAPGNAQTSKLPPCHCLFMFNVQLDRSGEPLLCLHLTQRSCDIALGIPYNIAGYSFLLELFSRFTGIRAGIFAHTLVDAHVYTKKPDGSMAEYDHVPGLELQLSRTPRALPRLSIDPKIRGLDDIKPLLEASTEEVMRHFVLTGYDPYPAISFKVAV
>AIA17473.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|0
PSAFFLRKMGYPAVVGESFHSDEWRKEINSKKDWRKAFAYAKKLGYPVIAKPNSKSQGKGVYLSHSSQELKKALMEIFTLDRIALVQRPVSGHDYRIVVLDGTIISAYERIPLSVTGDGSTSIKKLLVQKQANFKKNGRDTRIKSDDPRIPIKLAKQKLTLSSVPGQGQKVFLLDNANLSSGGDAVDVTQEMHPAWKKLAARIAKDMNLRFTGIDVIVPAGLSVAPKKYWLLEVNDSPGIDNYAAIGPAQRKVVENLYRTVLKAMAR
>AIA17412.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KCNKRGLEEGDLGPGSYGPAWRAFSTAEGKPFDQITHLVEQITEMPHLRTHLVVPWIPQYLGRGTGKQQKVVVVPCHGFMHVIVNNGELSVHHFQRSADVPVGLVFNMVQYALFTMMLAQVTGYKAKELVYTLSDAHMFMQQKEAVEELLSREPRAFPTVTLDPSVKNIFDF
>AIA17356.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTPFDQIYQGIIKNIMDNGIREMSERTGLETSALPGVSFSIDPIKDGFPILTLRKIPIKVFIAEQMWFLSGARKPEDFLRDHTKIWDIFTNPGDVVTVAYGYRWRKHFGRDQIALLIDLLKNEPSSRHGVVIAWDPAQDGLSLQKKKNVPCPYTFTVNIIGGKLHFHNIVRSNDMVLGFPHDVAGFCLLQYILAQKLGVEVGIYSHSISNAHIYSNHYEGAKEMIARTNDHPQISIILPENSFERAEEKDVTLLDDLLNQVTTQYKPMDA
>AIA17316.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAFKAVKSELLWFLAMKDKERASDEELKALNGSERTIWTDNAESEYWKPKIQFPGDLGRIYGIQWRSWKSPDGKVVDQIAELIKKLKNTPYDRRLIVSAWNPGELDDMALPPCHMMFQCFVSGDKLSLHMVQRSCDLFLGVPFNIASYSMLLHMLAQVTGLKAHECILTLQDAHVYHDHFDAVKEQLSREPMALPQLWLNPEVKDIDSFTMEDIKLENYQSHPSIKAKMAV
>AIA17272.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|0
MPSLGRKISVDLPSEKSGNLPGPDYFDKEYNGKWRSPYILSMAIGQGELQLTTLQMAHAASIIANEGTYTDPHILKARVPPGQKPVVEYYPRRRVSIDYRHFEPVIEGMSGAVRAGTATLAYNPQFEVCGKTGTSQNPHGEDHSVFFGFAPRDNPKIAIAVYIENAGWGGAYATPVAGLMMEKYLKGEIIESRKALEERMLTADLIHKPKS
>AIA17265.1|FEATURES|farme|bacitracin|uppP|antibiotic target alteration|0
MEIYKPFAERTPDSQYQDLLRRIWEEGTEVMPIHGEKAKMVVGAQLRYRLANGFPVITERDLSGVFFKGALAEHIAFLNGARTQEQLEAFGCKWWDRWVTKERTAIFNLPEGDLGDGSYGAAWAAFPTAEGKPFNQVEHLMQQIKERPYLRTH
>AIA17231.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
EREVSLSSGKACARALREQGYNVREIDVKRDLTDLITQLEPRPDVAFNALHGRGGEDGCIQGVLEILAIPYTHSAPLASALAMNKQKAKEILKPMGVPCPDGQLVHIDDLRKGIAPFKPPYVVKPNNEGSSVGVFIIRQGDNKPPLGLDKWSYGPYALVEKYIPGKELSVAVMGAHLHKARALTVTEIKANTEFYDYEAKYAAGGSTHVIPAPINQDVFNEAMRIAAFAHEKLGCTGVTRSDF
>AIA17162.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKTLLILCGGRSDEHEISLISAHCVLEALDRSLFTPVVVGISKKGTWHLLDEKSFYTGGLRADTIKLNETGPTVMLAPFSKNGRGKLEANGKAVEFDAVFPILHGPFGEDGTLQGMLDMIGVPYVGANCGASWNCMDKVITKTICKENQIRTADFVALDSIEDFAPKKSKILALGTPMFVKPARLGSSVGVSKVSDPSQLEAAVRTAFKYDGKILIERGVKGREIECAVLGLRQNAKASLPGEIVVSPKIGWYSYEAKYLLKDGAETLAPAPLPEKTTKAVQEFVLKTFRAMECDGMARIDLFLEEKTDALYLNELNTIPGFTPISMYPKMWEATGVAYPKLITELVRLGYERIGKPF
>AIA17143.1|FEATURES|farme|beta_lactam|K678_12262|antibiotic target alteration|1
MKACGGDALGYARALTRVERIRRNAPALAAAATGGSLESRIRRLVDASYRERSTGGVSAGLILLTTLFAAVLCVHAAFSGKISVPPTSERASDSPVKTVSEDFRSPAAFGEKSILPDEGFAGENDELRRIARSALGRHHGSVIIMNPQTGRLETVVNQDLAFRREWNPASTFKLVTSLAALDKQKIAANDLIDLSETAENLNLTDALAFSRNEYFGILGRRVGSEKLFDYARRFGLGRLTGVNLPGEIAGRLPVSDFGLNAGEVGIYGRQIEITPLQLAVLVSALANRGTVVRPFAGRPPENSRPAPAGLNVSPDSIAEIVAGMRSAVEKGTGRAAFNDSLAIAGKTGTAREGRDDIGLFASFAPIENPRFVVVVALREPDADGAAAAEIAGIIYRELGEMPIEN
>AIA17062.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MLGNDAPIASLPGEIIPNHEFYSYEAKYTDDGATLKAPATLSPAVTKNIQALAIQAFQTLCCDGMARVDFFLRNNEEIIINELNTIPGFTTTSMYPRMWQSSGIHYPDVIYKLIELALEKFESEAVLKTDYVE
>AIA17057.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKIRVAVLCGGKSAEHEVSINSARNIIAALDPKKYDVTLIGIDKQGRWHLGNSVKLLGSHEVHHISGTEGLALMPGKSSELFLDAAQKQWLQPIDVVFPVLHGPHGEDGTVQGLLKLANIPFVGTGVLGSAVCMDKDVMKRLLREAGLPIPKFLVYNRRDVAKINFENVSAQLGLPCFIKPANLGSSVGISKVRNQQEFAAAVDAAFLYDNKIIIEE
>AIA17041.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
AAVAKAGVVAPSTVELADAEAALAQYGKLVAKPVADGSSYGLIFVNGPAELDQLKAAAAREAYVIEPFVAGAEATCGVLEQGGKVFALPPVEIRPADGAFDYVGKYLAKTTEEICPATFAPQINAAMQEAALKAHKTVGAGGYSRSDFIVTPKGPIFLEINTLPGMTAASLYPKSLKAQGIAFRDFLDGQIALAVARAKEAVS
>AIA17036.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKDIPKKIAVLKGGPGSERKVSLATAAGVSKALRSLGADVVDIDVQGPDFQVPSDAELGFITIHGTFGEDGQIQKILEDRGVPYTGEDMEGSKLAFDKIRSKEKFREHGVTTPEWEVIEPGQHPKIPLPIVVKPPREGSTVGVMIVKSPDQLDYAIAEAAKYGRDLLIEKFVSGRELTIGILGDQALPILEIIPKGGFYDFNNKYPFLNPQSGGGATHVCPAEIDEAKTREIQDLALGAFRALNLKVYGRVDVLLPENGPPTVLEVNTIPGMTEASLLPEAAAAAGIDYVSLCARIIELSAARTKGASK
>AIA16878.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MAYTGEGVSSSQIAFDKIRTKEKFREHGVATPAWEVIHAGQRPTIPLPIVVKTPRQGSTVGVVIVKSENELESAIAEAAKYDRELLIEKFVSGRELTIGILGDQALPIIEIIPKGGFYDFNNKYPFLNPKAGGGAEHVCPANIAAEKTNEIQNLALRAFRAAGLQVYGRVDVILPDNGPGTVLEINTIPGMTEASLLPEAAAVAGISYTDLCARIIALSQVRQRDARARTRTEDQR
>AIA16860.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MNGGFGKVAVLLGGRSAEREVSLKSGAAVLAALQRSGVNAQAFDPAERPLHELQGFDRVFIALHGRYGEDGTIQGALELMGIPYTGSGVMASSVGMDKWRTKLLWRAAGIVTPNFELVEADSDMAGIEARLGLPLFVKPANEGSSIGISKVKQKGGLKAAYEEAAKADPLVLAEKFIGGGEYTVGILGGMALPIIRIVPANEFYDYEAKYLRNDTQYLCPCGLSQAQEDQIRAEALQAFRIVGGRGWGRVDFLMDEAGRHYFLEVNTSPGMTDHSLVPMAAKAAGI
>AIA16803.1|FEATURES|farme|beta_lactam|TaR3-like_MBL-fold|antibiotic target alteration|0
MRNRTREVLSRFVESAHGKRGDVEGFLKHLPPHLFGGFGGNTPCIEVSTGDSRVIIDGGSGIRPLGYELMGGPCGKGQGEVHLIFTHFHWDHLIGLPFFVPIFIPGNKIHMYAVQPELEQVIRAVFKKPFFPVPYEYLGSKISFHALEPRKEFRLGDLSITPYQLDHPDPCWGYRFEHGGKTYAHCVDTEARRDG
>AIA16691.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MNVLVLGGGISAEREVSVRSTAAVVSALGAAGYAVVQADPADSDFDLATLAGKCDVVLPVLHGAGGEDGVLQKQLETIGVPFVGSGSAACALTFDKAQYREFVIARGVRVAAGQVVDQAQFETSGLRTKPYVLKPIDGGSSVDTVIVHNVAQQPDETYFDDLFARYDRMLVEELIEGQEITVGVLGDQPLPVILIVPPSDGEFDYENKYNGRTQEIVGPSQIPSETQQKAQELALQIHQMTGCRHLSRTDMILGLDGQLYVLETNTLPGMTDHSLFP
>AIA16629.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAMNMSKENMTKEFGKVGVLFGGRSAEREVSLMSGAGVLQALQSKGIDAHGFGTGLRSLSELAAEKFDRVFIALHGRYGEDGSLQGALEQLGIPYTGSGVMASSIAMDKVMTKRIWLSHGLPTPRFAAFDAQATSAAQLQQAAVELGMPLMLKAPHEGSTIGISKVSNATDMEAGFAHCAKYDEVVLAEEFISGRELTVPVLGKGRSARALPIVEIRAPQGNYDYQNKYFSDDTQYLCPAPLDAELTEKIQALAVQAFNAVGCAGWGRVDFMLRAADNAPYLLELNSSPGMTGHSLVPMSAKASGVSYEDLCVEILRSAALELHATQDWKPE
>AIA16617.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSRKIRVGVLFGGRSAEHEVSLQSAKNIIDAIDKSRYEVILIGIDRDGRWRLGDGSKMLDAGSPEAGVPEPSGDDPDVALVPGRQADQFISLGGAQSPEAIDVVFPVLHGPFGEDGTVQGLLKLANIPFVGAGVLGSAVGMDKDVMKRLLRDAGIPVGRFLSFQKYGAREPDFDAVVGELGLPLFIKPANLGSSVGIHKATDADSFHRAVDDAFGFDTKILVEEFIEGREIECSVLGNDQPIASVPGEILPRHEFYSYEAKYLDESGAALEIPAKLDLETSTRLRDLAVRTFLALCCEGMARVDFFLKKNGEILVNEINTIPGFTRISMYPKLWEASGISYGELIDRLIQLAIERHERERKLRTTYR
>AIA16567.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTTKIRIGVIYGGRSGEHEVSVRSARSVIEAVDPEKYEVIPVAITKEGRWLSPAESASLLPESAQRRLSNYAGVDSDGSTTLVVDPSRGGLLRQEGAGAVDQRLDVVFPVLHGTYGEDGTIQGLLEMAGIPYVGCGVLASSTGMDKVTMKTLFRHAGLPVCKYVWFLRRDWEGKPSEVRERIEREIGYPCFVKPANLGSSVGVSRADDEESLVKAVNLAARYDRRIIVEEGLDAREIECAVMGNDEPEASLPGEYVVHDEQARFLDYTEKYSSTGHVEFVVPAPIPKRLASRIRELAVRAYKAVDGAGFARVDFFLRRDDNKLLVNELNTIPGLTDVSGFPQMWEASGVPFKQVIDRLVELAFERHAEKARNTTSL
>AIA16554.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMQQIKERPYLRTHILSPWIPQYTLQHSGLTRRVVVAPCHGYVHVLCFPETKELVIHHFQRSGDLPVGVPFNFMQYAAFGLMVGQLIGYTLKEVVYTFSDVHMYESQYDKVRELLKREPKKLPTVVIADEAKGISDIMDFRPEHFVLSDYDPHPKMGIPTPV
>AIA16534.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTIIVLAGGISAERDVSLRSGQAVVEALESKGYRTILHDPIHGIDNLPEADAVFLALHGEGGEDGSLQADLEAVGRVYVGADATASALCFDKQVYKKLLAERDFPLANGQIVTKETIWQSPLTSQPFVLKPVDGGSSIDTHIIRDPANMPKAVIEKTLETYGEMLLEELIEGVELTVGILGDTPLQVVEIIPPAGGEFDFENKYNGASAELCPPEHLDQETQRQAQELALQVHGLTGVRDLSRTDMIATPDGRLVVLETNTLPGLTPQSLYPKAAAASGIGMPELVDRLVQMALNRA
>AIA16495.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTYILQPYDDLLEYVLEHGKEKQDRTGIGTLSVFGTQTRYDISEYFPLLTRRKVWPKAIFAELLWMISGSTNIKDLQNLGSHIWDQWQSEEFEQKNNFVPGSLGPVYGFQLRHFGGLYWQGEKEDFTYGYGGVDQLQQVVDLLRSDPDSRRNLFSLWNPKDLYRQKLPVCHYSFQVYVDDGKLSGMLTQRSCDLAIGCPANIQCYSTLLYMLAQQTGYQPGEFIHSIGSAHCYLNQLEGVQEYVCREVVSSPKLELKPAKTINDYAMDNFNVIGYNPLGKISIPVAV
>AIA16382.1|FEATURES|farme|multidrug|Mdr|antibiotic target alteration|0
LNNEQFGWVLSAFSLAYALFEIPSGVLGDRIGQRAVLIRIVLWWSIFTALTGLASGLVTLILVRFLFGMGEAGAFPTSTAVISHWFPANETTRGLSALFLGQTIGAAIAPLIVVPIAESHGWRSSFFVNGAFGLIWVLALFRWFRNNPAEMKGITAEERTYIEKNRRFQKHATSFLWRKVLKNRSLRALVAAFFCAQWGQYFFVAWMPVYLQEGKHFSEDQMKITTFLVFITAIVGVLISGFVGDWLAQKKGVVFGRRVLGMCALGGLSLSLFATAFLSDTRSVSASLITGYAFFVATGA
>AIA16369.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
PFYISKKGEWRSGAPLLGPAESKEVLTFSSGDAAAAPASNALAPIFGAIQTKGDVAIASTNTAGTKDTGLDVIFPLLHGTFGEDGTIQGLLEMANIPYVGAGVLASAVGMDKVMMKKVFAQEGLPQCVFRHFTRTEWEKNRAYHLVELETAIGYPCFVKPANLGSSVGISKARNQQELIEAVNFAFQYDRKVIVEENIDAREIEVAILGNDEPMASVAGEIVSSNEFYDYKAKYVDGNSAMIIPADIPAETSEQIRQLAVQAFLAVDGSGLSRVDFFLGKTDQKIYINEINTMPGFTPFSMYPLLWKESGKPYTELLDDLIRLAIERHTAKQNIQYSFDVE
>AIA16318.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MYKPYDQRVPDTQYRDALQSILDKGRWSETRQGPRAKTLIGVQMHFPFENGFPVITDRSIKSFWQKPIGELCGFINGARTREQLAEFGCTWWDEWTSLEKTSKRGLQPGDIGPGSYGAAFHDFPTADGGSFDQYKHIVEQIKELPELRTHFVTPWIPQYIVRGEGKKQQVTIAPCHGWVHVRIIENKLSLHMFQRSGDMPIGVPSNMIQYSALAMMIGHLTGYEPYEYVHTVSDAHIYEDQIEKLLPMLEREPRAFPTVRLTEEGKKITDIHDFRMEHFELSDYDPHPSIPKIPVAT
>AIA16168.1|FEATURES|farme|bacitracin|uppP|antibiotic target alteration|0
MEPRYKPYDERSRDFQYRELLIKCLPREMHPGGKGEFVKNEFQPTGRYSNFAAAPLDFYFDNGFPLITERRLGFWRKFLNEMWAFINGARTLDELRQYGDEKTWPNFWEKWVYPEKCAVFGLVPGDLGNGSYSVLGKYPTV
>AIA16137.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTRKLNQRNEMMRTTILFGGTNKERLVSVASAQALHQALPEAELWFWDVADTVHEVASQMLLGHARPFEDEFKPGNRGLPLEAALDKAKSEDRVLVLGLHGGRAENGELQAMCELRGIPFTGSGSASSNLAFDKAAAKRFAAIAGVAAPAGVALENLDAAFAEYGRLIAKPARDGSSYGLIFVNAKQDLVAVRNAAKTEEYLIEPFVAGVEATCGVLEQSDGTLMSLPPIEIVPGEGTFDYAAKYLLKSTQEICPGRFSADISAQLMDQALRAHRALSCSGYSRTDFIVSAKGLVYLETNTLPGLTAASLYPKALKAQGIEFSDFLRDQIALAERRSRERV
>AIA16045.1|FEATURES|farme|macrolide-lincosamide-streptogramin|RlmA(II)|antibiotic target alteration|0
MKNGDHPGHSTSHTAASAFSGDAVKSYLEGPPRQVPGFSSLHRMATLLMAERMPDNGRVLVLGAGGGLELKALAEAQAGWTFDGVDPSADMLQLARQVAGEHGNRIGFHRGNIDVAPEGPFDAAVCLLTFHHIPIEQRLETLLQIRRRLKSGAPFVIAHMSFLQSEPERSIWIDRHLAFGAIDGTDPARVENARKAMRERLHILAPEEEETMLREAGFSGVTLFYTAFSFRGWVAYA
>AIA15953.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQEGFPLVTTKKVHMKSIVHELLWFLKGETNIAYLKENGVSIWDEWADENGELGPVYGKQWRSWEGNGGEVIDQISDVIAQIKKNPDSRRLIVSAWNVADLPKMALMPCHSLFQFYVAENKLSCQLYQRSADVFLGVPFNIASYALLTLMMAQVCDLQPGDFVHTFGDVHIYSNHLEQVKLQLSRTPFTLPTMKLNPAVKNIFDFRFEDFTLENYQSHPAIKAPVAV
>AIA15950.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
METQRLLAEEKQGRGDTNVAILGDPSRSGLVRLGSRASEPERLDVVFPVLHGTFGEDGTLQGLLEMAAIPFVGCGTLASACGMDKVTMKALFKDAGLPICRHTWLLRSDWDHDQNKVIRKIIREIGFPCFIKPANLGSSVGVSKATDKKSLAKGIDLAARYDRKIMIEEEVVGREIECAVIGNEEPRASLPGEYVIHEESARFLDYTEKYSSTGHVEFLVPAKIPKATVKKIQAMAAVAYKSIDASGLSRVDFFLKPDGELLINEINTLPGLTEVSGFPKMWEATGVPFKSVIDQLIQMAIERHRERARNETSI
>AIA15719.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|1
MVKITERDMKDYWITIHPKKAEQKITKTDRKKVQDGKMTDEELYKRQLERISKKDLESFKDELEVLAIKRQMEGGYSNTPKIIKSDVTNEQYAVISEHLDELPGVDTTTYWERSYPENSTLRTLLGNVSSANEGLPKEKIQYYLSRGYSRNDQVGTSYLEKQYEAQLRGQKEEVKYVTDKKGSLLNTIQVSKGERGNDLVLTIDMKLQKAVEKQITDQLLAKKQMNGTEFLDRAFVIMMDPHTGEILTMAGKKYTIDKTTGTPKIEDFSLGNISTSYEMGSVVKGATVLAGLDSGAITPNTILVDNPIKIKGTPIKKSAEAVGLGPLNYSSALKYSSNVFMFKTVMAMAGLQYQPNMTLPIKADTFTKLRFYYNQFGLGVSTGIDLDNESIGLQGGNTIAGTALDLGIGQYDTYTPLQIVQYISTIANGGYRIKPQIVKEIRKPTIKTDEIGGTQYSFESEVLNRITMKEEYIKDIQNAFKRVTQEKGGTGYVAFNTAKYNPAGKSGTAQAYQKNPNGGDPIEVNNSTFVAYAPADKPEIAVAVAVPSAFLPNTPNTITKELARSALDTYFDLKKKGTV
>AIA15693.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VAQSGLFGYRNRMQPYLDLMRRILDEGVEQHDRTGTGTLSVFGHQMRFDLSKGFPLLTTKKLHIRSIMIELLWFLSGDTNVQWLQENKVSIWDEWADAAGELGPVYGKQWRRWETADGREIDQIRELIALIKRDPGSRRQIVSAWNPGDIGRMALPPCHLLFQTYVANGKLSLQMYQRSADVFLGVPFNIASYALLTHMLAQQCGLEAGDFVWTGGDCHLYSNHLDQAREQLTRDCRKLPKLAILRRPTDIADYRYEDFEISGYDPHPHIKAAVAV
>AIA15667.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
HKVVVETGINGREIECAVLGNDYPQASTCGEIVLNSEFYAYDTKYIDDNGAKVVVPAVIDATVNDKIRQTAVDAYQALGCSGMARVDVFLTADNEVIINEINTLPGFTNISMYPKLWQASGLDYTSLITRLIELALERHQANVALKTTMNT
>AIA15631.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MEDEKLAKVLVAVRDSSRYASVADDTVRRIATASLSAARGDVNDAVKRTKRGLHEIFGAYLPSTPRYDKLLGLLREAQSVEERRDVLSRTMSSHASTKERLPILTEFYAAVFERLPQPPRVIADLACGMNPLTVEWMPVGEDVLYRASDIDSRLMAFLDEALTVLGVPHEVAVHDLLTGPDPKPADVTLLLKAVPCIETQQKKLGWGLIDAINSPVVVVSFPTKTLGQKSKGMYRTYSSGFAAHAEGRPWQVEELEFGNELVYVVQK
>AIA15433.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAKFDQIYQTLLQDIMTKGVREVNQRTGHETAALPGLAFSIGIEQDGFPLLTLRKIPTKIFIAEQIWFTSGARKPDDFLRDYTRIWDDFTNPGDVVTVAYGYRWRKHFGRDQLGKLVALLEKDPSSRHGVVVTWDPSADGLGGVSKGNVPCPYTFTVNIIGGRLNMMNVVRSNDMILGFPHDVPGFALLQLMLAQRLGVKPGIYSHIIANAHVYDIHYDAAQEMISRPTDHPKVVLELPENSFLRAEKKDHDLVEEINDVLVSQYQPAERIKGLKIVL
>AIA15403.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target alteration|1
MKRFHLVVAATHVSQGIGRAGTIPWKLKGDMQYFKDVTSTVTKANAASLQNAVIMGKKTYLSIPVKFRPLVGRINVVLSRSSGVREELGLPDTVLTASSLEEALQLLSSPSVESRIDQIFVIGGASVYKEALESPRCGTIYLTKILKEYPDMDTFFPIIPADKFTLTSRTQVTTENDISYQFCTFDPVEEDRFTTQVVQATENPEEQQYLDLIKQILETGVRRGDRTGTGTISRFGVQMRFSLRDNVFPLLTTKKVFFRGVAEELLWFVAGCTNANVLSEKGVKIWDGNGSREFLDKSGLSHREVGDLGPVYGFQVRVLHCSSSMMSCLNPY
>AIA15387.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLEDIKKNGVLKPNRTGTDQIGVFGRQLRFDLSQGFPAMTTKKLFMRGIIHELIWFLQGSTNIKYLVDNDVHIWDEWPYRHYLMEQGKAVPDSASAEWQTGIQEFTQKIKEDSKFAKKWGELGPVYGYQWRNWPAPDGRHIDQIARAIDLIKNNPASRRIIVSAWNTADIDEMSKAGIPPCHLLFQFYVADGKLSCQMYQRSADTFLGVPFNIASYSLLTMMMAQVTGLQPGDFVHTFGDTHLYVNHLEQVDKQLSRQPRKLPTMKINPKVKSIDDFKFEDFELVGYDPHPGIKAPIAV
>AIA15346.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
TCDATTSAISMNKAYTKSIVNGIKGLHCARSIQLHKKDFHDIAAIGAALKFPLFVKPNNGGSSVGMSKVYKITGLSEAINKAFKEDDQVLVEQFIEGREFSIGVARINGHIQVLPATEIKSTKDFFDYEAKYTPGASEEITPADIPDEKMGEIVEIVTQVYMRLNCRGMVRIDFILLGATSYFYFIEVNTTPGQSAASLIPQQVRAAGMNVGEFYGALIEGA
>AIA15257.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
SKLKSFLRRRIEVFEIHQTPKRKNFFGLVLGTFSLFIIASAAYGAQQSLRSNESVKPNNGIATFDPLIQKTTEKILSKYIKKFDAKGGFVIIVDSRNGKVLASVNQRNQKNRAEKNWALSYRLEPASVMKGIVVASALEEKVTTPNEELNCESGKYSYGGHLYQDWKPFKNLTTSEAIQKSSNICGIKIGQKLGSKKISDSLKDFGFGNSGSTSEFPEAMAGQIPQPSQLSEPDYIALITTGYTGAPGFYVTPLEVVMAYAAIANEGRLMKPILSSEPDSSVKFMKQVISPETSKQMKVILSDTVKKGTGTNAQSRLYTTAGKTSTAFRPEPSENILVGGERGIAGFAGLAPVENSRLAVYVGIIDPMNTTKGDPHGNTHAAPVFREVIEKVLQQMNVSPDKSLSPE
>AIA15248.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target alteration|1
MPKMNFSVVVAATSNTFGIGRKGTLPWKIAEDMEFFKTITSTASSGKINAVIMGRKTYESIPAKFKPLSGRTNVILSRNPELRNVLNLPESVHVKSNLSDALNLLKEDQAIDRIFVIGGESVYREALESKFCSKIYLTEVNTDIPDIDTFFPVIRANVFRMTQRGEEKSNGELKYRFTEYEQIQPSSTFTTPTEPVLSPNPEEQQYLSLIKDIIDNGVLRGDRTGTGTISKFGVQMRFNLRDNTLPLLTTKRVFWRGVAEELIWFVQGRTNSNELHDKGINIWDGNGSREFLDSRGLSHRVVGDLGPVYGFQWRHFGAEVSLP
>AIA15173.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MDKLLVLQGGKSSEREVSLRSAATVTQQLHALGYDVVVADPAEADFNLEQVARDCNVVLPMIHGADGEDGVWQKQLEAMDKTFLGSGSAACALTFDKSKYREFVTAQGVRMAAGETVDRAGFTSSGLHQKPYVLKPIDGGSSVDTVIVHQLADEPDEAYFDELFARHPSMLLEELIEGDEITVAVLDTQALPIILIVPPGDETFDYENKYNGRTQEIVDPPQLAEETKQKAQELALRLHRMTGCRHLSRTDMIVNGDGNLYVLETNTLPGLTDQSLFPKAAAAVGYDMRALVKCFVTLAKEV
>AIA15159.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MSSIKSDQLAKQFGKVAVLLGGDSAEREVSLNSGRLVLQGLRDAGIDAHPFDPAERPLAALKEEGFVRAFNALHGGYGENGQIQGALDFYGIRYTGSGVLGSALGLDKFRTKLVWQQLGIPTPPFETVLRGDDYAARATEIVAKLGLPLFVKPASEGSSVAVIKVKSADALPAALIEAVKYDRIVVVEKSIEGGGEYTACIAGNLDLPVIRIVPAGEFYDYHAKYVANDTQYLIPCGLAADEEARLKVLARRAFDVLGCTDWGRADFMLDAQGNPYFLEVNTAPGMTDHSLPPKAARAVGISYQELVVGVLALTLQD
>AIA15126.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAQRKTARVAVLGGGNSPEREVSLRSARAVSAALSQAGYEVSELDPSHYDTDSLIAQLAGFDVVFPVLHGKGGEDGTVQALLESIGMPFVGAGADVSALCFDKTAYKAHLQELGLSLPFGVVVDRNTVWSQELTKSPFVLKPYDGGSSVDTFIIRDPQACDRAAIEDALDRHHTMLLEELIIGTEITVGVVGEEALPVIEIIPPADQEFDYENKYNGQTQELCPPQHVEESVQITARQLAAHIHTRLNIRDFSRTDLMIRQGDDRLFILETNTIPGMTDQSLLPKAAKTAGYDMAVLCDRLVSAALERK
>AIA15123.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
PTPEWLMAPADVDDVEKKIGWPAVVKPSKQGSTLGLTIVKKPEDLAAAIKQAYEFDDEVMIEKFIPGRELTVPVLGDEVLPVGEIFPKNEIFDYESKYQTGGAEEVFPADLTGPETVAVGVLALNAHRALKLRGFSRIDFRLDDDGGFWCLEANTLPGLTAASLFPKGAAAAGIPFPDLCERLCRLAIEEHATRRRV
>AIA15036.1|FEATURES|farme|beta_lactam|pbp1b|antibiotic target alteration|0
MLRKRLRRKLTAKAKAKAAASASASKPRIEGNATTVSADSERVKAPKRNRRRFSKIAVWLGGLMVVIAGIAFFVTAHWVRGLDISKLENPLPEPTLIMDRNGKPASQLSSSRIVPVSLDQIPLDLRNAVIAVEDRRFYEHSGIDLWSTARALLRDLKSGEMKEGGSTLTQQLAKNMFLASDKTLSRKLKEAGYALKINTVYSKDEILELYLNSIYFGEGRWGVEGAAQEYFAKPVQELKLEEAALLAGLPKAPTTYSPAKNMQKALERRNLVLSLMKEQNFITEAAYEKAVAQPIVLKQHNEESLKGKYPSYVDYVIQEAADVYGFTEEQVLTNGLRIYTDLDPQVQQAAQDVYASDALFPESKPDQLIQSGAVIIDHKTGGIRALVGTRGPQVYRGFNHATQLKRQPGSSFKPLAVYGPALERGYTPSSSLYDGDLDIAGYRPKDWDGQTRGQVTLREAIMRSWNIPAVWLLNEIGIDAGIDFARRAGIALGPADRSLSIALGGLSEGVSPLQMAQAFGAIANLGVRHQAHAIVKVTTKEGYPLVEAQPQPAAVTKPAIAYSLTLLLQDAVKSGTGQAAALGRPTAGKTGTTQLPDTKEFADIGANGIKDAWFVGFTPELTAAVWIGYDQTDKNHYLTTGGAVPAAVFKEIMSRALRDVSASSFSVPDDYVPEPEPTSTWLQSIQEKLGIGKPAANAEQSKNKDNENGKTKGKGKPKEH
>AIA15030.1|FEATURES|farme|fosfomycin|fosB|antibiotic target alteration|0
SRLIENAAALVNDKRIEGISEIRDESDRDGMRIVFELKRGEQADVILNNLFKHTQLQISFGIINLSIVNGQPRELGLISTIKYFIEHRIDVVRRRTDYELRKAREREHILLGFRVALDNIDEVIRLIRAAKSPKEARDSLVAASTKFTFNEVYLKAAGAAEPMRQLSERQAQAIIELQLQRLTGMEQEKIANELADIQRRIAEYLEILGSEKVLRDLIVKELKEVQKDHADERRTKIIEDPGDIRLEDLVAVEDMAVTVTHGGYLKRTAVDTYRRQTRGGKGRIGMGTRNEDFVEYFLVASTHNYLLIFTNKGRVYWLKIYEIPDASTSGKGKHISNLINLQPDETVKAFLPVREFVPDRYIVMVTKLGVIKKSELSEFDNPLSRGIIGATN
>AIA15031.1|FEATURES|farme|quinolone|DNA_gyraseA_C|antibiotic target alteration|0
MIAARLSSGKDYIFLGSHAGQSIRFSEDKVRPMGRPARGVRGMDLDDKDYIVGAEVIGEEGLVLSISENGFGKRTAVGDYRLTNRGGKGVINMKTTSKTGKVVGILSVKEDSELMIVTRDGKMIRIDSGEIRQVGRSTQGVRLVRMEENDQVAAACLIPEADDKNGDDGQTNLTLQ
>AIA14996.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKRKLGIIFGGRSGEHEISIRSAATVIAEADPDKFDLLPVAISENGSWLSPADSCALFPSETRDLIQSRFGEMPDTVHRITGDASIGGFLADGGEVIKVDCVFPVLHGTFGEDGTIQGLLEMAGLAYIGCGVLGSSCGMDKVVMKTLFRDAGLPIGEYVWFLRSEWERAADVIVSQIESKLGFPCFVKPANLGSSVGISRAENTDGLRAAIDLAAEYDAKIIVEAGLDVREIECAVLGNDDPAASEPGEYLIRDQTKAFLDYTEKYSATGNNEFVVPAPLSAELSAKIRKMAAEAFKAVNGSGLARVDFFVRRDTGALILNEINTMPGLTDASGFPKMWAGSGKPFRQVIDELVELAIERFNDKARNKTAR
>AIA14964.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLQQIMREGVREVNQRTGHEVAAVPGLTFSMDLERDGFPLLTLRKIPTKIFIAEQIWFISGARKPDDFLREFTKIWDDFTNPGDVVTVAYGYRWRKHFGRDQLQKLVTLLQKDPSSRHGVVVTWDPSNDGLGGVNKGNVPCPYTFTVNIIGGRLNMMNVVRSNDMILGFPHDVAGFALLQLILAQKLGVRPGVYSHIVANAHVYDTHYHAANTMSERLTDHEPVIITLPSNAYDRAEKKDRALVEEINTQLTNQYTPDSAIKGLRIVL
>AIA14946.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MTATQTKLTLNKQTRIAVLYGGLSSEREVSLTSGKGCHDALKRLGYENAVLVDVGHDIARKLVDEKIEVAYIALHGKYGEDGCIQGLLELMGVPYTGCRVAASALTMNKALTKSVLKDAGLPVIDSVVLKAGTVNGKAVRYRAELPGDGQTHQRGLQHRHEQGGQGRGPERGPHHGL
>AIA14877.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNQYHDLLERILSDGAEKHDRTGTGTLSIFGHQMRFNLAAGFPLLTTKKLSLKSIVHELLWFLKGDTNIRYLQENGVSIWDEWADANGDLGPVYGSQWRSWPAPDGRSIDQISNVIDMIRRNPDSRRLIVSAWNPADVDRMALPPCHCLFQFYVANGKLSCQLYQRSADVFLGVPFNIASYALLTMMVAQVTGLKPGDFVHSLGDAHLYTNHLDQARLQLTRPTRALPIMKITPAVKDIFAFRYEDFVLEGYDPHPHIKAQVAV
>AIA14823.1|FEATURES|farme|trimethoprim|Thymidylat_synt|antibiotic target alteration|0
MKAYLDLLHDVMINGVVKNDRTGTGTRSVFGRQLRFKLADGFPLLTTKKLHTRSIFAELLWMIAGDTNNNTLRDQGVTIWDEWAKDDGSLGPIYGEQWRAWKGGYAGYHDAVMGKRERIDQLSQALDLLR
>AIA14810.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKQTTILFGGSNKERLVSVASAQALNAALPEADLWFWDADDTIYATKPEALRAHARPFEEPFTAYETRVGTLAEALDRAASDGRVLVLGLHGGRAENGELQAMCELRGVAFTGTGSAGSHLAFDKIAAKRFAALAGVAAPAGVSLADIDRAFAEYGRLIAKPARDGSSYGLIFVNAKQDLVAVRSAAKTEDYVIEPFVSGIEATCGVLERSDGTVIALPPIEIVPAEGAFDYTAKYLLKSTQEICPGRFSPDVTAAIMDHALRAHRALSCRGYSRTDFIVSGKGPVYLETNTLPGLTAASLYPKALKAQGIGFADFLRDQIVLAERAVRPA
>AIA14807.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSKVDKAEDLKEALTTAFKYADEVMVEQYVKGKSLTVGVVEVNGQPKVTPILELRPTKSEWYDLEAKYTEGGTEFIMPAELPDTVTTVIQDATLRAHLAAGCRGMSRIDFVVDAQNRFYILEINTIPGMTPLSDLPAQAKAMGIDYDQLVECILMTAVN
>AIA14801.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MMDRKVPGKIAVLMGGPGSERKVSLATARGVAKALRSLGAGVTEVDVKDENFEMPADAELGFITIHGTFGEDGQIQKILEKRGIAYTGENVLGSEVAFDKIRSKEKFREHGVTTPEWEVIQPGQRPTIPLPIVVKPPREGSTVGVAIVKTEDHLDFAIAEAAKYGRDLLVEKFVPGRELTIGILGDQALPILGNNSKGRFLRF
>AIA14758.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
YIDRQGKWWLLEMLGNVIDTHGAPQLAPVLGSGSFVTIPNNRVIKPDVILPILHGKNGEDGSVQGLAQLLHIPIVGCDMTASAICMDKIATKEILMTHHIPVVPYVTHRVNGPTLDFNHLSMKLGSPMFVKPARAGSSVGVSKIYSEEELTKALEVAHQHDDVVLIERGIVARELEVAALGNPPHYKISGVGEIKPGEDFYSY
>AIA14737.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MNVLVLAGGSSSEREVSLRSGANIEQSLRGLGHMVVTADPSGPDFNLKQLIAGIDAVFPILHGAGGEDGVLQEELEKLDVPFLGSGSKSSKLAFDKFAHKKLLVEKGILTPGWEMVDDRSFSGSQLARQPYVLKPFDGGSSVDTFIVRDPTNPPSGINRALEGHGKMLIEELIEGNELTVGVLGDESLPAILIVPPEGEEFDYENKYNGKTKEIVNPDTVSTNLQQQAQALALRVHQITGCRHFSRTDFMLSQSNQVYVLEINTIPGMTSESLFPKAAAAAGHDMNALTKKLLELTLAS
>AIA14721.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MATFDGVYQRLLTDIMSNGIREVNQRTGHETAGLPGVSFSIDVEKDGFPLLALRKIPTKIFIAEQIWFISGARKPEVFLRDFTKIWDDFTNPGDVVTVAYGYRWRRHFGRDQLGMLVSLLQKDPSSRHGVVVTWDPSSDGLGGANKANIPCPYTFTVNIMGGRLNMMNVVRSNDVILGLPHDVAGFCLLQLVLAQKLGVQPGVYTHTIANAHVYDIHYDAAQEMTKRTPDSPKITLQLPENAYARAEAKDVSLVEDINGPLVAQYHPGEAIKGLRIVL
>AIA14709.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSNKILVLQGGTSDEREVSLRSAANVIGWLEKDGYNVVVADPASADFNLADLSAHCDVVLPLLHGEGGEDGYLQGQLQELQKPFLGSDSGACELTFNKALYREFVIKQKIQMPQGVVVDRAQFDTAALRQAPYVLKPIDGGSSVDNVILPDLSKEPDSSYFDELFNRHREMLLEQLIGGQELTVGILRNKALPVIHIVPPENEEFDYENKYNGRSQEIVNPPDIPHEKQREAQNLALKLHVLTGCRHISRSDFILAEDGTLYTLETNTIPGMTEQSLFPKMAAADGVGMAALVRSFVEMAEGL
>AIA14696.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
AKLMRTTILFGGTNKERLVSVASAQALHQALPDADLWFWDADGTVHETRSEALLKHARPFEDAFKPGTPGIGPIEQALDQARAQDRVLVLGLHGGSAENGELQAMCEMRGIPFTGSGSACSHLAFDKIAAKRFAEIAGVKGPPGVALHDIEGALAQHGRLIAKPIRDGSSYGLLFVNSTQDLVAVRLAAKTEDYLIEPFIAGTEATCGVLEQLDGSLIALPPIEIIPAEGPFDYVAKYLAKATQEICPGRFTPEISRQLMEQSLKAHRALSCGGYSRSDFIITDKGPVYLETNTLPGLTKASLYPKALKAQGIDFADFLKDQITLAARRARK
>AIA14687.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRIGIFFGGPSREREISFAGGKTAFEYLDKSLFEPVPVFVDSFGRFILLQKELMYSTEIREFYPAPAHQKGGFKTYIESFPELANESVPPSIGTLISPEQFAEHFDFAFLAMHGPDCEDGAIQGLLEWYKIPYSGPGLMGSAVGIDKILQNDMIALVNGQDKKSWTLKYSQWVPREYPLLFQVLKKHLGLPLVIKAPHQGSSIGVAIVKEDSLDEFVSAVNQCFFQIELTSATWKEFDQAEKLAWGQKIANLDEGIGFPVIVGGKTIHHPSTLIDELESHFAAGNADALVSSANAEDQVLVEEFVNGQEFSCGCIQFDDGSPLALPPSEVIKMVTVFDFNAKYKPGASRKRIPVDTTLEKNQEIQQVIASVFQQLGIDVCARIDGFLTENGTILLHDPNTIPGMSPTSFIFKQMAEIGLNVTHALTYLVRQSIRERIRTGKQTWRLRDLLAGLDDQITANNAVSKPTEQIVFGATDEEYIQARLRYGKLNGEGKVKPVPVLKISESEYYKLPNPLMFKEYVADVEALLHTERHPLLTETSEKAARLTAFYAGEVSYEVEAFSELSALG
>AIA14662.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|0
MKTTILFGGTSRERLVSVASAQALTQALPEADLWFWDLDGTVHVASQAVLLGHEKPFEVPFKADSVTLGSMEAALDVAATEDRILVLGLHGGTAENGQFQVLAEARGVPFTGSGSAASHLAFDKTAAKLFAGLA
>AIA14637.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MRARCPVIEIRAPEGNYDYQHKYFGDETKYLCPAPLDQALTLRIQDLAVKAFNSLGCRGWSRVDFMLRSADNEPFLLEINTSPGMTGHSLVPMSASESGMSYEDLCVKILRSAALDLKPSADRKPV
>AIA14628.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGILFLFQAFTLVIIDVFNYNHNEMASFDVTYRSLLKDIMDKGVREANSRTGHETASLPGMSFSIDIESEGFPLLASRKIPLKLFIAEQIWFISGTRKPEIFLRNYTKIWDDFTNPGDVVTVAYGYRWRKHFGRDQLGSLISMLEKDKSSRHGVVITWDPIGGRLNLMNVVRSNDMMLGFPHDVAGFALLQAILAQRLNVKPGIYTHVIANAHIYDIHYEAARQIIKRPVGSAPIRLTLPEGSFKRAEDKDDNLVDEIYQNLAAEYEPGEAIKGLKIVL
>AIA14430.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAKFDELYKVLLESILNKGYRELNSRTDHETAALSGLTFSVDIKKDGFPILNLRKIPVQLFVAEQVWFISGARKPEIFLRNFTKIWDDFTNPGDVVTVAYGYRWRRHFGRDQLKLLVELLAKDPSSRQGVVVTWDPASDGLGGVSKSNVPCPYTFTVNIIGGRLNLLNVVRSNDMILGFPHDVAGFALLQCILAQKLGVEPGIYTHTIANAHVYDIHYEAAKDMIGRQSSKEPINLTLPDKSFDRAEKADISLVSEISDNLSAQSQPQQPIKGLKIVL
>AIA14294.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKSQAKHPEYQYLDLLQEILDNGIRKVDRGTDVVLYSLFGRQTRYDLSQGFPLLTTKKVYWKGVLHELYWFMSGNSNIKYLVDNNVHIWDDYPYKIYNWKREKTKLPELTKDEFVEKIATNAPFAKKWGELPKIYGEQWRRWPTRTPKRTVDQLGWVLQELKDDPDAKNLIVNSWNPEYLYTMATYEDASRFPICHNMYQISNRNGKLSLQLYQRSADMFLGVPFNIASYALLTIILAKLTGLEPGEFVHTFGDVHIYENHIDQVKEQLKRKPKPFPTVSIDKSVKTLDQFRPEHVTLENYDPHPMLKGELTVAGGFYEDKKKKAKKK
>AIA14193.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GFPLLTTKKVLWTGVVRELLWFLRGSTNIRDDLSQHTPIWDAWADEEGELGPIYGHQWRRWGAPFKQHARDKHELVGVREGVGIDQLQQAIDLIRKDPNSRRNIVSAWNVADIPHMALPPCHAFFQFYVSNGRLDLQLYQRSADIGLGVPFNIASYALLLMIVAQETGLTPGVFVHTLGDAHIYLNHIEGLKLQLTREPKPLPSVRIANKPMAELQFEDIQLIDYQHHPFIKLEVSV
>AIA14153.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MTTPTVAQELGKVGVLYGGRSAEREVSLMSGEGVLAALRSRGVDAHGFDPARQNLAQLAEQAYDRVFIALHGRYGEDGTLQGALEQLGIPYTGPGVMACALSMDKTMSKRVWMSHGLPTPRFMVLEKDANPAQLDAVASEL
>AIA14075.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
TANLLSQEMTESREALTIVGDPSSSGLVSVAADHGRASSMPVDVVFPVLHGTYGEDGTIQGLFEMADVPYVGCGVLASSCGMDKVTMKKLFREAGLPICKHVWFLRAEWEQKRASVVGRVARELGFPCFVKPANLGSSVGVSKATDKRTLAAAIDLAARYDRKVIVEEGLDAREIECAVLGNDEPEASQPGEYLIHDQQGAFLDYTEKYTNTGHVEFVVPAPIPKPLAARIRRMSVEAFKAIDGTGLARVDFFLRRDTNELLVNEVNTSPGLTDVSGYPKMWAASGLSFKQVIARLIELALARHEDKSRNETSL
>AIA14036.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTTTHPEYQYLDLIRRIIEKGFYRPSPHAPLPGKGANPGTYTLINQNMEFDLSTGQFPLMTLRQAFFKSILKELLWFLSGSTDNADLKAMKAGLWHPWDTPDTNQSIGWAPGQLGPIYGKQWRHWRATMSRPDGTLDSPGFDQITNLVEGIKSAPHSKRLFVSSYDPQDAKDCFVTTCHGTFFVSVFDDRLNLHQIQRSGDVPVGIPYNIASYSLLIYMLAQV
>AIA13848.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DTPDTNQSIGWAPGQLGPIYGKQWRHWRATMSRPDGTLDSPGFDQITNLVEGIKSAPHSKRLFVSSYDPQDAKDCFVTTCHGTFFVSVFDDRLNLHQIQRSGDVPVGIPYNIASYSLLIYMLAQVTGLQPGTLYHTISDAHVYGNQVPAMRSLLEREPLPYPSVRINPDVKDIFAFTVEDFELVGYEHQGPLDVPVAV
>AIA13798.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MPNYKPVSERTPDTQYRDILKHIYDNGEYGTTRQGPRAKTIIGVQAHYQIANGFPMIPDRDLSKFYAKPIDELAAFINGVRTREGLEEYGVTWWDAWTTPEKSQKRGLEPGDIGPGSYGAAFHDFPTADGGAFDQFKHLVEQMKELPELRTHFVTPWVPQYIVRGEGKQQKVTLAPCHGWVHVRIYNNAIHLHMFQRSADWPVGVPSNMVQYGALGLVLEHLTGYEFKEFVHTASDAHIYEDQMEKLPPLFDREPKPFPTMQLNAEGKKIKDIHEFRSHHFELTDYDPHPSIGRLPVAT
>AIA13756.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
KAPHEGSTICISKVASASEMQAGFDNCVRYDDTVLAEEFISGRELTVPVMGAGRDAHALPIVEIRAPQGNYDYEHKYFSDETQYLCPAPLDAALTARIQSLAVEAYRALGCSGWGRVDFMLRDVDNAPFLLEINTSPGMTGHSLVPMSARAAGVSYEDLCIDILRLARLDLKPTPGWKPV
>AIA13730.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MERDVSIASASQVVGALRSRGHQVIAYDSGRGRLAAADEQRLFAGKIDREPPDKRAVASLPTVVSAPDLADVDLVFLAMHGGTGEDGTVQALLDLAGIPYTGSGKLGSALGWDKDVAKRLFLAAGVPTAEWLMAPASPDLVAQRIGFPLIVKPNGQGSTVGLTLVATPAELAAAIELAGGFDSAVMIERYIAGREITVGILDDAPLAVGEIIPKTGPIFDYAAKYQSGGAQEIFPADLTPEQTARAQDLALRVHRALKLDTYSRVDFRMDAAGEFWCLE
>AIA13696.1|FEATURES|farme|macrolide-lincosamide-streptogramin|RlmA(II)|antibiotic target alteration|0
MAVSKKTFTTVDDDKLHQLLGKFVTDFGAAFHAGMVVIGMELGLYKDMANEGPTLPSELAERTGTNERYVREWLNSQAAGGYVEYDTDTGRYFLTAEQAFTLADETSPAYMPGAFLLAISALRAVPKITERFRTGDGLGWHEHDSGLFRGTELFFRPGYAANLVSSWIPSLEGVEAKLKDGAKVADVGCGLGASTILMAQAYPNSTFTGFDYHDASIEMAKERAREAGVSDRVNFEVAKAKDYPGTGYHLVTFFDCLHDMGDPVGASAHVLESLAPDGAWMIVEPFAEDNVEGNINPIGRAFYGASTLLCTPASLSQEVGLALGAQAGESKIREVVTEGGFTRFRRATQTPFNLVYEAKP
>AIA13550.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MGEKVRVGLVYGGRSGEHEVSLQTALAVMKAFDYTKYEIKPFYIAKDGEWRAGDTLLAPPSALDQLRLAGVDAIIGTSALMPVFGGQSENQDASIAISSVPGAVTISSVGQQVDAVEASEDGQIDVIFPLLHGTFGEDGTIQGLFEMANIPYVGAGVLASAVGMDKITMKKVFAQEGLPQCVYRYFNRTQWQKDSDFYIMEIETALGYPCFVKPANLGSSVGISKARNREELIAAVDYALRFDRKVIVEEFVDAREIEVSVLGNDEPRASVVGEITSSSEFYDYKAKYIDGKSMMHIPANIPAEVSDSVREMALRAFLAIDGSGLSRVDFFMRKEDGQVFINEVNTMPGFTPYSMYPLMWKESGVPYTELLDTLIALAIERHAEKQ
>AIA13354.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|0
AALRDKHPARLALPSGTNESAPLPQQARALIVVPGTSPEHFRIPVEAAQFLHSKLPDSSAIIDYSTLFSYALDNGLHNQYVVECLYGTEAIEWDEPIWRGAMDALGLRRVGSPIITCALAIDKLIQKRLFDALEVPTASWSLCSATSEALRLGWPMIVKPRRESQSKGVALLHDAREWEQFLKIVPVAELDCWLAESYLPGREFCVGVCSLSESQHEVLPILEIPHDAGHSINDPEDKAQRRGVVSFPEELPARLKSALETETLKVHRAFGSPPLARAEWRLDADGIPHIFEYDCTPGLTRSSYLTSMFEKTGRSVSDVLADLARSPQFRACRPAHASDSQPAA
>AIA13352.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKVIVLCGGSSPEREVSLRSGAAVAAALEKNGHDVRIVDPQDGLQNYGAELEHADVVFPVLHGVGGEDGSVQQVLEAIDVAYVGSSSAVSSLCFNKERTKKRLREAGIAVPEGMMVTSSTVWESPLVSKPFVLKPVDGGSSIDTFIVRAPEEADKLAIENALGRHKQMLLEELIEGIEITVGVVGDDAMPAIEIIPPEGGEFDYDNKYNGKTAELCPPVHVTPGQQYKVQKLAAKVHHVLGCRDLSRTDFIMDGSGAFYALELNTLPGMTDQSLLPKAAAAAGMSMEDLVDKLVRAAIKRGPKR
>AIA13349.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAKFDEIYKSLLKDILNNGQKELNTRTGHETAALAGLTFSLDIEKDGFPLLNLRKIPIRLFVAEQIWFISGARKPEIFLRNFTNIWDDFTNPGDVVTVAYGYRWRRHFGRDQLKLLVDLLAKDPSSRQGVVVTWDPAGDGLGGVSKSNVPCPYTFTVNIINGRLNLLNVVRSNDMILGFPHDVAGFALLQCILAQKLGVKPGIYTHTIANAHIYDIHYKAAEEMISRQHKQSKINLLLAENAYERAEKADVKLVAEIADSLSSQYKPEDSIKGLKIVL
>AIA13166.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MSRSSGDDITELITSVRSSQKYAAISGAMIRSIGLRELAARRNLKEAIKATKNKLHQVAGAYLDARLPYDDWLALLEAAVADDRRTTNDDESLANSKLRQACREIMRHHASTRERLPILESFYASTLASLGPVRSVLDLACGLNPLALPWMPLAPDARYYACDVYADMIALFE
>AIA13130.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTQHPEYQYLKLMADILQNGKSKPTRGIHGIKSIFGYQLKFDLRHGFPLLTTKKMPFQILLHELLWFVSGDSNIKYLQDHKIHYWDEFADKDLNLGPVYGVQWRHWQDPHSKDKNGEIDQLQWAIDQIKNNPHSKAILVSAWNPADLEEMRLPPCHTMFQFDVTKGKLRMLLYQRSSDVFLGLPFNIAQYTMLLCMVAKLTGLEARELVVSIGNAHLYNNHLEQGR
>AIA13114.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYHELLKSILEKGTEHQDRTGVGTISHFGHQTRFDLREGFPIVTTKRIPFRWVAEELFWFLSGDTNEANLRSRGVDIWAEWADEEHTKRFGREAGDLGPIYGYLWRSFGGHYPKLDGVDQIARLMREIRDNPNSRLIVTGWDPSQCDNVDLPPCHTLFQFKVENQKVLHCQLYQRSADAFLGVPFNISSYALLTHMIAHASGLEAGEFIYTLGDYHIYKNHLSQVEELLSRTPLKLPHLEIHSETGGPSGLEGLLKMRFEDLKLVGYESHGKIAAPVAV
>AIA13007.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MAHHASTRERLVILDEFYCTLFADLPPITSILDLACGLNPLAIPWMPLPAGVTYAACDIYQDQVDFLQQCFVVFGVEGAAKPCDLLQACPTQAADVVLLLKTIPCLEQVDKTIGRKLLDTLNAPILCVSFPAQSLGGRHKGMTVNYEQHFRELVADKPWRIERFDFATELVFRVLK
>AIA12964.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YDLSQGFPLLTTKKVYWKGVIQELYWFMSGQTNIKYLVDNNVHIWDDYPYKIYKQKINVIASKAKQSHKIESSIKDRRVAHAPRDDKSREMTKEEFIEKIKNDAAFAKKWGELPKIYGEMWRSWPTRKGGKIDQLGWVLKELKEDPDARNLLVTSWNPEYLYTMAAHEDASRFPICHNMYQVSQKDGKLYLQLYQRSADLFLGVPFNIASYSLLLLILCKITGYKPGEFVHTFGDAHIYANHIEQVKEQLKRKPKPFPKVVIDKSVKKLADFRPDLVTLEDYDPYPTLKGELTIAGGLYEKSVKSTRNG
>AIA12913.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MTEREKLPKKIAVLMGGPGSERKVSLATGRGVAKALRSLGAEVVDVDVRDENFQLPDNVDLAFITIHGTFGEDGQIQKILERRGIAYTGEGVSASEIAFDKIRTKEKFREHGVTTPPWEVIRTGERPTIPLPIVVKTPRQGSTVGVVIVKNESELESAINEASKYDRELLIEKFVAGRELTIGILGDQALPILEIIPKGGFYDFNNKYPFLNPQAGGGAEHVCPANIDARKTKEIQQLALRAFKAADLQVYGRVDVILSDSGEPFVLEINTIPGMTEASLLPEAAAAAGIGYVDLCARIIALSGVRQGCREQAPARTEGKQ
>AIA12778.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSAHCFGKGVSEVPPDHRSARHAAYRGSNSDHAGAGAGRRRRDVPRAACGAGEDGTLQGLLDLVGLPYTGSGRLASAIAMDKDISKRLMLDAAVPTPEWLMAPAPFEEVEKKLGLPVIVKPSKQGSTVGLTLVKTREEYEPAVRMAFQHDDEVMIEGFIAGREFTVPILGDAARFPSVRSSLRARFSTTRPSISPDRRARCFPRTSHPRRQRRCSSSRSRRTAR
>AIA12774.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
GKLKSKEKFHEHGVVTPEWEIVRSNERPKIPVPIAVKPPCQGSTVGIVIVKNEGELDSAMAEAAKYDEKLLIEKFVQGRELTIGILGDLALPIIEIIPKGGFYDFATKYPFLNPQAGASAQHICPANIDPAKTKEIQELALHAFRSLGLKVYARVDVMLSDTGEPFVLEANTIPGMTETSLLPEAAAVAGLSYPELCRRIIELSYAARPKGAGR
>AIA12637.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MGRCAFVVLPAALIKNPQDFKIAIHHELQHHRSGDTLWAWMTELLHCGFFINPAIYLWQKTITEIQEFSCDEALIGRRRVLPNDYGSCLLRVAEAALGVRRMQVGTTCMNAKSKNPKSFLRRRIEMFRQHEKPPRKRVFGLTLGLVCLFATVMTAYATQSPRTPINAKVNQGHAEFDPKIQAVTEKILREYVKKFKARGGFVLVSEPSTGRLLAAANVSDDHALQGNWALSYGFEPASAMKTIIAASAIDHRLTSTNEVQNCENGTYSYGAHVYHDWKPFQTLTTAKTIVYSSNICGIKIAEKLGTSGLHSTLTDFGFGVGGSASEFPEAMVGQIPDPNQMPAAEYIALGSTGYTENPGLKITPLEILQAYGAIANEGRLMKPIMSSLHDSAASVVRQVISPGTALAMKKVLTDVVLTGTGKNARSSIYTTAGKTSTAYNPNSPSHHLLGGQRGIGGFVGFAPVDRPRLVVYVAMIDPVGSQDGQPHGNEHAAPVFREVIEKLLPMMP
>AIA12475.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LMKQYHELLQSILDNGYEHEDRTGVGTISHFGYQTRFDLRSGFPIVTTKKIPFRWIAEELFWFLSGDTNELNLRAKGVDIWAEWADEAHTERFGRSAGDLGPVYGYLWRSFGGHYPKFDGVDQIKNLIDQIESNPNSRRLIVTGWDPHQADNVDLPPCHTLFQFKVEQSGLLHLQLYQRSADAFLGVPFNISSYALLLHMVAHVTGLKAGEFVYTLGDYHIYKNHLQQVRELLRREPLHLPRLEIVDEGKRFRGLAGLLAITYDNLKLVGYQSHGKIAAPVAV
>AIA12445.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MKVLVVGGGISAERDVSLASAKAVFNAAVAGGHVAEFYDWDGTTQWLKQHGSTFDVVLPILHGEGGEDGTIQKILEASDVPFLGSDSTASELCFDKNRTIDLLAHNGINTPQGEVVTYQDYLKNPLFNAAHVLKPYNGGSSVDTFIYPDPAQKNVQLIEEAFKRHSSMLLEPFIAGTEITVPILQDKLLPVIEIIPPEGGTFDFENKYNGKTRELVPAQNVSAQMQDKATKLGNEIHRLFNCRHLSRIDMIIQDEVIYVLEINTMPGMTNHSLFPKAALASGIDFAALVSYLIQISAAAV
>AIA12380.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MEDGLKSDDVVLDRVVEAVLGGSKYRHVSRALVREIGRVELGKGRGMKEAVKAVKNKLHQVAGAYVEGGDSGSRPYERWLGELREAAGSGDGESLKGGCRRIMGSHASTRERLPILEEFYGRIFEELPPVRSVVDVACGLNPLAIPWMGLADGTGYVAYDIYEDMMGFLGGVLGIFGVEGRGETRDVVAEPSVEEVDLALVLKAIPCLEQIDRSAGRRLLDGLKAKNMVVSFPVASLGGRNKGMAANYEARFWELAEGQDWVVKKLVFRSELVFVVAREGSL
>AIA12373.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
CKHTIENLGLPLFVKPCAMGSSVGIHKVTTKEKLISAIQDARQYDHTVLIEAFVPGREIELAVLENRNSVENPKVSIPGEIRVFHPDGFYSYSAKYLESEQTELIVGPALEGNLQQQLQKAAADIFVRLKCKGMARVDFFLCENKIYFSEINTLPGFTTISMYPKLWQASGITYGELLNELILLGMEEFARKKSLKTDY
>AIA12297.1|FEATURES|farme|beta_lactam|K678_12262|antibiotic target alteration|0
MIIMLNGVSSSGKSSIARALQDAWSTPLLHVGVDTFIDMLPARFCGEGQEARYGLQFVPVQTREGPVVEIRPGSYAKRLFAGMIGAIGALARARNAIIVDEVLFGDEMLREYIRELRGQTVYFVAIHCTQEIVEQARA
>AIA12257.1|FEATURES|farme|beta_lactam|PHAMO_510100|antibiotic target alteration|0
MLGYARRLGFGEPTGINDANEAMGKLPSSGLGVDAGRLGAYGEGIEVTPIQLAAITSAIANGGTLLVPRTPRTEQEGAQFEAQIRRHSVSRARSSLIRIKRIRKDLKGGQLLKAPLRIYSEQPAYFMCVYSSRTDICITV
>AIA12247.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKKRVAVLMGGFSVEREVSLSSAQGVLNALQELGHEAIPIDVTRDMRAFIQNLETHKPDIVLNILHGRWGEDGCMQGLLEMMGIPYSHTGVLGSALSMNKVVARMICEAKGIRIPEGQLAKLVDVCAGQVMKRPYVIKPVGEGSSLGVHIILDEKTPLPNPQEWPFEDEVLVERYIPGREIQVAVMGGKAIGAIEICPKGAFYDYEAKYTDGKATHLMPAPIHPQVYAQVLEWAEKAHDVLECRGITRSDFRYDDTQGEPGMLYYLETNPQPGLTPLSLVPEIAAHQGMTYAQLVQWMVEDASCRR
>AIA12163.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MNKSESIVREDIKNSHTILSNPYAKMEKKAQEHIDPKRFGKVALLLGGSSGERAVSLESGKAILEALQRKGVDVEAIDAQGDFIKRLVQGNFDRAFNIVHGKQGEDGVMQGLLEMLQLPYVGSDVAASALAMDKARSKLIWSTLGLPTNSFGLAYDFEQAKQIVQELKTFPLAVKPNAEGSSLGVTKLEKIEDLSVAFEKARPLWSSCD
>AIA12164.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MIEKWIEGSDFFVTLVGDEVFPAVQVKSAGEFYDYHAKYHSEETIYQCPPPLSDDEARKLAKIAQQAYFSLGCKGWGRVDLVRDRLGAFWILEVNTIPGMTSHSLVPMSAKAAGLSFDDLVIKILSTSLTQTEKERKQAYGAEI
>AIA12010.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYQDALRQILADGVRHEDRTGVGTTSVFGEVQMSFDLEKNFPIMTTKKVPLRWIFEELMWFLGGRTDNQWLNERKISIWDEWSTVEQTARFGRKEGDLGPVYGYLWRSFGGHYPEMDGSDQIARLMRDLKENPNSRRHLVSGWDPRVADEVALPPCHTLFQFKVEQINNEQYLSCKLYQRSADFFLGVPFNISSYALLTCMIAHIMGMKPRKFIHTFGDAHIYSNHHAAVDELLARTPLDLPNLEFVNTEHLVGKGLEGLLGFKWENINLI
>AIA11885.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQHVLQHGARKADRTGTGTLSVFGAQLRFDLDAGFPLLTTKKVHLKSIIHELLWFLRGDTNTRYLKENGVTIWDEWADANGELGPIYGYQWRSWPAPDGRHIDQITQALEQLKTNPDSRRILVSAWNVADLDRMALLPCHAFFQFYVADGRLSCQLYQRSADL
>AIA11850.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKAYLDLLKDILENGVEKGDRTGTGTTSVFGRQMRIDLSEGFPLLTTKKIHFKSVVHELLWFLSGSTNIGYLKENEVSIWDEWADEEGNLGRVYGAQWRTWLGPNGQTVDQIANVIRQIQTNPDSRRHLVSAWNPAEVDSMALPPCHYAFQFYVANGKLSCMFQMRSVDTFLGLPFNLASYALLTHMVADQCGLEVGDLIWTGGDVHIYMNHMEQVNRQLSREPYPLPKRVIKRKPDSIFDYQYEDFEVIGYQSHKGIKAPIAI
>AIA11841.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLRSILANGNEHQDRTGVGTISHFGYQTRFDLRQGFPIVTTKKVPFRWIAEELFWFLSGDTNEANLRARGVDIWAEWADEDHTRRFDREAGDLGPVYGYLWRSFGGNYPDRNGVDQIANLISEIGSNPNSRRLIVTGWDPRQANRVDLPPCHTLFQFKVENGTVLHCQLYQRSADAFLGVPFNISSYALLMHMVAHVCGLEVGDFVYTLGDYHIYKNHLEQVEELLAREPFPLPKLEIVDHDKRLRGLEGLLAMRYENLNLVGYQSHGKIAASVAV
>AIA11645.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LDEGERREDRTGTGTLSIFGTQTRYDLRQGFPLLTTKKVLWSGVVRELLWFLRGSTNVRDGLTQFTPIWDAWADERGELGPVYGHQWRKWGAPFAQHAKDQSEVAPERTGPGIDQIKGAIELIRKDPSSRRIIVSAWNVADLPHMALPPCHAFFQFYVSRGRLDMQLYQRSADIA
>AIA11543.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAHPEYQYLKLLAEILRNGKSKPTRGVHGIKSIFGYQMKFDLRHGFPILTTKKMPFKLMAHEMLWFVSGSSNIKYLQDHNIRYWDEFADKDLNLGPVYGVQWRHWQDPKGGEIDQLQWAIDQIKNNPHSKAILVSAWNPADLEEMRLPPCHTMFQFDVTKGKLRLQLYQRSSDVFLGLPFNISQYALLLYMVAHVTGLEARELVVSIGNAHLYTN
>AIA11522.1|FEATURES|farme|beta_lactam|TU73_12825|antibiotic target alteration|0
SDLPLEAEDSLTLLTVVPSDEGGEREGVLAPPYPVTTVGILAGARDLLCRTPASLRQEVHRGHAAHEILDAAAMHRAELLVIGACGLSPVTRFLLGSVADRVVRHATCPVLVVRPGSTAVRRVILGIDDSPSATRAAEWLRGFPLPAEAEVRLVTVLPLLESWLSSPAVLTPPLVDHTMTLAERERDV
>AIA11280.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELVRRVLDEGERREDRTGTGTLSIFGAQTRYDLRQGFPLLTTKKVLWTGVVRELLWFLRGSTNIRDELTQHTPIWDAWADEHGELGPIYGHQWRNWGAAFVKHANDGHALLGVRQGPGIDQLQQAIELIRKDPTSRRIIVSAWNVADLPHMALPPCHALFQFYVGRDRLDMQLYQRSADVALGVPFNIASYALLLMLVAQECGLTPGVFIHTLGDAHIYLNHVDGLKLQLTREPLPPPRVEIAKKPLSEIAFEDIQLLDYQHHPFLKFEVSV
>AIA11149.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTDVVVLYGGNSPEREVSIRSGKSVMTALDQAGIAYTSFDTANGLEFLDTLPKDSVVLPILHGVGGEDGSIQKELERRGLAYLGATSRVSEVCFDKSKALEVFQKNNIPTAAGAVVSQAEYASHPLAKKPHVLKVARGGSSIGTLLVPDPTAVDKQQVQALFELDDTAILVELVQGIEITVPVLDGKALPVIEIKPPEGGEFDYENKYNGKTAEICPPVSIDEATQKEAQHVAERVYEAVGCRHLGRVDIIVRPDGSMAVLEINTIPGMTDQSLFPKAAEVAGMDFPALVTKFVELAREDGGKQHDV
>AIA11144.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|0
MDSSINTYVLFGGTSEERNVSTASAQHVVEYLPDAALLFWEKDDTIAIVDRDDLINFPNPFYSDFKPRNPKSLGKITEAFKKMHPSTKVFLALHGGRGEDGWIQKILEDAKIFFSWIRKCCL
>AIA11145.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDKPLSKKLINKNGVKVAKELLLSTNPDQRENELRSFFAENGEVVLKPTDDGSSRGLKFIRTDQDLTDALVELRNQTRAYLVETYISGRELTVGVLEKSDGSLIPLPCSEVELDPGRIFDYDAKYLGKGCREITPARITADEARRAQEVALIAHKTFGCKSYSRTDVILQPDSVFFLETNTLPGITKASFYPQQLAAAGIGFEQFLKTVLDLSK
>AIA11097.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PVITERDLSGVFFKGALAEHIAFLHGARTQEQLEEFGCKWWSRWVTKERTAIFNLPEGDLGDGSYGAAWAAFPTAEGKPFNQIEHLMKQIKERPYLRTHILSPWIPQYTLQHEGLTRRVLQHEGLTRRVVVAPCHGYVHVLCFPETKELVIHHFQRSGDLPVGVPFNFMQYAAFGMMVSQLIGYTLKEVVYTFSDVHIYESQYEKVNQIIGREPRKLPTVQLSESAKDIADIMDFRPEHFELTD
>AIA11089.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNTYTKTPISKSSRIAVLYGGLSSEREVSLISGKNCFDAIQRLGYDNAILIDVGHDIARKLVEEKVEIAYIALHGKYGEDGCIQGLLELMGIPYTGCRVAASALTMNKALTKSILKDAGLPVIKSVVLKSGSVNGKPLNLDVQYPVMVKPINEGSSIGMSKVDKPEDLKEALQTAFKYADEVMVEEYVKGKSLTVGVVEVDGQPKVTPILELRPTKSEWYDLEAKYTEGGTEFILPAELSEEVTVAIQDATFKAHITAGCRGMSRVDFVTGPGNQFYILEINTIPGMTPLSDLPAQAKAMGISYEQLVECILKTAIN
>AIA10987.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYQQLLRHVLAHGSGHEDRTGVGTLSCFGYQTRYDLREGFPVITTKRVPFRWIAEELFWFLSGDTNEANLRARGVDIWKEWADLEHTSRFGRDEGDLGPVYGYLWRSFGGGYPERDGVDQIARLVREIEQNPNSRRLIVTGWDPRVADEVDLPPCHTLFQFKVERERVLHCQLYQRSADAFLGVPFNISS
>AIA10966.1|FEATURES|farme|glycopeptide|RNase_Z|antibiotic target alteration|0
MRIIPLGTSSGKPTLKRNVSALAVAREGEWLLFDCGEGTQTQIARAGLNPGRLAAIFITHLHGDHFNGLPGLLSTMGLDRRTRQLTLVGPQGMREYLDTLARLKILFVNYPFEVKEYGSMRELTTVYDAADYTVIAYPLDHRIFDIGYRLQERPRPGRFDLERATALGIPEGPLFGRLQSGKDVQLDDGRVIHPSDVLGSPRSGKAIAYCTDTRPFAGSVELARDADLLVHEATYTKELTEEAREYGHSTAAQAGCVARDSGARQLLITHFSTRYTDATPLLEEARAVFSNTIMAQDLVEVEV
>AIA10839.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MAAASRNPFYFKSLLRRRIEMFTSNRKPRAARWAGGIIGTTAVTLTIALAYGAEQSMRKDEIQPVNPGTAVVDPAIQKIAEAALGEAIKTHKAKGGFAIVAEPSSGKILAVANIDTTNKMSGRWALSQLLEPASIAKTLVVAQAIESGLTTPQEKHSCENGNYRYGSRVYHDWKPEGWNQLTTEETIAHSGTICTIKIAEKVSGDGLVKMLKDFGFGPEGTAKNFPEARTGVLPPLGNPYYPDVVPAVSAGFGFKITPIELVQAYGAIANGGSLMNPLPANADSSEIQAIRRVLSSQNAAKVKDILRQVVLKGTGQGTASSNLYSTAGKTASSHIPDLAKADGKKIGNFAGFIGFAPVNEPKVEVYVGIFAPGAGATPAHGSSHAAPVFKRIAEDVLKHWKVAPDQPQS
>AIA10770.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNNWNIVVMLGGPSAEREVSLRSGSAVAKALRSRGHQVTEVDPKDGTFSLPPKTDVVFLALHGTFGEDGTVQKELEKLGVPYTGCDPEASRIAFDKVLTKKRCVEAGVPTARFEIFAKSSAPWPANWQPPVVLKPVRQGSSVGLQFVNNVQEWSEKLSESLNYDTEVLMEEKIVGRETTVGILDGKALPIVEVRVKQGEFDYKNKYTPGASEHFCPADFDPATTRRIQEAALGAFKAIGGRDYSRVDVMVKTNGDPIVLEVNTLPGMTETSLLPDAAKAAGISYEQLCQKMVELALRRKK
>AMJ38507.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MKAAAKTQKPKRQEEHANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVKEGDMRSLRVQQVSTSRGMITDRSGRPLAVSVPVKAIWADPKEVHDAGGISVGDRWKALANALNIPLDQLSARINANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLTLSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNLSGTPKEAMRNRTITDVFEPGSTVKPMVVMTALQRGVVRENSVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESIVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASQPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALTTGDKNEFVINQGEGTGGRS
>AMJ37659.1|FEATURES|farme|beta_lactam|ampC|antibiotic target alteration|0
LDEVQANYILDMQLRRLTKFSTIELESERDELRERIEGLVLIVNDESELRRVVSEDLAEVSTKYGTPRRTVLLGAAPAVAAASAPLEVPDDPCWVLLSATGLLARIDTEDDLPSGGDRASHDVIISRARTTARGDFGIITSTGRLIRAHAIELASLPMTATAPSVAGGTPLADLVGLEKDEKALAVTSLSGEGPSLALGTRNGIVKRVNPELLGKDFWEVISLKDGDEVVGAVELDDENLELCFVTEGASLLHFPATAVRPQGRSGGGVTGIKAKDPVVFFGAAPSHGSSVVTIAASSPAAAGKEPGSVKVTPFDQFPPKGRATGGMRCQRFLKGETALVLAWIGPDPAVACAASGVPVELPEPSLRRDGSGDQGRQPILAVGTRNHGGDDVANPAERLDPDTSDDDLQPTDVRSGATPDAGGALIPAPESTLAKDSEESKPHRRRRRTRTEHDDKSEPDLFS
>AMJ36964.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MMKLLNKALLRMSDWSRTTWCLAILMTVAFVLIGRLAQLQVFDTFDLEKKNLLQVQVDRKLQSPRGTIYDRNGKPLAMSVVTKSLYADPKMIKQSPQEIADLISPYVTMSKENIVKALQEDTAFVWLNRMMDADKSKAVQQVIKDNNIAGLNFVEESKRYYPNGVLAAQVLGFVGTDDKGLDGLEMVLDDELKGGVQQEIVATDNKGNAIFGSVLSKFLPDKGKSVTLTIDATIQFIAERALDKAMVDTGAKHASVIVMDPKNGEILAMANRPSYDPNNYNQSGEEAFKNIAVTNLYEPGSTFKPIIASAALAAGKWKLDTVYNDKGAFAANGHIIRNWNGEGYGPVRLLDILKYSINTGMAEIGTLTGADILSKYIRDYGFGSETGIELPGEGAGILYNPEDMSKLDVATMSIGQGIAVTPLQMVRAFGALSNGGAMMKPHIIKSYSNSQGDVTSTTETSVVGQPVPAETAKTIVDILEKEVSEGGGTKAMVEGYHFGGKTGTAQKLDTKHGGYLDGQYIASFIGFGPVEDPKFVVLVVIDDPQKGSYYGSQIVAPVFKDIVSQLVRYYQMSPYVKESTPVAVKAANTLPEPKPGSDGSVTLPNFTGFTYGEVRDWLHKAGLAFKPDGTGTATSQDESSGTTVQAGTAITVHFRR
>AMJ33862.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MVRAFGAIANGGSMMKPHIVKSYSNIKGEVTSTTDPEVVGQPIPEETAKTIADILEKEVSEGGGTKAMVEGYHFGGKTGTAQKLDTKNGGYLAGRYIASFIGFGPVEDPKFVVLVAIDDSKKGSIYGSQIAAPVFKNIVSQLVRYYQMSPSVKDGATVAAVPAAKLPAVKPNGDGSVVLPDFRGYTFGEVRDWLHTAGLYFKPDGTGKAISQEQLPGTVVSPGTPIVVQFSH
>AMJ33861.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MNISGNDNKRIEYTVRVLLCIAVVLVGRLFFLQIIDKSDLQAKNLSQVQVDRKLQSPRGTIYDRNGRPLAMSVVTKSLYADPKMIKQSPSEVAELIAPYVTMSKADIVKSLQEDTAFVWIDRMMEPEKSKAVAQLIEDKNVEGLNFVEESKRYYPNGNLAAQVLGFVGTDDKGLDGLEMVLDDELKGGIQKELVATDRKGNAIFGSVLSKYLPDKGKSVTLTIDASIQFIAERALDKAMEDTGAKHASVIVMDPKTGEILAMANRPTYDPNHYSQGSEEDFKNIAVTNLYEPGSTFKPIIASAALASGKWKLDQVYNDKGSFAANGHVMQNWNGEGYGPVRLIDHRSRYCGNTIANGPCFWRYS
>AMJ33831.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MSLKNKIRRFMEKKNLNPMNNRKKVGIILFATSIGLFFLFAVRFSYIVIGGHVAGTSLAEKTKQLYQGSEVVKAKRGTIYDRNGVALAEDASSYSIKAILSKTYTSGDKKLYVEEKNFDKIAEILHKNLSIDKKDALNILEDGAKKELYQVEFGSYGKNISQETKQNIEADMKKEGVAGLYFVDHQARMYPNGVFSSHFIGYAVPDKDENGLVGKLGLESAYNDILSGKDGKIIYQKDNFQNPLPGTVAEEEKAVDGQDIYTTLDSRLQSYLETLMDQVNEEYQPEELTAVLMKAKTGEILAMGQRPTFNPETMEGLTGKDAIWRNFLVQDSYEPGSTMKVFTTAAAIEEGEFNENETFQSGKIQVEDATINDHDFGEKGVLTMRQALSWSSNVGMVILEQRLGGRWYNYLQKLGFGQSTHSGLDDEVNGALPTSNIVDRAMSAYGQAVGVTNFQMMKAFTSIANNGTMIQPRYISKVVDPQTGEERTTQTEVLGQPFSKETTEKVREYMRDVVESENYGSAYGVYSVPGYNVSAKTGTAQIASDTGGYQTGDTAYLYSIVEMVPSEDPDYVLYLTMKHPKTYDRMALAKIANPLMKRAMDFKETEEDSDTETKTEKVSVADYGNLEADVAAADAQKSGLQPVVIGNGKKVQKQSTAN
>JX009271.1_1099|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
VTKLRVGVIFGGKSAEHEVSLQSAKNIVDAIDKEKFDVTLLGIDKQGHWHINDASNYLLNAENPALIALNRSNKNVALIPGQEKQQLIESGSAGALGQLDVVFPIVHGTLGEDGSLQGLLRMANLPFVGAGVLGSAVSMDKDVTKRLLRDAGLAVAPFVTLTRSNRAKFTFEQLSERLGLPLFVKPANQGSSVGVSKVQD
>JX009269.1_1101|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
DAAVALAFSFDHKVLVESAIVGREIECAVLGNDDPQASLCGEIVLSDAFYSYDTKYINEQGAQVVVPAAITPEVSDKIREVALKAFRALECFGLARVDVFLTPDNNVVINEINTLPGFTNISMYPKLWAASGISYSQLITRLIELALERHQQDRALNSSVFDR
>KF630354.1_11335|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKDKKIIVLMGGPSKEAEVPRRTGAAIAEALESKGYNAQTLELNPRTVLKDIEDLGGEVVFNAIHGRYGEDGALQGLLEMAEIPYTGSGIMAHAVGMNKKVSKDVFKGANIPTAASESFNGNLESAEAIIEHIRKDFTIPVVVKSATQGSSIGVTIVRDEAQLEEAVTEALKYDPILVVEQFLDGREFTVSVLDGKALSVIEIRPHSGEYDYKSKYTVGATEYLVPAPISAEMTAEMQRIGELVYREVQGSGVIRVDVMTDHADNMYVLEYNTVPGMTATSLVPKAAKEMGIDFPTLCEKILLTASIGKF
>KF630337.1_11376|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGNSTEREVSIASGQGICKALRERNHRAIMIDPYFGRETLEEDLFPAEYDIEKEAEQMRRNSAGLEATMKSRRGFFGPNVLSVCEKADIVFLALHGSNGEDGKVQSVLDLMGIKYTGSNPLSSGMAMDKGITKMVFEAKGVPTPKGITLEKGDNSRLTDYGMEFPVVVKPCCGGSSVGVFIVKNESEYAQALLEAFSYEDKVVVEQYITGREFSVAVVDGKAYPVIEIAPLQGFYDYKNKYQAGSCVETCPAEISASLTKEMQRYAEQGYEALKLQAYARLDFIMDEEGNMYCLEANTLPGMTPTSLIPQEAKVIGMNYPQLCEKLIEVSLKKYQ
>KF630331.1_11392|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
TCGEVVLNSDFYSYDTKYIDDKGAQVVVPADIDPAINDKIRAIAIRAYQTLGCCGMARVDVFLTQENEVVINEINTLPGFTNISMYPKLWQASGLSYPELITRLIELALERHAADSALKSSVNG
>KF630327.1_11398|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|0
MAKKRVVVLYGGRADEHSISCISTAGVLGAMDTERFEPIPVGITKDGKWIINGEDPRGWNLDGGRAADRKDHPGIAPGDA
>KF630327.1_11399|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLDAAGIPTAPGVTVDARNFTAADGLAEIEDAGLTYPLFVKPSRAGSSFGVTKVEKADDRETQQDRLAAAIATAGEHDWKVLVEQGIDGREIECAVLCPKAGDEPEAAGPAKSCSIIRTTTSSTISTPSTWMPPPATWKCLPICRSACLRTCVTWPVARSRPWMVPA
>KF630321.1_11415|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTDKIAVLLGGTSAEREVSLNSGAAVLAGLREGGIDAYPVDPKEVDVTQLKSMGFQKVFIALHGRGGEDGTLQGMLELMGLPYTGSGVMASALSMDKLRSKLLWQSAGLPVAPWVALTRAEFEKGLNDKQLAEISSLGLPVIVKPSREGSSVGMSKVVAENALQDALRLAFQHDEEVLIEKWLSGPEFTVAILGEEILPSIRIQPAGTFYDYEAKYLSDETQYFCPAGLEASQEANLQALVLKAWTTLGCKGWGRIDVMLDSDGQFYLLEANTSPGMTSHSLVPMAARQAGMSFSQLVVRILELAD
>KF630290.1_11498|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTLRKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMMDQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKPGHDKLTLNAILNQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELVHVIADAHIYDRHIPIIKEMIKRETYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF630279.1_11521|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTLRRTALKSAMDEILWIWQKKSNNIHDLHSHIWDSWADESGSIGKAYGYQLGVKHQYKEGMMDQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNDKLTLNAILNQRSQDILAANNWNVCQYALLLMMMAQVCDMEAGELLHVVADCHIYDRHIPLIKELIQRKPYPAPVVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPIAV
>KF630276.1_11529|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MGVKIMKKKVAVLMGGISTEREVSLNSGKSVVDALDRDKYEVYEIILNDKMDVINKMPKGIEFAFLMLHGKYGEDGTVQAILESMDIPYSGCGPLTSAMCMDKNITKKMLRDSGIPTADWTIARSIEDIDYDKIEEMGYPVFIKPNSGGSSVATFKVECREDVEDAVRAGLEVDDIVMIEAYLPGDEYTSFVLDGEVYPTIKISSPTGFFDFESKYSTGANAAKEEVVYLEKDLQDQINKASKAVWDTFYCRAYVRADFILSNGTFYVLELNTLPGMTPTSLIPRSANAKGLSYSELVDKIMETSLK
>KF630217.1_11654|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSTERDVSLTSGAGICRTLRENGHQAFLLDVFLGFPYDSDKLEEVFTLPNAGLEIADGIKTTEPDLAAIKASREDQSDCFLGPNVIDICRLADIVFMGLHGDVGENGKLQATFDILGIKYTGPNYLGSALAMDKGVTKQIFKMAGVPTPLGTNLTKDRKDTALSDLGLTLPVVVKPCSGGSSIGVYIVDTMDAYKEAVENSFRYEDEIVIEPYIKGREFAVGIIDGKALPVIEIIPKTGFFDYANKYQDGCTEEICPANIDKEVTERMQRAAELAFKALKLDIYSRADFLLDENNDIYCLEVNSLLGMTAASLLPKEARAAGITYGDLCELIIQKSLARYNA
>KF630210.1_11667|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKETLVLLYGGRSAEREVSVLSAESVMRAINYDKFFVKTYFITQSGDFIKTQEFSSKPADDEKLMTNATVVESQKIKPSDIYEEGAVVFPVLHGPMGEDGSIQGFLEILKMPYVGTNILSSSVAMDKISTKHVLESAGVPLVAYVTYVEGADLEKAVAEVNEKLTYPVFIKPANMGSSVGISKADDEEGLRSAIDLALKYDSRILVETGVNAREIEVGILGNADVQTTLPGEVVKDVAFYDYDAKYIDNKITMDIPAHIDSNIMEEMRGYATTAFRAIGGCGLSRCDFFLTEDGHVYLNELNTMPGFTQWSMYPLLWENMGLAYSDLIEKLVELAKEMFEKRESHLI
>KF630210.1_11669|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|0
VVNSSSAYATGTYMKSSTVTIAGKTGTAETYAVDANGNAVTTVNLSVLAYDYSTSDDSHIAVAVIVPHLTSSDNHTNQYIARDIINLYMSTYVNQ
>KF630210.1_11670|FEATURES|farme|beta_lactam|CCC_03326|antibiotic target alteration|1
NPRGEIYDAAGNLLVSNTVKQVVAFTRSNTITAEEMKELAAKLSTLVTFTETNVTTRQKKDYYLADSDTYAAVVKSLPDDEKYDSYGNNLTESEIYANAINAVTDDEINYSEDELKLVYIFSQMNAASTFSTVNLTTGDLTEEQIAYITANQSKLSGISIATDWDRETPTSSLASIIGTVSSKHSGLPAEEADDYLAKGYSLNDRVGTSYLEKEYEEYLQGTHTVREITTDKNGNVVSDEVTSEGKAGQNLKLTVNSDFQAGVESILNQYYSADIADGYATYSEGAYAVALNPQTGAILAMAGLSHETGSSTTTLDALGTINDIFVPGSVVKAATLTAGWESDVISGNQVIADQSINIAGSSAITSWFTGSGSTNITAVQALEYSSNTYMVQVALKMMGQEYYSGMSLATTGMKEAMEELRAAYAEYGMGTSTGIDLPENTTGYISDDYSAGNVLTEAFGQYDSYTPMQLAQYAATVANGGKRIAPHLVDSIYDNDGTDGIGTLGKTIETNVLNQINIQTMIWTFCNKGSIKW
>KF630206.1_11681|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
LPLVVKPVASGSSIGVSIAYTAEELRRSLTEGLALGGRTVLEEYIRGREIQVGILEDKALPSIEIIPKQGFYDYANKYQPGAALEVCPAEITPEEEARVRAAALRVYETLGLSVYSRADFILTEDGEPWFLEINTLPGMTPTSLLPQEAAAAGIDYNELCQRIVHASLEARKQGR
>KF630190.1_11720|FEATURES|farme|beta_lactam|pbp1b|antibiotic target alteration|0
NRAYQSYRQPGSCIKPLNVYTPYLQLGNTPDTKVTDSQIDGGPANADASYAGEMTLTDAVKWSKNTVAWNIYQQITPKTGSSFLIKMGFHKIWVDKDYNAGALGGFTYGVTTEEMAGGYAALANDGVYRKATCIRLIVNASNKTVVNETDRDSKVYDKSASRMMTQMLREVVLSGTGTSANVENAVVAGKTGTTNASKDVWFCGYSKYYTTTVWAGYDYPKEMSGVNSRVNAIFKDFMTAVHTNLPVTDFSTVTQQTTQPETTAAVQEETESLPQETTAIVPETTGIEQVTPQQT
>KF630186.1_11724|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MDVLEKCKDIDLAFLALHGEFGEDGSVQNLLETMGIPYTGAGMLCSAICMSKDASKRMLKSEGILTPNWYTARRGQEIEYDVIEKIGYPMFAKPNCGGSSVATFKVTNREELVHSIEEGFKWDEEVIIEEFIKGEEITSFIMNGEVYPTIRITANKGDFFDFASKYDDGGASEDIVYYPADVQEMINDITKKCYRLFNCQVYVRIDMILREGKAYVLELNTLPGMTKNSLIPKSANAKGLSYSGLLDKIVEYSVRVRGCSRI
>KF630179.1_11741|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICRTLIEKGHDAFLLDVFLGLEHAPEHLEDVFTLPGHGLEIAKNISCEEPDLAAVKASRPDQSDCFLGPNVIELCRLADITFLGLHGGEGENGKLQATFDLLGIRYTGPDSLGCAVAMDKGLTKQVFLQAGIDTPAGVTIHKKSKDRSLALTGLSLPVVIKPCSGGSSIGVYIVSTEEEYAEALEKSFFYEDEVVVEEYIKGREFACGVIDNEALPPIEIIPKTGFFDYANKYQADATLEVCPADIPEETASRMMELTVKAFRALKLNVYSRADFLLDEKGNLYCLEMNTLPGMTAASLLPKEAKAAGIEYGDLCELIIKKSLEARY
>KF630167.1_11774|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
WEVDNSGTIGERYGAVVKKHDIIRKILKQLEENPWNRRNVISLWDYEAFENTDGLLPCAFQTMYDVRRVDGEIYLDATLTQRSNDMLVSHHINAMQYVALQMMIAKHFGWKVGKFFYFVNNLHIYDNQFEQARELLSRESTDCKPRLVLNVPDGTDFFDIKPEDFELVDYEPVKPQIKFDLAI
>KF630148.1_11824|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLDLPFCTVKLATMALTPEQLADIRTRIPARPETDIPMPYEDLVRKILTEGTLKSDRTGTGTVSLFGQQMRFDLSEYFPLLTTKTVFFKGLAYELLWFLKGSTNVRWLQERNVHIWDEWADENGDLGPVYGAQWRSWPAPTPDDPNRTIDQISNVLDLVENHPDSRRMVVSAWNPAEVENMALPPCHALFQFYVADGKLSCQLYQRSCDMFLGVPFNIASYSLLTLMIAQQAGLQPGEFVWTGGDCHVYDNHIDQVLEQLSRDPYPYPQIRINKADSLFDYDYSDFEIVGYQHHPTIKAPVAV
>KF630119.1_11908|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGEDPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPYGEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAASEFAAEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVSKVEHEGDAAELAAAVFEASHHDWRVLVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYVNSDASHVEVPASLPEETLNRVRETAKKAFIAVDGAGLSRVDTFVTADGEVMVNEINTMPGFTPISMYPKAWEATGVSYTNLITMLIEGVLR
>KF630117.1_11911|FEATURES|farme|glycopeptide|vanM|antibiotic target alteration|0
VGVDTGGCNIQFAINPNTGRIIVIEMNPRVSRSSALASKATGFPIAKIATKLALGYTLDEIQNDITQSTPASFEPTIDYVVTKVPRFAFEKFPGADPTLTTSMKSVGEAMALAGNFQESLGKAMRSIDKRHMGFNWDGDKPDVQEVEQLLEAIKVPTEHRYLQIQRALWGGATEQQIFDATKIDPWFIRQFVLINETALEIKEASKLSRKLLKKAKLAGLSDLQIAHLRHLGDEGENTIRELRWSYDLRPVFKTVDTCAAEFDAVTPYYYSCYADESELRPREREAVIILGSGPNRIGQGIEFDYTCVHAVQELGKDYDTIMVNCNPETVSTDYDMSDRLYFEPLTFEDVLEIYEAEKKMGPVKGVIVQLGGQTPLSLAARLKAAGVPILGTTPESIDLAENRELFGEVLKKAEMNAPRYGTALSLDEAREAAHNIGYPVLVRPSYVLGGRGMEIVYDDAQLCKYVDRALKEAQADTVVSGRLPSPLLIDKFLQDAVEIDVDALFDGEELYIGGIMEHVEEAGVHSGDAACTLPPSTLSDDQIRRLREGTYAIAKGCGVQGLINVQYAFMANTLYVIEANPRASRTVPFASKATGVALAKAAARIMAGETIQQQRDNGLLLPHGDGGDIRRGQQVAVKESVLPFKRFRTPLGKTVDVLLGPEMRSTGEVMGFDRDFPHAFAKSQLAAYDGGLPTSGNVFISVNDTDKRQLPLF
>KF630115.1_11918|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADTQYLGIIENILDHGIYGQNRTGIATYKLPQQIMQFNLQEEFPILTTKFVAFKTAVKELLWIWQMQSNDVRKLQEMNVHVWDEWMREDGTIGKAYGYQIAKYKQLDKLIKTIKEGPDSRRMIVTLWNIEDLDDMALQPCAYETLWDVGDGYLNCMLIQRSGDMGLGVPFNTAQYAALQCMIAQVTGLKPGKFTHVINNAHIYENHVDALREQLARRNQALPAPKIIVNPEVKDFYDFTPEDVTLDGYEHLGKLSMTVAV
>KF630101.1_11947|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKMARRIALLCGGASGEREVSLLSAAAVEEALEKRYEVIKIDTGVEGWAHTLLDSSVEGVFICLHGGAGENGSIQGFCESVGLPYTGPGVLSSAIAMDKFVAKLLVESFRIPTPGYIRVLRGEECNIEDIRTKLGGKLVVKPSTEGSALGVSIVDNGDDLACAIDTALELAPSVLVEQFISGRELTVAVLGGEKPRVLPPIEIIPANEFYDYEAKYEQGMAQHICPANLTEEELRQCEEMALGAHDALGCYGVSRTDCILDERNRLWYLETNTIPGMTGTSLLPDAAKAVGITFDELCWNIMEDAWSRC
>KF630041.1_12088|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VKEVLSLWQKRETERQENRMSYADKVFINMCRDIIENGTSTEGEKVRPKWEDGTAAYTIKKFGVVNRYDLSKEFPALTLRRTAIKSCVDELLWIWQKKSNNVHELKSHIWDSWADENGSIGKAYGYQMQVKHQYKEGMMDQVDRVLYDLKENPYSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTKEEGSEQLTLNGILNQRSQDVLTANNWNVCQYAVLLHMFAQVCGMKAGELVHVIADAHIYDRHIPLIEELISREPLPAPKFWLNPEVKDFYDFTPDDVRLEDYETHPQIKNIPVAI
>KF630025.1_12136|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GEMDQVDNVLWQLKNTPYSRRILTNIYKFDDLAEMNLEPCAYSMTFNVTGDRLNAVLNQRSQDILAANNWNVVQYSVLLHMFAQVSGLRAGELVHVIADAHIYDRHIPVIEELVSRPQYPAPKFRLNPEIKDFYDFTVDDVMIEDYQKNPQILNIPIAI
>KF630024.1_12137|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MVCKALREKNHQAVLVDVFCGIDVKGNLEDVFAEEAYDIDKAAEYMHSFDAGLNEMIASRRRFFGPNVLELCEAADVVFLALHGANGEDGKVQATFDLLGIPYTGTGYLSSALAMDKSITKQFFRAHHVPTPNGVTLKKGQESEPLSGFGLELPVVVKPCCGGSSVGVYIAHTNEEYWQAMKDAFSYEPEVVVEEYIEGREFSVGVVDGKAYPIIEIAPIEGFYDYTNKYKAGSTVETCPAVLTEEQTKEMQKHAEDGAAALGIGNYCRLDFMMRKDGRMYCLEANTLPGMTPTSLLPQEAQVLGISYPELCELLIQLSLRKRGKNA
>KF630016.1_12160|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIINGEDPRGWNLDGGELPTVKITPESRPVMLDPSRGQDGFFIGEPSHINSADSGFGTSFVSMSDPEMHHVLTSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLDAAGIPTAPGVTVDARNFTAADVLAEIEAAGLTYPLFVKPSRAGSSFGVTKVEKADDRETQQDRLAAAIATAGEHDWKVLVEQGIDGREIECAVLCPKAGDEPEASWPGEIVLDHQNDDQFYDFDSKYMDASASHVEVPANLPVSVLEDVRDVARRAFKAVDGAGLSRVDTFVTPDGTVMVNEINTMPGFTPISMYPKAWDATGVSYTELITRLIEGVLR
>KF630005.1_12184|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
DKDKYDIVPIGITKDGRWFRYDGNAENIKSDKWHEDKEHCIPAYIVPDTAIHGMIELRKEGTAFTRLDGVFPVLHGKNGEDGTVQGLIEMAGIPVMGCGTLASALCMDKYRAHVVAEEAGIAVPKACSIIGRVTDRQLFEAVSELTYPLFVKPVNAGSSYGISVAETPGELVSALELALQYDNEVIIEEKIDGFEVGCSVIGDGKGNEIVGRVDEIELFNGCFFDYTMKYTGVDSKIHSPGRLDPETEEKVNQAGIKLFRALGCKGFARIDMFLTPDKEIVFSEANTIPGFTSVSRFPKMMAGIGMEYKDVIDKIIEYSFR
>KF630001.1_12196|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTILVLFGGCSTEYEVSLHSAYAVLSHMDPARYTPLAVGITREGQWLCYTGDLSRLEDGTWQQAADCIPCTPLVEREAHALLLLDGSGRRLLFDAVFPVLHGKNGEDGTVQGLFELAGVPVIGCGTLSSALCMDKDRAHQLAALAGIRVPRSHVFHSSDDFSRIAQAAEELGYPVFVKPVRAGSSFGITKVSGPEELPAAMEEAFRHDSAVILEETIPGFEVGCAVMGNEELTVGLVDEIALSEGFFNYEEKYTLKTSAIHCPARIPPEKAAEIQAAAKTIYRALDCRVFARVDLFLTPDGEIVFNEVNTIPGFTAHSRYPSMMQGIGISFGELVTRLIELGVAG
>KF629997.1_12204|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLYDEQYLTIAQNILDHGYYDTNRTGVPTYKLPHQIMQFDLEREFPILTTKKVAFKTAVKELLWIFKEQSNDVKRLQEQNVHIWDEWEMEDGTIGTSYGWVVQKFHQMDTLLQQLKTNPQDRRMMLNLWQIPYLDTGALYPCCFLTMWDVTDGRLNCMLVQRSADWGLGVPFNTSQYAVLVHLLALVSNLRPGLLTHVINNAHIYENQVEGIRLQLTRRAEAYEAPTLWVNPEIQNFYEFQIQDIKLMGYKSHDKISMEVAV
>KF629994.1_12216|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADTIFVDMCRDILDNGYFTEGQDVRARWEDGSSAYTIKRFGIVNRYDLSKEFPALTLRPTGWKNAIDELLWIWQKKTNDITQLQSHIWDAWAGEDNTIGKAYGYQLGKQYNFRQGRMDQVDNVIWQLKNTPASRRIMTNIYNFEDLSKMGLEPCAYSMTFNVTDNRLNAILNQRSQDVLVANNWNVVQYAVLVHMLAQVCGYEAGELVHVIADAHIYDKHVPLVEELIGRTQYPAPKFEMNPDVKDFYEFTLDDFKLENYQAGPQIKNIPVAE
>KF629993.1_12221|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVVLRRPGKVVSFAHVGRTAEKRCSFCGCSAGTEKSVTFGRKTMRQYLELLDKIMKEGAVKGDRTGTGTKSIFGYQMRFDLAEGFPLLTTKKLHLRSIIHELLWFLAGDTNIKYLHENKVTIWDEWASPEGDLGPIYGYQWRSWPAPDGRHIDQIAAVVESIRTNPDSRRHIVSAWNVADIDRMALPPCHALFQFYVAEGRLSCQLYQRSADVFLGVPFNIASYALLTMMMAQVTGLRPGDFIHTLGDAHIYLNHTEQAAEQLRRTPRPLPVMKLNPAVDSIFGFRYEDFTLEGYDPYPSIKAPIAV
>KF629992.1_12222|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YFKTCIDELLWIWQQKSNNIHDLRGHIWDSWADGTGSIGKAYGYQLAVKHQYPEGEFDQVDRVLYDLKHNPSSRRILTNLYNHHDLSEMALYPCAYSMTFNVTGDTLNANAILNQRSQDMLAANNWNVVQYAVLVHMLAQVSDLVPGELVHVIADAHIYDRHVPIIEKMLAQTPSSAPVFRMDPSVTDFYAFTRDSFSLEDYIPAPFEDQIPIAI
>KF629986.1_12240|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELLNRVLTEGVRKEDRTGTGTISVFGHQMRFNLEEGFPLLTTKKLHLKSIIYELLWFLNGDTNVKYLQDHGVRIWNEWADADGSLGHIYGYQWRSWPDYKGGSIDQITEAVETIKHNPDSRRIIVSAWNVADLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQATGLKAGDFVHTLGDAHIYSNHLEQVKLQLTREPRALPRMEINPDVKSIFDFKFEDFNLTGYDPHPHIKGEVAV
>KF629978.1_12263|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GTSAYTIKKFGVVNRYDLSKEFPALTLRRTGIKSCVDEMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVLFDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGKDKLVLNAVLNQRSQDILAANNWNVCQYSLLLMMIAQACDMEAGELVHVIADCHIYDRHIPVIKELISRKPYPAPTVKLNPEIKDFYKFTTDDLIVENYETWPQIKNIPIAV
>KF629971.1_12285|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGGDKVSKADKLFVNMCRDILRDGFSSEGQIVRARWEDGTPAHTIKKFGIVNRYDLQEEFPALTLRPTAIKSAVDEMLWIWQKKSNNIKDLNSHIWDEWADEDGSIGKAYGYQLGVKYKFPHGEMDQVDNVLWQLKNTPYSRRIMTNIYKFDDLMEMGLEPCAYSMTFNVTGNRLNGILNQRSQDILAANNWNVVQYSVLIHMMAQVSGLKPGELVHVISDAHIYDRHVDIISEMIERPQYPAPKFILNPEVKNFYDFTTDDIRVEDYQKNPQIKNIPIAV
>KF629960.1_12313|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKAPVDRNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFACNQYLKGFGVRIAESLLLRGGQSVTDEDVMEKIGLPCFIKTSLGGSSFGVTKVTAKEQIQPAIAKAFAEAQEVLVEAFMDGTEITCGCYKTKDKSVVFPITEVVSYNEYFDYEAKYNGASDEITPARISDDLTRRVQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSFIPQQVRAAGMEMKDVMTDIIENKFKD
>KF629956.1_12330|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MRIVVLAGGLSTEREVSISSGTLVAEALRSKGHEVVLLDVFMGYEENICDIDALFKQNYSFTDGNSIGDDVENTITNIKEAKENRLDKTSRYIGRNVIEICAEADITFLALHGGEGENGQLQATLDLFGIKYTGSGYLGSALAMNKGLTKSVFMQKNINTPSGELYKNEKDALAWNMFPCIVKPCSGGSSVGVSKVENADQYKKAVKEALKYEDEIVVEQFVTGREFSVGLIGGKALPPIEIAPKSGMYDYAAKYQAGATVETCPADIDEETDKKLRDAATEAYEALHLESYARIDFLLDKGGFTYCLEANTLPGMTPTSLLPQEAAVEGISYPDLCEKIIEISLAKYPKEKSDF
>KF629953.1_12337|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGLSPERDVSLSSGSLIANALIENGHDVLLLDLYLGYDGDAAQAEFLNRSDSERYSYTIPEREPDLEALKASSGNGRRLVGNGVLELCQRADVVFIALHGDIGENGQLQAMFDVLGVCYTGTDYTGCLLAMDKDISKKLMAANGISTAGWRSFPIRQQEECDFSQVRYPCVVKPCNGGSSVGVTMVDDADGLEEAIRAARVYEDQVIVEDRIFGREFSVGILNGEALPVIEVIPKEGFYDYKNKYQTGMTQEICPAQLPDRLTRRLQESALAVHQLLRLGCYSRIDFMLDRNNQVYCLEANTLPGMTPTSLIPQEAEAAGISYPQLCERIVQQAWSEKRA
>KF629948.1_12354|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQIFLANCQEILSRGTWDTHLPVRPRWEDGTPAHTVKCFGLVNRYDLREEFPIQTIRRMYLKSAVEELLWIWQKKSNNVRALSTGIWDAWADETGSIGKAYGYQMGVKHRYPEGEMDQVDRVLYDLKHNPSSRRILTNLYNHHDLSEMALYPCAYSMTFNVSGHTLNAILNQRSQDMLAANNWNVVQYAVLVHMMAQVSGLEAGELVHVIADAHIYDRHVPIVERMLEKEPRPAPRFVMDPSVTDFYRFTRDSFSLEGYEPHPFEDKIPVAI
>KF629943.1_12366|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKVLVLFGGVSSEHEVSLVSARSVIQNIPRDRYEVLTLGITKQGEWLLYEGDPEALPEDNWLECGKRTPAVLSPDASHHGLLIFENGAARVEHVDVVFPVLHGKNGEDGTMQGLLQLAQLPFVGCGCTASAITMDKAITNAMTDVAGIAQAKWLPLTRDGYQKDAAALRQKAIGRLGFPIFVKPANAGSSVGVGKARNETELADAIEKAFLHDDKLVLEEGIDGMEVECAVLGNEKPKASTVGEVVPCNDFYDYEAKYIAADSELHIPARLPADTLEAVRAAACRVFTEMGCSGLARVDFFVRKSDGAVLLNEPNTIPGFTPISMYPKLWEHTGLPYGELLDRLIQLALKKWEPKD
>KF629941.1_12373|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MICFVACICYKICYNKNVKQNSLKEGVKKMTKGDIYTKEIITRILEEGCWDQDPRPKYADGTKAHTLSVNHGMCTYDLAKGEIPLITLRPIATKSSIGELLWIYQDESNDLNVLRDKYGVTWWDEWDIGNRTIGSVYGETVRRHNLMKNLLQGLKENPDGRRHIINLWQESDFLEPHGLKPCAFLTEWNVRHGQDGMDYLDMCLVQRSSDFLTAGCINQVQYVVLQYLVARHLNLRPGRFTWFYNNIQIYDRHLDQAHELLQRDGIECQPKIVLNEEKQNFYDFQVEDVQIVDYPKELIKKKNPQLKFEIGI
>KF629920.1_12436|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|0
VNSPAVFLPEKHFRSLKLFQKDGLFDYANKYQAGGASEICPPISLDAETQELIQRAGERAFEALRMDVYSRADFIVSDADGEFYCLEMNALPGMTAASLLPKAAKAAGYEYSELCEAIIQESMKARY
>KF629913.1_12455|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGLSTERQVALTSGTGVCRALRERGHQAILVDMFLGLESYEGRLEDIFDAPDGLCGDNRVTEEAPDLEAVRRSRKDQGPSLLGKDVLAVCAMADIVFLALHGSCGEDGRIQATLDLLGVPYTGSGYLGSCMAMDKSVTKRFLESEGIRTAPWRDVHYTASDIPRLVEELEVPCAVKIVNGGSSIGVELPDTKEQLREALTKLLTYGDHVVVEKKIKGREIQIAVLGDTYLPAVEIIPRGEYFDYVSKYQKGGAQEICPAPITEEEWHQIGEMALKLHRGLGLSVYSRSDFLLDEEGKAWCLEINTLPGMTPTSLVPQEAAQVGLSYADLCERIVEESLKARGVQRT
>KF629910.1_12466|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPAITLRKTYIKSATDELLWIWQKKSNNIHDLHSHIWDSWADESGSIGKAYGYQLGVKHQYKEGMMDQVDRVIYDLKHNPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQEKGDDRLTLNGILNQRSQDVLAANNWNVCQYAVLMHMLAQVCDMRVGELVHVIADAHIYDRHVPIVKELIERPQYDAPKFWLNPDIKDFYQFTTDDIKITDYVTGEQIKDIPIAV
>KF629908.1_12474|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KQKLMVVCGGQSSEHIVSRMSCTSVMNNLNKENYDVTLVGIDQDGSWYILDQNQEDLAKDTWLENAKAFQDVFGLLKQQDVVLPILHGAFGEDGTIQGLFELAGVPYVGCRVLASAVSMDKIYTKKILETAGIPQVKSLYVKKRYDGKLVVVNKQFDEIEDIEKTVEEELGFPCFIKASRSGSSVGCYRCDHKEDLMTKLIEASKYDRHIVVEECVDCIELETAVLGNDDPVVSRVGQIMRHGEFYTFESKYEDEESKTCIPALVDQEIQDKIREYALRVFKAVDGHGLSRVDFFLDKKTNQIYLNEINTLPGFTKISMYPQLMNDFGISYSELLDRVIQLAFDK
>KF629902.1_12493|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKLFGKKVIYLEKLNVCVIFGGVSSEHEISKISAATVIDSLDTAKYNIHKIFIDTEGNWIYFDKPTSEISTLPAGEYDKAIISPSRGDKGLLRFKNNGDIENIKTDVIIPVLHGKNGEDGTIQGLFEIAGIPYVGSGVLGSAVCMDKCVAKILFKEAGIPQADWITVRTSDISNDNWIKNVEEKLGFPCFIKPSNAGSSVGISKAHNREEVIEGVNLAFEHDSKVLIEEFVAASEVESAVIGNTDPMVAENIGEIAPANEFYDFDAKYNDSSSKITIPANVTKDVEAKLKDYAIRAYKICECGGLSRVDFFVDKESGTVRLNEINTLPGFTSISMYPKMWEKSGVGNFKLLDNLINYALDKNNK
>KF629900.1_12501|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKKLNIALLAGGNSSEREVALASAAMILDAFDRSRYNVIPVDVHGLHWTCKGAGDRKVEVDKTDFSVPVGDGKIRFDYAFIMIHGTPGEDGKLQGYLEMMGIPYSTSGFVSSVETF
>KF629893.1_12523|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MELKSGGIKDKHMSMADEIFINMCRDILENGTSTEGEKVRPHWPDGTSAYTIKKFGVVNRYDLSKEFPLLTLRRTALKSATDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQLGVKHLYKEGLFDQVDRVIYDLKNNPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKIGHDKLTLNAILNQRSQDILAANNWNVCQYAVLMHMLAQVCDMRVGELVHVIADAHIYDRHIPIIKELIQRPTYDAPTFWLNPDVKDFYEFTRNDVRLDNYVTGPQIQDIPIAI
>KF629888.1_12541|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLTSGAGICKTLLENGHQAYLLDLYFGLENAPANLEDVFTLPGAGLEIAKNISTKEPDLEVLKKSRPDQSDCMFGPNVIELCRMADITFVALHGSVGENGKLQAAFDLLGIKYTGCNSFGCALSMNKLVTKQIYKMSGVPTPRGTHLTKETKDLPLSELGYYLPLVVKPCENGSSIGVYICHTEEEYNNAVRESFEKNPDEELVIEPYIKGREFASAVIAGKALPLVEIIPKDGVFNYENKYQAGGAQEICPPVSIDEETQQRMMRAGEEAFAALRMDVYARADFIIDDEDGEFYSLEMNALPGMTAASLLPKAAKAAGIEYNELCERIIEESMNARYR
>KF629882.1_12560|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VKKKLLVLCGGQSSEHIVSRMSCTSVLNNLDKEKYDLTLVGIDLDGNWYYLDADQQDLAKDNWLENSQPVDDIYGLLRKQDVAFPVLHGLYGEDGTIQGLFELAKVAYVGCRVFSSSVAMDKIYTKKILDTVGIPQVKSIYIKKRYDNKLVVVNNNFDEIDDVENYIVKELGMPCFIKASRSGSSVGCYRCDSQEELMDRLNEAAKYDRHIVVEECVDCIELETAVLGNDDVIVSRVGQIMPHGEFYTFESKYEDEESKTCIPALVDQSIQEQIRAYAIKAFKAIDGHGLSRVDFFLDKKTNKIYLNEINTMPGFTKISMYPQLMDDFGISYSELLDRLIELAVQK
>KF629875.1_12583|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MGYDVKQKIDTNAKIAVLMGGPSNEAEISRRSGKNIFKALQNLGYKNAELIEVDENIAATLRTKNIEFVYNAMHGRFGEDGCIQGMLEVMGIPYTGCGVMASSVCMNKEYTKNILKEAGIPLIKSVLIKKGEDYKEKIKELKYPFMLKPVSEGSSIGMYKVNNPEEMAECFEKSAKYGQDVMVEEFIQGKGLTVGVLEDGDKMFATEIIEFRTKTEWYDYEAKYTAGMTEFIIPAELSEEMTKKVKQIAVDAFKACDCRGVSRVDFMVADDKAYVLEINTSPGMTDLSDLPAQSNAMGIDYDTLVQII
>KF629864.1_12609|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
VECAVLGGGEKPVQSSGVGEILAAADFYDFDAKYYNEESRTVINPELPGNAAEKVKKAAEKIFNAVDGYGLARVDFFVTDSGEVIFNEINTMPGFTAISMYPMLWEAAGIPKKQLIDRLIELAFER
>KF629836.1_12682|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKQNLAVIFGGQSSEHEISCMSASNIIQCIDAQRYNIILVGITKEGHWVEAADLNAVQDGSWRQSKTSIVLSPDATRKGLYRMSEDEKAQFVHLDVIFPVLHGLYGEDGTVQGLFKLAGIPFVGCGLFASAAGMDTLYTKIIVDTLGIRQAKYVPVYKEELPKMDEVVARVESALEYPVFVKPSRAGSSKGVNKAANREQLKNALIEAADNDRKILVEETIIGREVECAVLGNLDVKASGVGEILSADEFYDFDAKYYNSESKTLVDPPMPENMREQIREDAVKIFMALDGRGLSRVDFFLTESGVVFNEINTLPGFTAISMYPMLWEAQGIPKKELVQKLIDLAFER
>KF629832.1_12691|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TNLHVTVQDVLAANNWNVCQYAVLMHMLAQVCDMQVGELVHVIADAHIYDRHIPIIKELIGREQHPAPKFTLNPEIKDFYQFTTKDITIEDYVTGPQIKNIPIAV
>KF629827.1_12704|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRADTQYLGIIKNILDAGSLGDNRTGMPAYKLPHQIMQFDLEKEFPILTTKFVAFKTSVKEILWIWQKQSNDVRLLQQWNCHVWDEWMREDGTIGKAYGYQLGKYHQVDTLLETLKKDPQSRRMVVDLWNVKDLPDMALYPCAFLTMWDVSDDGRLNCMLVQRSGDMGLGVPFNMAQYAALVHMIAQVSGLRVGLFTHVINNAHVYRNHVDAMKTQLARLPKAYDTPVLKLNPDVHDFYDFKPEDIVLENYKHHEKIAMEVSV
>KF629825.1_12711|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRRICDEGVVRGDRTGTGTRSVFGHQMRFDLGEGFPLLTTKKVFLKGVIHELLWFLRGDTNIRYLVENGVHIWDNDAYRYYNELCVRHGVLPVDRETFLSAAGGESPVEGYRFGDLNHVYGWQWRSWGRPDGSAIDQIARAVDTIRRNPESRRIIVSAWNVAEVDDMALPPCHVLFQFYVADGRLSCQLYQRSADTFLGVPFNIASYALLTLMMAQVCDLRPGDFVHTLGDTHLYLNHMEQVAEQLSRTPRKLPSMRLNPAVRSIFDFRYEDFTLEGYDPWPAIKAPMSF
>KF629808.1_12762|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGISTERDVSLVTGASVCRALRENGHKAIFVDLFLGLEQVPDPLEALFDAPDGLCPDVKISAVAPDLEAVRRSRADQSTRLFGPHVLEVCALADLVFLGLHGQDGEDGRIQAAFDLLGIRYTGGGYLGSGMAMDKSITKMIMDQVGIPNAPWRNIPHYTEADIPRLTEELEVPCAVKVVNGGSSLGLALPDTKEELAQALHDLLRYGSHILVEKKIHGRELTVAVLGDRWLPAAETIPASGAFDYAAKYQPMAAGGAREICPAEITPEQMAAAGELALRLHRALG
>KF629804.1_12774|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKQQVNKIRVALLFGSCSSEHEVSCVSAAAWADALATMPDRYEVILVGITKQGRWLKYSGSTEGMRSGSWEQDASCVPCVLSPDRSDHGLLVHSANGYELLPVDVVAPILHGKNGEDGTIQGLLELAAIPYVGCGVLASAACMDKAVANTIMDAYHVPHCHWCSAVRAEAETQRSTLLTRVENRLPYPIFVKPANAGSSVGITKAHNREELNTAIDTALREDDKVVFEEFIDGQEVECAAIGNPDNPQEVRTTRPGEILAGAEFYTYDDKYKNGISKTVIPAHLPDQKLDEVKTLAARAYLALGCAGLARCDFFVEHGTGRVLCNELNTLPGFTPISMYPKLMENEGYSFAALVDKLIGLALSKKRGAY
>KF629795.1_12796|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
DVKDLGKIAVVMGGSSGEREVSLMSGSGVLKALQSVGADVVKFDPAEQPLSDLAGIDRAFLILHGKGGEDGVIQGVMEFLKIPYTGSGVQASAIGIDKEMTKAVWEAQGIPVPRGMVLRNETDCEEAHRRFNGNLVIKPSKEGSSLGLYKLKNATLDQVKEAFAKSQEAGMTVLAEEYVFGRELTVAV
>KF629794.1_12797|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
LTPRREQAREEILRPAHGRLFRPINHERKQQINMEKLNVVALFGGQSSEHVVSCMSVQNVAANINKEKYNVILVGITEEGRWLKVDSLDEVKNDTWRTSGSRAVLSPDATEKVLWVIRHGKAEKIPVDVVFPVLHGLYGEDGTVQGILELAQIPYVGCGVLASAVSMDKLSTKLIVKDLGIRQAEYVPVMKEELEQMDQVAKRVEDAFPYPVFIKPSNAGSSRGVSRADDRKSLENGLKEAALHDRRILVEEMIVGHEVECAVFGGGKEEVRASGVGEILAAADFYDFDAKYYNSDSRTVVDPELPGNAAEEIRESAVRIFKAVDGYGLSRVDFFVKEDGEVVFNEINTMPGFTAISMYPMLWEARGVGKEKLVDDLLEHALKRYER
>KF629791.1_12807|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
METRRKKTGMSLADHIFIDMCKDVIENGTSTEGEKVRPVWEDGTSAYTIKRFGVVNRYDLRKEFPALTLRKTALKSAMDEILWIWQKKSNNIHDLHSHIWDSWADENGSIGKAYGYQLGVKHKYKEGMLDQVDRLIYDLKNNPYSRRMLTNIYVHQDLSEMNLYPCAYSMTFNVTGDRLNAILNQRSQDVLAANNWNVVQYAVLVHMLAQVTGFKPGELVHVIADAHIYDRHIPIVKELITRPTHPAPKFYMNPDVKDFYDFTLDDFRIEDYETGPQIKNIPIAI
>KF629789.1_12813|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPLGWSPDEGLPTVEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTIQGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAACIPVAPGITLDARSFDKASEFKANADAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASHHDWRILVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPANLPEETLNLVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEATGVRYTDLITMLIEGVLR
>KF629788.1_12816|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSTERDVSFKTGEMVTKALRENGHQVILLDVFMGYSDKEEDLTGIFDRAEAVSVKVAAIPETAPDLEKVKAQRKDQSDNFFGPNVIELCRMADIVFMALHGENGENGKIQAAFDLFGIRYTGTGYLGSALAMNKGMAKQLFLENGIPTPRGTSLKRGEDAAKIETCGIHFPCVVKPCSGGSSIGVSIVHDKAEYEQALKEAFRWENELVIEEYVKGREFSVGVIDFQALPIIEIAPVEGFYDYKNKYKAGSTVETCPAELSEQITKEMQGYAEKVAEVLGLNAYSRTDFLLDAEDHIFCLEANTLPGMTPTSLLPQEAKVTGVDFNQLCEKLIESSMRKYKN
>KF629773.1_12859|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSNENKKLTLAVIFGGVSSEHDISCISAKGIISNIDYNKYNVILLGITKDGRWYIFNDDISLLPNDRWTESKSLIPAYISPDTSVGGIVTAKGEVIELDCVFPVLHGKNGEDGTIQGLLQLAQIPYVGCDATSSGVCMDKAVANAVADAFDIPQAKWCAFTQYTFNKDRQQCIEYAVNKLGFPIFVKPANAGSSVGITKAHNVNELIEAMAVAFKEDKKAVLEEFIDGHEVECAVLGNDEPIPAEVGEIKAAADFYDFDAKYNNPQSELCIPADIPEEKRNEVRVQAVKAYKALGCEGMSRVDFFVRKSDGAVLLNEINTIPGQTPISMYPKLFEAAGVPYKELIDRLIGCALSRGGKF
>KF629762.1_12891|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRIIVLAGGLSTERDVSLSSGAGICRTLREKGHDAFLLDPFLGLPDAGDNLEAAFTRPDAGLSLASGIRSTEPDLEAVKASREDKSDCFFGANVIELCRLADIVFMGLHGDVGENGKLQAAFDVLGIRYTGSGSLGCALSMDKEITKVIFEANHIPTPKGTWMKRSTADHSLASTGLPLPLVVKPCSGGSSIGVYITQTEEEFDKAVKESFRYEDEIIIEEYIKGRELACGVIDGKALPVIEICPKTGWFDYANKYQDGMTEEMCPARIPEETAKKIQAISEHAFQALKLDVYARADFLLTEDGNIYCLEYNSLPGMTAASLLPKEAKAAGIEFGELCELLIEKSMDARYCG
>KF629755.1_12910|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKRLNIALMAGGDSSERGIALQSAAQIASALDPAKYDITLIDLHGRDWHYTSPDGRQWQVDKNDFSITIDGEHKAFDYALILIHGTPGENGRLQGYLDMMGIPYSSCSMTSSVVTFDKITTKRTVAEFGIPLARGFFFGRDSRIDPKEIVRTLGLPVFVKPNASGSSFGVTKVKSEADILPAVAEAFTESDEILIEECIQGREMGCGMLIAKGREYIFPITEIVSKKEFFDYEAKYTAGCSDEITPADIAPEIKAELNRLTALAYKACRCRGVVRVDFIVTPEGKPYLIEINSIPGMSGGSIVPKQVREAGMTLGELYDLIIEDTYDRDRR
>KF629753.1_12915|FEATURES|farme|macrolide-lincosamide-streptogramin|RlmA(II)|antibiotic target alteration|0
MEYSKEDLMEAKKQIWGVGENMGTEESKKIWEENAQFWDNAMGDESNEFHREVVRPKVTELLSPNPADYILDIACGNGNYSSYLAQRGASVVAFDYSKKMIELAKRRQSQYAKQIEFCVADATDRKSILELKRNRAFTKAVSNMAIMDITDIEPLLMAVYELLQESGIFVFATQHPCFVTLTEKYMTPHSYYDIAIEGQPKEQIYYHRSIQDIFNLCFRAGFVIDGFYEECFKTNKEIPMVMIVRLKKVKRDSLK
>KF629746.1_12941|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRKSGKGIDKRRRYMSYADKVFIDMCRDIIDNGTSTEGEKVRPVWEDGTSAYTIKRFGVVNRYDLSKEFPALTLRRTAIKSCVDELLWIWQKKSNNVNELKSHIWDSWADETGSIGKAYGYQMGVKHQYKEGRMDQTDRVIFDLKNNPYSRRIMTNIYVHNDLHEMHLYPCAYSMTFNVTKEKDSEKLTLNAILNQRSQDVLAANNWNVCQYAVLVHMLAQVCGMKAGEFVHVIADAHIYDRHVPMIEELISREPLPAPTFWLNPEITDFYDFTPDDVRLDRYETHPQIKNIPIAV
>KF629743.1_12951|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTKADTIFKENITKIMEEGVWSEQARPKYKDGTTANSKYITGAFAEYDLSKGEFPITTLRPIAIKSAIKEVFWIYQDQTNSLDVLEDKYNVHYWNDWEVEGVPANNGDKRSIGQRYGAVVKKHDIINRLLAQLEANPWNRRNVISLWDYEAFEETAGLQPCAFQTMFDVRRVGEDIYLDATLTQRSNDMLVAHHINAMQYVALQMMIAKHFGWKVGKFFYFINNLHIYDNQFEQAEELLNRQPSDCQPRLVLNVPDGTNFFDIKPEDFELVDYDPVKPQLKFDLAI
>KF629740.1_12957|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
EGERKVFDYALIIIHGTPGEDGRLQGYLDMMGVPYSSCSMTSSVITFDKVTTKRTVAGRGINLAREIFLCKGETAGPDEVIAEFGLPLFIKPNASGSSFGVTKVHTRDEVLPAVEAAFAQSDEVLIEECIEGREMGCGMMVAGGREYLFPITEIVSKKDFFDYQAKYTEGYSDEITPAQIAPEIAEELHRMTRIAYKACRCSGVVRVDFIVTPEGKPYMIEINSIPGMSAGSIVPKQAKAMGMTLGEMFDLVIADTCRK
>KF629723.1_13002|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSQLFFRNPLQIFVNYDKIENEISAPLCVLSDFCERSWHFSCFRQHIGSKSSLPADMMHQASNRPQYCPAAGYQLIKEFRHMAKIRVAVLFGGVSSEHDVSLISAENVIRSIPKDKYEVLCIGITKKGRWLYFPGDITEISTGAWEQNPDCSAAILSPDPLHGGIITIENGETYIKKVDVVFPVLHGRNGEDGRLQGIMEMARIPYVGCGVLSSAVCMDKGMTHTVLDYNGIQTAKWASVHQRDLNKLDEKCVAIAETLGFPLFVKPANAGSSVGVNKANDLESLKDAVQIAFTHDEKVIIEEFIDGRELEVAVFGYDAPIASYVGEIEPAAEFYDYDDKYVNGTSKLYIPARITDQESDRIRETALRAYQALGCKGLSRVDFFLAKDGSVILNEINTLPGFTSISMYPKLMEHLGMSQEYLVDKLIEQAMENVART
>KF629718.1_13018|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LIQRKVMYMTDRISVAVLFGGVSSEHEISCISAASVLNHIDRDRYDISTIGITKEGNWFLTGSPVANIGDGSWEKDDSNRRAFIAPDRSVGGIMAETGDGRFEILKVDVVLPMLHGRNGEDGTIQGLFQIAGIPFVGSGTAASAASMDKVMTKAIINQSGVVAQAGCCVSYRNVYESDRPAETERIREFFKNTFPLFVKPANAGSSVGITKVKEEENLPAALELAFGEDDKVLVEEAIKGREIEVAVLGNESPQASCIGEIFAANEFYDYNAKYENSMSRTAIVRDLPPEKEEEIRSKAVKVYETMGCAGMARIDFFLEESGRVVLNELNTLPGFTSISMYPKLMEHLGMSQEYLVDKLIEQAMENVART
>KF629715.1_13033|FEATURES|farme|beta_lactam|OCH-5|antibiotic target alteration|0
MKQYLDLLQHVLDHGILKEDRTGTGTISVFGYQMRFNMDEGFPCLTTKKLHLKSIIYELLWFLQGDTNVKYLQDNSVRI
>KF629684.1_13122|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNLKQEKIAVLLGGTSAEREVSLNSGAAVLNALLSQGYNAYGIDPKEYNVANLKADGFDRVFNILHGRGGEDGTMQGLLEQIGLPYTGCGVMASALTMDKMRTKMLWKAFGLPVADMEIVTKENAHELNPQAVVEKLGLPLMVKPSLEGSSVGLTKVKAVEELRSAVDYALKFDNTILIEEWLAGDELTVPVLGGEVLPAVRIVPEGEFYDYDAKYISDNTQYFCPAGLSAEREQELAKLVKRAYDVVGCRGWSRIDVMTDAQGDFRLVEVNTNPGMTSHSLFPKSASTVGISFKQLVVKILELSA
>KF629677.1_13141|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|0
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMRGPSLGGTITGRK
>KF629676.1_13144|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLYSQYCGKRCFNMDIVVLCGGLSPERNVSLSSGTKIASALMELGHRVVLCDMFFGLEDYAGELDGIFNDPPALGGTRIEEAAPDLEAVRAARKLRSDSMFGDRVLELCGMADIVFMALHGRCGEDGRVQAAFDLLGIKYTGSGHLGSAIAMDKDLTKRVVAPLGVLTPEWKLYDCRTLEPETVCAESPLPCVVKPVDSGSSIGVEIARTRQELLEALTRACAEGGAVVVERYIAGREIQIGLLDGRALPSIEIRPLQGFYDYKNKYQPGAAEEITPAPIPAEAEERLAKAALTVYKALGLAAYSRADFIYDGEGNFWFLEINTLPGMTPTSLVPQEAAVLGIS
>KF629642.1_13216|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LQLFAPVLNAILNQRSQDILAANNWNVCQYAVLMHMLAQVCDMQVGELVHVIADAHIYDRHIPLVKELISREPLPAPTFWLNPEVKDFYRFTRDDVRLDNYQTGPQITNIPIAV
>KF629637.1_13229|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSEYDVDAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLMGIKYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKGVSMLKENCTRNIHDLGMEFPVVVKTCCGGSSVGVYIVNNQKEYEEALTDACQYGADIVVEEYIKGREFSVAVVDDKAYPIIEIAPIQGFYDYKNKYQAGSTVETCPAEISPELTAKMQENAVKAAKALGLTGYSRLDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGMDYPTLCEELIRISLKKYE
>KF629605.1_13311|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MGGKSSEHDVSLISAKTVIESIDKDRYSVIMVGITKDGQWKLIDTIAHLEDGSWVNSKTSAYICPDTGSKELLLERGGKTERISIDVVFPVLHGMNGEDGTVQGLLELAAIPYVGCGVLASACSMDKFYTKVIVDAIGVRQAKFVGVRRHELSNMDEVVARVEAGVPYPVFVKPSKAGSSQGVSKAENREELVTALHLAAKHDSKILVEETIVGREIECGVLGMNEPKASGVGEVLSAEEFYSYDAKYNNEESRTVVDPELPEGKAEEIRKDAVAIFKALDCSGLSRVDFFLTKDTNEVVFNEINTLPGFTAISMYPMLWEARGLNKKALVQKLIDLAMNRYDV
>KF629579.1_13375|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADNIFIDMCKDVIENGTSTEGEKVRPVWEDGTPAYTIKRFGVVNRYDLRKEFPALTLRKTALKSAMDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQLGVKHLYKEGLFDQVDRVIYDLKNNPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKIGHDKLTLNAVLNQRSQDVLAANNWNVVQYSVLLHMLAQVCDMEVGELVHVIADAHIYDRHVPIIKELISRTPYPAPKFWLNPEIKDFYQFTRNDVRADDYVTGEQIKDIPIAI
>KF629567.1_13413|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MINNDKKITLAVIFGGVSSEHDISCISAKGIVSNIDYSKYNLILLGITKDGRWFIFNDNIELLPEDKWLNSKSLVPAYISPDSSVHGIVTAKGEIIKLDCVFPVLHGKNGEDGTVQGLLQLAQIPYVGCDATSSGVCMDKAVANAVADAFGINQAKWCAFTQYDFNKNRQECIDTAVNKLGFPIFVKPANAGSSVGITKAHDIPELIEAMNVAFNEDKKAVLEEFIDGHEVECAVLGNVEPIAAEVGEIKAAAEFYDFDAKYNNPASELCIPADIDLEKRNEVKAQAVKAYKALGCEGMSRVDFFVRNSDGAVLLNEINTIPGQTPISMYPKLFEAAGVPYKELIDRLIGCALSRGGKF
>KF629564.1_13417|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VVTLPTPGRKADIMKKSVLVVFGGQSSEHIVSCMSAINVIKNIDTERYDVTLIGITEEGKWLLVDSVEQIEDESWRKNTTTAILSPDATEKSVIVLKDGKAEMIRIDVVFPVLHGLWGEDGTVQGIFELAKIPYVGCGVLASSVSMDKVYTKQIVDHTGVRQAAYELVIRKELEKMDEVVARIENRFAYPVFIKPSNAGSSRGVSKASDREELIAGLKEAAHHDRKILVEETIVGREIECAVFGNGTEPVIASGVGEILAVADFYDFDAKYYNAESRTVVNPELPGDAAERVRQAARRIFKAVDGYGLSRVDFFVTKDGEVIFNEINTMPGFTAISMYPMLFEAAGIPKPEMVTKLIEHGLKRYEA
>KF629548.1_13470|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VAETETAKIILERKSRRRKMKIVVLAAGTSTEREVSIVSGTEVCKALRSRGHQAILVDVFFGKEGADPATAFDGDYDVDAEAAYISSFNAQVKDAVASGREFFGPGVIELCKAADVIFMALHGANGEDGRVQAYFDLCGIPYTGTGYLSSAMAMDKGITKKIFRTSGVPTPRGVELKKGKDSMNLADYNMELPVVVKTCCGGSSVGVYITKTPEEYEEALKGAFSYEDEVVVEEYIEGREFSVGVVDGKAYPIIEIAPVEGFYDYKNKYSAGATIDTCPAVLTEEQTRQMQTYAEAGCKALAVEGYARLDFLMKEDGSMYCLEANTLPGMTPTSLLPQEAAVLGIDYAQLCEKLIEISMRKYQK
>KF629545.1_13478|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
NAIDAERFDVVPVGITKTGQWIVGGEDPRSWSLNDGTLPEVVATADSRAVTLDVSRGQDGFFADDPGQPDHVISLGHIDAVFPVLHGVYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKIVLNAAGIPTAPGIMVDARHATGESVYDEVKKAKLAYPLFVKPSRAGSSFGVTKVEQADDEQAQIAALEAAVAEAGKHDWKVLVEQGIDAREIECAVLCAAPGDEPEASWPGEIVLDHRDQGDDQFYDFDSKYMDSSASHVEVPANLPVSVLEDVRDVARRAFAAVDGAGLSRVDTFVTPDGTVMVNEINTMPGFTPISMYPKAWDASGIGYTELITRLIEGVLC
>KF629532.1_13512|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MAKRVTVKELNSYVYEQKRRYKIMKIVVLAGGTSTEREISIVSGTGICGALRQKGHEAILVDIFCGVENVDWENPFPAEYDVEKAAEYMSSFNPQIKEMEKKRRSFFGPNVLELCEKCDIVFLGLHGANGEDGKVQATFDLLGIRYTGTGYLSSAMAMDKRITKEVFLMNHVPTPGGFTMTRDNLEKDIAKHGLEFPVVVKTSCGGSSVGVYIVNDQKEYEEALTDACQYGADIVVEEYIKGREFSVAVVDDKAYPIIEIAPIQGFYDYKNKYQAGSTVETCPAEISPELTAKMQENAVKAAKALGLTGYSRLDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGMDYPTLCEELIRISLKKYE
>KF629516.1_13562|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DLHEMNLYPCAYSMTFNVTKERGSDRLTLNGILNQRSNDVLAANNWNVCQYAVLLHMLAQVCDMQVGEFVHVIADAHIYDRHVPMIEELIKREPLPAPKFWLNPEIKDFYQFTRNDVKLIDYETHEQIKDIPVAV
>KF629505.1_13594|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VITKNNTVAVLMGGVSREADISRKTGTAILQALLSLGYHAVKVEYNPSCVLKQLKAVGAEVVFIALHGKYGEDGTIQSILELSKIPYTGSGVSSSAITMDKIISSRVFKDAGVRMAFSKPYYLKNGIDTVAESIEKNFKFPVVLKPACEGSTIGLEIVYEKEKLKEALKRVFAIESRILAEAYLDGKEFTIAVLNGKALPIIQICPHSGQYDFHSKYTSGATDYIVPAPLPGAAADEMTRMAILGYEAAECSGVVRFDFRTDKRGTPFLLEANSIPGMTETSLVPKAAAAIGMDFPSLCENILLKAGVGKV
>KF629500.1_13606|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSQWDKDYLCLCRRILEEGTEVVNRTGTNTIKVPSHNFHFDLSKEFPILTTKQLFIRQAVLEMLWIYQAQSNDVRWLQERDVKIWNEWEIDDEGYWNASQMLPDENGKLVKTPVHKFFGKEWAHTIGTAYGYIVNKFQMTQQLIDKIKNHPEDRRMVMTLWQNDYLDTAVLPSCVWSSEWDVTDGKLNCWVHQRSCDVPLGLPFNVTQYATLLCMLAQVCGLKPGTMDWSIKDAHIYVNQIDGIKEQLKRFDEQGDLPAPKLWLNPEIDDFFKFDNSRDCNDVKLIDYKHMGKIKFPISQ
>KF629480.1_13662|FEATURES|farme|macrolide-lincosamide-streptogramin|clpX|antibiotic target alteration|0
MVGNRTNDVKVYCSFCGKSQDEVKKIIAGNNVFICNECVALSQEIIKEELAEEVLADLAEVPKPKELLATLDEYVVGQERAKRALAVAVYNHYKRVSFAESRDEEDVELQKSNILLIGPTGSGKTFLAQTLAKSLNVPFAIADATSLTEAGYVGEDVENILLKLIQAADFNIERAERGIIYVDEIDKIAKKGENVSITRDVSGEGVQQALLKIIEGTVASVPPQGGRKHPNQEMIQINTKNILFIVGGAFDGIEDIVKQRLGEKVIGFGQNNRKIDEDASYMQEIISEDIQKFGLIPEFIGRLPVVAALEQLTTDDLVRILTEPRNALVKQYQTLLSYDGVELEFDEDALQAIANKAIERKTGARGLRSIIEETMMDIMFEIPSRVEVTKVRITKDAVEGKDKPILEIA
>KF629472.1_13690|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLELCVIFGGQSPEHEISRKSVTSVLNNLNKDKYNISTIGITKNGAWYLYTGDYAKIESGEWEQDTENKKKAILSPDAEDKAIIVFDGDKVMKIHPDVIFPVLHGEFGEDGTIQGLFELSGIPYVGMGVMASANGTDKTSSKIVFASADIPQADWVVVNKTDNFEDKMDEIENKLGYPCFVKPARTGSSVGVGKAHDRKELKAALENAAQFDRKILVEENIDGHEVECAVLGNEDVKAATVGEIMPTVEFYDFDAKYNDNSTELQIPADLPKETIEQIREYAVRAFKALDGSGLSRVDFFVKHSDGSVVLNEINTLPGFTNISMYPKLWGAVGIEYSELLDKLIELAEKRVK
>KF629471.1_13694|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEKIKLAIIFGGKSSEYPVSLHSAGSLIHKINKEHYELIFIGISKDGKWYAYDGDVDGIEHDTWLCEEHCTPCVLSSSEGCRGFLKLHADGTFTRIEVDCIFPILHGKNGEDGTIQGLFELSGIPYVGCGHMSSAICMDKEMAHIVMEHAGISCAPFVCVYEADDLDYRKVYEHAKETLGLPIFIKPANAGSSFGIHRMESFDGFEEAMKDAFYHDGKGKVILETTIEGFEIGVAVMGNKELFAGSVDEIETAAPFFDYEGKYEMVDSHIYCPARISPKLFEEAREIAKKAYRAMNCKGMTRVDMFVTPEDTIILNEVNTIPGFTDTSRYPTMMKEAGIPFPELIDKLVALAMEE
>KF629463.1_13712|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MSRADEIFKANCRDILDSGVWDTDLTVRPHWEDGTPAHTVKKFGLVNRYNLQEEFPILTLRRTYFKTCIDELLWIWQQKSNNIHDLRGHIWDSWADETGSIGKAYS
>KF629448.1_13752|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KAYCYQLAVKHHYPEGDMDQVDRVLYDLKHNPASRRILTNIYNFQDLHEMALYPCAYSMTFNVSGRTLNAILNQRSQDMLAANNWNVVQYAVLVHMMAQVSGLEAGELVHVIADAHIYDRHVPIIEKMLEREPRPAPKFIMDPAVTDFYQFTRDSFSLEGYDPQPFEDKIPVAI
>KF629442.1_13767|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADKIFVTMCQDILENGTSTEGEKVRPHWEDGTSAYTIKKFGVVNRYDLSKEFPAITLRKTAIKTCTEEMLWIWQRKSNNIHDLNSTVWDEWADENGSIGKAYGYQLAQKHQYREGMMDQVDRVIYDLKNNPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKQGDDKLTLNAILNQRSQDVLTANNWNVCQYAVLMNMLAQVCDMKVGELVHVIADAHIYDRHVELVKELITRQQHPATKFWLNPEIKDFYQFTPDDIKVTDYVTGPQIKNIPVAI
>KF629433.1_13789|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKIVVLAGGLSPERNVSLSSGSMVCQALRDRGHQVALVDLFFGLEDHKGEPEELFNAPIPDSFKKVSRQAPDLEQVRASRKWKDASAIGPGVLDLCKKADVVYLGLHGACGEDGRIQAALDLLGVPYTGSGYLSSAIAMDKDLTKRLVADKVVTPRWMRVDLTEEQLDGLVEEVSLPAVIKPVDSGSSIGVFIANDKAELRHALEESVKLGGRVVIEQYIKGREIQVAVLNGKPLPSIEITPKEGFYDYENKYQPGAALEVCPAPIPAEWEERIGKAAVAVFETVGLSVYARADFIVTEDGTPYFLEINTLPGMTPTSLVPQEAAAVGMDYGTLCETIIRSSLELRNKEL
>KF629411.1_13851|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKTRVAVIFGGMSNEHDISLISASNVIAHLDPDKYEIIPVGITKKGRWFFYPGDISGIKDGSWETNPDCVPAAILPDPLYGGIAKVSDGRMNLVKIDVVFPVLHGKYGEDGTIQGLLDMAGIPYVGCGCFASAACMDKEYAHCVLQYNGINMAKYRTVKQSDLNNLDAVCEKIAAELKYPLFVKPACSGSSVGVNKATCFEDLKNAVKLAFTHDKKVIVEEFIKGRELECAVLGTDNPFASEVGEILSCNDFYDYDAKYILGTSGLNIPANIPKEASLEIRETAVKAFKALGCFGLSRVDFFLADNGKVYLNELNTMPGFTSISMYPKLMGNLGIPYGELLDRLIKLAYERN
>KF629401.1_13878|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVCGGDTSEFQVSLRSAQGIYSFIVKEKYTLYIVEMHGLDWHVQLPDGGKAPIDRNDFSFQMNGRKVTFDFAYITIHGTPGEDGRLQGYFDLLHIPYSCCGVLAAALTYDKFACNQYLKVFGVRIAESLVLRQGQSISDEDVIEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQPAIVKAFDEAQEVLIEAYMEGTEVTCGCYKTKEKSVVFPITEVVTENEFFDYDAKYNGQVSEITPARLSDDLTHRIQTLTSAIYDILGASGIIRVDYIITAGDKVNLLEVNTTPGMTATSFIPQQVRAAGLDIKDVMTDIIENQL
>KF629400.1_13882|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQIFLANCQEILSRGTWDTHLPVRPRWEDGTPAHTVKCFGLVNRYDLREEFPIQTIRRMYLKSAVEELLWIWQKKSNNVRALSTGIWDAWADETGSIGKAYGYQMGVKHRYPEGEMDQVDRVLYDLKHNPSSRRILTNLYNHHDLSEMALYPCAYSMTFNVTGDTLNAILHQRSQDMLTANGWNVMQYAVLVHMLAQVSGLEAGELVHVIADAHIYDRHVPLVEELLGRTPYPAPRLRLDPAVTDFYAFTPDSVQLENYRYHPLKEKIPVAI
>KF629394.1_13900|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DLSKEFPALTLRRTAVKSAIDEVLWIWQKKSNNIHDLKSHIWDEWADPDGSIGKAYGYQMQVKHQYKEGMMDQVDRVLYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKRPGEDKLLNNAQCHFKPALPGYSCGK
>KF629394.1_13901|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VQYAALVHMFAQVCGMQVGELVHVIADAHIYDRHIPLIKELISRETHPAPDFWMNPEIKDFYDFTPDDFRVENYVTGPQIKNIPIAV
>KF629389.1_13914|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LEDKKKRIGVIFGGKSGEYEVSLLSAASVIRVLNTQKYEPVYIGITKEGKWKRYDGDADSIENGSWLAEAEDLNPGDLKQYIDFALPIVHGPYCEDGKLQGFLETMDIPYGGCGVLASAVAMDKQVARQVFLRAGLPMCKHVFLTKAEWQDEQETVLARIEQRIGYPNFVKPANLGSSVGISKAKDRTSLIEALALALSYDSRVIVEEFVDCRELETGILGNDYPAAAEVGEILSSAEFYDYEAKYSDGASRICIPAEISAEDREEIRMMAVKACKAIGGEGYCRVDFFKDRRTGKLYLNEINTIPGFTKYSMFPLLWEAAGVKYPDTVERIIELGYERYYTKNHRETML
>KF629386.1_13922|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MESVEFRSMKKNVVVIFGGDSSEHDVSCLSATTVIKNMDTEKYNVILVGITKEGKWLLVDSVKDIEDGSWREGEVKAFISPDTTTRSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQGLFELSKIPYVGCGVLASAVSMDKVYTKIIVDHIGIDQAKFVHVRESDFEHLEEAMDRVEKEIPYPIFVKPSCAGSSKGVSKAENREELEAALYEAVKHDRNILCEETIVGREVECAVLGDRTQVKSTCVGEILAAEEAAFYDFDAKYNNAESKTVVDPEMPEESKRKIKEDAEAIFRAVDGFGLSRVDFFLEESGRVVFNEINTLPGFTSISMYPMLWKACGLDIPELLDTLIDQAMTRYR
>KF629382.1_13931|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMQSEDKLCVVVLFGGMSSEHEVSRVSAGTFVDNLDRARYEVLTVGITREGRWLCTEATSAQMADGSWEELPGNMPCVISPDRADHGMILFTPSGQVEKLHVDVVIPALHGLWGEDGTVQGLLELAGIPYVGCGVLASAVCMDKAVANALFDAAGIPHTKWLSACRWEIESDLDGVCDGAIAKLGWPIFVKPANAGSSVGITKAHDRDELKQAIALALENDHKVVFEAFVDGHEVECAVIGSDPAVATRPGEILAGAEFYTYDDKYKNGVSQVVIPARLSEEKLDEVKTYAAMAYTALNCEGLARCDFFVEHGTNRVMINEINTFPGFTPISMYPKLMEHEGTPVPALIDHLIELALERTEKQHG
>KF629381.1_13933|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PSYSVTKEPGEERLILNGVLNQRSQDVLAANNWNVCQYAILLMMVAQVNDMIPGELVHVIADAHIYDRHVPMIEELISREPLPAPTFWLNPEITDFYDFTPDDVRLDRYETHPQIKNIPIAV
>KF629380.1_13937|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGTSTERDVSIVSGTGICSALRQKNHQAILVDVFCGLENVDWADPFPESYDVEEAVSYIRSFNRHIEELKKSRKEFFGPNVLELCKKADFVFLGLHGSNGEDGRLQAVFDLMGIPYTGTGYLSSAMAMDKGVTKAMFQMRGVPTPGGKAMKKKDRVETPQELGLDFPVVVKTCCGGSSIGVYIVDNQADYTKALDGAFTYENEVVVEEFVEGTEYTVAVVDGKAYPVVQIVPVQGFYDYENKYKPGAVKETCPAPISEELTRRLQEYAVEGYHALEMESYGRLDFIVTKDEKIYCLEANTLPGMTPTSLIPQEAAVLGMDYPTLCEELIRVSMKKSTNEEN
>KF629367.1_13976|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMNKNDVVAVIMGGPSAEREISLVTGAAIAGALREKGYNVAEIDLEPKKLALQLEECSAKVVFNAVHGMYGEDGRLQTLLEMLEIPYTGSGMLASALGMDKAASKRIMQAAGIATPKSLIFVKGETHDFCGEILSAFKKMPVVVKPATQGSSIGVEIVKNDTDINSAMEKAFTYSREVVVEEFIQGKELTVAIMQDGGMAVALPVINIVPHSGVYDFHSKYTKGETEYLVPAPLDKETTRHVQELAVATYKVLGCSGVARVDVMLDEAGKGYVLEANTVPGMTATSLVPKAAAAVGISFPDLCEKILLSASLNDK
>KF629355.1_14013|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKTTVAVIFGGCSSEYEISLLSASSIIRNIPKDKYEIIMLGITKEGHWLLFNGDVDEIENGTWEQHSENRTAFLSPDRGIHGIVMETEYGFSAIRIDVIFPVLHGKNGEDGTIQGLFQLSGIPFVGCDTLASAVCMDKAVTNILLEAAGIDQANFMWFYASDYENVKEQVKEDIMADLGGYPVFVKPANAGSSVGVSKAKNAAELDKAVAVAAKEDKKIVIEECIVGKEVECAVMGNAIPKVSVVGEIAPSAEFYDYEDKYKNGTSKVYIPAPLDDELSAEICNTAAKAYRALGCSGLSRVDFFVRDSDNAILLNEINTLPGFTSISMYSMLWKACGIDYGHLLDHIIQFAFDK
>KF629347.1_14038|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PSYSVTKEPGEERLILNGVLNQRSQDVLAANNWNVCQYAILLMMVAQVNDMIPGELVHVIADAHIYDRHVPVIEELIKREQYPAPKVSLNPEVKDFYKFTTDDLIVEDYQAGEQIKNIPIAV
>KF629335.1_14076|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKIKVAVLFGGQSSEHDISCISAATVIESIDREKYDVITVGITKDGRWIKTDNVEDIKSGKWREGKVTMILSPDRIHKGFVEIEDGKAEVTEVDVVFPVLHGLYGEDGTIQGILELAGIPYVGCGVVASAVSMDKLFTKKIVDGLKDVRQAKYVPVRRYELKEMDKILDGIEERLPYPVFVKPSNAGSSKGVSKAGDRAGLEKALRLAAEHDEKILVEETIVGREIECAVLGTSDVKASGVGEILAADSAAFYDFDAKYNNAESKTVINPELPDGKTDEVRNDAVRIFKAVDGFGLSRVDFFIENGTNDVVFNEINTMPGFTSISMYPMLWADRGIEKKELVDELINEAFTRHKI
>KF629322.1_14121|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNMNIVVLAGGISTEREVSIVSGTGVCQALRKKGHRAILVDVFCGDARVASECIEDCFPKEYDVASAADYMRSMSEEIEEIKKSGREFFGPNVLKLCKLADIVFLALHGADGEGGTVQAAFDLLRIPYTGSGHLGSAMAMDKNISKRLFQAYGVPTASGIALKKENPRLAAAENGVGLPCIVKPCCGGSSVGVTIAHTEEEYEEALSAAFSYENEVIVEAYIHGREFSAGVIDGKAYPIIEIAPVEGFYDYQNKYTAGATIETCPAELSKEQTEQMQSYAVKAYEALQLSGYGRMDFMMDEQGRMYCLEANTLPGMTPTSLLPQEAAAVGIAFPELCELLIEVSMKARGQKR
>KF629321.1_14124|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSEKYRKKVKVAVIFGGYSSEYSVSLESSSAVIKNLDPEKYEVLPVGITKEGQWFSYTGSVENIENDTWQQSEYCTPAMISPDRNTHGLVLLGEDGAKTMPIDVAFPVMHGKNGEDGTIQGLITMAGIPLAGCGILASALCMDKDRAHLVAEAAGVRVPKAMVLTQGDDRKMAVDFALKTGYPVYVKPVKAGSSYGVTKVEKPVELQSAIIKAFQYDDEVIIEENMDGFEVGCAVLGNRNLITGEVDEIQLSGGFFDFTEKYTLKTSEIHVPARIELRKMQEIKQIAKTIYRALGCRGFARVDMFLTPDGEIVFNEVNTIPGFTEHSRYPGMMKAAGLEFPEILERIIRLAME
>KF629317.1_14133|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
REELLVGIEEALKYDSRIVLEKGINAREIEVAVIGNEEVKASIAGEIKPAKDFYDYEDKYINGTSTYDIPANIKAEDMEDIRRMAIEAFKGIDGKGLSRVDFFIDKDSGEIFINEINTLPGFTNISMYPKMWEATGLEYSKLIDRLIELALDSKK
>KF629307.1_14160|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKIVVLAGGISTERDVSLSSGRGVYNALKERGHQVILLDVFLGYEGDPGNIFELDRDWVKDVAPVSEVAPDIDKIKASRKKPSNILFGDHVIEICQMADIVFMALHGDCGENGKVQAVFDLFGIKYTGTDSFSSALAMDKSITKQLFLQNGVPTPASHLLTGKDDPYKPEFPCVVKVSGGGSSVGVYIVQNEKEYADAVQDAFRYDAKVLVEQYIKGREFTDCVIEGKPYPVVEIEPVSGFYDYKNKYQAGSTIETCPAKISDELTKKIQDTALKAYQVLGIKTYARMDVLMDENGDVYCLEANTLPGMTPTSLIPQEAAVLGISYGELCELIIEISLKRW
>KF629291.1_14203|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NLYNFQDLHEMALYPCAYSMTFNVSGDTLNAILNQRSQDMLTANNWNVVQYSVLVHMMAQVSGLKAGELVHVIADAHIYDRHVPAVEKLLAQEPQAAPTFHMDEAVTDFYQFTRDSFSLEGYHPLPFDDEIPVAI
>KF629290.1_14207|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MNKKAPHRISEQHLTVLSWSAPLLAQLIMLIVMCMQRHWLYAAMLAPSLLGSALMLITMIMRVRHEETNSNTITGSDSPVPTHHNGNEIDHAQLFADMPSISFEHLHGLDNDPLIWRTIVRNWLVRSPTNGIGMSEHGIFHIDLASSGPHAMVAGTTGSGKSELLISWCMALAIRHSPQTLHFVFLDFKGGSTFNALERLPHTVGNVCDLDLAHAVRALNAIEQELARREALVSAERVSRFDQLSHPPARLVVVIDEFHALRDRLPDYMQRLNRLASLGRSLGMHLIVCTQNPMGQVHADMKANISLSICLRVTDQMQSNELIGTKDAALIPPAFPGAAYCHDGQRTVPFRCSAVHDIDSLVHAINTASAFSGTTNPSPLFSAPLAPHAGKDDLTAPQREAWHHVPFALSDDGVLISTAFLDVGHGNIAVIGACGSGKTNLLLCCASRLYESGRCTIRFTRKTNSEWTTDDGRISPQHERTIWFVDDADELLSPFAAMPEADKLKTALADPSVTVIAAVEKPQSTLLERCLTRVAFPCGERATDVMMGIPSAVLDGFGVDDYAIAGRGVFIQQARACPVQCAEFQGF
>KF629272.1_14254|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKKNLAVIFGGRSSEHEVSCVSVVTIAKAVDLEKYNMFLIGITKDGEWKLVEDIAGIEDGSWKESPVSAIISPDTKGGLIISQDDMMKVQPIDVIFPVLHGMYGEDGTIQGLFEMADIPYVGCGVFASAASMDKFYTKLVVDTLGIRQAVYVPVLAEQLDDIDEVTARVEAKLSYPVFVKPSKAGSSKGVSKADDRAALVVALKEAAKHDYKILVEETIVGREIECAVLGYGKNTKASRVGEILAAAEFYDFDAKYNNAESKTVIGADLPDGKEAEVQKDAVAIFNALDGFGLSRVDFFLEKDTNEVIFNEINTLPGFTSISMYPMLWKDKGYSIESLVETLIEMAKERP
>KF629266.1_14269|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLQRFGGEFLQQFLHSLRRWKNMKIVVLAGGTSTERDVSIVSGTGICQALRQKGHQAILVDVFCGLESVDWANPFPAEYDVEKAAEYIKSFNSQMKELKKTRRDFFGPNVIELCKKADFVFLGLHGANGEDGKLQAAFDLMGIPYTGTGYLSSAMAMDKGVTKAMFQMRGVSTPGGKSMKKKDRQDSLAALGMEFPVVVKTCCGGSSIGVYIVDDQEAYRKALDEAFEYENEVVVEEFIKGVEYTVAVVDGTAYPVVQIVPKEGFYDYENKYKPGAVQETCPAPISEELTKRLQEAAVDGYHALEMESYARLDFIVTEDEKIYCLEANTLPGMTPTSLIPQEAAVLGMDYPTLCEELIRVSQKKYE
>KF629265.1_14271|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSHADQLFLQNCREILSHGVWDTDLPVRPRWEDGTPAHTIKKFGIINRYQLQEEFPILTLRRTYWKSAVDELLWIWQKKSNNIHDLSSHIWDQWADESGSIGKAYGYQLSVKHHYPEGDMDQVDRVLYDLKHNPASRRILTSLYNFEDLHDMHLYPCAYSMTFNVSGKVLNAILNQRSQDMLTANNWNVVQYAILVHMFAQVSGLVPGELVHVIADAHIYDRHIPIVERMLERAPAPAPRLIIDSSVTDFYAFTPDSFRLDGYTPATFEEKIPIAI
>KF629264.1_14273|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
MNETKKLRVALFFGGVSSEHEVSCVSASTWLRALAQAPCADRYEVFPVGITKQGRWLACSPTPEAMADGSWEKGADCTPCVLSPDRTDHGIWLLKDGKAELVHIDICAPVMHGKNGEDGTIQGLFELARIPYVGCGVL
>KF629263.1_14275|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEVVLMKVGVIMGGISSEREISLNSGNSIMENIDKNKYDVVPVVIDEKADIINKVKDLDFALLALHGKFGEDGTVQSVLQTLDIPYSGCGPLSSALCMDKDLTKVVLAANGIRTAKWLNVKSVEEIDYEAIEKMGYPVFIKPTNGGSSVATFKVYDKEKVQEAVEEGLKWDTEVMIEEFVDGDEITCPVFDNKLFPIIAIKPKSDFFDYTQKYSAGGADEVIVELEENLHKEVEAMALRTYKALKCEVYSRIDMIVNKEGIPYILEVNTLPGMTAASLFPKSAKGQGYSYSEFLDLIIETSLKVNRAV
>KF629262.1_14278|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MNTLKRDLKIALLLGGPGSEREVSLVSGNSVYDALCRAGFTDVTKVDVHGPDFRLPEGTELAYNIIHGTFGEDGTLQAILEERGVPYTGAGSRSSALCFNKSESKKVFLEAGVPTPHAEILDCSHGIVMPSLPLPFVIKPPCEGSSVGVHIVRRQEDVLPAMEEAVTHGTTVLVEEFIQGKELTVGILDGKALPVIHICPRSGFYDLSNKYPWMNMGGGTDYICPADLPEETAANVQEAALKAYKAAGVEVYGRVDVLLREEDGAPFVLEINTIPGMTPSSLLPKAAAASGWPYEDLCEKIAELSLVTPRK
>KF629259.1_14285|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
ESMNIVVLAGGTSTEREISIVTGTGVCKALRQKGHNAILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQAADIVFMGLHGSNGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKGVSMLKENCTRNIQDLGMEFPVVVKTCCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVEEYIKGREFSVAVVDGKAYPIIEIAPKQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHYAEAGAKALCIEGYARFDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEELIRISLKKYSK
>KF629256.1_14295|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSIADRVFIENCRDIISNGVWDTDRPVRPRWEDGSPAHTVKLFGVVNRYDLSQEFPIMTLRKTGFRNAIDELLWIWQKKSNNIHDLHSHIWDAWADGSGSIGKAYGYQLGVKHHYPEGDMDQVDRILYDLKHNPGSRRIISNIYNHADLSEMRLYPCAYSMTFNVSGSRLNAILNQRSQDMLVANNWNVCQYAVLVYMMAQVSGLEAGMLMHVIADAHIYDRHVPLVEELISREPLDAPRFIIDKSIDDFYKFTVDSFSLEGYESHGSIGKIPVAV
>KF629254.1_14303|FEATURES|farme|kasugamycin|KsgA|antibiotic target alteration|0
HLRGAEFTTALLNDPLIDIKYDLHNAEVLDHLPEGAFATVSNHPIGSIDGIMLIDIFASRRPDFKVMVNGVLTKIGAMGDNFVSVKPDSNNQGANLKNINGVRISLQQLKEGHPMGFFPAGGISMYNKKTKKIQDLPWTHSVIRLIRKAKVPVYPVYFDFLNSRFFYWLGRIDWRIRTLRIPAEAFNKRGRTVDVYIGEPVSPEEIQNIADDKDLAEFLYQRTYAAKK
>KF629249.1_14314|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
GASVCRALRENGHRAILLDLFLGLEEVPADLEKLFDAPDGLCPDVRIDAQAPDLETVRKSRKDQSDRLFGPHVLEVCAACDIVFLGLHGMDGEDGRVQAAFDLLGIRYTGSGYLGSGMAMDKSITKYIMERAGIPTAPWRDIPAYTEADIPALTAELEVPCAVKIVNGGSSIGVALPDTKEELSQALRELLRYGNHVIVEKKIKGRELTVGVLGERYLPAVEIVAKSGNFDYEAKYQTGGSEEICPAPITEEQQRRMGEYALRLHRALGLSVYSRTDFILDEEGNPWCLEVNSLPGLTPASLVPKEAAAVGMTYGQLCEEIVQRSYQIKRRG
>KF629233.1_14351|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLHRIRTEGVRKDDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELLWFLKGDTNVKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYEGGFIDQISEAVETIRKNPDSRRIIVNAWNVADLKNMNLPPCHMFFQFYVADGRLSLQMYQRSADSFLGVPFNIASYALLLQMMAQVTGLKPGDFIHTLGDAHIYLNHLEQVDLQLSREPRPLPRMILNPDVKNIFDFKYEDFQLEGYDPWPHIAGKVSV
>KF629229.1_14361|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VKKLLIICGGQSTEHIISRMSCTSVLKNINKEKYDITLAGIEKDGTWYILNQTQDDLVNDSWLEGAVKVEDVYGLLRQQEVVYPVLHGMYGEDGTIQGLLELAEVPYVGCKVLGSSVAMDKIYTKKILETVGIPQVKSLYVKKRYDGTLVVVDNTFDESADIADSVEKELRYPCFIKASNSGSSVGCYRVDEEKELMPRLEEAAQYDRKIVIEECVDCIELETAVLGNDDPIVSRVGQIMPHGVFYTFESKYEDEESKTCIPALVDEKIQEEIRNYALKVFKAIDGHGLSRVDFFLDKKTNKVYLNEINTMPGFTKISMYPQLMADFGITYSDLIDKLIE
>KF629227.1_14366|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLELCVIFGGQSPEHEISRKSVTSVLNNLNKDKYNISTIGITKNGAWYLYTGDYAKIESGEWEQDTENKKKAILSPDAEDKAILVFDGDKVTKIHPDVIFPVLHGEFGEDGTIQGLFELSGIPYVGMGVMASANGMEWIRPHQKSCLQVQIFRRLIGLL
>KF629221.1_14379|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELLDRVLREGVKKEDRTGTGTYSVFGHQMRFNLEDGFPLLTTKKLHLKSIIYELLWFLQGDTNAKYLQEHGVRIWNEWADPDGNLGHIYGFQWRSWPDYKGGNIDQISEVVETIKHNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQMYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKSIFDFKFEDFELVNYDPHPHIAGAVAV
>KF629193.1_14455|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLISGAGICKTLRESGHQAYLLDVYFGLPYDADKLDEVFDLPDAGLGIAEGIKTTMPDLDALKKSRPDQSDCYLGPNVIELCRMADITFMALHGSVGENGKLQATFDILGIRYTGPNSLGCSLSMNKLVAKQIFKMSRVATPRGTSLNRQTKDTPLDELGYYLPLVIKPCSGGSSIGVFIVHTEEEYLDAIHQSFDVHQEEEVVIEPYIKGREFACGILAGKALPIVEIIPKDGVFNYENKYQAGGAQEICPPVSLDEKTQKKMKRMAEKAFRTLRMDVYARADFIVDDTDGKFYCLEMNGLPGMTPASLIPKAAKAAGLEYGDLCEQIIDESIKARYQ
>KF629181.1_14495|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MNIVVLAGGTSTERDISIMTSVKVCESLRRNGHNANIIDVFFVIEDKAAETFFDDNGNDLEKIAADMKKKDILVDDELADRKKSGKGFFGDNVLALCLKADIVFMGLHGSNGEDGKIQAVFELMGIKYTGTDYISSAISMSKELTKKVLVPDGIPMPKGVALKKGHKIEYVPYPCVVKPCCGGSSVGVSIVSNESEFKSALTEAFSYEDNILVEEYIKGREFSVGVLDGKALPVIEIEPLEGFYDYKNKYKAGATKETCPADLPKEISEKMQRWAEKACESAGVTTYARVDQLLTEDGSIYCLEINTLPGMTATSLLPQEAQAAGISYDELTEKIIEISLKRYE
>KF629178.1_14503|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VISPVSAVILSVLRREFKGSIGKITGFRKKMLVFWGSFAYDMYADRFLICGGGKEEPVLKKLSVCVLFGGVSSEHEVSLRSAESVLNRLDKDKYHIFPVGITKDGDWILFGGKDYGMLPAGTWQNCEDNRRAALSPVRGQGLLSFENDCVVRERIDVVFPVMHGENCEDGAIQGLLQIAGIPYVGPHVAASAACMDKTITKLIADAAGVLQAAWQLVTREGFARSRENALNTVEARFAYPVFVKPAGTGSSVGVAKAKDRAALEAAIEAALKYDRKGLVEEFISGQEVEVAVLGNDNPFASICGEIDSGAEFYDYDAKYISDCAHLYIPARISEQTTEQVRELAVRVYKAMGCRGMSRVGFFVKSDGEVVFNEINTIPGFTSISMYPKLFEASGIPYSDLLDNLIALALEA
>KF629175.1_14510|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MIKKRILVIFGGQSSEHIVSCMSAVNVINNIDRDTYDVLIVGITEEGHWLLVDSVEAIQDESWRDGTVQAVLSPDATEKSVIVIDGAGIKKIKVDGAFPVLHGLYGEDGTIQGLFELAKLPYVGCGVLASAVSMDKFFTKIIADRVGVRQAAYEPVMKEEIAGTEGMAEAVKRVEARFAYPVFIKPSNAGSSRGVSKAENREQLTEGLTEAARHDRKILVEETIVGHEIECAVFGNGKEPVIASGVGEVLAAAQFYDFEAKYFNAESRTVVNPELPGDSAERVRRAAVEIFKAVDGYGLARVDFFVTKDGDVVFNEINTMPGFTAISMYPMLFEAAGISKTELVGKLIEHGMKRY
>KF629168.1_14530|FEATURES|farme|aminoglycoside|rmtB|antibiotic target alteration|1
MSAKKVFNADDVAASILKSPKYRAIAPDAVNRIAAEECQKGGADCEKRARNRLHQIADAFMNQKEQSMLWDMLERGDLDAALGQHASTRERMATREEYMSLIARHCPPGGIICDAACGLDPLMLGAAGYAVRGLDIQMTCVDVINAWARRESWDVKAEGADLLGRAELPKSDLTLFMKLLPVLDAQRAGEGMRLLSLSSSPRVIVSFPTRTLGGRGVGMERNYGERFESALPVEFEICERMATGNELFYALRRV
>KF629161.1_14546|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLSGGFCTERHVGLVSGSGVCRALREKGHQAIFVDMFMGLENYQGKLEDIFDAPDGLLEKVAIEETAPDLEAVRAARQDKSPSLLGKDVLKVCAMADAVFLAMHGANGEDGRIQATLDLLGVPYTGSGYLGSAMAMDKAVTKRMMDSLGIRTAPWVDVHYKKEDIPRLTQELMVPCAVKMVNGGSSIGMALPDTREELEKALYDLLPYGGHVVVEKKIKGREIQIAVLGDTYLPAVEIIPKGEYFDYVCKYQKDGAQEICPAPISDEEWRQVGEMALKLHQGLGLSVYSRSDFLLDDEGKAWCLEINTLPGMTPTSLVPQEAAQVGLSYADLCEKIVLDSIEARKAEYR
>KF629159.1_14550|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKPTLAVLFGGCSPEYSVSLQSSYAVLSNLNPDRYTVLPVGITQSGQWFHYTGAYDRIATDSWAEDPGCLTPVVVSQDRSVHGLLAFSAPRHQVIQVDYALPILHGKNGEDGTVQGLLELAGIPVVGCGTLASALCMDKDRAHKLASLAGVAVPASLVLKLGEDPQAAVDFARQTGYPLFVKPVKAGSSYGISQIHQEEELLPALDLAFQYDNQVILEETIPGFEVGCAVIGTRELLVGEIDEIELSGGFFDFTEKYTLKTSAIHVPARVDPQTAQAVKQTAKVLYRALGCAGFARVDLFLTPQGKIVFNEINTIPGFTEHSRFPGMMQAAGMTFPEILDTILGQVMAP
>KF629134.1_14610|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MMKRNIAIVAGGDSSEIVISLKSAEGIFSFLDKDKYNVYIAIVKRDEWAVKLPGGEHTPIDKNDFSFRENGEIRHFDFAYITIHGTPGEDGRLQGYFDMIGMPYSSCGMFVSALTFNKFACNHYLKGFGVDIARSIHLFKGQTVTDEEVVSRLGLPVFVKPNDGGSSFGVTKVKEASAIQPAIDKAFSEGREVVIESFIDGTEVTCGCYKTSDKEVVFPLTEGVTNNEFFDFDAKYNGQVQEITPARISAEQTEKVQRETSRIYDILGAKGLIRVDYIIPADGEPKLLEVNTTPGMTATSFIPQQVRAAGLEMKDVMTDIIENEFN
>KF629132.1_14620|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLAGGLSPERDVSLSSGALIASALSRRGHAVKIIDVYEGICDLPDDITAVFERGKSYSSPVGEAEPDLDAVRRRNGNRDALVGPGVLEVCAAADVVFLGLHGAIGENGQLQATLDCAGIKHYTGTGYAGALLSMDKDLTKQLISRAGVPTADWIYFDTATGKKSDITENVGLPCVVKPTSCGSSVGVTIVRSADELDAALAAAEKYESKLVVEKMIKGRELTVGVLDGKALPPVEIIPKAGFYDYKNKYQSGMTTELCPAPLTDDETRKVQELAVRTFRALRMEQYGRVDFIYGEDGVFYCLEANALPGMTPTSLLPQEAAAVGIGYDELCDMLADMAKNK
>KF629127.1_14634|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VKILVLAGGLSPEREVSLSTGTMVCNALREKGQDAILVDLFYGVEELPGDIESFFADKTPLPPYTIESAVPDLSRLREESLSRPYGTIGKNVIELCKAADIVFMALHGEPGENGMVQAMLDMLDIKYTGAGYRGSAVAMDKALTKHILVSRGINTAEGVMLKRGEPLPDVPLPCIVKPCSGGSSIGVRRVLDRADVLPAVEEAFKYEDDILIESFVNGREITCGVLGDTALPPAEVIPKGGFYDYAHKYQSGLITEICPAELPAEVTAEVQDISLRVFRALGLEVYARMDFIYDGRDFYCLEANTLPGMTPTSHLPQEAKAMGISYPELCMRIIELSLEKYNK
>KF629112.1_14660|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
SAESVLNHIDESKYNLFPVGITKEGDWILYGGKDYSKLVTGEWRSCPENRRATISPVRGQGLLSFEGDCVVRERIDVVFPVLHGENGEDGAMQGLLQMAGIPYVGPHIAASAVAMDKSLTKLVADQAGVPQAAWQLVRAGELENHMENTLDLLENRFRYPMFVKPAGTGSSVGVSKVGDRDALRSGLRYAGKYDKKILVEEFINGKEIEVAVMGNDNPMASICGEIDSGAEFYDYDAKYLTETSKAYIPARIPAEVEEVVRETAVKVYNAVGCQGLSRVDFFVTHDENRVVFNEINTLPGFTSISMYPKLFEASGIPYSQLIDELLRLAVEAFR
>KF629102.1_14688|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLCGGNSTEREVSIDSGSNVCEALRSKGHNAILIDVYFGLDDIEIFEKSNREYNVEEEKKKIQELSKYVDEKRREFFGKNVIEICSKADIVFMALHGKNGEDGKCQATLDLFGIKYTGSGPLASAIGMDKAVTKQIFLSKNVPTAKSAWIKKGEPSDLNTIGMEIPVVVKACNGGSSVGVVLVKDESEYDGALKECFDLDDTVLVENYIEGREFSIGVIDNKALPVVEIIPKTGWYDYKNKYAPGATDHVCPANLDEELTKKMQKVAEDACAAIGCEPYARADIMMDKDNNMYCLEVNTLPGMTKTSLIPDEARAIGIDYPTLCDNLVKLSMK
>KF629099.1_14695|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KYEIVLIGITKKGEWFQYVGDISKISDGEWENDTKNKKKAFISPDTSTGGIIVIENDTFSTIKIDAVIPVLHGKNGEDGTIQGLLQLAKIPFVGCNLLSSATCMDKIDTNIILTYAGIKKAKFAFVTENDFKSDKEKCINYIEKTLPDYPLFVKPSNAGSSVGVSKVLSRDELIKAVEIALCEDRRILIEENISGQEVECAVLGNENPIASIVGEIAPANDFYDYEAKYINDNSKLYIPARISDEISNKIREIAIKAYKVMGCSGLSRIDFFVEKDSNEIYLNELNTFPGFTSISMYPKLFENTGIPYSELIDRLINLAFER
>KF629093.1_14709|FEATURES|farme|glycopeptide|VanA|antibiotic target alteration|1
MKIVVLAGGTSTERDVSIVSGTGICGALRQKGHQAILVDVFCGQEEVDWEDPFPAEYDVEKAAAYIRGFNLQMAELKKTRKNFFGPNVIDLCKKADFVFLGLHGANGEDGKVQATFDLMGIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKTCCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKALSDHRNCSASGIL
>KF629080.1_14748|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
DCVVRERIDVVFPVLHGENGEDGSIQGLLQLAGLPYVGPGVAASATCMDKTLTKLVADRAGIRQAAWRLVTARELANNPEAVLDGVEKAFSYPVFIKPAGTGSSVGVSKAKNREALLAALTNASKYDSKILVEEFINGREVEVAVLGNAGPAASVCGEIDSGTEFYDYDAKYISDCAQLYIPARISEEVSERVRDNAIRIYEAMGCRGLSRVDFFVTYEGQEIVFNEINTLPGFTSISMYPKLFEAS
>KF629067.1_14782|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAEKTNLLVMFGGASSEHEVSCVSAASVLQHISEEKYNIYKTGITKEGNWFLTSSPVVNISDGSWENDENNRRICILPHRGDENILVENEDGTYEKLRVDVVFPVLHGKNGEDGTMQGLLQIAGIPFVGSEAAASAASMDKAVTKAVISQHGIVAQAECCVSSRHTYDADREREAARIKEFFEGRLPLFVKPANAGSSVGISKVKSYDDLAAALDTAFAEDRKVLVEEMIEGREIEVAVLGNEEPQASCIGEIFAANEFYDYNAKYENMKSETAIVKDLSEEKEEEIRRAAVDVYEAMGCRGLARVDFFLEKGGRVVFNEINTLPGFTQISMYPKLWEECGLSYSDLIDRLIELALEEAGQW
>KF629059.1_14799|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSQADKLFVAMCQEILDHGYSSQGQTVRAKWEDGTPAHTIKQFGIVNRYDLQEEFPALTLRPTAIKSAVDEMLWIWQKKSNNIKDLSSHIWDEWADENGSIGKAYGYQLGVKYKFPHGEMDQVDNVLWQLKHTPYSRRIMTNIYKFDDLMEMGLEPCAYSMTFNVTGDRLNAILNQRSQDILTANNWNVVQYAVLVHMMAQVSGLKPGQLVHVIADAHIYDRHVDIVREMIQRPQYPAPKFSLNPEITDFYDFTTDDILIEDYEKNPQIRNIPVAI
>KF629057.1_14806|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGISTERTVSLVSGTGVCQALRRKGHQAILVDMFMGLENQPADLNTLFDAPDGLCPDVKIEVQAPDLDAVRRSRPDQSPSRIGPHVLDICRLADIVFLGLHGQDGEDGRIQATLDLLGVPYTGAGYLGSAIAMDKIAAKEMMDANGIPNPKWQKLTYTEAEIPQLAETLPMPCVVKAPTGGSSLGVYLPKDRAELADALRQVRSFCHEVLVEQRIYGRELTDAVLGERYLPPVETFPSVENFDYEAKYQAGGAKEICPAELTEEQAKAVGEMALRVHKALGLAVYSRTDMILDENGQLWCLEANSLPGMTPTSFVPKEAAAVGISYDDLCEEIVRQSLKIKRR
>KF629052.1_14819|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
IPYVGCGVLGSAVCMDKAVANTIMDAAGVPHCKWASAIRAELEGDHKTLLDSIEQRLGYPIFVKPANAGSSVGITKATDRAVLEQAVVTALKEDDKVVFEEFIDGQEVECAAIGNPDDPATVSTTRPGEILAGAEFYTYDDKYKNGVSQTVIPAHLSEEKLDEVRTEARRAYLALGCAGLSRCDFFVERGTGRVLCNELNTLPGFTSISMYPKLMEHEGLSYAQLVDRLLQLALHRRKGAY
>KF629049.1_14824|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
KVAAHIESELGYPVYIKPANMGSSVGITKATDKKTLTEGLQLAAKYDRRVLAEEGINCREIETAVLGNYNIEASVTGEIVATDDFYDYDSKYIDDGKPKMKIPADLPAEISDKIREYAVKAFGAIDGAGFARCDFFLDKDNGNIYINEINTIPGFTAFSMFPLLWENTGSPYSETIERIIRLGYERYNAKN
>KF629046.1_14835|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTTNYVSKADKIFIENIQDILNNGTSTVGHKIRPIYKDGTPAHTIYVNQIVEKYDISKGEFPITTLRPIAIKSAIKEILWIYQDQSNDLSVLEEKHNIMWWRDWEVDNTNTIGQRYGATVKKYDLMNKLLDGLTNEPYTRRHIIDLYQYADFEETAGLHPCAFLTVWSARGEYLDMTLHQRSSDYLVAGHVNKMQYVALLMMVARHVGLKPGVFMHVVDNLHIYDRHIDQAKELLSRTPSEKQPKLILKEGKTNFYDFSLDDFELIDYEPVKPQLKFDLGI
>KF629045.1_14837|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLGGGISTERSVSLVTATSVCRALRDAGHKAIFVDMFLGLENYTGRLEDAFDAPDGFCGSVSISETAPDLEAVKASRKLKSPSHLGVGVLDICALADCVFLGLHGIDGEDGKIQAALELLGVPYTGSGPLGSAMAMDKAVAKRIMESAGILTPKWREITYTADDVPALVQELPVPCVVKAVDGGSSIGVSLPDTREQLEQALYDVLRYGRRIVVEEKIVGREFTQPVLGDDYLSTIQIVPPEGSTFDYAAKYQSGAAAARELCPAPCTEEEHRLLGETALKLHHALGLSVYSRADFILDAEGRPWCLEVNTLPGMTPNSLIPKAAKEAGMTYQELCEKIVSLSLAK
>KF629031.1_14874|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADEVFIANCKDILENGTWDTDYNVRPHWEDGTSAHTIKKFGIVNRYDLSKEFPAMTLRKTFIKSATDELLWIWQKKSNNVNDFKGHVWDAWANEDGSIGKAYGYQLGVKHHYPEGDFDQVDRVLYDLKHNPLSRRILTNIYVHADLSEMNLYPCAYSMTFNVTGKKLNAILNQRSQDMLTANSWNVCQYATLVHMIAQVSGLEPGEFVHVIADAHIYDKHVPIVEELIKREPYDAPKFVLDKSITDFYKFTPDSVHFEDYNYHEFTEKIPVAI
>KF629025.1_14888|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSQADKLFVAMCQEILDHGYSSQGQTVRAKWEDGTPAHTIKQFGIVNRYDLQEEFPALTLRPTAIKSAVDEMLWIWQKKSNNIKDLSSHIWDEWADENGSIGKAYGYQLGKKHKYKEGEMDQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQDILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIVKELIQRPVYPAPKVALNPEVKDFYKFTVDDFTIEDYEAGPQIKNIPIAI
>KF629020.1_14899|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PTLEVQLGIKHQYKEGMFDQVDRVIYDLKHNPASRRILTNIYNFEDLHEMNLYPCAYSMTFNVTGDTLNAILNQRSQDMLTANNWNVVQYAVLTHMMAQVAGLKVGELVHVIADCHIYDRHIPAVKAMLELDGYPTPTFRMDESITDFYAFTKDSFSMENYQFHPFNFEIPMAI
>KF629015.1_14919|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
LTGAEFYTYDDKYKNGISKTVIPARLPDQKLDEVKTLAARAYLALGCAGLARCDFFVEHGTGRVLCNELNTLPGFTSISMYPKLMEHEGLSYAQLVDRLLQLALHRRKGAY
>KF628992.1_14988|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
YKIGKGDGIMDIVVLAGGLSTERDVSFVTGNMVSKALRKNGHRVILLDVFMGYSDKKEDISDIFEHTEEVSVQIEEIPTVAPDLAAVKASRADQSDNFFGPNVIEICQKADVVFMALHGENGENGKIQAAFDLFGIRYTGTGYLGSALAMDKNIAKQFFVANGIPTPGGIRMKRDEQIRDFAKTGLNLPCVVKPCCGGSSIGVSIVRTIEEYEAALEEAFRWEEEILIEDYIEGREFSVGVLEGKALPIIEIAPVEGFYDYKNKYKAGSAVETCPAQLSEAVTKQMQQYAVEVTKALGLGAYSRMDFLLDSDEKMYCLEANTLPGMTPTSLLPQEAQAVGVSFEQLCEKLIELSLKKYA
>KF628987.1_15005|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGTSTERSVSITSGTMVCKALREKNHQAVLVDVFCGTDVKGNLEDVFAEEAYDIDKAAEYMHSFDAGLNEMIASRRRFFGPNVLELCEAADVVFLALHGANGEDGKVQATFDLLGIPYTGTGYLSSALAMDKSITKQFFRAHHVADPERRDPEKRPGERAFVRLWPGASGCRKTVLRRFQCRCLYCTHERRILAGYEGCFLLRTGGCR
>KF628986.1_15008|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LQIFVDYDKIENEESSLLSVLPVLYTEFGGRSVLKSAVSGYIIVSGMTPVLAATGFGFALLLRSRLSQIIKEYRHMAKIRVAVLFGGVSSEHDVSLVSAENVIRSIPKEKYEVLCIGITKKGRWLYFPGDVSEISTGAWEQNPDCTAAILSPDPLHGGIVTIENGETYIKKVDVVFPVLHGRNGEDGRLQGIMEMARIPYVGCGVLSSAVCMDKGMTHTVLDYNGIQTAKWASVHQRDLNKLNEKCVAIAETLGFPLFVKPANAGSSVGVSKATDLESLKDAVQIAFTHDEKVIIEEFIDGRELEVAVFGYDAPIASYVGEIEPAAEFYDYDDKYVNGSSKLYIPARITDQESDRIRETALRAYQALGCKGLSRVDFFLSKDGSIILNEINTLPGFTSISMYPKLMEHLGMKQEYLVDKLIEQAMENAART
>KF628979.1_15022|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|0
MNKRLKEILKQYEERKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNAILVDNFLRTGAGGLG
>KF628966.1_15054|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MKVLLLAGGWSPEREVSLKGGEQIAAALKERGHSVTLCDPAKDFERLMDMAREHDAAFINLHGAPGEDGLVQAILDRVNCPYQGAGPAGSFLALHKAAARQIFRDAGLNIPDGVFLPRHPGPNWKPDLQYPMFVKSNTGGSSLHLSRVTNEEELYTALNSLFSMGEEAIVETAVVGREVTCGVLGEEALAPILVVSKGNYFDYHNKYAPDGAQEICPAPIAPEETAKVQDAALRAHHALGLKGYSRADFILQDDGTLYILEVNTTPGMTSTSLVPREAAVKGMSFADLVERLLELALER
>KF628963.1_15061|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VKQKLLVLCGGQSSEHIVSRMSCTSVLNNLNHDKYDITLVGIDLDGKWYRLNHDQDDLSLDSWLDNSVEVENVFELLKEHDVAFPVLHGLYGEDGTIQGLFELTKIPYVGARVLCSSVSMDKIYTKKILDTVKIPQVKSAYVKKRYDNRLVIITKDFEEIYDVEEYIVNEIGMPCFIKASRSGSSLGCYRCDNREDLIGKLEAAAKYDRHIVVEENIDCIELETAVLGNDDVIVSRVGQIMPHGEFYTFESKYEDAESKTCIPALVDEKIQEKIREYAIKAFKAVDGHGLSRVDFFLDKKTNNIYLNEINTMPVY
>KF628956.1_15084|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLKLGVVFGGQSSEYSVSLHSVASFLRQIHNEKYDITMIGIDQNGQFYVYDGSIDDIEHDHWIPQATKAAWVHKGIMALDGKNTVKELDCVFPVLHGKNGEDGCVQGLLELMNIHYVGCDVMSSAISMDKEIMHILCDEANIPCADYVCLKANEENPSFEMIQEKISLPWIVKPCNAGSSYGVHKVENKEEFEEACKDAFFYDGRGKILVEKAIEGFEIGCAVMGNEEVFTGSCDEIQISGGIFDFEGKYEMKGAEIICPARIDEETFTKAKALAAKTYKAMNCCGMARVDMFVTPQKEVILNELNTIPGFTATSRYPSMMKEAGIEFGDLIDKLIDLAMQRTISAC
>KF628952.1_15094|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKKVLVLFGGVSSEHDVSCVPASYVVSNIPRDKYEVCPLGITKEGEWFLFEGDVSLLPEDKWIKSGKCTKALLSPDRKDHGITVFRESGPEKIHIDVCFPVMHGKNGEDGTIQGLLELAGIPYVGCGVLASSVCMDKAVTNTLADQAGIAQAKWLATDVNEYAKTAPNS
>KF628933.1_15131|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|0
VALTSGTGVCRALRERGHKAILVDMFLGLENYEGRLEDIFDAPDGLCPDNRVESAAPDLEAVRRSRKDQSPSMLGKDVLTVCRMADIVFLALHGACGEDG
>KF628932.1_15134|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
VEKAAAYIRGFNLQMAELKKTRKNFFGPNVIDLCKKADFVFLGLHGANGEDGKLQGAFDLMGIPYTGTGYLSSAMAMDKGVTKAMFQMRGVPTPAGKAMKKKDRVETPQELGMELPVVVKTCCGGSSVGVYITKTPGRIRRGTARCILLRG
>KF628888.1_15247|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKIAVLCGGLSPERNVSISSGTKIAGALQESGHQVVLLDMFFGLEDYTGDIAHVFDDPPALGGTRIDESAPDLEAVRAQRKLQSPSLFGEHVLEVCAMADIVFLALHGRTGEDGRVQATLDLLGIPYTGSGYLGSAIAMDKDLTKRVVAPLGVKTPAWMLVESDGMDIDAVCAQAKLPCVVKPDDSGSSIGVSIANDEAELRAALKAAANEGSRILIEQYIRGREVQIGILGDKALPSIEIIPAEGFYDYRNKYQPGAAREITPAEIPAETEQRLADAALTVFHALNLSAYSRADFILDAEGELWFLEINTLPGMTPTSLVPQEAAAVGISYSELCEQIIADALHK
>KF628887.1_15249|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
QQKMKKTIAIVAGGDSSEHDVSLRSAEGIHSFLDKERYEVYIIEIKGMTWEAHLKDGSRSNVDRNDFSFMEGGKRIRPDFAYITIHGTPGENGILQGYFDLIHLPYSTSDVLVEAMTFNKFTLNQYLKGFGVSVSESLIVRKGFEHLVTDDEIIEKIGLPCFVKPNAGGSSFGVTKVKSADQIHEAILKAMRESDEVMVEAFMEGTEISQGCYKTQEKEVVLPATEVVSDNEFFDYNAKYNGQVREITPARLKEETAERVSLITSMIYDILGCSGIIRVDYIITHTTDENGKERERINMLEVNTTPGMTATSFIPQQVRAAGMDMKDVLTDIIENKLS
>KF628867.1_15296|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICKTLLEKGHDAFLLDVFMGLPDAPENLEDVFTLPNHGLEIAKNISTTEPDLAAVKASRPDQSDCFLGPNVIELCRLADITFLGLHGGEGENGKLQATFDLLGIRYTGPDSLGCALAMDKGVTKVIFQRCNVSTPGGGWLYKKDLDKPLSEMGLSLPVVVKPCSGGSSIGVYIVNTEEEYREALEKSFQYEDELIIEPYIKGREFACGIIDGKALPPIEIIPKTGFFDYANKYQDGGSEEICPANISEEISQKMQELTVRAFHALKLNVYSRADFLLDENDNLYCLEVNTLPGMTAASLLPKEAKAVGIEYGDLCELIIQKSLEARYQ
>KF628851.1_15335|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSPERNVSLSSGTMITHALRSLGHQAALVDMYFGLEDYDGPLEAFFDRDVTDRWKQVDPKAPDLEAVKRQRKWKSPNQFGQGVLALCQMADIVFLAFHGTCGEDGRVQAAFDLMGIPYTGAGYLGSAIAMDKDFTKRLIAELDVATPKWRRAEYTMKDIDSLTSTTPVPCVVKPVASGSSIGVSIAHTKKELYAALVKGLEFGGQCVLEQYVKGREIQVGILAGKALPSIEIIPSDGFYDYENKYQPGAAKEVCPAEIPPEWEKAVGKAAETVYEALGLTVYSRADFIVTEDGTPWFLEINTLPGMTPTSLVPQEAAAIGLDYAGLCQRIIDESLKARNG
>KF628834.1_15380|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIAVLAGGISTEREVSIVSGTGVCKALREKGHRAILIDVFCGDERIDITDKEEVFPAQYDVDASAAYMRSMNGSIEAAKASGREFFGPNVLAVCKMADVVFLALHGADGEGGTVQAAFDLFRIPYTGSGPLGSAMAMDKGISRKLFRECGVPTAAGLSLKREEKRLSASENGVGLPCIVKPCCGGSSVGVAIAHTQEEYEDALTLAFGYEEEVVVEQFIEGREFSAGVIDGKPYPVIEIAPVEGFYDYKNKYTAGSTIETCPAVLSEEKTREMQQYAVKAYEALHLEGYGRMDFMMDGDENLYCLEANTLPGMTPTSLLPQEAAAVGIDFGSLCELLIEVSKKRWQ
>KF628832.1_15386|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTLRRTALKSAMDEILWIYRDQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDFDQMDRVLYDLKHTPYSRRIKTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMILNQRSQDILAANNWNVCQYAVLLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVRELIGRPQFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF628827.1_15401|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGCIARYRLEALMSKADELFVSMCQDILDNGTTTEGQKVRPHWEDGTPAYTIKNFGVTNRYDLREEFPALTLRRTALKSAMDEILWIYQRKSNNINDLHSHIWDEWADETGSIGKAYGYQIAQKSHYVEGDFDQMDRVLYDLQHTPFSRRIMTNMYTFSDLSEMHLYPCAYSVTYNVTEQPGDEKPTLNMVLMQRSQDILAANNWNVCQYAILLMMVAQSCGMIAGELLHVIVDAHIYDRHVDIVRELIARPQYSAPRVSLNPEVTNFYDFTTDDLIVEGYEHGPQIKNIPIAV
>KF628818.1_15425|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEKLRVGIVFGGKSAEHEVSLQSAKNIVNAIDKSRFDVVLLGIDKQGQWHVSDASNYLLNADDPAHIALRPSATSLAQVPGKHEHQLVDAQNGQPLPTVDVIFPIVHGTLGEDGSLQGMLRVANLPFVGSDVLASAACMDKDVTKRLLRDAGLNIAPFITLTRANRHNISFAEVESKLGLPLFVKPANQGSSVGVSKVTSEEQYAIAVDLAFEFDHKVIVEQGIKGREIECAVLGNDNPQASTCGEIVLTSDFYAYDTKYIDEDGAKVVVPAAIAPEINDKIRAIAVQAYQTLGCAGMARVDVFLTPENEVVINEINTLPGFTNISMYPKLWQASGLGCTDLITRLIELALERHAADNALKTTM
>KF628809.1_15446|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADHIFIDMCRDILENGTDTMGEKVRPKWEDTGESAYTIKRFGVVNRYDLRKEFPALTLRKTALKSCMDEILWIYQKKSNNIHDLNSHIWDAWADEDGSIGTCYGDVVGRKFIYKGEETDQMDYVLRQLKENPYSRRIMTNLYQFEYLHSGALDPCCYSMTYNVTKDAAEDRLVLNGVLNQRSQDVLAANNWNVCQYSILLMMVAQVNDMIPGELVHVIADAHIYDRHVPAVRELISRTPYAAPKVTLNPEIKDFYDFTTKDLIVEDYQAGPQIRNIPIAV
>KF628789.1_15496|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKEGDLFMKIIVLAGGLSTERDVSLSSSAGICRTLLEKGHDAFLLDVFLGFPYDADRLEEVFTLPGHGLEIAKNISTSEPDIDAVKASRPDQSDCFLGPNVIELCRMADITFLGLHGGEGENGKLQATFDLLGIKYTGPDSLGCAVAMDKGFTKQVFLQTGIDTPAGVSLHKKEKEKSLEALGLTLPVVVKPCSGGSSIGVYIVNSKEEYESALNKSFKYEDEVVIEDYIRGREFACGIIDGKALPPIEIIPKTGFFDYANKYQDGATDEVCPANTSREISDRMMELTVKAYHALKLNVYSRADFLLDDAGGLYCLEMNTLPGMTAASLLPKEAKAVGIEYGDLCELIIQKSLEARYQK
>KF628777.1_15529|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
MEKKNIDWSNLGFSYLKTDYRYVSNYKDGAWDEGAMITDDTVTISECAGVLQYAQTVFEGLKAYTTEDGRIVTFRPDLNGERMENSARRLEMPVFSKERFIQAVKETVKANAAYVPPYGSGATLYIRPYMFGSNPVIGVKPADEYQFRVFTTPVGPYFKGGVKPLTIRVSDFDRAAPNGTGHIKAGLNYAMSLHAIVDAHSQGFDENMYLDPGTRTKVEETGGANFLFITKDNTVVTPKSHSILPSITRRSLIYVAEHYLGLKVEEREVLLDEVKDFAECGLCGTAAVISPVGKIVDHGREILLPAGMEQMGPVTQKLYDTLTGIQMGRLEAPEGWIQVIE
>KF628771.1_15543|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKNIAVIFGGRSSEHEVSCVSAATVIRSLDEEKYNVILVGITKDGRWLLVDKLKEIEDGSWRESRVNAIISPDTEDRALVLLAEGTYRLQPVDVIFPVLHGLNGEDGTIQGLFEMARIPYVGCGVLASAVSMDKVYTKIIVEDLGIRQARFVHIRRSDLDQMEDALDRAEAKLSYPMFVKPSRAGSSVGVSKAEDREGLSKALLKAAEHDRNILVEETIVGREVECAVLGGKEIKASGVGEILAAADFYDYDAKYNNEESKTLIDPPMSEETREEIRKSAADIFKAVDGYGLSRVDFFIAEDGEVVFNEINTLPGFTSISMYPMLWAAQGIKTPALADELIRLAEERFE
>KF628759.1_15570|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLAGGISTEREISIVSGTKVCEALREKGHRAILLDVFFGNTGLQADCAFTEAYDVNAAAAYMRSFDSKLEEAVKTQKEFFGPMVLELCKAADVVFLALHGENGENGKVQAAFDLLGITYTGSGYLGSALAMDKGISKQLFLENGVPTPKSVMLKKAEGMKQPETIGICLPCVVKTCCGGSSVGVYIANTREEYEQAVKNAFHYEDEIIIETYVKGREFSIGVVDGEAYPIIEIAPIQGFYDYKNKYEAGSTIETCPAELAADLTKKMQDYAVMAYHVLRLENYARVDFLMDESNNMYCLEANTLPGMTPTSLLPQEAGALGMSFADLCEKLIEVSLKK
>KF628752.1_15590|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADMTFIQMCKDILENGTSTEGEKVRPKWPDGTPAYTVKKFGVVNRYDLSKEFPLLTLRRTALKSATDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQLGVRHQYKQGMMDQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGEEKLTLNAVLNQRSQDVLVANNWNVVQYSVLVHMLAQVCDMQVGELVHVIADAHIYDRHIPIIQELIARQPYPAPKFSLNPEVKDFYQFTRNDVSVEDYITGEQIKDIPIAI
>KF628727.1_15662|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GISSEREISLKSGMSIVENIDKEKYDVESIIIDKKEDIINKVKGIDFALLALHGKFGEDGTVQSVLQTLGIAYSGCGPLSSAMCMDKDVTKSMLKSAGIRTAPWINLRENDNVDYDEINKLGYPVVVKPTHGGSSVATFIVKEEKQIEECVAEAFKWDNEVMIEKFIKGDEITCPVFADKMMPVIAIKPKKGEFFDFTSKYEDGGSEEIVVELEKSLHEEVEKMALETYKALKCEVYSRVDMIVTSEGTPYILEVNTLPGMTKNSLIPKSAAALNIGF
>KF628718.1_15685|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDMCKYVLENGENREDRTGTGTRSVFGYQTRYDLRDGFPLMTTKKMFLRPIAEELLWFIKGDTNIKYLVDRNVKIWNEWPYEDFKKSPDFNGETIEEFVEKIKTDDEFAKKHGDLGPVYGAQWRDFNYEGVDQLAKLVDSLTNNPFSRRHIICAWNPAQVDNMALPPCHAFLQFYVSADKKYLSCQLYQRSADIFLGVPFNIASYALMTEMLARTCGYEAKEFIHTIGDAHIYKDHFEVVKQQIAREPLPKCKLVLNPDVKSIFDYKIEDIKIEDYQSHGKLVGKVSV
>KF628696.1_15731|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRADELFIENCKEILAHGVWDTEQEVRPRWADGAPAHTVKKFGIVNRYDLRAEFPVQTIRKMAFKSAVDELLWIWQKKSNNIHDLSSHIWDAWADESGSIGKAYGYQLGVKHRYPEGEFDQVDRVLYDLKHNPASRRILTSLYNHHDLSEMALYPCAWSVTFNVSGRTLNAVLNQRSQDMLTANGWNVMQYAVLVHFLARASGLEAGELVHVIADAHIYDRHVPVVEELIARTPYEAPRLWLDPAVTDFYAFTKDSVRLEGYRFHPLEQPIPVAV
>KF628693.1_15750|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLYDKKYLNIVEDILNNGYYDNNRTGMPTYKLPHQVMQFNLEKEFPILTTKFVAFKTAVKEMLWIYRDQSNDVTKLQEQNVHIWDEWVDENNTIGRGYGYQIAKFHQIDKLIETLKTNPQDRRMLMTMWNIEDLPHMTLQPCCFMTMWDVTDGKLNCMLIQRSGDIPLGVPFNTSQYAVLVHLIAQVTGLKPGLFTHVINNAHIYENQVEGMKLQLTRANDEYEAPKLWINPEITNFYDFTADDIKLIDYKYHPAIKMEVSV
>KF628683.1_15780|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNIVVLAGGSSTEREVSIVSGQGICTALRRRNHKAVLVDAYFGKESWGEEMFPQTYDIDAEIKYMQEKSGELEETMKNRKEFFGPNVLEICKAADMVFLALHGSNGEDGKVQSVFDLMGIPYTGSGPLSSGMAMDKGITKMVFEAKGVPTPKGITLQKGKCSSELADYDMDFPVIVKPCCGGSSVGVCIAKNQEEYEAALDESFSYENEAVVEQFVEGREFSVAVVDGKAYPVIEIAPLQGFYDYKNKYEAGSTIETCPAEISESLTKEMQKNTQSRAIKRWACRPTADWILSWTKTETCTVWRQTPCRE
>KF628659.1_15842|FEATURES|farme|multidrug|MuxC|antibiotic target alteration|0
GGPVGAVISAAWSLRHTLFKVLIRFICVVVFLILFLILTIPVFFIEWLIGKFNRNARDYSCLRIVQWGFKAILKVTGVHTTVIGFENIPDEPVLFIGNHRSFFDILLTYSRCPRLTGYVAKKEMEKIPLLSTWMRFVYCLFLDRENPKEGLKTILQAIDYVKQGISICIFPEGTRNKGEELSMLPFKEGAFKIAAKTGRAIVPISMNNTAAIFENQFPRIKKVNVVVEYGTQIYPKDLAPEDKKHIGAYVQNIIQETINKNAELI
>KF628646.1_15884|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKVGVIMGGISSEREISLKSGNSIVEKIDKTKYEVIPVVIDNKEDIITKVKGLDFALLALHGKFGEDGTVQSVLQTLDIPYSGCGPISSGVCMDKDFTKRVLKANDIRTARWINVSSVDEIDYDKIEEMGYPVFVKPTNGGSSVATFKVKEKSEIRAAVEEGLKWDCEVMIEEFVEGEEITCPVFDGEMWPVIAIKPHSDFFDYTQKYAADGADEIVVQLEENLHKEVEKMALDTYKALKCQVYARVDMIVDKNGIPYILEVNTLPGMTPASLFPKSAAAINISYSGLLDKIIETSMKVKRSH
>KF628642.1_15892|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MKITVLAGGYSPERDVSLSSGSLIANALMEQGHEVFFLDPWLGIKAGERVHYRTREEGPGFAYDIGGEAPDLELLGAEAGAEKSLIGPGVLEACREADMVFIALHGSTGENGQIQAVLEAYGIPHTGSGYMGSLLAMDKNISKILMRAAGVATPDWYLAEKGKSSQPEFLPCVVKPLDCGSSVGVTIVDKEEEWHTALEAAFSYGDRVLVEKKITGREFSVGVLGGRALPAIEIIPEKGFYDYKNKYQPGMTREICPAGIDEKQESRLEAAALTVHRILELGYYSRVDFLMDGDGAIYCLEANTLPGMTPFSLLPQEAKAAGITYQELCEAIVKNGKGAAL
>KF628635.1_15912|FEATURES|farme|macrolide-lincosamide-streptogramin|vatD|antibiotic target alteration|0
MQAFIACYCAISLIKSVLERRNYFELETDGYYNRKAKVLQHYKNKSLYHFGKNRYIIVEATTIRNYGG
>KF628612.1_15977|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NWNVVQYSVLLHMLAQVCGMEPGEFVHVIADAHIYDRHIPIIEELIKRPVYDAPKFSMNPDVKDFYEFTVDDFKIEDYKAGEQIKDIPIAI
>KF628607.1_15988|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNIVVLAGGSSTEREVSIVSGQGICTALRRRNHKAVLVDAYFGKESWGEEMFPQTYDIDAEIKYMQEKSGELEETMKNRKEFFGPNVLEICKAADMVFLALHGSNGEDGKVQSVFDLMGIPYTGSGPLSSGMAMDKGITKMVFEAKGVPTPKGITLQKGKCSSELADYDMDFPVIVKPCCGGSSVGVCIAKNQEEYEAALDESFSYENEAVVEQFIEGREFSVAVVDGKAYPVIEIAPLQGFYDYKNKYEAGSTIETCPAEISESLTREMQRYAEQGYKALGLQAYGRLDFIMDKDGNMYCLEANTLPGMTPTSLIPQEAKVLGMDYPELCEKLIEVSLKKYK
>KF628587.1_16042|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTKQYKDLLRKILEEGTTKTDRTGTGTKSVFGYQMRFDLQKGFPLLTTKRVAFGLIKSELLWFLHGDTNIKYLLEHNNHIWDEWAFERYVSSPKYTGPDMTDFGRRCLEDEAFNEVYQEVKKDFCEKILTDDAFAVEFGELGNIYGSQWRHWKTTKGETIDQIADLLNLLKNSPDSRRMIVSAWNPEDEPSMELPPCHTMFQFYVADGKLSCQLYQRSADVFLGVPFNIASYALLTHLIANEVGLEVGEFVHTLGDAHIYLNHMEQVETQLAREERELPTLVLKHPEKSMFDIDVDDVIVEGYNPHPTIKAPIAV
>KF628552.1_16118|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSTLKLAVIFGGKSSEYPVSLHSAASLIRSLHKDKYELIFIGISKDGEWFAYDGDVDAIEHDTWMDGNITPCVLSCSTAQKGFLKLKEDGSYETLPVDCIFPVLHGKNGEDGTIQGLFELSGIPYVGCDHMSSAICMDKEMAHIVMENAGIPCAPYLCVYEDEHLDYRHIYEEAKAKLGLPIFIKPANAGSSFGIHKIASFDDFEESMKDAFYHDGRGKVILETTIEGFEIGCAVMGNKELFAGSVDEIETAAPFFDYEGKYQMVDSHIYCPARISKELFEEARSLALKDYRAMNCKGMTRVDMFVTPQQSIVMNEVNTIPGFTDTSRYPTMMKEAGIEFGDLLDKLIAFALTR
>KF628532.1_16168|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNLIMKIVVLAGGTSTERDISIMSGTGICKALRQKGHQAVLVDIFCGTENVDWADPFPEEYDVDQAVEYMKSFNPQIETMKAERRSFFGPNVLELCQAADIAFLGLHGANGEDGKVQAAFDLMGIKYTGTGYLSSAIAMDKCMTKEFFLANHVPTPKGATLTGENGFDTDLSVLGLEFPVVVKTSCGGSSVGVYIVNDQKEYEEALKEVSIYGNEAVVEEYIKGREFSVSVVDGKAYPIIEIAPIQGFYDYKNKYQAGSTVETCPAHISQELTDKMQDLAVKAAKALKLEAYSRLDFLMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGMDYPQLCEELIRCSMKKYR
>KF628525.1_16186|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMQSEDKLCVVVLFGGMSSEHEVSRVSVGNFVNNIDREKYEVLTVGITKEGRWLYTEATAAQMADGSWEELAGNMACVISPDRADHGMILFTPEGHVEKVHVDVVIPVLHGLWGEDGTVQGLLELAGIPYVGCGVLASAVCMDKAVANALFEANGVPHTRWLAADRWEIESDLEGVCEGVEKKLGWPVFVKPANAGSSVGISKAPDRDELKQAIALALENDHKVVFEAFVDGHEVECAVIGSDPAVATRPGEILAGAEFYTYDDKYKNGVSQVVIPARLSEEKLDEVKTYAAMAYTALNCEGLARCDFFVEHGTNRVMINEINTFPGFTPISMYPKLMEHEGTPRARPDRSPDRTCAGKDGKAAWITAPSAYLTAAWAA
>KF628519.1_16205|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MRIVVLAGGLSTERDVSISSGIKVASALREKGNEVVLLDVFMGYEENFCDIDALFKHNYSFTDSLGVGTEIPDIKTVKENRLDKSSRFIGMNVIEICAEADITYLALHGGEGENGQIQATLDLFGIKYTGSGYLGSALAMNKALTKSVLIQNRVTTPAGRVYKSAQDAEDWSYYPCVVKPCSGGSSVGITKAENRAEYLESVKEAFKYEKEIVVEQFIEGREFSVGVIGGRALPPIEIIPKTGFYDYVAKYQAGATDEICPADITASEDDVLRKAAEAAFKALNLQSYARIDFILDKVSGEAYCLEANSLPGMTPTSLLPQEAAAEGIDYPSLCEKIIEVSLEKYN
>KF628518.1_16209|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADELLQENCRQILSQGTWDTDLPVRPRWEDGTPAHTIKLFGLVNRYDLREEFPIQTIRRMYLKSAVDELLWIWQKKSNNIYDLNSSIWDAWADETGSIGKAYGYQLGVKHHYPEGDMDQVDRVLYDLKHNPASRRILTNLYNHHDLSEMALYPCAYSMTFNVTGKTLNAILHQRSQDMLTANGWNVMQYAVLVRLLAQVSGLEAGELVHVIADAHIYDRHVPLVEELLTRKPYPAPKLWLDPGVTDFYAFTTDHLRLEGYQCHELGEKIPVAI
>KF628478.1_16324|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GYSNERDVSLSSGGSICRALRERGHNAYLLDAFLGLEKAPENLVDVFTLPGGGLEIATGIQTSEPDLDALWASRPGDSPSYLGPNVLELCSLADITFLALHGGLGENGKLQAAFDTLGIRYTGPDSLGCALSMDKGVTKDLFHSAGVPTPYGTHISRKNKDISLESLQIPLPLVVKPCSGGSSIGVHFVHTEEEFREAMRLSFEKEDEVVIEPFIDGREYACGIFDGQALPLVEIIPDGGVFDYVHKYQSGGASEICPATSVDQETTEAIQKTGVLAAQALRLNVYCRADFIVDARTGQFYCLEVNSLPGMTSASLLPKAAKAAGYEYGEFCERIIEKSLDARYR
>KF628464.1_16358|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VLGEIPFVRRAGRIGRNDFKNAGEMEQYLDLLRRIKAEGVVRGDRTGTGTKGVFGHQMRFDLSEGFPLLTTKKVFLKGVIHELLWFLAGDTNIKYLVDNGVHIWDNDAFRYYNELCVRHGVLPVDRDTFLRAAQDGVESPVEGYRFGDLNHVYGYQWRSWPKPDGRFIDQIAQAVELIRHNPESRRIIVSAWNVAEIGDMALPPCHVLFQFYVAGGRLSCQLYQRSADTFLGVPFNIASYALLTLMTAQVCGLEPGEFVHTLGDAHLYLNHMEQADEQLSREPRPLPVMRLNPDVKSLFDFRYGDFTLEGYDPWPAIKAPMSF
>KF628447.1_16402|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQAFLLDVFFGLPCDSDKLEEVFDRPDGGLEISKGISTSVPDLDALRKSRPDQSPSEIGPNVIELCQMADITFMALHGSIGENGKLQATFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTVKTKDTRLDELGYYLPLVVKPCSNGSSIGVYICHTEEDYYNAIHKSFDIDNTDEVVIEPFIKGREFACGILAGKALPLVEIVPKDGLFDYANKYQAGGASEICPPISLDAETQELIQRAGEEAFAALRMDVYARADFIIDDEDGEFYSLEMNALPGMTAASLLPKAAKAAGIEYNELCERIIEESMNARYR
>KF628442.1_16415|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLAGGLSTERDVSFKTGDMVTKALRKNGHQVILLDVFMGYGEEEQDITGIFEHSEEASVKVTDIPETAPDLDKVRKSRKDQSACFFGPNVIAMCRMADIVFMALHGENGENGKIQAAFDLFGIRYTGSDYLSSAIAMNKNMAKQFFEANGIPCPKGIYMKKKDRKDSLAEIGITLPCVVKPCCGGSSIGVSIVKEESNFTKALDDAFFWEDEILIEEYVEGREFSVGVIKGRALPVIEIAPKEGFYDYKNKYKAGSTVETCPADIKDSVAKEMQKHAVKVAEALGLDTYSRIDFLVNAKDEVYCLEANTLPGMTATSLLPQEAKVEGVNFEELCQQLVDISMEKYGA
>KF628436.1_16429|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSTERDVSLTSGTMICNALRRIGHRAILVDLFFGTDVPKNIEEAFCAEGFLQPRPVAAEAPDIDAIKKSRPDSGYGEIGKNVLALCQAADIVFMALHGEIGENGKLQAIFDVMGIRYTGAGFLGSAIAMQKGIAKQIFLQNDIPTPFGKIYTKKTCDKIREDFQFPVIVKPCSGGSSIGITRADTFDELVRSLDEAFRYEDEVLVEQFVSGREFTCGVLDKSALPVAEVIPNEGFYDYKHKYQAGMITEVVPANIPEEISKRIQEASLKVTKALGLEVYSRMDFILDDAGKIYCLEANTLPGMTPTSHFPQEAKSIGMSYEELCQNI
>KF628429.1_16446|FEATURES|farme|trimethoprim|thymidylate_synthase|antibiotic target alteration|0
MSKWDRDYLGLCRRILDEGVEVVNRTGTNSIKVPSHHFHFDLSEEFPILTTKQLFIRQAVLEMLWIYQVQSNDVRWLRERDVNIWNEWETDDNGTWHATQLVPDENGNLVKKQITKEFGREFAHTIGTAYGYIVNKFQMTQNLIDKIKNHPEDRRMVMTLWQNDYLDTAVLPSCVWSSEWDVTNGYLNCWVHQRSCDVPLGLPFNVTQYAVLMFMLAKVTGLKPGTMDWSIKDAHIYVNQVDGIKEQLRRLDEEGDLPAPKLWLNPEVDDFFKFDNSRDCLDVKLVDYKHLGKIKFPISQ
>KF628410.1_16485|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKSLSVCILFGGVSPEHEVSLRSAESVLNNIDESKYNVFPVGITKEGKWILYGGKDYSDLPSGRWLTHPDNRQTAISPIRGQGLLTFEGDCVVRQQIDVVFPVLHGENGEDGTIQGLLQLAGIPYVGPHVAASAVAMDKTLTKLVVDQAGITQAAWKLVRRSDMGSRMEGTLDALEARFAYPMFVKPAGTGSSVGVSKATEREDLKKALLEAGKYDDKVLVEEFIRGREIEVAVMGNESPVASVCGEIDSGADFYDYDAKYITDTSVSYIPARIPEDVAETVRDTAVKVYKAIGCQGLSRVDFFVTWQENRVVFNEINTIPGFTSISMYPKLFGASGVPYSQLIDKI
>KF628390.1_16532|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MAKENLVVIFGGRSSEHEVSCISVQTVAKGVDLEKYNMTLVGITKDGRWLKADNIESIADGSWYDSKVTAVISPDTRRELIVFSDAGVERQKVDVIFPVLHGMYGEDGTIQGLFEMADIPYVGCGVLASAASMDKFYTKIIVDHIGVSQARFVPVLAEDFSDIDSAMDRVEAELDYPVFVKPSKAGSSKGVNKATDRASLLYAL
>KF628383.1_16547|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MIAHALKRLGHRPALVDLYFGLEDPAGPLEACFDQPVPDRWKQVDPQAPDLEAVKAARPGESPSQFGPGVLELCRQADLVFLALHGACGEDGRVQAAFDLMGIPYTGSGYVGSALAMDKDLTKRLVAPLGVKTPQWKRADYTDRDIDRLTSTTPVPCVVKPVASGSSIGVSIAHTKKELHAALVEGLAYGGQCVLEQYVAGREIQVAVLAGKALPSIEIIPSDGFYDYENKYQPGAAREVCPAPIPPAWEQAVGQAAVTVYQALGLAVYARADFIVDQGGTPWFLEINTLPGMTPTSLVPQEAAAVGMDYETLCQTIIDESLKARQGGR
>KF628378.1_16559|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSYIERKRPQNCGMRRKIMKIVVLAGGISTEREISIVSGTQVCKALRSRGHQAILVDVYFGREDADPMQAFTDEYDVDAAAAYARSFDGQVEKSIQEGKAFFGTNVIALCQAADVVFLALHGENGENGKVQAAFDLLGIRYTGSGYLGSAIAMDKGLSKQLFWQNEVPTPAGFILRKGEDISLEAHGMTLPCVVKPCCGGSSVGVTIPKTQEEYEAAVADAFSYEDVIVVEEYIKGREFSVGVVDGIAYPIIEIAPIEGFYDYTNKYKAGSTVETCPAVLTKEQTEQMQAYAVKGFKALQLDNYGRLDFMMSEDGKMYCLEANTLPGMTPTSLLPQEAKVLGIEYEDLCQLLIDISMRDE
>KF628373.1_16575|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NEYPNMKQYLDLLNRILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELLWFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIKHNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIASYALLLQMVAQVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIFSFKYEDFELVNYDPWPHIAGKVSV
>KF628370.1_16582|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGYSNERDVSLSSGASICKALRERGHQAYLLDAFMGLEYNPGKLEEVFDLPDGGLGIAAGIQVKEPDLDALWASRPGDSVSYLGPNVLELCSMADITFMALHGSLGENGKLQATFDVLGIRYTGPNSLGCALSMDKGVTKEIFKIQGVPTPDGTHLRRSDRHTSLDALGFRLPVVVKPCSGGSSIGVFIVHTEEEYKDALEQSFQKEDEIVIEPFIDGREYACGIFDGKALPLVEIVPKDGFFDYVNKYQLGGASEICPAQSLDAVKTAQIQAAGEKAYAALRLDVYSRADFIVDNNTGEFYCLEVNSLPGMTSASLLPKAAKAAGYEYGEFCELIIQKSMEARYQ
>KF628368.1_16589|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|0
KALTVKAFHALKLNVYSRADFLLDDSGNLYCLEMNTLPGMTAASLLPKEAKAIGIEYGDLCELIIQKSLEARYSS
>CBI71209.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIVGVAKNGVIGSDQTIPWRVPSDMAFFKRTTMGKPVVMGRKQYETVGKPLPGRTNIVITRQQDYQPEGVLVFHDIDSALQRAREIAQADGVDEIMIIGGGELYAQLMSRADRLYVSHIDLSPPGDVRFPAIAPEQWTVVDLPEVAPSPRDEATYRVKVYERRRDAAH
>ACI02049.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MNAIVAVDNNWAIGNKGKLLVSIPNDMKRFREITTGKVVVLGRKTMATFPNGMPLKNRTNIVLTKDEKYKAGDAVVVHSIDELLEELKKYYTADVYIIGGDSVYKQMLPYVDTCEVTKINYCYEADSYFPNLEKDDEWKKTGESEEFTYFDTEYTFERWKRKN
>AIA17719.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MMISHIAACSQNRVIGKDNHLPWKIPEDWKFFKDKTSGHILIMGRKTFESLGKPLPNRLNVVITRDPTYQAPGAVVLPSVEAALEFAQTKFKDYPDEVFIGGGGEIYKQTLAIADRVYLTVIHKDFDGDAFYPTLPEGEFQEVEKRDRTDPIPFTFFTYDRVKFKA
>AIA15511.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSLEPSAEPLIALVVAMGENRAIGRGGGLPWRLSSDLRYFRKITMGKPVLMGRRTFKSLPRVLDGRLNVVLSRDRGFVAPDAVMAHSLGEGLAAARASAKRTGAPEIMVIGGEDVFRAVLPQTGRIYLTEVHASPDADTWFPELDMRDWREVSREAHPPGPKDDHAFSFVVLDRKR
>AIA13957.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKSGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGRPLPGRVMIIITRNERTAFEGCFIARSIEEAVSLARERGESELFICGGAEIYAQTLGAADRLYLTLVHADCDADTFFPDWNSDEWIETESEHHTADEKNQYSFTFKVLERKHVDLLQSPGEH
>AIA13937.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MDEKRGIGKDGGLPWRLSSDLKRFRELTMGHHIVVGRKTFESIGRPLPGREMIVVTRNESFAPEGCFIARSVEDAIQFAKERGESELFICGGAEIYAQTLDRADRLYLTLVHADCDADTFFPDWNSDEWIETESAHCTSDEKNQYSFTFKVLERKHVDLLQSPGEH
>AIA13614.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSTDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQMIIVTRSESFAPEGCFIAHSISDAISLARERGEGELFICGGAEIYAQAMSAADRMYLTLVHADANADTFFPEWSREQWIERESQSHAADEKNQYPFTFKLLVKQPTD
>AIA13149.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQMIIVTRSESFAPEGCFIAHSISDAVSLARKRGESELFICGGAEIYAQTFGVADRMYLTVVHADSEADTFFPEWDRDEWVELESEHRTADEKNQYPFTFKVLEKKSKI
>AIA12693.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDMKRFRQLTMGHHIIVGRKTFESIGKPLPGRQMIIVTRNESISFEGCFIAHSVSDAISLARERGESELFICGGAEIYAQSFGAADRMYLTLVHADCDADIFFPEWDRDEWIEVESEHHAADEKNQYSFTFKVLEKKSKT
>AIA12624.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MDEKRGIGKAGGLPWRLSADMRRFRELTMGHHIIVGRKTFQSIGRPLPGRQTIIVTRNESFKPEGCFVAGSVRQAISLAESRGESEAFICGGAEIYAHSLGRADRMLLTLVHADCDADIFFPEWDRDEWIEVESEHHAADEKNQYSFT
>AIA11934.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDMKRFRELTMGHHIMVGRKTFESIGKPLPGRQMIIVTRSESFAPEGCFIAHSIPDAISFARERGESELFICGGAEIYAQMLGVADRMYLTLVHADSEADTFFPEWGRDEWIEVESEQRAADEKNQHPFTFKVLEKRNQRLDR
>AIA10815.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISFLVAIDEKRGIGKAGHLPWRLSSDLKRFRELTMGHHIVVGRKTFESIGKPLPGRQMIVVTRNESIAFEGCFVAHSVEAAIGLARERGESELFICGGAEIYAQSLGAADRMYLTLVHADCDADTFFPEWDGDEWVEVEREHRTADEKNQYSFTFKVLARKKRNSNI
>AIA17257.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MISIFVAMTKNRVIGEKDQLPWRLSSDLKRFKELTTGHPVIMGRQTYESLPIKFRPLPNRTNIVLTRNKDFDAPECIVAHSLAQGIEEAKLHNGSDEIFIMGGGQIYEQALPLTDRIYLTEVETTAQKGDTFFPKLHKNDWYIKKAGGFEQDEKNQYAATFYIYDRKETND
>AIA16192.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIAALAQNHVIGKDNDLPWHLPDDMKFFMQTTKGHHCIMGRKNYDSIPEKFRPLPNRTNIVVTRQKGFHAAGCIVVNSIEDALGIARNNGEQEAFIIGGADIYKLGFGFADRLYLTEIQTTLQGDTYFPEFTKDEWRETSRKHHGADERHAYGFDFVIYDRIVNR
>AIA19283.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVAIDDKRAIGKDNKLMWHIPRDMKRFKSLSAGHVVIMGRKTYESIGKPLPNRTNIVITRDLNFFAPGVLVTHSFEEALKKSRETEKEEICIIGGGQVYEESLPYADRIYLTIVHDDFEGTVFFPDYSQFSREIEREDHEEDGHRFTFLTLEKP
>AIA19278.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISTIVATAEGSVIGKEGGMPWYLPAELAHFKELTMGHPIIMGRKTHESIGRSLPGRYNIVITRDKGYGPAEGSVVANSLGEALKMAKKQDGADEIFIIGGEQIYAHAIPLLERIYLTRVKAKVDGDRFFKYDPTKWEEVSSEQHKADDKNKYDYEFVILERA
>AIA19214.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIVSQIAAMAKNRVIGKNNSLPWKLPEDLKFFKEKTDGKILIMGRKTFESLPGHLPNRFHIVISRSPIESDEEDVRFVTSIDEALKVAEEMTEEWPEEVFVVGGGEIYQQTLHLVDKIYLTIIDQEIEGDAYFPDFGPENFKLVEEARRDKPWPFRFCTYLRK
>AIA19199.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSKLEIVLVVAVAENWVIGKDGQLPWHLPADLRHFKSVTMGAPMIMGRKTFESLPGILPGRPHIVMTRDREWKAEGAITVNSIAEAVGAVSGDRVSVIGGAEIFKLFQDSATRLELTRIWRKYDGDIYYQAIDQGLWIEVKREFHEAEGDNPAFTIFSCVPDPERGYPVEPLHAAWD
>AIA19182.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MISIIVAVDEKRGIGKNNNLLFKIPEDFKRMQQITTGHPIIMGKKTFESIGRVLPNRTNIVVTRDPDFEFDKTLVVHSLEDAVRQAQTCSGNEEIFIFGGGQIFKESIEKGLVDRMYLTVVKGDYHADTFFPDYSEFTKVIEKEEKDADGFTYTFLTLEK
>AIA19136.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKSIVVAYDSRRGIGASNDLLWQRDLPADLAHFKKLTMGGSLIMGRNTFESIGRALPGRENIVVTHRPLDVVDVVAVDSLAKAYETAHGNQFIIGGGQIYNQSIADVDIVYATEVHETFSQAEVFFPELGDGWREVAREVHVADDRNKYAYDFVTYARR
>AIA19102.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKNLSVIVAVAENGVIGREGHLPWRLSADLQRFKRLTMGHHLIMGRRTFESIGRPLPGRTTIVVTRQTNASWPGVLTAHSLEEAYRMASSDNEMFVVGGGEIYRQALADAERLYLTLVHADVEGDTRFVDVDWSLWELVEEEHREADQRNTAATTFCVYKKKN
>AIA19075.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTPKISMIAAIQKKDRGIGNDNKLLFAIKEDLQRFKALTTGHPIVMGRKTFESIGRPLPNRTNIVITRNTDFVAEGCVVVSSLDEAIGKAKEVEQIEIFIIGGGEIYKQALPFTDRLYITEVEGEEEATVFFPEYTEFSKIISEGKTT
>AIA19047.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRNIASQPYLPHYALSFQQFLRRIVMKRLNMIAAVGAQDRVIGRDNQLPWSQYLVPDLQRFKRLTMGCVLLVGRNTWFSFPPKMRPLPGRITFIVSTTLTPADVPEGVLICPTLDDAIVLATSLYPKLEGFIIGGQRMYEEGMAYADRLEITEVGEKPPGNVFFPDYSAFSKVIEETVETYEGIELKYRTLERP
>AIA19021.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRVSYFLFVLSASQCIIGPMTKPRVSVIAVLSKESRAVGIKNGLLWKIKGDLPRFKELTTGHPIIMGRKTYESIGRPLPDRVNIVITRNPDYHPEGVLVVSSLEEALDLAKQKESEEIFVIGGGEIWKMAMPFIDRLYLTVVDDEPIADVFFPEYSQFKKEISREEHLEHHPPFTYITLEK
>AIA19008.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MISIIVAVGNDNVIGKDNSLIWHLPADMKFFKEKTTGHCIITGRKNYESIPEKFRPLPNRTNIVITRQKDYSAPGAIIVDSIKKAFDLAKEVKDDEIFIIGGAEIFKQTLNVTDKIYLTKIHHSFDGDVFFPELNKQQWKETQRTKGITDDKNKYEYEFLTFEKIV
>AIA18933.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MRLTIVVAMDRNRVIGKNGDIPWAGKLRADMEHFKQFTMGKVVVMGRKTYDSIPARFKPLSGRENIVLTKNLEFKALGCAVFHEVEPVEMISVSREVCVLGGAEIYKLFFEATDELIVTEVDTEVLGGDTFFPEILPVEWDRRVLFRQEVDEKNQFSFTVCQYTRVLEM
>AIA18932.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQARISAIAALGHNLAIGKGNELLWHIPEDLKRFKALTLGHPVVMGRKTFESIAAMLGKPLPGRPNIVITRDPTWRYEGVHVAHTVEDALALAKELDQEEIFVIGGAQIYEAALPHTDRLYLTLIDDTKEGDAYFPAYENIFTKKLSEEVREHDGLKYTWVDLER
>AIA18861.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MILSIVVAAAENGVIGRDNSLPWRLPDDLKRFKELTMGKPMIMGRKTFESIGRPLPGRTNIVVTRQGDLRFEGCIMVDSLDGALAAAGAASEVMLVGGAQLYRDAMPRVDRIYLTRVHAAVAGDVFLPSLDAHEWRETIIATHPADERHAYSFTFVNLDRVAS
>AIA18837.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSLIVALDRRRGIGKDNRLPWRLSADLKRFRELTMGHHLIVGRKTFESIGKPLPGRQMIIVTRQAGLQVESCFVAQSVDEALRLARERGESEVFVIGGAEIYAQTLALADRLYLTLVEAEVEADTFFPEFDEAEWLAQETVQHEADEKNQYPFTFKSLVKT
>AIA18830.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPPPKIIAIAAMNENRVIGAQGKIPWHIPEDMKRFAQLTTGYTVLMGRKTYESLPDAYRPLPDRHNIVVTRRADSLKGQEGIRVVDSARAFIMRCMTNVERLETTKLWIIGGGEIYGETMPLWEEVYLTLVKGKQAG
>AIA18813.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTLPLILVVAVAENGVIGRDNQLLWRLKTDLGRFRRLTMGKPMIMGRKTFQSIGKPLLGRETIVLTRDAGFAAEGVHVVHTWEEAVAKGAELATRMGADSVAVAGGAEIYALALPQVQSIFLTKVQAEPEGDAVFPDFDRSQFRETRREDHPKGGDDEHSFTFIDLERRR
>AIA18773.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|1
MKPYLDLMRHVLEQGTPKTDRTGTGTLSVFGHQLRFDLRQGFPLLTTKKLHMRSIIYELLWFLRGDTNIGYLQEHGVRIWNEWADEQGELGPVYGRQWRSWQAADGRSIDQISQVIEQIKTNPDSRRLIVSAWNVGELERMALMPCHLLFQFYVANGRLSCQMYQRSADIFLGVPFNIASYALLTMMMAQVCGLEPGEFIHTLADAHLYSNHLEQARLQLERAAAPFAAHADQPGGHFDIRLRLFRLRADGLRSAPAYQGGGGRLIVSLLVAMDERRGIGRRGGLPWRLSSDLKRFRELTMGHHIVVGRKTFEAIGKPLAGRQMIIVTRDPDYHIAGCFTVHSIAEALELARQHGETELFICGGAEIYARTMELAERLYLTRVHADCDADTFFPEFNPEDWLETASETHAADEKNQHPFTFSLLERKA
>AIA18713.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGEQPSSAGRRPEVIGIAAVARNGVIGAGNDIPWRIPEDWARFKAITTGHVLIMGRKTYDSIGRALPGRTTIVVTRDQTWRAGGVIIVADPDAAFERAYALTPAKIFVAGGGQIYASSWDRLDTLEITAVDAEPVGDVLFPTIGSDWHEADRDEHDGFSFITFRRQSD
>AIA18697.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIHSIIVAQSQNRVIGINNTLPWHLPADLKRFKAITMGHHMIMGRKTYESIGKPLPGRTSIVITRNNDLQYEGCVMAHSLEEAFKIAEGNNETEAFVIGGADLIKQSIDSCDKLYLTTIHQDFEGDTFLNELSSDWKVIEHTDHVPDEKNLYSYSFITYGK
>AIA18680.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLSTIVATAKNGVIGKEGGLPWYLPAELAHFKEITMGHPIIMGRKTHESIGRALPGRANIVITREKSYKSKGVTIAHSLDEAITEAKKSAGSDEIFIIGGEAIYKQAMPQLNRIYLTEVDAEVHGDKFFKYDADQWQEIRRDKHLPDDKNQYGYSFVLLEKA
>AIA18652.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MILSHIVAVIENEVIGKDNDLLWHYSEDLNYFKKRTTGKIMIMGRKTFESLKKPLPKRFHIVVSRHNIDSEYPNVKFVGSLSEAYRLAEKMTLSDEWPEEVMIVGGGQIYKESLKDADFLYITRIPGEYQGDTYYSLNIPPEFRIAFSQFSNEVPGLRYEIWSKVRPDED
>AIA18625.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKTSIVGFAKNMVIGKNQDMPWGHGLKDDLRHFKELTTGQAIIMGSKTYESLGRPLPNRQNIVISRTPSVIEGVTVVDSLDKAYAAVEPGRETFVIGGGQIYKLAMDTIDRIIATEVEGEYGGDVFFPPIDPSVWREVSREHHDADERNTHAFDFVTYERI
>AIA18609.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIAAVAENGVIGKDNKLPWHIKSEWQYFMRMTRHKPVIMGRLTFESLGAPLKDRANIIVTRNAGYKHEGIIVTATLEKALDIARKIAAETRQDEIMIGGGAEIYRLALPLADTLYLTEIHLKPEGDTKFPAFDRSGWVETKREFHKAQAGETADYTIIVLERKK
>AIA18584.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTSLHEKFRPLPNRTNIVVTRQKNFNAPGCLVVHDIHEALSISKKENEPEAFIIGGAEIYKLSMPDADRLYLTEINADVDGDTFFPRFDKTEWKETTRTHHESDEKHKFSFDFVIYDRIKK
>AIA18505.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MFVSIVVAIAENHAIGKNNKLLWHLPKDLKHFKEITSGHTIIMGRKTYDSVGKPLPNRRNIVVTRQDIAIDGCEVVNSLPDALKLAEGVDEVFIVGGAEIYKQAMPLTDRIYLTIVHEDFDGDTYFPEIKEDIWKEIAREDHQPDEKHAFAYSFITLERR
>AIA18485.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MKTILLAAMTANGFIARSTNELADWTSKEDKKFFVEETKKAGVMIMGRTTFATIGRALPGRLIVVLTGKPEEVEVTEGVETASGDLKTILEGLEKRGYSSVVIAGGANVYSQFLNAGLVDELALTVEAKLFTSGVPLAQNLSHELSLTLLETRMLGEKSVLLRHRVNLSTEAR
>AIA18465.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MKHFKAIAAMSLNRVIGAGNKIPWHLPEDFKWFKATTTGHVILMGRKTFESIGKPLPNRTTIVLSRSVWSHPVVRTIHNLDELPALVGSQQVFICGGAQIYEQTLPLCSDLFLTLVKCEVADGDAFFPPFEDSFELTEEIRDTPEFKILHYRKRN
>AIA18419.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRISTIVAVAKNGVIGKEGGLPWYLPAELARFKEVTMGHPIIMGRKTYESIGRALPGRTNIAITRNKDFKAEGCIVVDSLETAIAEAKKAEGADEIFIIGGEQIYKEAMPLLNRIYLTKVDADVKGDKFFHYDPKKWKEISSEKHSADEINKYSFTFTTLQRI
>AIA18414.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTLSIIVAVSENNLIGVNNDLPWHLSADLKRMKTITMGHHLIMGRKTFESLGKPLPGRTSIIITRNKNYQVPPECIVVPSLKEALAAVKNDNEPFIVGGGEIFREALPLVNKIYLTRIHQRFEGDTYFPELNEKEWKQVSRNDFQRDEKNNYAYSFINLERIRKS
>AIA18378.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISTIVAVAKNGVIGKEGGLPWYLPAELARFKEVTMGHPIIMGRKTHESIGRPLPGRTNIVVTRNKGFKADGCIVVDSLEKAIVEAKKGEGADEIFIIGGEQIYKEAMPMLNRIYLTNVDAEVAGDKFFKYDLKKWKEISSEKHSADEKNRHNFEFTVLDRI
>AIA18354.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MRQYLELMRNVLEHGARKEDRTGTGTLSIFGYQMRFDLSEGFPLLTTKKLHLKSIIYELLWFLRGDTNVKYLQDHGVKIWDEWAEENGDLGPVYGAQWRSWKDPNGGSIDQISQLIDQIKTNPDSRRLIISAWNVVDIPRMHLAPCHCLFQFYVSEGRLSCQLYQRSADIFLGVPFNIRLLCVAHDDGGAGLRSETGRFRSHLRRRPSLPEPHRAGKTAVVAPALQSPSNEDQPRRQIHLRIQIRRISN
>AIA18317.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKISLIVAVSQNNVIGKDGKIPWFVRGEQKRFKELTSGHPVIMGRKTHESIGMELPGRLNVVITSNPNFPAYGKSVVVHSLQQALELEQVKQADEVFVIGGQQVFDEAMPLADRIYLTKVETVVAHGDKFFDFDAKGWKLVASEHYPKDEVPDRPFDFNIYTYDRQPQQ
>AIA18290.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNSPLKICAIVAMDEARVIGLNGKLPWHLPEDMKRFSKLTTGHTVLMGRKTYESLPPKFRPLPARKNIIVSRSFNAPEGVEVWNSPVECLQHYRAHPEKLPSDRLWVIGGAQIYQETEQFWDEIDLTFVKGKHEGDTFFDSFERDFSLVTEEPFSAGSFRIYKRNW
>AIA18272.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKISIIVAASENNIIGRNNDLPWHLPADMKYFKDTTMGHCVVMGRKNFESIPPKYSPLVGRTNIVITRQKDYNANGAIVVNSIQEAIDFSRNQNETECFITGGGEIFKQSIRLCNRIYLTRIHAVIEGDIYFPELNKEEWKEVSRKDIEPDEKNKFPFSFLIYERI
>AIA18264.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIVSLIAAVAANGVIGKNNDPPWKLPDDMRFFMETTKGHYVIMGRKNYDSLQDKFKPLPNRTNIVVTRQKNLNAPGCIVVNDVTKAIDTAKDGDEKEAFVIGGAEIYKLTLSSAHKLYLTEIQAAVEGDTYFPSFDKNDWKETYRKHHPSDERHKFAFDFVIYDRIK
>AIA18237.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKSRGIGKAGGLPWRLSSDMKRFRELTMGHHIMVGRKTFESIGKPLPGRQMIIVTRSESIAVEGCFIVRSVEEAVDLARERGEIELFVCGGAEIYAQTLGLADRLYLTLVHADCAADTFFPEWNSDDWIEMESEHRAADEKNQHPFTFKTFARKSQV
>AIA18208.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MISFIWAMDRNRVIGKENKLPWHIPEDLKFFKSSTMGHPIAMGRKTFVSIGRPLPGRENIIITRNKEYSYDGCTVVHSIEEFVEYCREKEEEYFVIGGAEIFKEMFPFADKLYITLIDEEFEGDTFFPEFDLGEWELHSFEKGPRNEKNPYDYEFRIYARKTEQ
>AIA18200.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSIVVAIAQNNAIGKDNKLLWHLPKDLKHFKEITSGHTIIMGRKTYESVGKPLPNRRNIIITRQNITIDGCEVVNSLPDALKLADGVHEVFIVGGAEIYKQAMQLTDRIYLTIVHENFDGDTYFPEIKEDIWKETEREDHQSDEKHAFSYSFITLERR
>AIA18166.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKISIIVAASENNVIGRNNDLPWYLPLDLKYFKDTTMGHCVVMGRKNFESIPPKYSPLVGRTNIVITRQKDYKANGAVVVNSIEDAIEYARRQSETECFITGGGEIFRQSLQYCDRIYLTRIHAVIEGDVYFPELNMNEWKEVSRDDRPADEKNNYSFSFLRFERIK
>AIA18163.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MDRNRGIGKNQTLPWSLPGDMKYFKRLTCQTSDPQKQNAVIMGRKTWESIPPKFRPLSNRLNVVLTRDAHYQAAADVVIANDLAAALEQCDRSDIEKIFVIGGASIYEQALQGRHVDRIFLTQIDAQYDCDTFFPVFEDRFGEVGDSTGGSDAGVSYRFKEFASLVSAFCLLLFLSCMPAHAADLRNGAAVFERATCAMCHPNGDNTLCPDKPLKGPAFMRRFSSDAAIEKVIRKGVPNSAMAPFDRDRISDKEMKDVVAYIRTFSANQKQPATKQPLSKSIPFKATPTKKAPAKKS
>AIA18155.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSTSPKISLVAAVAENGVIGDGTGMPWRIRSELKHFMQTTLHKPVIMGRKTFETLKAPLKDRANIVVTRDAAYKKPGAIVATSLDKALEIARAIAAETGADEIIVAGGAEIYRQALPFADRLHLTEIHAKPEGSVLFPSFDRKAWKQTRHEPRKALEGESADYTITVLERA
>AIA18132.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIVAMDEKRGIGKAGKLPWRLSSDLKNFRELTMGHHLIVGRKTFESIGKPLPGRQMIVVSRDRGFKPEGCLVAGSVQDALNIAQEHGETELFVIGGAEIYSQTLQAADRLYLTQVHAEVDADTFFPELNFGEWNPADSSFQLADDKNEYAFTFTVLIRKRH
>AIA18035.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSEIRKTIVVAVSENGIIGRDGDMPWRLSTDLKRFKALTLGKSVIMGRKTYESIGKPLPGRANVVISRQAAAIDHPDVRMARSLTEAIGLAEDIAKRSGEDEICIIGGGQIYTQALDLADRLCVTHVETSVDGDTSFPTIDPTLWRATETIEVPAGDKDSYPTKFVVYDRR
>AIA17994.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISAIVAMSQNRVIGVNNQLPWKIPEDLKRFKTLTLGHPVIMGRKTYESIGKVLPGRENIIITRQPHYSVPGATVVSSVEEAIRHCEGKSGEIFMIGGAEIYRQVMPKIQRLYLTLIEKQFEGDAFFPTWGKDEFKEVSREERSDPISFSFLVLERKK
>AIA17990.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGSKTWRSIGKALPGRQSIVLSRTEIEDLPDGVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPETVEDADVYMPLQFLDDFELVDSREIDEGLIVETFDRRT
>AIA17955.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|1
MKIIMIVAHTIDGFIAKSADQFIDWSSKEDKKMFREETKKAGVMIMGMTTYKTIGKPLPERLNIVLTSKADQLESIPDTLEYMNATPEEVIADLSARNFETVCVIGGARTYTEFLKAKLIDEIWLTIEPVIFGQGVTTFTDDIMGVKCYLTKFINLNENSLQLRFRLEYE
>AIA17940.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MQHKTFDVVVAADAKLGIGKGGTLPWKLPGDMAYFKRVTSTTSDPAKRNAVVMGRKTWDSIPAKFRPLPNRLNIVISRQSPEALGLPDSVLHAGDLSEALSKADADSIETVFVIGGGEIFAAAMRHAACRLLYLTDIQADFDCDTFLPDFQQDFVPAPGTEKVRETDNGIEYEFKVFARRSNHPASDASSVCAAESQRGART
>AIA17879.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MQVSYIFAMDRNRGIGFENKLPWRLPADLAFFKKTTLGHPVVMGRRTFDSLGGRTLPGRTNIVLTQNRSYTAEGCEVVHSADEAVERFGGAGELFVIGGTEAFRLFMPYVMRMYITRIEHEFVCDVFFDGLPEREWKLVSSEKGPRDEKNPYDYYFEVYERVDV
>AIA17864.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MSLSFIAAISKNGVIGRANDLPWRLPDDMKYFRETTKGHAVIMGRKNYESVPEKFKPLPYRVNIIVTRQKGFVAPGCHVVHSLEEGIKIGEASNTGEIFDIGGAELFKLGLPLAKRMYLTEIKAEVEGDVYFPGFDRKEWKEISRTAHGADERHAFAFDFVVYERLR
>AIA17843.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIAALGKNRVIGKGNDLLWHIPDDMKRFKALTNGHPVVMGRKTWESLPARFRPLPNRTNIVITRKSDYVAEGAQVVGSIEEALRASSNAPGAEEVFVIGGGEVYALALPFATRLYLTIISDEKDGDIYFPAYEHCFTRVIAREMRESTGLSYQFVTLER
>AIA17809.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSAIAAMARNRVIGVDGDLPWNIPEDFKFFKDKTSGHAMIMGRKTFESLPQALPGRLHIIVTRQEGYAPSLPANAKPGTALKVVSTIEDAVAFARTKTSEYGDEVFILGGGEIYKQMLSITDRIYLTEIHQDFPGDTKFPEFSKTEFIETERKPRKAGEGPNPSSVSFDFVTYDRK
>AIA17737.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTISIVVAIAANNAIGKDNQLLWRLPNDLKHFKQITSGHTIIMGRKTYDSVGKPLPNRRNIVITRQNMNIEGCEVVNSLDAALALCANEPEVFIVGGAEIYKQAMPLTDTIYLTIVHQSFEGDTYFPEIKANEWIEIEREDHNPDEKHKFAYSFITLKRP
>AIA17715.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MITIIAAVAANRVIGAAGKGMLWRIPADMNHFVELTTPHPVLMGRKTYESIPAKFRPLKDRLNVVITTNTDYQTSPGVLICSSLDEALKIAQQYDDNIFVAGGGSIYSQAIDKTDRLEITEVHQDYEGDVLFPIIDSTNWKEVHREDHEGFSFVRYERQ
>AIA17700.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MAASENGVIGKDNKLPWHLPDDLKYFKNLTWGLPILMGRKTFDSIGKPLPGRKSIVITRDKAWQHEGVAVVHSLDEAIQKAESFGAKEIFVIGGAQIFNTTLQTADRIYLTRIHSEFEGDVFFPEISETDWSLSSSRFLTADEKNAYDHTYQVWERKKPSS
>AIA17570.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
RSPYDIVNSVRLAYTQRFILIEAALMTTPRLSAIVAMSDNRVIGDKNQLPWHLPADLKYFKNLTSGHPILMGRKTYESIGRPLPNRTNIILTRNAEFTAPGCLVVTTIEEAMECAREAQSDEIFIIGGAEVYKQLLPHIERIYLTIVHDQFDGDAFFPELDEDQWQEVSRQNHDADENN
>AIA17548.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIKSIVVAASTNNAIGKNNQLLWHLPNDLKFFKNVTWGMPVLMGRKTYESLGNKPLNGRVNMILTTQKNFKREGVVTVNKIKDAIFFAGEHDYKELMILGGANVYSQTIGDANKIYITRVHHVFEDADAFFPVIDENKWKLVSNQDFFKDEKHAYDYSFQLWQRR
>AIA17500.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNGTKPFTVCVIVAMDQGRIIGFKNRLPWHIPEDMKRFAKLTTGHTVLMGRKTYESLPDKFRPLPKRKNMVITRSPAQFRAAEGVLVFSSPGAAIEHLHHHSEDVSGGQLWIIGGGEIYRETMEYVDQIYLTVVDGTHEGDVYFPEFEQDFVLAECETHEGFEYRLYRRKTQASAPD
>AIA17485.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNQGRISIIAAIDEKRGLGKNNDLLFKISGDMQRVRSLTTGHPLVMGRKTFASLGRLLPKRSHVVVTRDASSLESLSFQPEAVVGSLEEALEKAKEFEGAEEIFIFGGGQIFTEAVEKGLVDRLYLTIVKGEYDADTFFPDYSMFTKILKKEEHEEEGYSYTFLDLEK
>AIA17446.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
GDMRRVKRLTMGTTLIMGRITWESLGGRPLPGRRNLVVTQRDLPGVECFRDIRAALAVAEGPVWFFGGARIYQEAMSLANLIDMVYVPDHVTDPAAVKFPVIDPLEWDEGPLLPHEDEPALQRRVYTRRRRS
>AIA17402.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNLSIIVALSENNVVGINNQLPWRLSADLKRLKTLTMGHHLIMGRKTYESIGRPLPGRTNLIITRNRNYKAEGCVVVSSLKEALEKAKDDAEPFIFGGGEIFREGLPMVNKIYMTRIHENIQGDTRFPELNASEWKEISRQDFSADEKNDHDYSFIDLVRVG
>AIA17374.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKVFIIAALSADGYIGIDASHRATSWTTKADLQFFVRKTKEAGTIVMGRKTFETIERPLKDRRLIVLTSKPEDITIEDVEATSESLAELVARLEREGVTTLAVCGGSSIYTQFMEAGLAEELFITVMPKIFGQGLPLFGRQLDINLRLQHTEQLGENTVLLHYKTV
>AIA17354.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKVILVAAVAENGVIGTHNALPWYIPADLKHFKRITSGKTVLMGKNTFDSIMKRLGKPLPDRLNVVVSHQNLTLPEGVLLFHGIDEALDALHDKDEIMVIGGGQIYNQIMDKADKLILTEVHESVEGDVFFPKFDKNEWNETSRENFDEFSFVEYERK
>AIA17300.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILTAIAAMASNRVIGVDNDLPWNIPEDFKFFKDKTSGHAMIMGRKTFESLPFALPGRLHIIITRQADYAPELPANAKPGTAIKVVPTIDEAVAYARTQISKYGDEVFIAGGGEIYKQMLPITDRIYLTEIHKDFEGEAKFPEFSKTEFKEVYRSARKAGENGATVDFDFVTYERTR
>AIA17277.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISFLAAMDRNLVIGDEKGIPWHLPADLKRFRKLTLGKPIVMGRTTFEHIGRPLDKRTNIVMTRKLDYQPGGVIVAHSVDEALLFAGDVEELVIVGGGEVYRAFLPFVNRIYLTFVDGKFPGTAYFPAEIPTPTGHAWRETHREEHFADEKNPFDHTYLVVERSLASGSPGGPLEIRSLIA
>AIA17239.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEIVLIVAVAENGVIGRDNAIPWRLKSDQQRLKAITLNKPVVMGRKTFESLRRPLPGRTNIVVTRDPNYRAHGAVVATSFENARAIAIGDALRRFATEIAVIGGAEIYAQWMASATRLEITEVHARPEGDTHLAAIDLAAWEEVARVRNPAGPDDSVDFSYVTYRRRQQR
>AIA17213.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLVAAASENNVIGKNNWMPWDLPAELAHFRAYTRGKTVIMGRKTYDSVGRPMPNRHNIVITQQNLTIPGVDVVHSIEDALELAKKDGLEEICVIGGGSVYKAALPYANRIHLSRIHTTIEGGEAFFPDIDWSQWQEVSRAEHPADAENAIPYTMLVYERK
>AIA17205.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIKSLVVAASTNNAIGKDNQLLWHLPNDLKFLKNKTWAMPVLMGRKSFESLGNKPLKGRVNIVLTSSKFFKKEGIVLVNNLKDAYFFAGQNDYNEIMILGGGHVYEQTINESDKIYITRVHHVFEEADAFFPVIDENKWKLSFNEDHYKDEKHAYDYSFQLWERK
>AIA17170.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSQVVAISQNHAIGKDNQLIWHLPADLKHFKNVTMGHHMIMGRKTFESIGKPLPGRTTIIITRDKNYKADGCIVVNSLEEAIETARKADDTEACIVGGGEIFKQAMDLTDKIYLTIIEERFEADIFYPELDPKEWALASREDFKPDEKNKYYYSFCEYTRIK
>AIA17104.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKENTPEIAIIVAMDQKRGIGNDGKLPWPRIPEDMARFKELTVGHPVIMGRKTYESLPPKYRPLPDRPNIVLTRELGLSIPRCYTSHSISEALQLGELLDSKRICVIGGGEIYKKALPLADVLYLTNIDADFEADTFFPEFSDQFSIELKSRASHHNGLQYSFEDLARKK
>AIA17095.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKNLLVAYDQNHGIGATGDLLWRRDLPADLRHFRDLTTGNAVIMGRKTFDSIGQPLPHRQNIVISRQAPTIEGVTVVGSLDEAYAAVDPDKEPFVIGGGDIFWLALPDADRIFATEVQAVFPQATVFFPAIDRAEWFEVSRAHHPADKRNLYDFDFVIYERL
>AIA17084.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKKPCISIIVSIGKNMVIGRRDKLMWPISEDLKRFKRLTMSHPVIMGRKTFESILTSLGKPLPGRTNIVVTRDTTYAPEGAIITHSLEEAIQKASEVDQEEIFIGGGAQIYEQALPITDRLYLTLIDDAKEGDAYFPPYKHLFKKVIAEEPHDQNGLKYKWVDLERE
>AIA17076.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDEARGIGRNGRIPWRLSSDMKRFRELTMGHHIIVGRKTFESIGRPLPGRQTIIITRNPEFRAEGCSIVRSVDEALNLAKSRGESEAFICGGSQIYAETIGAAQRFYFTLVHARVESDAFFPEWDESEWTGKSSTYHEADDRDEYSSTFSLLEREGRPG
>AIA17026.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSHIVAVAQNDVIGAKNALPWNIPEDMKFFREKTKGKALIMGRKTFESVGHPLPHRLNVVVTRQKDFASDAPNVVVKPDLASAIEYCRGQTSKYGDEIFIIGGGEIFKESMSLVDVIYLTRIHRDFDGDIFYPQLPSDQFELIEQRDRTEPVPFSFLTYMRRK
>AIA16950.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MSISFLLAMDRNHGIGLNNKLPWRLPADLAHVKKLTMGHTLVMGRKTYESLGRPLPGRTNVVLTQNRDYQAPGCVVVHTVEEALSRFREGELFIFGGAEIFQLFMPYAEKMYVTYIDEEFAADTFLPEIDAREWELVSNQQGVKDEANPYTYYFRRYERRNGRQ
>AIA16911.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MMNRIALIWAMDKNGLIGANNKMPWRLPADMAYFRATTTGHPVIMGRLTYESIGKPLVDRTNIVLTRNDDYKPDGCIVVHSVEQTLDLYPEEKVFVIGGAQVYRQFLPHADLLYVTRIDHDFSGDEYFPDVDWSQWQLIQETPGQVDDRNPYPYTFQVYSKK
>AIA16888.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MISVIAAIDEKRGLGKGNDLLFKIPSDMKRLKELTTGHPLVMGRKTFESLGRKLPNRLHIVITRDAKSLKDLSFQPDVIVGSLEEALRQAQGENKEIFIFGGGQVFTEAVEKGLVDRLYLTVVQGDYGADTFFPDYSMFTKVVKEEEHEEGDYHYTFFILEK
>AIA16847.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTISLILAADENNCIGKNNTLPWHLPADMKLFREKTMGHCVVTGRKNYESIPDRFRPLPGRTNIVITRNKEYAAPGATIVHSLDAGIDTARQLGETEVFVIGGGEIFRQALPIAEQIYLTRIHHVFTGDVFFPALEPLEWKETERHDFPPDERNKYGFSFRVYHRAAPAISESQ
>AIA16834.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MWAMGRNRVIGAGGDIPWRLPADWAYLKATTMGHPILMGRKTYESIGKPLPGRTNIILTKNANFAPEGCVIVHSIEDAIKRYGSDDELFVLGGAEIYKLALPCADRLYATQIDHEFAGDTYFPVIDLSQWEVVSRRPGTRDEKNPYDYEFIVFWRKKEVSE
>AIA16822.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
PKLVYDKRMKYIIVAYDRNRVIGGGNKLLWQGHMKADMRRVKQLTTGNAIIMGRKTYESIGRALPNRQNIVVTHRPLEAEGITTVGTLDEAFAAVLPDRDAYIFGGGQIYKQALPVVDQIFATEIDKAFNGDIYFPTLGDDWHEITREDHQPDAENKYPYSFVTYAKTNLFKAA
>AIA16774.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKISLVAAVAQNGIIGKKNDLPWRLPDDMKFFMETTKGHVVILGRKNYESLPPKFQPLPGRTNIIVTRQENYDAPGSFVVNDIKNALEIAKESGETEAMVIGGSEIYALSLEYADRLYITEVLADVDGDVSFPAYNKKEWKEISRVHHDADQRHIYAFDFVVYERIEENLKYGDIDK
>AIA16750.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MPGDIRISLVAAMAQNRVIGDGPNIPWRIPGEQKIFRRLTEGGIIAMGRKTFESIGRALPNRETVVISRQRGYNAPGCTVVGAFDEAVEFARDRGGELFVAGGAEIYSQAMGRADRIYLTEIHRQFAGDALFPEIDASFTLVSTEEVAAEIPYTFKVYQRTRSADGRFRI
>AIA16712.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSIIVAVSENGVIGKDNKLIWHLPADMKFFREKTTGHFIITGRKNYESIPEKFRPLPDRTNIVITRQKNYHPAGTIIASSIPDALSFAEEFSNKEEVFIIGGAEIFNQVLPSCHRVYLTRIHEKFEGDVFFKDLPPEWKLIFSEKHEPDAKNKYPFTFETWEKN
>AIA16704.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLVAYDKQRGIGADSDLPWQRDMPADLKRFKELTTGNAIIMGWNTYESIGRVLPHRQNIVMSRSPRAEVEGMTLAGSLESAYAAVEPGRETFVIGGGQVYAQALPTVDRVFATEVDAVFESATVFFPPLDMAIWKETSREHHDSDERNKYPYDFVVYERQ
>AIA16682.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRISIIAAVATNGVIGREGRLPWHLSTDLKRFKQLTMGHAIIMGRRTWESIGRPLPGRRTIVVTRQSEYSVPEGVQVAASLDDALDAAQAAGECDAFVVGGAELYHEALGLADRLYFTEVAADVEGDTYFPVNFDTFEWESWVTTETEAHAADAENDYAFVFVTLERTDPTAMAE
>AIA16656.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MAKNRVIGASKKIPWHLPAELAMFKRITMGHHIIMGRNTWESIGRLLPGRTTVIVTRQSDYNVAGALIAESLEAALSMCRGDDEIFVIGGGQLYVGALAVSNRIYLTEVDAEVGGDTFMPEFSLSDWRAVSVESHPADDRNQYNYKVTVYDRIVS
>AIA16551.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISLIAARSRNGVIGKNNGLPWHLPDDMKYFMTTTRGHHAIMGRRNYDSLPDAFKPLPNRTNIVITRQRAFSAPGCIVVHDIAGALEFARTHSETEAFVIGGAEIYTLAMATADKLYLTEIDAEVQGDTYFPSFEKTQWQEVSRKHHDADERHAYAFDFVIYERIV
>AIA16421.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTEIVGIAAVARNGVIGSGNDIPWRIAEDWQRFKRLTMGQVLIMGRKTYDSIGRPLPGRTTFVITRDRMWRGDGVRVVPALDEAFQQAALLGPATIFVAGGGEIYRAAWDRLDRLEITEVDQIPPGEVTF
>AIA16390.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLVVAIDEKRGIGKEGKLPWRLSADLKRFREVTMGHHLIVGRKTFESIGRPLPGRQTILVTRNPDLKPEGVVVVHSVEDAIALAQERGETEAFVIGGAEIYARTIEAADRIYLTEVHAEVAADVFFPEFYRDEWIETQRIEHSKDEKNEHAFTFVVLERVTP
>AIA16386.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|0
MIRPFIIAAMTTDGFIAKDANHPAFWTSKEDKVRFVELTKRAGVVVMGSQTYKTLPRPLAERINIVYSRDKKFEGAEMTNDEPRALLSKLESRGFSEVAICGGSQIYNMFMKAKVVDKLYLTVEPLLFGKGVTLFKDDIVADLTLLSESKTEKGTVFLEYKVNYHGAQNL
>AIA16350.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MHIVLVAAVTANGFIARSTNELADWTSKEDKKFFVEETKKHGVMIMGRTTFATIGKPLPGRRIVVLTEKPEEVQVVEGSVETASGDLKTIIDGLSKRGYASCVIAGGSNVYSQFLNAGLVNELALTFEPVMFTSGVRLAEKLERELQLEVKSVEKLGENAILARYSVH
>AIA16342.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIILGPVAVAKNGVIGGGNDLPWYFPEDLKHFKEITMGKTVLMGRKTYDSIFKRLGKPLPGRKNVVITRDQNGVYPEGVLVFNDPEAAVAALPNEDIYVIGGAQIYSLFLPKAEKMFMTHVHKEYPGDAFFPEVNWDEWEKIEEEPHDQYTYSTYIRK
>AIA16325.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEKELCMITATDLDGVIGNDLEIPWPKLKADLQNFKNLTIGHTVMMGMKTFLSMNSKPLKDRTNIVVTRNRTWKPEQDNILVAHSLYEALYLAQDYGKGEKIWNIGGGMLYSAGLHSLTFDEIHVTTIQGHFEGNIKFPGVPKHLYELKRNELHHADEQNPYKFCYQLYRPYRYRA
>AIA16201.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVFIVAALTADGFIARNTTELADWTGTEDKKLFVELTKRAGVMVMGRTTFETIGRALPGRKTIVYSHRPLDIPDVEVTDEAPVDLLRRLEQDGHQEVAICGGAAVYTQFMEAGLVDELYLTMIPCLFGGGVRLFNASLESKLHLLDTRRLSDDVIMLQYEVEK
>AIA16175.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MVTLVAAVAKNGCIGKNGELPWSIPEDMKRFKKLTTGSIVVMGRKTWESIPKKFRPLPNRHNVVVTRQADYPVPDGVDRYTSLDEALDAFATNTVMVIGGAEIYNQAIGRADTLQLTHVDRDVDGDTFFPTIDPTIWKETWREDHEGFSFVTYERV
>AIA16164.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKANRLPWRLSSDMKRFRQLTMGHHIVVGRKTFESIGKPLPGRQMIIVTRNENFRPAECLIARSVEDALALARAAGESEVFICGGAEIYAESLSAADRMYLTLVHADCDADVFFPEFGDEWAEIESERRDADAKNQYPFTFKLLVKKQS
>AIA16147.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MMLSLIVAASENNVIGLDNDIPWRLPDDWKHFKDTTLGCPVIMGRKTHESIGRVLPGRRNIVVSRQKELKIEGCDVVASIQDALALAKTDAPREIFVIGGEGIFREALPLADRIYLTRVHATVEGDVFFPELNLKEWKEISRERHLADDHHPYAFDILILDRQK
>AIA16112.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTEKHVTGDLRRLALIWAQSSTGVIGRGNDIPWHLPEDQARFKQLTLGQTVVMGRLTWESLPAKVRPLPGRRNVVITRNPGYVADGAEVVTEIGDVFRGWVIGGAQIYAQALRFADRCEVTEIDLDLPPAEGDAMAPELDDSWTKTTGDWLTSSSGLRYRYCSYARTL
>AIA15855.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MGSTGGNMQKKKISIIAALGKNTRAIGKKNGLIWKIKGDLPRFQKITTGHPIIMGRKTFESLPKGALPDRLNIVVTRQEMNIPGAVTATSLDNAIMLAAKENADEIFVIGGGEIFKQALMLADRLYLTVVDSDEPGDIFFPDYSIFRKVISEERHNEHDPKFSYLVLER
>AIA15824.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISFVVAIAENNAIGKNNELLWSLPKDMKHFKTITSGHTIIMGRKTFDSMGKPLPNRRNIVITRKKDLQIPGAEVVNSLDQALALCNNEPEIFVIGGAEIYKEALPKTNRIYLTRVHQSFDGDAYFPELNMDEWVETGREEHLPDEKNQIAFTFLTLESK
>AIA15780.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|0
MDTPRIILLAAITADGKMARNTAHLSDWTSPEDKRVFVAESRRAGVIILGNNTYKTLPRPLPGRLHIVLTSSTADKTDIPGVVEYTSATPAEIAASLGSRGYTSAVLAGGAQINTLFLAHDMVDEIWLTVEPLIFGTGVHVFEGAAFDLRLRLISLEQINANAFLAKYSTRHEVAAPSNLAQPSRE
>AIA15768.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKASIVAYDHNRTIGNHGDIPWQGKMKSDSRYFRDTTMGHPVIMGRGTYEAMGRLLPKRLNIIVTRGELAVEGAIVVHTLEEAYRAANGDDKVFVIGGGQIYQAAMDSIDMIYATEIDAHTDGDAHFPVVDPSVWREVKRQHYDPDEQNVYAYDFVVYERI
>AIA15760.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVIEAAVARPEVIGIAAVARNGVIGTGNDIPWRIPEDWARFKAITMGHVLIMGRRTYDSIGRPLPGRTTVVVTRNQSWHADGVIVAADLDEAFARSGELSPERVFVAGGGQIYAAAWDRLDRLEITEVDAEPVGDVRFPTIGPEWTETARESRNGFAFITFEKR
>AIA15715.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|1
MHIRSVVAELLWFLQGATNVKWLHEQGVTIWDEWADDSGELGPIYGYQWRSWPTPDERHVDQIAAVIGGLKADPDSRRHLVSAWNVSDLEQMALPPCHTMFQFYVAPAPAGSDDPRGRLSCQLYQRSADIFLGVPFNIASYALLTHLVAQVCDLAVGDFVHTLGDAHLYTNHLEQARLQLTREPRGLPDAPAGSQHHRHRRLRAGAHQHRGLRPLRGDQGPDRGLRRMGRVTIVVAIGQNGVIGADGDMPWPRTGDQVQFKALTMGHPMIMGRTTYESIGRPLPGRTSIVLTRNPSWAAEGVEVAGDLPAGLARAAELDDEVFLIGGAQVYAAAIEAGVVDRMVVTHVHLSPEGDAWFPDVDWTAWHETSREKYDTYDIATYDRS
>AIA15609.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MSLSYIFAMDRNRVIGNENKLPWHLPADLKFFKKTTMGHPILMGRKTYESIGKPLPGRQNIVLTRSADYEADGCDIVHTAPEAIARFGESEEAFVIGGAELFHLFMPYADKMYITRIDHSFEGDTFFPEIREEEWRLIHVEQGVRDEQNPYAYRFEIYEKNK
>AIA15497.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTQPRITLIAAVSENGVIGRDLDMPWKLSTDLKRFKALTMGKPMIMGRKTFESIGKPLPGRETIVLTRDGAFSAEGVHVAHTWEEAVAKGEELAGKAGADAVAVAGGAEIYALALPHVQTLFLTQVHTALEGDAVFPSFDRSQFREVKREDHPQGPDDEHPFTFIDLERRR
>AIA15489.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGNQTPTGARRDPVARERRPEVIGIAAVARNGVIGAGNDIPWRIREDWGRFKAITMGHVLIMGRKTYDSIGRPLPGRTTVVVTRDPAWRADGVIVAADLDSAFDRAFALTPTKVFVAGGGQVYAAAWDRLDTLEITEVDAEPDGDITFPAIGADWHETDRDAREGFAFITFRRQSP
>AIA15341.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKYIIVAYDRNRAIGADNTLPWAGKMKADMARFKQLTTGNAIIMGRKTFESIGRALPSRQNIVLSSKAVDATEVQAVDSLDKAYAAVRPGAETYVIGGGQIYALARDTVDEILATEIDATIDGADAFFPVLGPEWRETSREHHGADENNAYAFDFVSYRRD
>AIA15306.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSDETPTGERPEVVGIAAVARNGVIGAGNDIPWRIREDWARFKEITMGHVLIMGRKTYDSIGRPLPGRTTIVVTRDPTWRADGVIVAPDLDAAFDGAFALGPAKVFVAGGGQVYAEAWGRLDTLEITEVDAEPAGDVIFPAIGSDWHESGRDERDGFAFITFRRLSE
>AIA15230.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVILVAALSSDGFIARAASHGADWTGTADKKIFVKLTKAMGIMVMGSTTFATIGRALPGRRTIVYTSNPQSITAEGVETTTEPPLDLINRLEQRGATGVAICGGAQIYTQFMQAGLIQDFYLTYVPVVFGEGITLFSSPLDVHLDLVTSEPIGEGAVLMHYRLKSLSS
>AIA15161.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIALIVAVDKQGVIGREHMIPWRLRDDLIKLKELTAGRAVILGRKTYDSMLTYYDRSGRPMPGALYIVVTRNRSYKPARDNATVAHSIEDAIEAAENFGDDIMVIGGEQIFTAMLPCAQRIYLTEVQTVAAGDAHFPVIDKKLWWEISREHHSKDVHNDHDYDFVVFERNKS
>AIA15094.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTIEISFVVAIAENNVIGRDGGLPWRLSTDLKRFKALTLGRPVVMGRVCYDSIGKPLPGRPNIVITRNPDFHPEGVIVAHSLEVALEKATAEAKRLGVDEICVIGGGVVYREAMKLATILRVTHIRAKIEGDTFFPEIDPAIWQAGEAEDVPAGEKDDFPTRFVTYRRKTAGV
>AIA15022.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDIAIYVAIAENGVIGRAGGLPWRLSSDLKRLKADTMGKPVIMGRKTYDSIGKPLPGRLNIVVTRNRDWRAEGVEAVRSLDEAVRLAEARARAMPGAGEIVVLGGGMLYAEALPMTDKLYVTHVRARIEGDTTFPEIDPAVWMIVSSLDVPAGEKDDYPTRHVVYRRRSGRR
>AIA15017.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTLGLIWAQSASGVIGMDGAIPWRVPEDSAHFRAVTGNADVVMGRRTWDSLPERFRPLPGRRNIVVTRQAGWNADGAVVADSVDAALRATAGDTWIIGGSELYESTIAKADVLEVSEIDTESRGDTFAPRIDDAWAPVQRDPADGSWHTSRTGIRYRFVRYERLGS
>AIA15009.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRASMPQISLVVAVSDNGMIGQNNQLLWHLSNDLKRFKAITLGKPIIMGRKTYQSIGRPLPGRKNIIVTHQKDLTIAGCEIAQTVEQALALAGDVPEIMVIGGGEIYQLFLPRAQIIHMTQVHTQIAGDTQFVTLDPNAWEEVFREEHAKDPQHEYDYSFVTLRRISPSR
>AIA14958.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKSIVVAYDMERTIGRDNDIPWAGKIPADMRHFKELTEGTSVIMGRNTWDSIPEAYRPLPRRQNIVVSLTQQAFKGALAAQSLEEAFSLAEHEIMVIGGAQIYAQALPLVDRVYATEINTHTEGGDTFFPELPSAEWYVDEAEMHLPEGKNLLPYNFFTYLRHDPLES
>AIA14912.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKPRITLIAAVAENGVIGRDLDMPWKLSSDLKRFKALTMGKPMIMGRKTFLSVGERPLPGRPHIIISRNPDYRPQGVDVVSSLEDALSLAAAKAAELGVDEVFVAGGGEIYRQAMPFADQLSVTHVEVSLEGDTFFPEIDPALFEKIDEVALPAGEKDNYPVRFTTYRRYHAYQ
>AIA14815.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MFYCLTLSIIVAASENNVIGVNNHLPWHLPVDMKYFKDTTMGKPIVMGRKSFEELGKVLPGRPNIMITRQPHYAAEGLHIVPSLEAGIEKAKTFGTEEIFITGGGEIFKMALSIVDRLYMTRVHATVQGDTYFPEFDPTGWKLVKNDRHEKDERHAYAMTFQVWERER
>AIA14814.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQISIIVAVSENGVIGKDNQLLWRLPDDLKRFKQLTLNHPMIMGRKTFDSIGKPLPGRTSIVITRDPNFAFEGVVVVHSLEKALATARDLNVDEAFVIGGGEIYKQVQTLADKLYVTEVKTMIDGDTFFEIENPDAWTETERIVHEADERHKLKFEFVNYIKQKF
>AIA14597.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MTDLRVSALVAMDENRIIGSNNQLPWHIPEDLKRFKELTTGHTVVMGRKTYESIPGKVRPLPNRKNVVVSRTPESLDVPAGVDAISSVKEWLDSCREGTVVLPSPEIWIIGGAQIYEETKSLWDELYLTVVHSTHQGDVYFPRFEDSFELVSQEDRPGYSFMRYKRL
>AIA14580.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
AIVVAFGKNHEIGADNDMPWSNSLKDDLKNFKELTSGSTIVVGRKTFDSFGGRPLANRENIVVTRLNEEIDGALVAHSLDDAYKLATNDDIFIIGGGQVYADSINDMDILYITEVHASFNNATVFFPQIDESLWLEVSREHHAADERNKYDFDFVKYERVSK
>AIA14547.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSIVVAIAENNAIGKDNQLLWHLPKDLKHFKEITSGHTIIMGRKTYESVGKPLPNRRNIIITRQNITIDGCEVVNSIDEALKLCVGEDEIFIVGGAEIYKQAMALTDRIYLTIVHQKFDGDTYFPEIKEDIWNETEREDHESDEKHLFPYSFITLERH
>AIA14428.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIKAFIIAAVTADGFIAKDQNHAAFWTSKEDKARFVELTKKAGVVVMGSQTYKTLPRPLQERVNIVYSRDKNFEGAEVTQDDPYELMRKLEARGFSEVAICGGSQIYSMFMKAKLVDKLYLTIEPLVFGSGITLFKEDMLFDLTLLSHTKTDKHTLLLEYKVNHHGGQSY
>AIA14314.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISAIAAVAENGVIGDKGQLPWHLPDDMKFFQRTTVNHHVITGRKNYESIPERFRPLRDRVNIVVTRAQGYQAPGAWVCASLEAAIDIARVADQKEVFIIGGGQIYAEALEKGLVTRLYLTTVHGKPKGDVKFPDIGKGWKEVWTERHEKDERHAFAFTFKVLQR
>AIA14286.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKVSMIVAMSENRVIGKENQLPWRLPEDLKRFKEITIGHPVIMGRKTFESIGRLLPGRENIVITRQTEFSFPGAVVKSSLEAALSYCERKAEESFIIGGAEIYRLGMPYATRIYLTLIRKSIEGDAYFPTLPSGFEETQRDDRNGDLPFSFLVLERKL
>AIA14249.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVRISIIAALGKNREIGKGSELLWYIPDDLKRFKALTLGHPCVMGRKTFESIVGMLKKPLPGRQNIVITRDPAWQYESVITASSVQDALAKARELDQQEIFVIGGAQIYKAVLPMVDRLYLTRIDASKDADKYFPAYEHIFTKKLAEESREHDGLKYTWVDLER
>AIA14243.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGSLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQMIIVTHSESFAPEGCFSVHSISDAISFARERGESELFVCGGAEIYAQMFGVADRMYLTLVHADSEADTFFPEWDSSEWIEVESEHRTADEKNQYPFTFKVLARKSQV
>AIA14208.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MHISLIAAMTEKSIIGKDNQLPWHIPEDLKYFKQITLGKPVVMGRKTFESMRSKPLPNRHNIILTTDLKFKSETCSVVHSISEAIKVVGQCEEMMVIGGATIYQQFLPLATRLYLSIVHENYDGDTYFPSITWDEWELKKENPGVLFTTKIYERRDSLR
>AIA14187.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MDEKRGIGKDGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQMIIVTRNESFAPEGCFSVHSISDAISFAKERGESELFICGGAEIYAETLGAADRLYLTLVHADCDADTFFPDCNSGEWIETESEHHAADEKNQYSFTFKVLERKHEA
>AIA14134.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGSLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQMIIVTRSESFAPAGCFIAHSISDAINLARERGESELFVCGGAEIYAQMLGVADRMYLTLVHADCDADTFFPDWNSDEWIETESEHHTADEKNQYSFTFKVLERKHVDLLQSPGEH
>AIA14130.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNDEGNVDMSVTLIAAAASNGVIGSNNKLPWRLPAEMAYFKRETLHKPVVMGRKTFESLPKPLSERTNVILSRTMPEAPEGCVLVRSVSEALEKYAGERLMVIGGADVYGQFLPFADRILLTEIDRRIEGDAYFPSFDRAVWKLVSRVPGTQDEKNPLPYAFCVYERADVE
>AIA14092.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MLHCFIIAVETLDGFIAEDKTQISTSWNSKEDKKSFVEITKRAGVVVMGSSTYETFMRPLKDRLNIIYSRSKKFEGVEMTNDLPEILLQKLEARGFKEVAICGGASIYTKFLKAGVVDTLYLTIEPVIFGQGVKFFNENLNLKLSLVSEEKTPSGALFLEYKVLK
>AIA14063.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSEIIGIAAVAVNGVIGADNDIPWRIPADWQRFKALTMGNVLIMGRKTYDSIGRPLPGRTTFVITRDRMWRGGGVHAMPSLDEAFEQALLLAPEIVFVAGGGEIYRAAWNRLTRLEITEVDRAPVGEVRFPTIDPGEWIETGRESYDGYRFVSYRRRSQREPAF
>AIA14043.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MILSAVVAVTEDNAIGKEGGIPWYLPADLAHMRDVTMGHPIIMGRKTHESIGRTLPGRTNIVISRNPAYQVFEGSLLVSSLEEALSKEDIQLEDEVFIFGGQEIYDQAMPQLQRIYLTRVHAKIPADKFFNYHPSQWQQISIEEHKADDKNQYDYDFCVLEKIQP
>AIA13970.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKSGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGRPLPGRVMIIITRSESIAVEGCFIARSVEEAVGLARERGESELFICGGAEIYAETLGAADRMYLTLVHADSEADTFFPEWNSSEWIEVESEHRTADEKNQYPFTFKVLARKSQV
>AIA13966.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MAIIGIVAVDENGAIGKNGSIPWHYSADVKFFKQQTIGHACVMGYKTWLSLKKPLKERLNIVLSRKSEVEPQPNVIVLRDTLSILTLKKFLACDLFIIGGEQIYRSFLPHMDRWIVTQIPVAVEGADTFMPEGYLKNFSPYDSQQLEENLKVTFYE
>AIA13853.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MPETLEAIKEQEQLVEIVDETPKMKLCIVAAIGENRELGKDNHLLWHLAEDMRFFKEVTMRHYVIMGRKSFESIPAKYRPLPDRVNVIISRDPDYMVEECYTCTSLEEGMRLAEENGEQRAFLIGGGQIYKLAMDADMVDEMYITHVHGSFPDAQVYFPEFDETQWRKTAVKSMVADLQNQFSFDIYLYEKLRPELNHQLDGTSEGQIPN
>AIA13571.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MAQESKVSLIAAIATSNRAIGKDGKLLWNLKEDMERFKTLTAGHPVIMGRKTWESIPEKYRPLPGRTNIVITRTRDYAAPGAVLAQTFPEALSLAKDAEGNDEIFAIGGQRVYECALPFASRMYLTLVERDFEGDAFFPSYPDFTKEVACEKKSEGDMHYTFVTLERTES
>AIA13449.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MQQQRVSIIAAIDEKNGLGKNNDLLFKIPGDMQRVRSLTTGHPLVMGRKTFASLGRLLPQRSHVVITRDPSSLETLSFQPEAVVSSLEEALEEVQKYPGAEEIFIFGGGQIFTEAIEKDLVDRLYLTLVKGEYDADTFFPDYSAFTKVITSEEHEEDGYSYMFLDLEK
>AIA13438.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQELVGIAAVARNGVIGSDGDIPWRIREDWQRFKAVTMGSVLIMGRKTYDSIGRPLPGRTTIVVTRDRRWRGDGVRVAPTVDEAFELASSLAPTGTVFVAGGGEIYRESWPRLDRLEITEVDAEPKGNVTLPAISVDDWEETVRDPHEGFAFVSYRRRLR
>AIA13426.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIMPEIMKSKIIGPKIIGIAAVAANGVIGSDNDIPWRISADWQRFKALTMGNVLIMGRKTYDSIGRALPGRTTFVITRDRMWRGNGVRVVSSVDEAIDQAMLLDVQKIFVAGGGEIYRAVWNRLNGLEITEVDQYPRGDVRFPDINPNDWTETGRERHEGYSFVSYRRRSRRESTV
>AIA13384.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPFEDDLMTTTSTPSRNVEGPASNAAEPAPTGAAMRLSIVAAVASNRAIGRDNALLWRLPGDMRHFRETTTGAPVIMGRKTWDSIGRPLPGRRNIVVTRQAGWSAVGAFTAGSLSEAIALASRPGDDVAVSGKAYVIGGAELYAQALPLADEMIITEVDGDFEGDTFFPLWEPQSFDGAARGERLEENGLGYRFVTYRRRR
>AIA13367.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MPWHLPDELKRFKNITMGKVLIMGRKTFESIGRPLPGRYTIVVSRSKEMLPRIVTPATSLESALKHAKEMAANWGNEICVVGGGEIYRQTLDVIQRIYLTRIHQNIDGDTTYPLEALKDFECKESEEVTSSAIPYAATIWDRK
>AIA13335.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTNDPMTNDPMSNDLMTNDPLTPMTISIIVAVSENNVIGKNNDLPWHLPADMKFFKDTTMGHCVVMGRKNFQSIPDKYSPLAGRTNIVVTRQKDFKAEGVITAHSIQEAIQVAKEKNETECFIIGGGEIFAQSLHFCDKIYLTRIHHVIDGDVHFPILNIDEWKELSRKDVPADEKNKFSFSFLTYGRLK
>AIA13308.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIWAQSSSGVIGRDNGIPWHVPEDMVRFKELTIGHTVIMGRLTWESLPAKFRPLPGRRNVVVTRQAGYTAEGAEIVTSLEDAPLDDAWVIGGSQIYGLALPLATRCEVTEVDMDLHREDDDALAPLLDEAWAGTEGPWQDSSSGLRYRYYSYKRI
>AIA13212.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MAIIAIVAVDKNLAIGKGGVIPWHYSADMKFFRRQTTGHACVMGYRTWESLGKPLKGRLNIVLSRKNTVDGQPEVIHFTDINSVLSLAEYLRCDLYVIGGAQIYKAFSERIDRWLVTEVPEPAEGADTFLNADFLSGFTANGVEVLEGGLKVTTYERYDGNSD
>AIA13198.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDMKRFRELTMGHHIIVGRKTFESIGKPLPGREMIIVTRSQSTAREGCFITHSVEEAVSLARERGESELFICGGAEIYAQTLGVADRLYLTLVHADCDADVFFPEWNGDEWVEVESADHTADEKNQYPFTFKVLARKHEA
>AIA13171.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MILSSIAAMAKNRVIGKDNKLPWSIPEDMKFFREKTKGHVMIMGRKTFESLEKPLPNRFHIVITRNQSYDYHDPMVEVVSGMPQALELSHMLLKKFSQRFGDEVFIIGGAEIYKQSMDLINRLYLTVIEKDFEGDAYFPEFDEKELKLVKKEDRSEPIPFSFRVYER
>AIA13159.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQMIIVTRSESFRPEGCLIARSVEDAVRLAEDRGESEAFICGGAEIYAQSLDKADRIYLTLVHADSDADTFFPEYNGDQWIERESEHHDADEKNQYPFTFKLLVKKASLDDRAKDQTA
>AIA13024.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKSIIVAVDKNMGIGAKNDLLWMRDLPDDLAHFKKMTTGASVIMGRNTFDSIGKPLPNRENIVVSHRPVGVDGVLTAADLPSAYQLARYPIFVIGGGRIYADAITDMDRLYVTEVVEEFPQATVFFPAIDKSVWREVSREHHDADERNKYAFDFVVYDRI
>AIA13003.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKPRLVIIAAVSRNGVIGRDGDMPWRLSTDLKRFKALTLGKPMLMGRKTFLSIGKSLPGRTTLVLTRDPAWQAEGVIAVRSVEEALQKIGDAPELCVVGGAEIYALTLPVTDVIHLTRIHASIPGDTRFPALDTSEWRETERVEHPADERHAYAMTFSTLERRRA
>AIA13000.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MKVFLIAAISADGFIARETNEVADWTSKEDKKLFVELTKRAGVMVMGRTTFETIGHALPGRKTIVYTHRDVEIEDVEVTDDAPANLVHRLHTEGYKEVAICGGSAMYTQFMQAGVVDELYLTIEPVLFGSGVPLFAGQLETRMQLIESRSLNDNVVLMHYEVEK
>AIA12974.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKITGLMACDPSGLIGKNGWIPWYYPKEFEHFKLTIGSSPLVMGSKTFESLPENILRDRMSIVFSHNGSNARGHDVTFISSLDEFLTLGIGEEIFMIGGAEVAHLFLKNKMIKKFILTKIKKAYDGDAFLDISLLDGFDKELIEDAPDYAIYRYRALS
>AIA12975.1|FEATURES|farme|sulfonamide|sul3|antibiotic target replacement|1
MIYIAIGSNLGDRHQNLERAIGLLKKRYFPNLHSSKILETEAIVPEGAPSEWSTPYLNMLVWGQCDIEPYELLRALQRIESEIGRPEVRDKWAPRIIDLDIILWDGISMNEPELKIPHHELQNRPFWLQLLKEAMQAKLVGIVNITPDSFSDGGLYNSPINAITRALELAQDGANIIELGAQSTRPGATLIGHRDEIDLLRPVLDGLAGSGINLSVDSFEPEVIDMILRNYDDVKWINDVRGDLSKRTLSVIAEKGLDIVTMHSLAIPADKNICISDAAPPIETIMNWAKLKIEFLMGCGFHLDKIIVDPGIGFSKNPAQDIALLKEAGKLKRLGCRTMIGHSRKSFISSFSYSEAKDRDIETLAISDYLNDKTDYLRVHNIKDHVKFFRARGVVG
>AIA12968.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSAIAAMAQNRVIGKDGTLPWKIPEDFKFFKDKTTGHIMIMGRKTFDSLGGPLPKRLHVVITRQKDYAPEGAIVARSVEHAVELTREILAKKEWPEEVFIIGGGQIYEEMLSKTDRIYLTEIHRTFDGDARFPEFSKNEFSEVERSHRDQPVPFDFVTYERNRR
>AIA12952.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKKISLVVAMSENGVIGHDNKLPWHLPNDLKHFKSLTLGKPIIMGRKTYESIGRPLPDRQNIVVTHQKDFSAPGCEVVHSVEEALKLTQDAPEAMVIGGGEIYRLFLSSANRIYQTIVHTEIQGETTFAAIDKKTWEETAHEEYFQDAKHAYDYSFVTLERRE
>AIA12948.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSFSLIVAMSENGVIGKDNQLPWHLPNDLKHFKALTMGKTIIMGRKTFESIGKVLPGRKNIIISSDTNYTVPDGTVIHNINELIAQDKHDSESEKMIIGGATLYNYFLDKANIIYLTKVHSVIEGDTFFPELSNEWEIAGVEHFEVDPKHEFAYSFITLKKVKL
>AIA12852.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISMVVAAADNNVIGKDNRLLWRLPNDMAFFKNVTWGMPVIMGRKTFQSLGKPLRGRTNIIITANKHFNPGNGVIVANSIAEAVEQAEATDAKECFVIGGGEIYKQSMGKANRIYMTRVHVSPSGDAFFPSINESEWKKISSAPFNADEKHAYSYTFEIWQRK
>AIA12549.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MVALVVAIAENGAIGKGGGLPWRLSSDMRYFRKITMGKPVIMGRRTFKSLPRVLDGRLNIVLTRDRGFVAPDAVMAYSLEEGLAAARASAERTGAGEIMVIGGEDVFREVLPQARRIYLTEVHASPDADTWFSDFDKRGWREVFRERYEAGPRDDHAFSFVVLERT
>AIA12515.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISAIAAVADNGVIGRDNDLPWHLPDDMKYFQRVTMGHPVITGRRNFESIPPKYRPLKGRLNIVVTHDAEYDAPGAAVVTSLDAALDRAKQEPGNEIFVIGGGQIFKEALGSDRIDRLYLTLVHAIIQGDTLFPVIDPMDWVERSREHHEADERHAHPFSFVVLDRRH
>AIA12513.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIISAIVAVAENRVIGRKGDLPWHLPDDLKFFQRTTLGHHVIMGRKNWDSIPLKYRPLKDRVNVVITRQERFDAFGAVVVGSLQEALALARHEGENEAFIIGGGQIFAEAFRMGTIDRIYMTRIHAQVEGDVFFPPLVGDWKEVWHEDHAADARHTYAFTFLRLERSVGKT
>AIA12468.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
MYCNARIIVAALTADGFIGRDSGHLADWTSKEDKQLFVRLTKEAGVLVMGANTYKTIGRPLPGRRNLVYSRSSLDFPGVEVVTEPPQALIARLEREGHTALAVCGGQAIYDMFLQAGVVTELYLTIEPVLFGSGIPLLKAPLAASLALKEFEKLNEHTILLHYEVTN
>AIA12428.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIAAIGKNRELGKDNALLWHIPGELPRFKRITTGHPIIMGRKTFESIGRILPNRTSIIITRDREGFLQMANSKWHIDPKQFIVVTSLEQAIEEAKKVEEKRLAVIASEAKQSHKDKIAAVADSSLAMTKEGEIFIIGGGQIFAQALPLTDKLYLTHVDQAFEADTFFPDYSAFTKVVEKDDHEDGGYRYSFVTLTK
>AIA12430.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
FPLLTTKKVYWKGVIQELYWFMSGQTNIKYLVDNNVHIWDDYPYKIYKQKINVIASKAKQSHKIESSIKDRRVAHAPRDDKSREMTKEEFIEKIKNDAAFAKKWGELPKIYGEMWRSWPTRKGGKIDQLGWVLKELKEDPDARNLLVTSWNPEYLYTMAAHEDASRFPICHNMYQVSQKDGKLYLQLYQRSADLFLGVPFNIASYSLLLLILCKITGYKPGEFVHTFGDAHIYANHIEQVKEQLKRKPKPFPKVVIDKSVKKLADFRPDLVTLEDYDPYPTLKGELTIAGGLYEKSVKSTRNG
>AIA12327.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MTTVGLIWAQSTSGIIGRGGGIPWRLPEDQARFKEITMGRTVVMGRLTWESLPERVRPLPGRKNVVLTRQADYMADGAHVVPTLQDALTDDITWVIGGEQIYSLALPIATRCEVTEVEIDLPRDDGDAVAPVLDESWIGNEGEWLTSAAGLRYRFFSYVRP
>AIA12308.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MQTVIIAALDEERGIGKDNALPWRISEDLKRFKALTMGNPIIMGRKTHQSIGRPLPGRTNIVITRDEGFQAAGCTVVHSLEQAQKAAKAEKAKQVFVIGGAEIYRSSLPEVDRLELTLVDGFYEADAFFPEYEDDFVVTKEESSKDDLHQYRFVTLERKK
>AIA12229.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIVSQLVAMDERRGIGKQGRLPWRLSADLKRFRQLTMGHHIVVGRKTYESIGKPLAGRQMIIVTRDADYKAAGCFTAHSITEAIELARARGEAELFICGGTEVYAQTLDLTERIYLTQVHADCDADTFFPEFNCDDWLETASERHAADEKNEYPFTFLVLVRKRAG
>AIA12221.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIVSLLVAMDEKRGIGKDGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGRPLPGREMIIVTRGESFAPEGCFIARSVEDAILFARDRGESELFICGGAEIYAQTLGAADRIYLTLVHADCDADTFFPECNSDEWVEQASERHSADEKNQHPFTFKVLARK
>AIA12187.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSASSAGETPIVALVVAMGENRAIGRGGDLPWHLRSDMRYFRAITMGKPIVMGRLTFKSLPRVLDGRLNVVLTRDLGFVAPDAVMAHSLEEGLAAARASAARTGAAEIMVIGGEDVFREVLPQTDRIYLTEVHASPDADTWFPELDMSEWREISREAHPAGPKDDHPFSFVVLDRMRKASS
>AIA12137.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSADLKRFKALTMGSAMVMGRKTFESLPGLLPGRRHIVLTSNPSWTANGAEVARDVESALRLAGDDRVSVIGGAEIFSLFMPRADRIELTEVLEDVPGDTFMPDPRAGRDWNISEQSVATTADGLPFRFVTLDKV
>AIA12100.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MPEIIGIAAVAANGVIGTGNDIPWRISADWQRFKALTMGHVLIMGRKTYDSIGRPLPGRTTFVITRDRMWRGKGVRAVPSVSEALDQAVQLDSGIVFVAGGGEIYRAAWDRLTGLEITEVEQYPDGDVTFPEIDPNEWIETARQAGDGYSFVSYRRRSLEQSTV
>AIA12032.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSVAGPLQEGKNLREITIVVARAENGVIGKDGKLPWHLPADLKHFKAVTSGAPMIMGRKTFESLPGLLPGRRHIVITRDPDWQAEGAEVAHSADEALSLAGNDRVSVIGGAEIIRLFEPHATAWELTKLHFDADGNTLLEAPNALWQEISREDHPAEDGRPAYTFVRLERA
>AIA11985.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIIGIVAVDQNGAIGKGGKLPWHYSSDMKFFKETTIGHACVMGYKTWLTLKRPLPNRLNIVMSRQSEIEPQESVIVIRDVESVLSRAENLAGHLFVIGGEQVYRAFLPHIERWLVTEVPLKVEGADTFVPAGYLDGFSETAVKKLEENLVVRTYDRDSLSRVNT
>AIA11940.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNLGKGTGERPVIALVVAIGENGAIGRGGELPWRLSSDMRYFRKVTMGKPVIMGRRTFKSLPRVLDGRLNIVLTRDQGFVAPDAVMAHSLDEGLAAARDSAARTDAGEIMVIGGEDVFREVLPQAHRIYLTEVHASPEADTWFPDFDKREWREVFRERHEAGPRDEHAFSFVVLERTDGP
>AIA11927.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNVFLIAAISADGFIARDAHQPANWTSKEDKKVFVELTKRARVMIMGRNTFETIGRALPGRRNIVYSSKPIDVEGIEVTNEKPTTLLEKLENEGYQEVAICGGQKIYDLFLAEGLVNTLYLTLEPKLFGNGLSIAKTSVDVDLHLKDVSKLNDDTLLLEYEVQNGSNPS
>AIA11889.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MSIIGIVAVDRKGAIGKGGQLPWHYSADMKFFKETTTGHACVMGHKTWLTLKKPLPNRLNIVLSRQSQIEAQELVAVHRNVESVLALSRDLKSDLFVIGGSKIYRAFLPYIEKWIVTEVPLTVEGADTFVPANYLEGFHRVGSKELGEGLVVRYYDRSEA
>AIA11879.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISLIAARSRNGVIGKNNDLPWRLPDDMKYFMTTTRGHHAIMGRKNYDSLPDAYKPLPNRTNIVVTRQRAFHAPGCIVVHDIDHALKLARTHGESETFVIGGAEIYALAMTQANRLYLTEIDAEIQGDTYFPSFDTTQWQEVSRKHHDVDDKHAYAFDFVIYERIA
>AIA11868.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLIAALTRNRVIGANGGIPWRIPEDATWFRQKTKGHPVLMGRKTYDSMGEPLKNRTNIVVTRNREFAPPNVLVAPTIQAGIQMAEGTPGSEELFVIGGQTIYEETLKLADRLYLTHLDVELTGDTFFPDFDTDDWTIIYEEPRPPVATFPHAFKFVIYERT
>AIA11838.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVSLIAALDRGNAIGRDNDLPWRLPDDLKRFKALTLGKPVLMGRKTAQSLGRALPGRRNLVLTRSGAVPFDGMEAVSSVEEALRLAQAGGASELCVIGGGEVYAQTLSAATHLFLTHVETHVEGAEAFFPAFDAKQWRVVSRERHEADAKHAFAFEFVDYERV
>AIA11821.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MISFIVAITKNHVMARDGGLPWHLKTDKEYYRAKANGHIVVMGSTTFEQVGTSITNREIIVLTRDSSYHPDGVTVAHSIQEALPKTDEEVMVLGGGQVFAAALPYADRMYITEIDAELQGDVFFPQFNRDEWREVSREHHRKDADNEYDFDFVVYDRTK
>AIA11816.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPEIIESEIVKPEIIGIAAVAANGVIGASNDIPWRIPADWQRFKALTMGNVLIMGRKTFESIGKPLPGRTSIVVTRNTSVEIEGAMVVHSLEDALAEARKIEASEVFIIGGGELYTQAQHLADRLYVTEVHSAFEGDTYFAIEDPTTWTENKRVHHGTDERHIFPFDFVDYFRQE
>AIA11802.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIVAYSKNHVIGRGGKMPWQGEMPGDAQHFRELSTGKTIIMGRKTYESIGHALPNRQNIVVSLEPFNAPDALVVHSLADAYGAAENEIAIIGGGQIYAAALEDADIVYATEINAEFEDGDTFFPVLSAEWQETAREDHKADEKNRYDYSFITYKKVDR
>AIA11764.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MTNTEQPRVIFIAALDEGRGIGKGGEIPWKIPEDLKRYMRLTTGHPLIVGRTTFEAIGKPLPNRTSIVVTRQEGYTVPEGHFVAHTIEEALQQAQELGDPTIYINGGGDIYRLALPYATDLQLTYVAGKHDADAFFPEFDPGDFKEVWSEDHPDHDPA
>AIA11761.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSVTLIAAVASNGIIGKDNTLIWRLPADQAFFKSQTIGKTVLMGRKTFESLKKPLIDRTNVILSRNLSVAPEGCELVRSISEALEKYSEEELMVIGGADIYAQTIDVADRLILTEIEQPFEGDTSFPDFDRSQWKLVSRTPGVQDERNLLPYSFCIYERE
>AIA11759.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MAIIGIVAVDRNGAIGKGGSIPWHYSADLKFFKEQTTGHACVMGRRTWLSLKRPLKERLNTVLSRSPDAGAGQEGILALPDKRSVLALAPYLSCNLYVIGGEQIYRTFQNEIERWIVTEIPLSVEGADTFMPQDFLRNFKPHRSISLADELKVIFYERTSAYNSED
>AIA11754.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEIVLIVAVADNGVIGRDNAIPWRLKSDLQRFKAITLNKPVVMGRKTFQSLRRPLPGRTNIVMTRDPDYRAADAVVTTSFENARAVAHGDALRRFATEIAVIGGAEIYAQWMASASRLEITEVHTRPKGDTHLAAIDPVAWEEVARVRNPAGPDDSADFSYVTYRRRQQR
>AIA11687.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|1
MKVFIIAAVTADGFIGKDEKHAAFWTSKEDKKRFVELTKRAGVVVMGSNTYATLPRPLKERTNIVYSRSKTFEGAETTQKSPQELILELERREFKEVAICGGASIYTMFMKAKVVDHLYLTVEPLIFGKGIKLFNEELTSQLTLVSAVQGENGSLLIEYKVNNSGSL
>AIA11627.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQMIIVTRSESIAVEGCFIVRSVEAAIGLARERGESELFVCGGAEIYAQTLGLADRLYLTLVHADCAADTFFPEWNSDDWIEMESEPRAADEKNQYSFTFKVLERKHEA
>AIA11607.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MGIAAVGRNRVIGDGQDIPWRISEDWKRFQTLTMGHVLIMGRKTYDSIGRPLPGRTTIVITRDGAWRGDGVQVAPSVEEAFTRAQTLGPATIFVAGGGEIYRAAWNRLDRLEVTEVDQAPEGEITFRRSIRRTGTRRAGNLATGTAS
>AIA11471.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSAKVIAIVAMDEARAIGKGGALPWHIPEDMARFKRLTAGHVVIMGRKTWDSLPQKFRPLPGRTNVVVTRNPATLVVPDGVVVASDPEAAVTEALATAGGERLVWIIGGSELYKSTLPLCHAIDVAHVPGRHDADAFLPPFEADFIPSYEESGEVCRWIRYVRRP
>AIA11407.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSHIVAAAQNGVIGTEGGLPWNIPEDMKFFKDKTKGHAMIMGRKTFESVGHPLPNRLNVVITRQTDFNANGATVVSSLDEAIEVCKQQTAKYGDEVFIIGGGEIYRQSMHIVDRIYLTRIYQDYDGDARYPEVDLDEFKEVSRQERTEPVPFTFLVFERKNRLH
>AIA11390.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDENRGIGIDNKLPWRLPEDLAFFRRTTSGHTVLMGRKTFESIGKPLPKRHNVILTRDAQFQAEGCEVIHSTDDFVHKYGAGAQEELFVIGGAEVYKQLLPYADRLYITEIAHTFHVDTYLESLDLTQWVEVSRVKGLRNEANPYDYDFVLYERKA
>AIA11304.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIVSAIAALSKNRVIGKNNDLPWRLPDDMKFFMETTKGHHVIMGRKNYDSLHAKFKPLPQRTNIVITRQKDLHAPGCIVLHAVEPGLEIARKNSETECFIIGGAEIYKLAMPYTTRLYLTEIDADIDGDTFFPEIDRKQWKEVARRHHPADAKHAHAFDIVTYDRVS
>AIA11212.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIAALSKNRVIGKNNDLPWKLPDDMKFFMEKTKGHHTIMGRKNYDSIPLKFKPLPQRTNIVVTRQKKFQAPGCIVVDSLENGLAIAQDNDEPETFIIGGAEIYKLGLPHANRLYLTEIDAEIDGDTFFPAVDRNQWKEISRLHHATDSRHAFAFDFVIYEKK
>AIA10894.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MAAITADGFIGKDASHLADWSSPEDKKLFVSLTKQAGTMVMGSKTFDTIGRALPGRRTIVYTTHPEKYQGLGVVATSEDPAKLVGRLAQEGCEDLAIVGGAQIYDQFLRAGLVDELYLTIEPVLFGKGINLLANSIETGLELKDTQKLNDNTILLHYAVKN
>AIA10610.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
GFPLLTLRKIPVKMFVAEQIWFVSGARKPADFLRDYTKIWDIFTNPADVVTVAYGYRWRKHFGRDQLGALVKLLKADPTSRHGVIVTWDPAGDGLGGTTRKNVPCPYTFTVNIIGGRLHFHNIVRSNDMVLGFPSDVAGFALLQLMLAQKLGVKPGMYSHSISNAHIYDNQYDAVKEMLKRKNTHKPIHAELPRNAFDRAEKKDAKLVQQIVSTFSSQYEPQEAIKGLQIVL
>AIA10606.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTAAVPARPEIVIIVAAAENGVIGRDNTIPWKLKADQQRLKAMTMGKPIVMGRKTFESLRRPLPGRTNIVITRDASYRAPGAIVTNSFENALVIARGDALRRGAPEIAILGGVDIYTRALPITDRLEITEVHARVDGDTRFPPIDPALWQETGRTRHAAGPDDTADYSYVTYCRQQPN
>AIA10570.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKTKISLIVAMSENRVIGKENSIPWHIPGELPRFKRITSGHPIIMGRKTFESIGRPLPQRLNIVITRDQAYTLEGAVVVHSLAEALEEAKLYYVAGSKYQENESKISLEPHPDPLLKGEGNDTFGEVFIIGGGQIFKDAMSLADKLYLTIIHKTIEGDTYFPEYPEFTKEVFREEHEHDGYRYTFLELER
>AIA10527.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTLPLILVVAIAENGVIGRDNHLLWRIKTDMGRFRRLTMGKPMIMGRKTFQSIGKPLPGRETIVLTRDEGFAAEGAHVAHTLEEAVAKGEELAARIGADAIAVVGGAEIYALALPQVQTLFLTEVHTAPEGDAVFPSFDRSQFREMKREDHLKGPG
>AIA10519.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MARNRVIGARNTIPWRLPGEQQTFKSITMGHHIIMGRNTWESIGRLLPGRTTVIVTRRPGYQVAGAIVAPSLEDAITACGGDEEIFVIGGAQLYAAALPLADRIYLTTVDADVQGDTLMPEFDLSEWRESSSQVFNADAKNQYDYGLAVYDRT
>AIA19306.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVSLIVAASQNNVIGKDGKIPWFVRGEQKRFKELTMGHPIIMGRKTHESTGRTLPGRLNVVISSNPNFKPFEGSVLVSSLQAALDLSEVKSAEEVFIIGGQQVFTEAMPLADRLYLTKIHTTVDGDKFFEYDPNDWRLVSSEFHKRDEVPDRPFDFEICLYERRR
>AIA19290.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MRIVLLAAVAENGVIGRDGDLPWRLSTDLKRFKANTMGKPIVMGRKTWESFPKRPLPGRLNIVITRNAGYRAEGAEVVGSLDDALKLARVRSRCDGAEEICIVGGGEIYRQAMPLADCLKITHVLTEVEGDTSFPAIDAEPWREVSSEPFEAGEKDSHRTRYAVYERRREP
>AIA19287.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MKISLIVATAENGVIGKDGKIPWFVRGEQARFKAITMGHPIIMGRNTHQSIGRTLPGRLNIVISSDPNLQLSEGSRLAHSFEEAVSMAEDSGAEEVFVIGGERVFKDAQPLADKLYLTKVHTEVEGDTFFQFDPKQWKMISCELFKKNEVPDRPFDFEVCLYERTSS
>AIA19259.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTISLVVAASENNVIGKNNGLPWTLPDDMKFFKNTTWGLPVIMGRKTFESMDNKALPGRINIIITRQKDYKAKDCVVVQSWNDAMFVAQETDCNEICVIGGGEIFKETITKADIIYLTRVHTVVDGDVFFPEIDEKKWKKASSREHAADEKHNFAFTFEKWERV
>AIA19186.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MHTFLIAAISLDGFIAEKTDQISTSWTSKEDKKFFSERTKQAGVIVMGSSTYKTIGRPLPGRLNVVYSKNSTFEFKDPSEGFVTDLEPKELLKKLQSEGQEEVAICGGAAIYSMFMKAGLIDTLYVTIEPVVFGSGVKLFSDDIKTSLQLMKAEKMGENAMLLEY
>AIA19185.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTISIIVAVSRNNVIGKEGDLPWRLPADLAHFKKITMGHPILMGQVTYDSIGRPLPGRKNIVITKDKNFKAEGCKIAYSINEALSLAKGFDEVFIIGGDSIYKQTIDLADKLYVTQVHAHVDGDRTFVFDKKKWRKVSSITHKVDANNALEFDWQEWVRK
>AIA19176.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MEEKLEIVVAADLDNGIGKDNGLPWRIPGDMKFFQSLTSNATEGGINAIIVGRKTWESIPEKRRPLKNRINIILTKNTAITAPDGVLVCNSLESALEALQGIEHQRCFIIGGAQIYKEALQHPLMTTIHLTRIMQEFDCDAHFPPIDDRFALAAVSDTMEENEIEYRFQRYEKKSAL
>AIA19173.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIALIAAVSKNGVIGNKGKLPWKLSTDLKRFAELTRGRPVIMGRKTFESIMAQLGKPLPGRKNIVLTRETSLAVPPEVHVVHSVEEAIKITDGEGEVFVIGGEAVYRSFFPHADRLYLTEVQTECEGDARFPEWDRTDWALRMGTRYFKKDDMDDFDFVFLEYVRKPIPHPH
>AIA19138.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISLIAARSRNGVIGKNNDLPWSLPDDSKYFMVTTRGHHAIMGRKNYDSLPDAYKPLPNRTNIVVTRQRAFSAPGCIVVHNIDDALNLARTRGESEAFVIGGAEIYTLALANANRLYLTEIEADVEGDTYFPSFDKTQWKEVSRKHHDADQRHTYAFDFVVYERIA
>AIA19126.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNTTKEVRSEGQTGQYDKEIILSLLVATDENNVIGKDNKLPWHLPNDLKYFKNLTWAMPILMGRKTFDSIGKPLPGRKSIVITRSSEWKHDGVEVVHSIEEAIASAKQAGVKEIFVIGGAEIFKTSFNQAFRIYRTLIHHAFEGDVYFPEIREEEWQLVSKRYCNTDEKNLFAHTFQVWERK
>AIA19053.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MNVFLIAAITLDGFIAEETSQVSTSWTSPEDKKWFNERTKKAKVIVMGSSTYKTIGRPLPGRLTIVMTRSSIPEATSNSTELRTFQGDPGELIDMLEKEGYEEVAICGGAQIYTQFLKARIINKTLSDS
>AIA19052.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRISAVVAMSEDRVIGKDNHLLWHLPADLKHFKTITMGKPILMGRKTHQSIGRVLPGRCNVVLTHDVNFQACGCVVAHSIETALAAVEYSDEVFVIGGAVLYQEMLPKIQRIYMTIVHHPFVGDAYFPETSPGDWYEADRAFYPADEKNNYDFSFLTLDRK
>AIA19044.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|1
MEILLYYQCMHTFLIAAISLDGFIAEKTDQISTSWTSKEDKKFFSERTKQAGVIVMGSSTYKTIGRPLPGRVNVVYSKSSQFEFKDENEGFVTDLAPADLLKKLERDGHDEVAICGGAMIYSMFMKAGLIDTLYLTIEPVLFGEGIKLFKDDISARLQLVNSSKMGENAVLLEYKLNK
>AIA19043.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
RKLKPMIIGIVAVDRNLAIGKGGQLPWHYSADMKFFKATTTGNAVVMGRRTWLTLKGPLKDRQNIVLSRSGDVSNHDSVMVMKDVEAVLEFARTIDQHLFVMGGAHVYESFLPYVERWVVTEIPLNVEGADTFMPANFLDGFEMYEMRQLDEGLRVKFYERV
>AIA19037.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
VAKNGVIGSNNSLPWYIPEDLRRFKALTTGKTVLMGKNTFDSIVNRIGKPLPNRKNIVLSRKTDLELPPDVQLVNNLESILKSDEPEIMVIGGGQLYNQIINDADKLHITHVHEDIDGDVMFPEVDWSQWKKTFEEPHGKFTFADYERI
>AIA19035.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKKGTDIDMKKKGAVISAIAAFGKNRALGKDNDLLWHIPDDLKRFKELTSGHPVIMGRKTWESLPEKFRPLPGRTNVVVTRQVGYAADGAIVVDGLSDAFLTAQDTPGAEETFIIGGAQIYAEALPYTTRLYLTVIDDGKEADVFFPEYETEFTKIISNESREWNGLKYRWVTLER
>AIA19033.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIIFVVAASENNALGKDNDLPWHLPDDFKRFKMLTAGHHIIMGRKTFESLPGKLPNRTHIIITRQKDYHPEGCIVVSSLEQALAAIPENEDAFIIGGGEIFKMAMPVADKIELTRVHANIEADAFFPEIDPAQWKLDFEEFHPKDERHAFDFTFQTFIRK
>AIA19032.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISMIVAASKNDVIGRDNKLPWHLPDDMKYFRDLTKGKTVIMGRKTYESIWHPLPNRRNIIISSTLKNVKDCEVFPTLGDALQALLHEKKSDEVFIIGGSRLFAEAIMEIMSDLRAHRLYLTRIHANIEGDIVLPDINCKHWKKISEKEHPKDKDHAYDFTFEVYERD
>AIA19010.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGRKTFESMKSKPLPGRKNIVITRQPGWNAEGVSVVDSVDAAASLAEQLNYKEIFIIGGGMIYLIAFDRANKIYMTRVHTDLEGDTYFPVIEKNDWSLVSKTENPADEKHAYAFSFQLWERKSM
>AIA19001.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MSIIGIVAIAKNLAIGKNGKLPWHYSADLKFFKQTTLNNTIVMGWNTWKEIGGKPLPKRLNVILSRSKNLENQPSLILLRNKQEVLALKNYLKGDLFLIGGAQTFADFSDVIDKWIVTEIPESPADADTFMPANFLEDFEMKEIVSLAEDLNAKIYERK
>AIA18990.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVRGEVEKDNDLLFKIPEDFQHMKNLTKGHPIIMGRRTFESIGRILPNRYNIIITRDPDFEFPGLSGDRGTIVNSLEAAITAAKRAPGSEEIIIFGGGQIFTEAVEKGLVDVLHLTVVDGDYGADTFFPEYEKQFSKVLSSEEGQSGEYHFKFLDLGK
>AIA18965.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIILGPVAIARNNVIGKNNELPWYIPEDLKHFKELTTGHTVIMGRKTYESIIARLGKPLPNRRSVVITSNTEYPVAEGVVKYTNLEEAIAAEDGPDKQVFLIGGQRIFAEGLQFANTIYTTEIHKDFDGDIYFPEFDK
>NP_415449.1|FEATURES|CARD|multidrug|ompF|reduced permeability to antibiotic|0
MMKRNILAVIVPALLVAGTANAAEIYNKDGNKVDLYGKAVGLHYFSKGNGENSYGGNGDM
TYARLGFKGETQINSDLTGYGQWEYNFQGNNSEGADAQTGNKTRLAFAGLKYADVGSFDY
GRNYGVVYDALGYTDMLPEFGGDTAYSDDFFVGRVGGVATYRNSNFFGLVDGLNFAVQYL
GKNERDTARRSNGDGVGGSISYEYEGFGIVGAYGAADRTNLQEAQPLGNGKKAEQWATGL
KYDANNIYLAANYGETRNATPITNKFTNTSGFANKTQDVLLVAQYQFDFGLRPSIAYTKS
KAKDVEGIGDVDLVNYFEVGATYYFNKNMSTYVDYIINQIDSDNKLGVGSDDTVAVGIVY
QF
>AAB57788.1|FEATURES|CARD|rifampin|rphB|reduced permeability to antibiotic|0
MKKSLIALTLAALPVAATADVTLYGAIKAGVQTYRSVEHTKGKVSKVETGSEIADFGSKI
GFKGQEDLGNGLKAVWQLEQGASVAGTNTGWGNKQSFVGLKGGFGTIRAGSLNSPLKNTG
ANVNAWESGKFTGNVLEISGMAQREHRYLSVRYDSPEFAGFSGSVQYAPKDNSGSNGESY
HVGLNYRNNGFFAQYAGLFQRYGEGTKKIEYEHQVYSIPSLFVEKLQVHRLVGGYDNNAL
YVSVAAQQQDAKLYGARRANSHNSQTEVAATAAYRFGNVTPRVSYAHGFKGTVDSADHDN
TYDQVVVGAEYDFSKRTSALVSAGWLQEGKGADKIVSTASAVVLRHKF
>YP_001844878|FEATURES|ARDB_deepARG|beta_lactam|oprD|resistance by absence|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATLAVLISAAIISSAQASEQSEA
KGFVEDANGSILFRTGYLTRDKKQGAKDTSSVAQSAIVSIESGFTPGIVGFGVGVVGDGS
FKIGENKNAGNQMIPKHNDGSAYDHWARGGGSVKARFSNTTVRYGTQVLDLPVLASNTGR
MVPEYFTGTLLTSHEIKNLEVVAGKFTKDQMSDQINTDADASGRGLDRAIVWGAKYKFND
NLNASYYGLDSKNALERHYANVNFKQPLANDSSLTYDFSGYHTKFDANAHTYSATGTVAP
NYAADGIAGEEKTNNIWAISGTYATGPHSVMLAYQQNTGNVGYDYGQNADGFQSIYLPNS
YMSDFIGNHEKSAQIQYNVDFGKLGVLPGLNWTTAFVYGWDIKVRNVTDDAQEREFFNQV
KYTVQSGFAKDASLRIRNSYYRASDAYQGAYIGDTNEWRIFLDIPVKLF